| 1 | [Clinical aspects on the therapy of cerebral sclerosis]. (Hoffmeister K) Med Klin 1967 Jun 09;62(23):910-2 1 Citation |
| 1 | Single dose amoxicillin (S) treatment of uncomplicated urinary tract infections (UTI) as effective as conventional therapy (C) (Ingelfinger JR, Avner ED, Tolkoff-Rubin NE) Pediatric Research 1981;15(4 II) 6 Citations |
| 1 | Single-dose amoxicillin therapy of uncomplicated pediatric urinary tract infections. (Avner ED, Ingelfinger JR, Herrin JT, Link DA, Marcus E, Tolkoff-Rubin NE, Russell-Getz L, Rubin RH) J Pediatr 1983 Apr;102(4):623-7 32 Citations |
| 1 | Assessment of the contributions of autoregulatory mechanisms to the antihypertensive actions of beta-adrenergic therapy. (Cowley AW Jr) Hypertension 1984;6(2 Pt 1):137-9 5 Citations |
| 1 | Evaluation of lithium therapy for alcoholism. (Fawcett J, Clark DC, Gibbons RD, Aagesen CA, Pisani VD, Tilkin JM, Sellers D, Stutzman D) J Clin Psychiatry 1984 Dec;45(12):494-9 41 Citations |
| 1 | Chemotherapy administration to the elderly patient (Longo WL, Carbone PP) Clinics in Oncology 1985;4(3):473-484 2 Citations |
| 1 | An infant fatality following verapamil therapy for supraventricular tachycardia: cardiovascular collapse following intravenous verapamil. (Garland JS, Berens RJ, Losek JD, Wilson AD) Pediatr Emerg Care 1985 Dec;1(4):198-200 24 Citations |
| 1 | Renal failure and dialysis therapy in children with hepatic failure in the perioperative period of orthotopic liver transplantation. (Ellis D, Avner ED) Clin Nephrol 1986 Jun;25(6):295-303 23 Citations |
| 1 | Intensive combination chemotherapy and interferons in the management of chronic myelogenous leukemia. (Kantarjian HM, Talpaz M, Kurzrock R, Keating MJ, McCredie KB, Gutterman J, Freireich EJ) Acta Haematol 1987;78 Suppl 1:70-4 8 Citations |
| 1 | Osteonecrosis, fractures, and protrusio acetabuli secondary to x-irradiation therapy for prostatic carcinoma. (Csuka M, Brewer BJ, Lynch KL, McCarty DJ) J Rheumatol 1987 Feb;14(1):165-70 28 Citations |
| 1 | A double-blind, placebo-controlled trial of lithium carbonate therapy for alcoholism. (Fawcett J, Clark DC, Aagesen CA, Pisani VD, Tilkin JM, Sellers D, McGuire M, Gibbons RD) Arch Gen Psychiatry 1987 Mar;44(3):248-56 97 Citations |
| 1 | Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator. (Owen J, Friedman KD, Grossman BA, Wilkins C, Berke AD, Powers ER) J Clin Invest 1987 Jun;79(6):1642-7 45 Citations |
| 1 | Lymphomatoid granulomatosis associated with a carotid sinus fistula: response to cytotoxic therapy. (Rosenthal AK, Rowe JM) Am J Med 1987 Aug;83(2):381-2 1 Citation |
| 1 | Cimetidine therapy of herpes simplex virus infections in immunocompromised patients. (Kurzrock R, Auber M, Mavligit GM) Clin Exp Dermatol 1987 Sep;12(5):326-31 26 Citations |
| 1 | Therapy of chronic myelogenous leukemia with recombinant interferon-gamma. (Kurzrock R, Talpaz M, Kantarjian H, Walters R, Saks S, Trujillo JM, Gutterman JU) Blood 1987 Oct;70(4):943-7 85 Citations |
| 1 | Recent advances in the therapy of chronic myelogenous leukemia. (Talpaz M, Kurzrock R, Kantarjian HM, Gutterman JU) Important Adv Oncol 1988:297-321 14 Citations |
| 1 | Therapy of chronic myelogenous leukemia: chemotherapy and interferons. (Talpaz M, Kantarjian HM, Kurzrock R, Gutterman J) Semin Hematol 1988 Jan;25(1):62-73 68 Citations |
| 1 | A role for photodynamic therapy in autologous bone marrow transplantation (Sieber F) Proceedings of SPIE - The International Society for Optical Engineering 19 February 1988;847:148-152 1 Citation |
| 1 | Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity. (Owen J, Friedman KD, Grossman BA, Wilkins C, Berke AD, Powers ER) Blood 1988 Aug;72(2):616-20 207 Citations |
| 1 | Herpes simplex virus infections and cimetidine therapy. (Cohen PR, Kurzrock R) J Am Acad Dermatol 1988 Oct;19(4):762-3 8 Citations |
| 1 | Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapy. (Shtalrid M, Talpaz M, Blick M, Romero P, Kantarjian H, Taylor K, Trujillo J, Schachner J, Gutterman JU, Kurzrock R) J Clin Oncol 1988 Oct;6(10):1569-75 42 Citations |
| 1 | Therapy of chronic myelogenous leukaemia with interferons. (Talpaz M, Kurzrock R, Kantarjian H, Gutterman J) Cancer Surv 1989;8(4):793-8 5 Citations |
| 1 | Does lithium carbonate therapy for alcoholism deter relapse drinking? (Clark DC, Fawcett J) Recent Dev Alcohol 1989;7:315-28 15 Citations |
| 1 | Photodynamic therapy and bone marrow transplantation. (Sieber F, Krueger GJ) Semin Hematol 1989 Jan;26(1):35-9 22 Citations |
| 1 | Therapy of chronic myelogenous leukemia with interferon. (Kurzrock R, Gutterman JU, Kantarjian H, Talpaz M) Cancer Invest 1989;7(1):83-91 6 Citations |
| 1 | An evaluation of early cyclosporine versus ALG therapy for primary cadaver renal allografts with immediate function. (Adams MB, Johnson CP, Roza AM) Transplant Proc 1989 Feb;21(1 Pt 2):1606-8 2 Citations |
| 1 | Dexamethasone therapy for bacterial meningitis. () N Engl J Med 1989 Feb 16;320(7):463-5 6 Citations |
| 1 | Interventions in the therapy of electromechanical dissociation. (Vanags B, Thakur RK, Stueven HA, Aufderheide T, Tresch DD) Resuscitation 1989 Apr;17(2):163-71 18 Citations |
| 1 | A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. (Horbar JD, Soll RF, Sutherland JM, Kotagal U, Philip AG, Kessler DL, Little GA, Edwards WH, Vidyasagar D, Raju TN) N Engl J Med 1989 Apr 13;320(15):959-65 162 Citations |
| 1 | Therapy using reproductive hormones. () Vet Rec 1989 Apr 29;124(17):471 |
| 1 | Recombinant interferon-alpha therapy of Philadelphia chromosome-negative myeloproliferative disorders with thrombocytosis. (Talpaz M, Kurzrock R, Kantarjian H, O'Brien S, Gutterman JU) Am J Med 1989 May;86(5):554-8 36 Citations |
| 1 | Transplant or chemotherapy in acute myelogenous leukaemia. International Bone Marrow Transplant Registry. () Lancet 1989 May 20;1(8647):1119-22 59 Citations |
| 1 | Corticosteroids as adjunctive therapy in bacterial meningitis. A meta-analysis of clinical trials. (Havens PL, Wendelberger KJ, Hoffman GM, Lee MB, Chusid MJ) Am J Dis Child 1989 Sep;143(9):1051-5 54 Citations |
| 1 | Small cell undifferentiated carcinoma of the maxillary sinus: technical considerations for radiation therapy. (Janjan NA, Campbell B, Wilson JF, Zellmer D) Med Dosim 1989 Dec;14(4):273-6 7 Citations |
| 1 | Treatment of acute myelogenous leukemia with chemotherapy and hematopoietic growth factors (Estey E, McCredie K, Keating MJ, Kantarjian HM, Kurzrock R, Talpaz M, Gutterman JU, Deisseroth AB) Cancer Bulletin 1990;42(3):156-161 3 Citations |
| 1 | Electroconvulsive therapy and fluoxetine (Harsch HH, Haddox JD) Convulsive Therapy 1990;6(3):250-251 22 Citations |
| 1 | Electroconvulsive Therapy and Fluoxetine. (Harsch HH, Haddox JD) Convuls Ther 1990;6(3):250-251 |
| 2 | Bilateral peripheral corneal edema after cefaclor therapy. (Platt LW) Arch Ophthalmol 1990 Feb;108(2):175 4 Citations |
| 1 | Radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: a review of recent techniques. (Janjan NA, Campbell B, Wilson JF, Toohill R) Cancer Treat Rev 1990 Mar;17(1):89-101 2 Citations |
| 1 | Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable B-cell neoplasms: a report of two pilot clinical trials and laboratory investigations. (Robins HI, Longo WL, Steeves RA, Cohen JD, Schmitt CL, Neville AJ, O'Keefe S, Lagoni R, Riggs C) Int J Radiat Oncol Biol Phys 1990 Apr;18(4):909-20 29 Citations |
| 1 | The characteristics and mechanisms of visual disturbance associated with anticonvulsant therapy. (Remler BF, Leigh RJ, Osorio I, Tomsak RL) Neurology 1990 May;40(5):791-6 43 Citations |
| 1 | Effects of problem-solving therapy on outcomes of parent training for single-parent families (Pfiffner LJ, Jouriles EN, Brown MM, Etscheidt MA, Kelly JA) Child and Family Behavior Therapy 5 May 1990;12(1):1-11 33 Citations |
| 1 | Fludarabine therapy in macroglobulinemic lymphoma. (Kantarjian HM, Alexanian R, Koller CA, Kurzrock R, Keating MJ) Blood 1990 May 15;75(10):1928-31 90 Citations |
| 1 | Radiation therapy in the treatment of cervical cancer: the University of Chicago/Michael Reese Hospital experience. (Rader JS, Haraf DJ, Halpern HJ, Rotmensch J, Spelbring DR, Sutton H, Javaheri G, Weichselbaum RR) J Surg Oncol 1990 Jul;44(3):157-65 14 Citations |
| 1 | Photodynamic therapy and bone marrow transplantation (Sieber F) Proceedings of SPIE - The International Society for Optical Engineering 21 July 1990;10306:209-218 3 Citations |
| 1 | Meningism in a ten-month-old infant during OKT3 therapy. (Rizzo JD, Rowe SA) J Heart Transplant 1990;9(6):727-8 2 Citations |
| 1 | Chronic therapy for congestive heart failure with benazepril HCl, a new angiotensin converting enzyme inhibitor. (Mirvis DM, Insel J, Boland MJ, Cinquegrani MP, Ghali JK, Rubin SA, Shanes J, DeSilva J, Whalen JJ) Am J Med Sci 1990 Dec;300(6):354-60 5 Citations |
| 1 | Atrial fibrillation, cardioversion, and electroconvulsive therapy (Harsch HH) Convulsive Therapy 1991;7(2):139-142 7 Citations |
| 1 | Atrial Fibrillation, Cardioversion, and Electroconvulsive Therapy. (Harsch HH) Convuls Ther 1991;7(2):139-142 |
| 1 | Concomitant adjuvant chemotherapy and radiotherapy for high risk breast cancer patients. (Hansen R, Erickson B, Komaki R, Janjan N, Cox J, Wilson JF, Anderson T) Breast Cancer Res Treat 1991;17(3):171-7 1 Citation |
| 1 | Cytokines in tumor therapy. Interleukin-3. (Kurzrock R, Estrov Z, Talpaz M, Gutterman JU) Am J Clin Oncol 1991;14 Suppl 1:S45-50 8 Citations |
| 1 | Bone remodelling after growth factor and cyclosporine A therapy for aplastic anemia. (Derfus BA, Csuka ME, Carrera GF, Hanson GA, Smith RE) J Rheumatol 1991 May;18(5):738-42 4 Citations |
| 1 | Evaluating new therapy for acute myeloid leukemia. (Keating A, Horowitz MM) Semin Hematol 1991 Jul;28(3 Suppl 4):70-1 |
| 1 | Does more intensive therapy increase cures in acute leukemia? (Gale RP, Butturini A, Horowitz MM) Semin Hematol 1991 Jul;28(3 Suppl 4):93-4 2 Citations |
| 1 | Foscarnet therapy of ganciclovir-resistant cytomegalovirus in marrow transplantation. (Drobyski WR, Knox KK, Carrigan DR, Ash RC) Transplantation 1991 Jul;52(1):155-7 41 Citations |
| 1 | Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. (Horowitz MM, Messerer D, Hoelzer D, Gale RP, Neiss A, Atkinson K, Barrett AJ, Büchner T, Freund M, Heil G) Ann Intern Med 1991 Jul 01;115(1):13-8 143 Citations |
| 1 | Preoperative chemoradiotherapy for adenocarcinoma of the pancreas. Rationale and technique. (Evans DB, Byrd DR, Mansfield PF) Am J Clin Oncol 1991 Aug;14(4):359-64 17 Citations |
| 1 | Osteoblastoma response to chemotherapy. (Camitta B, Wells R, Segura A, Unni KK, Murray K, Dunn D) Cancer 1991 Sep 01;68(5):999-1003 27 Citations |
| 1 | Use of amiodarone for short-term and adjuvant therapy in young patients. (Pongiglione G, Strasburger JF, Deal BJ, Benson DW Jr) Am J Cardiol 1991 Sep 01;68(6):603-8 44 Citations |
| 1 | Interferon alpha in the therapy of CML. (Talpaz M, Kantarjian H, Kurzrock R, Gutterman JU) Br J Haematol 1991 Oct;79 Suppl 1:38-41 14 Citations |
| 1 | Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia. (Schilling PJ, Kurzrock R, Kantarjian H, Gutterman JU, Talpaz M) Cancer 1991 Oct 01;68(7):1536-7 116 Citations |
| 1 | A phase II study alternating alpha-2a-interferon and gamma-interferon therapy in patients with chronic myelogenous leukemia. (Talpaz M, Kurzrock R, Kantarjian H, Rothberg J, Saks S, Evans L, Gutterman JU) Cancer 1991 Nov 15;68(10):2125-30 24 Citations |
| 1 | Pyrexial therapy in subcutaneous phycomycosis (Reddy BSN, Sourianarayanane A, Garg BR, Ratnakar C) Indian Journal of Dermatology, Venereology and Leprology 1992;58(3):192-194 |
| 1 | Therapy decisions in leukemia. (Atkinson KA, Horowitz MM, Sobocinski KA, Rimm AA, Bortin MM, Gale RP) Bone Marrow Transplant 1992 Jan;9(1):5-10 8 Citations |
| 1 | Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. (Laramore GE, Scott CB, al-Sarraf M, Haselow RE, Ervin TJ, Wheeler R, Jacobs JR, Schuller DE, Gahbauer RA, Schwade JG) Int J Radiat Oncol Biol Phys 1992;23(4):705-13 369 Citations |
| 1 | Bone marrow hypoplasia and aplasia complicating interferon therapy for chronic myelogenous leukemia. (Talpaz M, Kantarjian H, Kurzrock R, Gutterman JU) Cancer 1992 Jan 15;69(2):410-2 27 Citations |
| 1 | Feasibility of prehospital r-TPA therapy in chest pain patients. (Aufderheide TP, Haselow WC, Hendley GE, Robinson NA, Armaganian L, Hargarten KM, Olson DW, Valley VT, Stueven HA) Ann Emerg Med 1992 Apr;21(4):379-83 29 Citations |
| 1 | Reproducibility of electrophysiologic testing during antiarrhythmic therapy for ventricular arrhythmias secondary to coronary artery disease. (Ferrick KJ, Luce J, Miller S, Mercando AD, Kim SG, Roth JA, Fisher JD) Am J Cardiol 1992 May 15;69(16):1296-9 17 Citations |
| 1 | Treatment of recurrent metastatic medulloblastoma with intensive chemotherapy and allogeneic bone marrow transplantation. (Lundberg JH, Weissman DE, Beatty PA, Ash RC) J Neurooncol 1992 Jun;13(2):151-5 21 Citations |
| 1 | Radiation therapy in a case of systemic mastocytosis: evaluation of histamine levels and mucosal effects. (Janjan NA, Conway P, Lundberg J, Derfus G) Am J Clin Oncol 1992 Aug;15(4):337-9 12 Citations |
| 1 | Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. (Biggs JC, Horowitz MM, Gale RP, Ash RC, Atkinson K, Helbig W, Jacobsen N, Phillips GL, Rimm AA, Ringdén O) Blood 1992 Aug 15;80(4):1090-3 187 Citations |
| 1 | Toward gene therapy for Niemann-Pick disease (NPD): separation of retrovirally corrected and noncorrected NPD fibroblasts using a novel fluorescent sphingomyelin. (Dinur T, Schuchman EH, Fibach E, Dagan A, Suchi M, Desnick RJ, Gatt S) Hum Gene Ther 1992 Dec;3(6):633-9 15 Citations |
| 1 | Growth factor inhibitory molecules: A novel therapy of leukaemia (Estrov Z, Kurzrock R, Talpaz M) Interferons and Cytokines 1993(24):22-25 |
| 1 | Brachytherapy: More versatile, more important for local control (Erickson B, Janjan N, Wilson JF) IM - Internal Medicine 1993;14(5):33-46 1 Citation |
| 1 | No-suicide decisions and suicide contracts in therapy. (Clark DC, Kerkhof AJ) Crisis 1993;14(3):98-9 7 Citations |
| 1 | Phototherapy, photochemotherapy, and bone marrow transplantation. (Sieber F) J Hematother 1993;2(1):43-62 22 Citations |
| 1 | Prospective randomized comparison of quadruple vs triple therapy for first cadaver transplants with immediate function. (Johnson CP, Slakey DP, Callaluce RD, Browne BJ, Roza AM, Adams MB) Transplant Proc 1993 Feb;25(1 Pt 1):585-6 7 Citations |
| 2 | Enhancement of merocyanine 540-mediated phototherapy by salicylate. (Anderson MS, Kalyanaraman B, Feix JB) Cancer Res 1993 Feb 15;53(4):806-9 10 Citations |
| 3 | Hyperbaric oxygen therapy and squamous cell carcinoma cell line growth. (Sklizovic D, Sanger JR, Kindwall EP, Fink JG, Grunert BK, Campbell BH) Head Neck 1993;15(3):236-40 17 Citations |
| 1 | Intraoperative radiation therapy following pancreaticoduodenectomy. (Evans DB, Termuhlen PM, Byrd DR, Ames FC, Ochran TG, Rich TA) Ann Surg 1993 Jul;218(1):54-60 52 Citations |
| 1 | Role of interleukin-1 inhibitory molecules in therapy of acute and chronic myelogenous leukemia. (Estrov Z, Kurzrock R, Talpaz M) Leuk Lymphoma 1993 Aug;10(6):407-18 18 Citations |
| 1 | Osseointegrated dental implants as alternative therapy to bridge construction or orthodontics in young patients: seven years of clinical experience. (Ledermann PD, Hassell TM, Hefti AF) Pediatr Dent 1993;15(5):327-33 57 Citations |
| 1 | A prospective randomized comparison of quadruple versus triple therapy for first cadaver transplants with immediate function. (Slakey DP, Johnson CP, Callaluce RD, Browne BJ, Zhu YR, Roza AM, Adams MB) Transplantation 1993 Oct;56(4):827-31 36 Citations |
| 3 | The role of photodynamic therapy in posterior fossa brain tumors. A preclinical study in a canine glioma model. (Whelan HT, Schmidt MH, Segura AD, McAuliffe TL, Bajic DM, Murray KJ, Moulder JE, Strother DR, Thomas JP, Meyer GA) J Neurosurg 1993 Oct;79(4):562-8 52 Citations |
| 1 | Nasopharyngeal brachytherapy. (Erickson BA, Wilson JF) Am J Clin Oncol 1993 Oct;16(5):424-43 14 Citations |
| 2 | Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. (Drobyski WR, Keever CA, Roth MS, Koethe S, Hanson G, McFadden P, Gottschall JL, Ash RC, van Tuinen P, Horowitz MM) Blood 1993 Oct 15;82(8):2310-8 337 Citations |
| 1 | Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma. (Ajani JA, Mayer RJ, Ota DM, Steele GD, Evans D, Roh M, Sugarbaker DJ, Dumas P, Gray C, Vena DA) J Natl Cancer Inst 1993 Nov 17;85(22):1839-44 124 Citations |
| 1 | Influence of left ventricular function on survival and mode of death after implantable defibrillator therapy (Cleveland Clinic Foundation and Montefiore Medical Center experience). (Kim SG, Maloney JD, Pinski SL, Choue CW, Ferrick KJ, Roth JA, Gross J, Brodman R, Furman S, Fisher JD) Am J Cardiol 1993 Dec 01;72(17):1263-7 34 Citations |
| 1 | Delayed cardiac allograft rejection due to combined cyclosporine and antioxidant therapy. (Slakey DP, Roza AM, Pieper GM, Johnson CP, Adams MB) Transplantation 1993 Dec;56(6):1305-9 35 Citations |
| 1 | Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the intergroup study 0034 and the Radiation Therapy Oncology Group head and neck database. (Laramore GE, Scott CB, Schuller DE, Haselow RE, Ervin TJ, Wheeler R, al-Sarraf M, Gahbauer RA, Jacobs JR, Schwade JG) Int J Radiat Oncol Biol Phys 1993 Dec 01;27(5):1011-6 31 Citations |
| 1 | A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy. (Goodnough LT, Price TH, Friedman KD, Johnston M, Ciavarella D, Khan N, Sacher R, Vogler WR, Wissel M, Abels RI) Transfusion 1994 Jan;34(1):66-71 117 Citations |
| 1 | Adjuvant radiotherapy and chemotherapy for biliary and pancreatic cancer. (Rich TA, Evans DB, Curley SA, Ajani JA) Ann Oncol 1994;5 Suppl 3:75-80 25 Citations |
| 1 | “Ciprofloxacin/Vancomycin as Initial Empiric Therapy in Febrile Neutropenic Leukemia/Lymphoma Patients with Indwelling Venous Access Devices. Preliminary Results of an Effective Regimen with Reduced Hospital Stay” (Harvey, W, Moskowitz, M) Proc ASCO: Vol 13, p471 |
| 1 | Central nervous system Whipple's disease: relapse during therapy with trimethoprim-sulfamethoxazole and remission with cefixime. (Cooper GS, Blades EW, Remler BF, Salata RA, Bennert KW, Jacobs GH) Gastroenterology 1994 Mar;106(3):782-6 76 Citations |
| 2 | Photodynamic therapy. (Kaye AH, Hill JS) J Neurosurg 1994 Apr;80(4):774-5 |
| 1 | DNA ploidy and P-glycoprotein expression as predictive factors of response to neoadjuvant chemotherapy for invasive bladder cancer. (Sandlow J, Cohen MB, Robinson RA, Dreicer R, Williams RD) Urology 1994 Jun;43(6):787-91 16 Citations |
| 1 | Comparison of defibrillator therapy and other therapeutic modalities for sustained ventricular tachycardia or ventricular fibrillation associated with coronary artery disease. (Choue CW, Kim SG, Fisher JD, Roth JA, Ferrick KJ, Brodman R, Frame R, Gross J, Furman S) Am J Cardiol 1994 Jun 01;73(15):1075-9 20 Citations |
| 1 | The interleukin-8 receptor: a potential target for antipsoriatic therapy? (Kemény L, Kenderessy AS, Olasz E, Michel G, Ruzicka T, Farkas B, Dobozy A) Eur J Pharmacol 1994 Jun 13;258(3):269-72 23 Citations |
| 1 | [Pain assessment and therapy in bronchial carcinoma]. (Radbruch L, Zech D, Grond S, Jung H, Meuser T) Chirurg 1994 Aug;65(8):696-701 4 Citations |
| 1 | Erythropoietin response to anaemia is not altered by surgery or recombinant human erythropoietin therapy. (Goodnough LT, Price TH, Parvin CA, Friedman KD, Vogler WR, Khan N, Sacher R, Johnston M, Wissel M, Ciavarella D) Br J Haematol 1994 Aug;87(4):695-9 35 Citations |
| 1 | 2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disorders. (O'Brien S, Kurzrock R, Duvic M, Kantarjian H, Stass S, Robertson LE, Estey E, Pierce S, Keating MJ) Blood 1994 Aug 01;84(3):733-8 68 Citations |
| 1 | Comparison of chemotherapy and bone marrow transplants using two independent clinical databases. (Messerer D, Neiss A, Horowitz MM, Hoelzer D, Gale RP) J Clin Epidemiol 1994 Oct;47(10):1119-26 3 Citations |
| 1 | Pancreatitis associated with brain tumor therapy. (Margolis DA, Werlin SL, Murray KJ, Strother DR) Am J Pediatr Hematol Oncol 1994 Nov;16(4):301-4 2 Citations |
| 1 | Clostridium difficile toxin A therapy for HCT 116 human colon cancer in nude mice. (Redlich PN, Kushnaryov VM, Hernandez I, Grossberg SE) J Surg Oncol 1994 Nov;57(3):191-5 3 Citations |
| 1 | Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. (Barrett AJ, Horowitz MM, Pollock BH, Zhang MJ, Bortin MM, Buchanan GR, Camitta BM, Ochs J, Graham-Pole J, Rowlings PA) N Engl J Med 1994 Nov 10;331(19):1253-8 213 Citations |
| 1 | Preoperative chemoradiotherapy, pancreaticoduodenectomy, and external- beam intraoperative radiotherapy for pancreatic adenocarcinoma: The M.D. Anderson experience (Leach SD, Rich TA, Abbruzzese JL, Lee JE, Cleary KR, Katz RL, Charnsangavej C, Ames FC, Buchholz DJ, Fenoglio CJ, Stanford P, Evans DB) Cancer Bulletin 1994;46(6):518-524 3 Citations |
| 1 | Absence of immunohistochemical metallothionein staining in bladder tumor specimens predicts response to neoadjuvant cisplatin, methotrexate and vinblastine chemotherapy. (Bahnson RR, Becich M, Ernstoff MS, Sandlow J, Cohen MB, Williams RD) J Urol 1994 Dec;152(6 Pt 2):2272-5 38 Citations |
| 1 | Interleukin-1 and its inhibitors: implications for disease biology and therapy. (Estrov Z, Kurzrock R, Talpaz M) Cancer Treat Res 1995;80:51-82 10 Citations |
| 1 | Cisplatin, 5-fluorouracil, and leucovorin in the therapy of adenocarcinomas of the pancreas (Jones DV, Sugarman SM, Markowitz AB, Levin B, Abbruzzese JL, Evans DB, Charnsangavej C, Smith R, Patt YZ) Oncology Reports 1995;2(6):1121-1123 |
| 1 | Preoperative combined modality therapy for pancreatic cancer. (Rich TA, Evans DB) World J Surg 1995;19(2):264-9 31 Citations |
| 1 | Pacemakers and electrical therapy during advanced cardiac life support. (Aufderheide TP) Respir Care 1995 Apr;40(4):364-76; discussion 376-9 |
| 1 | Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy. (Gordon KB, Tajuddin A, Guitart J, Kuzel TM, Eramo LR, VonRoenn J) Cancer 1995 Apr 15;75(8):2169-73 155 Citations |
| 1 | Expression of deletion-containing dystrophins in mdx muscle: implications for gene therapy and dystrophin function. (Fritz JD, Danko I, Roberds SL, Campbell KP, Latendresse JS, Wolff JA) Pediatr Res 1995 Jun;37(6):693-700 10 Citations |
| 1 | Reproducibility of electrophysiological testing during antiarrhythmic therapy for ventricular arrhythmias unrelated to coronary artery disease. (Ferrick KJ, Maher M, Roth JA, Kim SG, Fisher JD) Pacing Clin Electrophysiol 1995 Jul;18(7):1395-400 6 Citations |
| 1 | Gel-entrapment bioartificial liver therapy in galactosamine hepatitis. (Sielaff TD, Hu MY, Amiot B, Rollins MD, Rao S, McGuire B, Bloomer JR, Hu WS, Cerra FB) J Surg Res 1995 Jul;59(1):179-84 76 Citations |
| 1 | Primary squamous cell carcinoma of the breast: sensitivity to cisplatinum-based chemotherapy. (Dejager D, Redlich PN, Dayer AM, Davis HL, Komorowski RA) J Surg Oncol 1995 Jul;59(3):199-203 67 Citations |
| 1 | Effect of season and climate on choice of therapy for breast cancer in older women. (Goodwin JS, Nattinger AB) J Am Geriatr Soc 1995 Sep;43(9):962-6 2 Citations |
| 1 | Adjuncts to antibacterial therapy. (Frank MO, Mandell GL) Infect Dis Clin North Am 1995 Sep;9(3):769-81 6 Citations |
| 1 | Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working Committee. (Zhang MJ, Hoelzer D, Horowitz MM, Gale RP, Messerer D, Klein JP, Löffler H, Sobocinski KA, Thiel E, Weisdorf DJ) Ann Intern Med 1995 Sep 15;123(6):428-31 92 Citations |
| 1 | Potentiation of merocyanine 540-mediated photodynamic therapy by salicylate and related drugs. (Traul DL, Anderson GS, Bilitz JM, Krieg M, Sieber F) Photochem Photobiol 1995 Oct;62(4):790-9 7 Citations |
| 1 | Interferon-alpha therapy for chronic myelogenous leukemia. (Wetzler M, Kantarjian H, Kurzrock R, Talpaz M) Am J Med 1995 Oct;99(4):402-11 54 Citations |
| 1 | Physico-chemical modeling of the role of free radicals in photodynamic therapy. III. Interactions of stable free radicals with excited photosensitizers studied by kinetic ESR spectroscopy. (Kriska T, Korecz L, Nemes I, Gál D) Biochem Biophys Res Commun 1995 Oct 04;215(1):192-8 20 Citations |
| 2 | Treatment of localized prostate cancer in African-American compared with Caucasian men. Less use of aggressive therapy for comparable disease. (Schapira MM, McAuliffe TL, Nattinger AB) Med Care 1995 Nov;33(11):1079-88 65 Citations |
| 1 | Cone-beam CT for radiotherapy applications. (Cho PS, Johnson RH, Griffin TW) Phys Med Biol 1995 Nov;40(11):1863-83 154 Citations |
| 1 | Erratum: Combined modality therapy for cutaneous T-cell lymphoma (Journal of the American Academy of Dermatology (1996) 34 (1022-1029)) (Duvic M, Lemak NA, Redman JR, Eifel PJ, Tucker SL, Cabanillas FF, Kurzrock R) Journal of the American Academy of Dermatology 1996;35(4):587 1 Citation |
| 1 | Vascular resection and intraoperative radiation therapy during pancreaticoduodenectomy: rationale and technique. (Evans DB, Lee JE, Leach SD, Fuhrman GM, Cusack JC Jr, Rich TA) Adv Surg 1996;29:235-62 21 Citations |
| 1 | Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. (Staley CA, Lee JE, Cleary KR, Abbruzzese JL, Fenoglio CJ, Rich TA, Evans DB) Am J Surg 1996 Jan;171(1):118-24; discussion 124-5 225 Citations |
| 1 | Patterns of recurrence following hysterectomy and radiation for cervical carcinoma: Relationship to residual disease and brachytherapy techniques (Lattanzi J, Erickson B) International Journal of Gynecological Cancer 1996;6(5):396-404 1 Citation |
| 1 | Chemotherapy versus transplants for acute myelogenous leukemia in second remission. (Gale RP, Horowitz MM, Rees JK, Gray RG, Oken MM, Estey EH, Kim KM, Zhang MJ, Ash RC, Atkinson K, Champlin RE, Dicke KA, Gajewski JL, Goldman JM, Helbig W, Henslee-Downey PS, Hinterberger W, Jacobsen N, Keating A, Klein JP, Marmont AM, Prentice HG, Reiffers J, Rimm AA, Bortin MM) Leukemia 1996 Jan;10(1):13-9 65 Citations |
| 1 | Demonstration of a brachytherapy boost dose-response relationship in glioblastoma multiforme: headed in the right direction. (Schultz CJ) Int J Radiat Oncol Biol Phys 1996 Apr 01;35(1):187-8 |
| 1 | Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia. (Heimpel H, Allan NC, Baccarani M, Guilhot F, Hehlmann R, Horowitz M, Kluin-Nelemans J, Schaefer U, Storb R, Thaler J) Bone Marrow Transplant 1996 May;17 Suppl 3:S39 1 Citation |
| 1 | Comparison of elderly and younger patients with out-of-hospital chest pain. Clinical characteristics, acute myocardial infarction, therapy, and outcomes. (Tresch DD, Brady WJ, Aufderheide TP, Lawrence SW, Williams KJ) Arch Intern Med 1996 May 27;156(10):1089-93 62 Citations |
| 1 | MR of recurrent high-grade astrocytomas after intralesional immunotherapy. (Smith MM, Thompson JE, Castillo M, Cush S, Mukherji SK, Miller CH, Quattrocchi KB) AJNR Am J Neuroradiol 1996;17(6):1065-71 43 Citations |
| 1 | Combined modality therapy for cutaneous T-cell lymphoma. (Duvic M, Lemak NA, Redman JR, Eifel PJ, Tucker SL, Cabanillas FF, Kurzrock R) J Am Acad Dermatol 1996 Jun;34(6):1022-9 81 Citations |
| 1 | In vivo experimental studies on the role of free radicals in photodynamic therapy. II. Photodynamic effect on free radical concentration in mice tumors measured by ESR spectroscopy. (Kriska T, Mal'tseva E, Gál D) Biochem Biophys Res Commun 1996 Jun 05;223(1):136-40 12 Citations |
| 2 | Tolerance to propofol generally does not develop in pediatric patients undergoing radiation therapy. (Setlock MA, Palmisano BW, Berens RJ, Rosner DR, Troshynski TJ, Murray KJ) Anesthesiology 1996 Jul;85(1):207-9 28 Citations |
| 1 | Resolution of a soft-tissue sarcoma in a patient with rheumatoid arthritis after discontinuation of azathioprine therapy. (Csuka ME, Hanson GA) Arch Intern Med 1996 Jul 22;156(14):1573-6 5 Citations |
| 1 | Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. (Lazarus CL, Logemann JA, Pauloski BR, Colangelo LA, Kahrilas PJ, Mittal BB, Pierce M) Laryngoscope 1996 Sep;106(9 Pt 1):1157-66 243 Citations |
| 1 | Recombinant human interferon-beta (rHuIFN-beta) and radiation therapy for inoperable non-small cell lung cancer. (Byhardt RW, Vaickus L, Witt PL, Chang AY, McAuliffe T, Wilson JF, Lawton CA, Breitmeyer J, Alger ME, Borden EC) J Interferon Cytokine Res 1996 Nov;16(11):891-902 13 Citations |
| 1 | Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy. (Parilla BV, Strasburger JF, Socol ML) Am J Perinatol 1996 Nov;13(8):483-6 82 Citations |
| 1 | HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission. (Gale RP, Büchner T, Zhang MJ, Heinecke A, Champlin RE, Dicke KA, Gluckman E, Good RA, Gratwohl A, Herzig RH, Keating A, Klein JP, Marmont AM, Prentice HG, Rowlings PA, Sobocinski KA, Speck B, Weiner RS, Horowitz MM) Leukemia 1996 Nov;10(11):1687-91 37 Citations |
| 1 | Gene therapy for fabry disease: Expression, secretion and uptake of a-galactosidase a (α-gal A) driven by a high titer recombinant retroviral vector (Medin JA, Tudor M, Simovitch R, Quirk JM, Tacobson S, Murray GJ, Brady RO) FASEB Journal 1996;10(6) |
| 1 | Effect of prior interferon therapy on outcome of hla-identical sibling bone marrow transplants for chronic myelogenous leukemia (CML) in first chronic phase (Horowitz MM, Giralt R Szvdlo S, Goldman J, Veum-Slone J) Experimental Hematology 1996;24(9):1143 5 Citations |
| 1 | Foreword: Brachytherapy in cancer management (Brady LW, Wilson JF, Erickson B, Micaily B) Seminars in Surgical Oncology 1997;13(3):155-156 |
| 1 | Intraarterial O6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea. (Kurpad SN, Dolan ME, McLendon RE, Archer GE, Moschel RC, Pegg AE, Bigner DD, Friedman HS) Cancer Chemother Pharmacol 1997;39(4):307-16 30 Citations |
| 1 | Selection of retrovirally transduced cells to enhance the efficiency of gene therapy. (Medin JA, Karlsson S) Proc Assoc Am Physicians 1997 Mar;109(2):111-9 11 Citations |
| 1 | Viral vectors for gene therapy of hematopoietic cells. (Medin JA, Karlsson S) Immunotechnology 1997 Mar;3(1):3-19 21 Citations |
| 1 | Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy. (Gordon KB, Chan LS, Woodley DT) Br J Dermatol 1997 Mar;136(3):415-20 62 Citations |
| 1 | Failure of aggressive therapy to alter outcome in pediatric near-drowning. (Spack L, Gedeit R, Splaingard M, Havens PL) Pediatr Emerg Care 1997 Apr;13(2):98-102 41 Citations |
| 1 | In vivo experimental studies on the role of free radicals in photodynamic therapy. III. Photodynamic effect on free radicals generated in cell cultures. (Gál D, Kriska T, Maltseva E) Biochem Biophys Res Commun 1997 Apr 07;233(1):173-6 15 Citations |
| 1 | Gene therapy of chronic myelogenous leukemia by use of antisense technology. (Shi Q, and Lu L.) Journal of Fujian Medical University 31 (4): 458-460. |
| 1 | Changes in body water compartments with diuretic therapy in infants with chronic lung disease. (Segar JL, Chemtob S, Bell EF) Early Hum Dev 1997 Apr 25;48(1-2):99-107 15 Citations |
| 1 | High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. (Antman KH, Rowlings PA, Vaughan WP, Pelz CJ, Fay JW, Fields KK, Freytes CO, Gale RP, Hillner BE, Holland HK, Kennedy MJ, Klein JP, Lazarus HM, McCarthy PL Jr, Saez R, Spitzer G, Stadtmauer EA, Williams SF, Wolff S, Sobocinski KA, Armitage JO, Horowitz MM) J Clin Oncol 1997 May;15(5):1870-9 309 Citations |
| 1 | Multimodality therapy for adenocarcinoma of the pancreas: The M.D. Anderson experience (Evans DB, Pisters PWT, Lee JE) Problems in General Surgery June 1997;14(2):117-124 2 Citations |
| 1 | The M.D. Anderson Cancer Center experience with interferon-alpha therapy in chronic myelogenous leukaemia. (Talpaz M, Kantarjian HM, O'Brien S, Kurzrock R) Baillieres Clin Haematol 1997 Jun;10(2):291-305 13 Citations |
| 1 | Treatment of multiple lesions of Bowen disease with isotretinoin and interferon alfa. Efficacy of combination chemotherapy. (Gordon KB, Roenigk HH, Gendleman M) Arch Dermatol 1997 Jun;133(6):691-3 21 Citations |
| 1 | Impact of peripherally inserted central catheters on phlebitic complications of peripheral intravenous therapy in spinal cord injury patients. (Paz-Fumagalli R, Miller YA, Russell BA, Crain MR, Beres RA, Mewissen MW) J Spinal Cord Med 1997 Jul;20(3):341-4 14 Citations |
| 1 | The medical therapy of cardioinhibitory syncope in pediatric patients. (Deal BJ, Strieper M, Scagliotti D, Hulse E, Auld D, Campbell R, Strasburger JF, Benson DW Jr) Pacing Clin Electrophysiol 1997 Jul;20(7):1759-61 32 Citations |
| 1 | Age-related changes in male gonadal function--implications for therapy (Maas, D., Jochen, A., Lalnde, B.) Drugs and Aging Drugs & Aging 11, 45-60 (1997) |
| 1 | Clinical indications for brachytherapy. (Erickson B, Wilson JF) J Surg Oncol 1997 Jul;65(3):218-27 19 Citations |
| 1 | Estrogen-progestin replacement therapy and endometrial cancer. (Pike MC, Peters RK, Cozen W, Probst-Hensch NM, Felix JC, Wan PC, Mack TM) J Natl Cancer Inst 1997 Aug 06;89(15):1110-6 289 Citations |
| 1 | Comparison of cryotherapy and laser photocoagulation in stage III retinopathy of prematurity. (Yang CM, Chen MS, Tsou Yau KI, Teng RJ) J Formos Med Assoc 1997 Sep;96(9):734-9 3 Citations |
| 1 | Results of limited initial periodontal therapy in smokers and non-smokers. (Pucher JJ, Shibley O, Dentino AR, Ciancio SG) J Periodontol 1997 Sep;68(9):851-6 29 Citations |
| 1 | Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy. (Zhang MJ, Baccarani M, Gale RP, McGlave PB, Atkinson K, Champlin RE, Dicke KA, Giralt S, Gluckman E, Goldman JM, Klein JP, Herzig RH, Masaoka T, O'Reilly RJ, Rozman C, Rowlings PA, Sobocinski KA, Speck B, Zwaan FE, Horowitz MM) Br J Haematol 1997 Oct;99(1):23-9 6 Citations |
| 1 | Lack of effect of growth hormone therapy on the count and density of melanocytic naevi in children. (Zvulunov A, Wyatt DT, Laud PW, Esterly NB) Br J Dermatol 1997 Oct;137(4):545-8 35 Citations |
| 3 | Adoptive immunotherapy for leukemia: donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction. HGTRI 0103. (Link CJ Jr, Burt RK, Traynor AE, Drobyski WR, Seregina T, Levy JP, Gordon L, Rosen ST, Burns WH, Camitta B, Casper J, Horowitz M, Juckett M, Lawton C, Margolis D, Pietryga D, Rowlings P, Taylor C, Furtado M, Stefka J, Gupta-Burt S, Kaiser H, Vesole DH) Hum Gene Ther 1998 Jan 01;9(1):115-34 37 Citations |
| 2 | Planned postradiotherapy neck dissection in patients with advanced head and neck cancer. (Boyd TS, Harari PM, Tannehill SP, Voytovich MC, Hartig GK, Ford CN, Foote RL, Campbell BH, Schultz CJ) Head Neck 1998 Mar;20(2):132-7 102 Citations |
| 1 | Use of a microsnare to aid direct thrombolytic therapy of dural sinus thrombosis. (Bagley LJ, Hurst RW, Galetta S, Teener J, Sinson GP) AJR Am J Roentgenol 1998 Mar;170(3):784-6 39 Citations |
| 1 | Successful treatment of transient acquired factor X deficiency by plasmapheresis with concomitant intravenous immunoglobulin and steroid therapy. (Smith SV, Liles DK, White GC 2nd, Brecher ME) Am J Hematol 1998 Mar;57(3):245-52 31 Citations |
| 1 | Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation. (Chen CS, Seidel K, Armitage JO, Fay JW, Appelbaum FR, Horowitz MM, Shpall EJ, Weiden PL, Antman KS, Champlin RE, Kersey JH, Sullivan KM) Biol Blood Marrow Transplant 1997 Dec;3(6):331-40 19 Citations |
| 1 | Group psychotherapy for persons with HIV and AIDS-related illnesses. (Kelly JA) Int J Group Psychother 1998 Apr;48(2):143-62 27 Citations |
| 1 | The effect of inhaled nitric oxide therapy on bleeding time and platelet aggregation in neonates. (George TN, Johnson KJ, Bates JN, Segar JL) J Pediatr 1998 Apr;132(4):731-4 90 Citations |
| 1 | Differential quantitative effects of interleukin (IL)-2 and IL-15 on cytotoxic activity and proliferation by lymphocytes from patients receiving in vivo IL-2 therapy. (de Jong JL, Farner NL, Javorsky BR, Lindstrom MJ, Hank JA, Sondel PM) Clin Cancer Res 1998 May;4(5):1287-96 11 Citations |
| 1 | Reversible parkinsonism in a child after bone marrow transplantation and lipid-based amphotericin B therapy. (Manley TJ, Chusid MJ, Rand SD, Wells D, Margolis DA) Pediatr Infect Dis J 1998 May;17(5):433-4 10 Citations |
| 1 | GM-CSF can improve the cytogenetic response obtained with interferon-alpha therapy in patients with chronic myelogenous leukemia. (Cortes J, Kantarjian H, O'Brien S, Kurzrock R, Keating M, Talpaz M) Leukemia 1998 Jun;12(6):860-4 51 Citations |
| 1 | Anticoagulation therapy in patients with venous thromboembolic disease. (Whittle J, Johnson P, Localio AR) J Gen Intern Med 1998 Jun;13(6):373-8 8 Citations |
| 1 | Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission. (Oh H, Gale RP, Zhang MJ, Passweg JR, Ino T, Murakami H, Ohno R, Rowlings PA, Sobocinski KA, Tanimoto M, Tomonaga M, Weisdorf DJ, Horowitz MM) Bone Marrow Transplant 1998 Aug;22(3):253-7 43 Citations |
| 1 | Initial therapy for chronic myelogenous leukemia: playing the odds. (Lee SJ, Anasetti C, Horowitz MM, Antin JH) J Clin Oncol 1998 Sep;16(9):2897-903 29 Citations |
| 1 | Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission. (Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR) Leuk Res 1998 Nov;22(11):973-81 14 Citations |
| 1 | Gene therapy and pancreatic cancer. (Pearson AS, Bouvet M, Evans DB, Roth JA) Front Biosci 1998 Nov 01;3:E230-7 25 Citations |
| 1 | Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. (Pisters PW, Abbruzzese JL, Janjan NA, Cleary KR, Charnsangavej C, Goswitz MS, Rich TA, Raijman I, Wolff RA, Lenzi R, Lee JE, Evans DB) J Clin Oncol 1998 Dec;16(12):3843-50 229 Citations |
| 1 | Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]. (Bouvet M, Bold RJ, Lee J, Evans DB, Abbruzzese JL, Chiao PJ, McConkey DJ, Chandra J, Chada S, Fang B, Roth JA) Ann Surg Oncol 1998 Dec;5(8):681-8 119 Citations |
| 1 | Cellular Pathophysiology of Polycystic Kidney Disease: Insights into Future Therapy (Avner ED) Japanese Journal of Nephrology January 1999;41(3):233-235 |
| 2 | Physico-chemical modeling of the role of free radicals in photodynamic therapy. IV. Quantitative aspects of photodynamic effects on free radicals generated in cell cultures. (Németh A, Jakus J, Kriska T, Keszler A, Vanyur R, Gál D) Biochem Biophys Res Commun 1999 Feb 16;255(2):360-6 11 Citations |
| 1 | Low grade glioma: a measuring radiographic response to radiotherapy. (Bauman G, Pahapill P, Macdonald D, Fisher B, Leighton C, Cairncross G) Can J Neurol Sci 1999 Feb;26(1):18-22 57 Citations |
| 1 | RAS and leukemia: from basic mechanisms to gene-directed therapy. (Beaupre DM, Kurzrock R) J Clin Oncol 1999 Mar;17(3):1071-9 167 Citations |
| 1 | Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. (Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS) N Engl J Med 1999 Mar 11;340(10):764-71 1141 Citations |
| 1 | Down-regulation of bcl-2 is a potential marker of the efficacy of progestin therapy in the treatment of endometrial hyperplasia. (Amezcua CA, Zheng W, Muderspach LI, Felix JC) Gynecol Oncol 1999 Apr;73(1):126-36 36 Citations |
| 1 | The American brachytherapy society survey of brachytherapy practice for carcinoma of the cervix in the United States. (Nag S, Orton C, Young D, Erickson B) Gynecol Oncol 1999 Apr;73(1):111-8 81 Citations |
| 1 | Irreversible glomerular lesions induced by crystal precipitation in a renal transplant after foscarnet therapy for cytomegalovirus infection. (Justrabo E, Zanetta G, Martin L, Assem M, Mousson C, Maurice-Estepa L, Rifle G, Tanter Y) Histopathology 1999 Apr;34(4):365-9 18 Citations |
| 1 | In vivo gene therapy with interleukin-12 inhibits primary vascular tumor growth and induces apoptosis in a mouse model. (Wang C, Quevedo ME, Lannutti BJ, Gordon KB, Guo D, Sun W, Paller AS) J Invest Dermatol 1999 May;112(5):775-81 32 Citations |
| 1 | Long-term survivors of childhood cancer: the late effects of therapy. (Schwartz CL) Oncologist 1999;4(1):45-54 156 Citations |
| 1 | Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience. (McClure MW, Berkowitz SD, Sparapani R, Tuttle R, Kleiman NS, Berdan LG, Lincoff AM, Deckers J, Diaz R, Karsch KR, Gretler D, Kitt M, Simoons M, Topol EJ, Califf RM, Harrington RA) Circulation 1999 Jun 08;99(22):2892-900 152 Citations |
| 1 | A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial. (Garland JS, Alex CP, Pauly TH, Whitehead VL, Brand J, Winston JF, Samuels DP, McAuliffe TL) Pediatrics 1999 Jul;104(1 Pt 1):91-9 144 Citations |
| 3 | T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation. (Drobyski WR, Hessner MJ, Klein JP, Kabler-Babbitt C, Vesole DH, Margolis DA, Keever-Taylor CA) Blood 1999 Jul 15;94(2):434-41 78 Citations |
| 1 | Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission. (Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR) Leuk Res 1999 Aug;23(8):709-18 13 Citations |
| 1 | Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase. (Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR) Leuk Res 1999 Sep;23(9):817-26 8 Citations |
| 1 | Pentostatin therapy of T-cell lymphomas with cutaneous manifestations. (Kurzrock R, Pilat S, Duvic M) J Clin Oncol 1999 Oct;17(10):3117-21 92 Citations |
| 1 | Cryotherapy extends the indications for treatment of colorectal liver metastases. (Wallace JR, Christians KK, Pitt HA, Quebbeman EJ) Surgery 1999 Oct;126(4):766-72; discussion 772-4 59 Citations |
| 1 | Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. (Rowlings PA, Williams SF, Antman KH, Fields KK, Fay JW, Reed E, Pelz CJ, Klein JP, Sobocinski KA, Kennedy MJ, Freytes CO, McCarthy PL Jr, Herzig RH, Stadtmauer EA, Lazarus HM, Pecora AL, Bitran JD, Wolff SN, Gale RP, Armitage JO, Vaughan WP, Spitzer G, Horowitz MM) JAMA 1999 Oct 13;282(14):1335-43 67 Citations |
| 1 | A multicentered clinical study of serum as adjuvant therapy for surgical treatment of macular holes. Vitrectomy for Macular Hole Study Group. (Banker AS, Freeman WR, Azen SP, Lai MY) Arch Ophthalmol 1999 Nov;117(11):1499-502 58 Citations |
| 1 | Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. (Ajani JA, Mansfield PF, Lynch PM, Pisters PW, Feig B, Dumas P, Evans DB, Raijman I, Hargraves K, Curley S, Ota DM) J Clin Oncol 1999 Aug;17(8):2403-11 91 Citations |
| 1 | A pilot study of recombinant human interleukin-4 therapy of myelofibrosis. (Giles FJ, Keating AR, Kurzrock R, Talpaz M) J Interferon Cytokine Res 1999 Nov;19(11):1253-5 4 Citations |
| 1 | Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy. (Johnson BD, Becker EE, LaBelle JL, Truitt RL) J Immunol 1999 Dec 15;163(12):6479-87 63 Citations |
| 1 | Endovascular therapy of iliac arteries: routine application of intraluminal stents does not improve clinical patency. (Cambria RA, Farooq MM, Mewissen MW, Freischlag JA, Seabrook GR, Crain MR, Goldblatt MI, Paz-Fumagalli R, Towne JB) Ann Vasc Surg 1999 Nov;13(6):599-605 19 Citations |
| 1 | A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404. (Prados MD, Scott C, Sandler H, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ Jr) Int J Radiat Oncol Biol Phys 1999 Dec 01;45(5):1109-15 74 Citations |
| 1 | Sleep disturbances associated with attention deficit hyperactivity disorder: The impact of psychiatric comorbidity and pharmacotherapy (Mick E, Biederman J, Jetton J, Faraone SV) Journal of Child and Adolescent Psychopharmacology 2000;10(3):223-231 126 Citations |
| 1 | Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registry. (Giralt S, Szydlo R, Goldman JM, Veum-Stone J, Biggs JC, Herzig RH, Klein JP, McGlave PB, Schiller G, Gale RP, Rowlings PA, Horowitz MM) Blood 2000 Jan 15;95(2):410-5 28 Citations |
| 1 | Antidepressant therapy for unexplained symptoms and symptom syndromes. (O'Malley PG, Jackson JL, Santoro J, Tomkins G, Balden E, Kroenke K) J Fam Pract 1999 Dec;48(12):980-90 299 Citations |
| 1 | Complications of minocycline therapy for acne vulgaris: case reports and review of the literature. (Somech R, Arav-Boger R, Assia A, Spirer Z, Jurgenson U) Pediatr Dermatol 1999;16(6):469-72 37 Citations |
| 1 | Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. (Alexander JH, Sparapani RA, Mahaffey KW, Deckers JW, Newby LK, Ohman EM, Corbalán R, Chierchia SL, Boland JB, Simoons ML, Califf RM, Topol EJ, Harrington RA) JAMA 2000 Jan 19;283(3):347-53 110 Citations |
| 3 | Erratum: T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation (Blood (July 15, 199) 94 (434-441)) (Drobyski WR, Hessner MJ, Klein JP, Kabler-Babbitt C, Vesole DH, Margolis DA, Keever-Taylor CA) Blood 15 February 2000;95(4):1137 |
| 1 | Physicochemical modeling of the role of free radicals in photodynamic therapy. (Shutova T, Kriska T, Németh A, Agabekov V, Gál D) Biochem Biophys Res Commun 2000 Apr 02;270(1):125-30 11 Citations |
| 1 | Whole body hyperthermia cytokine induction: a review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapy. (Katschinski DM, Wiedemann GJ, Longo W, d'Oleire FR, Spriggs D, Robins HI) Cytokine Growth Factor Rev 1999 Jun;10(2):93-7 55 Citations |
| 1 | Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. (Pignon JP, Bourhis J, Domenge C, Designé L) Lancet 2000 Mar 18;355(9208):949-55 2340 Citations |
| 1 | Adoptive immunotherapy using donor leukocyte infusions to treat relapsed hematologic malignancies after allogeneic bone marrow transplantation. (Drobyski WR) Cancer Treat Res 1999;101:233-66 1 Citation |
| 1 | A comparison of 12- and 15-lead ECGS in ED chest pain patients: impact on diagnosis, therapy, and disposition. (Brady WJ, Hwang V, Sullivan R, Chang N, Beagle C, Carter CT, Martin ML, Aufderheide TP) Am J Emerg Med 2000 May;18(3):239-43 41 Citations |
| 1 | Adoptively transferred gamma delta T cells indirectly regulate murine graft-versus-host reactivity following donor leukocyte infusion therapy in mice. (Drobyski WR, Vodanovic-Jankovic S, Klein J) J Immunol 2000 Aug 01;165(3):1634-40 38 Citations |
| 1 | The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. (Nag S, Erickson B, Thomadsen B, Orton C, Demanes JD, Petereit D) Int J Radiat Oncol Biol Phys 2000 Aug 01;48(1):201-11 429 Citations |
| 1 | Gene therapy for hemophilia: a step closer to reality. (White GC 2nd, Roberts HR) Mol Ther 2000 Mar;1(3):207-8 5 Citations |
| 1 | Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission. (Tallman MS, Rowlings PA, Milone G, Zhang MJ, Perez WS, Weisdorf D, Keating A, Gale RP, Geller RB, Laughlin MJ, Lazarus HM, Luger SM, McCarthy PL, Rowe JM, Saez RA, Vowels MR, Horowitz MM) Blood 2000 Aug 15;96(4):1254-8 108 Citations |
| 1 | Preliminary report of a phase I study of combined fractionated stereotactic radiosurgery and conventional external beam radiation therapy for unfavorable gliomas. (Regine WF, Patchell RA, Strottmann JM, Meigooni A, Sanders M, Young AB) Int J Radiat Oncol Biol Phys 2000 Sep 01;48(2):421-6 18 Citations |
| 1 | The role of coenzyme Q10 in the pathophysiology and therapy of experimental congestive heart failure in the dog. (Harker-Murray AK, Tajik AJ, Ishikura F, Meyer D, Burnett JC, Redfield MM) J Card Fail 2000 Sep;6(3):233-42 23 Citations |
| 1 | High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry report. (Stiff PJ, Veum-Stone J, Lazarus HM, Ayash L, Edwards JR, Keating A, Klein JP, Oblon DJ, Shea TC, Thomé S, Horowitz MM) Ann Intern Med 2000 Oct 03;133(7):504-15 48 Citations |
| 1 | The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. (Nag S, Erickson B, Parikh S, Gupta N, Varia M, Glasgow G) Int J Radiat Oncol Biol Phys 2000 Oct 01;48(3):779-90 220 Citations |
| 1 | Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. (Nattinger AB, Hoffmann RG, Kneusel RT, Schapira MM) Lancet 2000 Sep 30;356(9236):1148-53 158 Citations |
| 1 | rhIL-11 for the prevention of dose-limiting chemotherapy-induced thrombocytopenia. (Kurzrock R) Oncology (Williston Park) 2000 Sep;14(9 Suppl 8):9-11 9 Citations |
| 1 | Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. (Evans DB, Wolff RA, Hess KR) Ann Surg 2000 Nov;232(5):727 8 Citations |
| 1 | Apoptosis may be an early event of progestin therapy for endometrial hyperplasia. (Amezcua CA, Lu JJ, Felix JC, Stanczyk FZ, Zheng W) Gynecol Oncol 2000 Nov;79(2):169-76 56 Citations |
| 1 | Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient. (Arav-Boger R, Echavarria M, Forman M, Charache P, Persaud D) Pediatr Infect Dis J 2000 Nov;19(11):1097-100 55 Citations |
| 1 | Convergence and divergence of themes in successful psychotherapy: An assimilation analysis (Knobloch LM, Endres LM, Stiles WB, Silberschatz G) Psychotherapy 2001;38(1):31-39 29 Citations |
| 1 | Genetic variability in the response of normal murine hematopoietic progenitor cells to extracorporeal photochemotherapy. (Tsujino I, Sieber F) Photochem Photobiol 2000 Dec;72(6):810-4 4 Citations |
| 1 | Combined stereotactic split-course fractionated gamma knife radiosurgery and conventional radiation therapy for unfavorable gliomas: a phase I study. (Regine WF, Patchell RA, Strottmann JM, Meigooni A, Sanders M, Young B) J Neurosurg 2000 Dec;93 Suppl 3:37-41 18 Citations |
| 1 | Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). (Abraham WT) J Card Fail 2000 Dec;6(4):369-80 154 Citations |
| 1 | MRI and ultrasound guide gynecologic brachytherapy. (Erickson B) Diagn Imaging (San Franc) 2000 Dec;22(12):78-83 7 Citations |
| 1 | CT guidance assists brachytherapy for gynecologic disease. (Erickson B) Diagn Imaging (San Franc) 2000 Nov;22(11):167-71, 191 5 Citations |
| 1 | Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes. (Grigsby PW, Perez CA, Chao KS, Herzog T, Mutch DG, Rader J) Int J Radiat Oncol Biol Phys 2001 Mar 01;49(3):733-8 62 Citations |
| 1 | Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective. (White GC 2nd, Greenwood R, Escobar M, Frelinger JA) Haematologica 2000 Oct;85(10 Suppl):113-6 7 Citations |
| 1 | Hepatic angiosarcoma occurring after cyclophosphamide therapy: case report and review of the literature. (Rosenthal AK, Klausmeier M, Cronin ME, McLaughlin JK) Am J Clin Oncol 2000 Dec;23(6):581-3 18 Citations |
| 1 | Outcomes of acid suppressive therapy in patients with posterior laryngitis. (Ulualp SO, Toohill RJ, Shaker R) Otolaryngol Head Neck Surg 2001 Jan;124(1):16-22 65 Citations |
| 1 | Preselective gene therapy for Fabry disease. (Qin G, Takenaka T, Telsch K, Kelley L, Howard T, Levade T, Deans R, Howard BH, Malech HL, Brady RO, Medin JA) Proc Natl Acad Sci U S A 2001 Mar 13;98(6):3428-33 70 Citations |
| 1 | Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. (Breslin TM, Hess KR, Harbison DB, Jean ME, Cleary KR, Dackiw AP, Wolff RA, Abbruzzese JL, Janjan NA, Crane CH, Vauthey JN, Lee JE, Pisters PW, Evans DB) Ann Surg Oncol 2001 Mar;8(2):123-32 328 Citations |
| 1 | K cells: a novel target for insulin gene therapy for the prevention of diabetes. (Corbett JA) Trends Endocrinol Metab 2001;12(4):140-2 12 Citations |
| 1 | Treatment planning dosimetric parameters for a (90)Y coil source used in intravascular brachytherapy. (Patel NS, Chiu-Tsao ST, Fan P, Ahunbay E, Ravi K, Sherman W, Quon H, Pisch J, Tsao HS, Harrison LB) Cardiovasc Radiat Med 2001;2(2):83-92 11 Citations |
| 1 | Variation in therapy and outcome for pediatric head trauma patients. (Tilford JM, Simpson PM, Yeh TS, Lensing S, Aitken ME, Green JW, Harr J, Fiser DH) Crit Care Med 2001 May;29(5):1056-61 117 Citations |
| 1 | The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety. (Vakil NB, Shaker R, Johnson DA, Kovacs T, Baerg RD, Hwang C, D'Amico D, Hamelin B) Aliment Pharmacol Ther 2001 Jul;15(7):927-35 132 Citations |
| 1 | High-dose intra-arterial cisplatin boost with hyperfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck. (Regine WF, Valentino J, Arnold SM, Haydon RC, Sloan D, Kenady D, Strottmann J, Pulmano C, Mohiuddin M) J Clin Oncol 2001 Jul 15;19(14):3333-9 30 Citations |
| 1 | Preoperative chemoradiation therapy for pancreatic cancer. (Evans DB, Pisters PW) Surg Clin North Am 2001 Jun;81(3):709-13 3 Citations |
| 1 | Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation. (Giles FJ, Kantarjian HM, Kornblau SM, Thomas DA, Garcia-Manero G, Waddelow TA, David CL, Phan AT, Colburn DE, Rashid A, Estey EH) Cancer 2001 Jul 15;92(2):406-13 254 Citations |
| 1 | Gene therapy in hemophilia: clinical trials update. (White GC 2nd) Thromb Haemost 2001 Jul;86(1):172-7 27 Citations |
| 1 | Relationship of distance from a radiotherapy facility and initial breast cancer treatment. (Nattinger AB, Kneusel RT, Hoffmann RG, Gilligan MA) J Natl Cancer Inst 2001 Sep 05;93(17):1344-6 228 Citations |
| 1 | Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. (Crane CH, Janjan NA, Evans DB, Wolff RA, Ballo MT, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong A, Phan T, Nguyen Q, Abbruzzese JL) Int J Pancreatol 2001;29(1):9-18 74 Citations |
| 1 | Therapy of T cell lymphomas with pentostatin. (Kurzrock R) Ann N Y Acad Sci 2001 Sep;941:200-5 17 Citations |
| 1 | Radiation Therapy Oncology Group. Research Plan 2002-2006. Gynecology Cancer Working Group. (Greven KM, Levenback C, Chao CK, Delaney T, Del Priore G, Eifel P, Erickson BA, Followill D, Gaffney D, Garcia M, Gerszten K, Grigsby P, Henderson R, Hricak H, Hsu J, Jhingrin A, Kaye A, Kudelka A, Lukka H, Mutch D, Nag S, Rotman M, Shefter T, Smith W, Stehman F, Souhami L, Wenzel L, Winter KA, Wolfson A, Radiation Therapy Oncology Group) Int J Radiat Oncol Biol Phys 2001;51(3 Suppl 2):58-9 1 Citation |
| 1 | Radiation Therapy Oncology Group. Research Plan 2002-2006. Image-Guided Radiation Therapy Committee. (Michalski J, Purdy JA, Gaspar L, Souhami L, Ballow M, Bradley J, Chao CK, Crane C, Eisbruch A, Fallowil D, Forster K, Fowler J, Gillin MT, Graham ML, Harms WB, Huq MS, Kline RW, Mackie TR, Mukherji S, Podogorsak EB, Roach M, Ryu J, Sandler H, Schultz CJ, Schell M, Verhey LJ, Vicini F, Winter KA, Radiation Therapy Oncology Group) Int J Radiat Oncol Biol Phys 2001;51(3 Suppl 2):60-5 18 Citations |
| 1 | Progressive arterial thrombosis in a patient with non-Hodgkin's lymphoma, a lupus anticoagulant, factor V Leiden mutation and paraprotein, following chemotherapy. (Shaw BE, Perry D, Hoffbrand AV) Leuk Lymphoma 2001 Jun;42(1-2):221-3 9 Citations |
| 1 | The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase. (Lee SJ, Klein JP, Anasetti C, Antin JH, Loberiza FR, Bolwell BJ, LeMaistre CF, Litzow MR, Marks D, Waller EK, Matlack M, Giralt S, Horowitz MM) Blood 2001 Dec 01;98(12):3205-11 24 Citations |
| 1 | Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease. (Esmaeli B, Ahmadi A, Tang R, Schiffman J, Kurzrock R) Am J Ophthalmol 2001 Dec;132(6):945-7 50 Citations |
| 1 | Influence of a partner's HIV serostatus, use of highly active antiretroviral therapy, and viral load on perceptions of sexual risk behavior in a community sample of men who have sex with men. (Suarez TP, Kelly JA, Pinkerton SD, Stevenson YL, Hayat M, Smith MD, Ertl T) J Acquir Immune Defic Syndr 2001 Dec 15;28(5):471-7 97 Citations |
| 1 | Gene therapy for Fabry disease. (Siatskas C, Medin JA) J Inherit Metab Dis 2001;24 Suppl 2:25-41; discussion 11-2 35 Citations |
| 1 | The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix. (Nag S, Chao C, Erickson B, Fowler J, Gupta N, Martinez A, Thomadsen B, American Brachytherapy Society) Int J Radiat Oncol Biol Phys 2002 Jan 01;52(1):33-48 124 Citations |
| 2 | Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation. (Levine JE, Braun T, Penza SL, Beatty P, Cornetta K, Martino R, Drobyski WR, Barrett AJ, Porter DL, Giralt S, Leis J, Holmes HE, Johnson M, Horowitz M, Collins RH Jr) J Clin Oncol 2002 Jan 15;20(2):405-12 248 Citations |
| 1 | Initial experience with the combination of reteplase and abciximab for thrombolytic therapy in peripheral arterial occlusive disease: a pilot study. (Drescher P, Crain MR, Rilling WS) J Vasc Interv Radiol 2002 Jan;13(1):37-43 33 Citations |
| 1 | High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry. (Berry DA, Broadwater G, Klein JP, Antman K, Aisner J, Bitran J, Costanza M, Freytes CO, Stadtmauer E, Gale RP, Henderson IC, Lazarus HM, McCarthy PL Jr, Norton L, Parnes H, Pecora A, Perry MC, Rowlings P, Spitzer G, Horowitz MM) J Clin Oncol 2002 Feb 01;20(3):743-50 58 Citations |
| 1 | Growth hormone therapy during neonatal hypoxia in rats: body composition, bone mineral density, and insulin-like growth factor-1 expression. (Raff H, Bruder ED, Jankowski B, Oaks MK, Colman RJ) Endocrine 2001 Nov;16(2):139-43 7 Citations |
| 1 | Erratum: The American brachytherapy society recommendations for LDR brachytherapy of the cervix (International Journal of Radiation Oncology Biology Physics (2002) 52 (33-48)) (Nag S, Chao C, Erickson B, Fowler J, Gupta N, Martinez A, Thomadsen B) International Journal of Radiation Oncology Biology Physics 15 March 2002;52(4):1157 |
| 1 | The underuse of therapy in the secondary prevention of hip fractures. (Kamel HK, Duthie EH) Drugs Aging 2002;19(1):1-10 22 Citations |
| 1 | Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis. (Riddle MS, Jackson JL, Sanders JW, Blazes DL) Clin Infect Dis 2002 May 01;34(9):1192-8 152 Citations |
| 2 | Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. (Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, Levine SR) Circulation 2002 Apr 09;105(14):1679-85 406 Citations |
| 2 | Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: dose and dose rate effects. (Jones R, Gore E, Mieler W, Murray K, Gillin M, Albano K, Erickson B) Int J Radiat Oncol Biol Phys 2002 Mar 15;52(4):989-95 48 Citations |
| 1 | Biologic therapy for psoriasis: the new therapeutic frontier. (Singri P, West DP, Gordon KB) Arch Dermatol 2002 May;138(5):657-63 107 Citations |
| 1 | Post-transduction events in retrovirus-mediated gene therapy involving hematopoietic stem cells: beyond efficiency issues. (Medin JA, Fowler DH) J Cell Biochem Suppl 2002;38:46-54 4 Citations |
| 1 | Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy. (Lenzi R, Yalcin S, Evans DB, Abbruzzese JL) Cancer Invest 2002;20(4):464-72 41 Citations |
| 1 | Chronic myelogenous leukemia in T cell lymphoid blastic phase achieving durable complete cytogenetic and molecular remission with imatinib mesylate (STI571; Gleevec) therapy. (Atallah E, Talpaz M, O'brien S, Rios MB, Guo JQ, Arlinghaus R, Fernandes-Reese S, Kantarjian H) Cancer 2002 Jun 01;94(11):2996-9 19 Citations |
| 1 | Hemophilia gene therapy: update. (Monahan PE, White GC 2nd) Curr Opin Hematol 2002 Sep;9(5):430-6 10 Citations |
| 1 | Evaluation of Kodak EDR2 film for dose verification of intensity modulated radiation therapy delivered by a static multileaf collimator. (Zhu XR, Jursinic PA, Grimm DF, Lopez F, Rownd JJ, Gillin MT) Med Phys 2002 Aug;29(8):1687-92 109 Citations |
| 1 | Minor histocompatibility antigens: Molecular targets for adoptive cellular immunotherapy (Malarkannan S) Current Opinion in Organ Transplantation September 2002;7(3):299-304 3 Citations |
| 1 | Conference synopsis: hematopoietic stem cell therapy in autoimmune diseases, October 2001. () Biol Blood Marrow Transplant 2002;8(8):407-11 4 Citations |
| 2 | Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group. (Firat S, Byhardt RW, Gore E) Int J Radiat Oncol Biol Phys 2002 Oct 01;54(2):357-64 188 Citations |
| 1 | Role of antiviral therapy in the prevention of hepatocellular carcinoma. (Franco J, Saeian K) J Vasc Interv Radiol 2002 Sep;13(9 Pt 2):S191-6 10 Citations |
| 1 | ESPAC-1 trial of adjuvant therapy for resectable adenocarcinoma of the pancreas. (Evans DB, Hess KR, Pisters PW) Ann Surg 2002 Nov;236(5):694; author reply 694-6 28 Citations |
| 1 | Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure. (Suzuki G, Morita H, Mishima T, Sharov VG, Todor A, Tanhehco EJ, Rudolph AE, McMahon EG, Goldstein S, Sabbah HN) Circulation 2002 Dec 03;106(23):2967-72 200 Citations |
| 1 | Anti-tumor effect of Merocyanine 540-mediated photochemotherapy combined with Edelfosine: potential implications for the ex vivo purging of hematopoietic stem cell grafts from breast cancer patients. (Anderson GS, Miyagi K, Sampson RW, Sieber F) J Photochem Photobiol B 2002 Nov;68(2-3):101-8 24 Citations |
| 1 | A randomized controlled clinical trial to evaluate the effects of noncontact normothermic wound therapy on chronic full-thickness pressure ulcers. (Kloth LC, Berman JE, Nett M, Papanek PE, Dumit-Minkel S) Adv Skin Wound Care 2002;15(6):270-6 26 Citations |
| 1 | Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. (DeAngelis LM, Seiferheld W, Schold SC, Fisher B, Schultz CJ, Radiation Therapy Oncology Group Study 93-10) J Clin Oncol 2002 Dec 15;20(24):4643-8 652 Citations |
| 2 | Safe use of pulse oximetry during verteporphin therapy. (Woehlck H, Herrmann D, Kaslow O) Anesth Analg 2003 Jan;96(1):177-8, table of contents 6 Citations |
| 1 | Cancer recurrence and mortality in women using hormone replacement therapy: meta-analysis. (Meurer LN, Lená S) J Fam Pract 2002 Dec;51(12):1056-62 33 Citations |
| 1 | Prevalence of oral lesions and percent CD4+ T-lymphocytes in HIV-infected children on antiretroviral therapy. (Okunseri C, Badner V, Wiznia A, Rosenberg M) AIDS Patient Care STDS 2003 Jan;17(1):5-11 24 Citations |
| 1 | A phase II study of concomitant hyperfractionated radiation therapy and double dose intra-arterial cisplatin for squamous cell carcinoma of the head and neck. (Regine WF, Valentino J, Arnold SM, Sloan D, Kenady D, Strottmann J, Mohiuddin M) Technol Cancer Res Treat 2002 Apr;1(2):133-40 2 Citations |
| 1 | Preferential inactivation of paediatric solid tumour cells by sequential exposure to Merocyanine 540-mediated photodynamic therapy and Edelfosine: implications for the ex vivo purging of autologous haematopoietic stem cell grafts. (Anderson GS, Tsujino I, Miyagi K, Sampson R, Sieber F) J Photochem Photobiol B 2003 Feb;69(2):87-95 24 Citations |
| 1 | Radiation increases the activity of oncolytic adenovirus cancer gene therapy vectors that overexpress the ADP (E3-11.6K) protein. (Toth K, Tarakanova V, Doronin K, Ward P, Kuppuswamy M, Locke JE, Dawson JE, Kim HJ, Wold WS) Cancer Gene Ther 2003 Mar;10(3):193-200 41 Citations |
| 1 | Effects of long-term monotherapy with metoprolol CR/XL on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure. (Morita H, Suzuki G, Mishima T, Chaudhry PA, Anagnostopoulos PV, Tanhehco EJ, Sharov VG, Goldstein S, Sabbah HN) Cardiovasc Drugs Ther 2002 Sep;16(5):443-9 34 Citations |
| 1 | Determining the relative efficacy of highly active antiretroviral therapy. (Louie M, Hogan C, Di Mascio M, Hurley A, Simon V, Rooney J, Ruiz N, Brun S, Sun E, Perelson AS, Ho DD, Markowitz M) J Infect Dis 2003 Mar 15;187(6):896-900 85 Citations |
| 1 | Catheter-directed thrombolytic therapy in peripheral artery occlusions: combining reteplase and abciximab. (Drescher P, McGuckin J, Rilling WS, Crain MR) AJR Am J Roentgenol 2003 May;180(5):1385-91 21 Citations |
| 1 | E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo. (Cook JL, Miura TA, Iklé DN, Lewis AM Jr, Routes JM) Cancer Res 2003 Jun 15;63(12):3435-43 16 Citations |
| 1 | Modeling ADHD-type arousal with unilateral frontal cortex damage in rats and beneficial effects of play therapy. (Panksepp J, Burgdorf J, Turner C, Gordon N) Brain Cogn 2003 Jun;52(1):97-105 70 Citations |
| 1 | Prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation. (Kaufman DB, Burke GW III, Bruce DS, Johnson CP, Gaber AO, Sutherland DE, Merion RM, Gruber SA, Schweitzer E, Leone JP, Marsh CL, Alfrey E, Concepcion W, Stegall MD, Schulak JA, Gores PF, Benedetti E, Smith C, Henning AK, Kuehnel F, King S, Fitzsimmons WE) Am J Transplant 2003 Jul;3(7):855-64 55 Citations |
| 1 | Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. (Mehta MP, Rodrigus P, Terhaard CH, Rao A, Suh J, Roa W, Souhami L, Bezjak A, Leibenhaut M, Komaki R, Schultz C, Timmerman R, Curran W, Smith J, Phan SC, Miller RA, Renschler MF) J Clin Oncol 2003 Jul 01;21(13):2529-36 431 Citations |
| 1 | Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma. (Duvic M, Apisarnthanarax N, Cohen DS, Smith TL, Ha CS, Kurzrock R) J Am Acad Dermatol 2003 Jul;49(1):35-49 67 Citations |
| 1 | Physician counseling on hormone replacement therapy and bone loss: do socioeconomic and racial characteristics of women influence counseling? (Neuner JM, McCarthy EP, Davis RB, Phillips RS) J Womens Health (Larchmt) 2003 Jun;12(5):495-504 3 Citations |
| 2 | Leflunomide treatment of Crohn's disease patients intolerant to standard immunomodulator therapy. (Prajapati DN, Knox JF, Emmons J, Saeian K, Csuka ME, Binion DG) J Clin Gastroenterol 2003 Aug;37(2):125-8 40 Citations |
| 1 | The immunology of psoriasis and biologic immunotherapy. (Mehlis SL, Gordon KB) J Am Acad Dermatol 2003 Aug;49(2 Suppl):S44-50 111 Citations |
| 1 | A critical review of endoscopic therapy for gastroesophageal reflux disease. (Hogan WJ, Shaker R) Am J Med 2003 Aug 18;115 Suppl 3A:201S-210S 11 Citations |
| 1 | Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes. (Yazji S, Giles FJ, Tsimberidou AM, Estey EH, Kantarjian HM, O'Brien SA, Kurzrock R) Leukemia 2003 Nov;17(11):2101-6 78 Citations |
| 1 | Sequelae of cryotherapy in breast tissue. (Otterson MF, Redlich PN, McDonald A, Kristin Thorsen M, Klaas KK, Clowry LJ, Walker AP) Cryobiology 2003 Oct;47(2):174-8 7 Citations |
| 1 | Viral blip dynamics during highly active antiretroviral therapy. (Di Mascio M, Markowitz M, Louie M, Hogan C, Hurley A, Chung C, Ho DD, Perelson AS) J Virol 2003 Nov;77(22):12165-72 76 Citations |
| 1 | Adoptive immunotherapy in chimeras with donor lymphocytes. (Kolb HJ, Schmid C, Chen X, Woiciechowski A, Roskrow M, Weber M, Guenther W, Ledderose G, Schleuning M) Acta Haematol 2003;110(2-3):110-20 18 Citations |
| 1 | Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver (Br J Surg 2003; 90: 963-969). (Rahman S, Toogood GJ, Lodge PJ, Prasad KR) Br J Surg 2003 Nov;90(11):1453 4 Citations |
| 1 | Postmenopausal hormone therapy and its association with cognitive impairment. (Mitchell JL, Cruickshanks KJ, Klein BE, Palta M, Nondahl DM) Arch Intern Med 2003 Nov 10;163(20):2485-90 15 Citations |
| 1 | The female athlete triad: an emerging role for physical therapy. (Papanek PE) J Orthop Sports Phys Ther 2003 Oct;33(10):594-614 33 Citations |
| 2 | Gene therapy for platelet disorders: studies with Glanzmann's thrombasthenia. (Wilcox DA, White GC 2nd) J Thromb Haemost 2003 Nov;1(11):2300-11 33 Citations |
| 1 | Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses. (Wu HH, Talpaz M, Champlin RE, Pilat SR, Kurzrock R) Cancer 2003 Dec 01;98(11):2410-9 21 Citations |
| 1 | Swallowing dysfunction--preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. (Mittal BB, Pauloski BR, Haraf DJ, Pelzer HJ, Argiris A, Vokes EE, Rademaker A, Logemann JA) Int J Radiat Oncol Biol Phys 2003 Dec 01;57(5):1219-30 182 Citations |
| 1 | A controlled trial of rotigotine monotherapy in early Parkinson's disease. (Parkinson Study Group) Arch Neurol 2003 Dec;60(12):1721-8 227 Citations |
| 1 | A randomized trial of etanercept as monotherapy for psoriasis. (Gottlieb AB, Matheson RT, Lowe N, Krueger GG, Kang S, Goffe BS, Gaspari AA, Ling M, Weinstein GD, Nayak A, Gordon KB, Zitnik R) Arch Dermatol 2003 Dec;139(12):1627-32; discussion 1632 457 Citations |
| 1 | High dose therapy with autologous hematopoietic stem cell transplantation (HSCT) for patients with primary systemic amyloidosis (AL): An ABMTR study (Vesole DH, Pérez W, Reece D, Akasheh M, Horowitz M, Bredeson C) Amyloid and Amyloidosis 1 January 2004:164-166 |
| 2 | Menopausal hormone therapy decisions: insights from a multi-attribute model. (Schapira MM, Gilligan MA, McAuliffe TL, Nattinger AB) Patient Educ Couns 2004 Jan;52(1):89-95 18 Citations |
| 1 | Amiodarone therapy for drug-refractory fetal tachycardia. (Strasburger JF, Cuneo BF, Michon MM, Gotteiner NL, Deal BJ, McGregor SN, Oudijk MA, Meijboom EJ, Feinkind L, Hussey M, Parilla BV) Circulation 2004 Jan 27;109(3):375-9 175 Citations |
| 1 | Effect of chronic cytokine therapy on clonal dynamics in nonhuman primates. (Kuramoto K, Follmann DA, Hematti P, Sellers S, Agricola BA, Metzger ME, Donahue RE, von Kalle C, Dunbar CE) Blood 2004 Jun 01;103(11):4070-7 14 Citations |
| 1 | A randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure. (Konduri GG, Solimano A, Sokol GM, Singer J, Ehrenkranz RA, Singhal N, Wright LL, Van Meurs K, Stork E, Kirpalani H, Peliowski A, Neonatal Inhaled Nitric Oxide Study Group) Pediatrics 2004 Mar;113(3 Pt 1):559-64 163 Citations |
| 1 | The role of intraoperative radiotherapy in pancreatic cancer. (Crane CH, Beddar AS, Evans DB) Surg Oncol Clin N Am 2003 Oct;12(4):965-77 22 Citations |
| 1 | Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. (Prados MD, Seiferheld W, Sandler HM, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ Jr) Int J Radiat Oncol Biol Phys 2004 Mar 15;58(4):1147-52 111 Citations |
| 1 | Postmenopausal hormone therapy: a concise guide to therapeutic uses, formulations, risks, and alternatives. (Mitchell JL, Walsh J, Wang-Cheng R, Hardman JL) Prim Care 2003 Dec;30(4):671-96 3 Citations |
| 1 | Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018. (Regine WF, Schmitt FA, Scott CB, Dearth C, Patchell RA, Nichols RC Jr, Gore EM, Franklin RL 3rd, Suh JH, Mehta MP) Int J Radiat Oncol Biol Phys 2004 Apr 01;58(5):1346-52 72 Citations |
| 1 | The sculpted pear: An unfinished brachytherapy tale. (Erickson BA) Brachytherapy 2003;2(4):189-99 17 Citations |
| 1 | Comparison of solute clearance in three modes of continuous renal replacement therapy. (Parakininkas D, Greenbaum LA) Pediatr Crit Care Med 2004 May;5(3):269-74 42 Citations |
| 2 | Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. (Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao KS, Schultz CJ, Lee N, Fu KK, Radiation Therapy Oncology Group 9501/Intergroup) N Engl J Med 2004 May 06;350(19):1937-44 2756 Citations |
| 1 | Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. (Smith AR, Shenvi SV, Widlansky M, Suh JH, Hagen TM) Curr Med Chem 2004 May;11(9):1135-46 438 Citations |
| 1 | Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. (Grigsby PW, Siegel BA, Dehdashti F, Rader J, Zoberi I) J Clin Oncol 2004 Jun 01;22(11):2167-71 210 Citations |
| 1 | Modeling human hematopoietic stem cell gene therapy in nonhuman primates. (Hematti P) Curr Hematol Rep 2004 Jul;3(4):282-9 4 Citations |
| 1 | Subnormal rise of erythropoietin in patients receiving interferon and ribavirin combination therapy for hepatitis C. (Trivedi HS, Trivedi M) J Clin Gastroenterol 2004 Aug;38(7):595-8 14 Citations |
| 1 | Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview. (Barber FD, Mavligit G, Kurzrock R) Cancer Treat Rev 2004 Aug;30(5):425-36 39 Citations |
| 1 | Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. (Garden AS, Harris J, Vokes EE, Forastiere AA, Ridge JA, Jones C, Horwitz EM, Glisson BS, Nabell L, Cooper JS, Demas W, Gore E) J Clin Oncol 2004 Jul 15;22(14):2856-64 168 Citations |
| 1 | Infectivity enhanced adenoviral-mediated mda-7/IL-24 gene therapy for ovarian carcinoma. (Leath CA 3rd, Kataram M, Bhagavatula P, Gopalkrishnan RV, Dent P, Fisher PB, Pereboev A, Carey D, Lebedeva IV, Haisma HJ, Alvarez RD, Curiel DT, Mahasreshti PJ) Gynecol Oncol 2004 Aug;94(2):352-62 26 Citations |
| 1 | Surgical therapy for sudden cardiac death in children. (Jaquiss RD, Tweddell JS, Litwin SB) Pediatr Clin North Am 2004 Oct;51(5):1389-400 1 Citation |
| 1 | Neoadjuvant therapy for resectable pancreatic cancer. (Raut CP, Evans DB, Crane CH, Pisters PW, Wolff RA) Surg Oncol Clin N Am 2004 Oct;13(4):639-61, ix 54 Citations |
| 1 | Dynamics of intermittent viremia during highly active antiretroviral therapy in patients who initiate therapy during chronic versus acute and early human immunodeficiency virus type 1 infection. (Di Mascio M, Markowitz M, Louie M, Hurley A, Hogan C, Simon V, Follmann D, Ho DD, Perelson AS) J Virol 2004 Oct;78(19):10566-73 38 Citations |
| 1 | Neonatal dexamethasone therapy: short- and long-term consequences. (Raff H) Trends Endocrinol Metab 2004 Oct;15(8):351-2 27 Citations |
| 1 | Cutting balloon angioplasty vs. conventional balloon angioplasty in patients receiving intracoronary brachytherapy for the treatment of in-stent restenosis. (Fasseas P, Orford JL, Lennon R, O'Neill J, Denktas AE, Panetta CJ, Berger PB, Holmes DR) Catheter Cardiovasc Interv 2004 Oct;63(2):152-7 8 Citations |
| 1 | From laboratory to clinic: rationale for biologic therapy. (Mehlis S, Gordon KB) Dermatol Clin 2004 Oct;22(4):371-7, vii-viii 15 Citations |
| 1 | Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis. (Verbsky JW, White AJ) J Rheumatol 2004 Oct;31(10):2071-5 166 Citations |
| 1 | Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. (Souhami L, Seiferheld W, Brachman D, Podgorsak EB, Werner-Wasik M, Lustig R, Schultz CJ, Sause W, Okunieff P, Buckner J, Zamorano L, Mehta MP, Curran WJ Jr) Int J Radiat Oncol Biol Phys 2004 Nov 01;60(3):853-60 473 Citations |
| 1 | Soy immunotherapy for peanut-allergic mice: modulation of the peanut-allergic response. (Pons L, Ponnappan U, Hall RA, Simpson P, Cockrell G, West CM, Sampson HA, Helm RM, Burks AW) J Allergy Clin Immunol 2004 Oct;114(4):915-21 61 Citations |
| 1 | Transpupillary thermotherapy of occult choroidal neovascularization in age-related macular degeneration. (Kim JE, Perkins SL, Schwiesow T, Connor TB Jr, Han DP) Semin Ophthalmol 2001 Jun;16(2):86-9 17 Citations |
| 1 | Vagus nerve stimulation therapy: 5-year or greater outcome at a university-based epilepsy center. (Spanaki MV, Allen LS, Mueller WM, Morris GL 3rd) Seizure 2004 Dec;13(8):587-90 68 Citations |
| 1 | Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a patterns of care study. (Eifel PJ, Moughan J, Erickson B, Iarocci T, Grant D, Owen J) Int J Radiat Oncol Biol Phys 2004 Nov 15;60(4):1144-53 120 Citations |
| 1 | Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group. (Nag S, Cardenes H, Chang S, Das IJ, Erickson B, Ibbott GS, Lowenstein J, Roll J, Thomadsen B, Varia M, Image-Guided Brachytherapy Working Group) Int J Radiat Oncol Biol Phys 2004 Nov 15;60(4):1160-72 202 Citations |
| 1 | The formation of the therapeutic alliance in couple therapy. (Knobloch-Fedders LM, Pinsoft WM, Mann BJ) Fam Process 2004 Dec;43(4):425-42 75 Citations |
| 1 | Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis. (Gottlieb AB, Gordon KB, Lebwohl MG, Caro I, Walicke PA, Li N, Leonardi CL, EFALIZUMAB STUDY GROUP) J Drugs Dermatol 2004;3(6):614-24 80 Citations |
| 3 | SU‐FF‐J‐105: Tools for Voxel‐By‐Voxel Correlation of Radiotherapy Dose and MR Signals From Multiple Physiological/functional MRI Modalities (Ahunbay E, Schmainda K, Lund R, Prost R, Ulmer J, Alaly J, Deasy J, Schultz C, li X) Medical Physics June 2005;32(6):1944 |
| 1 | Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertension. (Katovich MJ, Grobe JL, Huentelman M, Raizada MK) Exp Physiol 2005 May;90(3):299-305 31 Citations |
| 1 | Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis. (Menter A, Gordon K, Carey W, Hamilton T, Glazer S, Caro I, Li N, Gulliver W) Arch Dermatol 2005 Jan;141(1):31-8 215 Citations |
| 1 | Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET. (Grigsby PW, Mutch DG, Rader J, Herzog TJ, Zoberi I, Siegel BA, Dehdashti F) Int J Radiat Oncol Biol Phys 2005 Feb 01;61(2):444-9 30 Citations |
| 1 | Cervix carcinoma, concurrent chemoradiotherapy, and salvage of isolated paraaortic lymph node recurrence. (Singh AK, Grigsby PW, Rader JS, Mutch DG, Powell MA) Int J Radiat Oncol Biol Phys 2005 Feb 01;61(2):450-5 68 Citations |
| 2 | Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. (Curtis RE, Metayer C, Rizzo JD, Socié G, Sobocinski KA, Flowers ME, Travis WD, Travis LB, Horowitz MM, Deeg HJ) Blood 2005 May 15;105(10):3802-11 281 Citations |
| 1 | Celecoxib and radiation therapy in non-small-cell lung cancer. (Gore E) Oncology (Williston Park) 2004 Dec;18(14 Suppl 14):10-4 23 Citations |
| 1 | Clinical inquiries. What is the interval for monitoring warfarin therapy once therapeutic levels have been achieved? (Meurer LN, Jamieson B, Guthmann R) J Fam Pract 2005 Feb;54(2):171-2 3 Citations |
| 1 | Minor histocompatibility antigens: Molecular targets for immunomodulation in tissue transplantation and tumor therapy (Malarkannan S, Regunathan J, Timler AM) Clinical and Applied Immunology Reviews March 2005;5(2):95-109 9 Citations |
| 1 | Immune therapy of chronic myelogenous leukemia. (Gale RP, Horowitz MM, Talpaz M, Scheinberg DA, Molldrem J, Li Z, Baccarani M, Goldman JM, Tura S) Leuk Res 2005 May;29(5):583-6 1 Citation |
| 1 | Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial. (Leonardi CL, Papp KA, Gordon KB, Menter A, Feldman SR, Caro I, Walicke PA, Compton PG, Gottlieb AB, Efalizumab Study Group) J Am Acad Dermatol 2005 Mar;52(3 Pt 1):425-33 223 Citations |
| 1 | Molecular mechanisms of resistance in antimalarial chemotherapy: the unmet challenge. (Arav-Boger R, Shapiro TA) Annu Rev Pharmacol Toxicol 2005;45:565-85 48 Citations |
| 2 | Recommendations for image-based intracavitary brachytherapy of cervix cancer: the GYN GEC ESTRO Working Group point of view: in regard to Nag et al. (Int J Radiat Oncol Biol Phys 2004;60:1160-1172). (Pötter R, Dimopoulos J, Kirisits C, Lang S, Haie-Meder C, Briot E, Dumas I, Van Limbergen E, De Brabandere M, Nulens A, Erickson B, Rownd J, Petrow P) Int J Radiat Oncol Biol Phys 2005 May 01;62(1):293-5; author reply 295-6 30 Citations |
| 1 | Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: an ASTRO outcomes initiative. (Morris DE, Emami B, Mauch PM, Konski AA, Tao ML, Ng AK, Klein EA, Mohideen N, Hurwitz MD, Fraas BA, Roach M 3rd, Gore EM, Tepper JE) Int J Radiat Oncol Biol Phys 2005 May 01;62(1):3-19 54 Citations |
| 1 | Importance of early diagnosis and therapy of acute meningococcal myocarditis: a case report with review of literature. (Razminia M, Salem Y, Elbzour M, Teves D, Deshmukh H, Khosla S) Am J Ther 2005;12(3):269-71 3 Citations |
| 1 | Phase I results of RTOG L-0117; a phase I/II dose intensification study using 3DCRT and concurrent chemotherapy for patients with Inoperable NSCLC. (Bradley JD, Graham M, Suzanne S, Byhardt R, Govindan R, Fowler J, Purdy J, Michalski J, Gore E, Choy H) J Clin Oncol 2005 Jun;23(16_suppl):7063 |
| 1 | Gene therapy for hemophilia? (White GC 2nd, Roberts HR) J Thromb Haemost 2005 Jun;3(6):1312 4 Citations |
| 1 | Effects of 670-nm phototherapy on development. (Yeager RL, Franzosa JA, Millsap DS, Angell-Yeager JL, Heise SS, Wakhungu P, Lim J, Whelan HT, Eells JT, Henshel DS) Photomed Laser Surg 2005 Jun;23(3):268-72 33 Citations |
| 1 | Role of photoproducts in the cytotoxic action of selenomerocyanine-mediated photodynamic therapy (Sieber F, Daziano JP, Sampson RW, Tsujino I, Miyagi K, Ostrowski MD, Anderson GS, Günther WHH, Krieg M) Progress in Biomedical Optics and Imaging - Proceedings of SPIE 2005;5689:56-65 1 Citation |
| 1 | Differing patterns of antiresorptive pharmacotherapy in nursing facility residents and community dwellers. (Jachna CM, Shireman TI, Whittle J, Ellerbeck EF, Rigler SK) J Am Geriatr Soc 2005 Aug;53(8):1275-81 34 Citations |
| 2 | Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study. (Erickson B, Eifel P, Moughan J, Rownd J, Iarocci T, Owen J) Int J Radiat Oncol Biol Phys 2005 Nov 15;63(4):1083-92 66 Citations |
| 1 | American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy. (Small W Jr, Erickson B, Kwakwa F) Int J Radiat Oncol Biol Phys 2005 Dec 01;63(5):1502-7 87 Citations |
| 3 | Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. (Eells JT, Wong-Riley MT, VerHoeve J, Henry M, Buchman EV, Kane MP, Gould LJ, Das R, Jett M, Hodgson BD, Margolis D, Whelan HT) Mitochondrion 2004 Sep;4(5-6):559-67 394 Citations |
| 1 | A new tool in the battle against Alzheimer's disease and aging: ex vivo gene therapy. (Ebert AD, Svendsen CN) Rejuvenation Res 2005;8(3):131-4 20 Citations |
| 1 | Using a Delphi panel to survey criteria for successful periodontal therapy in anterior teeth. (Lightfoot WS, Hefti A, Mariotti A) J Periodontol 2005 Sep;76(9):1508-12 5 Citations |
| 1 | Using a Delphi panel to survey criteria for successful periodontal therapy in posterior teeth. (Lightfoot WS, Hefti A, Mariotti A) J Periodontol 2005 Sep;76(9):1502-7 15 Citations |
| 1 | Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma. (Fisher B, Seiferheld W, Schultz C, DeAngelis L, Nelson D, Schold SC, Curran W, Mehta M) J Neurooncol 2005 Sep;74(2):201-5 83 Citations |
| 1 | APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trial. (Wimmer RS, Chauvenet AR, London WB, Villaluna D, de Alarcon PA, Schwartz CL) Pediatr Blood Cancer 2006 Mar;46(3):320-4 9 Citations |
| 1 | Long-term therapy with the acorn cardiac support device normalizes gene expression of growth factors and gelatinases in dogs with heart failure. (Rastogi S, Gupta RC, Mishra S, Morita H, Tanhehco EJ, Sabbah HN) J Heart Lung Transplant 2005 Oct;24(10):1619-25 21 Citations |
| 1 | Assessing nondrinking outcomes in combined pharmacotherapy and psychotherapy clinical trials for the treatment of alcohol dependence. (Cisler RA, Kivlahan DR, Donovan D, Mattson ME) J Stud Alcohol Suppl 2005 Jul(15):110-8; discussion 92-3 14 Citations |
| 1 | Hyperbaric oxygen therapy of cerebral ischemia. (Helms AK, Whelan HT, Torbey MT) Cerebrovasc Dis 2005;20(6):417-26 77 Citations |
| 1 | Incidence of infection during efalizumab therapy for psoriasis: analysis of the clinical trial experience. (Langley RG, Carey WP, Rafal ES, Tyring SK, Caro I, Wang X, Wetherill G, Gordon KB) Clin Ther 2005 Sep;27(9):1317-28 56 Citations |
| 1 | A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: preliminary results of RTOG P-0019. (Lee WR, DeSilvio M, Lawton C, Gillin M, Morton G, Firat S, Baikadi M, Kuettel M, Greven K, Sandler H) Int J Radiat Oncol Biol Phys 2006 Mar 01;64(3):804-9 34 Citations |
| 1 | The pulmonary status of patients with limited-stage small cell lung cancer 15 years after treatment with chemotherapy and chest irradiation. (Myers JN, O'neil KM, Walsh TE, Hoffmeister KJ, Venzon DJ, Johnson BE) Chest 2005 Nov;128(5):3261-8 9 Citations |
| 1 | Effect of GFP expression on the sensitivity of glioma cell lines to photodynamic therapy (Khatami S, Rendon A, Yoshimitsu M, Medin J, Lilge L) Progress in Biomedical Optics and Imaging - Proceedings of SPIE 2005;5969 |
| 2 | Kinematic implications of learned non-use for robotic therapy (Johnson MJ, Wisneski K, Hermsen A, Smith RQ, Walton T, Hingtgen B, McGuire JR, Harris GF) Proceedings of the 2005 IEEE 9th International Conference on Rehabilitation Robotics 2005;2005:70-73 2 Citations |
| 1 | SU‐FF‐J‐48: Developing In‐Line KV Fluoroscopic Verification for 4D Adaptive Radiotherapy (Li X, Khamene A, Tai A, Khater K, Celi J, Hristov D, Ofstad B) Medical Physics June 2006;33(6):2031 |
| 1 | SU‐FF‐J‐64: Feasibility of a Feedback‐Guided Breath‐Hold Technique for Thoracic Radiation Therapy (Kainz K, Liu H, Balter P, Tutt T, Hunjan S, Prado K, Liao Z) Medical Physics June 2006;33(6):2035 |
| 1 | Gene therapy for platelet disorders (Wilcox DA, White GC) Platelets, Second Edition 1 January 2006:1313-1325 |
| 2 | Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. (Pötter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, Dumas I, Erickson B, Lang S, Nulens A, Petrow P, Rownd J, Kirisits C, GEC ESTRO Working Group) Radiother Oncol 2006 Jan;78(1):67-77 1474 Citations |
| 1 | Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. (Lee CM, Szabo A, Shrieve DC, Macdonald OK, Gaffney DK) JAMA 2006 Jan 25;295(4):389-97 114 Citations |
| 1 | Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. (Tallman MS, Pérez WS, Lazarus HM, Gale RP, Maziarz RT, Rowe JM, Marks DI, Cahn JY, Bashey A, Bishop MR, Christiansen N, Frankel SR, García JJ, Ilhan O, Laughlin MJ, Liesveld J, Linker C, Litzow MR, Luger S, McCarthy PL, Milone GA, Pavlovsky S, Phillips GL, Russell JA, Saez RA, Schiller G, Sierra J, Weiner RS, Zander AR, Zhang MJ, Keating A, Weisdorf DJ, Horowitz MM) Biol Blood Marrow Transplant 2006 Feb;12(2):204-16 24 Citations |
| 1 | Bone morphogenetic protein gene therapy using a fibrin scaffold for a rabbit spinal-fusion experiment: Commentary (Wolfla CE, Benzel EC, Wang MY, Resnick DK) Neurosurgery February 2006;58(2):379-380 1 Citation |
| 1 | Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results. (Czito BG, Willett CG, Bendell JC, Morse MA, Tyler DS, Fernando NH, Mantyh CR, Blobe GC, Honeycutt W, Yu D, Clary BM, Pappas TN, Ludwig KA, Hurwitz HI) J Clin Oncol 2006 Feb 01;24(4):656-62 132 Citations |
| 1 | Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. (Tamm EP, Loyer EM, Faria S, Raut CP, Evans DB, Wolff RA, Crane CH, Dubrow RA, Charnsangavej C) Abdom Imaging 2006;31(5):568-74 62 Citations |
| 1 | Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapy. (Gordon KB, Gottlieb AB, Leonardi CL, Elewski BE, Wang A, Jahreis A, Zitnik R) J Dermatolog Treat 2006;17(1):9-17 110 Citations |
| 1 | Frequency of serum creatinine monitoring during allopurinol therapy in ambulatory patients. (Raebel MA, McClure DL, Simon SR, Chan KA, Feldstein AC, Gunter MJ, Lafata JE, Harrold L, Nelson WW, Platt R) Ann Pharmacother 2006 Mar;40(3):386-91 14 Citations |
| 1 | Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. (Eapen M, Raetz E, Zhang MJ, Muehlenbein C, Devidas M, Abshire T, Billett A, Homans A, Camitta B, Carroll WL, Davies SM, Children's Oncology Group, Center for International Blood and Marrow Transplant Research) Blood 2006 Jun 15;107(12):4961-7 139 Citations |
| 1 | Survivorship and mortality implications of developmental 670-nm phototherapy: dioxin co-exposure. (Yeager RL, Franzosa JA, Millsap DS, Lim J, Heise SS, Wakhungu P, Whelan HT, Eells JT, Henshel DS) Photomed Laser Surg 2006 Feb;24(1):29-32 10 Citations |
| 1 | Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. (Crane CH, Ellis LM, Abbruzzese JL, Amos C, Xiong HQ, Ho L, Evans DB, Tamm EP, Ng C, Pisters PW, Charnsangavej C, Delclos ME, O'Reilly M, Lee JE, Wolff RA) J Clin Oncol 2006 Mar 01;24(7):1145-51 199 Citations |
| 1 | T regulatory cells as an immunotherapy for transplantation. (Albert MH, Anasetti C, Yu XZ) Expert Opin Biol Ther 2006 Apr;6(4):315-24 19 Citations |
| 1 | Antidepressants and cognitive-behavioral therapy for symptom syndromes. (Jackson JL, O'Malley PG, Kroenke K) CNS Spectr 2006 Mar;11(3):212-22 81 Citations |
| 1 | Photodynamic therapy for extrafoveal choroidal neovascularization associated with choroidal nevus. (Moon SJ, Wirostko WJ) Retina 2006 Apr;26(4):477-9 4 Citations |
| 1 | Potentiation of the antitumor effect of Merocyanine 540-mediated photodynamic therapy by amifostine and amphotericin B. (Tsujino I, Miyagi K, Sampson RW, Sieber F) Photochem Photobiol 2006;82(2):458-65 20 Citations |
| 1 | Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer. (Wright JD, Viviano D, Powell MA, Gibb RK, Mutch DG, Grigsby PW, Rader JS) Gynecol Oncol 2006 Nov;103(2):489-93 100 Citations |
| 1 | Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma: Commentary (Lee CM, Szabo A, Shrieve DC, MacDonald OK, Gaffney DK) Obstetrical and Gynecological Survey June 2006;61(6):382-384 |
| 1 | Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma: A retrospective analysis. (Wright JD, Hagemann A, Rader JS, Viviano D, Gibb RK, Norris L, Mutch DG, Powell MA) Cancer 2006 Jul 01;107(1):83-9 123 Citations |
| 1 | A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023. (Cardinale R, Won M, Choucair A, Gillin M, Chakravarti A, Schultz C, Souhami L, Chen A, Pham H, Mehta M) Int J Radiat Oncol Biol Phys 2006 Aug 01;65(5):1422-8 91 Citations |
| 2 | Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III nonsmall cell lung cancer (NSCLC). (Firat S, Pleister A, Byhardt RW, Gore E) Am J Clin Oncol 2006 Jun;29(3):252-7 48 Citations |
| 1 | Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone? (Wong SJ, Machtay M, Li Y) J Clin Oncol 2006 Jun 10;24(17):2653-8 117 Citations |
| 1 | Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network. (Kahl BS, Longo WL, Eickhoff JC, Zehnder J, Jones C, Blank J, McFarland T, Bottner W, Rezazedeh H, Werndli J, Bailey HH, Wisconsin Oncology Network) Ann Oncol 2006 Sep;17(9):1418-23 98 Citations |
| 1 | POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group. (Kung FH, Schwartz CL, Ferree CR, London WB, Ternberg JL, Behm FG, Wharam MD, Falletta JM, de Alarcon P, Chauvenet AR, Children's Oncology Group) J Pediatr Hematol Oncol 2006 Jun;28(6):362-8 80 Citations |
| 1 | Frequency and effect of adjuvant radiation therapy in stage I endometrial adenocarcinoma (Lee CM, Szabo A, Shrieve DC, Macdonald OK, Gaffney DK) American Journal of Oncology Review July 2006;5(7):417-420 |
| 1 | Pulmonary hemorrhage and antithrombotic therapy: Case report and review of the literature (Gupta NI, Fasseas P, Schapira RM) Clinical Pulmonary Medicine July 2006;13(4):251-254 1 Citation |
| 1 | Relationship between swallow motility disorders on videofluorography and oral intake in patients treated for head and neck cancer with radiotherapy with or without chemotherapy. (Pauloski BR, Rademaker AW, Logemann JA, Newman L, MacCracken E, Gaziano J, Stachowiak L) Head Neck 2006 Dec;28(12):1069-76 79 Citations |
| 1 | Tumor volume changes on serial imaging with megavoltage CT for non-small-cell lung cancer during intensity-modulated radiotherapy: how reliable, consistent, and meaningful is the effect? (Siker ML, Tomé WA, Mehta MP) Int J Radiat Oncol Biol Phys 2006 Sep 01;66(1):135-41 105 Citations |
| 1 | Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. (Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H, Lee JE, Pisters PW, Evans DB, Wolff RA) Ann Surg Oncol 2006 Aug;13(8):1035-46 783 Citations |
| 1 | Obesity and its therapy: from genes to community action. (Skelton JA, DeMattia L, Miller L, Olivier M) Pediatr Clin North Am 2006 Aug;53(4):777-94 13 Citations |
| 1 | Brief report: embryonic growth and hatching implications of developmental 670-nm phototherapy and dioxin co-exposure. (Yeager RL, Franzosa JA, Millsap DS, Lim J, Hansen CM, Jasevicius AV, Heise SS, Wakhungu P, Whelan HT, Eells JT, Henshel DS) Photomed Laser Surg 2006 Jun;24(3):410-3 4 Citations |
| 1 | Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma. (Duvic M, Talpur R, Wen S, Kurzrock R, David CL, Apisarnthanarax N) Clin Lymphoma Myeloma 2006 Jul;7(1):51-8 148 Citations |
| 1 | Pulsed radiofrequency of the dorsal root ganglia is superior to pharmacotherapy or pulsed radiofrequency of the intercostal nerves in the treatment of chronic postsurgical thoracic pain. (Cohen SP, Sireci A, Wu CL, Larkin TM, Williams KA, Hurley RW) Pain Physician 2006 Jul;9(3):227-35 127 Citations |
| 1 | Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710. (Colman H, Berkey BA, Maor MH, Groves MD, Schultz CJ, Vermeulen S, Nelson DF, Mehta MP, Yung WK, Radiation Therapy Oncology Group) Int J Radiat Oncol Biol Phys 2006 Nov 01;66(3):818-24 51 Citations |
| 1 | Transpupillary thermotherapy with indocyanine green dye enhancement for the treatment of occult subfoveal choroidal neovascularization in age-related macular degeneration. (Kim JE, Shah KB, Han DP, Connor TB Jr) Ophthalmic Surg Lasers Imaging 2006;37(4):272-7 8 Citations |
| 1 | Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures. (Bosiers M, Hart JP, Deloose K, Verbist J, Peeters P) Vascular 2006;14(2):63-9 182 Citations |
| 1 | Periodontal therapy and preterm birth. (Hefti AF) Int J Dent Hyg 2006 Sep;4 Suppl 1:39-42; discussion 50-2 |
| 1 | Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. (Tamm EP et al.) Abdom Imaging 2006 Sep 12: |
| 2 | Relative efficacy of ondansetron, granisetron, dolasetron and palonosetron in controlling acute nausea and vomiting associated with platinum-based chemotherapy. (Hamadani M, Awab A, Chaudhary L, Tfayli A) J Oncol Pharm Pract 2006 Jun;12(2):67-8 3 Citations |
| 1 | The effect of early, intensive statin therapy on acute coronary syndrome: a meta-analysis of randomized controlled trials. (Hulten E, Jackson JL, Douglas K, George S, Villines TC) Arch Intern Med 2006 Sep 25;166(17):1814-21 190 Citations |
| 1 | Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma? (Siker ML, Chakravarti A, Mehta MP) Crit Rev Oncol Hematol 2006 Nov;60(2):99-111 31 Citations |
| 1 | A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086. (Benson CA, Vaida F, Havlir DV, Downey GF, Lederman MM, Gulick RM, Glesby MJ, Wantman M, Bixby CJ, Rinehart AR, Snyder S, Wang R, Patel S, Mellors JW, ACTG A5086 Study Team) J Infect Dis 2006 Nov 01;194(9):1309-18 19 Citations |
| 1 | Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment: impact of age at diagnosis. (Tward JD, Lee CM, Pappas LM, Szabo A, Gaffney DK, Shrieve DC) Cancer 2006 Nov 15;107(10):2392-400 58 Citations |
| 1 | Adjuvant therapy for renal cell carcinoma. (Jacobsohn KM, Wood CG) Semin Oncol 2006 Oct;33(5):576-82 38 Citations |
| 1 | Concurrent capecitabine and upper abdominal radiation therapy is well tolerated. (Das P, Wolff RA, Abbruzzese JL, Varadhachary GR, Evans DB, Vauthey JN, Baschnagel A, Delclos ME, Krishnan S, Janjan NA, Crane CH) Radiat Oncol 2006 Oct 24;1:41 20 Citations |
| 1 | Immunosuppressive therapy for acute porphyria: safety and efficacy in a patient with bone marrow failure. (Field JJ, Giannone L, Bessler M, Blinder MA) Pharmacotherapy 2006 Nov;26(11):1662-6 1 Citation |
| 1 | Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. (Otero RM, Nguyen HB, Huang DT, Gaieski DF, Goyal M, Gunnerson KJ, Trzeciak S, Sherwin R, Holthaus CV, Osborn T, Rivers EP) Chest 2006 Nov;130(5):1579-95 249 Citations |
| 2 | Suppressive anti-HCV therapy for prevention of donor to recipient transmission in stem cell transplantation. (Surapaneni SN, Hari P, Knox J, Daniel J, Saeian K) Am J Gastroenterol 2007 Feb;102(2):449-51 14 Citations |
| 1 | Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits. (Myers SE, Whitman BY, Carrel AL, Moerchen V, Bekx MT, Allen DB) Am J Med Genet A 2007 Mar 01;143A(5):443-8 126 Citations |
| 2 | The cell-adhesion and signaling molecule PECAM-1 is a molecular mediator of resistance to genotoxic chemotherapy. (Bergom C, Goel R, Paddock C, Gao C, Newman DK, Matsuyama S, Newman PJ) Cancer Biol Ther 2006 Dec;5(12):1699-707 27 Citations |
| 1 | Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy. (Zighelboim I, Taylor NP, Powell MA, Gibb RK, Rader JS, Mutch DG, Grigsby PW) Radiat Med 2006 Nov;24(9):625-30 36 Citations |
| 1 | A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis. (Moore A, Gordon KB, Kang S, Gottlieb A, Freundlich B, Xia HA, Stevens SR) J Am Acad Dermatol 2007 Apr;56(4):598-603 150 Citations |
| 1 | A descriptive analysis of postimplant dosimetric parameters from Radiation Therapy Oncology Group P0019. (Lee WR, Bae K, Lawton CA, Gillin MT, Morton G, Firat S, Baikadi M, Kuettel M, Greven K, Sandler H) Brachytherapy 2006;5(4):239-43 18 Citations |
| 1 | Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma. (Fayed A, Mutch DG, Rader JS, Gibb RK, Powell MA, Wright JD, Elnaqa I, Zoberi I, Grigsby PW) Int J Radiat Oncol Biol Phys 2007 Feb 01;67(2):480-4 33 Citations |
| 1 | Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials. (Mossoba ME, Medin JA) Expert Rev Vaccines 2006 Oct;5(5):717-32 24 Citations |
| 1 | Special considerations in the therapy of non-fibrillatory cardiac arrest (Aufderheide TP, Larabee TM, Paradis NA) Cardiac Arrest: The Science and Practice of Resuscitation Medicine 1 January 2007:725-746 |
| 2 | TU‐FF‐A2‐03: Image‐Guided Helical Tomotherapy to Treat Advanced Cancers of the Scalp: Prospects for Dose Conformity and Clinical Outcome (Kainz K, Wilson JF, Schultz C, Jursinic P, li XA) Medical Physics June 2007;34(6):2576 |
| 1 | SU‐FF‐J‐45: A Comparison of Daily Megavoltage CT and Ultrasound Imaging Guided Radiation Therapy for Prostate Cancer (Peng C, Kainz K, Lawton C, li X) Medical Physics June 2007;34(6):2378 |
| 1 | WE‐C‐M100F‐02: Simultaneous Irradiation of Prone Breast and Regional Lymph Nodes Using Helical Tomotherapy (Kainz K, White J, Herman J, England M, li X) Medical Physics June 2007;34(6):2592 |
| 3 | SU‐FF‐J‐93: Respiration Induced Abdominal Organ Motions and Anatomic Changes: Indications for Gated Radiation Therapy (Tai A, Erickson B, Khater K, Gore E, Dias L, li X) Medical Physics June 2007;34(6):2389-2390 |
| 3 | SU‐FF‐T‐54: A Three‐Phase Strategy for a Partial Implementation of Biologically Guided Radiation Therapy (li X, Stewart R, Semenenko V, qi S, Chen G, Ahunbay E, Schultz C) Medical Physics June 2007;34(6):2413 |
| 2 | MO‐E‐M100F‐04: Optimizing Low‐Dose Megavoltage Fluoroscopy for 4D Radiotherapy (Christensen J, Tai A, Chen G, Boettger T, Khamene A, Celi J, li X) Medical Physics June 2007;34(6):2528-2529 3 Citations |
| 1 | Addition of salmeterol to usual asthma pharmacotherapy may increase respiratory related deaths or life threatening experiences. (Lipchik RJ) Evid Based Med 2006 Oct;11(5):139 3 Citations |
| 1 | Effects of periodontal therapy during pregnancy on periodontal status, biologic parameters, and pregnancy outcomes: a pilot study. (Offenbacher S, Lin D, Strauss R, McKaig R, Irving J, Barros SP, Moss K, Barrow DA, Hefti A, Beck JD) J Periodontol 2006 Dec;77(12):2011-24 187 Citations |
| 1 | Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy. (Field JJ, Fenske TS, Blinder MA) Haemophilia 2007 Jan;13(1):46-50 35 Citations |
| 1 | The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review. (Oliansky DM, Rizzo JD, Aplan PD, Arceci RJ, Leone L, Ravindranath Y, Sanders JE, Smith FO 3rd, Wilmot F, McCarthy PL Jr, Hahn T) Biol Blood Marrow Transplant 2007 Jan;13(1):1-25 64 Citations |
| 2 | Intertriginous eruption associated with chemotherapy in pediatric patients. (Webber KA, Kos L, Holland KE, Margolis DA, Drolet BA) Arch Dermatol 2007 Jan;143(1):67-71 19 Citations |
| 1 | Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer. (Lazarus C, Logemann JA, Pauloski BR, Rademaker AW, Helenowski IB, Vonesh EF, Maccracken E, Mittal BB, Vokes EE, Haraf DJ) Head Neck 2007 Jul;29(7):632-7 91 Citations |
| 1 | Optimal initial therapy for patients with newly diagnosed chronic myeloid leukemia in chronic phase. (Atallah E, Cortes J) Curr Opin Hematol 2007 Mar;14(2):138-44 3 Citations |
| 1 | Lentiviral vectors for gene therapy of heart disease. (Higuchi K, Medin JA) J Cardiol 2007 Jan;49(1):1-11 3 Citations |
| 3 | Lentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia A. (Shi Q, Wilcox DA, Fahs SA, Fang J, Johnson BD, DU LM, Desai D, Montgomery RR) J Thromb Haemost 2007 Feb;5(2):352-61 119 Citations |
| 2 | Direct aperture optimization-based intensity-modulated radiotherapy for whole breast irradiation. (Ahunbay EE, Chen GP, Thatcher S, Jursinic PA, White J, Albano K, Li XA) Int J Radiat Oncol Biol Phys 2007 Mar 15;67(4):1248-58 60 Citations |
| 1 | Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up. (Konduri GG, Vohr B, Robertson C, Sokol GM, Solimano A, Singer J, Ehrenkranz RA, Singhal N, Wright LL, Van Meurs K, Stork E, Kirpalani H, Peliowski A, Johnson Y, Neonatal Inhaled Nitric Oxide Study Group) J Pediatr 2007 Mar;150(3):235-40, 240.e1 96 Citations |
| 1 | Hyperbaric oxygen therapy of acute ischemic stroke. (Helms AK, Whelan HT, Torbey MT) Stroke 2007 Apr;38(4):1137; author reply 1138-9 8 Citations |
| 1 | Melatonin as a principal component of red light therapy. (Yeager RL, Oleske DA, Sanders RA, Watkins JB 3rd, Eells JT, Henshel DS) Med Hypotheses 2007;69(2):372-6 17 Citations |
| 1 | Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy? (Aloia TA, Lee JE, Vauthey JN, Abdalla EK, Wolff RA, Varadhachary GR, Abbruzzese JL, Crane CH, Evans DB, Pisters PW) J Am Coll Surg 2007 Mar;204(3):347-55 114 Citations |
| 1 | Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancer. (Bedi M, Das P, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Eng C, Wolff RA, Janjan NA, Krishnan S, Crane CH) Gastrointest Cancer Res 2007 Mar;1(2):44-8 |
| 1 | Unopposed estradiol therapy in postmenopausal women: results from two randomized trials. (Steiner AZ, Xiang M, Mack WJ, Shoupe D, Felix JC, Lobo RA, Hodis HN) Obstet Gynecol 2007 Mar;109(3):581-7 15 Citations |
| 1 | Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019. (Lee WR, Bae K, Lawton C, Gillin M, Morton G, Firat S, Baikadi M, Kuettel M, Greven K, Sandler H) Cancer 2007 Apr 15;109(8):1506-12 59 Citations |
| 1 | Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene therapy. (Sato T, Neschadim A, Konrad M, Fowler DH, Lavie A, Medin JA) Mol Ther 2007 May;15(5):962-70 88 Citations |
| 1 | Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy. (Capowski EE, Schneider BL, Ebert AD, Seehus CR, Szulc J, Zufferey R, Aebischer P, Svendsen CN) J Neurosci Methods 2007 Jul 30;163(2):338-49 69 Citations |
| 2 | Decision-making at menopause: a randomized controlled trial of a computer-based hormone therapy decision-aid. (Schapira MM, Gilligan MA, McAuliffe T, Garmon G, Carnes M, Nattinger AB) Patient Educ Couns 2007 Jul;67(1-2):100-7 23 Citations |
| 1 | Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116. (Small W Jr, Winter K, Levenback C, Iyer R, Gaffney D, Asbell S, Erickson B, Jhingran A, Greven K) Int J Radiat Oncol Biol Phys 2007 Jul 15;68(4):1081-7 125 Citations |
| 1 | Image-based brachytherapy: a forum for collaboration between radiation oncologists and diagnostic radiologists. (Erickson B) J Am Coll Radiol 2005 Sep;2(9):753-8 4 Citations |
| 1 | Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors. (Burke MJ, Walterhouse DO, Jacobsohn DA, Duerst RE, Kletzel M) Pediatr Blood Cancer 2007 Aug;49(2):196-8 26 Citations |
| 1 | Therapeutic alliance and treatment progress in couple psychotherapy. (Knobloch-Fedders LM, Pinsof WM, Mann BJ) J Marital Fam Ther 2007 Apr;33(2):245-57 91 Citations |
| 1 | Congestive heart failure is a rare event in patients receiving imatinib therapy. (Atallah E, Durand JB, Kantarjian H, Cortes J) Blood 2007 Aug 15;110(4):1233-7 219 Citations |
| 1 | Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. (Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, Benson A 3rd, Espat J, Bilbao JI, Sharma RA, Thomas JP, Coldwell D) Int J Radiat Oncol Biol Phys 2007 May 01;68(1):13-23 581 Citations |
| 1 | A 5-drug regimen maximizing the dose of cyclophosphamide is effective therapy for adult Burkitt or Burkitt-like lymphomas. (Kujawski LA, Longo WL, Williams EC, Turman NJ, Brandt N, Mosher DF, Eickhoff JC, Kahl BS) Cancer Invest 2007 Mar;25(2):87-93 12 Citations |
| 1 | Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia. (Giralt SA, Arora M, Goldman JM, Lee SJ, Maziarz RT, McCarthy PL, Sobocinski KA, Horowitz MM, Chronic Leukemia Working Committee, Center for International Blood and Marrow Transplant Research) Br J Haematol 2007 Jun;137(5):461-7 68 Citations |
| 1 | Rectourethral fistula after combination radiotherapy for prostate cancer. (Marguet C, Raj GV, Brashears JH, Anscher MS, Ludwig K, Mouraviev V, Robertson CN, Polascik TJ) Urology 2007 May;69(5):898-901 45 Citations |
| 1 | External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer. (Lin LL, Mutch DG, Rader JS, Powell MA, Grigsby PW) Gynecol Oncol 2007 Jul;106(1):215-20 45 Citations |
| 1 | Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results. (Czito BG, Bendell JC, Willett CG, Morse MA, Blobe GC, Tyler DS, Thomas J, Ludwig KA, Mantyh CR, Ashton J, Yu D, Hurwitz HI) Int J Radiat Oncol Biol Phys 2007 Jun 01;68(2):472-8 133 Citations |
| 1 | Analyzing the short-term effect of placebo therapy in pulmonary arterial hypertension: potential implications for the design of future clinical trials. (Helman DL Jr, Brown AW, Jackson JL, Shorr AF) Chest 2007 Sep;132(3):764-72 15 Citations |
| 1 | Early withdrawal of calcineurin inhibitors and rescue immunosuppression with sirolimus-based therapy in renal transplant recipients with moderate to severe renal dysfunction. (Wali RK, Mohanlal V, Ramos E, Blahut S, Drachenberg C, Papadimitriou J, Dinits M, Joshi A, Philosophe B, Foster C, Cangro C, Nogueira J, Cooper M, Bartlett ST, Weir MR) Am J Transplant 2007 Jun;7(6):1572-83 47 Citations |
| 1 | Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch. (Gandhi SD, Weiskopf RB, Jungheinrich C, Koorn R, Miller D, Shangraw RE, Prough DS, Baus D, Bepperling F, Warltier DC) Anesthesiology 2007 Jun;106(6):1120-7 94 Citations |
| 1 | Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy. (Krishnan S, Rana V, Janjan NA, Varadhachary GR, Abbruzzese JL, Das P, Delclos ME, Gould MS, Evans DB, Wolff RA, Crane CH) Cancer 2007 Jul 01;110(1):47-55 241 Citations |
| 1 | FEM-based evaluation of deformable image registration for radiation therapy. (Zhong H, Peters T, Siebers JV) Phys Med Biol 2007 Aug 21;52(16):4721-38 52 Citations |
| 1 | Establishment of baseline toxicity expectations with standard frontline chemotherapy in acute myelogenous leukemia. (Atallah E, Cortes J, O'Brien S, Pierce S, Rios MB, Estey E, Markman M, Keating M, Freireich EJ, Kantarjian H) Blood 2007 Nov 15;110(10):3547-51 71 Citations |
| 1 | B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy. (Roth TJ, Sheinin Y, Lohse CM, Kuntz SM, Frigola X, Inman BA, Krambeck AE, McKenney ME, Karnes RJ, Blute ML, Cheville JC, Sebo TJ, Kwon ED) Cancer Res 2007 Aug 15;67(16):7893-900 222 Citations |
| 1 | Electroconvulsive therapy-induced asystole: occurrence after 39 previous uneventful treatments. (Holak EJ, Scott JP, Pagel PS) Can J Anaesth 2007 Sep;54(9):772-3 6 Citations |
| 1 | Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. (Spencer SA, Harris J, Wheeler RH, Machtay M, Schultz C, Spanos W, Rotman M, Meredith R, Ang KK) Head Neck 2008 Mar;30(3):281-8 297 Citations |
| 1 | Possible fractionated regimens for image-guided intensity-modulated radiation therapy of large arteriovenous malformations. (Qi XS, Schultz CJ, Li XA) Phys Med Biol 2007 Sep 21;52(18):5667-82 20 Citations |
| 1 | Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: A surveillance, epidemiology, and end results population study. (Lee CM, Szabo A, Shrieve DC, Macdonald OK, Tward JD, Skidmore TB, Gaffney DK) Cancer 2007 Nov 01;110(9):2092-100 29 Citations |
| 2 | Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist? (Hamadani M, Chaudhary L, Awan FT, Khan JK, Kojouri K, Ozer H, Tfayli A) J Oncol Pharm Pract 2007 Jun;13(2):69-75 24 Citations |
| 1 | The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status. (Gupta P, Ozel B, Stanczyk FZ, Felix JC, Mishell DR Jr) Menopause 2008;15(1):94-7 29 Citations |
| 1 | Intra- and interfractional variations for prone breast irradiation: an indication for image-guided radiotherapy. (Morrow NV, Stepaniak C, White J, Wilson JF, Li XA) Int J Radiat Oncol Biol Phys 2007 Nov 01;69(3):910-7 61 Citations |
| 1 | Clinical benefit of palliative radiation therapy in advanced gastric cancer. (Kim MM, Rana V, Janjan NA, Das P, Phan AT, Delclos ME, Mansfield PF, Ajani JA, Crane CH, Krishnan S) Acta Oncol 2008;47(3):421-7 87 Citations |
| 1 | A critical appraisal of the role of neoadjuvant chemotherapy for colorectal liver metastases: a case-controlled study. (Malik HZ, Farid S, Al-Mukthar A, Anthoney A, Toogood GJ, Lodge JP, Prasad KR) Ann Surg Oncol 2007 Dec;14(12):3519-26 26 Citations |
| 1 | Radiation therapy is associated with improved survival in patients with pancreatic adenocarcinoma: results of a study from the Surveillance, Epidemiology, and End Results (SEER) registry data. (Hazard L, Tward JD, Szabo A, Shrieve DC) Cancer 2007 Nov 15;110(10):2191-201 72 Citations |
| 1 | Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial. (Menter A, Tyring SK, Gordon K, Kimball AB, Leonardi CL, Langley RG, Strober BE, Kaul M, Gu Y, Okun M, Papp K) J Am Acad Dermatol 2008 Jan;58(1):106-15 809 Citations |
| 1 | Strategic plans to promote head and neck cancer translational research within the radiation therapy oncology group: a report from the translational research program. (Chung CH, Wong S, Ang KK, Hammond EH, Dicker AP, Harari PM, Le QT) Int J Radiat Oncol Biol Phys 2007;69(2 Suppl):S67-78 11 Citations |
| 1 | Feasibility study of TheraDrive: a low-cost game-based environment for the delivery of upper arm stroke therapy. (Johnson MJ, Ramachandran B, Paranjape RP, Kosasih JB) Conf Proc IEEE Eng Med Biol Soc 2006;2006:695-8 11 Citations |
| 1 | Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. (Langer CJ, Harris J, Horwitz EM, Nicolaou N, Kies M, Curran W, Wong S, Ang K) J Clin Oncol 2007 Oct 20;25(30):4800-5 305 Citations |
| 1 | Surgical Therapy of Barrett's Esophagus and Cancer (Lal DR, Oelschlager BK) Barrett's Esophagus and Esophageal Adenocarcinoma: Second Edition 25 October 2007:222-235 |
| 1 | Does androgen-deprivation therapy accelerate the development of frailty in older men with prostate cancer?: a conceptual review. (Bylow K, Mohile SG, Stadler WM, Dale W) Cancer 2007 Dec 15;110(12):2604-13 107 Citations |
| 1 | Bevacizumab therapy in patients with recurrent uterine neoplasms. (Wright JD, Powell MA, Rader JS, Mutch DG, Gibb RK) Anticancer Res 2007;27(5B):3525-8 40 Citations |
| 1 | Local radiotherapy induces homing of hematopoietic stem cells to the irradiated bone marrow. (Bastianutto C, Mian A, Symes J, Mocanu J, Alajez N, Sleep G, Shi W, Keating A, Crump M, Gospodarowicz M, Medin J, Minden M, Liu FF) Cancer Res 2007 Nov 01;67(21):10112-6 30 Citations |
| 1 | Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater. (Krishnan S, Rana V, Evans DB, Varadhachary G, Das P, Bhatia S, Delclos ME, Janjan NA, Wolff RA, Crane CH, Pisters PW) Int J Radiat Oncol Biol Phys 2008 Mar 01;70(3):735-43 66 Citations |
| 1 | Part XIII. Systemic antifungal therapy. (Busse KH, Gentry CA, Bronze MS, Greenfield RA) J Okla State Med Assoc 2007 Sep;100(9):344-51 |
| 1 | A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation. (Neschadim A, McCart JA, Keating A, Medin JA) Biol Blood Marrow Transplant 2007 Dec;13(12):1407-16 34 Citations |
| 1 | Acute toxicity of postoperative IMRT and chemotherapy for endometrial cancer. (Tierney RM, Powell MA, Mutch DG, Gibb RK, Rader JS, Grigsby PW) Radiat Med 2007 Nov;25(9):439-45 15 Citations |
| 1 | Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. (Eapen M, Zhang MJ, Devidas M, Raetz E, Barredo JC, Ritchey AK, Godder K, Grupp S, Lewis VA, Malloy K, Carroll WL, Davies SM, Camitta BM, Children's Oncology Group, Center for International Blood and Marrow Transplant Research) Leukemia 2008 Feb;22(2):281-6 48 Citations |
| 2 | Imagery rescripting and reprocessing therapy after failed prolonged exposure for post-traumatic stress disorder following industrial injury. (Grunert BK, Weis JM, Smucker MR, Christianson HF) J Behav Ther Exp Psychiatry 2007 Dec;38(4):317-28 125 Citations |
| 1 | Biologic Immunotherapy of Psoriasis (Gordon K) Handbook of Psoriasis: Second Edition 30 November 2007:328-337 |
| 1 | Gene therapy for platelet disorders (Wilcox DA, White GC) Platelets 2007:1313-1325 |
| 1 | A novel image based verification method for respiratory motion management in radiation therapy (Khamene A, Schaller C, Hornegger J, Celi JC, Ofstad B, Rietzel E, Li XA, Tai A, Bayouth J) Proceedings of the IEEE International Conference on Computer Vision 2007 3 Citations |
| 1 | Predicting preferential DNA vector insertion sites: implications for functional genomics and gene therapy. (Hackett CS, Geurts AM, Hackett PB) Genome Biol 2007;8 Suppl 1(Suppl 1):S12 51 Citations |
| 1 | Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. (Brown DB, Gould JE, Gervais DA, Goldberg SN, Murthy R, Millward SF, Rilling WS, Geschwind JF, Salem R, Vedantham S, Cardella JF, Soulen MC) J Vasc Interv Radiol 2007 Dec;18(12):1469-78 61 Citations |
| 1 | Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: a retrospective cohort study. (Brotman DJ, Bakhru M, Saber W, Aneja A, Bhatt DL, Tillan-Martinez K, Jaffer AK) J Hosp Med 2007 Nov;2(6):378-84 34 Citations |
| 2 | Effect of lower-level laser therapy on rabbit tibial fracture. (Liu X, Lyon R, Meier HT, Thometz J, Haworth ST) Photomed Laser Surg 2007 Dec;25(6):487-94 59 Citations |
| 1 | Cryopreservation of sperm after chemotherapy. (Brannigan RE, Sandlow JI) J Androl 2008;29(3):e1-2 5 Citations |
| 1 | SU‐GG‐J‐15: A Novel Registration Tool of Large Deformations for Adaptive Radiation Therapy (Godley A, Ahunbay E, Peng C, Christensen J, Li X) Medical Physics June 2008;35(6):2681-2682 |
| 1 | WE‐E‐AUD C‐02: Impact of Image Quality On CT Guided Prostate Radiotherapy (Morrow N, Lawton C, li X) Medical Physics June 2008;35(6):2955 2 Citations |
| 1 | Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia. (Tsimberidou AM, Wierda WG, Plunkett W, Kurzrock R, O'Brien S, Wen S, Ferrajoli A, Ravandi-Kashani F, Garcia-Manero G, Estrov Z, Kipps TJ, Brown JR, Fiorentino A, Lerner S, Kantarjian HM, Keating MJ) J Clin Oncol 2008 Jan 10;26(2):196-203 140 Citations |
| 1 | The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease. (Nojkov B, Rubenstein JH, Adlis SA, Shaw MJ, Saad R, Rai J, Weinman B, Chey WD) Aliment Pharmacol Ther 2008 Mar 15;27(6):473-82 92 Citations |
| 1 | Assessment of dose reconstruction errors in image-guided radiation therapy. (Zhong H, Weiss E, Siebers JV) Phys Med Biol 2008 Feb 07;53(3):719-36 28 Citations |
| 1 | Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era. (Schwartz DL, Rana V, Shaw S, Yazbeck C, Ang KK, Morrison WH, Rosenthal DI, Hoff A, Evans DB, Clayman GL, Garden AS, Sherman SI) Head Neck 2008 Jul;30(7):883-8 80 Citations |
| 2 | HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR. (Schlenk RF, Pasquini MC, Pérez WS, Zhang MJ, Krauter J, Antin JH, Bashey A, Bolwell BJ, Büchner T, Cahn JY, Cairo MS, Copelan EA, Cutler CS, Döhner H, Gale RP, Ilhan O, Lazarus HM, Liesveld JL, Litzow MR, Marks DI, Maziarz RT, McCarthy PL, Nimer SD, Sierra J, Tallman MS, Weisdorf DJ, Horowitz MM, Ganser A, CIBMTR Acute Leukemia Working Committee) Biol Blood Marrow Transplant 2008 Feb;14(2):187-96 47 Citations |
| 1 | Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. (Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, Ferguson WS, Gebhardt MC, Goorin AM, Harris M, Kleinerman E, Link MP, Nadel H, Nieder M, Siegal GP, Weiner MA, Wells RJ, Womer RB, Grier HE, Children's Oncology Group) J Clin Oncol 2008 Feb 01;26(4):633-8 658 Citations |
| 1 | Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma. (Gardner SL, Carreras J, Boudreau C, Camitta BM, Adams RH, Chen AR, Davies SM, Edwards JR, Grovas AC, Hale GA, Lazarus HM, Arora M, Stiff PJ, Eapen M) Bone Marrow Transplant 2008 May;41(10):867-72 24 Citations |
| 6 | Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma. (Vernon MR, Maheshwari M, Schultz CJ, Michel MA, Wong SJ, Campbell BH, Massey BL, Wilson JF, Wang D) Int J Radiat Oncol Biol Phys 2008 Mar 01;70(3):678-84 81 Citations |
| 1 | Patient-specific margins for proton therapy of lung. (Zhao L, Sandison GA, Farr JB, Hsi WC, Wu H, Li XA) Australas Phys Eng Sci Med 2007 Dec;30(4):344-8 |
| 1 | Chemotherapy-induced muscle wasting: association with NF-κB (Jeffrey S. Damrauer, Michael E. Stadler, Swarnali Acharyya, Albert S. Baldwin, Marion E. Couch, Denis C. Guttridge) Basic Applied Myology 18 (5): 139-148, 2008 |
| 1 | Resectable pancreatic cancer: the role for neoadjuvant/preoperative therapy. (Evans DB, Multidisciplinary Pancreatic Cancer Study Group) HPB (Oxford) 2006;8(5):365-8 25 Citations |
| 1 | Successful radiofrequency ablation therapy for intractable ventricular tachycardia with a ventricular assist device. (Osaki S, Alberte C, Murray MA, Brahmbhatt RD, Johnson MR, Edwards NM, Kohmoto T) J Heart Lung Transplant 2008 Mar;27(3):353-6 26 Citations |
| 1 | Pediatric heart failure therapy with beta-adrenoceptor antagonists. (Foerster SR, Canter CE) Paediatr Drugs 2008;10(2):125-34 16 Citations |
| 2 | Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. (Saad ER, Bresnahan BA, Cohen EP, Lu N, Orentas RJ, Vasudev B, Hariharan S) Transplantation 2008 Mar 27;85(6):850-4 94 Citations |
| 1 | Beyond therapy and enhancement: The alteration of human nature (Jotterand F) NanoEthics April 2008;2(1):15-23 42 Citations |
| 1 | Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy: how soon should we repeat endoscopic retrograde cholangiopancreatography? (Weston BR, Ross WA, Wolff RA, Evans D, Lee JE, Wang X, Xiao LC, Lee JH) Cancer 2008 Jun;112(11):2417-23 32 Citations |
| 1 | Chemoradiation therapy for potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgery. (Kim MM, Mansfield PF, Das P, Janjan NA, Badgwell BD, Phan AT, Delclos ME, Maru D, Ajani JA, Crane CH, Krishnan S) Int J Radiat Oncol Biol Phys 2008 May 01;71(1):167-72 15 Citations |
| 1 | Outcomes of endoluminal therapy for ostial disease of the major branches of the aortic arch. (Bakken AM, Palchik E, Saad WE, Hart JP, Singh MJ, Rhodes JM, Waldman DL, Davies MG) Ann Vasc Surg 2008;22(3):388-94 18 Citations |
| 1 | Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for medulloblastoma. (Muscal JA, Jones JY, Paulino AC, Bertuch AA, Su J, Woo SY, Mahoney DH Jr, Chintagumpala M) Int J Radiat Oncol Biol Phys 2009 Jan 01;73(1):214-21 15 Citations |
| 1 | Immuno-gene therapy approaches for cancer: from in vitro studies to clinical trials. (Loisel-Meyer S, Foley R, Medin JA) Front Biosci 2008 May 01;13:3202-14 21 Citations |
| 1 | Improved survival in patients with ventricular assist device therapy: the University of Wisconsin experience. (Osaki S, Edwards NM, Velez M, Johnson MR, Murray MA, Hoffmann JA, Kohmoto T) Eur J Cardiothorac Surg 2008 Aug;34(2):281-8 19 Citations |
| 1 | Systemic chemotherapy for adrenocortical carcinoma: comparative responses to conventional first-line therapies. (Fareau GG, Lopez A, Stava C, Vassilopoulou-Sellin R) Anticancer Drugs 2008 Jul;19(6):637-44 13 Citations |
| 1 | Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy. (Hare CB, Mellors J, Krambrink A, Su Z, Skiest D, Margolis DM, Patel SS, Barnas D, Frenkel L, Coombs RW, Aweeka F, Morse GD, Haas DW, Boltz V, Palmer S, Coffin J, Havlir DV) Clin Infect Dis 2008 Aug 01;47(3):421-4 28 Citations |
| 1 | Multiple squamous cell carcinomas of the skin after therapy with sorafenib combined with tipifarnib. (Hong DS, Reddy SB, Prieto VG, Wright JJ, Tannir NM, Cohen PR, Diwan AH, Evans HL, Kurzrock R) Arch Dermatol 2008 Jun;144(6):779-82 45 Citations |
| 1 | Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy. (Bylow K, Dale W, Mustian K, Stadler WM, Rodin M, Hall W, Lachs M, Mohile SG) Urology 2008 Aug;72(2):422-7 136 Citations |
| 1 | Adjuvant therapy for adenocarcinoma of the pancreas: analysis of reported trials and recommendations for future progress. (Wolff RA, Varadhachary GR, Evans DB) Ann Surg Oncol 2008 Oct;15(10):2773-86 52 Citations |
| 1 | IL-12 immunotherapy of murine leukaemia: comparison of systemic versus gene modified cell therapy. (Labbe A, Nelles M, Walia J, Jia L, Furlonger C, Nonaka T, Medin JA, Paige CJ) J Cell Mol Med 2009 Aug;13(8B):1962-1976 19 Citations |
| 1 | A deliverable four-dimensional intensity-modulated radiation therapy-planning method for dynamic multileaf collimator tumor tracking delivery. (Suh Y, Weiss E, Zhong H, Fatyga M, Siebers JV, Keall PJ) Int J Radiat Oncol Biol Phys 2008 Aug 01;71(5):1526-36 31 Citations |
| 1 | Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer? (Pisters PW, Evans DB) Ann Surg 2008 Aug;248(2):152-3 4 Citations |
| 1 | Budesonide induction and maintenance therapy for Crohn's disease during pregnancy. (Beaulieu DB, Ananthakrishnan AN, Issa M, Rosenbaum L, Skaros S, Newcomer JR, Kuhlmann RS, Otterson MF, Emmons J, Knox J, Binion DG) Inflamm Bowel Dis 2009 Jan;15(1):25-8 94 Citations |
| 1 | Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. (Heckman JT, Devera MB, Marsh JW, Fontes P, Amesur NB, Holloway SE, Nalesnik M, Geller DA, Steel JL, Gamblin TC) Ann Surg Oncol 2008 Nov;15(11):3169-77 115 Citations |
| 1 | Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. (Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC) Int J Radiat Oncol Biol Phys 2009 Mar 01;73(3):779-88 96 Citations |
| 1 | Modified constraint-induced movement therapy for a 12-month-old child with hemiplegia: a case report. (Cope SM, Forst HC, Bibis D, Liu XC) Am J Occup Ther 2008;62(4):430-7 41 Citations |
| 1 | Interplay of reverse transcriptase inhibitor therapy and gag p6 diversity in HIV type 1 subtype G and CRF02_AG. (Ojesina AI, Chaplin B, Sankalé JL, Murphy R, Idigbe E, Adewole I, Ekong E, Idoko J, Kanki PJ) AIDS Res Hum Retroviruses 2008 Sep;24(9):1167-74 7 Citations |
| 1 | Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemia. (Advani AS, Jin T, Ramsingh G, Tiu R, Saber W, Theil K, Sobecks R, Sekeres M, Copelan E, Sungren S, Tripp B, Kalaycio M) Leuk Lymphoma 2008 Aug;49(8):1560-6 6 Citations |
| 1 | High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma. (Hamadani M, Benson DM Jr, Lin TS, Porcu P, Blum KA, Devine SM) Eur J Haematol 2008 Dec;81(6):425-31 28 Citations |
| 2 | Correlation of echocardiographic markers and therapy in persistent pulmonary hypertension of the newborn. (Peterson AL, Deatsman S, Frommelt MA, Mussatto K, Frommelt PC) Pediatr Cardiol 2009 Feb;30(2):160-5 34 Citations |
| 1 | Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapy. (Bunin NJ, Davies SM, Aplenc R, Camitta BM, DeSantes KB, Goyal RK, Kapoor N, Kernan NA, Rosenthal J, Smith FO, Eapen M) J Clin Oncol 2008 Sep 10;26(26):4326-32 49 Citations |
| 1 | Aggressive combined modality therapy for recurrent colorectal cancer involving the duodenum and pancreas: a report of 5 cases. (Overman MJ, Fogelman D, Al-Kali A, Crane CH, Evans D, Abdalla EK, Pisters P, Kopetz S, Eng C, Wolff RA) Clin Colorectal Cancer 2008 Sep;7(5):338-42 |
| 1 | The moving target induced dosimetric effect vs. beam direction in proton radiotherapy of moving lung tumors (Zhao L, Sandison G, Farr J, Wu H, Fitzek M) BioMedical Engineering and Informatics: New Development and the Future - Proceedings of the 1st International Conference on BioMedical Engineering and Informatics, BMEI 2008 2008;2:804-808 |
| 1 | Biological surgery: synergetic angiogenic therapy using coadministration of two progenitor cell populations. (Li W, Silverstein RL) Circ Res 2008 Sep 26;103(7):684-6 |
| 1 | Factorial and construct validity of the revised short form integrative psychotherapy alliance scales for family, couple, and individual therapy. (Pinsof WM, Zinbarg R, Knobloch-Fedders LM) Fam Process 2008 Sep;47(3):281-301 114 Citations |
| 1 | Treatment of a CNS relapse while on therapy for Burkitt lymphoma. (Burke MJ, Dayton V) Pediatr Blood Cancer 2009 Feb;52(2):290-2 2 Citations |
| 1 | Reirradiation and concurrent chemotherapy after salvage surgery: pay now or pay later. (Wong SJ, Spencer S) J Clin Oncol 2008 Dec 01;26(34):5500-1 10 Citations |
| 1 | Multidisciplinary approach decreases length of stay and reduces cost for ventricular assist device therapy. (Murray MA, Osaki S, Edwards NM, Johnson MR, Bobadilla JL, Gordon EA, Sanderfoot M, Kohmoto T) Interact Cardiovasc Thorac Surg 2009 Jan;8(1):84-8 21 Citations |
| 1 | Management of complications of androgen deprivation therapy in the older man. (Mohile SG, Mustian K, Bylow K, Hall W, Dale W) Crit Rev Oncol Hematol 2009 Jun;70(3):235-55 60 Citations |
| 1 | Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir. (Ramanathan R, Pau AK, Busse KH, Zemskova M, Nieman L, Kwan R, Hammer JH, Mican JM, Maldarelli F) Clin Infect Dis 2008 Dec 15;47(12):e97-9 37 Citations |
| 1 | Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trial. (Nand S, Godwin J, Smith S, Barton K, Michaelis L, Alkan S, Veerappan R, Rychlik K, Germano E, Stiff P) Leuk Lymphoma 2008 Nov;49(11):2141-7 59 Citations |
| 1 | Prediction of the effect of injected ethanol on pulmonary arterial pressure during sclerotherapy of arteriovenous malformations: relationship with dose of ethanol. (Ko JS, Kim JA, Do YS, Kwon MA, Choi SJ, Gwak MS, Lee JJ, Yang M) J Vasc Interv Radiol 2009 Jan;20(1):39-45; quiz 45 36 Citations |
| 1 | Transient anti-CD40L co-stimulation blockade prevents immune responses against human bullous pemphigoid antigen 2: implications for gene therapy. (Lanschuetzer CM, Olasz EB, Lazarova Z, Yancey KB) J Invest Dermatol 2009 May;129(5):1203-7 14 Citations |
| 1 | Feasibility of integrating FES grasp assistance with a task- oriented robot-assisted therapy environment: A case study (Nathan DE, Johnson MJ, McGuire J) Proceedings of the 2nd Biennial IEEE/RAS-EMBS International Conference on Biomedical Robotics and Biomechatronics, BioRob 2008 2008:807-812 16 Citations |
| 1 | Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial? (Grubbs EG, Rafeeq S, Jimenez C, Feng L, Lee JE, Evans DB, Perrier ND) Surgery 2008 Dec;144(6):852-8; discussion 858-9 66 Citations |
| 1 | Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia. (Chang JE, Medlin SC, Kahl BS, Longo WL, Williams EC, Lionberger J, Kim K, Kim J, Esterberg E, Juckett MB) Leuk Lymphoma 2008 Dec;49(12):2298-307 48 Citations |
| 1 | Attractor and Lyapunov models for reach and grasp movements with application to robot-assisted therapy. (Guastello SJ, Nathan DE, Johnson MJ) Nonlinear Dynamics Psychol Life Sci 2009 Jan;13(1):99-121 19 Citations |
| 1 | The role of investigational therapy in management of patients with advanced metastatic malignancy. (Freireich EJ, Kurzrock R) J Clin Oncol 2009 Jan 10;27(2):304-6 28 Citations |
| 1 | Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment. (Schwartz DL, Lobo MJ, Ang KK, Morrison WH, Rosenthal DI, Ahamad A, Evans DB, Clayman G, Sherman SI, Garden AS) Int J Radiat Oncol Biol Phys 2009 Jul 15;74(4):1083-91 134 Citations |
| 1 | American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT). (Hartford AC, Palisca MG, Eichler TJ, Beyer DC, Devineni VR, Ibbott GS, Kavanagh B, Kent JS, Rosenthal SA, Schultz CJ, Tripuraneni P, Gaspar LE, American Society for Therapeutic Radiology and Oncology, American College of Radiology) Int J Radiat Oncol Biol Phys 2009 Jan 01;73(1):9-14 82 Citations |
| 1 | Preoperative therapy for patients with resectable adenocarcinoma of the pancreatic head (Varadhachary GR, Crane CH, Evans DB) American Journal of Hematology/ Oncology January 2009;8(1) |
| 2 | SU‐FF‐T‐115: Dosimetric Comparison of Helical Tomotherapy with Conventional Techniques for Simultaneous Irradiation of Prone Breast and Regional Lymph Nodes (Kainz K, White J, Chen G, Li X) Medical Physics June 2009;36(6):2546 |
| 1 | Prevention of heart allograft rejection by immunotherapy with ex vivo-expanded Foxp3+CD4+CD25+ natural regulatory T cells (Xia G, Zhang Z, Johnson BD) Heart Transplantation: Indications and Contradictions, Procedures and Complications 1 January 2009:25-49 |
| 2 | SU‐FF‐T‐595: Correlations of Organ Growth with Age, Body Mass, and Height for Pediatric Radiotherapy Treatment Planning (Kainz K, Firat S, Moulder J, Kalakota K, Bagley J, Li X) Medical Physics June 2009;36(6):2661 1 Citation |
| 1 | Rescue therapy for early antibody mediated rejection with a proteasome inhibitor: a case report. (Manitpisitkul W, Wilson N, Cooper M, Gurk-Turner C, Hurley H, Rasetto F, KuKuruga D, Barth RN, Philosophe B) Clin Transpl 2009:461-3 1 Citation |
| 1 | WE‐C‐BRC‐08: A Method to Evaluate Region‐Specific Pulmonary Function Using 4D CT Images for Lung Cancer Patients Undergoing Radiation Therapy (Zhong H, Fragoso M, Patel S, Ajlouni M, Movsas B, Chetty I) Medical Physics June 2009;36(6):2762 1 Citation |
| 2 | SU‐DD‐A3‐01: Swallowing‐Induced Target Motion and Dosimetric Impact for Head and Neck Cancer Radiotherapy as Assessed by Dynamic MRI (Paulson E, Bradley J, Ahunbay E, Wang D, li X) Medical Physics June 2009;36(6):2424 1 Citation |
| 2 | SU‐FF‐T‐79: Dosimetric QA Tests of An Online Replanning Technique for Prostate Adaptive Radiotherapy (Peng C, Ahunbay E, Chen G, Lawton C, li X) Medical Physics June 2009;36(6):2537 1 Citation |
| 1 | Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. (Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T, ANCHOR Study Group) Ophthalmology 2009 Jan;116(1):57-65.e5 1236 Citations |
| 1 | Sequential chemotherapy and irradiation in advanced stage endometrial cancer: A Gynecologic Oncology Group phase I trial of doxorubicin-cisplatin followed by whole abdomen irradiation. (Fowler JM, Brady WE, Grigsby PW, Cohn DE, Mannel RS, Rader JS) Gynecol Oncol 2009 Mar;112(3):553-7 16 Citations |
| 1 | Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trial. (Bressler NM, Chang TS, Fine JT, Dolan CM, Ward J, Anti-VEGF Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization in Age-Related Macular Degeneration (ANCHOR) Research Group) Arch Ophthalmol 2009 Jan;127(1):13-21 86 Citations |
| 1 | Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. (Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA) Ophthalmology 2009 Mar;116(3):544-551.e1 78 Citations |
| 1 | Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy. (Diabetes Research in Children Network Study Group, Weinzimer S, Xing D, Tansey M, Fiallo-Scharer R, Mauras N, Wysocki T, Beck R, Tamborlane W, Ruedy K) Pediatr Diabetes 2009 Apr;10(2):91-6 54 Citations |
| 1 | A comparison of daily megavoltage CT and ultrasound image guided radiation therapy for prostate cancer. (Peng C, Kainz K, Lawton C, Li XA) Med Phys 2008 Dec;35(12):5619-28 25 Citations |
| 1 | Leukotriene pathway in sickle cell disease: a potential target for directed therapy. (Knight-Perry J, DeBaun MR, Strunk RC, Field JJ) Expert Rev Hematol 2009 Feb;2(1):57-68 18 Citations |
| 2 | Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants? (Gale RP, Eapen M, Logan B, Zhang MJ, Lazarus HM) Bone Marrow Transplant 2009 Mar;43(6):435-46 25 Citations |
| 1 | Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory. (Jing W, Gershan JA, Johnson BD) Blood 2009 Apr 30;113(18):4449-57 40 Citations |
| 1 | Effects of low-level light therapy on hepatic antioxidant defense in acute and chronic diabetic rats. (Lim J, Ali ZM, Sanders RA, Snyder AC, Eells JT, Henshel DS, Watkins JB 3rd) J Biochem Mol Toxicol 2009;23(1):1-8 33 Citations |
| 1 | Neuroendocrine tumors: novel approaches in the age of targeted therapy. (Phan AT, Yao JC) Oncology (Williston Park) 2008 Dec;22(14):1617-23; discussion 1623-4, 1629 12 Citations |
| 1 | Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study. (Li XA, Tai A, Arthur DW, Buchholz TA, Macdonald S, Marks LB, Moran JM, Pierce LJ, Rabinovitch R, Taghian A, Vicini F, Woodward W, White JR, Radiation Therapy Oncology Group Multi-Institutional and Multiobserver Study) Int J Radiat Oncol Biol Phys 2009 Mar 01;73(3):944-51 333 Citations |
| 1 | Laying the foundation for progress research in family, couple, and individual therapy: the development and psychometric features of the initial systemic therapy inventory of change. (Pinsof WM, Zinbarg RE, Lebow JL, Knobloch-Fedders LM, Durbin E, Chambers A, Latta T, Karam E, Goldsmith J, Friedman G) Psychother Res 2009 Mar;19(2):143-56 80 Citations |
| 1 | Patient anxiety about prostate cancer independently predicts early initiation of androgen deprivation therapy for biochemical cancer recurrence in older men: a prospective cohort study. (Dale W, Hemmerich J, Bylow K, Mohile S, Mullaney M, Stadler WM) J Clin Oncol 2009 Apr 01;27(10):1557-63 49 Citations |
| 1 | Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors. (Shields CL, Palamar M, Sharma P, Ramasubramanian A, Leahey A, Meadows AT, Shields JA) Arch Ophthalmol 2009 Mar;127(3):282-90 60 Citations |
| 1 | Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia. (Jacobson LM, Milstone AM, Zenilman J, Carroll KC, Arav-Boger R) Pediatr Infect Dis J 2009 May;28(5):445-7 16 Citations |
| 1 | The haemodynamic effects of adjunctive hormone therapy in potential heart donors: a prospective randomized double-blind factorially designed controlled trial. (Venkateswaran RV, Steeds RP, Quinn DW, Nightingale P, Wilson IC, Mascaro JG, Thompson RD, Townend JN, Bonser RS) Eur Heart J 2009 Jul;30(14):1771-80 97 Citations |
| 1 | Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. (Pennathur A, Farkas A, Krasinskas AM, Ferson PF, Gooding WE, Gibson MK, Schuchert MJ, Landreneau RJ, Luketich JD) Ann Thorac Surg 2009 Apr;87(4):1048-54; discussion 1054-5 235 Citations |
| 1 | Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. (Bajaj JS, Zadvornova Y, Heuman DM, Hafeezullah M, Hoffmann RG, Sanyal AJ, Saeian K) Am J Gastroenterol 2009 May;104(5):1130-4 193 Citations |
| 1 | Investigation of helical tomotherapy for partial-breast irradiation of prone-positioned patients. (Kainz K, White J, Herman J, Li XA) Int J Radiat Oncol Biol Phys 2009 May 01;74(1):275-82 19 Citations |
| 3 | Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant. (Lazarus HM, Kan F, Tarima S, Champlin RE, Confer DL, Frey N, Gee AP, Wagner JE, Horowitz MM, Eapen M) Biol Blood Marrow Transplant 2009 May;15(5):589-96 27 Citations |
| 1 | Myasthenia gravis associated with etanercept therapy. (Fee DB, Kasarskis EJ) Muscle Nerve 2009 Jun;39(6):866-70 52 Citations |
| 3 | Complete and durable response of choroid metastasis from non-small cell lung cancer with systemic bevacizumab and chemotherapy. (George B, Wirostko WJ, Connor TB, Choong NW) J Thorac Oncol 2009 May;4(5):661-2 35 Citations |
| 1 | WITHDRAWN: Cognitive effects of androgen deprivation therapy in an older cohort of men with prostrate cancer. (Mohile SG et al.) Crit Rev Oncol Hematol 2009 May 14: |
| 1 | Prospect of JAK2 inhibitor therapy in myeloproliferative neoplasms. (Atallah E, Verstovsek S) Expert Rev Anticancer Ther 2009 May;9(5):663-70 29 Citations |
| 1 | A phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer: Initial analysis of Radiation Therapy Oncology Group 0214. (Gore EM, Bae K, Wong S, Bonner J, Sun A, Schild S, Gaspar LE, Bogart J, Werner-Wasik M, Choy H) J Clin Oncol 2009 May 20;27(15_suppl):7506 |
| 2 | A randomized study comparing the Shaker exercise with traditional therapy: a preliminary study. (Logemann JA, Rademaker A, Pauloski BR, Kelly A, Stangl-McBreen C, Antinoja J, Grande B, Farquharson J, Kern M, Easterling C, Shaker R) Dysphagia 2009 Dec;24(4):403-11 113 Citations |
| 1 | Automated registration of large deformations for adaptive radiation therapy of prostate cancer. (Godley A, Ahunbay E, Peng C, Li XA) Med Phys 2009 Apr;36(4):1433-41 53 Citations |
| 1 | Combined intravitreal anti-VEGF and verteporfin photodynamic therapy for juxtafoveal and extrafoveal choroidal neovascularization as an alternative to laser photocoagulation. (Han DP, McAllister JT, Weinberg DV, Kim JE, Wirostko WJ) Eye (Lond) 2010 Apr;24(4):713-6 19 Citations |
| 1 | Research progress in stroke therapy. (Ding Y, Zwagerman NT) Neurol Res 2009 May;31(4):329-30 |
| 1 | Proton therapy in the management of pediatric malignant tumors (Firat S, Jogal S) UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi 2009;19(1):53-57 1 Citation |
| 1 | Imaging biomarkers predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer. (Shah C, Miller TW, Wyatt SK, McKinley ET, Olivares MG, Sanchez V, Nolting DD, Buck JR, Zhao P, Ansari MS, Baldwin RM, Gore JC, Schiff R, Arteaga CL, Manning HC) Clin Cancer Res 2009 Jul 15;15(14):4712-21 77 Citations |
| 1 | Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. (Brown DB, Gould JE, Gervais DA, Goldberg SN, Murthy R, Millward SF, Rilling WS, Geschwind JF, Salem R, Vedantham S, Cardella JF, Soulen MC, Society of Interventional Radiology Technology Assessment Committee and the International Working Group on Image-Guided Tumor Ablation) J Vasc Interv Radiol 2009 Jul;20(7 Suppl):S425-34 104 Citations |
| 1 | Three-dimensional imaging in gynecologic brachytherapy: a survey of the American Brachytherapy Society. (Viswanathan AN, Erickson BA) Int J Radiat Oncol Biol Phys 2010 Jan 01;76(1):104-9 181 Citations |
| 1 | The proinflammatory environment in potential heart and lung donors: prevalence and impact of donor management and hormonal therapy. (Venkateswaran RV, Dronavalli V, Lambert PA, Steeds RP, Wilson IC, Thompson RD, Mascaro JG, Bonser RS) Transplantation 2009 Aug 27;88(4):582-8 60 Citations |
| 1 | Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. (Das P, Delclos ME, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Bedi M, Krishnan S, Crane CH) Int J Radiat Oncol Biol Phys 2010 May 01;77(1):60-5 93 Citations |
| 1 | Oral antiplatelet therapy in unstable angina/non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction, and percutaneous coronary intervention: is it time for a guideline update? (Saucedo JF) Am J Cardiol 2009 Sep 07;104(5 Suppl):4C-8C 1 Citation |
| 1 | Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024. (Rosenthal DI, Harris J, Forastiere AA, Weber RS, Ridge JA, Myers JN, Garden AS, Kuettel MR, Sidhu K, Schultz CJ, Trotti A, Ang KK) J Clin Oncol 2009 Oct 01;27(28):4727-32 35 Citations |
| 1 | Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's disease. (Rosh JR, Lerer T, Markowitz J, Goli SR, Mamula P, Noe JD, Pfefferkorn MD, Kelleher KT, Griffiths AM, Kugathasan S, Keljo D, Oliva-Hemker M, Crandall W, Carvalho RS, Mack DR, Hyams JS) Am J Gastroenterol 2009 Dec;104(12):3042-9 116 Citations |
| 1 | Superselective catheterization of the ophthalmic artery for intraarterial chemotherapy for retinoblastoma. (Shields CL, Ramasubramanian A, Rosenwasser R, Shields JA) Retina 2009 Sep;29(8):1207-9 40 Citations |
| 1 | Gene therapy for red-green colour blindness in adult primates. (Mancuso K, Hauswirth WW, Li Q, Connor TB, Kuchenbecker JA, Mauck MC, Neitz J, Neitz M) Nature 2009 Oct 08;461(7265):784-7 274 Citations |
| 1 | An on-line replanning method for head and neck adaptive radiotherapya). (Ahunbay EE, Peng C, Godley A, Schultz C, Li XA) Med Phys 2009 Oct;36(10):4776-4790 |
| 1 | Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. (Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JYM, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R) J Am Acad Dermatol 2010 Jan;62(1):114-135 325 Citations |
| 1 | Design and validation of low-cost assistive glove for hand assessment and therapy during activity of daily living-focused robotic stroke therapy. (Nathan DE, Johnson MJ, McGuire JR) J Rehabil Res Dev 2009;46(5):587-602 46 Citations |
| 1 | Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer. (Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutic S, Mutch DG, Powell MA, Grigsby PW) Int J Radiat Oncol Biol Phys 2010 Jul 15;77(4):1085-91 179 Citations |
| 1 | Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy. (Bhatia A, Rao A, Ang KK, Garden AS, Morrison WH, Rosenthal DI, Evans DB, Clayman G, Sherman SI, Schwartz DL) Head Neck 2010 Jul;32(7):829-36 78 Citations |
| 2 | Role of radiation therapy in cutaneous melanoma. (Shuff JH, Siker ML, Daly MD, Schultz CJ) Clin Plast Surg 2010 Jan;37(1):147-60 8 Citations |
| 1 | Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's disease. (Stein DJ, Ananthakrishnan AN, Issa M, Williams JB, Beaulieu DB, Zadvornova Y, Ward A, Johnson K, Knox JF, Skaros S, Binion DG) Inflamm Bowel Dis 2010 Jul;16(7):1173-9 20 Citations |
| 2 | Follicular lymphoma transformation to dual translocated Burkitt-like lymphoma: improved disease control associated with radiation therapy. (Parker SM, Olteanu H, VanTuinen P, Lawton CA, Schultz CJ, Christians KK, Fenske TS) Int J Hematol 2009 Dec;90(5):616-622 11 Citations |
| 2 | An on-line replanning method for head and neck adaptive radiotherapy. (Ahunbay EE, Peng C, Godley A, Schultz C, Li XA) Med Phys 2009 Oct;36(10):4776-90 58 Citations |
| 1 | Device therapy and cardiac transplantation for end-stage heart failure. (Boilson BA, Raichlin E, Park SJ, Kushwaha SS) Curr Probl Cardiol 2010 Jan;35(1):8-64 49 Citations |
| 1 | Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. (Cheng YC, Rondón G, Sanchez LF, McMannis JD, Couriel DR, de Lima MJ, Hosing C, Khouri IF, Giralt SA, Champlin RE, Ueno NT) Int J Hematol 2009 Dec;90(5):627-634 5 Citations |
| 2 | Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management. (Griffith LM, Cowan MJ, Notarangelo LD, Puck JM, Buckley RH, Candotti F, Conley ME, Fleisher TA, Gaspar HB, Kohn DB, Ochs HD, O'Reilly RJ, Rizzo JD, Roifman CM, Small TN, Shearer WT, Workshop Participants) J Allergy Clin Immunol 2009 Dec;124(6):1152-60.e12 105 Citations |
| 2 | Tracheoesophageal fistula associated with bevacizumab 21 months after completion of radiation therapy. (Gore E, Currey A, Choong N) J Thorac Oncol 2009 Dec;4(12):1590-1 23 Citations |
| 3 | Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. (Litzow MR, Tarima S, Pérez WS, Bolwell BJ, Cairo MS, Camitta BM, Cutler CS, de Lima M, Dipersio JF, Gale RP, Keating A, Lazarus HM, Luger S, Marks DI, Maziarz RT, McCarthy PL, Pasquini MC, Phillips GL, Rizzo JD, Sierra J, Tallman MS, Weisdorf DJ) Blood 2010 Mar 04;115(9):1850-7 199 Citations |
| 1 | Effects of induction with novel agents versus conventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myeloma. (Benson DM Jr, Panzner K, Hamadani M, Hofmeister CC, Bakan CE, Smith MK, Elder P, Krugh D, O'Donnell L, Devine SM) Leuk Lymphoma 2010 Feb;51(2):243-51 15 Citations |
| 2 | SU‐GG‐T‐509: Development of a Database and Software Tools for Outcome Analysis of Breast Cancer Radiotherapy (Prior P, Chen G, White J, li X) Medical Physics June 2010;37(6):3304 |
| 1 | SU‐GG‐J‐43: Accumulating Delivered Doses Based on Daily CT in Head and Neck Cancer Radiotherapy (hu B, Godley A, Ahunbay E, Wang K, li X) Medical Physics June 2010;37(6):3154 |
| 4 | SU‐GG‐T‐23: Feasibility of an Online Adaptive Replanning Scheme for Pancreatic Cancer Radiotherapy (Peng C, Liu F, Ahunbay E, Tai A, Erickson B, Kelly T, li X) Medical Physics June 2010;37(6):3188 |
| 1 | SU‐GG‐T‐148: Planning Study for Cone Beam Therapy (Chen G, hu X, Corbit C, Shukla H, li X) Medical Physics June 2010;37(6):3219 |
| 1 | SU‐GG‐J‐50: The Role of 4DCT Sorting in Treatment Planning for Image‐Guided Radiation Therapy (Glide‐hurst C, Zhong H, Kim J, Chetty I) Medical Physics June 2010;37(6):3156 |
| 2 | SU‐GG‐J‐136: High Fidelity, Low Distortion Diffusion‐Weighted MRI for Head and Neck Cancer Radiotherapy Planning (Paulson E, Ahunbay E, li X) Medical Physics June 2010;37(6):3177 |
| 1 | SU‐GG‐J‐108: Validation Study of a Software Tool for Consensus Analysis of Experts' Contours for Generating Atlases of Radiotherapy Target and Normal Structures (Al‐lozi R, li X, White J, Tai A, Michalski J, Bosch W, el Naqa I) Medical Physics June 2010;37(6):3170 |
| 1 | Rescue therapy for acute antibody mediated rejection with a proteosome inhibitor after kidney transplantation. (Manitpisitkul W, Wilson NS, Philosophe B, Cooper M, Drachenberg C, Kukuruga D, Nogueira J, Haririan A) Clin Transpl 2010:421-8 1 Citation |
| 1 | SU‐GG‐T‐20: GPU‐Accelerated Auto‐Segmentation for Online Adaptive Radiotherapy (Godley A, Peng C, Ahunbay E, li X) Medical Physics June 2010;37(6):3188 1 Citation |
| 1 | SU‐GG‐T‐29: Dosimetric Advantages of Online Adaptive Replanning for Radiotherapy of the Prostate and Seminal Vesicles (Holmes S, Peng C, Ahunbay E, Lawton C, Wang D, li X) Medical Physics June 2010;37(6):3190 2 Citations |
| 1 | Evolution and prospects for intracranial pharmacotherapy for refractory epilepsies: the subdural hybrid neuroprosthesis. (Ludvig N, Medveczky G, French JA, Carlson C, Devinsky O, Kuzniecky RI) Epilepsy Res Treat 2010;2010:725696 |
| 1 | Transcatheter arterial chemoembolization is a feasible palliative locoregional therapy for breast cancer liver metastases. (Cho SW, Kitisin K, Buck D, Steel J, Brufsky A, Gillespie R, Tsung A, Marsh JW, Geller DA, Gamblin TC) Int J Surg Oncol 2010;2010:251621 |
| 1 | A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department. (Kostic MA, Gutierrez FJ, Rieg TS, Moore TS, Gendron RT) Ann Emerg Med 2010 Jul;56(1):1-6 |
| 2 | Upper limb function and brain reorganization after constraint-induced movement therapy in children with hemiplegia. (Cope SM, Liu XC, Verber MD, Cayo C, Rao S, Tassone JC) Dev Neurorehabil 2010 Feb;13(1):19-30 35 Citations |
| 1 | Effects of repeat bolus ethanol injections on cardiopulmonary hemodynamic changes during embolotherapy of arteriovenous malformations of the extremities. (Shin BS, Do YS, Cho HS, Kim DI, Hahm TS, Kim CS, Ko JS, Bang SR, Park KB, Cho SK, Park HS, Kim S) J Vasc Interv Radiol 2010 Jan;21(1):81-9 51 Citations |
| 1 | Mesenchymal stem cell therapy for nonhealing cutaneous wounds. (Hanson SE, Bentz ML, Hematti P) Plast Reconstr Surg 2010 Feb;125(2):510-516 135 Citations |
| 1 | Cytoprotective induction of nitric oxide synthase in a cellular model of 5-aminolevulinic acid-based photodynamic therapy. (Bhowmick R, Girotti AW) Free Radic Biol Med 2010 May 15;48(10):1296-301 77 Citations |
| 2 | Expression of natural killer receptors in T- and NK-cells: comparison of healthy individuals, patients with prior stem cell transplant, and patients undergoing chemotherapy. (Olteanu H, Schur BC, Bredeson C, Atallah E, Kroft SH) Leuk Lymphoma 2010 Mar;51(3):481-7 5 Citations |
| 1 | The National Marrow Donor Program's symposium on patient advocacy in cellular transplantation therapy: addressing barriers to hematopoietic cell transplantation. (Murphy EA, Ferguson SS, Omondi NA, Getzendaner LC, Gajewski JL, Goldstein GA, Wingard JR, Rizzo JD, Majhail NS) Biol Blood Marrow Transplant 2010 Feb;16(2):147-56 15 Citations |
| 1 | Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction. (Ajani JA, Correa AM, Walsh GL, Komaki R, Lee JH, Vaporciyan AA, Rice DC, Yao JC, Maru DM, Hofstetter WL, Phan AT, Swisher SG) Cancer 2010 Apr 01;116(7):1656-63 16 Citations |
| 1 | Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms. (Stinchcombe TE, Gore EM) Oncologist 2010;15(2):187-95 87 Citations |
| 1 | Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas. (Yoon SS, Chen YL, Kirsch DG, Maduekwe UN, Rosenberg AE, Nielsen GP, Sahani DV, Choy E, Harmon DC, DeLaney TF) Ann Surg Oncol 2010 Jun;17(6):1515-29 101 Citations |
| 1 | Helicase inhibitors as specifically targeted antiviral therapy for hepatitis C. (Belon CA, Frick DN) Future Virol 2009 May 01;4(3):277-293 45 Citations |
| 1 | Molecular Therapeutics in Hematology: Gene Therapy (Medin JA) Molecular Hematology: Third Edition 10 March 2010:318-335 |
| 1 | Stereotactic body radiation therapy for inoperable early stage lung cancer. (Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, Gore E, Choy H) JAMA 2010 Mar 17;303(11):1070-6 2171 Citations |
| 1 | The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection. (Markowitz M, Vaida F, Hare CB, Boden D, Mohri H, Hecht FM, Kalayjian RC, Conrad A, Mildvan D, Aberg J, Hogan C, Kilby JM, Balfour HH Jr, Schafer K, Richman D, Little S) J Infect Dis 2010 May 01;201(9):1298-302 32 Citations |
| 1 | Effects of low-level light therapy on streptozotocin-induced diabetic kidney. (Lim J, Sanders RA, Snyder AC, Eells JT, Henshel DS, Watkins JB 3rd) J Photochem Photobiol B 2010 May 03;99(2):105-10 29 Citations |
| 1 | Functional repair of human donor lungs by IL-10 gene therapy. (Cypel M, Liu M, Rubacha M, Yeung JC, Hirayama S, Anraku M, Sato M, Medin J, Davidson BL, de Perrot M, Waddell TK, Slutsky AS, Keshavjee S) Sci Transl Med 2009 Oct 28;1(4):4ra9 270 Citations |
| 1 | Online adaptive replanning method for prostate radiotherapy. (Ahunbay EE, Peng C, Holmes S, Godley A, Lawton C, Li XA) Int J Radiat Oncol Biol Phys 2010 Aug 01;77(5):1561-72 84 Citations |
| 1 | Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117. (Bradley JD, Bae K, Graham MV, Byhardt R, Govindan R, Fowler J, Purdy JA, Michalski JM, Gore E, Choy H) J Clin Oncol 2010 May 10;28(14):2475-80 130 Citations |
| 1 | Chemotherapy resistance and retreatment: a dogma revisited. (Naing A, Kurzrock R) Clin Colorectal Cancer 2010 Apr;9(2):E1-4 |
| 1 | Antitumor effects on primary tumor and metastatic lymph nodes by superselective intra-arterial concurrent chemoradiotherapy for oral cancer. (Uehara M, Shiraishi T, Tobita T, Nonaka M, Asahina I) Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010 Aug;110(2):172-7 8 Citations |
| 1 | Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: in regard to Bekelman and Yahalom (Int J Radiat Oncol Biol Phys 2009;73:492-498). (Fitzgerald TJ, Bishop-Jodoin M, Cicchetti MG, Hanusik R, Kessel S, Laurie F, McCarten KM, Moni J, Pieters RS, Rosen N, Ulin K, Urie M, Chauvenet AR, Constine LS, Deye J, Vikram B, Friedman D, Marcus RB Jr, Mendenhall NP, Williams JL, Purdy J, Saltz J, Schwartz CL, White KS, Wolden S) Int J Radiat Oncol Biol Phys 2010 May 01;77(1):315-6 8 Citations |
| 1 | Fetal cardiac arrhythmia detection and in utero therapy. (Strasburger JF, Wakai RT) Nat Rev Cardiol 2010 May;7(5):277-90 110 Citations |
| 1 | A systematic review of dental disease in patients undergoing cancer therapy. (Hong CH, Napeñas JJ, Hodgson BD, Stokman MA, Mathers-Stauffer V, Elting LS, Spijkervet FK, Brennan MT, Dental Disease Section, Oral Care Study Group, Multi-national Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO)) Support Care Cancer 2010 Aug;18(8):1007-21 203 Citations |
| 3 | Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemia. (Olteanu H, Harrington AM, Ramirez S, Kroft SH, Hari P) Br J Haematol 2010 Aug;150(4):480-1 4 Citations |
| 1 | A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117. (Bradley JD, Moughan J, Graham MV, Byhardt R, Govindan R, Fowler J, Purdy JA, Michalski JM, Gore E, Choy H) Int J Radiat Oncol Biol Phys 2010 Jun 01;77(2):367-72 115 Citations |
| 1 | Mitochondrial targeting for photochemotherapy. Can selective tumor cell killing be predicted based on n-octanol/water distribution coefficients? (Belostotsky I, da Silva SM, Paez MG, Indig GL) Biotech Histochem 2011 Oct;86(5):302-14 15 Citations |
| 1 | Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study. (Friberg TR, Tolentino M, LEVEL Study Group, Weber P, Patel S, Campbell S, Goldbaum M) Br J Ophthalmol 2010 Dec;94(12):1611-7 46 Citations |
| 3 | Persistent localized bone marrow aplasia after radiotherapy with preserved peripheral counts: a study of 8 cases. (Harrington AM, Currey A, Olteanu H, Kroft SH) Ann Diagn Pathol 2010 Jun;14(3):168-72 4 Citations |
| 1 | Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. (Lim K, Small W Jr, Portelance L, Creutzberg C, Jürgenliemk-Schulz IM, Mundt A, Mell LK, Mayr N, Viswanathan A, Jhingran A, Erickson B, De los Santos J, Gaffney D, Yashar C, Beriwal S, Wolfson A, Taylor A, Bosch W, El Naqa I, Fyles A, Gyn IMRT Consortium) Int J Radiat Oncol Biol Phys 2011 Feb 01;79(2):348-55 380 Citations |
| 1 | Targeted therapy in non-small-cell lung cancer--is it becoming a reality? (Janku F, Stewart DJ, Kurzrock R) Nat Rev Clin Oncol 2010 Jul;7(7):401-14 247 Citations |
| 1 | Eating experiences of children and adolescents with chemotherapy-related nausea and mucositis. (Green R, Horn H, Erickson JM) J Pediatr Oncol Nurs 2010;27(4):209-16 45 Citations |
| 1 | Resistance to mammalian target of rapamycin inhibitor therapy in perivascular epithelioid cell tumors. (Subbiah V, Trent JC, Kurzrock R) J Clin Oncol 2010 Aug 20;28(24):e415 48 Citations |
| 1 | Pulmonary artery embolotherapy in a patient with type I hepatopulmonary syndrome after liver transplantation. (Lee HW, Suh KS, Kim J, Shin WY, Yi NJ, Jae HJ, Chung JW, Oh SW, Kang KW, Lee KU) Korean J Radiol 2010;11(4):485-9 12 Citations |
| 1 | Patterns of fatigue in adolescents receiving chemotherapy. (Erickson JM, Beck SL, Christian B, Dudley WN, Hollen PJ, Albritton K, Sennett MM, Dillon R, Godder K) Oncol Nurs Forum 2010 Jul;37(4):444-55 38 Citations |
| 1 | Evaluation of B7-H3 expression as a biomarker of biochemical recurrence after salvage radiation therapy for recurrent prostate cancer. (Parker AS, Heckman MG, Sheinin Y, Wu KJ, Hilton TW, Diehl NN, Pisansky TM, Schild SE, Kwon ED, Buskirk SJ) Int J Radiat Oncol Biol Phys 2011 Apr 01;79(5):1343-9 32 Citations |
| 1 | Beta-blocker therapy and hemophagocytic lymphohistiocytosis: a case report. (Müller C, Mänhardt LB, Willaschek C, Schneider EM, Stuth EA, Buchhorn R) Cardiol Res Pract 2010;2010:912757 5 Citations |
| 1 | Evaluation of a modified early goal-directed therapy protocol. (Crowe CA, Mistry CD, Rzechula K, Kulstad CE) Am J Emerg Med 2010 Jul;28(6):689-93 21 Citations |
| 1 | Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma? (Crosby MA, Tward JD, Szabo A, Lee CM, Gaffney DK) Am J Clin Oncol 2010 Aug;33(4):364-9 20 Citations |
| 1 | Anti-CD25 antibody (daclizumab) maintenance therapy in pancreas transplantation. (Kirchner VA, Suszynski TM, Radosevich DM, Humar A, Dunn TB, Hill MJ, Finger EB, Sutherland DE, Kandaswamy R) Transplant Proc 2010;42(6):2003-5 6 Citations |
| 1 | Tools for consensus analysis of experts' contours for radiotherapy structure definitions. (Allozi R, Li XA, White J, Apte A, Tai A, Michalski JM, Bosch WR, El Naqa I) Radiother Oncol 2010 Dec;97(3):572-8 88 Citations |
| 2 | Characterizing interfraction variations and their dosimetric effects in prostate cancer radiotherapy. (Peng C, Ahunbay E, Chen G, Anderson S, Lawton C, Li XA) Int J Radiat Oncol Biol Phys 2011 Mar 01;79(3):909-14 65 Citations |
| 2 | Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy. (Evans DB, Erickson BA, Ritch P) Ann Surg Oncol 2010 Nov;17(11):2803-5 61 Citations |
| 1 | Cytology versus visual inspection with acetic acid among women treated previously with cryotherapy in a low-resource setting. (Cremer M, Bullard K, Maza M, Peralta E, Moore E, Garcia L, Masch R, Lerner V, Alonzo TA, Felix J) Int J Gynaecol Obstet 2010 Dec;111(3):249-52 14 Citations |
| 1 | CPAP and bi-level PAP therapy: new and established roles. (Antonescu-Turcu A, Parthasarathy S) Respir Care 2010 Sep;55(9):1216-29 56 Citations |
| 5 | Socioeconomic factors associated with adjuvant hormone therapy use in older breast cancer survivors. (Yen TW, Czypinski LK, Sparapani RA, Guo C, Laud PW, Pezzin LE, Nattinger AB) Cancer 2011 Jan 15;117(2):398-405 19 Citations |
| 1 | Prevention of diabetic nephropathy in Ins2(+/)⁻(AkitaJ) mice by the mitochondria-targeted therapy MitoQ. (Chacko BK, Reily C, Srivastava A, Johnson MS, Ye Y, Ulasova E, Agarwal A, Zinn KR, Murphy MP, Kalyanaraman B, Darley-Usmar V) Biochem J 2010 Nov 15;432(1):9-19 199 Citations |
| 1 | Takotsubo cardiomyopathy after electroconvulsive therapy. (Beach SR, Wichman CL, Canterbury RJ) Psychosomatics 2010;51(5):432-6 24 Citations |
| 1 | Tranexamic acid: an alternative to aprotinin as antifibrinolytic therapy in pediatric congenital heart surgery. (Schindler E, Photiadis J, Sinzobahamvya N, Döres A, Asfour B, Hraska V) Eur J Cardiothorac Surg 2011 Apr;39(4):495-9 27 Citations |
| 1 | Promoter-specific lentivectors for long-term, cardiac-directed therapy of Fabry disease. (Lee CJ, Fan X, Guo X, Medin JA) J Cardiol 2011 Jan;57(1):115-22 33 Citations |
| 1 | Dramatic improvement of inoperable angiosarcoma with combination paclitaxel and bevacizumab chemotherapy. (Fuller CK, Charlson JA, Dankle SK, Russell TJ) J Am Acad Dermatol 2010 Oct;63(4):e83-4 36 Citations |
| 1 | Skull base osteoradionecrosis following radiotherapy for acromegaly (Harris MS, Moore LT, Pritz MB, Summerlin DJ, Moore MG) Laryngoscope October 2010;120(SUPPL. 3) |
| 1 | Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer. (Kerns SL, Ostrer H, Stock R, Li W, Moore J, Pearlman A, Campbell C, Shao Y, Stone N, Kusnetz L, Rosenstein BS) Int J Radiat Oncol Biol Phys 2010 Dec 01;78(5):1292-300 129 Citations |
| 1 | The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy. (Kizer NT, Thaker PH, Gao F, Zighelboim I, Powell MA, Rader JS, Mutch DG, Grigsby PW) Cancer 2011 Mar 01;117(5):948-56 80 Citations |
| 1 | The role of image guided radiotherapy in the treatment of soft tissue sarcoma (Bradley JA, Kainz K, Li XA, Wang D) Current Cancer Therapy Reviews 2010;6(3):207-213 2 Citations |
| 1 | Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group. (Machtay M, Bae K, Movsas B, Paulus R, Gore EM, Komaki R, Albain K, Sause WT, Curran WJ) Int J Radiat Oncol Biol Phys 2012 Jan 01;82(1):425-34 251 Citations |
| 1 | Rituximab and CHOP chemotherapy plus GM-CSF for previously untreated diffuse large B-cell lymphoma in the elderly: a Wisconsin oncology network study. (Chang JE, Seo S, Kim KM, Werndli JE, Bottner WA, Rodrigues GA, Sanchez FA, Saphner TJ, Longo WL, Kahl BS) Clin Lymphoma Myeloma Leuk 2010 Oct;10(5):379-84 14 Citations |
| 1 | Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. (Collins MP, Dyck PJ, Gronseth GS, Guillevin L, Hadden RD, Heuss D, Léger JM, Notermans NC, Pollard JD, Said G, Sobue G, Vrancken AF, Kissel JT, Peripheral Nerve Society) J Peripher Nerv Syst 2010 Sep;15(3):176-84 224 Citations |
| 2 | Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010. (Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R, Scheinberg P, Savage S, Maciejewski JP, Tiu RV, DiFronzo N, Horowitz MM, Antin JH) Biol Blood Marrow Transplant 2011 Mar;17(3):291-9 34 Citations |
| 2 | Irradiation toxic effects during intra-arterial chemotherapy for retinoblastoma: should we be concerned? (Vijayakrishnan R, Shields CL, Ramasubramanian A, Emrich J, Rosenwasser R, Shields JA) Arch Ophthalmol 2010 Nov;128(11):1427-31 42 Citations |
| 1 | Fatigue, sleep-wake disturbances, and quality of life in adolescents receiving chemotherapy. (Erickson JM, Beck SL, Christian BR, Dudley W, Hollen PJ, Albritton KA, Sennett M, Dillon RL, Godder K) J Pediatr Hematol Oncol 2011 Jan;33(1):e17-25 71 Citations |
| 1 | American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of high-dose-rate brachytherapy. (Erickson BA, Demanes DJ, Ibbott GS, Hayes JK, Hsu IC, Morris DE, Rabinovitch RA, Tward JD, Rosenthal SA) Int J Radiat Oncol Biol Phys 2011 Mar 01;79(3):641-9 40 Citations |
| 2 | Psychiatric risk factors for HIV disease progression: the role of inconsistent patterns of antiretroviral therapy utilization. (Carrico AW, Riley ED, Johnson MO, Charlebois ED, Neilands TB, Remien RH, Lightfoot MA, Steward WT, Weinhardt LS, Kelly JA, Rotheram-Borus MJ, Morin SF, Chesney MA) J Acquir Immune Defic Syndr 2011 Feb 01;56(2):146-50 117 Citations |
| 2 | Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. (Gore EM, Bae K, Wong SJ, Sun A, Bonner JA, Schild SE, Gaspar LE, Bogart JA, Werner-Wasik M, Choy H) J Clin Oncol 2011 Jan 20;29(3):272-8 257 Citations |
| 1 | Rapid upregulation of cytoprotective nitric oxide in breast tumor cells subjected to a photodynamic therapy-like oxidative challenge. (Bhowmick R, Girotti AW) Photochem Photobiol 2011;87(2):378-86 41 Citations |
| 5 | Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients. (Neuner JM, Yen TW, Sparapani RA, Laud PW, Nattinger AB) Osteoporos Int 2011 Nov;22(11):2847-55 32 Citations |
| 1 | Guidance for developing phase II cell therapy trial proposals for consideration by the Blood and Marrow Transplant Clinical Trials Network. (Horwitz EM, Horowitz MM, DiFronzo NL, Kohn DB, Heslop HE, Blood and Marrow Transplant Clinical Trials Network, State of the Science Cell and Gene Therapy Committee) Biol Blood Marrow Transplant 2011 Feb;17(2):192-6 1 Citation |
| 1 | A unique paradoxical reaction to tuberculosis therapy: case report and brief review of the literature. (Singh B, Iqbal FM, Sunkavalli KK, Chawla B) Am J Ther 2013;20(6):e706-9 4 Citations |
| 1 | Prevention of heart allograft rejection by immunotherapy with ex vivo-expanded Foxp3+CD4+CD25+ natural regulatory T cells (Xia G, Zhang Z, Johnson BD) Heart Transplantation: Indications and Contraindications, Procedures and Complications January 2011:25-49 |
| 1 | Radiation therapy and cancer treatment: From the basics to combination therapies that ignite immunity (Moretti A, Jaffray DA, Medin JA) Experimental and Applied Immunotherapy 2011:357-388 |
| 1 | SU‐E‐T‐780: Evaluation of Margin‐Reduction Using a Framework for Image‐Guided Adaptive Radiotherapy (IGART) of Prostate Cancer in the Clinical Setting () Medical Physics June 2011;38(6):3670 |
| 2 | TH‐C‐BRA‐04: Online Adaptive Radiotherapy for Prostate Cancer: Clinical Implementation and Initial Experience (li XA, Ahunbay E, Peng C, Chen G, Liu F, Lawton C) Medical Physics June 2011;38(6):3852-3853 |
| 1 | SU‐E‐T‐224: An Assessment of EBT2 Gafchromic Film as a Potential Means for Depth Dose Measurement of Radiotherapy Beams (Arjomandy B, Tailor R, Zhao L, Devic S) Medical Physics June 2011;38(6):3538 |
| 2 | SU‐E‐T‐44: Model Prediction of Radiation Induced Duodenal Toxicity for a Dose Escalation in Radiation Therapy of Pancreatic Cancer Using Published Reports (Prior P, Erickson B, li X) Medical Physics June 2011;38(6):3495 |
| 2 | SU‐D‐BRC‐02: Predicting Individual Lung Tumor Volume Change during Image‐ Guided Radiation Therapy for Adaptive Radiation Therapy (Tai A, Gore E, li AX) Medical Physics June 2011;38(6):3384 |
| 1 | Adaptive Radiation Therapy for Breast Cancer (Kainz K, Li XA, White J) Adaptive Radiation Therapy 1 January 2011:275-291 |
| 1 | Adaptive Radiotherapy for Treatment of Soft-Tissue Sarcoma (Bradley JA, Kainz K, Li XA, DeLaney TF, Wang D) Adaptive Radiation Therapy 1 January 2011:369-381 |
| 2 | SU‐E‐J‐142: A Comparison of TomoTherapy and Respiratory‐Gated IG‐IMRT for the Treatment of Pancreatic Cancer (Prah D, Erickson B, li X) Medical Physics June 2011;38(6):3475 1 Citation |
| 1 | Experimental and applied immunotherapy (Medin J, Fowler D) Experimental and Applied Immunotherapy 2011:1-442 1 Citation |
| 1 | Adaptive Radiation Therapy for Gynecologic Cancers (Erickson B, Lim K, Stewart J, Donnelly E, Small W, Fyles A, Milosevic M) Adaptive Radiation Therapy 1 January 2011:351-368 2 Citations |
| 1 | Generalized morphea after breast cancer radiation therapy. (Kushi J, Csuka ME) Case Rep Rheumatol 2011;2011:951948 |
| 1 | Radiation therapy and cancer treatment: From the basics to combination therapies that ignite immunity () Experimental and Applied Immunotherapy 2011:357-388 |
| 1 | The value of a trial of therapy - football as a 'proof-of-concept'. (Meadow W, Meadow X, Tanz RR, Lagatta J, Lantos J) Acta Paediatr 2011 Feb;100(2):167-9 11 Citations |
| 1 | Age as an independent prognostic factor in patients with glioblastoma: a Radiation Therapy Oncology Group and American College of Surgeons National Cancer Data Base comparison. (Siker ML, Wang M, Porter K, Nelson DF, Curran WJ, Michalski JM, Souhami L, Chakravarti A, Yung WK, Delrowe J, Coughlin CT, Mehta MP) J Neurooncol 2011 Aug;104(1):351-6 36 Citations |
| 1 | Alternative strategies for gene therapy of hemophilia. (Montgomery RR, Shi Q) Hematology Am Soc Hematol Educ Program 2010;2010:197-202 5 Citations |
| 4 | Semicontinuous low-dose-rate teletherapy for the treatment of recurrent glial brain tumors: final report of a phase I/II study. (Siker ML, Firat SY, Mueller W, Krouwer H, Schultz CJ) Int J Radiat Oncol Biol Phys 2012 Feb 01;82(2):765-72 7 Citations |
| 1 | Immune trigeminal sensory neuropathy with esophageal achalasia: improvement with long-term immunotherapy. (Figueroa JJ, Engelstad JK, Spinner RJ, Dyck PJ) Muscle Nerve 2011 Feb;43(2):289-93 |
| 1 | A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial. (Angiolillo DJ, Badimon JJ, Saucedo JF, Frelinger AL, Michelson AD, Jakubowski JA, Zhu B, Ojeh CK, Baker BA, Effron MB) Eur Heart J 2011 Apr;32(7):838-46 178 Citations |
| 1 | Impact of neoadjuvant chemotherapy on breast reconstruction. (Hu YY, Weeks CM, In H, Dodgion CM, Golshan M, Chun YS, Hassett MJ, Corso KA, Gu X, Lipsitz SR, Greenberg CC) Cancer 2011 Jul 01;117(13):2833-41 43 Citations |
| 1 | Obese frailty, physical performance deficits, and falls in older men with biochemical recurrence of prostate cancer on androgen deprivation therapy: a case-control study. (Bylow K, Hemmerich J, Mohile SG, Stadler WM, Sajid S, Dale W) Urology 2011 Apr;77(4):934-40 55 Citations |
| 1 | Helical tomotherapy for anal cancer: Initial clinical outcomes and organ motion. (Siker ML, Qi XS, Hu B, Wong SJ, Li XA, Erickson B) J Clin Oncol 2011 Feb;29(4_suppl):530 |
| 1 | An early computed tomography-guided antifungal treatment strategy is safe and efficacious in patients undergoing chemotherapy for high-risk acute leukemia. (Mohammed K, Dignan F, Ethell ME, Davies FE, Morgan GJ, Riley U, Evans S, Potter MN, Shaw BE) Leuk Lymphoma 2011 Feb;52(2):339-40 |
| 1 | Application of machine learning methods to describe the effects of conjugated equine estrogens therapy on region-specific brain volumes. (Casanova R, Espeland MA, Goveas JS, Davatzikos C, Gaussoin SA, Maldjian JA, Brunner RL, Kuller LH, Johnson KC, Mysiw WJ, Wagner B, Resnick SM, Women's Health Initiative Memory Study) Magn Reson Imaging 2011 May;29(4):546-53 17 Citations |
| 9 | Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer. (Zundel MT, Michel MA, Schultz CJ, Maheshwari M, Wong SJ, Campbell BH, Massey BL, Blumin J, Wilson JF, Wang D) Int J Radiat Oncol Biol Phys 2011 Dec 01;81(5):e825-32 37 Citations |
| 3 | Dynamic MRI analysis of tumor and organ motion during rest and deglutition and margin assessment for radiotherapy of head-and-neck cancer. (Bradley JA, Paulson ES, Ahunbay E, Schultz C, Li XA, Wang D) Int J Radiat Oncol Biol Phys 2011 Dec 01;81(5):e803-12 39 Citations |
| 2 | Muscle endurance, cancer-related fatigue, and radiotherapy in prostate cancer survivors. (Alt CA, Gore EM, Montagnini ML, Ng AV) Muscle Nerve 2011 Mar;43(3):415-24 12 Citations |
| 1 | Long-term therapy with bevacizumab in hereditary hemorrhagic telangiectasia. (Brinkerhoff BT, Poetker DM, Choong NW) N Engl J Med 2011 Feb 17;364(7):688-9 33 Citations |
| 2 | Adjuvant high dose rate brachytherapy for soft tissue sarcomas: initial experience report. (Bradley JA, Kleinman SH, Rownd J, King D, Hackbarth D, Whitfield R, Wang D) J Contemp Brachytherapy 2011 Mar;3(1):3-10 4 Citations |
| 1 | Impact of response to thalidomide-, lenalidomide- or bortezomib- containing induction therapy on the outcomes of multiple myeloma patients undergoing autologous transplantation. (Awan FT, Osman S, Kochuparambil ST, Gibson L, Remick SC, Abraham J, Craig M, Jillella A, Hamadani M) Bone Marrow Transplant 2012 Jan;47(1):146-8 5 Citations |
| 1 | Adjuvant therapy for pancreatic cancer: a logical strategy in search of progress. (Evans DB, Wolff RA) Ann Surg Oncol 2011 May;18(5):1224-8 1 Citation |
| 1 | Early neonatal intensive care unit therapy improves predictive power for the outcomes of ventilated extremely low birth weight infants. (Lagatta J, Andrews B, Caldarelli L, Schreiber M, Plesha-Troyke S, Meadow W) J Pediatr 2011 Sep;159(3):384-391.e1 17 Citations |
| 1 | Combination therapy with methotrexate and etanercept for refractory chronic recurrent multifocal osteomyelitis. (Eisenstein EM, Syverson GD, Vora SS, Williams CB) J Rheumatol 2011 Apr;38(4):782-3 25 Citations |
| 1 | Changes in pulmonary artery pressures during ethanol sclerotherapy for arteriovenous malformations: identifying the most vulnerable period. (Ko JS, Kim CS, Shin BS, Kim MJ, Lee JH, Kim KH, Do YS) Clin Radiol 2011 Jul;66(7):639-44 12 Citations |
| 1 | Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤ 6 brain metastases: a multi-institutional phase II trial. (McHaffie DR, Chabot P, Dagnault A, Suh JH, Fortin MA, Chang E, Timmerman R, Souhami L, Grecula J, Nabid A, Schultz C, Werner-Wasik M, Gaspar LE, Brachman D, Mody T, Mehta MP) J Neurooncol 2011 Nov;105(2):301-8 16 Citations |
| 1 | Contemporary etiology, outcomes, and therapy in pediatric myocarditis (Foerster SR, Canter CE) Progress in Pediatric Cardiology May 2011;31(2):123-128 8 Citations |
| 1 | Proposed angiographic criteria for measurement of vertebral artery origin stenosis: the vertebral origin treatment with endovascular therapy (VOTE) method. (Lazzaro MA, Badruddin A, Abraham MG, Edgell RC, Zaidat OO) J Stroke Cerebrovasc Dis 2012 Nov;21(8):712-6 5 Citations |
| 1 | Intensive insulin therapy in brain injury: a meta-analysis. (Zafar SN, Iqbal A, Farez MF, Kamatkar S, de Moya MA) J Neurotrauma 2011 Jul;28(7):1307-17 20 Citations |
| 1 | A description of professional pediatric physical therapy education. (Schreiber J, Goodgold S, Moerchen VA, Remec N, Aaron C, Kreger A) Pediatr Phys Ther 2011;23(2):201-4 46 Citations |
| 1 | Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: radiation therapy oncology group 0213. (Gore E, Bae K, Langer C, Extermann M, Movsas B, Okunieff P, Videtic G, Choy H) Clin Lung Cancer 2011 Mar;12(2):125-30 25 Citations |
| 1 | Intraocular pressure elevation during radioactive plaque brachytherapy for uveal melanoma. (Bhatia SK, Covert DJ, Wirostko WJ) Arch Ophthalmol 2011 May;129(5):668-9 2 Citations |
| 1 | Autophagy as a target for anticancer therapy. (Janku F, McConkey DJ, Hong DS, Kurzrock R) Nat Rev Clin Oncol 2011 May 17;8(9):528-39 717 Citations |
| 1 | Efficacy endpoints of RTOG 0247: A randomized phase II study of neoadjuvant capecitabine (C) and irinotecan (I) or C and oxaliplatin (O) with concurrent radiation therapy (RT) for locally advanced rectal cancer. (Wong SJ, Moughan J, Meropol NJ, Anne PR, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Haddock MG, Erickson B, Willett CG) J Clin Oncol 2011 May 20;29(15_suppl):3517 |
| 3 | Platelet gene therapy improves hemostatic function for integrin alphaIIbbeta3-deficient dogs. (Fang J, Jensen ES, Boudreaux MK, Du LM, Hawkins TB, Koukouritaki SB, Cornetta K, Wilcox DA) Proc Natl Acad Sci U S A 2011 Jun 07;108(23):9583-8 51 Citations |
| 2 | Validation of an online replanning technique for prostate adaptive radiotherapy. (Peng C, Chen G, Ahunbay E, Wang D, Lawton C, Li XA) Phys Med Biol 2011 Jun 21;56(12):3659-68 20 Citations |
| 1 | Oversight and management of a cell therapy clinical trial network: experience and lessons learned. (Moyé LA, Sayre SL, Westbrook L, Jorgenson BC, Handberg E, Anwaruddin S, Wagner KA, Skarlatos SI) Contemp Clin Trials 2011 Sep;32(5):614-9 5 Citations |
| 1 | Photodynamic therapy of cancer: an update. (Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J) CA Cancer J Clin 2011;61(4):250-81 4503 Citations |
| 3 | Internal margin assessment using cine MRI analysis of deglutition in head and neck cancer radiotherapy. (Paulson ES, Bradley JA, Wang D, Ahunbay EE, Schultz C, Li XA) Med Phys 2011 Apr;38(4):1740-7 17 Citations |
| 1 | [Pleiotropic effects of nicotinic acid therapy in men with coronary heart disease and elevated lipoprotein(a) levels]. (Safarova MS, Trukhacheva EP, Ezhov MV, Afanas'eva OI, Afanas'eva MI, Tripoten' MI, Liakishev AA, Pokrovskiĭ SN) Kardiologiia 2011;51(5):9-16 14 Citations |
| 1 | Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications. (Shields CL, Bianciotto CG, Jabbour P, Griffin GC, Ramasubramanian A, Rosenwasser R, Shields JA) Arch Ophthalmol 2011 Nov;129(11):1407-15 152 Citations |
| 1 | Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. (Shields CL, Bianciotto CG, Jabbour P, Ramasubramanian A, Lally SE, Griffin GC, Rosenwasser R, Shields JA) Arch Ophthalmol 2011 Nov;129(11):1399-406 199 Citations |
| 1 | Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. (Mayo SC, de Jong MC, Bloomston M, Pulitano C, Clary BM, Reddy SK, Clark Gamblin T, Celinski SA, Kooby DA, Staley CA, Stokes JB, Chu CK, Arrese D, Ferrero A, Schulick RD, Choti MA, Geschwind JF, Strub J, Bauer TW, Adams RB, Aldrighetti L, Mentha G, Capussotti L, Pawlik TM) Ann Surg Oncol 2011 Dec;18(13):3657-65 145 Citations |
| 1 | Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation. (Estrella JS, Rashid A, Fleming JB, Katz MH, Lee JE, Wolf RA, Varadhachary GR, Pisters PW, Abdalla EK, Vauthey JN, Wang H, Gomez HF, Evans DB, Abbruzzese JL, Wang H) Cancer 2012 Jan 01;118(1):268-77 76 Citations |
| 2 | Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer. (Wong SJ, Winter K, Meropol NJ, Anne PR, Kachnic L, Rashid A, Watson JC, Mitchell E, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG) Int J Radiat Oncol Biol Phys 2012 Mar 15;82(4):1367-75 67 Citations |
| 1 | Abandonment of high-dose chemotherapy/hematopoietic cell transplants for breast cancer following negative trial results. (Howard DH, Kenline C, Lazarus HM, Lemaistre CF, Maziarz RT, McCarthy PL Jr, Parsons SK, Szwajcer D, Douglas Rizzo J, Majhail NS) Health Serv Res 2011 Dec;46(6pt1):1762-77 26 Citations |
| 1 | Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study. (Kumar SK, Lee JH, Lahuerta JJ, Morgan G, Richardson PG, Crowley J, Haessler J, Feather J, Hoering A, Moreau P, LeLeu X, Hulin C, Klein SK, Sonneveld P, Siegel D, Bladé J, Goldschmidt H, Jagannath S, Miguel JS, Orlowski R, Palumbo A, Sezer O, Rajkumar SV, Durie BG, International Myeloma Working Group) Leukemia 2012 Jan;26(1):149-57 645 Citations |
| 1 | Endovascular therapy for chronic cerebrospinal venous insufficiency in multiple sclerosis. (Lazzaro MA, Zaidat OO, Mueller-Kronast N, Taqi MA, Woo D) Front Neurol 2011;2:44 3 Citations |
| 1 | Carotid plaque regression following 6-month statin therapy assessed by 3T cardiovascular magnetic resonance: comparison with ultrasound intima media thickness. (Migrino RQ, Bowers M, Harmann L, Prost R, LaDisa JF Jr) J Cardiovasc Magn Reson 2011 Aug 03;13(1):37 49 Citations |
| 1 | VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study. (Chang JE, Peterson C, Choi S, Eickhoff JC, Kim K, Yang DT, Gilbert LA, Rogers ES, Werndli JE, Huie MS, McFarland TA, Volk M, Blank J, Callander NS, Longo WL, Kahl BS) Br J Haematol 2011 Oct;155(2):190-7 51 Citations |
| 1 | Fluid overload at initiation of renal replacement therapy is associated with lack of renal recovery in patients with acute kidney injury. (Heung M, Wolfgram DF, Kommareddi M, Hu Y, Song PX, Ojo AO) Nephrol Dial Transplant 2012 Mar;27(3):956-61 174 Citations |
| 1 | Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology Network. (Kenkre VP, Long WL, Eickhoff JC, Blank JH, McFarland TA, Bottner W, Rezazedeh H, Werndli JE, Bailey HH, Kahl BS) Leuk Lymphoma 2011 Sep;52(9):1675-80 37 Citations |
| 1 | Bilateral assessment of functional tasks for robot-assisted therapy applications. (Johnson MJ, Wang S, Bai P, Strachota E, Tchekanov G, Melbye J, McGuire J) Med Biol Eng Comput 2011 Oct;49(10):1157-71 23 Citations |
| 1 | Extended-field irradiation and intracavitary brachytherapy combined with cisplatin and amifostine for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm II of Radiation Therapy Oncology Group (RTOG) 0116. (Small W Jr, Winter K, Levenback C, Iyer R, Hymes SR, Jhingran A, Gaffney D, Erickson B, Greven K) Int J Gynecol Cancer 2011 Oct;21(7):1266-75 36 Citations |
| 1 | Performance of endovenous foam sclerotherapy in the USA. (Rathbun S, Norris A, Morrison N, Gibson K, Hohenwalter E, Lohr J, Raymond-Martimbeau P, Worthington-Kirsch R, Stoner J) Phlebology 2012 Mar;27(2):59-66 11 Citations |
| 1 | Lymphedema and arm symptoms following three-dimensional conformal radiation therapy (3DCRT) for node-positive breast cancer (BC) patients. (Sparks I, Prior P, Xiang Q, Li XA, Yen TW, White JR) J Clin Oncol 2011 Sep 20;29(27_suppl):130 |
| 1 | Choosing first-line therapy for chronic lymphocytic leukemia. (Jaglowski S, Jones JA) Expert Rev Anticancer Ther 2011 Sep;11(9):1379-90 16 Citations |
| 1 | Subperiosteal abscess of the orbit: duration of intravenous antibiotic therapy in nonsurgical cases. (Emmett Hurley P, Harris GJ) Ophthalmic Plast Reconstr Surg 2012;28(1):22-6 28 Citations |
| 3 | Multimodal endovascular therapy of traumatic and spontaneous carotid cavernous fistula using coils, n-BCA, Onyx and stent graft. (Zaidat OO, Lazzaro MA, Niu T, Hong SH, Fitzsimmons BF, Lynch JR, Sinson GP) J Neurointerv Surg 2011 Sep;3(3):255-62 36 Citations |
| 1 | Correction of murine Bernard-Soulier syndrome by lentivirus-mediated gene therapy. (Kanaji S, Kuether EL, Fahs SA, Schroeder JA, Ware J, Montgomery RR, Shi Q) Mol Ther 2012 Mar;20(3):625-32 30 Citations |
| 1 | Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicity. (Rocque G, Onitilo A, Engel J, Pettke E, Boshoven A, Kim K, Rishi S, Waack B, Wisinski KB, Tevaarwerk A, Burkard ME) Breast Cancer Res Treat 2012 Jan;131(2):713-21 17 Citations |
| 1 | Gynecologic radiation therapy: Novel approaches to image-guidance and management (Viswanathan AN, Kirisits C, Erickson BE, Pötter R) Gynecologic Radiation Therapy: Novel Approaches to Image-Guidance and Management 2011:1-308 26 Citations |
| 2 | Image-based approaches to interstitial brachytherapy (Viswanathan AN, Erickson BE, Rownd J) Gynecologic Radiation Therapy: Novel Approaches to Image-Guidance and Management 2011:247-259 28 Citations |
| 1 | ACR Appropriateness Criteria® role of adjuvant therapy in the management of early stage cervical cancer. (Wolfson AH, Varia MA, Moore D, Rao GG, Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Small W Jr, Yashar CM, Yuh W, Cardenes HR, American College of Radiology (ACR)) Gynecol Oncol 2012 Apr;125(1):256-62 15 Citations |
| 1 | Anticoagulation-induced severe bleeding in a patient receiving bevacizumab therapy. (Munoz J, Hong D, Kurzrock R) Int J Hematol 2012 Jan;95(1):1-2 3 Citations |
| 1 | Psychosis in the context of sodium oxybate therapy. (Langford J, Gross WL) J Clin Sleep Med 2011 Dec 15;7(6):665-6 15 Citations |
| 1 | The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals. (Hogan CM, Degruttola V, Sun X, Fiscus SA, Del Rio C, Hare CB, Markowitz M, Connick E, Macatangay B, Tashima KT, Kallungal B, Camp R, Morton T, Daar ES, Little S, A5217 Study Team) J Infect Dis 2012 Jan 01;205(1):87-96 98 Citations |
| 1 | Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'. (Freed J, Talano J, Small T, Ricci A, Cairo MS) Bone Marrow Transplant 2012 Dec;47(12):1489-98 21 Citations |
| 1 | The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128. (Viswanathan AN, Moughan J, Small W Jr, Levenback C, Iyer R, Hymes S, Dicker AP, Miller B, Erickson B, Gaffney DK) Int J Gynecol Cancer 2012 Jan;22(1):123-31 108 Citations |
| 1 | SU‐C‐BRCD‐05: A Failure Mode and Effects Analysis (FMEA) Approach for Craniospinal Irradiation (CSI) with Proton Therapy (PT) (Cheng C, Allgower C, Simmons J, Conley T, Das I, Zhao L, Zhao Q, Johnstone P, Buchsbaum J) Medical Physics June 2012;39(6):3600 |
| 2 | TH‐E‐218‐09: Extracting Patient‐Specific Radiobiological Parameters for Radiobiologically Adaptive Radiotherapy Based on Radiation Response for Lung Cancer (Tai A, Gore E, li X) Medical Physics June 2012;39(6):4019 |
| 1 | Gene Therapy for Platelet Disorders (Wilcox DA) Platelets, Third Edition 1 January 2012:1313-1327 |
| 1 | SU‐E‐T‐295: Factors Affecting Accuracy in Proton Therapy (Cheng C, Zhao L, Zhao Q, Moskvin V, Buchsbaum J, Das I) Medical Physics June 2012;39(6):3771 1 Citation |
| 1 | Brachytherapy for Other Treatment Sites (Strnad V, Erickson B, Kudrimoti M) Comprehensive Brachytherapy: Physical and Clinical Aspects 1 January 2012:337-365 2 Citations |
| 1 | SU‐C‐BRB‐03: Modeling of Radiation‐Induced Sensorineural Hearing Loss from IMRT and Chemotherapy for Nasopharyngeal Carcinoma (Tai A, Wang J, Bao Y, Chen M, li X) Medical Physics June 2012;39(6):3601 2 Citations |
| 1 | Brachytherapy for Gynecologic Cancers (Erickson B, Kudrimoti M, Haie-Meder C) Comprehensive Brachytherapy: Physical and Clinical Aspects 1 January 2012:295-318 2 Citations |
| 1 | EBT2 film as a depth-dose measurement tool for radiotherapy beams over a wide range of energies and modalities (Arjomandy B, Tailor R, Zhao L, Devic S) Medical Physics February 2012;39(2):912-921 56 Citations |
| 4 | Prone whole-breast irradiation using three-dimensional conformal radiotherapy in women undergoing breast conservation for early disease yields high rates of excellent to good cosmetic outcomes in patients with large and/or pendulous breasts. (Bergom C, Kelly T, Morrow N, Wilson JF, Walker A, Xiang Q, Ahn KW, White J) Int J Radiat Oncol Biol Phys 2012 Jul 01;83(3):821-8 47 Citations |
| 2 | Evaluation of combined bevacizumab plus irinotecan therapy in brain tumors using magnetic resonance imaging measures of relative cerebral blood volume. (Pechman KR, Donohoe DL, Bedekar DP, Kurpad SN, Schmainda KM) Magn Reson Med 2012 Oct;68(4):1266-72 6 Citations |
| 1 | A second chance for a PPARγ targeted therapy? (Norris AW, Sigmund CD) Circ Res 2012 Jan 06;110(1):8-11 11 Citations |
| 1 | Factor VIII/von Willebrand factor concentrate therapy for ventricular assist device-associated acquired von Willebrand disease. (Cushing M, Kawaguchi K, Friedman KD, Mark T) Transfusion 2012 Jul;52(7):1535-41 23 Citations |
| 1 | Evaluation of the clinical relevance of body composition parameters in patients with cancer metastatic to the liver treated with hepatic arterial infusion chemotherapy. (Parsons HA, Tsimberidou AM, Pontikos M, Fu S, Hong D, Wen S, Baracos VE, Kurzrock R) Nutr Cancer 2012;64(2):206-17 29 Citations |
| 2 | American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer. (Beriwal S, Demanes DJ, Erickson B, Jones E, De Los Santos JF, Cormack RA, Yashar C, Rownd JJ, Viswanathan AN, American Brachytherapy Society) Brachytherapy 2012;11(1):68-75 157 Citations |
| 2 | American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. (Small W Jr, Beriwal S, Demanes DJ, Dusenbery KE, Eifel P, Erickson B, Jones E, Rownd JJ, De Los Santos JF, Viswanathan AN, Gaffney D, American Brachytherapy Society) Brachytherapy 2012;11(1):58-67 230 Citations |
| 1 | American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. (Viswanathan AN, Beriwal S, De Los Santos JF, Demanes DJ, Gaffney D, Hansen J, Jones E, Kirisits C, Thomadsen B, Erickson B, American Brachytherapy Society) Brachytherapy 2012;11(1):47-52 460 Citations |
| 1 | Cell fate control gene therapy based on engineered variants of human deoxycytidine kinase. (Neschadim A, Wang JC, Sato T, Fowler DH, Lavie A, Medin JA) Mol Ther 2012 May;20(5):1002-13 20 Citations |
| 1 | Building a better hormone therapy? How understanding the rapid effects of sex steroid hormones could lead to new therapeutics for age-related memory decline. (Frick KM) Behav Neurosci 2012 Feb;126(1):29-53 51 Citations |
| 1 | Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy. (Kharofa J, Cohen EP, Tomic R, Xiang Q, Gore E) Int J Radiat Oncol Biol Phys 2012 Sep 01;84(1):238-43 107 Citations |
| 1 | Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) study. (Richman S, Gee AP, McKenna DH, Traverse JH, Henry TD, Fisk D, Pepine CJ, Bloom J, Willerson JT, Prater K, Zhao D, Koç JR, Anwaruddin S, Taylor DA, Cogle CR, Moyé LA, Simari RD, Skarlatos SI) Transfusion 2012 Oct;52(10):2225-33 4 Citations |
| 1 | Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate. (Lawton CA, Yan Y, Lee WR, Gillin M, Firat S, Baikadi M, Crook J, Kuettel M, Morton G, Sandler H) Int J Radiat Oncol Biol Phys 2012 Apr 01;82(5):e795-801 52 Citations |
| 1 | Intramuscular versus intravenous therapy for prehospital status epilepticus. (Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, Barsan W, NETT Investigators) N Engl J Med 2012 Feb 16;366(7):591-600 |
| 3 | Immunophenotypic stability of Sézary cells by flow cytometry: usefulness of flow cytometry in assessing response to and guiding alemtuzumab therapy. (Vaughan J, Harrington AM, Hari PN, Kroft SH, Olteanu H) Am J Clin Pathol 2012 Mar;137(3):403-11 24 Citations |
| 1 | New strategies for advanced neuroendocrine tumors in the era of targeted therapy. (Dong M, Phan AT, Yao JC) Clin Cancer Res 2012 Apr 01;18(7):1830-6 44 Citations |
| 1 | Neonatal diuretic therapy: furosemide, thiazides, and spironolactone. (Segar JL) Clin Perinatol 2012 Mar;39(1):209-20 46 Citations |
| 1 | Impact of computed tomography image quality on image-guided radiation therapy based on soft tissue registration. (Morrow NV, Lawton CA, Qi XS, Li XA) Int J Radiat Oncol Biol Phys 2012 Apr 01;82(5):e733-8 46 Citations |
| 1 | Radiation exposure during intra-arterial chemotherapy for retinoblastoma - Reply (Shields CL, Vijayakrishnan R, Ramasubramanian A, Emrich J, Jabbour P, Shields JA) Archives of Ophthalmology March 2012;130(3):404-405 |
| 1 | Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study. (Levine JE, Logan BR, Wu J, Alousi AM, Bolaños-Meade J, Ferrara JL, Ho VT, Weisdorf DJ, Paczesny S) Blood 2012 Apr 19;119(16):3854-60 148 Citations |
| 1 | Bystander killing of malignant cells via the delivery of engineered thymidine-active deoxycytidine kinase for suicide gene therapy of cancer. (Neschadim A, Wang JC, Lavie A, Medin JA) Cancer Gene Ther 2012 May;19(5):320-7 20 Citations |
| 1 | A semi-empirical model for the therapeutic range shift estimation caused by inhomogeneities in proton beam therapy. (Moskvin V, Cheng CW, Fanelli L, Zhao L, Das IJ) J Appl Clin Med Phys 2012 Mar 08;13(2):3631 13 Citations |
| 1 | Antiplatelet therapy for patients with diabetes mellitus and acute coronary syndrome. (Saucedo JF) Prim Care Diabetes 2012 Oct;6(3):167-77 8 Citations |
| 1 | The power of subtle interpersonal hostility in psychodynamic psychotherapy: a speech acts analysis. (Anderson T, Knobloch-Fedders LM, Stiles WB, Ordoñez T, Heckman BD) Psychother Res 2012;22(3):348-62 9 Citations |
| 2 | Severe central sleep apnea in a child with leukemia on chronic methadone therapy. (Amos LB, D'Andrea LA) Pediatr Pulmonol 2013 Jan;48(1):85-7 8 Citations |
| 1 | Characterization and management of interfractional anatomic changes for pancreatic cancer radiotherapy. (Liu F, Erickson B, Peng C, Li XA) Int J Radiat Oncol Biol Phys 2012 Jul 01;83(3):e423-9 98 Citations |
| 1 | Survival of 1,181 patients in a phase I clinic: the MD Anderson Clinical Center for targeted therapy experience. (Wheler J, Tsimberidou AM, Hong D, Naing A, Falchook G, Piha-Paul S, Fu S, Moulder S, Stephen B, Wen S, Kurzrock R) Clin Cancer Res 2012 May 15;18(10):2922-9 83 Citations |
| 2 | Simultaneous irradiation of the breast and regional lymph nodes in prone position using helical tomotherapy. (Kainz K, White J, Chen GP, Hermand J, England M, Li XA) Br J Radiol 2012 Oct;85(1018):e899-905 9 Citations |
| 1 | Jorge Felix Saucedo, MD, MBA: a conversation with the editor on optimizing antiplatelet and antithrombotic therapy in patients having percutaneous coronary intervention for acute coronary syndromes. (Saucedo JF, Roberts WC) Proc (Bayl Univ Med Cent) 2012 Apr;25(2):136-8 |
| 2 | A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer. (Yao X, Hosenpud J, Chitambar CR, Charlson J, Cheng YC) J Cancer 2012;3:145-51 11 Citations |
| 2 | Efficacy and safety of self-expandable metal stents for biliary decompression in patients receiving neoadjuvant therapy for pancreatic cancer: a prospective study. (Aadam AA, Evans DB, Khan A, Oh Y, Dua K) Gastrointest Endosc 2012 Jul;76(1):67-75 90 Citations |
| 1 | Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis. (Sourianarayanane A, El-Gazzaz G, Sanabria JR, Menon KV, Quintini C, Hashimoto K, Kelly D, Eghtesad B, Miller C, Fung J, Aucejo F) HPB (Oxford) 2012 May;14(5):325-32 15 Citations |
| 1 | Hyperbaric oxygen therapy in necrotizing soft tissue infections. (Massey PR, Sakran JV, Mills AM, Sarani B, Aufhauser DD Jr, Sims CA, Pascual JL, Kelz RR, Holena DN) J Surg Res 2012 Sep;177(1):146-51 56 Citations |
| 1 | Calibrating the imaging and therapy performance of magneto-fluorescent gold nanoshells for breast cancer (Dowell A, Chen W, Biswal N, Ayala-Orozco C, Giuliano M, Schiff R, Halas NJ, Joshi A) Progress in Biomedical Optics and Imaging - Proceedings of SPIE 2012;8233 1 Citation |
| 3 | Elective lymph node irradiation with intensity-modulated radiotherapy: is conventional dose fractionation necessary? (Bedi M, Firat S, Semenenko VA, Schultz C, Tripp P, Byhardt R, Wang D) Int J Radiat Oncol Biol Phys 2012 May 01;83(1):e87-92 12 Citations |
| 1 | Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung. (Suntharalingam M, Paulus R, Edelman MJ, Krasna M, Burrows W, Gore E, Wilson LD, Choy H) Int J Radiat Oncol Biol Phys 2012 Oct 01;84(2):456-63 90 Citations |
| 1 | Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy. (Tendulkar RD, Rehman S, Shukla ME, Reddy CA, Moore H, Budd GT, Dietz J, Crowe JP, Macklis R) Int J Radiat Oncol Biol Phys 2012 Aug 01;83(5):e577-81 88 Citations |
| 1 | Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials. (Angiolillo DJ, Schneider DJ, Bhatt DL, French WJ, Price MJ, Saucedo JF, Shaburishvili T, Huber K, Prats J, Liu T, Harrington RA, Becker RC) J Thromb Thrombolysis 2012 Jul;34(1):44-55 136 Citations |
| 1 | Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell Mobilization. (Awan FT, Kochuparambil ST, Deremer D, Cumpston A, Craig M, Jillella A, Hamadani M) J Oncol 2012;2012:931071 13 Citations |
| 1 | Intraperitoneal and intravenous chemotherapy in peritoneal carcinomatosis. (Tsimberidou AM, Fu S, Subbiah IM, Naing A, Hong DS, Wen S, Fortier AH, Lim J, Kurzrock R) Hepatogastroenterology 2012 Jun;59(116):960-4 3 Citations |
| 1 | Long-term behavioral, electrophysiological, and neurochemical monitoring of the safety of an experimental antiepileptic implant, the muscimol-delivering Subdural Pharmacotherapy Device in monkeys. (Ludvig N, Tang HM, Baptiste SL, Medveczky G, Vaynberg JK, Vazquez-DeRose J, Stefanov DG, Devinsky O, French JA, Carlson C, Kuzniecky RI) J Neurosurg 2012 Jul;117(1):162-75 9 Citations |
| 1 | Pharmacotherapy of insomnia. (Ioachimescu OC, El-Solh AA) Expert Opin Pharmacother 2012 Jun;13(9):1243-60 23 Citations |
| 1 | Accumulating daily-varied dose distributions of prostate radiation therapy with soft-tissue-based kV CT guidance. (Godley A, Ahunbay E, Peng C, Li XA) J Appl Clin Med Phys 2012 May 10;13(3):3859 19 Citations |
| 1 | Diverse cutaneous side effects associated with BRAF inhibitor therapy: a clinicopathologic study. (Chu EY, Wanat KA, Miller CJ, Amaravadi RK, Fecher LA, Brose MS, McGettigan S, Giles LR, Schuchter LM, Seykora JT, Rosenbach M) J Am Acad Dermatol 2012 Dec;67(6):1265-72 159 Citations |
| 2 | Lentivirus-mediated platelet gene therapy of murine hemophilia A with pre-existing anti-factor VIII immunity. (Kuether EL, Schroeder JA, Fahs SA, Cooley BC, Chen Y, Montgomery RR, Wilcox DA, Shi Q) J Thromb Haemost 2012 Aug;10(8):1570-80 93 Citations |
| 1 | SU-E-T-579: Dosimetric Benefits of Online Adaptive Replanning for Post-Operative Radiation Therapy of Prostate Bed. (Liu F, Ahunbay E, Lawton C, Li X) Med Phys 2012 Jun;39(6Part19):3839 |
| 2 | SU-E-T-256: Radiation Dose Responses for Chemoradiation Therapy of Pancreatic Cancer: An Analysis of Compiled Clinical Data Using Biophysical Models. (Moraru I, Tai A, Erickson B, Li X) Med Phys 2012 Jun;39(6Part13):3762 |
| 1 | Intraventricular rituximab and systemic chemotherapy for treatment of central nervous system post-transplant lymphoproliferative disorder after kidney transplantation. (Twombley K, Pokala H, Ardura MI, Harker-Murray P, Johnson-Welch SF, Weinberg A, Seikaly M) Pediatr Transplant 2012 Sep;16(6):E201-9 16 Citations |
| 2 | SU-E-J-11: Characterization of Interfractioanal Anatomical Variations in Post-Operative Radiation Therapy for Prostate Bed. (Liu F, Ahunbay E, Christian R, Lawton C, Wang D, Li X) Med Phys 2012 Jun;39(6Part6):3654 |
| 2 | Does extracorporeal shock wave therapy enhance healing of osteochondritis dissecans of the rabbit knee?: a pilot study. (Lyon R, Liu XC, Kubin M, Schwab J) Clin Orthop Relat Res 2013 Apr;471(4):1159-65 25 Citations |
| 1 | Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance. (Balko JM, Cook RS, Vaught DB, Kuba MG, Miller TW, Bhola NE, Sanders ME, Granja-Ingram NM, Smith JJ, Meszoely IM, Salter J, Dowsett M, Stemke-Hale K, González-Angulo AM, Mills GB, Pinto JA, Gómez HL, Arteaga CL) Nat Med 2012 Jul;18(7):1052-9 221 Citations |
| 1 | Refusal of Life-Saving Therapy (Marco CA, Derse AR) Ethical Problems in Emergency Medicine: A Discussion-Based Review 20 June 2012:89-97 3 Citations |
| 1 | Clinical outcomes of radiotherapy as initial local therapy for Graves' ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgery. (Prabhu RS, Liebman L, Wojno T, Hayek B, Hall WA, Crocker I) Radiat Oncol 2012 Jun 19;7:95 34 Citations |
| 1 | Dose correction in lung for HDR breast brachytherapy (Slessinger E, Pepin E, Zhao Q, Zhao L, Das I) Journal of Contemporary Brachytherapy 30 June 2012;4(2):106-110 |
| 1 | Electrolyte therapy reduces spike-and-wave discharges in the WAG/Rij rat model of absence epilepsy. (Talnov AN, Isaeva E, Savotchenko AV, Dovgalets GV, Ochoa JG, Holmes GL, Isaev D) Epilepsy Behav 2012 Aug;24(4):399-402 1 Citation |
| 1 | Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. (Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Lustig R, Ensley JF, Thorstad W, Schultz CJ, Yom SS, Ang KK) Int J Radiat Oncol Biol Phys 2012 Dec 01;84(5):1198-205 438 Citations |
| 1 | SU-E-T-579: Dosimetric Benefits of Online Adaptive Replanning for Post-Operative Radiation Therapy of Prostate Bed. (Liu F, Ahunbay E, Lawton C, Li X) Med Phys 2012 Jun;39(6):3839 |
| 1 | SU-E-J-11: Characterization of Interfractioanal Anatomical Variations in Post-Operative Radiation Therapy for Prostate Bed. (Liu F, Ahunbay E, Christian R, Lawton C, Wang D, Li X) Med Phys 2012 Jun;39(6):3654 |
| 1 | Systemic toxicity from occlusive therapy with topical 5-fluorouracil: a case report and review of the literature. (Sargen M, Wanat KA, Jambusaria A, Rosenbach M, Sobanko J, Miller CJ) Dermatol Surg 2012 Oct;38(10):1756-9 10 Citations |
| 1 | ACR Appropriateness Criteria® definitive therapy for early-stage cervical cancer. (Small W Jr, Strauss JB, Jhingran A, Yashar CM, Cardenes HR, Erickson-Wittmann BA, Gullett N, Kidd E, Lee LJ, Mayr NA, Moore D, Puthawala AA, Rao GG, Varia MA, Wahl AO, Wolfson AH, Yuh W, Gaffney DK) Am J Clin Oncol 2012 Aug;35(4):399-405 14 Citations |
| 1 | Driveline infections in left ventricular assist devices: implications for destination therapy. (Sharma V, Deo SV, Stulak JM, Durham LA 3rd, Daly RC, Park SJ, Baddour LM, Mehra K, Joyce LD) Ann Thorac Surg 2012 Nov;94(5):1381-6 93 Citations |
| 1 | Results from the Quality Research in Radiation Oncology (QRRO) survey: Evaluation of dosimetric outcomes for low-dose-rate prostate brachytherapy. (Zelefsky MJ, Cohen GN, Bosch WR, Morikawa L, Khalid N, Crozier CL, Lee WR, Zietman A, Owen J, Wilson JF, Devlin PM) Brachytherapy 2013;12(1):19-24 2 Citations |
| 1 | Association of clinical response and long-term outcome among patients with biopsied orbital pseudotumor receiving modern radiation therapy. (Prabhu RS, Kandula S, Liebman L, Wojno TH, Hayek B, Hall WA, Shu HK, Crocker I) Int J Radiat Oncol Biol Phys 2013 Mar 01;85(3):643-9 21 Citations |
| 1 | Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy. (Huppler AR, Bishu S, Gaffen SL) Arthritis Res Ther 2012 Jul 23;14(4):217 115 Citations |
| 1 | Nasal septum perforation induced by bevacizumab therapy in patients with breast cancer (Chaudhary L, Wilkinson R, Armeni M, Jordan C, Price A, Filburn S, Abraham J) Community Oncology August 2012;9(8):259-262 1 Citation |
| 1 | Splenomegaly in myelofibrosis--new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors. (Randhawa J, Ostojic A, Vrhovac R, Atallah E, Verstovsek S) J Hematol Oncol 2012 Aug 01;5:43 30 Citations |
| 2 | Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation. (Pasquini MC, Devine S, Mendizabal A, Baden LR, Wingard JR, Lazarus HM, Appelbaum FR, Keever-Taylor CA, Horowitz MM, Carter S, O'Reilly RJ, Soiffer RJ) J Clin Oncol 2012 Sep 10;30(26):3194-201 139 Citations |
| 1 | Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy. (Hu L, Wu C, Zhao X, Heist R, Su L, Zhao Y, Han B, Cao S, Chu M, Dai J, Dong J, Shu Y, Xu L, Chen Y, Wang Y, Lu F, Jiang Y, Yu D, Chen H, Tan W, Ma H, Chen J, Jin G, Wu T, Lu D, Christiani DC, Lin D, Hu Z, Shen H) Clin Cancer Res 2012 Oct 01;18(19):5507-14 54 Citations |
| 1 | GB virus C viremia is associated with higher levels of double-negative T cells and lower T-cell activation in HIV-infected individuals receiving antiretroviral therapy. (Bhattarai N, Rydze RT, Chivero ET, Stapleton JT) J Infect Dis 2012 Nov;206(9):1469-72 21 Citations |
| 4 | Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). (Chase NM, Verbsky JW, Hintermeyer MK, Waukau JK, Tomita-Mitchell A, Casper JT, Singh S, Shahir KS, Tisol WB, Nugent ML, Rao RN, Mackinnon AC, Goodman LR, Simpson PM, Routes JM) J Clin Immunol 2013 Jan;33(1):30-9 179 Citations |
| 1 | Reply re: "subperiosteal abscess of the orbit: Duration of intravenous antibiotic therapy in nonsurgical cases" (Hurley PE, Harris GJ) Ophthalmic Plastic and Reconstructive Surgery September 2012;28(5):385-386 3 Citations |
| 1 | Left ventricular ejection fraction assessment among patients with acute myocardial infarction and its association with hospital quality of care and evidence-based therapy use. (Miller AL, Dib C, Li L, Chen AY, Amsterdam E, Funk M, Saucedo JF, Wang TY) Circ Cardiovasc Qual Outcomes 2012 Sep 01;5(5):662-71 36 Citations |
| 1 | Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: a 1 H MRS study. (Qi J, Fong Y, Saltz L, D'Angelica MI, Kemeny NE, Gonen M, Shia J, Shukla-Dave A, Jarnagin WR, Do RK, Schwartz LH, Koutcher JA, Zakian KL) NMR Biomed 2013 Feb;26(2):204-12 8 Citations |
| 1 | Targeted therapy in rare cancers--adopting the orphans. (Munoz J, Kurzrock R) Nat Rev Clin Oncol 2012 Nov;9(11):631-42 33 Citations |
| 1 | The FGFR4-G388R single-nucleotide polymorphism alters pancreatic neuroendocrine tumor progression and response to mTOR inhibition therapy. (Serra S, Zheng L, Hassan M, Phan AT, Woodhouse LJ, Yao JC, Ezzat S, Asa SL) Cancer Res 2012 Nov 15;72(22):5683-91 45 Citations |
| 1 | Gene therapy for aromatic L-amino acid decarboxylase deficiency. (Zwagerman NT, Richardson RM) Neurosurgery 2012 Oct;71(4):N10-2 4 Citations |
| 1 | Long-term outcome from RTOG 9517: A phase I/II study of accelerated partial breast irradiation (APBI) with mulitcatheter brachytherapy (MCT) following lumpectomy for early-stage breast cancer. (Winter KA, Kuske RR, Bolton JS, Arthur DW, Scroggins T, Rabinovitch R, Kelly TR, Toonkel LM, Vicini FA, McCormick B) J Clin Oncol 2012 Sep 20;30(27_suppl):147 |
| 1 | Clinical applications of retinal gene therapy. (Lipinski DM, Thake M, MacLaren RE) Prog Retin Eye Res 2013 Jan;32:22-47 109 Citations |
| 1 | Reappraising the role of autologous transplantation for indolent B-cell lymphomas in the chemoimmunotherapy era: is it still relevant? (Hamadani M) Bone Marrow Transplant 2013 Aug;48(8):1013-21 14 Citations |
| 1 | Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. (Migliorati C, Hewson I, Lalla RV, Antunes HS, Estilo CL, Hodgson B, Lopes NN, Schubert MM, Bowen J, Elad S, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO)) Support Care Cancer 2013 Jan;21(1):333-41 192 Citations |
| 1 | Regression of advanced group e retinoblastoma with intraarterial chemotherapy. (Ramasubramanian A, Sinha N, Rosenwasser RH, Shields CL) Retin Cases Brief Rep 2012;6(4):406-8 |
| 1 | Post-radiation damage to the pelvic girdle in cervical cancer patients: Is intensity modulated radiation therapy safer than conventional radiation? (Ioffe Y, Hillen T, Zhou G, Schwarz J, Mutch D, Powell M, Rader J, Zighelboim I, Hagemann A, Thaker P) Gynecol Oncol 2012 Oct;127(1 Suppl):S10 |
| 1 | A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer. (Kerns SL, Stock R, Stone N, Buckstein M, Shao Y, Campbell C, Rath L, De Ruysscher D, Lammering G, Hixson R, Cesaretti J, Terk M, Ostrer H, Rosenstein BS) Int J Radiat Oncol Biol Phys 2013 Jan 01;85(1):e21-8 53 Citations |
| 1 | Complications of endovascular therapy for acute ischemic stroke and proposed management approach. (Darkhabani Z, Nguyen T, Lazzaro MA, Zaidat OO, Lynch JR, Fitzsimmons BF, Linfante I) Neurology 2012 Sep 25;79(13 Suppl 1):S192-8 25 Citations |
| 1 | Demand-supply of neurointerventionalists for endovascular ischemic stroke therapy. (Zaidat OO, Lazzaro M, McGinley E, Edgell RC, Nguyen T, Linfante I, Janjua N) Neurology 2012 Sep 25;79(13 Suppl 1):S35-41 57 Citations |
| 1 | Revascularization grading in endovascular acute ischemic stroke therapy. (Zaidat OO, Lazzaro MA, Liebeskind DS, Janjua N, Wechsler L, Nogueira RG, Edgell RC, Kalia JS, Badruddin A, English J, Yavagal D, Kirmani JF, Alexandrov AV, Khatri P) Neurology 2012 Sep 25;79(13 Suppl 1):S110-6 61 Citations |
| 1 | Temporal patterns of selected late toxicities in patients treated with brachytherapy or brachytherapy plus external beam radiation for prostate adenocarcinoma. (Buckstein M, Kerns S, Forysthe K, Stone NN, Stock RG) BJU Int 2013 Mar;111(3 Pt B):E43-7 8 Citations |
| 1 | Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. (Haas DM, Caldwell DM, Kirkpatrick P, McIntosh JJ, Welton NJ) BMJ 2012 Oct 09;345:e6226 293 Citations |
| 1 | Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes. (Farrokhi F, Klindukhova O, Chandra P, Peng L, Smiley D, Newton C, Pasquel F, Fereira ME, Umpierrez G) J Diabetes Sci Technol 2012 Sep 01;6(5):1022-9 60 Citations |
| 1 | Hemoglobin levels triggering erythropoiesis-stimulating agent therapy in patients with cancer: the shift after United States Food and Drug Administration policy changes. (Stroupe KT, Tarlov E, Lee TA, Weichle TW, Zhang QL, Michaelis LC, Ozer H, Durazo-Arvizu R, Browning MM, Hynes DM) Pharmacotherapy 2012 Nov;32(11):988-97 5 Citations |
| 1 | Iron chelation therapy in patients with transfusion-dependent myelodysplastic syndrome. (Mast AE, Field JJ) Transfusion 2012 Oct;52(10):2078-80 3 Citations |
| 8 | IL-10 produced by induced regulatory T cells (iTregs) controls colitis and pathogenic ex-iTregs during immunotherapy. (Schmitt EG, Haribhai D, Williams JB, Aggarwal P, Jia S, Charbonnier LM, Yan K, Lorier R, Turner A, Ziegelbauer J, Georgiev P, Simpson P, Salzman NH, Hessner MJ, Broeckel U, Chatila TA, Williams CB) J Immunol 2012 Dec 15;189(12):5638-48 74 Citations |
| 1 | Aberrations in the epidermal growth factor receptor gene in 958 patients with diverse advanced tumors: implications for therapy. (Wheler JJ, Falchook GS, Tsimberidou AM, Hong DS, Naing A, Piha-Paul SA, Chen SS, Fu S, Stephen B, Fok JY, Janku F, Kurzrock R) Ann Oncol 2013 Mar;24(3):838-42 20 Citations |
| 1 | Optimizing drug therapy in the surgical intensive care unit. (Peppard WJ, Peppard SR, Somberg L) Surg Clin North Am 2012 Dec;92(6):1573-620 2 Citations |
| 1 | Sweet syndrome in a field of radiation therapy. (Wanat KA, Kovarik CL, Quon H, Miller CJ) J Am Acad Dermatol 2012 Dec;67(6):e284-6 8 Citations |
| 1 | Clinical trial registration in physiotherapy journals: recommendations from the International Society of Physiotherapy Journal Editors. (Costa LO, Christine Lin CW, Grossi DB, Mancini MC, Swisher AK, Cook C, Vaughn D, Elkins MR, Sheikh U, Moore A, Jull G, Craik RL, Maher CG, de Jesus Guirro RR, Marques AP, Harms M, Brooks D, Simoneau GG, Strupstad JH) Man Ther 2013 Feb;18(1):1-3 8 Citations |
| 1 | American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for Intensity-modulated Radiation Therapy (IMRT). (Hartford AC, Galvin JM, Beyer DC, Eichler TJ, Ibbott GS, Kavanagh B, Schultz CJ, Rosenthal SA, American College of Radiology, American Society for Radiation Oncology) Am J Clin Oncol 2012 Dec;35(6):612-7 78 Citations |
| 1 | Cancer testis antigens: A new paradigm for cancer therapy. (Suri A, Saini S, Sinha A, Agarwal S, Verma A, Parashar D, Singh S, Gupta N, Jagadish N) Oncoimmunology 2012 Oct 01;1(7):1194-1196 44 Citations |
| 1 | Clinical trial registration in physiotherapy journals: recommendations from the International Society of Physiotherapy Journal Editors. (Costa LO, Lin CW, Grossi DB, Mancini MC, Swisher AK, Cook C, Vaughn D, Elkins MR, Sheikh U, Moore A, Jull G, Craik RL, Maher CG, Guirro RR, Marques AP, Harms M, Brooks D, Simoneau GG, Strupstad JH) J Physiother 2012;58(4):211-3 10 Citations |
| 1 | RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients. (Chakravarti A, Wang M, Robins HI, Lautenschlaeger T, Curran WJ, Brachman DG, Schultz CJ, Choucair A, Dolled-Filhart M, Christiansen J, Gustavson M, Molinaro A, Mischel P, Dicker AP, Bredel M, Mehta M) Int J Radiat Oncol Biol Phys 2013 Apr 01;85(5):1206-11 132 Citations |
| 1 | Comparison of tissue characterization curves for different CT scanners: Implication in proton therapy treatment planning (Cheng CW, Zhao L, Wolanski M, Zhao Q, James J, Dikeman K, Mills M, Li M, Srivastava SP, Lu XQ, Das IJ) Translational Cancer Research 1 December 2012;1(4):236-246 19 Citations |
| 1 | Clinical trial registration in physiotherapy journals: recommendations from the International Society of Physiotherapy Journal Editors. (Costa LO, Lin CW, Grossi DB, Mancini MC, Swisher AK, Cook CE, Vaughn DW, Elkins MR, Sheikh U, Moore A, Jull GA, Craik RL, Maher CG, Guirro RR, Marques AP, Harms M, Brooks D, Simoneau GG, Strupstad JH) J Orthop Sports Phys Ther 2012 Dec;42(12):978-81 6 Citations |
| 1 | It's about time: lessons for solid tumors from chronic myelogenous leukemia therapy. (Westin JR, Kurzrock R) Mol Cancer Ther 2012 Dec;11(12):2549-55 48 Citations |
| 1 | Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity. (Barnett GC, Elliott RM, Alsner J, Andreassen CN, Abdelhay O, Burnet NG, Chang-Claude J, Coles CE, Gutiérrez-Enríquez S, Fuentes-Raspall MJ, Alonso-Muñoz MC, Kerns S, Raabe A, Symonds RP, Seibold P, Talbot CJ, Wenz F, Wilkinson J, Yarnold J, Dunning AM, Rosenstein BS, West CM, Bentzen SM) Radiother Oncol 2012 Dec;105(3):289-95 59 Citations |
| 1 | Transient repetitive exposure to low level light therapy enhances collateral blood vessel growth in the ischemic hindlimb of the tight skin mouse. (Zaidi M, Krolikowki JG, Jones DW, Pritchard KA Jr, Struve J, Nandedkar SD, Lohr NL, Pagel PS, Weihrauch D) Photochem Photobiol 2013;89(3):709-13 18 Citations |
| 1 | Lymphocyte phenotype during therapy for acute graft-versus-host disease: a brief report from BMT-CTN 0302. (Bolaños-Meade J, Wu J, Logan BR, Levine JE, Ho VT, Alousi AM, Weisdorf DJ, Luznik L, Blood and Marrow Transplant Clinical Trials Network) Biol Blood Marrow Transplant 2013 Mar;19(3):481-5 5 Citations |
| 1 | Treatment efficiency of volumetric modulated arc therapy in comparison with intensity-modulated radiotherapy in the treatment of prostate cancer. (Hall WA, Fox TH, Jiang X, Prabhu RS, Rossi PJ, Godette K, Jani AB) J Am Coll Radiol 2013 Feb;10(2):128-34 17 Citations |
| 1 | Cytoprotective signaling associated with nitric oxide upregulation in tumor cells subjected to photodynamic therapy-like oxidative stress. (Bhowmick R, Girotti AW) Free Radic Biol Med 2013 Apr;57:39-48 63 Citations |
| 2 | SU‐E‐CAMPUS‐J‐05: Extracting Patient‐Specific Radiobiological Parameters From Tumor Regression for Biologically‐Based Adaptive Radiation Therapy of Head and Neck Cancer (Tai A, Schultz C, li X) Medical Physics June 2013;40(6):379 |
| 2 | SU‐E‐J‐129: Dosimetric Impact of Interfractional Anatomy Changes On Breast Radiotherapy Based On Accumulative Dose: IMRT Versus 3DCRT (Morrow N, Ahunbay E, Currey A, li X) Medical Physics June 2013;40(6):180 |
| 1 | SU‐E‐T‐81: Characteristics of Microchambers for Dosimetry in Proton Beam Therapy (Das I, Coutinho L, Zhao L, Mcewen M, Cheng C) Medical Physics June 2013;40(6):222 |
| 2 | SU‐E‐J‐112: Improving Target Delineation by Using Deformably Registered Multi‐Modality Images for Radiation Therapy of Pancreatic Cancer (Cungeng Y, Moraru I, Dalah E, Hart V, Paulson E, Erickson B, li X) Medical Physics June 2013;40(6):176 |
| 1 | TH‐E‐WAB‐01: MR Guided Therapy Planning (Paulson E, Cao Y, Cormack R) Medical Physics June 2013;40(6):550 |
| 1 | SU‐E‐T‐277: Modeling Normal Tissue Complication Probability Based On Compiled Clinical Data From Skin Cancer Radiotherapy (Prior P, Wilson J, li X) Medical Physics June 2013;40(6):267-268 1 Citation |
| 1 | SU‐E‐T‐450: Dose Perturbation of Spinal Metal Implants in Proton Beam Therapy (Jia Y, Zhao L, Cheng C, Mcdonald M, Das I) Medical Physics June 2013;40(6):309 2 Citations |
| 1 | Neoadjuvant chemotherapy with capecitabine and temozolomide for unresectable pancreatic neuroendocrine tumor. (Devata S, Kim EJ) Case Rep Oncol 2012 Sep;5(3):622-6 17 Citations |
| 2 | SU‐E‐T‐464: Dosimetric Assessment of a New Multi‐Center Protocol for Radiotherapy of Multiple Ipsilateral Breast Cancers (Chen G, Currey A, Yen T, li X) Medical Physics June 2013;40(6):312 |
| 2 | SU‐D‐WAB‐03: Online Adaptive Stereotactic Body Radiotherapy for Lung Lesions (Ahunbay E, Liu F, Bedi M, Gore E, li X) Medical Physics June 2013;40(6):107 |
| 1 | Clinical trial registration in physical therapy journals: Recommendations from the International Society of Physiotherapy Journal Editors. (Costa LO, Lin CW, Grossi DB, Mancini MC, Swisher AK, Cook C, Vaughn D, Elkins MR, Sheikh U, Moore A, Jull G, Craik RL, Maher CG, Guirro RR, Marques AP, Harms M, Brooks D, Simoneau GG, Strupstad JH, International Society of Physiotherapy Journal Editors) Phys Ther 2013 Jan;93(1):6-10 20 Citations |
| 1 | Recent advances in systemic therapies and radiotherapy for gallbladder cancer. (Caldow Pilgrim CH, Groeschl RT, Quebbeman EJ, Gamblin TC) Surg Oncol 2013 Mar;22(1):61-7 32 Citations |
| 1 | Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy. (Lawlor MW, Armstrong D, Viola MG, Widrick JJ, Meng H, Grange RW, Childers MK, Hsu CP, O'Callaghan M, Pierson CR, Buj-Bello A, Beggs AH) Hum Mol Genet 2013 Apr 15;22(8):1525-38 68 Citations |
| 1 | A pilot study to measure upper extremity H-reflexes following neuromuscular electrical stimulation therapy after stroke. (Stowe AM, Hughes-Zahner L, Barnes VK, Herbelin LL, Schindler-Ivens SM, Quaney BM) Neurosci Lett 2013 Feb 22;535:1-6 9 Citations |
| 1 | Suppressed excitement for epilepsy gene therapy. (Zwagerman NT, Richardson RM) Neurosurgery 2013 Feb;72(2):N10-1 |
| 4 | Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research. (Hamadani M, Saber W, Ahn KW, Carreras J, Cairo MS, Fenske TS, Gale RP, Gibson J, Hale GA, Hari PN, Hsu JW, Inwards DJ, Kamble RT, Klein A, Maharaj D, Marks DI, Rizzieri DA, Savani BN, Schouten HC, Waller EK, Wirk B, Lazarus HM) Biol Blood Marrow Transplant 2013 Apr;19(4):625-31 72 Citations |
| 1 | Clinical trial registration in physical therapy journals: recommendations from the International Society of Physiotherapy Journal Editors. (Costa LO, Lin CW, Grossi DB, Mancini MC, Swisher AK, Cook C, Vaughn D, Elkins MR, Sheikh U, Moore A, Jull G, Craik RL, Maher CG, Guirro RR, Marques AP, Harms M, Brooks D, Simoneau GG, Strupstad JH, International Society of Physiotherapy Journal Editors) Rev Bras Fisioter 2012;16(6):v-ix 5 Citations |
| 1 | Case series analysis of post-brachytherapy prostate edema and its relevance to post-implant dosimetry. Post-implant prostate edema and dosimetry. (Tejwani A, Bieniek E, Puckett L, Lavaf A, Guirguis A, Bennish A, Ashamalla H) J Contemp Brachytherapy 2012 Jun;4(2):75-80 11 Citations |
| 1 | Five-year outcomes of squamous cell carcinoma of the tonsil treated with radiotherapy. (Mourad WF, Hu KS, Puckett L, Hauerstock D, Shourbaji RA, Li Z, Manolidis S, Schantz S, Tran T, Jacobson A, Urken M, Culliney B, Persky M, Harrison LB) Am J Clin Oncol 2014 Feb;37(1):57-62 6 Citations |
| 1 | Biomarker-directed therapy of squamous carcinomas of the head and neck: targeting PI3K/PTEN/mTOR pathway. (Holsinger FC, Piha-Paul SA, Janku F, Hong DS, Atkins JT, Tsimberidou AM, Kurzrock R) J Clin Oncol 2013 Mar 20;31(9):e137-40 28 Citations |
| 1 | A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer. (Kerns SL, Stone NN, Stock RG, Rath L, Ostrer H, Rosenstein BS) J Urol 2013 Jul;190(1):102-8 52 Citations |
| 4 | Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma. (Hamadani M, Saber W, Ahn KW, Carreras J, Cairo MS, Fenske TS, Gale RP, Gibson J, Hale GA, Hari PN, Hsu JW, Inwards DJ, Kamble RT, Klein A, Maharaj D, Marks DI, Rizzieri DA, Savani BN, Schouten HC, Waller EK, Wirk B, Laport GG, Montoto S, Maloney DG, Lazarus HM) Biol Blood Marrow Transplant 2013 May;19(5):746-53 84 Citations |
| 1 | Performance of endovenous foam sclerotherapy in the USA for the treatment of venous disorders: ACP/SVM/AVF/SIR quality improvement guidelines. (Rathbun S, Norris A, Morrison N, Gibson K, Raymond-Martimbeau P, Worthington-Kirsch R, Hohenwalter E, Lohr J, McLafferty R, Stoner J) Phlebology 2014 Mar;29(2):76-82 16 Citations |
| 1 | Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trials. (Subbiah IM, Subbiah V, Tsimberidou AM, Naing A, Kaseb AO, Javle M, Fu S, Hong DS, Piha-Paul S, Wheler JJ, Hess KR, Janku F, Falchook GS, Wolff RA, Kurzrock R) Oncotarget 2013 Jan;4(1):156-65 31 Citations |
| 2 | Statistical model for prediction of hearing loss in patients receiving cisplatin chemotherapy. (Johnson A, Tarima S, Wong S, Friedland DR, Runge CL) JAMA Otolaryngol Head Neck Surg 2013 Mar;139(3):256-64 13 Citations |
| 1 | Restoration of altered somatosensory cortical representation with spinal cord stimulation therapy in a patient with complex regional pain syndrome: a magnetoencephalography case study. (Pahapill PA, Zhang W) Neuromodulation 2014 Jan;17(1):22-6; discussion 26-7 16 Citations |
| 1 | Spirituality, religiosity, depression, anxiety, and drug-use consequences during methadone maintenance therapy. (Piacentine LB) West J Nurs Res 2013 Jul;35(6):795-814 6 Citations |
| 1 | Impact of GH replacement therapy on sleep in adult patients with GH deficiency of pituitary origin. (Morselli LL, Nedeltcheva A, Leproult R, Spiegel K, Martino E, Legros JJ, Weiss RE, Mockel J, Van Cauter E, Copinschi G) Eur J Endocrinol 2013 May;168(5):763-70 24 Citations |
| 1 | Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma. (DeSimone JA, Guenova E, Carter JB, Chaney KS, Aldridge JR, Noell CM, Dorosario AA, Hansen JL, Kupper TS, Devlin PM) J Am Acad Dermatol 2013 Jul;69(1):61-5 33 Citations |
| 1 | Children with pulmonary arterial hypertension and prostanoid therapy: long-term hemodynamics. (Siehr SL, Ivy DD, Miller-Reed K, Ogawa M, Rosenthal DN, Feinstein JA) J Heart Lung Transplant 2013 May;32(5):546-52 58 Citations |
| 1 | Factors related to biopsy willingness in patients with advanced cancer in a phase 1 clinic for molecularly targeted therapy. (Hong DS, George GC, Iwuanyanwu EC, Tavana B, Falchook GS, Piha-Paul SA, Wheler JJ, Mistry RH, Lei X, Kurzrock R) J Cancer Res Clin Oncol 2013 Jun;139(6):963-70 8 Citations |
| 1 | EndoFLIP assessment of achalasia therapy: interpreting the distensibility data is a bit of a stretch. (Massey BT) Gastroenterology 2013 Apr;144(4):e17-8 8 Citations |
| 1 | Hormone Replacement Therapy (Janssen JAMJL, Van Der Lely AJ, Rogol AD, Ioachimescu AG) Pituitary Disorders: Diagnosis and Management 8 March 2013:265-276 |
| 1 | Evaluation of Adherence to Quality Measures for Prostate Cancer Radiotherapy in the United States: Results from the Quality Research in Radiation Oncology (QRRO) Survey. (Zelefsky MJ, Lee WR, Zietman A, Khalid N, Crozier C, Owen J, Wilson JF) Pract Radiat Oncol 2013 Jan;3(1):2-8 20 Citations |
| 1 | Prostate-specific antigen response after short-term hormone therapy plus external-beam radiotherapy and outcome in patients treated on Radiation Therapy Oncology Group study 9413. (Cury FL, Hunt D, Roach M 3rd, Shipley W, Gore E, Hsu IC, Krisch RE, Seider MJ, Sandler H, Lawton C) Cancer 2013 Jun 01;119(11):1999-2004 17 Citations |
| 5 | Prognostic variables in patients with primary soft tissue sarcoma of the extremity and trunk treated with neoadjuvant radiotherapy or neoadjuvant sequential chemoradiotherapy. (Bedi M, King DM, Shivakoti M, Wang T, Zambrano EV, Charlson J, Hackbarth D, Neilson J, Whitfield R, Wang D) Radiat Oncol 2013 Mar 14;8:60 23 Citations |
| 1 | In vivo multi-tissue efficacy of peroxisome proliferator-activated receptor-γ therapy on glucose and fatty acid metabolism in obese type 2 diabetic rats. (Nemanich S, Rani S, Shoghi K) Obesity (Silver Spring) 2013 Dec;21(12):2522-9 10 Citations |
| 2 | Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. (Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, Marks DS, Tirschwell DL, RESPECT Investigators) N Engl J Med 2013 Mar 21;368(12):1092-100 |
| 1 | The impact of clinical and sociodemographic features on quality of life in patients with early stage cancers using the Functional Assessment of Cancer Therapy-General assessment tool. (Popovic M, Lao N, Zeng L, Zhang L, Cella D, Beaumont JL, Chow R, Chiu N, Chiu L, Lam H, Poon M, Chow E) Support Care Cancer 2013 Aug;21(8):2267-77 6 Citations |
| 1 | Feasibility of interactive text message response (ITR) as a novel, real-time measure of adherence to antiretroviral therapy for HIV+ youth. (Dowshen N, Kuhns LM, Gray C, Lee S, Garofalo R) AIDS Behav 2013 Jul;17(6):2237-43 53 Citations |
| 4 | The effect of smoking and major vein resection on post-therapy lymphedema in soft tissue sarcomas treated with neoadjuvant radiation and limb-salvage surgery. (Bedi M, King DM, Whitfield R, Hackbarth DA, Neilson JC, Charlson JA, Wang D) Am J Clin Oncol 2015 Apr;38(2):184-8 9 Citations |
| 1 | Melanoma patients in a phase I clinic: molecular aberrations, targeted therapy and outcomes. (Henary H, Hong DS, Falchook GS, Tsimberidou A, George GC, Wen S, Wheler J, Fu S, Naing A, Piha-Paul S, Janku F, Kim KB, Hwu P, Kurzrock R) Ann Oncol 2013 Aug;24(8):2158-65 14 Citations |
| 1 | Factors affecting accuracy in proton therapy (Cheng CW, Das IJ, Zhao L, Zhao Q, Johnstone PAS) IFMBE Proceedings 2013;39 IFMBE:1769-1771 |
| 3 | Is hematopoietic cell transplantation still a valid option for mantle cell lymphoma in first remission in the chemoimmunotherapy-era? (Chaudhary L, Kharfan-Dabaja MA, Hari P, Hamadani M) Bone Marrow Transplant 2013 Nov;48(12):1489-96 9 Citations |
| 1 | Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214. (Gondi V, Paulus R, Bruner DW, Meyers CA, Gore EM, Wolfson A, Werner-Wasik M, Sun AY, Choy H, Movsas B) Int J Radiat Oncol Biol Phys 2013 Jul 15;86(4):656-64 169 Citations |
| 1 | Effects of combination therapy with dipeptidyl peptidase-IV and histone deacetylase inhibitors in the non-obese diabetic mouse model of type 1 diabetes. (Cabrera SM, Colvin SC, Tersey SA, Maier B, Nadler JL, Mirmira RG) Clin Exp Immunol 2013 Jun;172(3):375-82 32 Citations |
| 1 | Lentivirus IL-10 gene therapy down-regulates IL-17 and attenuates mouse orthotopic lung allograft rejection. (Hirayama S, Sato M, Loisel-Meyer S, Matsuda Y, Oishi H, Guan Z, Saito T, Yeung J, Cypel M, Hwang DM, Medin JA, Liu M, Keshavjee S) Am J Transplant 2013 Jun;13(6):1586-93 40 Citations |
| 1 | The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma. (Hall WA, Colbert LE, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Prabhu RS, Kauh J, Landry JC) Cancer 2013 Jun 15;119(12):2350-7 12 Citations |
| 1 | Barriers To Initial Administration Of Airway Clearance Therapy In Pediatric Cystic Fibrosis Hospitalizations (Antos, Nicholas J; Walsh-Kelly, CD; Quintero, DR) Am J Respir Crit Care Med. [Abstract]. May 2013. 187: A3887 |
| 1 | Harnessing autophagy for cell fate control gene therapy. (Felizardo TC, Foley J, Steed K, Dropulic B, Amarnath S, Medin JA, Fowler DH) Autophagy 2013 Jul;9(7):1069-79 8 Citations |
| 1 | P53 mutations in advanced cancers: clinical characteristics, outcomes, and correlation between progression-free survival and bevacizumab-containing therapy. (Said R, Hong DS, Warneke CL, Lee JJ, Wheler JJ, Janku F, Naing A, Falchook GS, Fu S, Piha-Paul S, Tsimberidou AM, Kurzrock R) Oncotarget 2013 May;4(5):705-14 102 Citations |
| 1 | Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy. (Kurzrock R, Atkins J, Wheler J, Fu S, Naing A, Busaidy N, Hong D, Sherman S) Ann Oncol 2013 Sep;24(9):2256-61 31 Citations |
| 1 | Quantitative X-ray computed tomography peritoneography in malignant peritoneal mesothelioma patients receiving intraperitoneal chemotherapy. (Leinwand JC, Zhao B, Guo X, Krishnamoorthy S, Qi J, Graziano JH, Slavkovic VN, Bates GE, Lewin SN, Allendorf JD, Chabot JA, Schwartz LH, Taub RN) Ann Surg Oncol 2013 Dec;20 Suppl 3(Suppl 3):S553-9 9 Citations |
| 1 | Should platelet function testing guide antiplatelet therapy for patients with coronary artery stenting or acute coronary syndromes? (Cohoon KP, Heit JA) Clin Chem 2013 Sep;59(9):1299-300 5 Citations |
| 1 | Self-care strategies to relieve fatigue in patients receiving radiation therapy. (Erickson JM, Spurlock LK, Kramer JC, Davis MA) Clin J Oncol Nurs 2013 Jun;17(3):319-24 6 Citations |
| 1 | Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer. (Kerns SL, Stock RG, Stone NN, Blacksburg SR, Rath L, Vega A, Fachal L, Gómez-Caamaño A, De Ruysscher D, Lammering G, Parliament M, Blackshaw M, Sia M, Cesaretti J, Terk M, Hixson R, Rosenstein BS, Ostrer H) Radiother Oncol 2013 Jun;107(3):372-6 73 Citations |
| 2 | SU-D-WAB-03: Online Adaptive Stereotactic Body Radiotherapy for Lung Lesions. (Ahunbay E, Liu F, Bedi M, Gore E, Li X) Med Phys 2013 Jun;40(6Part3):107 |
| 1 | Has the Foundation for Physical Therapy advanced the body of knowledge? (Schindler-Ivens SM, Struhar J, Jermé MG) Phys Ther 2013 Jun;93(6):718-20 1 Citation |
| 1 | Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study. (Hoang T, Campbell TC, Zhang C, Kim K, Kolesar JM, Oettel KR, Blank JH, Robinson EG, Ahuja HG, Kirschling RJ, Johnson PH, Huie MS, Wims ME, Larson MM, Hernan HR, Traynor AM) Invest New Drugs 2014 Feb;32(1):195-9 36 Citations |
| 1 | Neoadjuvant versus induction chemotherapy: more than semantics. (Devisetty K, Wong SJ) J Clin Oncol 2013 Aug 10;31(23):2971-2 9 Citations |
| 1 | Clinical trial registration in physiotherapy journals: recommendations from the international society of physiotherapy journal editors. (Leonardo OP, Lin CC, Bevilaqua DG, Mancini MC, Swisher AK, Cook C, Vaughn D, Elkins MR, Sheikh U, Moore A, Jull G, Craik RL, Maher CG, de Jesus Guirro RR, Marques AP, Harms M, Brooks D, Simoneau GG, Strupstad JH) Cardiopulm Phys Ther J 2013 Mar;24(1):4-6 |
| 1 | The novel cancer-testis antigen A-kinase anchor protein 4 (AKAP4) is a potential target for immunotherapy of ovarian serous carcinoma. (Agarwal S, Saini S, Parashar D, Verma A, Sinha A, Jagadish N, Batra A, Suri S, Gupta A, Ansari AS, Lohiya NK, Suri A) Oncoimmunology 2013 May 01;2(5):e24270 39 Citations |
| 2 | Peripheral blood stem cell mobilization in multiple myeloma patients treat in the novel therapy-era with plerixafor and G-CSF has superior efficacy but significantly higher costs compared to mobilization with low-dose cyclophosphamide and G-CSF. (Chaudhary L, Awan F, Cumpston A, Leadmon S, Watkins K, Tse W, Craig M, Hamadani M) J Clin Apher 2013 Oct;28(5):359-67 28 Citations |
| 1 | Negative pressure wound therapy in infants and children: a single-institution experience. (Rentea RM, Somers KK, Cassidy L, Enters J, Arca MJ) J Surg Res 2013 Sep;184(1):658-64 29 Citations |
| 1 | Long-term effects of recombinant human growth hormone therapy in children with Prader-Willi syndrome. (Wolfgram PM, Carrel AL, Allen DB) Curr Opin Pediatr 2013 Aug;25(4):509-14 43 Citations |
| 1 | Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years. (Espeland MA, Shumaker SA, Leng I, Manson JE, Brown CM, LeBlanc ES, Vaughan L, Robinson J, Rapp SR, Goveas JS, Wactawski-Wende J, Stefanick ML, Li W, Resnick SM, WHIMSY Study Group) JAMA Intern Med 2013 Aug 12;173(15):1429-36 166 Citations |
| 1 | The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate. (Hall WA, Nickleach DC, Master VA, Prabhu RS, Rossi PJ, Godette K, Cooper S, Jani AB) Cancer 2013 Sep 15;119(18):3272-9 35 Citations |
| 1 | Empirical amphotericin B therapy on day 4 or day 8 of febrile neutropenia. (Malhotra P, Makkar A, Guru Murthy GS, Varma N, Varma S, Chakrabarti A) Mycoses 2014 Feb;57(2):110-5 8 Citations |
| 3 | A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia. (Wong SJ, Campbell B, Massey B, Lynch DP, Cohen EEW, Blair E, Selle R, Shklovskaya J, Jovanovic BD, Skripkauskas S, Dew A, Kulesza P, Parimi V, Bergan RC, Szabo E) Oral Oncol 2013 Sep;49(9):970-976 28 Citations |
| 1 | Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis. (Williams-Karnesky RL, Sandau US, Lusardi TA, Lytle NK, Farrell JM, Pritchard EM, Kaplan DL, Boison D) J Clin Invest 2013 Aug;123(8):3552-63 215 Citations |
| 3 | Mitochondria-targeted antioxidant and glycolysis inhibition: synergistic therapy in hepatocellular carcinoma. (Dilip A, Cheng G, Joseph J, Kunnimalaiyaan S, Kalyanaraman B, Kunnimalaiyaan M, Gamblin TC) Anticancer Drugs 2013 Oct;24(9):881-8 27 Citations |
| 1 | Immunoediting and antigen loss: overcoming the achilles heel of immunotherapy with antigen non-specific therapies. (Monjazeb AM, Zamora AE, Grossenbacher SK, Mirsoian A, Sckisel GD, Murphy WJ) Front Oncol 2013;3:197 37 Citations |
| 2 | Sympathetic neuropathy and dysphagia following doxycycline sclerotherapy. (Wang KL, Chun RH, Kerschner JE, Sulman CG) Int J Pediatr Otorhinolaryngol 2013 Sep;77(9):1613-6 8 Citations |
| 1 | Management and outcome in hepatorenal syndrome: need for renal replacement therapy in non-transplanted patients. (Sourianarayanane A, Raina R, Garg G, McCullough AJ, O'Shea RS) Int Urol Nephrol 2014 Apr;46(4):793-800 22 Citations |
| 4 | A phase I/II study piloting accelerated partial breast irradiation using CT-guided intensity modulated radiation therapy in the prone position. (Bergom C, Prior P, Kainz K, Morrow NV, Ahunbay EE, Walker A, Allen Li X, White J) Radiother Oncol 2013 Aug;108(2):215-9 19 Citations |
| 2 | Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma. (Costa LJ, Zhang MJ, Zhong X, Dispenzieri A, Lonial S, Krishnan A, Freytes C, Vesole D, Gale RP, Anderson K, Wirk B, Savani BN, Waller EK, Schouten H, Lazarus H, Meehan K, Sharma M, Kamble R, Vij R, Kumar S, Nishihori T, Kindwall-Keller T, Saber W, Hari PN) Biol Blood Marrow Transplant 2013 Nov;19(11):1615-24 98 Citations |
| 1 | Comparable survival for pediatric acute myeloid leukemia with poor-risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation. (Kelly MJ, Horan JT, Alonzo TA, Eapen M, Gerbing RB, He W, Lange BJ, Parsons SK, Woods WG) Pediatr Blood Cancer 2014 Feb;61(2):269-75 32 Citations |
| 1 | Gene Therapy for Platelet Disorders (Wilcox DA) Platelets 2013:1313-1327 1 Citation |
| 1 | Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. (Practice Committee of American Society for Reproductive Medicine) Fertil Steril 2013 Nov;100(5):1214-23 243 Citations |
| 1 | Effectiveness of VF induction with DC fibber versus conventional induction methods in patients on chronic amiodarone therapy. (Rubenstein JC, Gupta MS, Kim MH) J Interv Card Electrophysiol 2013 Nov;38(2):137-41 4 Citations |
| 1 | Demand-supply of neurointerventionalists for endovascular ischemic stroke therapy. (Zaidat OO, Lazzaro MA, Linfante I, Nguyen T, Janjua N) Neurology 2013 Jul 16;81(3):305-6 5 Citations |
| 1 | Anesthetic management including extracorporeal membrane oxygenation therapy of liver transplant recipient with life-threatening hypoxemia -a case report-. (Yoo CS, Shin YH, Ko JS, Gwak MS, Kim GS) Korean J Anesthesiol 2013 Aug;65(2):151-7 19 Citations |
| 1 | Development of a software for quantitative evaluation radiotherapy target and organ-at-risk segmentation comparison. (Kalpathy-Cramer J, Awan M, Bedrick S, Rasch CR, Rosenthal DI, Fuller CD) J Digit Imaging 2014 Feb;27(1):108-19 10 Citations |
| 1 | Platelet gene therapy by lentiviral gene delivery to hematopoietic stem cells restores hemostasis and induces humoral immune tolerance in FIX(null) mice. (Chen Y, Schroeder JA, Kuether EL, Zhang G, Shi Q) Mol Ther 2014 Jan;22(1):169-77 49 Citations |
| 1 | Inhibitory neuron therapy for epilepsy. (Zwagerman NT, Richardson RM) Neurosurgery 2013 Oct;73(4):N18-9 2 Citations |
| 1 | Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients? (Taber DJ, Srinivas TM, Pilch NA, Meadows HB, Fleming JN, McGillicuddy JW, Bratton CF, Thomas B, Chavin KD, Baliga PK, Egede LE) Am J Nephrol 2013;38(4):285-91 24 Citations |
| 1 | Human cone visual pigment deletions spare sufficient photoreceptors to warrant gene therapy. (Cideciyan AV, Hufnagel RB, Carroll J, Sumaroka A, Luo X, Schwartz SB, Dubra A, Land M, Michaelides M, Gardner JC, Hardcastle AJ, Moore AT, Sisk RA, Ahmed ZM, Kohl S, Wissinger B, Jacobson SG) Hum Gene Ther 2013 Dec;24(12):993-1006 97 Citations |
| 1 | Open-label bendamustine monotherapy for pediatric patients with relapsed or refractory acute leukemia: efficacy and tolerability. (Fraser C, Brown P, Megason G, Ahn HS, Cho B, Kirov I, Frankel L, Aplenc R, Bensen-Kennedy D, Munteanu M, Weaver J, Harker-Murray P) J Pediatr Hematol Oncol 2014 May;36(4):e212-8 12 Citations |
| 1 | Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy. (Bouchlaka MN, Sckisel GD, Chen M, Mirsoian A, Zamora AE, Maverakis E, Wilkins DE, Alderson KL, Hsiao HH, Weiss JM, Monjazeb AM, Hesdorffer C, Ferrucci L, Longo DL, Blazar BR, Wiltrout RH, Redelman D, Taub DD, Murphy WJ) J Exp Med 2013 Oct 21;210(11):2223-37 129 Citations |
| 1 | Pro-survival and pro-growth effects of stress-induced nitric oxide in a prostate cancer photodynamic therapy model. (Bhowmick R, Girotti AW) Cancer Lett 2014 Feb 01;343(1):115-22 59 Citations |
| 1 | The effect of depressive symptoms and CD4 count on adherence to highly active antiretroviral therapy in sub-Saharan Africa. (Memiah P, Shumba C, Etienne-Mesubi M, Agbor S, Hossain MB, Komba P, Niyang M, Biadgilign S) J Int Assoc Provid AIDS Care 2014;13(4):346-52 41 Citations |
| 1 | An assessment of PTV margin based on actual accumulated dose for prostate cancer radiotherapy. (Wen N, Kumarasiri A, Nurushev T, Burmeister J, Xing L, Liu D, Glide-Hurst C, Kim J, Zhong H, Movsas B, Chetty IJ) Phys Med Biol 2013 Nov 07;58(21):7733-44 17 Citations |
| 2 | Patient-reported outcomes in patients with nonmelanomatous skin cancers of the face treated with orthovoltage radiation therapy: a cross-sectional survey. (Kharofa J, Currey A, Wilson JF) Int J Radiat Oncol Biol Phys 2013 Nov 15;87(4):636-7 13 Citations |
| 2 | Retinal structure and function in achromatopsia: implications for gene therapy. (Sundaram V, Wilde C, Aboshiha J, Cowing J, Han C, Langlo CS, Chana R, Davidson AE, Sergouniotis PI, Bainbridge JW, Ali RR, Dubra A, Rubin G, Webster AR, Moore AT, Nardini M, Carroll J, Michaelides M) Ophthalmology 2014 Jan;121(1):234-245 146 Citations |
| 1 | Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus. (Toh E, Wilson J, Sebag-Montefiore D, Botterill I) Colorectal Dis 2014 Mar;16(3):O90-7 33 Citations |
| 1 | A novel approach for establishing benchmark CBCT/CT deformable image registrations in prostate cancer radiotherapy. (Kim J, Kumar S, Liu C, Zhong H, Pradhan D, Shah M, Cattaneo R, Yechieli R, Robbins JR, Elshaikh MA, Chetty IJ) Phys Med Biol 2013 Nov 21;58(22):8077-97 33 Citations |
| 1 | A possible role for statin therapy in solitary pancreas transplantation? (Scalea JR, Cooper M) Transplant Proc 2013 Nov;45(9):3348-50 |
| 3 | Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission. (Warlick ED, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM, George B, Savani BN, Ustun C, Marks DI, Waller EK, Baron F, Freytes CO, Socie G, Akpek G, Schouten HC, Lazarus HM, Horwitz EM, Koreth J, Cahn JY, Bornhauser M, Seftel M, Cairo MS, Laughlin MJ, Sabloff M, Ringdén O, Gale RP, Kamble RT, Vij R, Gergis U, Mathews V, Saber W, Chen YB, Liesveld JL, Cutler CS, Ghobadi A, Uy GL, Eapen M, Weisdorf DJ, Litzow MR) Biol Blood Marrow Transplant 2014 Feb;20(2):202-8 35 Citations |
| 1 | The engineered thymidylate kinase (TMPK)/AZT enzyme-prodrug axis offers efficient bystander cell killing for suicide gene therapy of cancer. (Sato T, Neschadim A, Lavie A, Yanagisawa T, Medin JA) PLoS One 2013;8(10):e78711 28 Citations |
| 1 | Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients. (Kurtzberg J, Prockop S, Teira P, Bittencourt H, Lewis V, Chan KW, Horn B, Yu L, Talano JA, Nemecek E, Mills CR, Chaudhury S) Biol Blood Marrow Transplant 2014 Feb;20(2):229-35 190 Citations |
| 1 | The Vulnerable Elders Survey-13 predicts mortality in older adults with later-stage colorectal cancer receiving chemotherapy: a prospective pilot study. (Ramsdale E, Polite B, Hemmerich J, Bylow K, Kindler HL, Mohile S, Dale W) J Am Geriatr Soc 2013 Nov;61(11):2043-4 12 Citations |
| 1 | Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A (Lily M. Du, Paquita Nurden, Alan T. Nurden, Timothy C. Nichols, Dwight A. Bellinger, Eric S. Jensen, Sandra L. Haberichter, Elizabeth Merricks,
Robin A. Raymer, Juan Fang, Sevasti B. Koukouritaki,
Paula M. Jacobi, Troy B. Hawkins, Kenneth Cornetta,
Qizhen Shi & David A. Wilcox) Nature Communications |
| 1 | Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival. (Tzeng CW, Tran Cao HS, Lee JE, Pisters PW, Varadhachary GR, Wolff RA, Abbruzzese JL, Crane CH, Evans DB, Wang H, Abbott DE, Vauthey JN, Aloia TA, Fleming JB, Katz MH) J Gastrointest Surg 2014 Jan;18(1):16-24; discussion 24-5 171 Citations |
| 1 | Double-blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma. (Grivas PD, Daignault S, Tagawa ST, Nanus DM, Stadler WM, Dreicer R, Kohli M, Petrylak DP, Vaughn DJ, Bylow KA, Wong SG, Sottnik JL, Keller ET, Al-Hawary M, Smith DC, Hussain M) Cancer 2014 Mar 01;120(5):692-701 94 Citations |
| 4 | Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A. (Du LM, Nurden P, Nurden AT, Nichols TC, Bellinger DA, Jensen ES, Haberichter SL, Merricks E, Raymer RA, Fang J, Koukouritaki SB, Jacobi PM, Hawkins TB, Cornetta K, Shi Q, Wilcox DA) Nat Commun 2013;4:2773 103 Citations |
| 1 | Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM). (Krauze AV, Won M, Graves C, Corn BW, Muanza TM, Howard SP, Mahadevan A, Schultz CJ, Haas ML, Mehta MP, Camphausen KA) Biomark Res 2013 Oct 31;1(1):29 4 Citations |
| 1 | Localized interleukin-12 delivery for immunotherapy of solid tumours. (Wei LZ, Xu Y, Nelles EM, Furlonger C, Wang JC, Di Grappa MA, Khokha R, Medin JA, Paige CJ) J Cell Mol Med 2013 Nov;17(11):1465-74 15 Citations |
| 1 | Using patient-specific phantoms to evaluate deformable image registration algorithms for adaptive radiation therapy. (Stanley N, Glide-Hurst C, Kim J, Adams J, Li S, Wen N, Chetty IJ, Zhong H) J Appl Clin Med Phys 2013 Nov 04;14(6):4363 41 Citations |
| 1 | Prevalence of Depressive Symptoms Amongst Highly Active Antiretroviral Therapy (HAART) Patients in AIDSRelief Uganda. (Shumba C, Atukunda R, Imakit R, Memiah P) J Public Health Afr 2013 Dec 03;4(2):e19 7 Citations |
| 1 | Platelet gene therapy corrects the hemophilic phenotype in immunocompromised hemophilia A mice transplanted with genetically manipulated human cord blood stem cells. (Shi Q, Kuether EL, Chen Y, Schroeder JA, Fahs SA, Montgomery RR) Blood 2014 Jan 16;123(3):395-403 44 Citations |
| 1 | Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer. (Hall WA, Petrova AV, Colbert LE, Hardy CW, Fisher SB, Saka B, Shelton JW, Warren MD, Pantazides BG, Gandhi K, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Volkan Adsay N, Curran WJ, Landry JC, Maithel SK, Yu DS) Oncogene 2014 Nov 20;33(47):5450-6 18 Citations |
| 1 | An interprofessional consensus of core competencies for prelicensure education in pain management: curriculum application for physical therapy. (Hoeger Bement MK, St Marie BJ, Nordstrom TM, Christensen N, Mongoven JM, Koebner IJ, Fishman SM, Sluka KA) Phys Ther 2014 Apr;94(4):451-65 51 Citations |
| 1 | Multivariate analysis of factors effecting overall survival in minority based population of breast cancer patients receiving neoadjuvant chemotherapy: A single institution experience (M Shah; S Jain; S Abhijai) Cancer Research Cancer Res (2013) 73 (24_Supplement): P6-06-51. |
| 1 | Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry). (Dasari TW, Cohen DJ, Kleiman NS, Keyes MJ, Yen CH, Hanna EB, Saucedo JF) Am J Cardiol 2014 Feb 15;113(4):621-5 16 Citations |
| 1 | Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy. (Sweeney WE Jr, Avner ED) Pediatr Res 2014 Jan;75(1-2):148-57 40 Citations |
| 1 | Audio-visual biofeedback does not improve the reliability of target delineation using maximum intensity projection in 4-dimensional computed tomography radiation therapy planning. (Lu W, Neuner GA, George R, Wang Z, Sasor S, Huang X, Regine WF, Feigenberg SJ, D'Souza WD) Int J Radiat Oncol Biol Phys 2014 Jan 01;88(1):229-35 9 Citations |
| 1 | Down regulation of SPAG9 reduces growth and invasive potential of triple-negative breast cancer cells: possible implications in targeted therapy. (Sinha A, Agarwal S, Parashar D, Verma A, Saini S, Jagadish N, Ansari AS, Lohiya NK, Suri A) J Exp Clin Cancer Res 2013 Sep 19;32(1):69 42 Citations |
| 2 | Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality. (Fenske TS, Zhang MJ, Carreras J, Ayala E, Burns LJ, Cashen A, Costa LJ, Freytes CO, Gale RP, Hamadani M, Holmberg LA, Inwards DJ, Lazarus HM, Maziarz RT, Munker R, Perales MA, Rizzieri DA, Schouten HC, Smith SM, Waller EK, Wirk BM, Laport GG, Maloney DG, Montoto S, Hari PN) J Clin Oncol 2014 Feb 01;32(4):273-81 124 Citations |
| 1 | Habit Reversal Therapy for Body-Focused Repetitive Behaviors in Williams Syndrome: A Case Study. (Conelea CA, Klein-Tasman BP) J Dev Phys Disabil 2013 Dec 01;25(6) 5 Citations |
| 1 | Essential competencies in entry-level pediatric physical therapy education. (Rapport MJ, Furze J, Martin K, Schreiber J, Dannemiller LA, Dibiasio PA, Moerchen VA) Pediatr Phys Ther 2014;26(1):7-18 64 Citations |
| 1 | Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases. (Morris-Stiff G, White AD, Gomez D, Cameron IC, Farid S, Toogood GJ, Lodge JP, Prasad KR) Eur J Surg Oncol 2014 Aug;40(8):1016-20 31 Citations |
| 1 | Erratum: Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy (Abdominal Imaging (2006) 31 (568-574) DOI: 10.1007/s00261-005-0194-y) (Tamm EP, Loyer EM, Faria S, Raut CP, Evans DB, Wolff RA, Crane CH, Dubrow RA, Charnsangavej C) Abdominal Imaging February 2014;39(1):236 |
| 2 | Biospleen device for extracorporeal sepsis therapy (Kang JH, Super M, Yung CW, Cooper RM, Domansky K, Graveline AR, Mammoto T, Berthet JB, Tobin H, Cartwright MJ, Watters AL, Rottman M, Waterhouse A, Mammoto A, Gamini N, Rodas MJ, Kole A, Jiang A, Valentin TM, Diaz A, Ingber DE) 18th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2014 2014:2516-2517 |
| 1 | Home-Based Parent-Child Therapy in Low-Income African American, Caucasian, and Latino Families: A Comparative Examination of Treatment Outcomes (Gresl BL, Fox RA, Fleischmann A) Child and Family Behavior Therapy January 2014;36(1):33-50 15 Citations |
| 1 | Platelet Gene Therapy by Lentiviral Gene Delivery to Hematopoietic Stem Cells Restores Hemostasis and Induces Humoral Immune Tolerance in FIX(null) Mice. (Chen Y, Schroeder JA, Kuether EL, Zhang G, Shi Q) Mol Ther 2014 Jan;22(1):169-177 |
| 1 | Atypical lentigines in a man with mixed African American and white race/ethnicity receiving long-term voriconazole therapy. (Massey PR, Wanat KA, Elenitsas R, Rosenbach M) JAMA Dermatol 2014 Mar;150(3):334-5 4 Citations |
| 1 | Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. (Colbert LE, Hall WA, Nickleach D, Switchenko J, Kooby DA, Liu Y, Gillespie T, Lipscomb J, Kauh J, Landry JC) Cancer 2014 Feb 15;120(4):499-506 39 Citations |
| 1 | L'enregistrement des essais cliniques dans les revues de physiothérapie : recommandations de l'International Society of Physiotherapy Journal Editors. (Costa LO, Lin CW, Grossi DB, Mancini MC, Swisher AK, Cook C, Vaughn D, Elkins MR, Sheikh U, Moore A, Jull G, Craik RL, Maher CG, Guirro RR, Marques AP, Harms M, Brooks D, Simoneau GG, Strupstad JH) Physiother Can 2013;65(2):109-15 |
| 1 | Clinical trial registration in physiotherapy journals: recommendations from the international society of physiotherapy journal editors. (Costa LO, Lin CW, Grossi DB, Mancini MC, Swisher AK, Cook C, Vaughn D, Elkins MR, Sheikh U, Moore A, Jull G, Craik RL, Maher CG, Guirro RR, Marques AP, Harms M, Brooks D, Simoneau GG, Strupstad JH) Physiother Can 2013;65(2):109-15 |
| 1 | Patterns of radiation therapy practice for patients treated for intact cervical cancer in 2005 to 2007: a quality research in radiation oncology study. (Eifel PJ, Ho A, Khalid N, Erickson B, Owen J) Int J Radiat Oncol Biol Phys 2014 Jun 01;89(2):249-56 81 Citations |
| 1 | Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy. (Kerns SL, Ostrer H, Rosenstein BS) Cancer Discov 2014 Feb;4(2):155-65 97 Citations |
| 1 | Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy. (Childers MK, Joubert R, Poulard K, Moal C, Grange RW, Doering JA, Lawlor MW, Rider BE, Jamet T, Danièle N, Martin S, Rivière C, Soker T, Hammer C, Van Wittenberghe L, Lockard M, Guan X, Goddard M, Mitchell E, Barber J, Williams JK, Mack DL, Furth ME, Vignaud A, Masurier C, Mavilio F, Moullier P, Beggs AH, Buj-Bello A) Sci Transl Med 2014 Jan 22;6(220):220ra10 140 Citations |
| 1 | Neoadjuvant chemotherapy for localized pancreatic cancer: too little or too long? (White RR, Evans DB) Ann Surg Oncol 2014 May;21(5):1508-9 1 Citation |
| 1 | Impact of targeted therapy on outcome of chronic lymphocytic leukemia patients with relapsed del(17p13.1) karyotype at a single center. (Stephens DM, Ruppert AS, Jones JA, Woyach J, Maddocks K, Jaglowski SM, Andritsos LA, Flynn JM, Grever MR, Lozanski G, Johnson AJ, Muthusamy N, Heerema NA, Byrd JC) Leukemia 2014 Jun;28(6):1365-8 18 Citations |
| 3 | Chemotherapy-induced regression of an adrenocorticotropin-secreting pituitary carcinoma accompanied by secondary adrenal insufficiency. (Cornell RF, Kelly DF, Bordo G, Carroll TB, Duong HT, Kim J, Takasumi Y, Thomas JP, Wong YL, Findling JW) Case Rep Endocrinol 2013;2013:675298 |
| 1 | Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy. (Duléry R, Mohty M, Duhamel A, Robin M, Beguin Y, Michallet M, Vigouroux S, Lioure B, Garnier A, El Cheikh J, Bulabois CE, Huynh A, Bay JO, Daguindau E, Ceballos P, Clément L, Dauriac C, Maillard N, Legrand F, Cornillon J, Guillerm G, François S, Lapusan S, Chevallier P, Damaj G, Yakoub-Agha I) Biol Blood Marrow Transplant 2014 May;20(5):646-54 23 Citations |
| 1 | Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: A 1H MRS study. [26, 2, 204-212] (Qi J, Fong Y, Saltz L, D'Angelica MI, Kemeny NE, Gonen M, Shia J, Shukla-Dave A, Jarnagin WR, Do RKG, Schwartz LH, Koutcher JA, Zakian KL) NMR in Biomedicine February 2014;27(2):235 |
| 1 | The development of Moyamoya syndrome after proton beam therapy. (Zwagerman NT, Foster K, Jakacki R, Khan FH, Yock TI, Greene S) Pediatr Blood Cancer 2014 Aug;61(8):1490-2 20 Citations |
| 1 | Antiinflammatory therapy outcomes for mild OSA in children. (Kheirandish-Gozal L, Bhattacharjee R, Bandla HPR, Gozal D) Chest 2014 Jul;146(1):88-95 102 Citations |
| 1 | Impact of dose size in single fraction spatially fractionated (grid) radiotherapy for melanoma. (Zhang H, Zhong H, Barth RF, Cao M, Das IJ) Med Phys 2014 Feb;41(2):021727 35 Citations |
| 1 | Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation. (Pilch NA, Taber DJ, Moussa O, Thomas B, Denmark S, Meadows HB, McGillicuddy JW, Srinivas TR, Baliga PK, Chavin KD) Ann Surg 2014 May;259(5):888-93 38 Citations |
| 1 | External Beam Radiotherapy and Bone Metastases (Johnstone C, Lutz ST) Cancer Metastasis - Biology and Treatment 2014;21(1):175-185 1 Citation |
| 1 | Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy. (Prabhu RS, Hanasoge S, Magliocca KR, Hall WA, Chen SA, Higgins KA, Saba NF, El-Deiry M, Grist W, Wadsworth JT, Chen AY, Beitler JJ) Head Neck 2015 Jun;37(6):777-82 62 Citations |
| 1 | Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group. (Tower RL, Jones TL, Camitta BM, Asselin BL, Bell BA, Chauvenet A, Devidas M, Halperin EC, Pullen J, Shuster JJ, Winick N, Kurtzberg J) J Pediatr Hematol Oncol 2014 Jul;36(5):353-61 8 Citations |
| 1 | Dose--volume modeling of brachial plexus-associated neuropathy after radiation therapy for head-and-neck cancer: findings from a prospective screening protocol. (Chen AM, Wang PC, Daly ME, Cui J, Hall WH, Vijayakumar S, Phillips TL, Farwell DG, Purdy JA) Int J Radiat Oncol Biol Phys 2014 Mar 15;88(4):771-7 43 Citations |
| 1 | Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy. (Bednarski BK, Habra MA, Phan A, Milton DR, Wood C, Vauthey N, Evans DB, Katz MH, Ng CS, Perrier ND, Lee JE, Grubbs EG) World J Surg 2014 Jun;38(6):1318-27 51 Citations |
| 1 | MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. (Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S, Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO)) Cancer 2014 May 15;120(10):1453-61 874 Citations |
| 4 | Combined online and offline adaptive radiation therapy: a dosimetric feasibility study. (Yang C, Liu F, Ahunbay E, Chang YW, Lawton C, Schultz C, Wang D, Firat S, Erickson B, Li XA) Pract Radiat Oncol 2014;4(1):e75-83 12 Citations |
| 2 | Radiation dose responses for chemoradiation therapy of pancreatic cancer: an analysis of compiled clinical data using biophysical models. (Moraru IC, Tai A, Erickson B, Li XA) Pract Radiat Oncol 2014;4(1):13-9 37 Citations |
| 1 | Hepatic arterial infusion therapy in advanced cancer and liver-predominant disease: the MD Anderson Experience. (Tsimberidou AM, Vaklavas C, Fu S, Wen S, Lim JA, Hong D, Wheler J, Naing A, Uehara C, Wallace M, Kurzrock R) Hepatogastroenterology 2013 Oct;60(127):1611-23 11 Citations |
| 1 | An update from the United States National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program: a decade of cell therapy. (Wood D, Wesselschmidt R, Hematti P, Gee AP, Rooney C, Silberstein L, Armant M, Couture L, Wagner JE, McKenna DH Jr, Hei D, Mondoro TH, Welniak L, Lindblad R) Clin Transl Sci 2014 Apr;7(2):93-9 7 Citations |
| 1 | HER2 aberrations in cancer: implications for therapy. (Yan M, Parker BA, Schwab R, Kurzrock R) Cancer Treat Rev 2014 Jul;40(6):770-80 194 Citations |
| 1 | Effect of induction chemotherapy on swallow physiology and saliva production in patients with head and neck cancer: a pilot study. (Mittal BB, Pauloski BR, Rademaker AW, Discekici-Harris M, Helenowski IB, Mellot A, Agulnik M, Logemann JA) Head Neck 2015 Apr;37(4):567-72 14 Citations |
| 3 | Early therapy-related myeloid sarcoma and deletion of 9q22.32 to q31.1. (Brickler MM, Basel DG, Gheorghe G, Margolis DM, Kelly ME, Ehrhardt MJ) Pediatr Blood Cancer 2014 Sep;61(9):1701-3 2 Citations |
| 1 | Reduced acute toxicity associated with the use of volumetric modulated arc therapy for the treatment of adenocarcinoma of the prostate. (Hall WA, Colbert L, Nickleach D, Shelton J, Marcus DM, Switchenko J, Rossi PJ, Godette K, Cooper S, Jani AB) Pract Radiat Oncol 2013;3(4):e157-64 12 Citations |
| 1 | Idiopathic granulomatous mastitis--a prospective study of 49 women and treatment outcomes with steroid therapy. (Pandey TS, Mackinnon JC, Bressler L, Millar A, Marcus EE, Ganschow PS) Breast J 2014;20(3):258-66 100 Citations |
| 1 | A Feasibility Study to Measure Physical Activity, Fatigue, Sleep-Wake Disturbances, and Depression in Young Adults During Chemotherapy. (Erickson JM, Adelstein KE, Letzkus LC) J Adolesc Young Adult Oncol 2014 Mar 01;3(1):37-41 |
| 1 | High-dose IgG therapy mitigates bile duct-targeted inflammation and obstruction in a mouse model of biliary atresia. (Fenner EK, Boguniewicz J, Tucker RM, Sokol RJ, Mack CL) Pediatr Res 2014 Jul;76(1):72-80 17 Citations |
| 1 | Looking back, looking forward: A historical reflection on psychotherapy process research. (Knobloch-Fedders LM, Elkin I, Kiesler DJ) Psychother Res 2015;25(4):383-95 20 Citations |
| 2 | Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer. (Dalah E, Moraru I, Paulson E, Erickson B, Li XA) Int J Radiat Oncol Biol Phys 2014 Jul 01;89(3):633-40 36 Citations |
| 1 | Evaluation of a novel blood pressure scoring method and its association with clinical response in cancer patients treated with anti-vascular endothelial growth factor therapy. (Bilen MA, Durand JB, McQuinn L, Hess KR, Fu S, Falchook GS, Hong DS, Wheler JJ, Said R, Ewer MS, Kurzrock R, Naing A) Invest New Drugs 2014 Aug;32(4):717-22 3 Citations |
| 1 | The influence of radiation therapy dose escalation on overall survival in unresectable pancreatic adenocarcinoma. (Hall WA, Colbert LE, Nickleach D, Switchenko J, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Prabhu RS, Kauh J, Landry JC) J Gastrointest Oncol 2014 Apr;5(2):77-85 13 Citations |
| 1 | The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American Society for Radiation Oncology evidence-based guideline. (Klopp A, Smith BD, Alektiar K, Cabrera A, Damato AL, Erickson B, Fleming G, Gaffney D, Greven K, Lu K, Miller D, Moore D, Petereit D, Schefter T, Small W Jr, Yashar C, Viswanathan AN) Pract Radiat Oncol 2014;4(3):137-144 163 Citations |
| 1 | Radiation therapy for non-melanoma skin cancer in immunosuppressed patients and cutaneous toxicity from this therapy (Currey AD, Olasz EB, Wilson JF, Lazarova Z) Skin Diseases in the Immunocompromised 1 May 2014:171-182 |
| 2 | Effect of treatment modality on the hypothalamic-pituitary function of patients treated with radiation therapy for pituitary adenomas: hypothalamic dose and endocrine outcomes. (Elson A, Bovi J, Kaur K, Maas D, Sinson G, Schultz C) Front Oncol 2014;4:73 16 Citations |
| 1 | A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity. (Barnett GC, Thompson D, Fachal L, Kerns S, Talbot C, Elliott RM, Dorling L, Coles CE, Dearnaley DP, Rosenstein BS, Vega A, Symonds P, Yarnold J, Baynes C, Michailidou K, Dennis J, Tyrer JP, Wilkinson JS, Gómez-Caamaño A, Tanteles GA, Platte R, Mayes R, Conroy D, Maranian M, Luccarini C, Gulliford SL, Sydes MR, Hall E, Haviland J, Misra V, Titley J, Bentzen SM, Pharoah PD, Burnet NG, Dunning AM, West CM) Radiother Oncol 2014 May;111(2):178-85 124 Citations |
| 2 | Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusion. (Nudelman KN, Wang Y, McDonald BC, Conroy SK, Smith DJ, West JD, O'Neill DP, Schneider BP, Saykin AJ) PLoS One 2014;9(5):e96713 49 Citations |
| 7 | 3-T MRI-based adaptive brachytherapy for cervix cancer: treatment technique and initial clinical outcomes. (Kharofa J, Morrow N, Kelly T, Rownd J, Paulson E, Rader J, Uyar D, Bradley W, Erickson B) Brachytherapy 2014;13(4):319-25 30 Citations |
| 1 | Delayed administration of a bio-engineered zinc-finger VEGF-A gene therapy is neuroprotective and attenuates allodynia following traumatic spinal cord injury. (Figley SA, Liu Y, Karadimas SK, Satkunendrarajah K, Fettes P, Spratt SK, Lee G, Ando D, Surosky R, Giedlin M, Fehlings MG) PLoS One 2014;9(5):e96137 33 Citations |
| 4 | Molecular profiling in gastric cancer: examining potential targets for chemotherapy. (Miura JT, Johnston FM, Thomas J, George B, Eastwood D, Tsai S, Christians KK, Turaga KK, Gamblin TC) J Surg Oncol 2014 Sep;110(3):302-6 9 Citations |
| 1 | Toxicity of targeted therapy: Implications for response and impact of genetic polymorphisms. (Liu S, Kurzrock R) Cancer Treat Rev 2014 Aug;40(7):883-91 138 Citations |
| 2 | SU-E-T-539: Fixed Versus Variable Optimization Points in Combined-Mode Modulated Arc Therapy Planning. (Kainz K, Prah D, Ahunbay E, Li X) Med Phys 2014 Jun;41(6):351 |
| 1 | SU-E-I-82: Improving CT Image Quality for Radiation Therapy Using Iterative Reconstruction Algorithms and Slightly Increasing Imaging Doses. (Noid G, Chen G, Tai A, Li X) Med Phys 2014 Jun;41(6):149 |
| 3 | MO-C-17A-06: Online Adaptive Re-Planning to Account for Independent Motions Between Multiple Targets During Radiotherapy of Lung Cancer. (Liu F, Tai A, Ahunbay E, Gore E, Johnstone C, Li X) Med Phys 2014 Jun;41(6):415 |
| 2 | SU-E-J-190: Characterization of Radiation Induced CT Number Changes in Tumor and Normal Lung During Radiation Therapy for Lung Cancer. (Yang C, Liu F, Tai A, Gore E, Johnstone C, Li X) Med Phys 2014 Jun;41(6):200 |
| 1 | A review of safety, quality management, and practice guidelines for high-dose-rate brachytherapy: executive summary. (Thomadsen BR, Erickson BA, Eifel PJ, Hsu IC, Patel RR, Petereit DG, Fraass BA, Rivard MJ) Pract Radiat Oncol 2014;4(2):65-70 46 Citations |
| 1 | A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia. (Burke MJ, Lamba JK, Pounds S, Cao X, Ghodke-Puranik Y, Lindgren BR, Weigel BJ, Verneris MR, Miller JS) Am J Hematol 2014 Sep;89(9):889-95 91 Citations |
| 1 | Late radiation-associated dysphagia (late-RAD) with lower cranial neuropathy after oropharyngeal radiotherapy: a preliminary dosimetric comparison. (Awan MJ, Mohamed AS, Lewin JS, Baron CA, Gunn GB, Rosenthal DI, Holsinger FC, Schwartz DL, Fuller CD, Hutcheson KA) Oral Oncol 2014 Aug;50(8):746-52 58 Citations |
| 1 | Comparison of swallowing function after intensity-modulated radiation therapy and conventional radiotherapy for head and neck cancer. (Pauloski BR, Rademaker AW, Logemann JA, Discekici-Harris M, Mittal BB) Head Neck 2015 Nov;37(11):1575-82 41 Citations |
| 1 | Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapy. (Wang C, Abdel-Mohsen M, Strain MC, Lada SM, Yukl S, Cockerham LR, Pilcher CD, Hecht FM, Sinclair E, Liegler T, Richman DD, Deeks SG, Pillai SK) J Infect Dis 2014 Dec 01;210(11):1838-43 10 Citations |
| 3 | Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 study rationale, design, and methods. (Saber W, Le Rademacher J, Sekeres M, Logan B, Lewis M, Mendizabal A, Leifer E, Appelbaum FR, Horowitz MM, Nakamura R, Cutler CS) Biol Blood Marrow Transplant 2014 Oct;20(10):1566-72 14 Citations |
| 1 | A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1. (Fachal L, Gómez-Caamaño A, Barnett GC, Peleteiro P, Carballo AM, Calvo-Crespo P, Kerns SL, Sánchez-García M, Lobato-Busto R, Dorling L, Elliott RM, Dearnaley DP, Sydes MR, Hall E, Burnet NG, Carracedo Á, Rosenstein BS, West CM, Dunning AM, Vega A) Nat Genet 2014 Aug;46(8):891-4 118 Citations |
| 1 | Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer. (Liu S, Meng X, Chen H, Liu W, Miller T, Murph M, Lu Y, Zhang F, Gagea M, Arteaga CL, Mills GB, Meric-Bernstam F, González-Angulo AM) Oncotarget 2014 Oct 15;5(19):9049-64 23 Citations |
| 3 | Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation. (Hamadani M, Hari PN, Zhang Y, Carreras J, Akpek G, Aljurf MD, Ayala E, Bachanova V, Chen AI, Chen YB, Costa LJ, Fenske TS, Freytes CO, Ganguly S, Hertzberg MS, Holmberg LA, Inwards DJ, Kamble RT, Kanfer EJ, Lazarus HM, Marks DI, Nishihori T, Olsson R, Reddy NM, Rizzieri DA, Savani BN, Solh M, Vose JM, Wirk B, Maloney DG, Smith SM, Montoto S, Saber W, Alpdogan O, Cashen A, Dandoy C, Finke R, Gale R, Gibson J, Hsu JW, Janakiraman N, Laughlin MJ, Lill M, Cairo MS, Munker R, Rowlings PA, Schouten HC, Shea TC, Stiff PJ, Waller EK) Biol Blood Marrow Transplant 2014 Nov;20(11):1729-36 126 Citations |
| 1 | Laser therapy versus observation for symptomatic retinal artery macroaneurysms. (Meyer JC, Ahmad BU, Blinder KJ, Shah GK) Graefes Arch Clin Exp Ophthalmol 2015 Apr;253(4):537-41 17 Citations |
| 1 | Sub-100nm gold nanomatryoshkas improve photo-thermal therapy efficacy in large and highly aggressive triple negative breast tumors. (Ayala-Orozco C, Urban C, Bishnoi S, Urban A, Charron H, Mitchell T, Shea M, Nanda S, Schiff R, Halas N, Joshi A) J Control Release 2014 Oct 10;191:90-97 85 Citations |
| 1 | Bisphosphonate therapy for osteogenesis imperfecta. (Dwan K, Phillipi CA, Steiner RD, Basel D) Cochrane Database Syst Rev 2014 Jul 23(7):CD005088 198 Citations |
| 1 | Impact of ageing and body mass on cancer immunotherapy outcomes (Sckisel GD, Monjazeb AM, Mirsoian A, Zamora AE, Grossenbacher S, Murphy WJ) ,Tumor Immunology and Immunotherapy, pp.15-30, Oxford: Oxford University Press |
| 1 | An acute care surgery dilemma: emergent laparoscopic cholecystectomy in patients on aspirin therapy. (Joseph B, Rawashdeh B, Aziz H, Kulvatunyou N, Pandit V, Jehangir Q, O'Keeffe T, Tang A, Green DJ, Friese RS, Rhee P) Am J Surg 2015 Apr;209(4):689-94 31 Citations |
| 1 | Impact of margin status and neoadjuvant chemotherapy on survival, recurrence after liver resection for colorectal liver metastasis. (Pandanaboyana S, White A, Pathak S, Hidalgo EL, Toogood G, Lodge JP, Prasad KR) Ann Surg Oncol 2015 Jan;22(1):173-9 32 Citations |
| 1 | Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation. (Kim SY, Le Rademacher J, Antin JH, Anderlini P, Ayas M, Battiwalla M, Carreras J, Kurtzberg J, Nakamura R, Eapen M, Deeg HJ) Haematologica 2014 Dec;99(12):1868-75 23 Citations |
| 1 | Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help. (Monjazeb AM, Tietze JK, Grossenbacher SK, Hsiao HH, Zamora AE, Mirsoian A, Koehn B, Blazar BR, Weiss JM, Wiltrout RH, Sckisel GD, Murphy WJ) PLoS One 2014;9(8):e102709 29 Citations |
| 1 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. (Helm JH, Miura JT, Glenn JA, Marcus RK, Larrieux G, Jayakrishnan TT, Donahue AE, Gamblin TC, Turaga KK, Johnston FM) Ann Surg Oncol 2015 May;22(5):1686-93 216 Citations |
| 1 | Attenuation of anti-tuberculosis therapy induced hepatotoxicity by Spirulina fusiformis, a candidate food supplement. (Martin SJ, Baskaran UL, Vedi M, Sabina EP) Toxicol Mech Methods 2014 Dec;24(8):584-92 19 Citations |
| 1 | Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). (Jayakrishnan TT, Zacharias AJ, Sharma A, Pappas SG, Gamblin TC, Turaga KK) World J Surg Oncol 2014 Aug 21;12:270 53 Citations |
| 4 | Defining the role of adjuvant external beam radiotherapy on resected adenocarcinoma of the ampulla of vater. (Miura JT, Jayakrishnan TT, Amini A, Johnston FM, Tsai S, Erickson B, Quebbeman EJ, Christians KK, Evans DB, Gamblin TC, Turaga KK) J Gastrointest Surg 2014 Nov;18(11):2003-8 12 Citations |
| 2 | Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network. (Callander N, Markovina S, Eickhoff J, Hutson P, Campbell T, Hematti P, Go R, Hegeman R, Longo W, Williams E, Asimakopoulos F, Miyamoto S) Cancer Chemother Pharmacol 2014 Oct;74(4):875-82 31 Citations |
| 3 | Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802. (Bolaños-Meade J, Logan BR, Alousi AM, Antin JH, Barowski K, Carter SL, Goldstein SC, Hexner EO, Horowitz MM, Lee SJ, Levine JE, MacMillan ML, Martin PJ, Mendizabal AM, Nakamura R, Pasquini MC, Weisdorf DJ, Westervelt P, Ho VT) Blood 2014 Nov 20;124(22):3221-7; quiz 3335 94 Citations |
| 1 | Outcomes of immunosuppressant therapy with lower dose of antithymocyte globulin and cyclosporine in aplastic anemia. (Malhotra P, Bodh V, Guru Murthy GS, Datta AK, Varma N, Varma S) Hematology 2015 May;20(4):239-44 11 Citations |
| 1 | Stereotactic body radiotherapy for a large arteriovenous malformation of the head and neck. (Koyfman SA, Shukla ME, Bricker A, Djemil T, Wood B, Masaryk T, Suh JH) Laryngoscope 2015 Feb;125(2):379-82 8 Citations |
| 2 | The effect of margin status and molecular subtype on women with invasive breast cancer treated with breast-conservation therapy. (Currey AD, Tuyishimire B, Lin J, Kong AL) J Clin Oncol 2014 Sep 10;32(26_suppl):83 |
| 2 | An extracorporeal blood-cleansing device for sepsis therapy. (Kang JH, Super M, Yung CW, Cooper RM, Domansky K, Graveline AR, Mammoto T, Berthet JB, Tobin H, Cartwright MJ, Watters AL, Rottman M, Waterhouse A, Mammoto A, Gamini N, Rodas MJ, Kole A, Jiang A, Valentin TM, Diaz A, Takahashi K, Ingber DE) Nat Med 2014 Oct;20(10):1211-6 271 Citations |
| 1 | Triple-negative breast cancer patients treated at MD Anderson Cancer Center in phase I trials: improved outcomes with combination chemotherapy and targeted agents. (Ganesan P, Moulder S, Lee JJ, Janku F, Valero V, Zinner RG, Naing A, Fu S, Tsimberidou AM, Hong D, Stephen B, Stephens P, Yelensky R, Meric-Bernstam F, Kurzrock R, Wheler JJ) Mol Cancer Ther 2014 Dec;13(12):3175-84 33 Citations |
| 1 | Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events. (El-Said H, Hegde S, Foerster S, Hellenbrand W, Kreutzer J, Trucco SM, Holzer R, Burch G, Mirani A, Nicolas R, Porras D, Bergersen L, Moore J) Catheter Cardiovasc Interv 2015 Feb 01;85(2):227-33 51 Citations |
| 1 | Novel approaches in anaplastic thyroid cancer therapy. (Hsu KT, Yu XM, Audhya AW, Jaume JC, Lloyd RV, Miyamoto S, Prolla TA, Chen H) Oncologist 2014 Nov;19(11):1148-55 47 Citations |
| 1 | Tocolytics Used as Adjunctive Therapy at the Time of Cerclage Placement: A Systematic Review (Smith J, DeFranco E ) Poster presentation at the 2014 annual meeting of the Central Association of Obstetricians & Gynecologists, Albuquerque, NM |
| 1 | Adalimumab retreatment successfully restores clinical response and health-related quality of life in patients with moderate to severe psoriasis who undergo therapy interruption. (Gordon KB, Gottlieb AB, Langely RG, van de Kerkhof P, Belasco KT, Sundaram M, Okun M, Serra L) J Eur Acad Dermatol Venereol 2015 Apr;29(4):767-76 19 Citations |
| 1 | Update on the use of hydroxyurea therapy in sickle cell disease. (Wong TE, Brandow AM, Lim W, Lottenberg R) Blood 2014 Dec 18;124(26):3850-7; quiz 4004 84 Citations |
| 1 | Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer. (Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Lee Burnett O 3rd, D'Souza DP, Patil N, Haddock MG, Jhingran A, Jones EL, Kunos CA, Lee LJ, Lin LL, Mayr NA, Petersen I, Petric P, Portelance L, Small W Jr, Strauss JB, Townamchai K, Wolfson AH, Yashar CM, Bosch W) Int J Radiat Oncol Biol Phys 2014 Oct 01;90(2):320-8 167 Citations |
| 1 | Immunotherapy for secondary glioblastoma multiforme: toward an isocitrate dehydrogenase vaccine. (Abecassis IJ, Morton RP, Nerva JD, Kim LJ) World Neurosurg 2014 Dec;82(6):933-5 2 Citations |
| 1 | Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031. (Friedman DL, Chen L, Wolden S, Buxton A, McCarten K, FitzGerald TJ, Kessel S, De Alarcon PA, Chen AR, Kobrinsky N, Ehrlich P, Hutchison RE, Constine LS, Schwartz CL) J Clin Oncol 2014 Nov 10;32(32):3651-8 204 Citations |
| 1 | Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies (PACT) program. (Lindblad RW, Ibenana L, Wagner JE, McKenna DH Jr, Hei DJ, Hematti P, Couture LA, Silberstein LE, Armant M, Rooney CM, Gee AP, Welniak LA, Heath Mondoro T, Wood DA, Styers D) Transfusion 2015 Mar;55(3):674-9 5 Citations |
| 1 | Synergy between VEGF/VEGFR inhibitors and chemotherapy agents in the phase I clinic. (Tang C, Hess K, Jardim DL, Gagliato Dde M, Tsimberidou AM, Falchook G, Fu S, Janku F, Naing A, Piha-Paul S, Subbiah V, Wheler J, Zinner RG, Kurzrock R, Ellis LM, Meric-Berstam F, Hong DS) Clin Cancer Res 2014 Dec 01;20(23):5956-63 10 Citations |
| 1 | Is intraoperative frozen section analysis of reexcision specimens of value in preventing reoperation in breast-conserving therapy? (Jorns JM, Daignault S, Sabel MS, Wu AJ) Am J Clin Pathol 2014 Nov;142(5):601-8 26 Citations |
| 2 | The IBV Valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysema. (Wood DE, Nader DA, Springmeyer SC, Elstad MR, Coxson HO, Chan A, Rai NS, Mularski RA, Cooper CB, Wise RA, Jones PW, Mehta AC, Gonzalez X, Sterman DH, IBV Valve Trial Research Team) J Bronchology Interv Pulmonol 2014 Oct;21(4):288-97 60 Citations |
| 1 | Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants. (ElHassan NO, Bird TM, King AJ, Ambadwar PB, Jaquiss RD, Kaiser JR, Robbins JM) J Neonatal Perinatal Med 2014 Jan 01;7(3):229-35 10 Citations |
| 1 | Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic. (Jardim DL, Tang C, Gagliato Dde M, Falchook GS, Hess K, Janku F, Fu S, Wheler JJ, Zinner RG, Naing A, Tsimberidou AM, Holla V, Li MM, Roy-Chowdhuri S, Luthra R, Salgia R, Kurzrock R, Meric-Bernstam F, Hong DS) Clin Cancer Res 2014 Dec 15;20(24):6336-45 74 Citations |
| 1 | Chronic vitamin K antagonist therapy and bleeding risk in ST elevation myocardial infarction patients. (Karrowni W, Wang TY, Chen AY, Thomas L, Saucedo JF, El Accaoui RN) Heart 2015 Feb;101(4):264-70 3 Citations |
| 1 | Predictors and Outcomes Associated with Rescue Therapy in SWIFT. (Lazzaro MA, Zaidat OO, Saver JL, SWIFT investigators) Interv Neurol 2014 Aug;2(4):178-82 |
| 1 | Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art. (Randall JM, Millard F, Kurzrock R) Cancer Metastasis Rev 2014 Dec;33(4):1109-24 76 Citations |
| 1 | Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity. (Nguyen-Tan PF, Zhang Q, Ang KK, Weber RS, Rosenthal DI, Soulieres D, Kim H, Silverman C, Raben A, Galloway TJ, Fortin A, Gore E, Westra WH, Chung CH, Jordan RC, Gillison ML, List M, Le QT) J Clin Oncol 2014 Dec 01;32(34):3858-66 386 Citations |
| 1 | Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab. (Falchook GS, Wheler JJ, Naing A, Jackson EF, Janku F, Hong D, Ng CS, Tannir NM, Lawhorn KN, Huang M, Angelo LS, Vishwamitra D, Hess K, Howard AN, Parkhurst KL, Amin HM, Kurzrock R) Oncotarget 2014 Nov 15;5(21):10280-92 53 Citations |
| 1 | Quality assurance assessment of diagnostic and radiation therapy-simulation CT image registration for head and neck radiation therapy: anatomic region of interest-based comparison of rigid and deformable algorithms. (Mohamed AS, Ruangskul MN, Awan MJ, Baron CA, Kalpathy-Cramer J, Castillo R, Castillo E, Guerrero TM, Kocak-Uzel E, Yang J, Court LE, Kantor ME, Gunn GB, Colen RR, Frank SJ, Garden AS, Rosenthal DI, Fuller CD) Radiology 2015 Mar;274(3):752-63 58 Citations |
| 1 | Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base. (Mikell JL, Gillespie TW, Hall WA, Nickleach DC, Liu Y, Lipscomb J, Ramalingam SS, Rajpara RS, Force SD, Fernandez FG, Owonikoko TK, Pillai RN, Khuri FR, Curran WJ, Higgins KA) J Thorac Oncol 2015 Mar;10(3):462-71 97 Citations |
| 4 | Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration data. (Santana-Davila R, Devisetty K, Szabo A, Sparapani R, Arce-Lara C, Gore EM, Moran A, Williams CD, Kelley MJ, Whittle J) J Clin Oncol 2015 Feb 20;33(6):567-74 115 Citations |
| 1 | Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience. (Hou MM, Liu X, Wheler J, Naing A, Hong D, Coleman RL, Tsimberidou A, Janku F, Zinner R, Lu K, Kurzrock R, Fu S) Oncotarget 2014 Nov 30;5(22):11168-79 57 Citations |
| 1 | Eruptive keratoacanthomas after radiation therapy for keratoacanthoma centrifugum marginatum. (Lindsay DP, Kharofa J, Junck M, Olasz E, Frank Wilson J) Pract Radiat Oncol 2015;5(3):203-206 2 Citations |
| 1 | The current state of physical therapy pain curricula in the United States: a faculty survey. (Hoeger Bement MK, Sluka KA) J Pain 2015 Feb;16(2):144-52 53 Citations |
| 1 | Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: quantitative image analysis of post-radiotherapy response. (Tang C, Fuller CD, Garden AS, Awan MJ, Colen RR, Morrison WH, Frank SJ, Beadle BM, Phan J, Sturgis EM, Zafereo ME, Weber RS, Rosenthal DI, Gunn GB) Oral Oncol 2015 Feb;51(2):195-201 14 Citations |
| 2 | Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer. (Wong SJ, Moughan J, Meropol NJ, Anne PR, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG) Int J Radiat Oncol Biol Phys 2015 Jan 01;91(1):116-23 31 Citations |
| 1 | Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma. (Vij R, Kumar S, Zhang MJ, Zhong X, Huang J, Dispenzieri A, Abidi MH, Bird JM, Freytes CO, Gale RP, Kindwall-Keller TL, Kyle RA, Landsburg DJ, Lazarus HM, Munker R, Roy V, Sharma M, Vogl DT, Wirk B, Hari PN) Biol Blood Marrow Transplant 2015 Feb;21(2):335-41 64 Citations |
| 1 | Deformable image registration based automatic CT-to-CT contour propagation for head and neck adaptive radiotherapy in the routine clinical setting. (Kumarasiri A, Siddiqui F, Liu C, Yechieli R, Shah M, Pradhan D, Zhong H, Chetty IJ, Kim J) Med Phys 2014 Dec;41(12):121712 83 Citations |
| 1 | Differential platelet levels affect response to taxane-based therapy in ovarian cancer. (Bottsford-Miller J, Choi HJ, Dalton HJ, Stone RL, Cho MS, Haemmerle M, Nick AM, Pradeep S, Zand B, Previs RA, Pecot CV, Crane EK, Hu W, Lutgendorf SK, Afshar-Kharghan V, Sood AK) Clin Cancer Res 2015 Feb 01;21(3):602-10 85 Citations |
| 1 | Improved human observer performance in digital reconstructed radiograph verification in head and neck cancer radiotherapy. (Sturgeon JD, Cox JA, Mayo LL, Gunn GB, Zhang L, Balter PA, Dong L, Awan M, Kocak-Uzel E, Mohamed AS, Rosenthal DI, Fuller CD) Int J Comput Assist Radiol Surg 2015 Oct;10(10):1667-73 4 Citations |
| 2 | Implementation of Polymerase Chain Reaction to Rule Out Clostridium difficile Infection Is Associated With Reduced Empiric Antibiotic Duration of Therapy. (Peppard WJ, Ledeboer NA) Hosp Pharm 2014 Jul;49(7):639-43 9 Citations |
| 1 | Use of High-Flow Continuous Renal Replacement Therapy with Citrate Anticoagulation to Control Intracranial Pressure by Maintaining Hypernatremia in a Patient with Acute Brain Injury and Renal Failure. (Medow JE, Sanghvi SR, Hofmann RM) Clin Med Res 2015 Jun;13(2):89-93 8 Citations |
| 2 | Effect of radiotherapy on the survival of patients with stage I and stage II mantle cell lymphoma: analysis of the Surveillance, Epidemiology and End Results database. (Guru Murthy GS, Venkitachalam R, Mehta P) Clin Lymphoma Myeloma Leuk 2014 Sep;14 Suppl:S90-5 15 Citations |
| 1 | miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib. (Guinn D, Ruppert AS, Maddocks K, Jaglowski S, Gordon A, Lin TS, Larson R, Marcucci G, Hertlein E, Woyach J, Johnson AJ, Byrd JC) Leukemia 2015 May;29(5):1210-3 18 Citations |
| 1 | Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study. (Gibbs P, Gebski V, Van Buskirk M, Thurston K, Cade DN, Van Hazel GA, SIRFLOX Study Group) BMC Cancer 2014 Dec 01;14:897 55 Citations |
| 1 | The effect of depressive symptoms and CD4 count on adherence to highly active antiretroviral therapy in sub-Saharan Africa. (Memiah P, Shumba C, Etienne-Mesubi M, Agbor S, Hossain MB, Komba P, Niyang M, Biadgilign S) J Int Assoc Provid AIDS Care 2014;13(4):346-52 |
| 2 | Additional support for neoadjuvant therapy in the management of pancreatic cancer. (Christians KK, Evans DB) Ann Surg Oncol 2015 Jun;22(6):1755-8 5 Citations |
| 1 | Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer. (Cooper AB, Slack R, Fogelman D, Holmes HM, Petzel M, Parker N, Balachandran A, Garg N, Ngo-Huang A, Varadhachary G, Evans DB, Lee JE, Aloia T, Conrad C, Vauthey JN, Fleming JB, Katz MH) Ann Surg Oncol 2015 Jul;22(7):2416-23 130 Citations |
| 1 | Radiogenomics: the search for genetic predictors of radiotherapy response. (Kerns SL, West CM, Andreassen CN, Barnett GC, Bentzen SM, Burnet NG, Dekker A, De Ruysscher D, Dunning A, Parliament M, Talbot C, Vega A, Rosenstein BS) Future Oncol 2014 Dec;10(15):2391-406 62 Citations |
| 1 | Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910. (Pisansky TM, Hunt D, Gomella LG, Amin MB, Balogh AG, Chinn DM, Seider MJ, Duclos M, Rosenthal SA, Bauman GS, Gore EM, Rotman MZ, Lukka HR, Shipley WU, Dignam JJ, Sandler HM) J Clin Oncol 2015 Feb 01;33(4):332-9 111 Citations |
| 1 | Patterns of relapse from a phase 3 Study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children's Oncology Group. (Dharmarajan KV, Friedman DL, Schwartz CL, Chen L, FitzGerald TJ, McCarten KM, Kessel SK, Iandoli M, Constine LS, Wolden SL) Int J Radiat Oncol Biol Phys 2015 May 01;92(1):60-6 22 Citations |
| 1 | Drug induced periarticular thenar erythema with onycholysis related to nano-albumin bound paclitaxel therapy (Dow EN, Piccolo J, Segal EM, Charlson JA) Cancer Treatment Communications 2015;4:161-164 5 Citations |
| 1 | Targeted therapy for hereditary cancer syndromes: neurofibromatosis type 1, neurofibromatosis type 2, and Gorlin syndrome. (Agarwal R, Liebe S, Turski ML, Vidwans SJ, Janku F, Garrido-Laguna I, Munoz J, Schwab R, Rodon J, Kurzrock R, Subbiah V, Pan-Cancer Working Group) Discov Med 2014 Dec;18(101):323-30 8 Citations |
| 1 | Targeted therapy for hereditary cancer syndromes: hereditary breast and ovarian cancer syndrome, Lynch syndrome, familial adenomatous polyposis, and Li-Fraumeni syndrome. (Agarwal R, Liebe S, Turski ML, Vidwans SJ, Janku F, Garrido-Laguna I, Munoz J, Schwab R, Rodon J, Kurzrock R, Subbiah V, Pan-Cancer Working Group) Discov Med 2014 Dec;18(101):331-9 14 Citations |
| 1 | Effects of hospital-based physical therapy on hospital discharge outcomes among hospitalized older adults with community-acquired pneumonia and declining physical function (Kim SJ, Lee JH, Han B, Lam J, Bukowy E, Rao A, Vulcano J, Andreeva A, Bertelson H, Shin HP, Yoo JW) Aging and Disease 2015;6(3):174-179 40 Citations |
| 1 | Drug induced periarticular thenar erythema with onycholysis related to nano-albumin bound paclitaxel therapy () Cancer Treatment Communications 2015;4:161-164 |
| 1 | Management of anticoagulation and antiplatelet therapy in patients with left ventricular assist devices. (Baumann Kreuziger LM) J Thromb Thrombolysis 2015 Apr;39(3):337-44 34 Citations |
| 1 | An automatic dosimetric and geometric tracking system for head and neck adaptive radiotherapy (Liu C, Kumarasiri A, Kamal M, Chetvertkov M, Gordon J, Zhong H, Siddiqui F, Chetty IJ, Kim J) IFMBE Proceedings 2015;51:570-574 |
| 1 | Pulmonary effects of antineoplastic therapy (Dhakal S, Weiner D, Schwartz C, Constine LS) Pediatric Oncology 2015;2015:201-227 2 Citations |
| 1 | Morphological analysis of tumor regression and its impact on deformable image registration for adaptive radiotherapy of lung cancer patients (Zhong H, Kim J, Gordon JJ, Brown SL, Movsas B, Chetty IJ) IFMBE Proceedings 2015;51:579-582 6 Citations |
| 1 | New frontiers in aortic therapy: focus on current trials and devices in transcatheter aortic valve replacement. (Gutsche JT, Patel PA, Walsh EK, Sophocles A, Chern SY, Jones DB, Anwaruddin S, Desai ND, Weiss SJ, Augoustides JG) J Cardiothorac Vasc Anesth 2015 Apr;29(2):536-41 19 Citations |
| 1 | A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality. (MacMillan ML, Robin M, Harris AC, DeFor TE, Martin PJ, Alousi A, Ho VT, Bolaños-Meade J, Ferrara JL, Jones R, Arora M, Blazar BR, Holtan SG, Jacobsohn D, Pasquini M, Socie G, Antin JH, Levine JE, Weisdorf DJ) Biol Blood Marrow Transplant 2015 Apr;21(4):761-7 222 Citations |
| 2 | Neoadjuvant therapy for localized pancreatic cancer: support is growing? (Evans DB, Ritch PS, Erickson BA) Ann Surg 2015 Jan;261(1):18-20 19 Citations |
| 1 | Select host restriction factors are associated with HIV persistence during antiretroviral therapy. (Abdel-Mohsen M, Wang C, Strain MC, Lada SM, Deng X, Cockerham LR, Pilcher CD, Hecht FM, Liegler T, Richman DD, Deeks SG, Pillai SK) AIDS 2015 Feb 20;29(4):411-20 42 Citations |
| 1 | CT-guided implantation of intrahepatic fiducial markers for proton beam therapy of liver lesions: assessment of success rate and complications. (Kulkarni NM, Hong TS, Kambadakone A, Arellano RS) AJR Am J Roentgenol 2015 Feb;204(2):W207-13 18 Citations |
| 1 | Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma. (Jing W, Gershan JA, Weber J, Tlomak D, McOlash L, Sabatos-Peyton C, Johnson BD) J Immunother Cancer 2015;3(1):2 100 Citations |
| 1 | Brachytherapy: where has it gone? (Petereit DG, Frank SJ, Viswanathan AN, Erickson B, Eifel P, Nguyen PL, Wazer DE) J Clin Oncol 2015 Mar 20;33(9):980-2 108 Citations |
| 1 | Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial. (Wang D, Zhang Q, Eisenberg BL, Kane JM, Li XA, Lucas D, Petersen IA, DeLaney TF, Freeman CR, Finkelstein SE, Hitchcock YJ, Bedi M, Singh AK, Dundas G, Kirsch DG) J Clin Oncol 2015 Jul 10;33(20):2231-8 219 Citations |
| 1 | Steroid therapy attenuates acute phase reactant response among children on ventricular assist device support. (Byrnes JW, Bhutta AT, Rettiganti MR, Gomez A, Garcia X, Dyamenahalli U, Johnson C, Jaquiss RD, Imamura M, Prodhan P) Ann Thorac Surg 2015 Apr;99(4):1392-8 33 Citations |
| 1 | Radiotherapy quality assurance report from children's oncology group AHOD0031. (Dharmarajan KV, Friedman DL, FitzGerald TJ, McCarten KM, Constine LS, Chen L, Kessel SK, Iandoli M, Laurie F, Schwartz CL, Wolden SL) Int J Radiat Oncol Biol Phys 2015 Apr 01;91(5):1065-71 14 Citations |
| 6 | Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations. (Nattinger AB, Pezzin LE, McGinley EL, Charlson JA, Yen TW, Neuner JM) Springerplus 2015;4(1):54 13 Citations |
| 1 | VEGF-A Expression Correlates with TP53 Mutations in Non-Small Cell Lung Cancer: Implications for Antiangiogenesis Therapy. (Schwaederlé M, Lazar V, Validire P, Hansson J, Lacroix L, Soria JC, Pawitan Y, Kurzrock R) Cancer Res 2015 Apr 01;75(7):1187-90 105 Citations |
| 1 | Estimation of daily interfractional larynx residual setup error after isocentric alignment for head and neck radiotherapy: quality assurance implications for target volume and organs-at-risk margination using daily CT on- rails imaging. (Baron CA, Awan MJ, Mohamed AS, Akel I, Rosenthal DI, Gunn GB, Garden AS, Dyer BA, Court L, Sevak PR, Kocak-Uzel E, Fuller CD) J Appl Clin Med Phys 2014 Jan 08;16(1):5108 19 Citations |
| 5 | Comparing the quality of passively-scattered proton and photon tomotherapy plans for brain and head and neck disease sites. (Kainz K, Firat S, Wilson JF, Schultz C, Siker M, Wang A, Olson D, Li XA) Phys Med Biol 2015 Mar 21;60(6):2167-77 1 Citation |
| 3 | Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. (Chen YB, Lane AA, Logan B, Zhu X, Akpek G, Aljurf M, Artz A, Bredeson CN, Cooke KR, Ho VT, Lazarus HM, Olsson R, Saber W, McCarthy P, Pasquini MC) Biol Blood Marrow Transplant 2015 Jun;21(6):1046-1053 138 Citations |
| 1 | PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy. (Patel SP, Kurzrock R) Mol Cancer Ther 2015 Apr;14(4):847-56 1861 Citations |
| 1 | Tumor-generated nitric oxide as an antagonist of photodynamic therapy. (Girotti AW) Photochem Photobiol Sci 2015 Aug;14(8):1425-32 13 Citations |
| 1 | The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. (Parfrey PS, Drüeke TB, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Kubo Y, Dehmel B, Goodman WG, Chertow GM, Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators) Clin J Am Soc Nephrol 2015 May 07;10(5):791-9 81 Citations |
| 1 | Use of Helical TomoTherapy for the Focal Hypofractionated Treatment of Limited Brain Metastases in the Initial and Recurrent Setting. (Elson A, Walker A, Bovi JA, Schultz C) Front Oncol 2015;5:27 6 Citations |
| 1 | Targeted therapy for genetic cancer syndromes: Fanconi anemia, medullary thyroid cancer, tuberous sclerosis, and RASopathies. (Agarwal R, Liebe S, Turski ML, Vidwans SJ, Janku F, Garrido-Laguna I, Munoz J, Schwab R, Rodon J, Kurzrock R, Subbiah V, Pan-Cancer Working Group) Discov Med 2015 Feb;19(103):101-8 2 Citations |
| 1 | Targeted therapy for genetic cancer syndromes: Von Hippel-Lindau disease, Cowden syndrome, and Proteus syndrome. (Agarwal R, Liebe S, Turski ML, Vidwans SJ, Janku F, Garrido-Laguna I, Munoz J, Schwab R, Rodon J, Kurzrock R, Subbiah V, Pan-Cancer Working Group) Discov Med 2015 Feb;19(103):109-16 15 Citations |
| 1 | Adherence to Guidelines for Adjuvant Imatinib Therapy for GIST: A Multi-institutional Analysis. (Bischof DA, Dodson R, Jimenez MC, Behman R, Cocieru A, Blazer DG 3rd, Fisher SB, Squires MH 3rd, Kooby DA, Maithel SK, Groeschl RT, Gamblin TC, Bauer TW, Karanicolas PJ, Law C, Quereshy FA, Pawlik TM) J Gastrointest Surg 2015 Jun;19(6):1022-8 14 Citations |
| 1 | Seeing is saving: the benefit of 3D imaging in gynecologic brachytherapy. (Viswanathan AN, Erickson BA) Gynecol Oncol 2015 Jul;138(1):207-15 26 Citations |
| 1 | Target and organ dose estimation from intensity modulated head and neck radiation therapy using 3 deformable image registration algorithms. (Kumarasiri A, Liu C, Siddiqui F, Zhong H, Chetty IJ, Kim J) Pract Radiat Oncol 2015;5(4):e317-25 7 Citations |
| 1 | Promises and Pitfalls: Development of the National Brachytherapy Registry. (Wallner PE, Kupelian P, Erickson B, Alektiar K) J Am Coll Radiol 2015 Jul;12(7):670-1 1 Citation |
| 1 | An adaptive MR-CT registration method for MRI-guided prostate cancer radiotherapy. (Zhong H, Wen N, Gordon JJ, Elshaikh MA, Movsas B, Chetty IJ) Phys Med Biol 2015 Apr 07;60(7):2837-51 30 Citations |
| 5 | Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma. (Miura JT, Johnston FM, Tsai S, George B, Thomas J, Eastwood D, Banerjee A, Christians KK, Turaga KK, Pawlik TM, Clark Gamblin T) Ann Surg Oncol 2015 Oct;22(11):3716-23 88 Citations |
| 1 | Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy. (Tsimberidou AM, Said R, Culotta K, Wistuba I, Jelinek J, Fu S, Falchook G, Naing A, Piha-Paul S, Zinner R, Siddik ZH, He G, Hess K, Stewart DJ, Kurzrock R, Issa JP) Clin Epigenetics 2015;7(1):29 13 Citations |
| 1 | Lentiviral vectors in cancer immunotherapy. (Oldham RA, Berinstein EM, Medin JA) Immunotherapy 2015;7(3):271-84 29 Citations |
| 1 | Life expectancy and its role in palliative radiotherapy fractionation (Johnstone C) Palliative Radiation Therapy: Utilization of Advanced Technologies April 01, 2015;1:89-112 |
| 2 | Computed tomography number changes observed during computed tomography-guided radiation therapy for head and neck cancer. (Feng M, Yang C, Chen X, Xu S, Moraru I, Lang J, Schultz C, Li XA) Int J Radiat Oncol Biol Phys 2015 Apr 01;91(5):1041-7 22 Citations |
| 2 | Neoadjuvant Chemotherapy and Radiochemotherapy: Is There a Survival Advantage for Pancreatic Cancer Patients? (Tsai S, George B, Christians KK, Evans DB) Pancreatic Cancer, Cystic Neoplasms and Endocrine Tumors: Diagnosis and Management 7 April 2015:103-119 1 Citation |
| 1 | Antithrombotic therapy for left ventricular assist devices in adults: a systematic review. (Baumann Kreuziger LM, Kim B, Wieselthaler GM) J Thromb Haemost 2015 Jun;13(6):946-55 57 Citations |
| 1 | NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer. (Viswanathan AN, Moughan J, Miller BE, Xiao Y, Jhingran A, Portelance L, Bosch WR, Matulonis UA, Horowitz NS, Mannel RS, Souhami L, Erickson BA, Winter KA, Small W Jr, Gaffney DK) Cancer 2015 Jul 01;121(13):2156-63 43 Citations |
| 1 | Weight change associated with third-generation adjuvant chemotherapy in breast cancer patients. (Chaudhary LN, Wen S, Xiao J, Swisher AK, Kurian S, Abraham J) J Community Support Oncol 2014 Oct;12(10):355-60 13 Citations |
| 1 | CNTF Gene Therapy Confers Lifelong Neuroprotection in a Mouse Model of Human Retinitis Pigmentosa. (Lipinski DM, Barnard AR, Singh MS, Martin C, Lee EJ, Davies WIL, MacLaren RE) Mol Ther 2015 Aug;23(8):1308-1319 68 Citations |
| 4 | Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme. (Elson A, Paulson E, Bovi J, Siker M, Schultz C, Laviolette PS) J Neurooncol 2015 May;123(1):179-88 22 Citations |
| 1 | Tocolytics used as adjunctive therapy at the time of cerclage placement: a systematic review. (Smith J, DeFranco EA) J Perinatol 2015 Aug;35(8):561-5 14 Citations |
| 1 | Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy. (Rodrigues HV, Ke D, Lim J, Stephen B, Bellido J, Janku F, Zinner R, Tsimberidou A, Hong D, Piha-Paul S, Fu S, Naing A, Subbiah V, Karp D, Falchook G, Kurzrock R, Wheler J) Invest New Drugs 2015 Jun;33(3):700-9 13 Citations |
| 1 | Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial. (Rodon J, Soria JC, Berger R, Batist G, Tsimberidou A, Bresson C, Lee JJ, Rubin E, Onn A, Schilsky RL, Miller WH, Eggermont AM, Mendelsohn J, Lazar V, Kurzrock R) Ann Oncol 2015 Aug;26(8):1791-8 68 Citations |
| 1 | Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma. (Jensen JL, Rakhmilevich A, Heninger E, Broman AT, Hope C, Phan F, Miyamoto S, Maroulakou I, Callander N, Hematti P, Chesi M, Bergsagel PL, Sondel P, Asimakopoulos F) Cancer Immunol Res 2015 Aug;3(8):881-90 24 Citations |
| 1 | The important role of von Willebrand factor in platelet-derived FVIII gene therapy for murine hemophilia A in the presence of inhibitory antibodies. (Shi Q, Schroeder JA, Kuether EL, Montgomery RR) J Thromb Haemost 2015 Jul;13(7):1301-9 19 Citations |
| 1 | Adjuvant radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline. (Rodrigues G, Choy H, Bradley J, Rosenzweig KE, Bogart J, Curran WJ Jr, Gore E, Langer C, Louie AV, Lutz S, Machtay M, Puri V, Werner-Wasik M, Videtic GMM) Pract Radiat Oncol 2015;5(3):149-155 44 Citations |
| 1 | Definitive radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline. (Rodrigues G, Choy H, Bradley J, Rosenzweig KE, Bogart J, Curran WJ Jr, Gore E, Langer C, Louie AV, Lutz S, Machtay M, Puri V, Werner-Wasik M, Videtic GMM) Pract Radiat Oncol 2015;5(3):141-148 77 Citations |
| 1 | Simultaneously Targeting the NS3 Protease and Helicase Activities for More Effective Hepatitis C Virus Therapy. (Ndjomou J, Corby MJ, Sweeney NL, Hanson AM, Aydin C, Ali A, Schiffer CA, Li K, Frankowski KJ, Schoenen FJ, Frick DN) ACS Chem Biol 2015 Aug 21;10(8):1887-96 9 Citations |
| 5 | Photodynamic therapy (PDT) for malignant brain tumors--where do we stand? (Quirk BJ, Brandal G, Donlon S, Vera JC, Mang TS, Foy AB, Lew SM, Girotti AW, Jogal S, LaViolette PS, Connelly JM, Whelan HT) Photodiagnosis Photodyn Ther 2015 Sep;12(3):530-44 189 Citations |
| 1 | Chronic pain management: pharmacotherapy for chronic pain. (Chang KL, Fillingim R, Hurley RW, Schmidt S) FP Essent 2015 May;432:27-38 |
| 1 | Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial. (Chung ES, Miller L, Patel AN, Anderson RD, Mendelsohn FO, Traverse J, Silver KH, Shin J, Ewald G, Farr MJ, Anwaruddin S, Plat F, Fisher SJ, AuWerter AT, Pastore JM, Aras R, Penn MS) Eur Heart J 2015 Sep 01;36(33):2228-38 145 Citations |
| 1 | Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. (Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Drüeke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J, Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators*) Circulation 2015 Jul 07;132(1):27-39 266 Citations |
| 1 | Accelerated migration and invasion of prostate cancer cells after a photodynamic therapy-like challenge: Role of nitric oxide. (Fahey JM, Girotti AW) Nitric Oxide 2015 Sep 15;49:47-55 70 Citations |
| 1 | Evaluation of Bystander Cell Killing Effects in Suicide Gene Therapy of Cancer: Engineered Thymidylate Kinase (TMPK)/AZT Enzyme-Prodrug Axis. (Sato T, Neschadim A, Nakagawa R, Yanagisawa T, Medin JA) Methods Mol Biol 2015;1317:55-67 3 Citations |
| 1 | XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients. (Seibold P, Behrens S, Schmezer P, Helmbold I, Barnett G, Coles C, Yarnold J, Talbot CJ, Imai T, Azria D, Koch CA, Dunning AM, Burnet N, Bliss JM, Symonds RP, Rattay T, Suga T, Kerns SL, Bourgier C, Vallis KA, Sautter-Bihl ML, Claßen J, Debus J, Schnabel T, Rosenstein BS, Wenz F, West CM, Popanda O, Chang-Claude J) Int J Radiat Oncol Biol Phys 2015 Aug 01;92(5):1084-1092 64 Citations |
| 1 | Confirming, Validating, and Norming the Factor Structure of Systemic Therapy Inventory of Change Initial and Intersession. (Pinsof WM, Zinbarg RE, Shimokawa K, Latta TA, Goldsmith JZ, Knobloch-Fedders LM, Chambers AL, Lebow JL) Fam Process 2015 Sep;54(3):464-84 28 Citations |
| 1 | Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model. (Ravoori MK, Nishimura M, Singh SP, Lu C, Han L, Hobbs BP, Pradeep S, Choi HJ, Bankson JA, Sood AK, Kundra V) PLoS One 2015;10(6):e0131095 10 Citations |
| 1 | Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408. (Krauss DJ, Hu C, Bahary JP, Souhami L, Gore EM, Chafe SM, Leibenhaut MH, Narayan S, Torres-Roca J, Michalski J, Zeitzer KL, Donavanik V, Sandler H, McGowan DG, Jones CU, Shipley WU) Int J Radiat Oncol Biol Phys 2015 Jul 15;92(4):863-73 27 Citations |
| 2 | Non-metastatic Pancreatic Cancer: Resectable, Borderline Resectable, and Locally Advanced-Definitions of Increasing Importance for the Optimal Delivery of Multimodality Therapy. (Evans DB, George B, Tsai S) Ann Surg Oncol 2015 Oct;22(11):3409-13 71 Citations |
| 1 | SU-E-T-153: Burst-Mode Modulated Arc Therapy with Flattening-Filter-Free Beams Versus Flattening-Filtered Beams. (Kainz K, Lawton C, Li X) Med Phys 2015 Jun;42(6):3367 |
| 1 | TH-AB-304-04: Tumor Control Probability Modeling for Stereotactic Body Radiation Therapy of Early-Stage Lung Cancer Using Multiple Bio-Physical Models. (Liu F, Tai A, Lee P, Biswas T, Ding G, El Naqa I, Grimm J, Jackson A, Kong F, LaCouture T, Loo B, Miften M, Solberg T, Li X) Med Phys 2015 Jun;42(6):3701 |
| 1 | SU-E-I-04: Improving CT Quality for Radiation Therapy of Patients with High Body Mass Index Using Iterative Reconstruction Algorithms. (Noid G, Tai A, Li X) Med Phys 2015 Jun;42(6):3242 |
| 1 | WE-G-BRD-07: Automated MR Image Standardization and Auto-Contouring Strategy for MRI-Based Adaptive Brachytherapy for Cervix Cancer. (Saleh HA, Erickson B, Paulson E) Med Phys 2015 Jun;42(6):3689 |
| 1 | SU-E-J-65: Motion Difference Between the Pancreas and Nearby Veins for Pancreas Motion Monitoring Using Ultrasound During Radiation Therapy. (Omari E, Zhang J, Erickson B, Li X) Med Phys 2015 Jun;42(6):3278 |
| 1 | SU-D-210-06: Feasibility for Monitoring the Head of the Pancreas Motion Through a Surrogate Using Ultrasound During Radiation Therapy Delivery. (Omari E, Noid G, Ehlers C, Erickson B, Quiroz F, Cooper D, Lachaine M, Li X) Med Phys 2015 Jun;42(6):3223 |
| 1 | SU-E-P-14: Dosimetric Effects of Magnetic Field in MRI-Guided Radiation Therapy Delivery for Breast Cancer. (Chen G, Currey A, Li X) Med Phys 2015 Jun;42(6):3229 |
| 2 | SU-E-J-31: Monitor Interfractional Variation of Tumor Respiratory Motion Using 4D KV Conebeam Computed Tomography for Stereotactic Body Radiation Therapy of Lung Cancer. (Tai A, Prior P, Gore E, Johnstone C, Li X) Med Phys 2015 Jun;42(6):3270 |
| 1 | Quantitative single-particle digital autoradiography with α-particle emitters for targeted radionuclide therapy using the iQID camera. (Miller BW, Frost SH, Frayo SL, Kenoyer AL, Santos E, Jones JC, Green DJ, Hamlin DK, Wilbur DS, Fisher DR, Orozco JJ, Press OW, Pagel JM, Sandmaier BM) Med Phys 2015 Jul;42(7):4094-105 55 Citations |
| 1 | Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma. (Ikeda S, Hansel DE, Kurzrock R) Cancer Treat Rev 2015 Sep;41(8):699-706 13 Citations |
| 1 | Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled Trials. (Jones JL, Kaplan GG, Peyrin-Biroulet L, Baidoo L, Devlin S, Melmed GY, Tanyingoh D, Raffals L, Irving P, Kozuch P, Sparrow M, Velayos F, Bressler B, Cheifetz A, Colombel JF, Siegel CA) Clin Gastroenterol Hepatol 2015 Dec;13(13):2233-40.e1-2; quiz e177-8 96 Citations |
| 1 | A Qualitative Study Exploring the Perceptions of Sedentary Behavior in Prostate Cancer Survivors Receiving Androgen-Deprivation Therapy. (Trinh L, Arbour-Nicitopoulos KP, Sabiston CM, Alibhai SM, Jones JM, Berry SR, Loblaw A, Faulkner GE) Oncol Nurs Forum 2015 Jul;42(4):398-406 19 Citations |
| 1 | A Case of Non-Cirrhotic Portal Hypertension Associated With Chronic Didanosine Therapy. (Stotts M, Chisholm P, Nurutdinova D, Maddur H) ACG Case Rep J 2015 Jan;2(2):119-20 |
| 1 | Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trials. (Subbiah IM, Falchook GS, Kaseb AO, Hess KR, Tsimberidou AM, Fu S, Subbiah V, Hong DS, Naing A, Piha-Paul SA, Akmal O, Janku F, Kurzrock R) Oncotarget 2015 Sep 29;6(29):28453-62 13 Citations |
| 1 | Radiation Therapy for NMSC in Immunosuppressed Patients (Nicholas Zajdel, BS, Adam Currey, MD, J. Frank Wilson, MD, Zelmira Lazarova, MD, and Edit B. Olasz, MD, PhD) The Dermatologist |
| 1 | Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia. (Maddocks KJ, Ruppert AS, Lozanski G, Heerema NA, Zhao W, Abruzzo L, Lozanski A, Davis M, Gordon A, Smith LL, Mantel R, Jones JA, Flynn JM, Jaglowski SM, Andritsos LA, Awan F, Blum KA, Grever MR, Johnson AJ, Byrd JC, Woyach JA) JAMA Oncol 2015 Apr;1(1):80-7 515 Citations |
| 1 | Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer. (Schwarz JK, Beriwal S, Esthappan J, Erickson B, Feltmate C, Fyles A, Gaffney D, Jones E, Klopp A, Small W Jr, Thomadsen B, Yashar C, Viswanathan A) Brachytherapy 2015;14(5):587-99 89 Citations |
| 1 | Long-Term Opioid Therapy for Chronic Pain. (Lubrano M, Wanderer JP, Ehrenfeld JM) Ann Intern Med 2015 Jul 21;163(2):147 |
| 1 | A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy. (Di Trapani E, Sanchez-Salas R, Gandaglia G, Rocchini L, Moschini M, Lizee D, Carneiro A, Sivaraman A, Barret E, Rozet F, Galiano M, Bennamoun M, Colombo R, Suardi N, Briganti A, Montorsi F, Cathelineau X) World J Urol 2016 Feb;34(2):207-13 16 Citations |
| 1 | Negative pressure wound therapy use to decrease surgical nosocomial events in colorectal resections (NEPTUNE): study protocol for a randomized controlled trial. (Chadi SA, Vogt KN, Knowles S, Murphy PB, Van Koughnett JA, Brackstone M, Ott MC) Trials 2015 Jul 30;16:322 19 Citations |
| 1 | Restoration of epigenetically silenced SULF1 expression by 5-aza-2-deoxycytidine sensitizes hepatocellular carcinoma cells to chemotherapy-induced apoptosis. (Shire A, Lomberk G, Lai JP, Zou H, Tsuchiya N, Aderca I, Moser CD, Gulaid KH, Oseini A, Hu C, Warsame O, Jenkins RB, Roberts LR) Med Epigenet 2015;3(1):1-18 |
| 1 | Negative-Pressure Wound Therapy in the Management of High-Grade Ventral Hernia Repairs. (Rodriguez-Unda N, Soares KC, Azoury SC, Baltodano PA, Hicks CW, Burce KK, Cornell P, Cooney CM, Eckhauser FE) J Gastrointest Surg 2015 Nov;19(11):2054-61 13 Citations |
| 4 | Use of neoadjuvant therapy in patients 75 years of age and older with pancreatic cancer. (Miura JT, Krepline AN, George B, Ritch PS, Erickson BA, Johnston FM, Oshima K, Christians KK, Evans DB, Tsai S) Surgery 2015 Dec;158(6):1545-55 30 Citations |
| 1 | Pharmacotherapy for Hyperglycemia in Noncritically Ill Hospitalized Patients. (Mendez CE, Umpierrez GE) Diabetes Spectr 2014 Aug;27(3):180-8 35 Citations |
| 1 | Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation. (Hess CN, Peterson ED, Peng SA, de Lemos JA, Fosbol EL, Thomas L, Bhatt DL, Saucedo JF, Wang TY) J Am Coll Cardiol 2015 Aug 11;66(6):616-27 97 Citations |
| 3 | Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma. (Miura JT, Charlson J, Gamblin TC, Eastwood D, Banerjee A, Johnston FM, Turaga KK) Eur J Surg Oncol 2015 Oct;41(10):1386-92 71 Citations |
| 1 | Omission of Physical Therapy Recommendations for High-Risk Patients Transitioning From the Hospital to Subacute Care Facilities. (Polnaszek B, Mirr J, Roiland R, Gilmore-Bykovskyi A, Hovanes M, Kind A) Arch Phys Med Rehabil 2015 Nov;96(11):1966-72.e3 19 Citations |
| 4 | Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer. (Aldakkak M, Christians KK, Krepline AN, George B, Ritch PS, Erickson BA, Johnston FM, Evans DB, Tsai S) HPB (Oxford) 2015 Oct;17(10):942-52 54 Citations |
| 1 | External beam radiotherapy and bone metastases. Bone Matastases: A Translational and Clinical Approach (JOHNSTONE C, Lutz S.) 2nd edition, Chapter 9, December 2013 |
| 1 | The importance of 3-D CT treatment planning to optimize outcomes from accelerated partial breast irradiation(APBI) with brachytherapy in in early stage breast cancer. (CURREY AD, Kelly TR, Bovi JA, Rownd J, Morrow N, White JR) Poster presentation at ASTRO Oct 28-31, 2012, Boston MA. |
| 1 | Survival and Recurrence Patterns After 3D Conformal Radiotherapy For Whole Breast Irradiation In The Prone Position. (Saeed H, Cheng H, Kelly TR, Wilson JF, Bovi J, White J, CURREY A, Bergom C:) Poster presentation at ASTRO. Oct 18-21, 2015, San Antonio TX |
| 1 | Toxicity and Cosmetic Outcome after breast conservation and prone whole-breast irradiation using three-dimensional conformal radiotherapy. (Saeed H, Cheng H, Kelly TR, Wilson JF, Bovi J, White J, CURREY A, Bergom C:) Poster presentation at ASTRO. Oct 18-21, 2015, San Antonio TX. |
| 1 | External beam radiotherapy and bone metastases. (JOHNSTONE C, LUTZ S.) Ann Palliat Med 2014;3(2):114-122 |
| 5 | Neoadjuvant therapy for localized pancreatic cancer: guiding principles. (Fathi A, Christians KK, George B, Ritch PS, Erickson BA, Tolat P, Johnston FM, Evans DB, Tsai S) J Gastrointest Oncol 2015 Aug;6(4):418-29 51 Citations |
| 1 | The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate. (Hall WA, Nickleach DC, Master VA, Prabhu RS, Rossi PJ, Godette K, Cooper S, Jani AB ) Cancer. 2013 Sep 15;119(18):3272-9 |
| 1 | Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. (Colbert LE, Hall WA, Nickleach D, Switchenko J, Kooby DA, Liu Y, Gillespie T, Lipscomb J, Kauh J, Landry JC) Cancer. 2014 Feb 15;120(4):499-506 PMID: 24390739 |
| 1 | Chromodomain Helicase Binding Protein 5 (CHD5) Is Associated With Improved Overall Survival In Patients Undergoing Adjuvant Therapy For Resected Pancreatic Adenocarcinoma. (Hall WA, Hardy CW, Colbert LE, Landry JC, Fisher SB, Sarka B, Petrova AV, Pantazides BG, Maithel SK, Kowalski J, Gandhi K, Kooby D, El-Rayes BF, Staley CA, Adsay V, Yu DS.) Oncogene. ePub Nov 25, 2013. PMID: 24276239. |
| 3 | Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation. (Uy GL, Costa LJ, Hari PN, Zhang MJ, Huang JX, Anderson KC, Bredeson CN, Callander NS, Cornell RF, Perez MA, Dispenzieri A, Freytes CO, Gale RP, Garfall A, Gertz MA, Gibson J, Hamadani M, Lazarus HM, Kalaycio ME, Kamble RT, Kharfan-Dabaja MA, Krishnan AY, Kumar SK, Kyle RA, Landau HJ, Lee CH, Maiolino A, Marks DI, Mark TM, Munker R, Nishihori T, Olsson RF, Ramanathan M, Rodriguez TE, Saad AA, Savani BN, Schiller GJ, Schouten HC, Schriber JR, Scott E, Seo S, Sharma M, Ganguly S, Stadtmauer EA, Tay J, To LB, Vesole DH, Vogl DT, Wagner JL, Wirk B, Wood WA, D'Souza A) Bone Marrow Transplant 2015 Dec;50(12):1513-8 33 Citations |
| 1 | Adverse Drug Events-based Tumor Stratification for Ovarian Cancer Patients Receiving Platinum Therapy. (Wang C, Zimmermann MT, Chute CG, Jiang G) AMIA Jt Summits Transl Sci Proc 2015;2015:51-5 |
| 1 | Whole-exome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapy-treated diffuse large B-cell lymphoma. (Novak AJ, Asmann YW, Maurer MJ, Wang C, Slager SL, Hodge LS, Manske M, Price-Troska T, Yang ZZ, Zimmermann MT, Nowakowski GS, Ansell SM, Witzig TE, McPhail E, Ketterling R, Feldman AL, Dogan A, Link BK, Habermann TM, Cerhan JR) Blood Cancer J 2015 Aug 28;5(8):e346 54 Citations |
| 2 | Retroperitoneal solitary fibrous tumor: surgery as first line therapy. (Rajeev R, Patel M, Jayakrishnan TT, Johnston FM, Bedi M, Charlson J, Turaga KK) Clin Sarcoma Res 2015;5:19 |
| 1 | Pulmonary effects of antineoplastic therapy (Dhakal S, Weiner D, Schwartz C, Constine LS) Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach: Third Edition 3 September 2015:201-227 1 Citation |
| 2 | Hematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age Groups. (Deeg HJ, Bredeson C, Farnia S, Ballen K, Gupta V, Mesa RA, Popat U, Hari P, Saber W, Seftel M, Tamari R, Petersdorf EW) Biol Blood Marrow Transplant 2015 Nov;21(11):1883-7 39 Citations |
| 1 | Treatment response in couple therapy: Relationship adjustment and individual functioning change processes. (Knobloch-Fedders LM, Pinsof WM, Haase CM) J Fam Psychol 2015 Oct;29(5):657-66 21 Citations |
| 3 | Intrahepatic cholangiocarcinoma and gallbladder cancer: distinguishing molecular profiles to guide potential therapy. (Potkonjak M, Miura JT, Turaga KK, Johnston FM, Tsai S, Christians KK, Gamblin TC) HPB (Oxford) 2015 Dec;17(12):1119-23 12 Citations |
| 1 | The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention. (Kerns SL, Kundu S, Oh JH, Singhal SK, Janelsins M, Travis LB, Deasy JO, Janssens AC, Ostrer H, Parliament M, Usmani N, Rosenstein BS) Semin Radiat Oncol 2015 Oct;25(4):281-91 49 Citations |
| 1 | Experiential Learning With Children: An Essential Component of Professional Physical Therapy Education. (Schreiber J, Moerchen VA, Rapport MJ, Martin K, Furze J, Lundeen H, Pelletier E) Pediatr Phys Ther 2015;27(4):356-67 28 Citations |
| 1 | Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group. (Schwartz CL, Wexler LH, Krailo MD, Teot LA, Devidas M, Steinherz LJ, Goorin AM, Gebhardt MC, Healey JH, Sato JK, Meyers PA, Grier HE, Bernstein ML, Lipshultz SE) Pediatr Blood Cancer 2016 Jan;63(1):54-61 78 Citations |
| 1 | Infliximab Therapy for Corticosteroid-Resistant Ipilimumab-Induced Colitis. (Beniwal-Patel P, Matkowskyj K, Caldera F) J Gastrointestin Liver Dis 2015 Sep;24(3):274 7 Citations |
| 1 | Inhibitory effects of merocyanine 540-mediated photodynamic therapy on cellular immune functions: A role in the prophylaxis of graft-versus-host disease? (Traul DL, Sieber F) J Photochem Photobiol B 2015 Dec;153:153-63 14 Citations |
| 1 | Primary Cryotherapy for High-Grade Clinically Localized Prostate Cancer: Oncologic and Functional Outcomes from the COLD Registry. (Tay KJ, Polascik TJ, Elshafei A, Cher ML, Given RW, Mouraviev V, Ross AE, Jones JS) J Endourol 2016 Jan;30(1):43-8 28 Citations |
| 6 | Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations. (Nattinger AB, Pezzin LE, McGinley EL, Charlson JA, Yen TW, Neuner JM) Springerplus 2015;4:531 |
| 2 | Reducing the Human Burden of Breast Cancer: Advanced Radiation Therapy Yields Improved Treatment Outcomes. (Currey AD, Bergom C, Kelly TR, Wilson JF) Breast J 2015;21(6):610-20 8 Citations |
| 6 | Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy after adrenalectomy for hypercortisolism: Results of a novel, multidisciplinary institutional protocol. (Ortiz DI, Findling JW, Carroll TB, Javorsky BR, Carr AA, Evans DB, Yen TW, Wang TS) Surgery 2016 Jan;159(1):259-65 30 Citations |
| 1 | Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios. (Lim K, Erickson B, Jürgenliemk-Schulz IM, Gaffney D, Creutzberg CL, Viswanathan A, Portelance L, Beriwal S, Wolfson A, Bosch W, De Los Santos J, Yashar C, Jhingran A, Varia M, El Naqa I, King B, Fyles A) Pract Radiat Oncol 2015;5(6):e557-65 8 Citations |
| 1 | siRNA Therapy, Challenges and Underlying Perspectives of Dendrimer as Delivery Vector. (Tekade RK, Maheshwari RG, Sharma PA, Tekade M, Chauhan AS) Curr Pharm Des 2015;21(31):4614-36 65 Citations |
| 1 | Outcomes of Multimodality Therapy in Pediatric Patients With Ruptured and Unruptured Brain Arteriovenous Malformations. (Nerva JD, Kim LJ, Barber J, Rockhill JK, Hallam DK, Ghodke BV, Sekhar LN) Neurosurgery 2016 May;78(5):695-707 38 Citations |
| 1 | Targeted Therapy in Translational Cancer Research (Tsimberidou AM, Kurzrock R, Anderson KC) Targeted Therapy in Translational Cancer Research 30 October 2015:1-378 3 Citations |
| 1 | A Smartphone-based Decision Support Tool Improves Test Performance Concerning Application of the Guidelines for Managing Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy. (McEvoy MD, Hand WR, Stiegler MP, DiLorenzo AN, Ehrenfeld JM, Moran KR, Lekowski R, Nunnally ME, Manning EL, Shi Y, Shotwell MS, Gupta RK, Corey JM, Schell RM) Anesthesiology 2016 Jan;124(1):186-98 21 Citations |
| 1 | Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer. (Previs RA, Armaiz-Pena GN, Lin YG, Davis AN, Pradeep S, Dalton HJ, Hansen JM, Merritt WM, Nick AM, Langley RR, Coleman RL, Sood AK) Mol Cancer Ther 2015 Dec;14(12):2677-86 9 Citations |
| 2 | Cerebral Perfusion and Gray Matter Changes Associated With Chemotherapy-Induced Peripheral Neuropathy. (Nudelman KN, McDonald BC, Wang Y, Smith DJ, West JD, O'Neill DP, Zanville NR, Champion VL, Schneider BP, Saykin AJ) J Clin Oncol 2016 Mar 01;34(7):677-83 43 Citations |
| 1 | Beta-cell replacement therapy: current outcomes and future landscape. (Dunn TB, Kirchner V, Bellin MD) Curr Opin Organ Transplant 2015 Dec;20(6):681-90 10 Citations |
| 1 | Negative pressure wound therapy for high-risk wounds in lower extremity revascularization: study protocol for a randomized controlled trial. (Murphy P, Lee K, Dubois L, DeRose G, Forbes T, Power A) Trials 2015 Nov 04;16:504 10 Citations |
| 1 | Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis--A Comprehensive Review and Guide to Therapy. I. Systemic Disease. (Kohanim S, Palioura S, Saeed HN, Akpek EK, Amescua G, Basu S, Blomquist PH, Bouchard CS, Dart JK, Gai X, Gomes JA, Gregory DG, Iyer G, Jacobs DS, Johnson AJ, Kinoshita S, Mantagos IS, Mehta JS, Perez VL, Pflugfelder SC, Sangwan VS, Sippel KC, Sotozono C, Srinivasan B, Tan DT, Tandon R, Tseng SC, Ueta M, Chodosh J) Ocul Surf 2016 Jan;14(1):2-19 113 Citations |
| 1 | The American Board of Radiology Focused Practice Recognition in Brachytherapy (FPRB) Program: Opportunities lost, lessons learned, and future implications. (Wallner PE, Kupelian P, Erickson B, Alektiar KM, Laszakovits D, Henson TM, Wang PC, Steinberg ML) Pract Radiat Oncol 2015;5(6):427-32 6 Citations |
| 1 | Successful Application of Closed-Loop Artificial Pancreas Therapy After Islet Autotransplantation. (Forlenza GP, Nathan BM, Moran AM, Dunn TB, Beilman GJ, Pruett TL, Bellin MD) Am J Transplant 2016 Feb;16(2):527-34 17 Citations |
| 5 | Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy. (Christians KK, Heimler JW, George B, Ritch PS, Erickson BA, Johnston F, Tolat PP, Foley WD, Evans DB, Tsai S) Surgery 2016 Mar;159(3):893-900 105 Citations |
| 2 | Emerging immunotherapy in pediatric lymphoma. (Erker C, Harker-Murray P, Burke MJ) Future Oncol 2016 Jan;12(2):257-70 5 Citations |
| 1 | Vaginal brachytherapy for postoperative endometrial cancer: 2014 Survey of the American Brachytherapy Society. (Harkenrider MM, Grover S, Erickson BA, Viswanathan AN, Small C, Kliethermes S, Small W Jr) Brachytherapy 2016;15(1):23-9 63 Citations |
| 1 | Siltuximab: a targeted therapy for idiopathic multicentric Castleman disease. (Fajgenbaum DC, Kurzrock R) Immunotherapy 2016;8(1):17-26 24 Citations |
| 1 | Outcomes with multimodal therapy for elderly patients with rectal cancer. (Thiels CA, Bergquist JR, Meyers AJ, Johnson CL, Behm KT, Hayman AV, Habermann EB, Larson DW, Mathis KL) Br J Surg 2016 Jan;103(2):e106-14 20 Citations |
| 1 | Concurrent or sequential letrozole with adjuvant breast radiotherapy: final results of the CO-HO-RT phase II randomized trial. (Bourgier C, Kerns S, Gourgou S, Lemanski C, Gutowski M, Fenoglietto P, Romieu G, Crompton N, Lacombe J, Pèlegrin A, Ozsahin M, Rosenstein B, Azria D) Ann Oncol 2016 Mar;27(3):474-80 38 Citations |
| 1 | Ocular dysmotility after intra-arterial chemotherapy for retinoblastoma. (Lambert NG, Winegar BA, Feola GP, Ramasubramanian A) J AAPOS 2015 Dec;19(6):574-7 4 Citations |
| 1 | Long-term follow-up of children with chronic myeloid leukemia after hematopoietic stem cell transplantation and tyrosine kinase inhibitor therapy. (Broglie L, Hijiya N, Helenowski IB, Dilley K, Schneiderman J, Tse W, Duerst R, Kletzel M, Morgan E, Chaudhury S) Leuk Lymphoma 2016;57(4):949-52 5 Citations |
| 1 | Dose perturbation effect of metallic spinal implants in proton beam therapy. (Jia Y, Zhao L, Cheng CW, McDonald MW, Das IJ) J Appl Clin Med Phys 2015 Sep 08;16(5):333-343 30 Citations |
| 2 | Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission. (Seftel MD, Neuberg D, Zhang MJ, Wang HL, Ballen KK, Bergeron J, Couban S, Freytes CO, Hamadani M, Kharfan-Dabaja MA, Lazarus HM, Nishihori T, Paulson K, Saber W, Sallan SE, Soiffer R, Tallman MS, Woolfrey AE, DeAngelo DJ, Weisdorf DJ, Acute Leukemia Committee of the CIBMTR and the Dana Farber ALL Consortium) Am J Hematol 2016 Mar;91(3):322-9 67 Citations |
| 1 | Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Peripheral T Cell Lymphomas as Front-Line Consolidation or in the Relapsed/Refractory Setting: A Systematic Review/Meta-Analysis. (El-Asmar J, Reljic T, Ayala E, Hamadani M, Nishihori T, Kumar A, Kharfan-Dabaja MA) Biol Blood Marrow Transplant 2016 May;22(5):802-14 42 Citations |
| 2 | Upper extremity assessment in children with physical impairments receiving intensive rehabilitative therapy in a community setting (Zarb RM, Rammer JR, Osborn C, Daley RA, Tarima S, Harris GF) Critical Reviews in Physical and Rehabilitation Medicine 2016;28(4):271-281 |
| 1 | Gynecologic Brachytherapy: Vaginal Cancer (Vargo JA, Viswanathan AN, Erickson BA, Beriwal S) Medical Radiology 2016:279-285 |
| 1 | Gynecologic Brachytherapy: Endometrial Cancer (Vargo JA, Viswanathan AN, Erickson BA, Beriwal S) Medical Radiology 2016:253-268 |
| 1 | Gynecologic Brachytherapy: Cervical Cancer (Vargo JA, Viswanathan AN, Erickson BA, Beriwal S) Medical Radiology 2016:269-278 |
| 1 | Use of VV ECMO as a Novel Therapy for Severe Acute Chest Syndrome with Diffuse Alveolar Hemorrhage. Am
J Resp Grit Care Med. 2016; 193:A1869 (Samir Sultan, Gregory Chu, Robert A. Raschke, Suresh Uppalapu) |
| 1 | Early Versus Delayed Mortality among HIV Infected Patients Initiating Highly Active Antiretroviral Therapy in Tanzania. (Memiah P, Mbizo J, Komba P, Telwa E, Mwakyusa S, Maghimbi A, Etienne M, Phillips A, Swain C, Hill A, Shumba C, Biadgilign S) J Res Appl Sci 2016;3(1):178-185 |
| 1 | Experimental Cell Therapy for Liver Dysfunction (Wang B, Wertheim JA) Translating Regenerative Medicine to the Clinic 2016:309-313 |
| 1 | Role of Endogenous Nitric Oxide in Hyperaggressiveness of Tumor Cells that Survive a Photodynamic Therapy Challenge. (Girotti AW) Crit Rev Oncog 2016;21(5-6):353-363 |
| 1 | International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. (Galipeau J, Krampera M, Barrett J, Dazzi F, Deans RJ, DeBruijn J, Dominici M, Fibbe WE, Gee AP, Gimble JM, Hematti P, Koh MB, LeBlanc K, Martin I, McNiece IK, Mendicino M, Oh S, Ortiz L, Phinney DG, Planat V, Shi Y, Stroncek DF, Viswanathan S, Weiss DJ, Sensebe L) Cytotherapy 2016 Feb;18(2):151-9 390 Citations |
| 5 | Safety of ruxolitinib therapy prior to allogeneic hematopoietic stem-cell transplantation for myeloproliferative neoplasms. (Hanif A, Hari PN, Atallah E, Carlson KS, Pasquini MC, Michaelis LC) Bone Marrow Transplant 2016 Apr;51(4):617-8 20 Citations |
| 1 | Towards in vivo amplification: Overcoming hurdles in the use of hematopoietic stem cells in transplantation and gene therapy. (Nagree MS, López-Vásquez L, Medin JA) World J Stem Cells 2015 Dec 26;7(11):1233-50 |
| 1 | Improving the Safety of Oral Chemotherapy at an Academic Medical Center. (Shah NN, Casella E, Capozzi D, McGettigan S, Gangadhar TC, Schuchter L, Myers JS) J Oncol Pract 2016 Jan;12(1):e71-6 21 Citations |
| 1 | Focal Therapy for Prostate Cancer: An "À la Carte" Approach. (Sivaraman A, Barret E) Eur Urol 2016 Jun;69(6):973-5 88 Citations |
| 1 | A Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia. (Kantarjian HM, Lioure B, Kim SK, Atallah E, Leguay T, Kelly K, Marolleau JP, Escoffre-Barbe M, Thomas XG, Cortes J, Jabbour E, O'Brien S, Bories P, Oprea C, Hatteville L, Dombret H) Clin Lymphoma Myeloma Leuk 2016 Mar;16(3):139-45 64 Citations |
| 1 | Chimeric Antigen Receptor (CAR) therapy for multiple myeloma. (Atanackovic D, Radhakrishnan SV, Bhardwaj N, Luetkens T) Br J Haematol 2016 Mar;172(5):685-98 57 Citations |
| 1 | How Will Big Data Improve Clinical and Basic Research in Radiation Therapy? (Rosenstein BS, Capala J, Efstathiou JA, Hammerbacher J, Kerns SL, Kong FS, Ostrer H, Prior FW, Vikram B, Wong J, Xiao Y) Int J Radiat Oncol Biol Phys 2016 Jul 01;95(3):895-904 25 Citations |
| 1 | Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium. (Gaudet MM, Barrdahl M, Lindström S, Travis RC, Auer PL, Buring JE, Chanock SJ, Eliassen AH, Gapstur SM, Giles GG, Gunter M, Haiman C, Hunter DJ, Joshi AD, Kaaks R, Khaw KT, Lee IM, Le Marchand L, Milne RL, Peeters PH, Sund M, Tamimi R, Trichopoulou A, Weiderpass E, Yang XR, Prentice RL, Feigelson HS, Canzian F, Kraft P) Breast Cancer Res Treat 2016 Feb;155(3):531-40 1 Citation |
| 1 | Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic. (Majchrzak K, Nelson MH, Bailey SR, Bowers JS, Yu XZ, Rubinstein MP, Himes RA, Paulos CM) Cancer Immunol Immunother 2016 Mar;65(3):247-59 35 Citations |
| 1 | Association of early withdrawal of life-sustaining therapy for perceived neurological prognosis with mortality after cardiac arrest. (Elmer J, Torres C, Aufderheide TP, Austin MA, Callaway CW, Golan E, Herren H, Jasti J, Kudenchuk PJ, Scales DC, Stub D, Richardson DK, Zive DM, Resuscitation Outcomes Consortium) Resuscitation 2016 May;102:127-35 326 Citations |
| 1 | Role of Akt inhibition on Notch1 expression in hepatocellular carcinoma: potential role for dual targeted therapy. (Sokolowski KM, Balamurugan M, Kunnimalaiyaan S, Wilson J, Gamblin TC, Kunnimalaiyaan M) Am J Surg 2016 Apr;211(4):755-60 6 Citations |
| 2 | Margin reduction from image guided radiation therapy for soft tissue sarcoma: Secondary analysis of Radiation Therapy Oncology Group 0630 results. (Li XA, Chen X, Zhang Q, Kirsch DG, Petersen I, DeLaney TF, Freeman CR, Trotti A, Hitchcock Y, Bedi M, Haddock M, Salerno K, Dundas G, Wang D) Pract Radiat Oncol 2016;6(4):e135-e140 19 Citations |
| 1 | Non-eligibility for reperfusion therapy in patients presenting with ST-segment elevation myocardial infarction: Contemporary insights from the National Cardiovascular Data Registry (NCDR). (Dasari TW, Hamilton S, Chen AY, Wang TY, Peterson ED, de Lemos JA, Saucedo JF) Am Heart J 2016 Feb;172:1-8 13 Citations |
| 1 | Targeted approaches to induce immune tolerance for Pompe disease therapy. (Doerfler PA, Nayak S, Corti M, Morel L, Herzog RW, Byrne BJ) Mol Ther Methods Clin Dev 2016;3:15053 45 Citations |
| 1 | Perceived cognitive changes with chemotherapy for breast cancer: A pilot study. (Piacentine LB, Miller JF, Haberlein S, Bloom AS) Appl Nurs Res 2016 Feb;29:9-11 10 Citations |
| 1 | Cost Differential of Chemotherapy for Solid Tumors. (Nadeem H, Jayakrishnan TT, Rajeev R, Johnston FM, Gamblin TC, Turaga KK) J Oncol Pract 2016 Mar;12(3):e299-307, 251 13 Citations |
| 1 | Definitive Surgical Therapy after Open Neck Biopsy for HPV-Related Oropharyngeal Cancer. (Zenga J, Graboyes EM, Haughey BH, Paniello RC, Mehrad M, Lewis JS Jr, Thorstad WL, Nussenbaum B, Rich JT) Otolaryngol Head Neck Surg 2016 Apr;154(4):657-66 18 Citations |
| 1 | Image Guided Cervical Brachytherapy: 2014 Survey of the American Brachytherapy Society. (Grover S, Harkenrider MM, Cho LP, Erickson B, Small C, Small W Jr, Viswanathan AN) Int J Radiat Oncol Biol Phys 2016 Mar 01;94(3):598-604 104 Citations |
| 1 | Health-Related Quality of Life in Locally Advanced Cervical Cancer Patients After Definitive Chemoradiation Therapy Including Image Guided Adaptive Brachytherapy: An Analysis From the EMBRACE Study. (Kirchheiner K, Pötter R, Tanderup K, Lindegaard JC, Haie-Meder C, Petrič P, Mahantshetty U, Jürgenliemk-Schulz IM, Rai B, Cooper R, Dörr W, Nout RA, EMBRACE Collaborative Group) Int J Radiat Oncol Biol Phys 2016 Apr 01;94(5):1088-98 86 Citations |
| 1 | Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis - A Comprehensive Review and Guide to Therapy. II. Ophthalmic Disease. (Kohanim S, Palioura S, Saeed HN, Akpek EK, Amescua G, Basu S, Blomquist PH, Bouchard CS, Dart JK, Gai X, Gomes JA, Gregory DG, Iyer G, Jacobs DS, Johnson AJ, Kinoshita S, Mantagos IS, Mehta JS, Perez VL, Pflugfelder SC, Sangwan VS, Sippel KC, Sotozono C, Srinivasan B, Tan DT, Tandon R, Tseng SC, Ueta M, Chodosh J) Ocul Surf 2016 Apr;14(2):168-88 165 Citations |
| 2 | Quality of Life and Long-Term Therapy in Patients with Chronic Myeloid Leukemia. (Flynn KE, Atallah E) Curr Hematol Malig Rep 2016 Apr;11(2):80-5 42 Citations |
| 6 | Alternatively Activated Macrophages Boost Induced Regulatory T and Th17 Cell Responses during Immunotherapy for Colitis. (Haribhai D, Ziegelbauer J, Jia S, Upchurch K, Yan K, Schmitt EG, Salzman NH, Simpson P, Hessner MJ, Chatila TA, Williams CB) J Immunol 2016 Apr 15;196(8):3305-17 40 Citations |
| 1 | Exploration of Imaging Biomarkers for Predicting Survival of Patients With Advanced Non-Small Cell Lung Cancer Treated With Antiangiogenic Chemotherapy. (Hayano K, Kulkarni NM, Duda DG, Heist RS, Sahani DV) AJR Am J Roentgenol 2016 May;206(5):987-93 31 Citations |
| 4 | A Comparison of Lumpectomy Cavity Delineations Between Use of Magnetic Resonance Imaging and Computed Tomography Acquired With Patient in Prone Position for Radiation Therapy Planning of Breast Cancer. (Huang W, Currey A, Chen X, Li B, Bergom C, Kelly T, Wilson JF, Li XA) Int J Radiat Oncol Biol Phys 2016 Mar 15;94(4):832-40 17 Citations |
| 1 | Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies. (Monjazeb AM, Kent MS, Grossenbacher SK, Mall C, Zamora AE, Mirsoian A, Chen M, Kol A, Shiao SL, Reddy A, Perks JR, T N Culp W, Sparger EE, Canter RJ, Sckisel GD, Murphy WJ) Clin Cancer Res 2016 Sep 01;22(17):4328-40 95 Citations |
| 2 | Neoadjuvant radiotherapy for retroperitoneal sarcoma: A systematic review. (Cheng H, Miura JT, Lalehzari M, Rajeev R, Donahue AE, Bedi M, Gamblin TC, Turaga KK, Johnston FM) J Surg Oncol 2016 May;113(6):628-34 25 Citations |
| 1 | Outcomes of Primary Endodontic Therapy Provided by Endodontic Specialists Compared with Other Providers. (Burry JC, Stover S, Eichmiller F, Bhagavatula P) J Endod 2016 May;42(5):702-5 67 Citations |
| 1 | Hepatic Perfusion Therapy. (Rajeev R, Gamblin TC, Turaga KK) Surg Clin North Am 2016 Apr;96(2):357-68 1 Citation |
| 1 | Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227. (Glass J, Won M, Schultz CJ, Brat D, Bartlett NL, Suh JH, Werner-Wasik M, Fisher BJ, Liepman MK, Augspurger M, Bokstein F, Bovi JA, Solhjem MC, Mehta MP) J Clin Oncol 2016 May 10;34(14):1620-5 117 Citations |
| 1 | 2015 JOSPT Awards: Back Pain and Anterior Cruciate Ligament Injuries Are a Continued Focus of Research and Clinical Attention in Physical Therapy. (Simoneau GG) J Orthop Sports Phys Ther 2016 Apr;46(4):230-1 2 Citations |
| 1 | Radiation-induced CT number changes in GTV and parotid glands during the course of radiation therapy for nasopharyngeal cancer. (Xu S, Wu Z, Yang C, Ma L, Qu B, Chen G, Yao W, Wang S, Liu Y, Li XA) Br J Radiol 2016 Jun;89(1062):20140819 8 Citations |
| 1 | A novel cancer testis antigen target A-kinase anchor protein (AKAP4) for the early diagnosis and immunotherapy of colon cancer. (Jagadish N, Parashar D, Gupta N, Agarwal S, Sharma A, Fatima R, Suri V, Kumar R, Gupta A, Lohiya NK, Suri A) Oncoimmunology 2016 Feb;5(2):e1078965 24 Citations |
| 1 | Is Four Stage Management the Future of Univentricular Hearts? Destination Therapy in the Young. (Jaquiss RD, Aziz H) Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2016;19(1):50-4 25 Citations |
| 1 | Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy. (Vasu S, Wu H, Satoskar A, Puto M, Roddy J, Blum W, Klisovic R, Andritsos L, Hofmeister C, Benson DM, Efebera Y, Jaglowski S, Penza S, Cohen D, Devine S, Cataland S) Bone Marrow Transplant 2016 Sep;51(9):1241-4 55 Citations |
| 1 | FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal. (Haemmerle M, Bottsford-Miller J, Pradeep S, Taylor ML, Choi HJ, Hansen JM, Dalton HJ, Stone RL, Cho MS, Nick AM, Nagaraja AS, Gutschner T, Gharpure KM, Mangala LS, Rupaimoole R, Han HD, Zand B, Armaiz-Pena GN, Wu SY, Pecot CV, Burns AR, Lopez-Berestein G, Afshar-Kharghan V, Sood AK) J Clin Invest 2016 May 02;126(5):1885-96 105 Citations |
| 1 | Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity. (Ahmed M, Dorling L, Kerns S, Fachal L, Elliott R, Partliament M, Rosenstein BS, Vega A, Gómez-Caamaño A, Barnett G, Dearnaley DP, Hall E, Sydes M, Burnet N, Pharoah PD, Eeles R, West CM) Br J Cancer 2016 May 10;114(10):1165-74 19 Citations |
| 1 | ALSUntangled No. 35: Hyperbaric Oxygen Therapy. (ALSUntangled Group) Amyotroph Lateral Scler Frontotemporal Degener 2016;17(7-8):622-624 2 Citations |
| 1 | Racial differences in receipt of adjuvant hormonal therapy among Medicaid enrollees in South Carolina diagnosed with breast cancer. (Felder TM, Do DP, Lu ZK, Lal LS, Heiney SP, Bennett CL) Breast Cancer Res Treat 2016 May;157(1):193-200 5 Citations |
| 2 | An analysis of tumor control probability of stereotactic body radiation therapy for lung cancer with a regrowth model. (Tai A, Liu F, Gore E, Li XA) Phys Med Biol 2016 May 21;61(10):3903-13 19 Citations |
| 1 | Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma. (Gaffney DK, King B, Viswanathan AN, Barkati M, Beriwal S, Eifel P, Erickson B, Fyles A, Goulart J, Harkenrider M, Jhingran A, Klopp A, Koh WJ, Lim K, Petersen I, Portelance L, Small W Jr, Stewart A, Wiebe E, Wolfson A, Yashar C, Bosch W) Int J Radiat Oncol Biol Phys 2016 Jul 15;95(4):1191-200 86 Citations |
| 1 | Allogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older Patients. (Fenske TS, Hamadani M, Cohen JB, Costa LJ, Kahl BS, Evens AM, Hamlin PA, Lazarus HM, Petersdorf E, Bredeson C) Biol Blood Marrow Transplant 2016 Sep;22(9):1543-1551 41 Citations |
| 1 | Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer. (O'Donnell PH, Alanee S, Stratton KL, Garcia-Grossman IR, Cao H, Ostrovnaya I, Plimack ER, Manschreck C, Ganshert C, Smith ND, Steinberg GD, Vijai J, Offit K, Stadler WM, Bajorin DF) Clin Genitourin Cancer 2016 Dec;14(6):511-517 5 Citations |
| 1 | Stereotactic body radiation therapy of liver tumors: post-treatment appearances and evaluation of treatment response: a pictorial review. (Haddad MM, Merrell KW, Hallemeier CL, Johnson GB, Mounajjed T, Olivier KR, Fidler JL, Venkatesh SK) Abdom Radiol (NY) 2016 Oct;41(10):2061-77 41 Citations |
| 6 | Response to comments on: Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy following adrenalectomy for hypercortisolism: Results of a novel, multidisciplinary institutional protocol. (Ortiz DI, Findling JW, Carroll TB, Javorsky BR, Carr AA, Evans DB, Yen TW, Wang TS) Surgery 2016 Jul;160(1):249-250 |
| 1 | Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer. (Guancial EA, Kilari D, Xiao GQ, Abu-Farsakh SH, Baran A, Messing EM, Kim ES) PLoS One 2016;11(5):e0155503 6 Citations |
| 1 | Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study. (Wheler JJ, Janku F, Naing A, Li Y, Stephen B, Zinner R, Subbiah V, Fu S, Karp D, Falchook GS, Tsimberidou AM, Piha-Paul S, Anderson R, Ke D, Miller V, Yelensky R, Lee JJ, Hong DS, Kurzrock R) Cancer Res 2016 Jul 01;76(13):3690-701 198 Citations |
| 4 | Cystectomy and Urinary Diversion for the Management of a Devastated Lower Urinary Tract Following Prostatic Cryotherapy and/or Radiotherapy. (Sack BS, Langenstroer P, Guralnick ML, Jacobsohn KM, O'Connor RC) WMJ 2016 Apr;115(2):70-3 18 Citations |
| 1 | Development of a deformable dosimetric phantom to verify dose accumulation algorithms for adaptive radiotherapy. (Zhong H, Adams J, Glide-Hurst C, Zhang H, Li H, Chetty IJ) J Med Phys 2016;41(2):106-14 15 Citations |
| 1 | Negative impact of tumor-generated nitric oxide on photodynamic therapy (Girotti AW) Handbook of Photodynamic Therapy: Updates on Recent Applications of Porphyrin-Based Compounds 1 June 2016:401-420 |
| 2 | Signaling in Effector Lymphocytes: Insights toward Safer Immunotherapy. (Rajasekaran K, Riese MJ, Rao S, Wang L, Thakar MS, Sentman CL, Malarkannan S) Front Immunol 2016;7:176 27 Citations |
| 2 | Moving Beyond Autologous Transplantation in Multiple Myeloma: Consolidation, Maintenance, Allogeneic Transplant, and Immune Therapy. (Krishnan A, Vij R, Keller J, Dhakal B, Hari P) Am Soc Clin Oncol Educ Book 2016;35:210-21 7 Citations |
| 1 | Immunotherapy with iTreg and nTreg Cells in a Murine Model of Inflammatory Bowel Disease. (Haribhai D, Chatila TA, Williams CB) Methods Mol Biol 2016;1422:197-211 23 Citations |
| 1 | The management of patients with esophageal cancer and coronary artery stenosis undergoing radiotherapy or concurrent chemoradiotherapy: a single-center experience. (Luo H, Chen X, Zhang Q, Wang L, Qiao L, Liang N, Xie J, Yu X, Song M, Liu Z, Lv Y, Liu F, Tian Y, Cheng J, Deng G, Zhang J, Li XA, Zhang J) J BUON 2016;21(2):419-26 |
| 1 | Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma. (Fox RG, Lytle NK, Jaquish DV, Park FD, Ito T, Bajaj J, Koechlein CS, Zimdahl B, Yano M, Kopp J, Kritzik M, Sicklick J, Sander M, Grandgenett PM, Hollingsworth MA, Shibata S, Pizzo D, Valasek M, Sasik R, Scadeng M, Okano H, Kim Y, MacLeod AR, Lowy AM, Reya T) Nature 2016 Jun 16;534(7607):407-411 118 Citations |
| 1 | Development of Eosinophilic Fasciitis during Infliximab Therapy for Psoriatic Arthritis. (Hariman R, Patel P, Strouse J, Collins MP, Rosenthal A) Case Rep Rheumatol 2016;2016:7906013 |
| 5 | Hematopoietic Progenitor Cell Mobilization with Ifosfamide, Carboplatin, and Etoposide Chemotherapy versus Plerixafor-Based Strategies in Patients with Hodgkin and Non-Hodgkin Lymphoma. (Dhakal B, Veltri LW, Fenske TS, Eastwood D, Craig MD, Cumpston A, Shillingburg A, Esselman J, Watkins K, Pasquini MC, D'Souza A, Hari P, Kanate AS, Hamadani M) Biol Blood Marrow Transplant 2016 Oct;22(10):1773-1780 8 Citations |
| 1 | Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer. (Frisina RD, Wheeler HE, Fossa SD, Kerns SL, Fung C, Sesso HD, Monahan PO, Feldman DR, Hamilton R, Vaughn DJ, Beard CJ, Budnick A, Johnson EM, Ardeshir-Rouhani-Fard S, Einhorn LH, Lipshultz SE, Dolan ME, Travis LB) J Clin Oncol 2016 Aug 10;34(23):2712-20 208 Citations |
| 1 | Severe TSH elevation and pituitary enlargement after changing thyroid replacement to compounded T4/T3 therapy (Pappy AL, Oyesiku N, Ioachimescu A) Journal of Investigative Medicine High Impact Case Reports July 2016;4(3) 5 Citations |
| 2 | Negative pressure therapy is effective in abdominal incision closure. (Kugler NW, Carver TW, Paul JS) J Surg Res 2016 Jun 15;203(2):491-4 20 Citations |
| 1 | Association of concurrent acid-suppression therapy with survival outcomes and adverse event incidence in oncology patients receiving erlotinib. (Lam LH, Capparelli EV, Kurzrock R) Cancer Chemother Pharmacol 2016 Aug;78(2):427-32 23 Citations |
| 1 | Keratoacanthoma-appearing melanoma metastases in a patient receiving pembrolizumab therapy. (Schopper H, Bontumasi NM, Milhem M, Wanat KA) JAAD Case Rep 2016 May;2(3):247-9 |
| 1 | High intensity focused ultrasound for Focal Therapy of prostate cancer. (Sivaraman A) Arch Esp Urol 2016 Jul;69(6):311-6 6 Citations |
| 2 | Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry: A Comparison of CMML-1 vs CMML-2, Myeloproliferative vs Dysplastic, De Novo vs Therapy-Related, and CMML-Specific Cytogenetic Risk Subtypes. (Harrington AM, Schelling LA, Ordobazari A, Olteanu H, Hosking PR, Kroft SH) Am J Clin Pathol 2016 Aug;146(2):170-81 14 Citations |
| 1 | [Localized prostate cancer Focal Therapy: "A la carte" Model]. (Linares Espinós E, Barret E, Sivaraman A, Pérez-Reggeti JI, Sánchez-Salas R, Rozet F, Galiano M, Cathelineau X) Arch Esp Urol 2016 Jul;69(6):345-52 8 Citations |
| 1 | NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH ADVANCED VISUAL LOSS TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: Clinical Outcome and Prognostic Indicators. (Vogel RN, Davis DB, Kimura BH, Rathinavelu S, Graves GS, Szabo A, Han DP) Retina 2017 Feb;37(2):257-264 8 Citations |
| 1 | Management of patients with metastatic medullary thyroid carcinoma: The role for systemic therapy (Fareau GG) Medullary Thyroid Cancer 20 July 2016:157-164 |
| 1 | Best Practices for Intrathecal Baclofen Therapy: Dosing and Long-Term Management. (Boster AL, Adair RL, Gooch JL, Nelson ME, Toomer A, Urquidez J, Saulino M) Neuromodulation 2016 Aug;19(6):623-31 56 Citations |
| 1 | Best Practices for Intrathecal Baclofen Therapy: Patient Selection. (Saulino M, Ivanhoe CB, McGuire JR, Ridley B, Shilt JS, Boster AL) Neuromodulation 2016 Aug;19(6):607-15 67 Citations |
| 1 | Treatment-related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemia. (Sun W, Orgel E, Malvar J, Sposto R, Wilkes JJ, Gardner R, Tolbert VP, Smith A, Hur M, Hoffman J, Rheingold SR, Burke MJ, Wayne AS) Pediatr Blood Cancer 2016 Nov;63(11):1943-8 19 Citations |
| 1 | Association of a Family History of Coronary Heart Disease With Initiation of Statin Therapy in Individuals at Intermediate Risk: Post Hoc Analysis of a Randomized Clinical Trial. (Safarova MS, Bailey KR, Kullo IJ) JAMA Cardiol 2016 Jun 01;1(3):364-6 10 Citations |
| 1 | Potential cerebral malaria therapy: intramuscular arteether and vitamin D co-administration. (Dwivedi H, Singh SK, Chauhan BS, Gunjan S, Tripathi R) Parasitology 2016 Oct;143(12):1557-68 14 Citations |
| 1 | Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer. (Duran R, Mirpour S, Pekurovsky V, Ganapathy-Kanniappan S, Brayton CF, Cornish TC, Gorodetski B, Reyes J, Chapiro J, Schernthaner RE, Frangakis C, Lin M, Sun JD, Hart CP, Geschwind JF) Clin Cancer Res 2017 Jan 15;23(2):536-548 28 Citations |
| 1 | Development and Validation of a Small Animal Immobilizer and Positioning System for the Study of Delivery of Intracranial and Extracranial Radiotherapy Using the Gamma Knife System. (Awan MJ, Dorth J, Mani A, Kim H, Zheng Y, Mislmani M, Welford S, Yuan J, Wessels BW, Lo SS, Letterio J, Machtay M, Sloan A, Sohn JW) Technol Cancer Res Treat 2017 Apr;16(2):203-210 5 Citations |
| 1 | Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. (Andreassen CN, Rosenstein BS, Kerns SL, Ostrer H, De Ruysscher D, Cesaretti JA, Barnett GC, Dunning AM, Dorling L, West CML, Burnet NG, Elliott R, Coles C, Hall E, Fachal L, Vega A, Gómez-Caamaño A, Talbot CJ, Symonds RP, De Ruyck K, Thierens H, Ost P, Chang-Claude J, Seibold P, Popanda O, Overgaard M, Dearnaley D, Sydes MR, Azria D, Koch CA, Parliament M, Blackshaw M, Sia M, Fuentes-Raspall MJ, Ramon Y Cajal T, Barnadas A, Vesprini D, Gutiérrez-Enríquez S, Mollà M, Díez O, Yarnold JR, Overgaard J, Bentzen SM, Alsner J, International Radiogenomics Consortium (RgC)) Radiother Oncol 2016 Dec;121(3):431-439 100 Citations |
| 1 | Bowel Auto-segmentation in Online Adaptive MRI-guided Radiation Therapy by Using a Multi-region Labeling Algorithm (Yonggang Lu, Rojano Kashani, Ishita Chen, Hanlin Wan, Nichole M. Maughan, David Muccigrosso, and Parag J. Parikh) AAPM Annual Meeting |
| 1 | Low-level laser (light) therapy for the treatment of visual system injury and disease (Eells JT, Gopalakrishnan S, Salzman MM, Valter K, Provis J, Natoli R, Mitrofanis J, Stone J, Fitzgerald M) Handbook of Low-Level Laser Therapy 31 July 2016:435-452 |
| 1 | Evaluation of Negative Pressure Wound Therapy versus Dermabond Closure Over Orthopedic Incisions in the Hip and Knee. (Winkler C, Clifton B, Wooldridge AN, Anderson G, Walker G, Brindley GW. ) Texas Orthopaedic Journal |
| 1 | Long-Term Cancer Outcomes From Study NRG Oncology/RTOG 9517: A Phase 2 Study of Accelerated Partial Breast Irradiation With Multicatheter Brachytherapy After Lumpectomy for Early-Stage Breast Cancer. (White J, Winter K, Kuske RR, Bolton JS, Arthur DW, Scroggins T, Rabinovitch RA, Kelly T, Toonkel LM, Vicini FA, McCormick B) Int J Radiat Oncol Biol Phys 2016 Aug 01;95(5):1460-1465 49 Citations |
| 1 | Inhaled nitric oxide therapy for pulmonary disorders of the term and preterm infant. (Sokol GM, Konduri GG, Van Meurs KP) Semin Perinatol 2016 Oct;40(6):356-369 32 Citations |
| 1 | Engineering Hematopoietic Cells for Cancer Immunotherapy: Strategies to Address Safety and Toxicity Concerns. (Resetca D, Neschadim A, Medin JA) J Immunother 2016 Sep;39(7):249-59 8 Citations |
| 4 | Technical Note: Dose effects of 1.5 T transverse magnetic field on tissue interfaces in MRI-guided radiotherapy. (Chen X, Prior P, Chen GP, Schultz CJ, Li XA) Med Phys 2016 Aug;43(8):4797 46 Citations |
| 1 | Dynamic contrast-enhanced MRI detects acute radiotherapy-induced alterations in mandibular microvasculature: Prospective assessment of imaging biomarkers of normal tissue injury (Sandulache VC, Hobbs BP, Mohamed RAS, Frank SJ, Song J, Ding Y, Ger R, Court LE, Kalpathy-Cramer J, Hazle JD, Wang J, Awan MJ, Rosenthal DI, Garden AS, Gunn GB, Colen RR, Elshafeey N, Elbanan M, Hutcheson KA, Lewin JS, Chambers MS, Hofstede TM, Weber RS, Lai SY, Fuller CD) Scientific Reports 8 August 2016;6 12 Citations |
| 1 | ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy. (Yasukawa M, Liu Y, Hu L, Cogdell D, Gharpure KM, Pradeep S, Nagaraja AS, Sood AK, Zhang W) Oncotarget 2017 Oct 24;8(51):88410-88420 12 Citations |
| 1 | Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent chemotherapy and radiation therapy in high-risk squamous cell carcinoma of the head and neck. (b. Spencer SA, Harris J, Wheeler RH, Machtay M, SCHULTZ C, Spanos W, Rotman M, Meredith R, Ang KK ) N Engl J Med 350 (19): 1937-1944 |
| 1 | Treatment of recurrent glioblastoma with Bevacizumba with or without re-irradiation using a pulsed-low-dose radietion therapy technique: A single institution experience. ( Bovi JA, Prah M, Rand SD, SCHULTZ CJ, Schmanda KM) Int J Radiat Oncol Biol Phys 90:S1, Abs #2179, S288 |
| 1 | Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. (b. Spencer SA, Harris J, Wheeler RH, Machtay M, SCHULTZ C, Spanos W, Rotman M, Meredith R, Ang KK) Head Neck Mar;30(3):281-8 |
| 1 | Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice. (Baumgartner CK, Mattson JG, Weiler H, Shi Q, Montgomery RR) J Thromb Haemost 2017 Jan;15(1):98-109 18 Citations |
| 2 | Radiation-induced changes in intestinal and tissue-nonspecific alkaline phosphatase: implications for recovery after radiation therapy. (Rentea RM, Lam V, Biesterveld B, Fredrich KM, Callison J, Fish BL, Baker JE, Komorowski R, Gourlay DM, Otterson MF) Am J Surg 2016 Oct;212(4):602-608 10 Citations |
| 1 | Long-term Effects on Cognitive Trajectories of Postmenopausal Hormone Therapy in Two Age Groups. (Espeland MA, Rapp SR, Manson JE, Goveas JS, Shumaker SA, Hayden KM, Weitlauf JC, Gaussoin SA, Baker LD, Padula CB, Hou L, Resnick SM, WHIMSY and WHIMS-ECHO Study Groups) J Gerontol A Biol Sci Med Sci 2017 Jun 01;72(6):838-845 48 Citations |
| 7 | Association of Locoregional Control With High Body Mass Index in Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer. (Bergom C, Kelly T, Bedi M, Saeed H, Prior P, Rein LE, Szabo A, Wilson JF, Currey AD, White J) Int J Radiat Oncol Biol Phys 2016 Sep 01;96(1):65-71 24 Citations |
| 1 | Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer. (Kerns SL, Dorling L, Fachal L, Bentzen S, Pharoah PD, Barnes DR, Gómez-Caamaño A, Carballo AM, Dearnaley DP, Peleteiro P, Gulliford SL, Hall E, Michailidou K, Carracedo Á, Sia M, Stock R, Stone NN, Sydes MR, Tyrer JP, Ahmed S, Parliament M, Ostrer H, Rosenstein BS, Vega A, Burnet NG, Dunning AM, Barnett GC, West CM, Radiogenomics Consortium) EBioMedicine 2016 Aug;10:150-63 69 Citations |
| 4 | Disseminated Mycotic Aneurysms following Intravesical Bacillus Calmette-Guérin Therapy for Bladder Cancer: Case Discussion and Systematic Treatment Algorithm. (Lee CJ, Davila D, Dua A, Keyashian B, Dux J, Seabrook GR, Brown K, Malinowski M, Hieb RA, Lewis B) Ann Vasc Surg 2017 Feb;39:284.e5-284.e10 7 Citations |
| 1 | Differentiating hypersensitivity versus infusion-related reactions in pediatric patients receiving intravenous asparaginase therapy for acute lymphoblastic leukemia. (Burke MJ, Rheingold SR) Leuk Lymphoma 2017 Mar;58(3):540-551 38 Citations |
| 1 | A retrospective study showing the extent of compliance with perioperative guidelines in patients with coronary stents with regard to double antiplatelet therapy. (Woolard AA, Ehrenfeld JM, Eagle SS, Wanderer JP) J Clin Anesth 2016 Sep;33:179-84 1 Citation |
| 1 | Neoadjuvant therapy versus upfront surgical strategies in resectable pancreatic cancer: A Markov decision analysis. (de Geus SW, Evans DB, Bliss LA, Eskander MF, Smith JK, Wolff RA, Miksad RA, Weinstein MC, Tseng JF) Eur J Surg Oncol 2016 Oct;42(10):1552-60 51 Citations |
| 1 | Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. (Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KLB, Butterfass-Bahloul T, Calaminus G, Daldrup-Link HE, Eriksson M, Gebhardt MC, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier HE, Hale JP, Hall KS, Hardes J, Hawkins DS, Helmke K, Hogendoorn PCW, Isakoff MS, Janeway KA, Jürgens H, Kager L, Kühne T, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Meyers PA, Mottl H, Nathrath M, Papai Z, Randall RL, Reichardt P, Renard M, Safwat AA, Schwartz CL, Stevens MCG, Strauss SJ, Teot L, Werner M, Sydes MR, Whelan JS) Lancet Oncol 2016 Oct;17(10):1396-1408 420 Citations |
| 2 | Preliminary results on the feasibility of using ultrasound to monitor intrafractional motion during radiation therapy for pancreatic cancer. (Omari EA, Erickson B, Ehlers C, Quiroz F, Noid G, Cooper DT, Lachaine M, Li XA) Med Phys 2016 Sep;43(9):5252 17 Citations |
| 2 | Antagonistic Effects of Endogenous Nitric Oxide in a Glioblastoma Photodynamic Therapy Model. (Fahey JM, Emmer JV, Korytowski W, Hogg N, Girotti AW) Photochem Photobiol 2016 Nov;92(6):842-853 42 Citations |
| 1 | Anti-TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy. (Voelker J, Berg PH, Sheetz M, Duffin K, Shen T, Moser B, Greene T, Blumenthal SS, Rychlik I, Yagil Y, Zaoui P, Lewis JB) J Am Soc Nephrol 2017 Mar;28(3):953-962 231 Citations |
| 1 | Is Radiotherapy Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical Margins and Lymph Node Status on Survival. (Hammad AY, Berger NG, Eastwood D, Tsai S, Turaga KK, Christian KK, Johnston FM, Pawlik TM, Gamblin TC) Ann Surg Oncol 2016 Dec;23(Suppl 5):912-920 28 Citations |
| 1 | Postmastectomy Radiation Therapy Reduces Locoregional Recurrence in Breast Cancer Patients With 1-3 Positive Lymph Nodes: Eight-Year Results. (Pham YD, Rehman S, Reddy CA, Shukla ME, Moore H, Budd T, Crowe JP, Shah CS, Cherian S, Tendulkar RD) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E20 |
| 2 | Pulsed Reduced Dose Rate Reirradiation (PRDR) Using Modulated Arc (mARC) Intensity Modulated Radiation Therapy for Recurrent Gliomas: Initial Clinical Outcomes of a Novel Technique. (Siker ML, Firat S, Prah D, Schultz CJ, Dayal A, Masterson C, Connelly JM, Mueller WM, Bovi JA) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E125-E126 |
| 3 | Clinical experience with planning, quality assurance, and delivery of burst-mode modulated arc therapy. (Kainz K, Prah D, Ahunbay E, Li XA) J Appl Clin Med Phys 2016 Sep 08;17(5):47-59 1 Citation |
| 1 | Pulsed Reduced Dose Rate Reirradiation (PRDR) Using Modulated Arc (mARC) Intensity Modulated Radiation Therapy for Recurrent Gliomas: Initial Clinical Outcomes of a Novel Technique (M.L. Siker
S. Firat
D. Prah
C.J. Schultz
A. Dayal
C. Masterson
J.M. Connelly
W.M. Mueller
J.A. Bovi
) International Journal of Radiation Oncology, Biology, Physics POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E125-E126, OCTOBER 01, 2016 |
| 1 | Pulsed Reduced Dose Rate Reirradiation (PRDR) Using Modulated Arc (mARC) Intensity Modulated Radiation Therapy for Recurrent Gliomas: Initial Clinical Outcomes of a Novel Technique (M.L. Siker
S. Firat
D. Prah
C.J. Schultz
A. Dayal
C. Masterson
J.M. Connelly
W.M. Mueller
J.A. Bovi
) International Journal of Radiation Oncology, Biology, Physics POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E125-E126, OCTOBER 01, 2016 |
| 1 | Correlation of ADC Texture With Treatment Response for Chemoradiation Therapy of Pancreatic Cancer (D. Schott
W.A. Hall
T. Gilat Schmidt
E. Dalah
K. Oshima
E.S. Paulson
P.M. Knechtges
B.A. Erickson
A. Li) International Journal of Radiation Oncology, Biology, Physics ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S70, OCTOBER 01, 2016 |
| 1 | A Computed Tomography Imaging Feature of Pancreatic Cancer As a Predictive Biomarker for Escalated Dose Radiation Therapy (S. Moningi
A. Amer
L.E. Colbert
Y. Lee
W.A. Hall
B.A. Erickson
G.R. Varadhachary
P. Das
C.M. Taniguchi
J.B. Fleming
M. Katz
C.H. Crane
E.J. Koay) International Journal of Radiation Oncology, Biology, Physics POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E171-E172, OCTOBER 01, 2016 |
| 1 | The Impact of Dose on Overall Survival in Unresectable Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (A.Y. Hammad
R.K. Schmid
B.A. Erickson
T.C. Gamblin
J.R. Robbins) International Journal of Radiation Oncology, Biology, Physics POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E152, OCTOBER 01, 2016 |
| 1 | Computed Tomography Consensus Clinical Target Volume Contouring for Intensity Modulated Radiation Therapy in Intact Cervical Carcinoma (C.M. Yashar
I.A. Petersen
W.R. Bosch
K.V. Albuquerque
S. Beriwal
J.P. Chino
B.A. Erickson
J. Feddock
D.K. Gaffney
R. Iyer
A.H. Klopp
C. Kunos
J.S. Mayadev
L. Portelance
A.N. Viswanathan
A.H. Wolfson
A. Jhingran
L.K. Mell
) International Journal of Radiation Oncology, Biology, Physics ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S13-S14, OCTOBER 01, 2016 |
| 1 | Updated 4-Year Results for NRG Oncology/RTOG 0921: A Phase 2 Study of Postoperative Intensity Modulated Radiation Therapy With Concurrent Cisplatin and Bevacizumab Followed by Carboplatin and Paclitaxel for Patients With Endometrial Cancer (A.N. Viswanathan
K. Winter
B.E. Miller
Y. Xiao
A. Jhingran
L. Portelance
W.R. Bosch
U. Matulonis
N. Horowitz
R. Mannel
L. Souhami
B.A. Erickson
W. Small Jr.
D.K. Gaffney) International Journal of Radiation Oncology, Biology, Physics ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S49-S50, OCTOBER 01, 2016 |
| 1 | Improving Delineation of Gross Tumor Volume Using Magnetic Resonance Imaging for External Beam Radiation Therapy of Locally Advanced Cervical Cancer (Y. Song
X. Chen
B.A. Erickson
A. Li) International Journal of Radiation Oncology, Biology, Physics POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E303-E304, OCTOBER 01, 2016 |
| 1 | Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy in Head and Neck Squamous Cell Carcinoma: A Pooled Analysis of NRG Oncology/RTOG 0129 and 0522 (M. Yao
Q. Zhang
C.R. Woods
P.F. Nguyen-Tan
D.I. Rosenthal
A.S. Garden
W.L. Thorstad
P.R. Anne
C.J. Schultz
J.J. Caudell
E. Filion
J.A. Ridge
C.U. Jones
H. Kim
S.S. Yom
D. Raben
J.A. Bonner
M. Machtay
J. Harris
Q.T. Le) International Journal of Radiation Oncology, Biology, Physics ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S116-S117, OCTOBER 01, 2016 |
| 1 | Diffuse Alveolar Hemorrhage (DAH) in Hepatitis C Virus (HCV) Associated Cryoglobulinemia After Completion of HCV Therapy (AbhijaiSinghMD ChandrakantaChuturvedulaMD, GurbirGIllMD, ReshmaAbrahamMD, PieushaMalhotraMD) Chest https://doi.org/10.1016/j.chest.2016.08.544 |
| 1 | Correlation of ADC Texture With Treatment Response for Chemoradiation Therapy of Pancreatic Cancer (D. Schott
W.A. Hall
T. Gilat Schmidt
E. Dalah
K. Oshima
E.S. Paulson
P.M. Knechtges
B.A. Erickson
A. Li) International Journal of Radiation Oncology, Biology, Physics ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S70, OCTOBER 01, 2016 |
| 1 | Early Cardiotoxicity in Thoracic Radiation Therapy for Lung and Esophageal Cancer (J. Borkenhagen
C. Rapp
S. Klawikowski
L.E. Rein
E.M. Gore
) International Journal of Radiation Oncology, Biology, Physics POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E428, OCTOBER 01, 2016 |
| 1 | Quantitative Computed Tomography for Tumor Response Assessment During Radiation Therapy for Lung Cancer (J. Paul
E.M. Gore
A. Li) International Journal of Radiation Oncology, Biology, Physics EPOSTER ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , S193, OCTOBER 01, 2016 |
| 1 | A Computed Tomography Imaging Feature of Pancreatic Cancer As a Predictive Biomarker for Escalated Dose Radiation Therapy (S. Moningi
A. Amer
L.E. Colbert
Y. Lee
W.A. Hall
B.A. Erickson
G.R. Varadhachary
P. Das
C.M. Taniguchi
J.B. Fleming
M. Katz
C.H. Crane
E.J. Koay) International Journal of Radiation Oncology, Biology, Physics POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E171-E172, OCTOBER 01, 2016 |
| 1 | Radiation for Pancreatic Adenocarcinoma: An End-of-Life Treatment? Assessing Appropriate Radiation Therapy Utilization in the National Cancer Data Base (NCDB) (L.E. Colbert
K.V. Dharmarajan
J. Switchenko
C.M. Taniguchi
W.A. Hall
T.W. Gillespie
D.A. Kooby
J. Lipscomb
J.C. Landry) International Journal of Radiation Oncology, Biology, Physics EPOSTER ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , S195, OCTOBER 01, 2016 |
| 1 | Effect of antiplatelet therapy on mortality and acute lung injury in critically ill patients: A systematic review and meta-analysis. (Mohananey D, Sethi J, Villablanca PA, Ali MS, Kumar R, Baruah A, Bhatia N, Agrawal S, Hussain Z, Shamoun FE, Augoustides JT, Ramakrishna H) Ann Card Anaesth 2016;19(4):626-637 13 Citations |
| 1 | Regulatory T-Cell Therapy for Graft-versus-host Disease. (Heinrichs J, Bastian D, Veerapathran A, Anasetti C, Betts B, Yu XZ) J Immunol Res Ther 2016;1(1):1-14 |
| 1 | Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study. (Iannaccone M, D Ascenzo F, De Filippo O, Gagliardi M, Southern DA, Raposeiras-Roubín S, Abu-Assi E, Henriques JPS, Saucedo J, González-Juanatey JR, Wilton SB, Kikkert WJ, Nuñez-Gil I, Ariza-Sole A, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Huczek Z, Nie SP, Fujii T, Correia L, Kawashiri MA, García-Acuña JM, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, Möllmann H, Shiomi H, Kowara M, Filipiak K, Wang X, Yan Y, Fan JY, Ikari Y, Nakahashi T, Sakata K, Yamagishi M, Moretti C, Gaita F, Kalpak O, Kedev S) Am J Cardiovasc Drugs 2017 Feb;17(1):61-71 12 Citations |
| 4 | Management of independent motion between multiple targets in lung cancer radiation therapy. (Liu F, Tai A, Ahunbay E, Gore E, Johnstone C, Li XA) Pract Radiat Oncol 2017;7(1):26-34 5 Citations |
| 1 | Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival. (Chen JX, Rose S, White SB, El-Haddad G, Fidelman N, Yarmohammadi H, Hwang W, Sze DY, Kothary N, Stashek K, Wileyto EP, Salem R, Metz DC, Soulen MC) Cardiovasc Intervent Radiol 2017 Jan;40(1):69-80 81 Citations |
| 1 | Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles. (Rana S, Cheng C, Zhao L, Park S, Larson G, Vargas C, Dunn M, Zheng Y) J Med Radiat Sci 2017 Mar;64(1):18-24 14 Citations |
| 1 | The time and cost investment required to obtain and initiate direct-acting antiviral therapy. (Loy V, Benyashvili T, Adams W, Pavkov D, O'Mahoney M, Cotler SJ) Antivir Ther 2016;21(8):731-733 5 Citations |
| 1 | Near-infrared photothermal therapy of Prussian-blue-functionalized lanthanide-ion-doped inorganic/plasmonic multifunctional nanostructures for the selective targeting of HER2-expressing breast cancer cells. (Parchur AK, Li Q, Zhou A) Biomater Sci 2016 Nov 15;4(12):1781-1791 37 Citations |
| 5 | Venous thromboembolism prophylaxis during neoadjuvant therapy for resectable and borderline resectable pancreatic cancer-Is it indicated? (Krepline AN, Christians KK, George B, Ritch PS, Erickson BA, Tolat P, Evans DB, Tsai S) J Surg Oncol 2016 Oct;114(5):581-586 26 Citations |
| 1 | Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity? (Herskind C, Talbot CJ, Kerns SL, Veldwijk MR, Rosenstein BS, West CM) Cancer Lett 2016 Nov 01;382(1):95-109 65 Citations |
| 1 | Modulation of the Anti-Tumor Efficacy of Photodynamic Therapy by Nitric Oxide. (Girotti AW) Cancers (Basel) 2016 Oct 20;8(10) 23 Citations |
| 1 | Neuronal protection against oxidative insult by polyanhydride nanoparticle-based mitochondria-targeted antioxidant therapy. (Brenza TM, Ghaisas S, Ramirez JEV, Harischandra D, Anantharam V, Kalyanaraman B, Kanthasamy AG, Narasimhan B) Nanomedicine 2017 Apr;13(3):809-820 84 Citations |
| 3 | Magnetic Resonance Imaging-Based Radiomic Profiles Predict Patient Prognosis in Newly Diagnosed Glioblastoma Before Therapy. (McGarry SD, Hurrell SL, Kaczmarowski AL, Cochran EJ, Connelly J, Rand SD, Schmainda KM, LaViolette PS) Tomography 2016 Sep;2(3):223-228 |
| 1 | Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy. (Mangala LS, Wang H, Jiang D, Wu SY, Somasunderam A, Volk DE, Lokesh GLR, Li X, Pradeep S, Yang X, Haemmerle M, Rodriguez-Aguayo C, Nagaraja AS, Rupaimoole R, Bayraktar E, Bayraktar R, Li L, Tanaka T, Hu W, Ivan C, Gharpure KM, McGuire MH, Thiviyanathan V, Zhang X, Maiti SN, Bulayeva N, Choi HJ, Dorniak PL, Cooper LJ, Rosenblatt KP, Lopez-Berestein G, Gorenstein DG, Sood AK) JCI Insight 2016 Oct 20;1(17):e87754 13 Citations |
| 1 | Multiple Means by Which Nitric Oxide can Antagonize Photodynamic Therapy. (Girotti AW, Fahey JM, Korytowski W) Curr Med Chem 2016;23(24):2754-2769 19 Citations |
| 1 | Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience. (Cloyd JM, Katz MH, Prakash L, Varadhachary GR, Wolff RA, Shroff RT, Javle M, Fogelman D, Overman M, Crane CH, Koay EJ, Das P, Krishnan S, Minsky BD, Lee JH, Bhutani MS, Weston B, Ross W, Bhosale P, Tamm EP, Wang H, Maitra A, Kim MP, Aloia TA, Vauthey JN, Fleming JB, Abbruzzese JL, Pisters PW, Evans DB, Lee JE) J Gastrointest Surg 2017 Jan;21(1):164-174 123 Citations |
| 1 | Poly (amidoamine) dendrimer-mediated hybrid formulation for combination therapy of ramipril and hydrochlorothiazide. (Singh MK, Pooja D, Kulhari H, Jain SK, Sistla R, Chauhan AS) Eur J Pharm Sci 2017 Jan 01;96:84-92 39 Citations |
| 1 | Salvage therapy for refractory hemophagocytic lymphohistiocytosis: A review of the published experience. (Marsh RA, Jordan MB, Talano JA, Nichols KE, Kumar A, Naqvi A, Vaiselbuh SR, Histiocyte Society Salvage Therapy Working Group) Pediatr Blood Cancer 2017 Apr;64(4) 47 Citations |
| 1 | Bisphosphonate therapy for osteogenesis imperfecta. (Dwan K, Phillipi CA, Steiner RD, Basel D) Cochrane Database Syst Rev 2016 Oct 19;10(10):CD005088 90 Citations |
| 2 | Harnessing bacteriocin biology as targeted therapy in the GI tract. (Kommineni S, Kristich CJ, Salzman NH) Gut Microbes 2016 Nov;7(6):512-517 16 Citations |
| 5 | Preoperative Radiation Therapy Followed by Reexcision May Improve Local Control and Progression-Free Survival in Unplanned Excisions of Soft Tissue Sarcomas of the Extremity and Chest-Wall. (Saeed H, King DM, Johnstone CA, Charlson JA, Hackbarth DA, Neilson JC, Bedi M) Int J Surg Oncol 2016;2016:5963167 25 Citations |
| 1 | Upper Airway Stimulation Therapy. (Green KK, Woodson BT) Otolaryngol Clin North Am 2016 Dec;49(6):1425-1431 7 Citations |
| 1 | No Increase in Fractures After Stopping Hormone Therapy: Results From the Women's Health Initiative. (Watts NB, Cauley JA, Jackson RD, LaCroix AZ, Lewis CE, Manson JE, Neuner JM, Phillips LS, Stefanick ML, Wactawski-Wende J, Crandall C, Women’s Health Initiative Investigators) J Clin Endocrinol Metab 2017 Jan 01;102(1):302-308 47 Citations |
| 1 | Immune--Mediated Colitis with Novel Immunotherapy : PD-1 Inhibitor Associated Gastrointestinal Toxicity. (Gondal B, Patel P, Gallan A, Hart J, Bissonnette M) Acta Gastroenterol Belg 2016;79(2):379-381 3 Citations |
| 1 | Cell-Intrinsic Barriers of T Cell-Based Immunotherapy. (Ghoneim HE, Zamora AE, Thomas PG, Youngblood BA) Trends Mol Med 2016 Dec;22(12):1000-1011 59 Citations |
| 2 | Adherence to chronic opioid therapy prescribing guidelines in a primary care clinic. (Kay C, Wozniak E, Koller S, Ye A, Bernstein J) J Opioid Manag 2016;12(5):333-345 6 Citations |
| 1 | Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma. (Paudyal R, Oh JH, Riaz N, Venigalla P, Li J, Hatzoglou V, Leeman J, Nunez DA, Lu Y, Deasy JO, Lee N, Shukla-Dave A) J Magn Reson Imaging 2017 Apr;45(4):1013-1023 53 Citations |
| 4 | Multimodality Therapy in Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Importance of Locoregional Therapies for a Systemic Disease. (Tsai S, Christians KK, Ritch PS, George B, Khan AH, Erickson B, Evans DB) J Oncol Pract 2016 Oct;12(10):915-923 20 Citations |
| 3 | Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma. (Cornell RF, D'Souza A, Kassim AA, Costa LJ, Innis-Shelton RD, Zhang MJ, Huang J, Abidi M, Aiello J, Akpek G, Bashey A, Bashir Q, Cerny J, Comenzo R, Diaz MA, Freytes C, Gale RP, Ganguly S, Hamadani M, Hashmi S, Holmberg L, Hossain N, Kamble RT, Kharfan-Dabaja M, Kindwall-Keller T, Kyle R, Kumar S, Lazarus H, Lee C, Maiolino A, Marks DI, Meehan K, Mikhael J, Nath R, Nishihori T, Olsson RF, Ramanathan M, Saad A, Seo S, Usmani S, Vesole D, Vij R, Vogl D, Wirk BM, Yared J, Krishnan A, Mark T, Nieto Y, Hari P) Biol Blood Marrow Transplant 2017 Feb;23(2):269-277 20 Citations |
| 1 | Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 Trial. (Charpentier AM, Friedman DL, Wolden S, Schwartz C, Gill B, Sykes J, Albert-Green A, Kelly KM, Constine LS, Hodgson DC) Int J Radiat Oncol Biol Phys 2016 Dec 01;96(5):943-950 18 Citations |
| 1 | Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models. (Liu F, Tai A, Lee P, Biswas T, Ding GX, El Naqa I, Grimm J, Jackson A, Kong FS, LaCouture T, Loo B Jr, Miften M, Solberg T, Li XA) Radiother Oncol 2017 Feb;122(2):286-294 50 Citations |
| 1 | In vitro biomechanical properties, fluorescence imaging, surface-enhanced Raman spectroscopy, and photothermal therapy evaluation of luminescent functionalized CaMoO4:Eu@Au hybrid nanorods on human lung adenocarcinoma epithelial cells. (Li Q, Parchur AK, Zhou A) Sci Technol Adv Mater 2016;17(1):346-360 27 Citations |
| 1 | Enhanced aggressiveness of bystander cells in an anti-tumor photodynamic therapy model: Role of nitric oxide produced by targeted cells. (Bazak J, Fahey JM, Wawak K, Korytowski W, Girotti AW) Free Radic Biol Med 2017 Jan;102:111-121 40 Citations |
| 1 | Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL). (Shah N, Rauenzahn S, Veltri L, Wen S, Craig M, Hamadani M, Kanate AS, Cumpston A) Bone Marrow Transplant 2017 Feb;52(2):321-322 2 Citations |
| 4 | Poor Glycemic Control Is Associated with Failure to Complete Neoadjuvant Therapy and Surgery in Patients with Localized Pancreatic Cancer. (Rajamanickam ES, Christians KK, Aldakkak M, Krepline AN, Ritch PS, George B, Erickson BA, Foley WD, Aburajab M, Evans DB, Tsai S) J Gastrointest Surg 2017 Mar;21(3):496-505 10 Citations |
| 1 | Acid Ceramidase Deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy. (Dworski S, Lu P, Khan A, Maranda B, Mitchell JJ, Parini R, Di Rocco M, Hugle B, Yoshimitsu M, Magnusson B, Makay B, Arslan N, Guelbert N, Ehlert K, Jarisch A, Gardner-Medwin J, Dagher R, Terreri MT, Lorenco CM, Barillas-Arias L, Tanpaiboon P, Solyom A, Norris JS, He X, Schuchman EH, Levade T, Medin JA) Biochim Biophys Acta Mol Basis Dis 2017 Feb;1863(2):386-394 36 Citations |
| 1 | American Brachytherapy Society: Brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries. (Suneja G, Brown D, Chang A, Erickson B, Fidarova E, Grover S, Mahantshetty U, Nag S, Narayan K, Bvochora-Nsingo M, Viegas C, Viswanathan AN, Lin MY, Gaffney D) Brachytherapy 2017;16(1):85-94 45 Citations |
| 1 | Preclinical validation: LV/IL-12 transduction of patient leukemia cells for immunotherapy of AML. (Huang J, Liu Y, Au BC, Barber DL, Arruda A, Schambach A, Rothe M, Minden MD, Paige CJ, Medin JA) Mol Ther Methods Clin Dev 2016;3:16074 18 Citations |
| 1 | Systemic therapy with oncolytic myxoma virus cures established residual multiple myeloma in mice. (Bartee E, Bartee MY, Bogen B, Yu XZ) Mol Ther Oncolytics 2016;3:16032 27 Citations |
| 1 | Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy. (Ikeda S, Goodman AM, Cohen PR, Jensen TJ, Ellison CK, Frampton G, Miller V, Patel SP, Kurzrock R) NPJ Genom Med 2016;1:16037- 114 Citations |
| 1 | Caution Must Be Exercised When Performing Deformable Dose Accumulation for Tumors Undergoing Mass Changes During Fractionated Radiation Therapy. (Zhong H, Chetty IJ) Int J Radiat Oncol Biol Phys 2017 Jan 01;97(1):182-183 34 Citations |
| 1 | Biomarkers of Outcome in Patients With Localized Prostate Cancer Treated With Radiotherapy. (Hall WA, Lawton CA, Jani AB, Pollack A, Feng FY) Semin Radiat Oncol 2017 Jan;27(1):11-20 11 Citations |
| 1 | Electrochemotherapy - yet another innovative application. (Olasz EB, Kis E) Br J Dermatol 2016 Dec;175(6):1148-1149 1 Citation |
| 2 | Investigation of undersampling and reconstruction algorithm dependence on respiratory correlated 4D-MRI for online MR-guided radiation therapy. (Mickevicius NJ, Paulson ES) Phys Med Biol 2017 Apr 21;62(8):2910-2921 50 Citations |
| 1 | Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813. (Chang S, Zhang P, Cairncross JG, Gilbert MR, Bahary JP, Dolinskas CA, Chakravarti A, Aldape KD, Bell EH, Schiff D, Jaeckle K, Brown PD, Barger GR, Werner-Wasik M, Shih H, Brachman D, Penas-Prado M, Robins HI, Belanger K, Schultz C, Hunter G, Mehta M) Neuro Oncol 2017 Feb 01;19(2):252-258 70 Citations |
| 4 | Medicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy. (Biggers A, Shi Y, Charlson J, Smith EC, Smallwood AJ, Nattinger AB, Laud PW, Neuner JM) J Clin Oncol 2016 Dec 20;34(36):4398-4404 35 Citations |
| 1 | Nitric oxide-mediated resistance to photodynamic therapy in a human breast tumor xenograft model: Improved outcome with NOS2 inhibitors. (Fahey JM, Girotti AW) Nitric Oxide 2017 Jan 30;62:52-61 49 Citations |
| 7 | Outcome analysis of continuous intraoperative renal replacement therapy in the highest acuity liver transplant recipients: A single-center experience. (Zimmerman MA, Selim M, Kim J, Regner K, Saeian K, Zanowski S, Martin A, Connolly LA, Lauer KK, Woehlck HJ, Hong JC) Surgery 2017 May;161(5):1279-1286 22 Citations |
| 1 | CryoPen®, A gasless cryotherapy system adapted for low-resource settings (Cremer M, Garai J, Taxa L, Salinas M, Felix J, Alfaro K, Haas M, Zevallos A) 2016 IEEE Healthcare Innovation Point-of-Care Technologies Conference, HI-POCT 2016 27 December 2016:130-133 1 Citation |
| 1 | Mechanical Circulatory Support and Antithrombotic Therapy: Looking for the Holy Grail. (Massicotte MP, Maul TM, Snyder TA, Baumann Kreuziger L) ASAIO J 2017;63(1):1-4 7 Citations |
| 1 | Prognostic modeling and analysis of tumor response to fractionated radiotherapy for patients with squamous cell lung cancer (Zhong H, Sharifi H, Li H, Mao W, Chetty IJ) Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 2017;10209 LNCS:549-559 1 Citation |
| 1 | ADAMTS16 mutations sensitize ovarian cancer cells to platinumbased chemotherapy (Yasukawa M, Liu Y, Hu L, Cogdell D, Gharpure KM, Pradeep S, Nagaraja AS, Sood AK, Zhang W) Oncotarget 2017;8(51):88410-88420 12 Citations |
| 1 | SU-F-J-71: Improving CT Quality for Radiation Therapy Planning and Delivery Guidance Using a Non-Linear Contrast Enhancement Technique. (Noid G, Tai A, Li X) Med Phys 2016 Jun;43(6):3422 |
| 1 | TH-CD-202-03: Enhancing Soft-Tissue CT Contrast for Radiation Therapy Using Mono-Energetic Decompositions of Dual Energy CT. (Noid G, Tai A, Liu Y, Li X) Med Phys 2016 Jun;43(6):3876-3877 |
| 1 | SU-F-T-525: Monitordeep-Inspiratory Breathhold with a Laser Sensor for Radiation Therapy of Left Breast Cancer. (Tai A, Li DJ, Currey A, Li XA) Med Phys 2016 Jun;43(6):3584 |
| 3 | Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a "real world" study. (Epperla N, Hamadani M, Cashen AF, Ahn KW, Oak E, Kanate AS, Calzada O, Cohen JB, Farmer L, Ghosh N, Tallarico M, Nabhan C, Costa LJ, Kenkre VP, Hari PN, Fenske TS) Hematol Oncol 2017 Dec;35(4):528-535 59 Citations |
| 1 | Pathogen boosted adoptive cell transfer immunotherapy to treat solid tumors. (Xin G, Schauder DM, Jing W, Jiang A, Joshi NS, Johnson B, Cui W) Proc Natl Acad Sci U S A 2017 Jan 24;114(4):740-745 26 Citations |
| 1 | Current Strategies for the Immunotherapy of Multiple Myeloma. (Luetkens T, Yousef S, Radhakrishnan SV, Atanackovic D) Oncology (Williston Park) 2017 Jan 15;31(1):55-63 |
| 3 | Recommendations for MRI-based contouring of gross tumor volume and organs at risk for radiation therapy of pancreatic cancer. (Heerkens HD, Hall WA, Li XA, Knechtges P, Dalah E, Paulson ES, van den Berg CAT, Meijer GJ, Koay EJ, Crane CH, Aitken K, van Vulpen M, Erickson BA) Pract Radiat Oncol 2017;7(2):126-136 50 Citations |
| 1 | Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study. (von Gruenigen VE, Huang HQ, Beumer JH, Lankes HA, Tew W, Herzog T, Hurria A, Mannel RS, Rizack T, Landrum LM, Rose PG, Salani R, Bradley WH, Rutherford TJ, Higgins RV, Secord AA, Fleming G) Gynecol Oncol 2017 Mar;144(3):459-467 62 Citations |
| 1 | VAMONOS (Veterans Affairs' Metabolism, Obstructed and Non-Obstructed Sleep) Study: Effects of CPAP Therapy on Glucose Metabolism in Patients with Obstructive Sleep Apnea. (Ioachimescu OC, Anthony J Jr, Constantin T, Ciavatta MM, McCarver K, Sweeney ME) J Clin Sleep Med 2017 Mar 15;13(3):455-466 35 Citations |
| 1 | Reducing the Shock of Acute Respiratory Distress Syndrome: Is Veno-Venous ECMO a Viable Therapy in the Hemodynamically Unstable Patient? (Fierro MA, Bartz RR) Anesth Analg 2017 Mar;124(3):716-718 4 Citations |
| 1 | The effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients-A multi-institutional analysis. (Buettner S, Koerkamp BG, Ejaz A, Buisman FE, Kim Y, Margonis GA, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Marsh JW, IJzermans JN, Pawlik TM) J Surg Oncol 2017 Mar;115(3):312-318 54 Citations |
| 1 | The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of radionuclide-based high-dose-rate brachytherapy. (Erickson BA, Bittner NH, Chadha M, Mourtada F, Demanes DJ) Brachytherapy 2017;16(1):75-84 7 Citations |
| 1 | The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of low-dose-rate brachytherapy. (Viswanathan AN, Erickson BA, Ibbott GS, Small W Jr, Eifel PJ) Brachytherapy 2017;16(1):68-74 11 Citations |
| 1 | American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer. (Mayadev J, Viswanathan A, Liu Y, Li CS, Albuquerque K, Damato AL, Beriwal S, Erickson B) Brachytherapy 2017;16(1):22-43 35 Citations |
| 1 | Impact of DPP-4 inhibition on acute and chronic endothelial function in humans with type 2 diabetes on background metformin therapy. (Widlansky ME, Puppala VK, Suboc TM, Malik M, Branum A, Signorelli K, Wang J, Ying R, Tanner MJ, Tyagi S) Vasc Med 2017 Jun;22(3):189-196 29 Citations |
| 1 | Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy. (Wang Y, Xie Y, Li J, Peng ZH, Sheinin Y, Zhou J, Oupický D) ACS Nano 2017 Feb 28;11(2):2227-2238 434 Citations |
| 1 | Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis. (Blauvelt A, Papp KA, Sofen H, Augustin M, Yosipovitch G, Katoh N, Mrowietz U, Ohtsuki M, Poulin Y, Shrom D, Burge R, See K, Mallbris L, Gordon KB) J Eur Acad Dermatol Venereol 2017 Jun;31(6):1004-1013 58 Citations |
| 1 | Predictors of response to platinum (Pt)-based chemotherapy in metastatic castration-resistant prostate cancer (mCRPC) (Kilari, D., Bylow, K. and Berlin, K.E.K.) 2017 Genitourinary Cancers Symposium |
| 1 | Computational methods using genome-wide association studies to predict radiotherapy complications and to identify correlative molecular processes. (Oh JH, Kerns S, Ostrer H, Powell SN, Rosenstein B, Deasy JO) Sci Rep 2017 Feb 24;7:43381 39 Citations |
| 1 | Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs. (Mack DL, Poulard K, Goddard MA, Latournerie V, Snyder JM, Grange RW, Elverman MR, Denard J, Veron P, Buscara L, Le Bec C, Hogrel JY, Brezovec AG, Meng H, Yang L, Liu F, O'Callaghan M, Gopal N, Kelly VE, Smith BK, Strande JL, Mavilio F, Beggs AH, Mingozzi F, Lawlor MW, Buj-Bello A, Childers MK) Mol Ther 2017 Apr 05;25(4):839-854 93 Citations |
| 1 | Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy. (Fung C, Sesso HD, Williams AM, Kerns SL, Monahan P, Abu Zaid M, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Kollmannsberger CK, Cook R, Althouse S, Ardeshir-Rouhani-Fard S, Lipshultz SE, Einhorn LH, Fossa SD, Travis LB, Platinum Study Group) J Clin Oncol 2017 Apr 10;35(11):1211-1222 82 Citations |
| 1 | Keratinocyte Cancer Therapies Enter the Era of Targeted and Immunotherapy: Join the Club. (Olasz EB, Babakoohi S, Lazarova Z) JAMA Dermatol 2017 Apr 01;153(4):253-255 |
| 1 | Prospective Qualitative and Quantitative Analysis of Real-Time Peer Review Quality Assurance Rounds Incorporating Direct Physical Examination for Head and Neck Cancer Radiation Therapy. (Cardenas CE, Mohamed ASR, Tao R, Wong AJR, Awan MJ, Kuruvila S, Aristophanous M, Gunn GB, Phan J, Beadle BM, Frank SJ, Garden AS, Morrison WH, Fuller CD, Rosenthal DI) Int J Radiat Oncol Biol Phys 2017 Jul 01;98(3):532-540 54 Citations |
| 1 | Healthcare Costs and Utilization for Patients Age 50 to 64 Years with Acute Myeloid Leukemia Treated with Chemotherapy or with Chemotherapy and Allogeneic Hematopoietic Cell Transplantation. (Preussler JM, Meyer CL, Mau LW, Majhail NS, Denzen EM, Edsall KC, Farnia SH, Saber W, Burns LJ, Vanness DJ) Biol Blood Marrow Transplant 2017 Jun;23(6):1021-1028 32 Citations |
| 1 | Gene therapy (Shi Q, Montgomery RR) Platelets in Thrombotic and Non-Thrombotic Disorders: Pathophysiology, Pharmacology and Therapeutics: an Update 8 March 2017:1431-1445 |
| 1 | Stereotactic radiosurgery and stereotactic fractionated radiotherapy for metastatic tumors of the spine. (Mariano JM, Torio EF, Santos MS, Sih IM, Torcuator RA) Neurol Res 2017 Apr;39(4):298-304 3 Citations |
| 1 | Enzyme replacement therapy for Farber disease: Proof-of-concept studies in cells and mice. (He X, Dworski S, Zhu C, DeAngelis V, Solyom A, Medin JA, Simonaro CM, Schuchman EH) BBA Clin 2017 Jun;7:85-96 35 Citations |
| 2 | Considerations Regarding the Role of Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma in the Elderly. (Hall WA, Erickson B) J Oncol Pract 2017 Mar;13(3):171-172 |
| 2 | Clinical experience with planning, quality assurance, and delivery of burst-mode modulated arc therapy. (Kainz K, Prah D, Ahunbay E, Li XA) J Appl Clin Med Phys 2016 Sep;17(5):1-13 1 Citation |
| 1 | Direct Xa inhibitors in addition to antiplatelet therapy in acute coronary syndrome: meta-analysis of randomized trials. (Villablanca PA, Holmes D Jr, Mohananey D, Briceno DF, Núñez Gil IJ, Kargoli F, Gupta T, Kizer JR, Bortnick AE, Wiley J, Menegus MA, Pyo R, García M, Ramakrishna H, Mookadam F) Coron Artery Dis 2017 Aug;28(5):395-405 6 Citations |
| 2 | The Unique Issues With Brachytherapy in Low- and Middle-Income Countries. (Grover S, Longo J, Einck J, Puri P, Brown D, Chino J, Mahantshetty U, Yashar C, Erickson B) Semin Radiat Oncol 2017 Apr;27(2):136-142 35 Citations |
| 1 | Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma. (Moy JD, Moskovitz JM, Ferris RL) Eur J Cancer 2017 May;76:152-166 84 Citations |
| 1 | Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for Immunotherapy. (Yanik EL, Kaunitz GJ, Cottrell TR, Succaria F, McMiller TL, Ascierto ML, Esandrio J, Xu H, Ogurtsova A, Cornish T, Lipson EJ, Topalian SL, Engels EA, Taube JM) JAMA Oncol 2017 Jul 01;3(7):974-978 66 Citations |
| 1 | Bystander effects of nitric oxide in anti-tumor photodynamic therapy (J. Bazak, J.M. Fahey, K. Wawak, W. Korytowski, A.W. Girotti) Cancer Cell Microenvironment 4:e1511.doi:10.14800/ccm.1511 |
| 1 | Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project. (Tay KJ, Scheltema MJ, Ahmed HU, Barret E, Coleman JA, Dominguez-Escrig J, Ghai S, Huang J, Jones JS, Klotz LH, Robertson CN, Sanchez-Salas R, Scionti S, Sivaraman A, de la Rosette J, Polascik TJ) Prostate Cancer Prostatic Dis 2017 Sep;20(3):294-299 123 Citations |
| 1 | Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate. (Kato S, Goodman A, Walavalkar V, Barkauskas DA, Sharabi A, Kurzrock R) Clin Cancer Res 2017 Aug 01;23(15):4242-4250 726 Citations |
| 1 | Long-term effects of systemic gene therapy in a canine model of myotubular myopathy. (Elverman M, Goddard MA, Mack D, Snyder JM, Lawlor MW, Meng H, Beggs AH, Buj-Bello A, Poulard K, Marsh AP, Grange RW, Kelly VE, Childers MK) Muscle Nerve 2017 Nov;56(5):943-953 53 Citations |
| 1 | Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma. (Subbiah V, Meyer C, Zinner R, Meric-Bernstam F, Zahurak ML, O'Connor A, Roszik J, Shaw K, Ludwig JA, Kurzrock R, Azad NA) Clin Cancer Res 2017 Aug 01;23(15):4027-4034 39 Citations |
| 3 | Self-Expanding Metal Stents Improve Swallowing and Maintain Nutrition During Neoadjuvant Therapy for Esophageal Cancer. (Smith ZL, Gonzaga JE, Haasler GB, Gore EM, Dua KS) Dig Dis Sci 2017 Jun;62(6):1647-1656 9 Citations |
| 1 | Osteogenic Sarcoma: Systemic Chemotherapy Options for Localized Disease. (Harrison DJ, Schwartz CL) Curr Treat Options Oncol 2017 Apr;18(4):24 53 Citations |
| 1 | Protection by Inhaled Hydrogen Therapy in a Rat Model of Acute Lung Injury Can be Tracked in vivo Using Molecular Imaging. (Audi SH, Jacobs ER, Zhang X, Camara AK, Zhao M, Medhora MM, Rizzo B, Clough AV) Shock 2017 Apr 11 |
| 1 | Saline versus balanced crystalloids for intravenous fluid therapy in the emergency department: study protocol for a cluster-randomized, multiple-crossover trial. (Self WH, Semler MW, Wanderer JP, Ehrenfeld JM, Byrne DW, Wang L, Atchison L, Felbinger M, Jones ID, Russ S, Shaw AD, Bernard GR, Rice TW) Trials 2017 Apr 13;18(1):178 27 Citations |
| 1 | Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine. (Husain H, Melnikova VO, Kosco K, Woodward B, More S, Pingle SC, Weihe E, Park BH, Tewari M, Erlander MG, Cohen E, Lippman SM, Kurzrock R) Clin Cancer Res 2017 Aug 15;23(16):4716-4723 105 Citations |
| 1 | Longitudinal thumbnail fissures due to erlotinib therapy for lung cancer. (Dasanu CA, Alvarez-Argote J, Lippman SM, Plaxe SC) J Oncol Pharm Pract 2018 Apr;24(3):229-231 2 Citations |
| 1 | A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study. (Monk BJ, Brady MF, Aghajanian C, Lankes HA, Rizack T, Leach J, Fowler JM, Higgins R, Hanjani P, Morgan M, Edwards R, Bradley W, Kolevska T, Foukas P, Swisher EM, Anderson KS, Gottardo R, Bryan JK, Newkirk M, Manjarrez KL, Mannel RS, Hershberg RM, Coukos G) Ann Oncol 2017 May 01;28(5):996-1004 73 Citations |
| 3 | Early Assessment of Treatment Responses During Radiation Therapy for Lung Cancer Using Quantitative Analysis of Daily Computed Tomography. (Paul J, Yang C, Wu H, Tai A, Dalah E, Zheng C, Johnstone C, Kong FM, Gore E, Li XA) Int J Radiat Oncol Biol Phys 2017 Jun 01;98(2):463-472 19 Citations |
| 1 | Adaptive radiotherapy for NSCLC patients: utilizing the principle of energy conservation to evaluate dose mapping operations. (Zhong H, Chetty IJ) Phys Med Biol 2017 Jun 07;62(11):4333-4345 17 Citations |
| 1 | Use of medical expulsive therapy in children: An assessment of nationwide practice patterns and outcomes. (Ellison JS, Merguerian PA, Fu BC, Holt SK, Lendvay TS, Gore JL, Shnorhavorian M) J Pediatr Urol 2017 Oct;13(5):509.e1-509.e7 19 Citations |
| 1 | Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation. (Zhong J, Patel K, Switchenko J, Cassidy RJ, Hall WA, Gillespie T, Patel PR, Kooby D, Landry J) Cancer 2017 Sep 15;123(18):3486-3493 105 Citations |
| 2 | Factors associated with palliative care use in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. (Morris RS, Gani F, Hammad AY, Peltier W, Gamblin TC, Turaga KK, Johnston FM) J Surg Res 2017 May 01;211:79-86 10 Citations |
| 1 | Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic Options. (Moskovitz JM, Moy J, Seiwert TY, Ferris RL) Oncologist 2017 Jun;22(6):680-693 24 Citations |
| 2 | Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation. (Cheng YC, Shi Y, Zhang MJ, Brazauskas R, Hemmer MT, Bishop MR, Nieto Y, Stadtmauer E, Ayash L, Gale RP, Lazarus H, Holmberg L, Lill M, Olsson RF, Wirk BM, Arora M, Hari P, Ueno N) J Cancer 2017;8(6):1009-1017 8 Citations |
| 1 | Development of Collaborative Drug Therapy Management and Clinical Pharmacy Services in an Outpatient Psychiatric Clinic. (Tewksbury A, Bozymski KM, Ruekert L, Lum C, Cunningham E, Covington F) J Pharm Pract 2018 Jun;31(3):272-278 13 Citations |
| 1 | Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center. (Sharabi A, Kim SS, Kato S, Sanders PD, Patel SP, Sanghvi P, Weihe E, Kurzrock R) Oncologist 2017 Jun;22(6):631-637 95 Citations |
| 1 | Comparative analysis of the effect of bevacizumab maintenance regimens after first-line chemotherapy in patients with metastatic colorectal cancer (MCRC): A single institution experience (Song Y, Mohamed A, Ismail H, Abdallah N, Suprapaneni M, Dyson G, Kamgar M, Akhras A, Mettu J, Ahmed A, Tesfaye AA, Philip PA, Shields AF) Journal of Clinical Oncology 35, no. 15_suppl.e15032 |
| 1 | Know Thyself? Questioning the Theoretical Foundations of Cognitive Behavioral Therapy (Leder G) Review of Philosophy and Psychology 1 June 2017;8(2):391-410 22 Citations |
| 1 | Treatment of the Brown Recluse Spider Bite with Hyperbaric Oxygen Therapy (Stanton M) Hyperbaric Medicine Practice, 4th Edition Stanton M. Treatment of the Brown Recluse Spider Bite
with Hyperbaric Oxygen Therapy. In: Whelan H, Kindwall E, eds. Hyperbaric Medicine Practice, 4th ed. North Palm Beach: Best Publishing Company;2017 |
| 3 | Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory study. (Chen X, Oshima K, Schott D, Wu H, Hall W, Song Y, Tao Y, Li D, Zheng C, Knechtges P, Erickson B, Li XA) PLoS One 2017;12(6):e0178961 75 Citations |
| 1 | Response to "Commentary re. Utilization of medical expulsive therapy in children: An assessment of nationwide practice patterns and outcomes". (Ellison JS) J Pediatr Urol 2017 Oct;13(5):546 3 Citations |
| 1 | Elotuzumab as a novel anti-myeloma immunotherapy. (Radhakrishnan SV, Bhardwaj N, Steinbach M, Weidner J, Luetkens T, Atanackovic D) Hum Vaccin Immunother 2017 Aug 03;13(8):1751-1757 5 Citations |
| 1 | Outcome of adolescents and young adults compared to children with Hodgkin lymphoma treated with response-based chemotherapy on pediatric protocols: A Children's Oncology Group report. (Fernández KS, Schwartz CL, Chen L, Constine LS, Chauvenet A, de Alarcón PA) Pediatr Blood Cancer 2017 Dec;64(12) 16 Citations |
| 1 | Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839. (Edelman MJ, Hu C, Le QT, Donington JS, D'Souza WD, Dicker AP, Loo BW, Gore EM, Videtic GMM, Evans NR, Leach JW, Diehn M, Feigenberg SJ, Chen Y, Paulus R, Bradley JD) J Thorac Oncol 2017 Sep;12(9):1413-1420 18 Citations |
| 1 | Adoptive cell therapy using PD-1+ myeloma-reactive T cells eliminates established myeloma in mice. (Jing W, Gershan JA, Blitzer GC, Palen K, Weber J, McOlash L, Riese M, Johnson BD) J Immunother Cancer 2017;5:51 27 Citations |
| 1 | Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium. (Agopian VG, Harlander-Locke MP, Ruiz RM, Klintmalm GB, Senguttuvan S, Florman SS, Haydel B, Hoteit M, Levine MH, Lee DD, Taner CB, Verna EC, Halazun KJ, Abdelmessih R, Tevar AD, Humar A, Aucejo F, Chapman WC, Vachharajani N, Nguyen MH, Melcher ML, Nydam TL, Mobley C, Ghobrial RM, Amundsen B, Markmann JF, Langnas AN, Carney CA, Berumen J, Hemming AW, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Busuttil RW) Ann Surg 2017 Sep;266(3):525-535 141 Citations |
| 1 | Radiogenomics and radiotherapy response modeling. (El Naqa I, Kerns SL, Coates J, Luo Y, Speers C, West CML, Rosenstein BS, Ten Haken RK) Phys Med Biol 2017 Aug 01;62(16):R179-R206 45 Citations |
| 1 | The impact of using an intraoperative goal directed fluid therapy protocol on clinical outcomes in patients undergoing total pancreatectomy and islet cell autotransplantation. (Wagar MK, Magnuson J, Liu PT, Kirchner V, Wilhelm JJ, Freeman ML, Bellin MD, Pruett TL, Beilman GJ, Dunn TB) Pancreatology 2017;17(4):586-591 4 Citations |
| 1 | Hypoxic tumors can be sensitized to radiation therapy by repurposing papaverine as an inhibitor of mitochondrial respiration (Martin Benej, Ioanna Papandreou, Xiangqian Hong, Bing Yu, Nicholas Denko) Proceedings of the American Association for Cancer Research Annual Meeting 2017 |
| 1 | What is the evidence to support the use of plasma exchange as first-line therapy for N-methyl d-aspartate receptor antibody encephalitis? (Gehrie EA, Coberly EA, Treml A, Tormey C, Booth GS) J Clin Apher 2018 Feb;33(1):126-127 2 Citations |
| 1 | Symptom self-management strategies reported by adolescents and young adults with cancer receiving chemotherapy. (Linder LA, Erickson JM, Stegenga K, Macpherson CF, Wawrzynski S, Wilson C, Ameringer S) Support Care Cancer 2017 Dec;25(12):3793-3806 37 Citations |
| 1 | Metformin therapy reduces the risk of malignancy after heart transplantation. (Peled Y, Lavee J, Raichlin E, Katz M, Arad M, Kassif Y, Peled A, Asher E, Elian D, Har-Zahav Y, Shlomo N, Freimark D, Goldenberg I, Klempfner R) J Heart Lung Transplant 2017 Dec;36(12):1350-1357 16 Citations |
| 1 | C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy. (Epperla N, Maddocks KJ, Salhab M, Chavez JC, Reddy N, Karmali R, Umyarova E, Bachanova V, Costa C, Glenn M, Calzada O, Xavier AC, Zhou Z, Hossain NM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Barta SK, Chhabra S, Lansigan F, Mehta A, Jaglal MV, Evens AM, Flowers CR, Cohen JB, Fenske TS, Hamadani M, Costa LJ) Cancer 2017 Nov 15;123(22):4411-4418 24 Citations |
| 1 | Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1. (Mateos MV, Masszi T, Grzasko N, Hansson M, Sandhu I, Pour L, Viterbo L, Jackson SR, Stoppa AM, Gimsing P, Hamadani M, Borsaru G, Berg D, Lin J, Di Bacco A, van de Velde H, Richardson PG, Moreau P) Haematologica 2017 Oct;102(10):1767-1775 47 Citations |
| 1 | Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/gynecologic oncology group study (Von Gruenigen VE, Huang HQ, Beumer JH, Lankes HA, Tew W, Herzog T, Hurria A, Mannel RS, Rizack T, Landrum LM, Rose PG, Salani R, Bradley WH, Rutherford TJ, Higgins RV, Secord AA, Fleming G) Obstetrical and Gynecological Survey 1 August 2017;72(8):481-482 |
| 1 | Preventing Discontinuation of Radiation Therapy: Predictive Factors to Improve Patient Selection for Palliative Treatment. (Puckett LL, Luitweiler E, Potters L, Teckie S) J Oncol Pract 2017 Sep;13(9):e782-e791 13 Citations |
| 11 | Etanercept and Corticosteroid Therapy for the Treatment of Late-Onset Idiopathic Pneumonia Syndrome. (Thompson J, Yin Z, D'Souza A, Fenske T, Hamadani M, Hari P, Rizzo JD, Pasquini M, Saber W, Shah N, Shaw BE, Shahir K, Banerjee A, Drobyski WR) Biol Blood Marrow Transplant 2017 Nov;23(11):1955-1960 25 Citations |
| 1 | Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. (Lacas B, Bourhis J, Overgaard J, Zhang Q, Grégoire V, Nankivell M, Zackrisson B, Szutkowski Z, Suwiński R, Poulsen M, O'Sullivan B, Corvò R, Laskar SG, Fallai C, Yamazaki H, Dobrowsky W, Cho KH, Beadle B, Langendijk JA, Viegas CMP, Hay J, Lotayef M, Parmar MKB, Aupérin A, van Herpen C, Maingon P, Trotti AM, Grau C, Pignon JP, Blanchard P, MARCH Collaborative Group) Lancet Oncol 2017 Sep;18(9):1221-1237 266 Citations |
| 1 | First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials. (Wasan HS, Gibbs P, Sharma NK, Taieb J, Heinemann V, Ricke J, Peeters M, Findlay M, Weaver A, Mills J, Wilson C, Adams R, Francis A, Moschandreas J, Virdee PS, Dutton P, Love S, Gebski V, Gray A, FOXFIRE trial investigators, SIRFLOX trial investigators, FOXFIRE-Global trial investigators, van Hazel G, Sharma RA) Lancet Oncol 2017 Sep;18(9):1159-1171 295 Citations |
| 1 | Appearance of New Cutaneous Superficial Basal Cell Carcinomas during Successful Nivolumab Treatment of Refractory Metastatic Disease: Implications for Immunotherapy in Early Versus Late Disease. (Cohen PR, Kato S, Goodman AM, Ikeda S, Kurzrock R) Int J Mol Sci 2017 Jul 31;18(8) 32 Citations |
| 1 | Immune tolerance induced by platelet-targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediated. (Chen Y, Luo X, Schroeder JA, Chen J, Baumgartner CK, Hu J, Shi Q) J Thromb Haemost 2017 Oct;15(10):1994-2004 29 Citations |
| 1 | Trials in head and neck oncology: Evolution of perioperative adjuvant therapy. (Zenga J, Pipkorn P, Adkins DR, Thorstad WL, Nussenbaum B) Oral Oncol 2017 Sep;72:80-89 4 Citations |
| 1 | Transoral Resection of Human Papillomavirus (HPV)-Positive Squamous Cell Carcinoma of the Oropharynx: Outcomes with and Without Adjuvant Therapy. (Jackson RS, Sinha P, Zenga J, Kallogjeri D, Suko J, Martin E, Moore EJ, Haughey BH) Ann Surg Oncol 2017 Nov;24(12):3494-3501 24 Citations |
| 1 | Preconditioned random forest regression: Application to genome-wide study for radiotherapy toxicity prediction (Lee S, Ostrer H, Kerns S, Deasy JO, Rosenstein B, Oh JH) ACM-BCB 2017 - Proceedings of the 8th ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics 20 August 2017:593 |
| 1 | Factors associated with second-line triplet therapy in routine care in relapsed/refractory multiple myeloma. (Hari P, Romanus D, Henk HJ, Becker LK, Noga SJ, Morrison VA) J Clin Pharm Ther 2018 Feb;43(1):45-51 3 Citations |
| 1 | Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers. (Goodman AM, Kato S, Bazhenova L, Patel SP, Frampton GM, Miller V, Stephens PJ, Daniels GA, Kurzrock R) Mol Cancer Ther 2017 Nov;16(11):2598-2608 1739 Citations |
| 1 | Erratum to: Transoral Resection of Human Papillomavirus (HPV)-Positive Squamous Cell Carcinoma of the Oropharynx: Outcomes with and Without Adjuvant Therapy. (Jackson RS, Sinha P, Zenga J, Kallogjeri D, Suko J, Martin E, Moore EJ, Haughey BH) Ann Surg Oncol 2017 Dec;24(Suppl 3):695 |
| 7 | Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy? (Barnes CA, Krepline AN, Aldakkak M, Clarke CN, Christians KK, Khan AH, Hunt BC, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S) J Gastrointest Surg 2017 Nov;21(11):1793-1803 29 Citations |
| 1 | Outcomes after physical therapy for the treatment of temporomandibular disorders () |
| 1 | Macrophages Facilitate Resistance to Anti-VEGF Therapy by Altered VEGFR Expression. (Dalton HJ, Pradeep S, McGuire M, Hailemichael Y, Ma S, Lyons Y, Armaiz-Pena GN, Previs RA, Hansen JM, Rupaimoole R, Gonzalez-Villasana V, Cho MS, Wu SY, Mangala LS, Jennings NB, Hu W, Langley R, Mu H, Andreeff M, Bar-Eli M, Overwijk W, Ram P, Lopez-Berestein G, Coleman RL, Sood AK) Clin Cancer Res 2017 Nov 15;23(22):7034-7046 77 Citations |
| 1 | Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. (Hyman MC, Vemulapalli S, Szeto WY, Stebbins A, Patel PA, Matsouaka RA, Herrmann HC, Anwaruddin S, Kobayashi T, Desai ND, Vallabhajosyula P, McCarthy FH, Li R, Bavaria JE, Giri J) Circulation 2017 Nov 28;136(22):2132-2140 185 Citations |
| 1 | Randomized clinical trial of negative pressure wound therapy for high-risk groin wounds in lower extremity revascularization. (Lee K, Murphy PB, Ingves MV, Duncan A, DeRose G, Dubois L, Forbes TL, Power A) J Vasc Surg 2017 Dec;66(6):1814-1819 77 Citations |
| 1 | A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma. (Dispenzieri A, D'Souza A, Gertz MA, Laumann K, Wiseman G, Lacy MQ, LaPlant B, Buadi F, Hayman SR, Kumar SK, Dingli D, Hogan WJ, Ansell SM, Gastineau DA, Inwards DJ, Micallef IN, Porrata LF, Johnston PB, Litzow MR, Witzig TE) Bone Marrow Transplant 2017 Oct;52(10):1372-1377 12 Citations |
| 1 | Analysis of the whole transcriptome from gingivo-buccal squamous cell carcinoma reveals deregulated immune landscape and suggests targets for immunotherapy. (Singh R, De Sarkar N, Sarkar S, Roy R, Chattopadhyay E, Ray A, Biswas NK, Maitra A, Roy B) PLoS One 2017;12(9):e0183606 6 Citations |
| 1 | American Brachytherapy Society recurrent carcinoma of the endometrium task force patterns of care and review of the literature. (Kamrava M, Beriwal S, Erickson B, Gaffney D, Jhingran A, Klopp A, Park SJ, Viswanathan A, Yashar C, Lin L) Brachytherapy 2017;16(6):1129-1143 26 Citations |
| 1 | Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke. (Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, Tirschwell DL, RESPECT Investigators) N Engl J Med 2017 Sep 14;377(11):1022-1032 836 Citations |
| 2 | Protection by Inhaled Hydrogen Therapy in a Rat Model of Acute Lung Injury can be Tracked in vivo Using Molecular Imaging. (Audi SH, Jacobs ER, Zhang X, Camara AKS, Zhao M, Medhora MM, Rizzo B, Clough AV) Shock 2017 Oct;48(4):467-476 23 Citations |
| 1 | Dosing immunotherapy combinations: Analysis of 3,526 patients for toxicity and response patterns. (Nikanjam M, Patel H, Kurzrock R) Oncoimmunology 2017;6(8):e1338997 32 Citations |
| 1 | Ibrutinib for chronic graft-versus-host disease after failure of prior therapy. (Miklos D, Cutler CS, Arora M, Waller EK, Jagasia M, Pusic I, Flowers ME, Logan AC, Nakamura R, Blazar BR, Li Y, Chang S, Lal I, Dubovsky J, James DF, Styles L, Jaglowski S) Blood 2017 Nov 23;130(21):2243-2250 382 Citations |
| 1 | Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study. (Hyams JS, Davis S, Mack DR, Boyle B, Griffiths AM, LeLeiko NS, Sauer CG, Keljo DJ, Markowitz J, Baker SS, Rosh J, Baldassano RN, Patel A, Pfefferkorn M, Otley A, Heyman M, Noe J, Oliva-Hemker M, Rufo P, Strople J, Ziring D, Guthery SL, Sudel B, Benkov K, Wali P, Moulton D, Evans J, Kappelman MD, Marquis A, Sylvester FA, Collins MH, Venkateswaran S, Dubinsky M, Tangpricha V, Spada KL, Britt A, Saul B, Gotman N, Wang J, Serrano J, Kugathasan S, Walters T, Denson LA) Lancet Gastroenterol Hepatol 2017 Dec;2(12):855-868 70 Citations |
| 2 | Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference. (Hall WA, Bergom C, Thompson RF, Baschnagel AM, Vijayakumar S, Willers H, Li XA, Schultz CJ, Wilson GD, West CML, Capala J, Coleman CN, Torres-Roca JF, Weidhaas J, Feng FY) Int J Radiat Oncol Biol Phys 2018 Jun 01;101(2):274-284 54 Citations |
| 1 | Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3. (Schaller TH, Batich KA, Suryadevara CM, Desai R, Sampson JH) Expert Rev Clin Immunol 2017 Nov;13(11):1049-1060 103 Citations |
| 1 | Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor-Based Immunotherapy. (Khagi Y, Goodman AM, Daniels GA, Patel SP, Sacco AG, Randall JM, Bazhenova LA, Kurzrock R) Clin Cancer Res 2017 Oct 01;23(19):5729-5736 178 Citations |
| 4 | Successful Treatment of Invasive Conidiobolus Infection During Therapy for Acute Lymphoblastic Leukemia. (Erker C, Huppler AR, Walsh TJ, McCormick ME, Suchi M, Bhatt NS, Kehl SC, Southwood J, Harker-Murray P) J Pediatr Hematol Oncol 2018 Oct;40(7):e446-e449 8 Citations |
| 1 | Microbiome & Immunotherapy: Antibiotic Use Is Associated with Inferior Survival for Lung Cancer Patients Receiving PD-1 Inhibitors (Jonathan R Thompson, Carlos Arce-Lara, Aniko Szabo, Smitha Menon) World Conference on Lung Cancer Abstract 693 |
| 1 | Genomics of Immunotherapy-Associated Hyperprogressors-Response. (Kato S, Kurzrock R) Clin Cancer Res 2017 Oct 15;23(20):6376 9 Citations |
| 1 | Rare Tumor Clinic: The University of California San Diego Moores Cancer Center Experience with a Precision Therapy Approach. (Kato S, Kurasaki K, Ikeda S, Kurzrock R) Oncologist 2018 Feb;23(2):171-178 35 Citations |
| 1 | Intracranial Hemorrhage Complicating Herpes Simplex Encephalitis on Antiviral Therapy: A Case Report and Review of the Literature. (ElShimy G, Mariyam Joy C, Berlin F, Lashin W) Case Rep Infect Dis 2017;2017:6038146 |
| 1 | Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP). (Mitamura T, Pradeep S, McGuire M, Wu SY, Ma S, Hatakeyama H, Lyons YA, Hisamatsu T, Noh K, Villar-Prados A, Chen X, Ivan C, Rodriguez-Aguayo C, Hu W, Lopez-Berestein G, Coleman RL, Sood AK) Oncogene 2018 Feb 08;37(6):722-731 34 Citations |
| 1 | High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana. (Ryan K, Anderson M, Gyurova I, Ambroggio L, Moyo S, Sebunya T, Makhema J, Marlink R, Essex M, Musonda R, Gaseitsiwe S, Blackard JT) Open Forum Infect Dis 2017;4(4):ofx195 31 Citations |
| 1 | Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson Precision Medicine Study. (Tsimberidou AM, Hong DS, Ye Y, Cartwright C, Wheler JJ, Falchook GS, Naing A, Fu S, Piha-Paul S, Janku F, Meric-Bernstam F, Hwu P, Kee B, Kies MS, Broaddus R, Mendelsohn J, Hess KR, Kurzrock R) JCO Precis Oncol 2017;2017 131 Citations |
| 2 | Perceived Risk of Intimate Partner Violence Among STI Clinic Patients: Implications for Partner Notification and Patient-Delivered Partner Therapy. (John SA, Walsh JL, Cho YI, Weinhardt LS) Arch Sex Behav 2018 Feb;47(2):481-492 16 Citations |
| 1 | Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial. (Bird JA, Spergel JM, Jones SM, Rachid R, Assa'ad AH, Wang J, Leonard SA, Laubach SS, Kim EH, Vickery BP, Davis BP, Heimall J, Cianferoni A, MacGinnitie AJ, Crestani E, Burks AW, ARC001 Study Group) J Allergy Clin Immunol Pract 2018;6(2):476-485.e3 162 Citations |
| 2 | Reducing radiation dose and enhancing imaging quality of 4DCT for radiation therapy using iterative reconstruction algorithms. (Noid G, Tai A, Chen GP, Robbins J, Li XA) Adv Radiat Oncol 2017;2(3):515-521 14 Citations |
| 1 | A Combined Basic Science and Population Science Approach Demonstrating the Potential for Simvastatin to Mitigate Cardiovascular Disease after Lower Hemi Body Radiotherapy (Olson J, Taylor R, Sparapani R, Lenarczyk M, Baker J) Circulation https://www.ahajournals.org/doi/10.1161/circ.136.suppl_1.24082 |
| 1 | Molecular Tumor Boards: Realizing Precision Oncology Therapy. (Patel M, Kato SM, Kurzrock R) Clin Pharmacol Ther 2018 Feb;103(2):206-209 22 Citations |
| 2 | Triple-Negative Breast Cancer: Who Should Receive Neoadjuvant Chemotherapy? (Chaudhary LN, Wilkinson KH, Kong A) Surg Oncol Clin N Am 2018 Jan;27(1):141-153 127 Citations |
| 1 | HDACis (class I), cancer stem cell, and phytochemicals: Cancer therapy and prevention implications. (Bayat S, Shekari Khaniani M, Choupani J, Alivand MR, Mansoori Derakhshan S) Biomed Pharmacother 2018 Jan;97:1445-1453 35 Citations |
| 1 | Hypokalemia: A potentially life-threatening complication of tenofovir therapy. (Koratala A, Ruchi R) SAGE Open Med Case Rep 2017;5:2050313X17741010 |
| 1 | Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy. (Delitto D, George TJ Jr, Loftus TJ, Qiu P, Chang GJ, Allegra CJ, Hall WA, Hughes SJ, Tan SA, Shaw CM, Iqbal A) J Natl Cancer Inst 2018 May 01;110(5):460-466 18 Citations |
| 1 | Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancer. (Kimmick GG, Li X, Fleming ST, Sabatino SA, Wilson JF, Lipscomb J, Cress R, Bergom C, Anderson RT, Wu XC, Written on behalf of the Center for Disease Control and Prevention National Program of Cancer Registry Patterns of Care Study Group) J Geriatr Oncol 2018 May;9(3):214-220 27 Citations |
| 1 | Peroxisomes contribute to oxidative stress in neurons during doxorubicin-based chemotherapy. (Moruno-Manchon JF, Uzor NE, Kesler SR, Wefel JS, Townley DM, Nagaraja AS, Pradeep S, Mangala LS, Sood AK, Tsvetkov AS) Mol Cell Neurosci 2018 Jan;86:65-71 38 Citations |
| 1 | Small and Micro-Scale Recombinant Adeno-Associated Virus Production and Purification for Ocular Gene Therapy Applications. (Reid CA, Lipinski DM) Methods Mol Biol 2018;1715:19-31 18 Citations |
| 1 | VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study. (Chang JE, Carmichael LL, Kim K, Peterson C, Yang DT, Traynor AM, Werndli JE, Huie MS, McFarland TA, Volk M, Blank J, Callander NS, Longo WL, Kahl BS) Clin Lymphoma Myeloma Leuk 2018 Jan;18(1):e61-e67 12 Citations |
| 1 | Survival following salvage therapy for primary refractory peripheral T-cell lymphomas (PTCL). (Zhang JY, Briski R, Devata S, Kaminski MS, Phillips TJ, Mayer TL, Bailey NG, Wilcox RA) Am J Hematol 2018 Mar;93(3):394-400 25 Citations |
| 1 | Resolvins suppress tumor growth and enhance cancer therapy. (Sulciner ML, Serhan CN, Gilligan MM, Mudge DK, Chang J, Gartung A, Lehner KA, Bielenberg DR, Schmidt B, Dalli J, Greene ER, Gus-Brautbar Y, Piwowarski J, Mammoto T, Zurakowski D, Perretti M, Sukhatme VP, Kaipainen A, Kieran MW, Huang S, Panigrahy D) J Exp Med 2018 Jan 02;215(1):115-140 215 Citations |
| 1 | Cognitive Behavioral Therapy for Insomnia, Mindfulness, and Yoga in Patients With Breast Cancer with Sleep Disturbance: A Literature Review (Zeichner SB, Zeichner RL, Gogineni K, Shatil S, Ioachimescu O) Breast Cancer: Basic and Clinical Research 5 December 2017;11 31 Citations |
| 1 | Bystander effects of nitric oxide in anti-tumor photodynamic therapy. (Bazak J, Fahey JM, Wawak K, Korytowski W, Girotti AW) Cancer Cell Microenviron 2017;4(1) |
| 1 | A Complication of Percutaneous Sclerotherapy for Congenital Pulmonary Airway Malformation: Intravascular Injection and Cardiac Necrosis. (H Chon A, Takeda MR, Felix JC, Chmait RH) Fetal Pediatr Pathol 2017 Dec;36(6):437-444 9 Citations |
| 1 | Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408. (Nichols RC, Hu C, Bahary JP, Zeitzer KL, Souhami L, Leibenhaut MH, Rotman M, Gore EM, Balogh AG, McGowan D, Michalski J, Raben A, Rudoler S, Jones CU, Sandler H) Adv Radiat Oncol 2017;2(4):608-614 16 Citations |
| 1 | Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining "Actionability" of a Molecular Lesion and Patient Management Support. (Chae YK, Pan AP, Davis AA, Patel SP, Carneiro BA, Kurzrock R, Giles FJ) Mol Cancer Ther 2017 Dec;16(12):2645-2655 59 Citations |
| 1 | Non-chemotherapy drug-induced neutropenia: key points to manage the challenges. (Curtis BR) Hematology Am Soc Hematol Educ Program 2017 Dec 08;2017(1):187-193 67 Citations |
| 5 | Geographic Variation of Adjuvant Breast Cancer Therapy Initiation in the United States: Lessons From Medicare Part D. (Charlson JA, McGinley EL, Nattinger AB, Neuner JM, Pezzin LE) J Natl Compr Canc Netw 2017 Dec;15(12):1509-1517 4 Citations |
| 1 | Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Gray Zone Lymphoma: A US Multicenter Collaborative Study. (Kharfan-Dabaja MA, Raj R, Nikolaenko L, Ahmed S, Reddy N, Nathan S, Cherry M, El-Jurdi N, Obiozor C, Fenske TS, Song J, Muzzafar T, Ayala E, Savani B, Khawandanah M, Caimi PF, Hamadani M, Forman SJ, Hussaini M, de Lima M, Olteanu H, Shah B, Chavez JC, Al Malki M, Kumar A, Ganguly S) Biol Blood Marrow Transplant 2018 Mar;24(3):486-493 4 Citations |
| 1 | Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy. (Lyons YA, Pradeep S, Wu SY, Haemmerle M, Hansen JM, Wagner MJ, Villar-Prados A, Nagaraja AS, Dood RL, Previs RA, Hu W, Zhao Y, Mak DH, Xiao Z, Melendez BD, Lizee GA, Mercado-Uribe I, Baggerly KA, Hwu P, Liu J, Overwijk WW, Coleman RL, Sood AK) Oncotarget 2017 Nov 14;8(57):96496-96505 54 Citations |
| 5 | Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy. (Neuner JM, Shi Y, Kong AL, Kamaraju S, Smith EC, Smallwood AJ, Laud PW, Charlson JA) J Cancer Surviv 2018 Apr;12(2):268-275 8 Citations |
| 2 | Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis. (Casulo C, Friedberg JW, Ahn KW, Flowers C, DiGilio A, Smith SM, Ahmed S, Inwards D, Aljurf M, Chen AI, Choe H, Cohen J, Copelan E, Farooq U, Fenske TS, Freytes C, Gaballa S, Ganguly S, Jethava Y, Kamble RT, Kenkre VP, Lazarus H, Lazaryan A, Olsson RF, Rezvani AR, Rizzieri D, Seo S, Shah GL, Shah N, Solh M, Sureda A, William B, Cumpston A, Zelenetz AD, Link BK, Hamadani M) Biol Blood Marrow Transplant 2018 Jun;24(6):1163-1171 107 Citations |
| 1 | The promising role of monoclonal antibodies for immunotherapy of the HIV-associated cancer, non-Hodgkin lymphoma. (Rezahosseini O, Hanaei S, Hamadani M, Keshavarz-Fathi M, Rezaei N) Int Rev Immunol 2018 May 04;37(3):165-173 4 Citations |
| 1 | Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131. (Salzer WL, Burke MJ, Devidas M, Chen S, Gore L, Larsen EC, Borowitz M, Wood B, Heerema NA, Carroll AJ, Hilden JM, Loh ML, Raetz EA, Winick NJ, Carroll WL, Hunger SP) Cancer 2018 Mar 15;124(6):1150-1159 46 Citations |
| 1 | The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy. (McKenzie JA, Mbofung RM, Malu S, Zhang M, Ashkin E, Devi S, Williams L, Tieu T, Peng W, Pradeep S, Xu C, Zorro Manrique S, Liu C, Huang L, Chen Y, Forget MA, Haymaker C, Bernatchez C, Satani N, Muller F, Roszik J, Kalra A, Heffernan T, Sood A, Hu J, Amaria R, Davis RE, Hwu P) J Natl Cancer Inst 2018 Jul 01;110(7):777-786 73 Citations |
| 1 | Effects of Maintenance on Quality of Performance of Cryotherapy Devices for Treatment of Precancerous Cervical Lesions. (Maza M, Figueroa R, Laskow B, Juárez A, Alfaro K, Alonzo TA, Felix JC, Gage JC, Cremer M) J Low Genit Tract Dis 2018 Jan;22(1):47-51 3 Citations |
| 1 | Prolonged renal allograft survival without immunosuppressive therapy. (Koratala A, Alquadan KF) CEN Case Rep 2018 May;7(1):178-179 |
| 1 | Medical non-endocrine-targeted therapies: Ejaculatory dysfunction and immunotherapy (Johnson DP, Sandlow JI) Encyclopedia of Reproduction 1 January 2018:324-327 |
| 1 | Immunotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC) (Moy J, Ferris RL) Current Cancer Research 2018:365-396 |
| 1 | Medical Non-Endocrine-Targeted Therapies: Ejaculatory Dysfunction and Immunotherapy (Johnson DP, Sandlow JI) Encyclopedia of Reproduction: Volume 1-6, Second Edition 1 January 2018;4:324-327 |
| 1 | Neurotoxicity Related to Radiotherapy and Chemotherapy for Nonsmall Cell and Small Cell Lung Cancer (Stinchcombe TE, Gore EM) IASLC Thoracic Oncology 1 January 2018:409-417.e2 1 Citation |
| 1 | Anticoagulant prophylaxis and therapy in children: current challenges and emerging issues. (Newall F, Branchford B, Male C) J Thromb Haemost 2018 Feb;16(2):196-208 36 Citations |
| 1 | Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study. (Hainsworth JD, Meric-Bernstam F, Swanton C, Hurwitz H, Spigel DR, Sweeney C, Burris H, Bose R, Yoo B, Stein A, Beattie M, Kurzrock R) J Clin Oncol 2018 Feb 20;36(6):536-542 390 Citations |
| 1 | Impact of triple antithrombotic therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention in real-world practice. (Yan Y, Wang X, Fan JY, Nie SP, Raposeiras-Roubín S, Abu-Assi E, Simao Henriques JP, D'Ascenzo F, Saucedo J, González-Juanatey JR, Wilton SB, Kikkert WJ, Nuñez-Gil I, Ariza-Sole A, Song XT, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Huczek Z, Fujii T, Correia LC, Kawashiri MA, Kedev S) J Geriatr Cardiol 2017 Nov;14(11):679-687 2 Citations |
| 1 | Barriers and Solutions to Delivery of Intensive Care Unit Nutrition Therapy. (Kozeniecki M, Pitts H, Patel JJ) Nutr Clin Pract 2018 Feb;33(1):8-15 27 Citations |
| 7 | Locally advanced pancreas cancer: Staging and goals of therapy. (Chatzizacharias NA, Tsai S, Griffin M, Tolat P, Ritch P, George B, Barnes C, Aldakkak M, Khan AH, Hall W, Erickson B, Evans DB, Christians KK) Surgery 2018 May;163(5):1053-1062 48 Citations |
| 1 | Platelet transfusion does not improve outcomes in patients with brain injury on antiplatelet therapy. (Holzmacher JL, Reynolds C, Patel M, Maluso P, Holland S, Gamsky N, Moore H, Acquista E, Carrick M, Amdur R, Hancock H, Metzler M, Dunn J, Sarani B) Brain Inj 2018;32(3):325-330 45 Citations |
| 1 | Immunologic and Virologic Outcomes of Obese and Nonobese Incarcerated Adults on Antiretroviral Therapy for HIV Infection. (Bunnell KL, Aldossari A, Perkins C, Schriever C, Chiampas TD, Young JD, Patel MC, Badowski M) J Int Assoc Provid AIDS Care 2018;17:2325957417752261 |
| 1 | Robotically Assisted Sonic Therapy as a Noninvasive Nonthermal Ablation Modality: Proof of Concept in a Porcine Liver Model. (Smolock AR, Cristescu MM, Vlaisavljevich E, Gendron-Fitzpatrick A, Green C, Cannata J, Ziemlewicz TJ, Lee FT Jr) Radiology 2018 May;287(2):485-493 65 Citations |
| 1 | Dual-antiplatelet Therapy Guidelines and Implications for Perioperative Management. (Stawiarski K, Kataria R, Bravo CA, Villablanca P, Mohananey D, Narasimhan S, Ramakrishna H) J Cardiothorac Vasc Anesth 2018 Apr;32(2):1072-1080 7 Citations |
| 1 | Salvage of recurrence after surgery and adjuvant therapy: A systematic review. (Zenga J, Gross J, Fowler S, Chen J, Vila P, Richmon JD, Varvares MA, Pipkorn P) Am J Otolaryngol 2018;39(2):223-227 18 Citations |
| 1 | Prolonged Duration of Therapy Is Associated With Improved Survival in Patients Treated for Relapsed/Refractory Multiple Myeloma in Routine Clinical Care in the United States. (Hari P, Romanus D, Palumbo A, Luptakova K, Rifkin RM, Tran LM, Raju A, Farrelly E, Noga SJ, Blazer M, Chari A) Clin Lymphoma Myeloma Leuk 2018 Feb;18(2):152-160 35 Citations |
| 1 | Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation. (Zheng Y, Sethi R, Mangala LS, Taylor C, Goldsmith J, Wang M, Masuda K, Carrami EM, Mannion D, Miranda F, Herrero-Gonzalez S, Hellner K, Chen F, Alsaadi A, Albukhari A, Fotso DC, Yau C, Jiang D, Pradeep S, Rodriguez-Aguayo C, Lopez-Berestein G, Knapp S, Gray NS, Campo L, Myers KA, Dhar S, Ferguson D, Bast RC Jr, Sood AK, von Delft F, Ahmed AA) Nat Commun 2018 Feb 02;9(1):476 39 Citations |
| 1 | NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients. (Ali AN, Zhang P, Yung WKA, Chen Y, Movsas B, Urtasun RC, Jones CU, Choi KN, Michalski JM, Fischbach AJ, Markoe AM, Schultz CJ, Penas-Prado M, Garg MK, Hartford AC, Kim HE, Won M, Curran WJ Jr) J Neurooncol 2018 Mar;137(1):39-47 30 Citations |
| 2 | Nitric oxide antagonism to glioblastoma photodynamic therapy and mitigation thereof by BET bromodomain inhibitor JQ1. (Fahey JM, Stancill JS, Smith BC, Girotti AW) J Biol Chem 2018 Apr 06;293(14):5345-5359 49 Citations |
| 1 | Rituximab therapy for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis. (Koratala A, Zeng X) Clin Case Rep 2018 Feb;6(2):442-443 |
| 1 | Transcranial direct current stimulation and constraint-induced therapy in cerebral palsy: A randomized, blinded, sham-controlled clinical trial. (Gillick B, Rich T, Nemanich S, Chen CY, Menk J, Mueller B, Chen M, Ward M, Meekins G, Feyma T, Krach L, Rudser K) Eur J Paediatr Neurol 2018 May;22(3):358-368 62 Citations |
| 4 | Correlation of ADC With Pathological Treatment Response for Radiation Therapy of Pancreatic Cancer. (Dalah E, Erickson B, Oshima K, Schott D, Hall WA, Paulson E, Tai A, Knechtges P, Li XA) Transl Oncol 2018 Apr;11(2):391-398 41 Citations |
| 2 | A multicentre stewardship initiative to decrease excessive duration of antibiotic therapy for the treatment of community-acquired pneumonia. (Foolad F, Huang AM, Nguyen CT, Colyer L, Lim M, Grieger J, Li J, Revolinski S, Mack M, Gandhi T, Wainaina JN, Eschenauer G, Patel TS, Marshall VD, Nagel J) J Antimicrob Chemother 2018 May 01;73(5):1402-1407 39 Citations |
| 2 | Expedited Partner Therapy: Pharmacist Refusal of Legal Prescriptions. (Borchardt LN, Pickett ML, Tan KT, Visotcky AM, Drendel AL) Sex Transm Dis 2018 May;45(5):350-353 14 Citations |
| 1 | Development and implementation of an antimicrobial lock therapy guideline in a pediatric hospital. (Zembles TN, Flannery LS, Huppler AR) Am J Health Syst Pharm 2018 Mar 01;75(5):299-303 6 Citations |
| 1 | Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development. (Racine JJ, Stewart I, Ratiu J, Christianson G, Lowell E, Helm K, Allocco J, Maser RS, Chen YG, Lutz CM, Roopenian D, Schloss J, DiLorenzo TP, Serreze DV) Diabetes 2018 May;67(5):923-935 16 Citations |
| 1 | Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy. (Floros KV, Lochmann TL, Hu B, Monterrubio C, Hughes MT, Wells JD, Morales CB, Ghotra MS, Costa C, Souers AJ, Boikos SA, Leverson JD, Tan M, Serra V, Koblinski JE, Arribas J, Prat A, Paré L, Miller TW, Dozmorov MG, Harada H, Windle BE, Scaltriti M, Faber AC) Proc Natl Acad Sci U S A 2018 Mar 13;115(11):E2594-E2603 27 Citations |
| 1 | TRUNK MUSCLE ACTIVATION in CHILDREN with SPASTIC DIPLEGIC CEREBRAL PALSY USING A HIPPOTHERAPY SIMULATOR (Flanagan AM, Liu XC, Cope S) Journal of Musculoskeletal Research 1 March 2018;21(1) 1 Citation |
| 1 | Novel Combination BMP7 and HGF Gene Therapy Instigates Selective Myofibroblast Apoptosis and Reduces Corneal Haze In Vivo. (Gupta S, Fink MK, Ghosh A, Tripathi R, Sinha PR, Sharma A, Hesemann NP, Chaurasia SS, Giuliano EA, Mohan RR) Invest Ophthalmol Vis Sci 2018 Feb 01;59(2):1045-1057 59 Citations |
| 1 | Immunotherapy for Head and Neck Squamous Cell Carcinoma. (Moskovitz J, Moy J, Ferris RL) Curr Oncol Rep 2018 Mar 03;20(2):22 128 Citations |
| 1 | Association of Tricuspid Regurgitation With Transcatheter Aortic Valve Replacement Outcomes: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. (McCarthy FH, Vemulapalli S, Li Z, Thourani V, Matsouaka RA, Desai ND, Kirtane A, Anwaruddin S, Williams ML, Giri J, Vallabhajosyula P, Li RH, Herrmann HC, Bavaria JE, Szeto WY) Ann Thorac Surg 2018 Apr;105(4):1121-1128 48 Citations |
| 1 | Upregulation of nitric oxide in tumor cells as a negative adaptation to photodynamic therapy. (Girotti AW) Lasers Surg Med 2018 Jul;50(5):590-598 22 Citations |
| 1 | Machine Learning on a Genome-wide Association Study to Predict Late Genitourinary Toxicity After Prostate Radiation Therapy. (Lee S, Kerns S, Ostrer H, Rosenstein B, Deasy JO, Oh JH) Int J Radiat Oncol Biol Phys 2018 May 01;101(1):128-135 71 Citations |
| 3 | Appropriate magnetic resonance imaging techniques for gross tumor volume delineation in external beam radiation therapy of locally advanced cervical cancer. (Song Y, Erickson B, Chen X, Li G, Wu G, Paulson E, Knechtges P, Li XA) Oncotarget 2018 Feb 09;9(11):10100-10109 6 Citations |
| 1 | Platelet-Targeted Gene Therapy for Hemophilia. (Shi Q) Mol Ther Methods Clin Dev 2018 Jun 15;9:100-108 29 Citations |
| 2 | Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema. (Jampol LM, Glassman AR, Liu D, Aiello LP, Bressler NM, Duh EJ, Quaggin S, Wells JA, Wykoff CC, Diabetic Retinopathy Clinical Research Network) Ophthalmology 2018 Jul;125(7):1054-1063 33 Citations |
| 1 | The role of tumor microenvironment in resistance to anti-angiogenic therapy. (Ma S, Pradeep S, Hu W, Zhang D, Coleman R, Sood A) F1000Res 2018;7:326 54 Citations |
| 1 | Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy. (Greenwell IB, Staton AD, Lee MJ, Switchenko JM, Saxe DF, Maly JJ, Blum KA, Grover NS, Mathews SP, Gordon MJ, Danilov AV, Epperla N, Fenske TS, Hamadani M, Park SI, Flowers CR, Cohen JB) Cancer 2018 Jun 01;124(11):2306-2315 44 Citations |
| 1 | Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy (Schneidewend R · Hosking P · Brazauskas R · Peterson J · Beaudin C · Michaelis L · Atallah E · Hari P · Carlson K) Acta Haematologica Acta Haematol 2018;139:171–175 |
| 4 | Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy. (Schneidewend R, Hosking P, Brazauskas R, Peterson J, Beaudin C, Michaelis L, Atallah E, Hari P, Carlson K) Acta Haematol 2018;139(3):171-175 |
| 1 | Liquid Biopsies and Cancer Immunotherapy. (Thompson JR, Menon SP) Cancer J 2018;24(2):78-83 18 Citations |
| 3 | Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease. (Lovell DJ, Johnson AL, Huang B, Gottlieb BS, Morris PW, Kimura Y, Onel K, Li SC, Grom AA, Taylor J, Brunner HI, Huggins JL, Nocton JJ, Haines KA, Edelheit BS, Shishov M, Jung LK, Williams CB, Tesher MS, Costanzo DM, Zemel LS, Dare JA, Passo MH, Ede KC, Olson JC, Cassidy EA, Griffin TA, Wagner-Weiner L, Weiss JE, Vogler LB, Rouster-Stevens KA, Beukelman T, Cron RQ, Kietz D, Schikler K, Schmidt KM, Mehta J, Wahezi DM, Ting TV, Verbsky JW, Eberhard BA, Spalding S, Chen C, Giannini EH) Arthritis Rheumatol 2018 Sep;70(9):1508-1518 31 Citations |
| 2 | Combined Nd:YAG laser and bleomycin sclerotherapy under the same anesthesia for cervicofacial venous malformations: A safe and effective treatment option. (Gregory S, Burrows PE, Ellinas H, Stadler M, Chun RH) Int J Pediatr Otorhinolaryngol 2018 May;108:30-34 7 Citations |
| 1 | Hyperprogressive disease in patients with non-small cell lung cancer on immunotherapy. (Kurman JS, Murgu SD) J Thorac Dis 2018 Feb;10(2):1124-1128 43 Citations |
| 1 | Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study. (Kerns SL, Fung C, Monahan PO, Ardeshir-Rouhani-Fard S, Abu Zaid MI, Williams AM, Stump TE, Sesso HD, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Huddart RA, Kim J, Kollmannsberger C, Sahasrabudhe DM, Cook R, Fossa SD, Einhorn LH, Travis LB, Platinum Study Group) J Clin Oncol 2018 May 20;36(15):1505-1512 93 Citations |
| 1 | Implementation of a simplified analytical random walk model dose calculation algorithm with nuclear interaction for treatment planning of scanning-beam proton therapy (Yao W, Moskvin V, Zhao L, Lukose R, Hua CH, Tsiamas P, Axente M, Merchant TE, Farr JB) Biomedical Physics and Engineering Express 6 April 2018;4(3) 2 Citations |
| 2 | In reply: Perioperative interruption of dual antiplatelet therapy. (Munyon R, Cohn SL, Slawski B, Smetana GW, Pfeifer K) Cleve Clin J Med 2018 Apr;85(4):262 |
| 4 | Current Predictive Indices and Nomograms To Enable Personalization of Radiation Therapy for Patients With Secondary Malignant Neoplasms of the Central Nervous System: A Review. (Gilbride L, Siker M, Bovi J, Gore E, Schultz C, Hall WA) Neurosurgery 2018 May 01;82(5):595-603 10 Citations |
| 2 | Epigenetic Therapy in a Patient With Down Syndrome and Refractory Acute Myeloid Leukemia. (Becktell K, Houser K, Burke MJ) J Pediatr Hematol Oncol 2019 Jan;41(1):e38-e40 14 Citations |
| 1 | Good Outcomes with the Intraventricular Vancomycin Therapy in a Patient with Ruptured Brain Abscesses. (Doan N, Nguyen H, Luyuan L, Shabani S, Gelsomino M, Johnson V) Asian J Neurosurg 2018;13(2):396-399 |
| 1 | Razelle Kurzrock and Shumei Kato on Immunotherapy and Hyperprogression of Disease. (Kurzrock R, Kato S) Oncology (Williston Park) 2018 Apr 15;32(4):150-1, 163 2 Citations |
| 1 | . Rationale and Design of DUAL Study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis. (D’Souza A, Flynn K, Chhabra S, Dhakal B, Hamadani M, Jacobson K, Pasquini M, Weihrauch D, Hari P) Contemporary Clinical Trials Communications 2017; 8:33-38 |
| 2 | Smoking is predictive of poorer distant metastasis-free and progression free-survival in soft tissue sarcoma patients treated with pre-operative radiotherapy or chemoradiotherapy. (Gannon NP, King DM, Bedi M) Clin Sarcoma Res 2018;8:7 |
| 6 | Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis. (D'Souza A, Flynn K, Chhabra S, Dhakal B, Hamadani M, Jacobsen K, Pasquini M, Weihrauch D, Hari P) Contemp Clin Trials Commun 2017 Dec;8:33-38 16 Citations |
| 1 | Comparative analysis for renal stereotactic body radiotherapy using Cyberknife, VMAT and proton therapy based treatment planning (Baydoun A, Vapiwala N, Ponsky LE, Awan M, Kassaee A, Sutton D, Podder TK, Zhang Y, Dobbins D, Muzic RF, Traughber B, Machtay M, Ellis R) Journal of Applied Clinical Medical Physics May 2018;19(3):125-130 6 Citations |
| 1 | Patterns of Involved-Field Radiation Therapy Protocol Deviations in Pediatric Versus Adolescent and Young Adults With Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD0031. (Parzuchowski A, Bush R, Pei Q, Friedman DL, FitzGerald TJ, Wolden SL, Dharmarajan KV, Constine LS, Laurie F, Kessel SK, Appel B, Fernandez K, Punnett A, Schwartz CL, Cox J, Terezakis SA) Int J Radiat Oncol Biol Phys 2018 Apr 01;100(5):1119-1125 5 Citations |
| 1 | Focal Therapy for Prostate Cancer: A More Vehement View of the Approach Could Translate into Real Benefits for Our Patients. (Sanchez-Salas R, de la Rosette J, Polascik TJ, Carneiro A, Sivaraman A, Cathelineau X, Walz J) Eur Urol 2018 Nov;74(5):537-539 6 Citations |
| 1 | Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology Group. (Keller FG, Castellino SM, Chen L, Pei Q, Voss SD, McCarten KM, Senn SL, Buxton AB, Bush R, Constine LS, Schwartz CL) Cancer 2018 Aug 01;124(15):3210-3219 48 Citations |
| 1 | Outcomes of salvage radical prostatectomy following more than one failed local therapy. (Sivaraman A, Scardino P, Eastham J) Investig Clin Urol 2018 May;59(3):152-157 4 Citations |
| 1 | Caffeine Sodium Benzoate for Electroconvulsive Therapy Augmentation. (Bozymski KM, Potter TG, Venkatachalam V, Pandurangi AK, Crouse EL) J ECT 2018 Dec;34(4):233-239 14 Citations |
| 10 | Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation. (Knight JM, Kerswill SA, Hari P, Cole SW, Logan BR, D'Souza A, Shah NN, Horowitz MM, Stolley MR, Sloan EK, Giles KE, Costanzo ES, Hamadani M, Chhabra S, Dhakal B, Rizzo JD) BMC Cancer 2018 May 24;18(1):593 31 Citations |
| 1 | Osmotic Therapy in Traumatic Brain Injury (Vedantam A, Gopinath SP) Current Trauma Reports 1 June 2018;4(2):121-126 1 Citation |
| 1 | Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial. (Timmerman RD, Paulus R, Pass HI, Gore EM, Edelman MJ, Galvin J, Straube WL, Nedzi LA, McGarry RC, Robinson CG, Schiff PB, Chang G, Loo BW Jr, Bradley JD, Choy H) JAMA Oncol 2018 Sep 01;4(9):1263-1266 293 Citations |
| 1 | Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients. (Kohli M, Li J, Du M, Hillman DW, Dehm SM, Tan W, Carlson R, Campion MB, Wang L, Wang L, Zhang H, Zhang P, Kilari D, Huang CC, Wang L) Prostate Cancer Prostatic Dis 2018 Sep;21(3):411-418 31 Citations |
| 1 | Chemotherapy-induced muscle wasting: Association with NF-κB and cancer cachexia (Damrauer JS, Stadler ME, Acharyya S, Baldwin AS, Couch ME, Guttridge DC) European Journal of Translational Myology 6 June 2018;28(2):158-166 104 Citations |
| 1 | Safety and efficacy of self-expanding metal stents for biliary drainage in patients receiving neoadjuvant therapy for pancreatic cancer. (Ballard DD, Rahman S, Ginnebaugh B, Khan A, Dua KS) Endosc Int Open 2018 Jun;6(6):E714-E721 |
| 1 | Clinicopathologic Features and Radiation Therapy Utilization in Patients with Male Breast Cancer: A National Cancer Database Study. (Weir J, Zhao YD, Herman T, Algan Ö) Breast Cancer (Auckl) 2018;12:1178223418770687 23 Citations |
| 1 | Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy. (Mangala LS, Wang H, Jiang D, Wu SY, Somasunderam A, Volk DE, Lokesh GLR, Li X, Pradeep S, Yang X, Haemmerle M, Rodriguez-Aguayo C, Nagaraja AS, Rupaimoole R, Bayraktar E, Bayraktar R, Li L, Tanaka T, Hu W, Ivan C, Gharpure KM, McGuire MH, Thiviyanathan V, Zhang X, Maiti SN, Bulayeva N, Choi HJ, Dorniak PL, Cooper LJ, Rosenblatt KP, Lopez-Berestein G, Gorenstein DG, Sood AK) JCI Insight 2018 Jun 07;3(11) 2 Citations |
| 1 | Vancomycin Monotherapy May Be Insufficient to Treat Methicillin-resistant Staphylococcus aureus Coinfection in Children With Influenza-related Critical Illness. (Randolph AG, Xu R, Novak T, Newhams MM, Bubeck Wardenburg J, Weiss SL, Sanders RC, Thomas NJ, Hall MW, Tarquinio KM, Cvijanovich N, Gedeit RG, Truemper EJ, Markovitz B, Hartman ME, Ackerman KG, Giuliano JS Jr, Shein SL, Moffitt KL, Pediatric Intensive Care Influenza Investigators from the Pediatric Acute Lung Injury and Sepsis Investigator’s Network) Clin Infect Dis 2019 Jan 18;68(3):365-372 35 Citations |
| 2 | Early Prediction of Acute Xerostomia During Radiation Therapy for Head and Neck Cancer Based on Texture Analysis of Daily CT. (Wu H, Chen X, Yang X, Tao Y, Xia Y, Deng X, Zheng C, Robbins J, Schultz C, Li XA) Int J Radiat Oncol Biol Phys 2018 Nov 15;102(4):1308-1318 29 Citations |
| 1 | Molecular Markers of Therapy-Resistant Glioblastoma and Potential Strategy to Combat Resistance. (Nguyen HS, Shabani S, Awad AJ, Kaushal M, Doan N) Int J Mol Sci 2018 Jun 14;19(6) 45 Citations |
| 1 | Simultaneous downregulation of miR-21 and miR-155 through oleuropein for breast cancer prevention and therapy. (Abtin M, Alivand MR, Khaniani MS, Bastami M, Zaeifizadeh M, Derakhshan SM) J Cell Biochem 2018 Sep;119(9):7151-7165 45 Citations |
| 1 | Bone Marrow-derived CD8+ T Cells From Pediatric Leukemia Patients Express PD1 and Expand Ex Vivo Following Induction Chemotherapy. (Palen K, Thakar M, Johnson BD, Gershan JA) J Pediatr Hematol Oncol 2019 Nov;41(8):648-652 2 Citations |
| 1 | Quantifying local tumor morphological changes with Jacobian map for prediction of pathologic tumor response to chemo-radiotherapy in locally advanced esophageal cancer. (Riyahi S, Choi W, Liu CJ, Zhong H, Wu AJ, Mechalakos JG, Lu W) Phys Med Biol 2018 Jul 19;63(14):145020 30 Citations |
| 1 | Using physical therapy to treat temporomandibular disorders. A cohort study () |
| 1 | Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial. (Bell EH, Zhang P, Fisher BJ, Macdonald DR, McElroy JP, Lesser GJ, Fleming J, Chakraborty AR, Liu Z, Becker AP, Fabian D, Aldape KD, Ashby LS, Werner-Wasik M, Walker EM, Bahary JP, Kwok Y, Yu HM, Laack NN, Schultz CJ, Gray HJ, Robins HI, Mehta MP, Chakravarti A) JAMA Oncol 2018 Oct 01;4(10):1405-1409 141 Citations |
| 1 | Editorial Preface for Targeted Cancer Therapy (Chen G, Li W) Acta Pharmaceutica Sinica B July 2018;8(4):501-502 4 Citations |
| 1 | Two birds, one stone: hesperetin alleviates chemotherapy-induced diarrhea and potentiates tumor inhibition. (Yu Y, Kong R, Cao H, Yin Z, Liu J, Nan X, Phan AT, Ding T, Zhao H, Wong STC) Oncotarget 2018 Jun 15;9(46):27958-27973 14 Citations |
| 4 | Vascular Interventional Radiology-Guided Photothermal Therapy of Colorectal Cancer Liver Metastasis with Theranostic Gold Nanorods. (Parchur AK, Sharma G, Jagtap JM, Gogineni VR, LaViolette PS, Flister MJ, White SB, Joshi A) ACS Nano 2018 Jul 24;12(7):6597-6611 112 Citations |
| 2 | Technical Note: Enhancing soft tissue contrast and radiation-induced image changes with dual-energy CT for radiation therapy. (Noid G, Tai A, Schott D, Mistry N, Liu Y, Gilat-Schmidt T, Robbins JR, Li XA) Med Phys 2018 Jul 04 11 Citations |
| 1 | Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma. (Retseck J, Nasr A, Lin Y, Lin H, Mendiratta P, Butterfield LH, Tarhini AA) J Transl Med 2018 Jul 04;16(1):184 43 Citations |
| 1 | Close Margins and Adjuvant Radiotherapy in Acinic Cell Carcinoma of the Parotid Gland. (Zenga J, Parikh AS, Emerick KS, Lin DT, Faquin WC, Deschler DG) JAMA Otolaryngol Head Neck Surg 2018 Nov 01;144(11):1011-1016 33 Citations |
| 2 | Stromal PTEN determines mammary epithelial response to radiotherapy. (Sizemore GM, Balakrishnan S, Thies KA, Hammer AM, Sizemore ST, Trimboli AJ, Cuitiño MC, Steck SA, Tozbikian G, Kladney RD, Shinde N, Das M, Park D, Majumder S, Krishnan S, Yu L, Fernandez SA, Chakravarti A, Shields PG, White JR, Yee LD, Rosol TJ, Ludwig T, Park M, Leone G, Ostrowski MC) Nat Commun 2018 Jul 17;9(1):2783 20 Citations |
| 1 | Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies. (Gibbs P, Heinemann V, Sharma NK, Taieb J, Ricke J, Peeters M, Findlay M, Robinson B, Jackson C, Strickland A, Gebski V, Van Buskirk M, Zhao H, van Hazel G, SIRFLOX and FOXFIRE Global Trial Investigators) Clin Colorectal Cancer 2018 Dec;17(4):e617-e629 59 Citations |
| 5 | Incidence and survival of therapy related myeloid neoplasm in United States. (Guru Murthy GS, Hamadani M, Dhakal B, Hari P, Atallah E) Leuk Res 2018 Aug;71:95-99 32 Citations |
| 1 | Abdominal, multi-organ, auto-contouring method for online adaptive magnetic resonance guided radiotherapy: An intelligent, multi-level fusion approach. (Liang F, Qian P, Su KH, Baydoun A, Leisser A, Van Hedent S, Kuo JW, Zhao K, Parikh P, Lu Y, Traughber BJ, Muzic RF Jr) Artif Intell Med 2018 Aug;90:34-41 53 Citations |
| 1 | Interpersonal behavior in couple therapy: Concurrent and prospective associations with depressive symptoms and relationship distress. (Knobloch-Fedders LM, Wilson SJ) Psychother Res 2020 Feb;30(2):183-194 |
| 1 | MRI guided stereotactic radiotherapy for locally advanced pancreatic cancer. (Heerkens HD, van Vulpen M, Erickson B, Reerink O, Intven MP, van den Berg CA, Molenaar IQ, Vleggaar FP, Meijer GJ) Br J Radiol 2018 Nov;91(1091):20170563 35 Citations |
| 1 | Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-study. (Grodecki K, Huczek Z, Scisło P, Kowara M, Raposeiras-Roubín S, D'Ascenzo F, Abu-Assi E, Henriques JPS, Saucedo J, González-Juanatey JR, Wilton SB, Kikkert WJ, Nuñez-Gil I, Ariza-Sole A, Song XT, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Nie SP, Fujii T, Correia L, Kawashiri MA, García-Acuña JM, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, Möllmann H, Shiomi H, Giordana F, Scarano S, Gaita F, Wang X, Yan Y, Fan JY, Ikari Y, Nakahashi T, Sakata K, Yamagishi M, Kalpak O, Kedev S, Opolski G, Filipiak KJ) Thromb Res 2018 Aug;168:156-163 22 Citations |
| 2 | Wisconsin's Enterra Therapy Experience: A multi-institutional review of gastric electrical stimulation for medically refractory gastroparesis. (Shada A, Nielsen A, Marowski S, Helm M, Funk LM, Kastenmeier A, Lidor A, Gould JC) Surgery 2018 Oct;164(4):760-765 29 Citations |
| 1 | Are Providers and Patients Following Hormonal Therapy Guidelines for Patients Over the Age of 70? The Influence of CALGB 9343. (Cortina CS, Agarwal S, Mulder LL, Poirier J, Rao R, Ansell DA, Madrigrano A) Clin Breast Cancer 2018 Dec;18(6):e1289-e1292 9 Citations |
| 6 | A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal Adenocarcinoma. (Tsai S, Christians KK, George B, Ritch PS, Dua K, Khan A, Mackinnon AC, Tolat P, Ahmad SA, Hall WA, Erickson BA, Evans DB) Ann Surg 2018 Oct;268(4):610-619 64 Citations |
| 2 | Development of an inducible anti-VEGF rAAV gene therapy strategy for the treatment of wet AMD. (Reid CA, Nettesheim ER, Connor TB, Lipinski DM) Sci Rep 2018 Aug 06;8(1):11763 53 Citations |
| 1 | Is Photodynamic Therapy Resistance a Special Case of Photobiomodulation? (Quirk BJ, Girotti AW, Whelan HT) Photomed Laser Surg 2018 Aug;36(8):397-398 3 Citations |
| 3 | Meta-analysis to Evaluate High-Dose Therapy Followed by Stem Cell Transplant in Patients With Multiple Myeloma-Reply. (Dhakal B, Szabo A, Hari P) JAMA Oncol 2018 Nov 01;4(11):1618 2 Citations |
| 1 | The role of immunotherapy in in vitro fertilization: a guideline. (Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine) Fertil Steril 2018 Aug;110(3):387-400 37 Citations |
| 1 | Consolidative Whole-Brain Radiation Therapy Versus Autologous Stem Cell Transplant for Primary Central Nervous System Lymphoma: A Large Dose of Perspective and Perhaps a Lower Dose of Radiation Are in Order. (Bovi JA, Schultz CJ, Mehta MP, Corn BW) Int J Radiat Oncol Biol Phys 2018 Sep 01;102(1):59-60 |
| 1 | How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD. (Jaglowski SM, Blazar BR) Blood Adv 2018 Aug 14;2(15):2012-2019 77 Citations |
| 1 | Editorial Preface for Targeted Cancer Therapy. (Chen G, Li W) Acta Pharm Sin B 2018 Jul;8(4):501-502 4 Citations |
| 2 | Targeting an oncogenic kinase/phosphatase signaling network for cancer therapy. (Qi XM, Wang F, Mortensen M, Wertz R, Chen G) Acta Pharm Sin B 2018 Jul;8(4):511-517 16 Citations |
| 1 | A bright future? Optogenetics in the periphery for pain research and therapy. (Mickle AD, Gereau RW 4th) Pain 2018 Sep;159 Suppl 1(Suppl 1):S65-S73 22 Citations |
| 1 | Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer. (Basho RK, Yam C, Gilcrease M, Murthy RK, Helgason T, Karp DD, Meric-Bernstam F, Hess KR, Valero V, Albarracin C, Litton JK, Chavez-MacGregor M, Hong D, Kurzrock R, Hortobagyi GN, Janku F, Moulder SL) Oncologist 2018 Nov;23(11):1300-1309 48 Citations |
| 1 | Health-related quality of life and long-term outcomes after endoscopic therapy for walled-off pancreatic necrosis. (Smith ZL, Gregory MH, Elsner J, Alajlan BA, Kodali D, Hollander T, Sayuk GS, Lang GD, Das KK, Mullady DK, Early DS, Kushnir VM) Dig Endosc 2019 Jan;31(1):77-85 9 Citations |
| 1 | Antithrombotic therapy management of adult and pediatric cardiac surgery patients. (Baumann Kreuziger L, Karkouti K, Tweddell J, Massicotte MP) J Thromb Haemost 2018 Nov;16(11):2133-2146 36 Citations |
| 1 | Amebic Encephalitis in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib Therapy. (Voshtina E, Huang H, Raj R, Atallah E) Case Rep Hematol 2018;2018:6514604 |
| 1 | Mono versus Dual Antiplatelet Therapy after Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis (Charl Khalil, MDa
, Wassim Mosleh, MDa
, Michael Megaly, MDb
, Sumeet Gandhi, MDc
, Fady H. Iskander, MD, MScd
,
Mina H. Iskander, MD, MScd
, Amira Ibrahim, MDa
, Tanvi Shah, MDa
, Catherine Ekladios, MDa
, and John Corbelli, MD) STRUCTURAL HEART |
| 1 | Finite Element Method-Based Hybrid MRI/CBCT Generation to Improve Liver Stereotactic Body Radiation Therapy Targets Localization Accuracy (Zeyu Zhang, Mark Chen, Ke Lu, Dongyang Guo, Zhuoran Jiang, Hualiang Zhong, Jason K Molitoris, Phuoc T Tran, Fang-Fang Yin, Lei Ren) IEEE Transactions on Radiation and Plasma Medical Sciences IEEE Transactions on Radiation and Plasma Medical Sciences, doi: 10.1109/TRPMS.2024.3466184. |
| 1 | Facilitating Colostrum Collection by Hospitalized Women in the Early Postpartum Period for Infant Trophic Feeding and Oral Immune Therapy. (Haase B, Johnson TS, Wagner CL) J Obstet Gynecol Neonatal Nurs 2018 Sep;47(5):654-660 3 Citations |
| 1 | Choosing the appropriate salvage therapy for B-cell non-Hodgkin lymphoma. (Hashmi H, Hamadani M, Awan FT) Expert Opin Pharmacother 2018 Oct;19(15):1631-1634 1 Citation |
| 1 | Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group. (Dickson PV, Kim L, Yen TWF, Yang A, Grubbs EG, Patel D, Solórzano CC) Ann Surg Oncol 2018 Nov;25(12):3453-3459 11 Citations |
| 2 | Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy. (Hinze CH, Foell D, Johnson AL, Spalding SJ, Gottlieb BS, Morris PW, Kimura Y, Onel K, Li SC, Grom AA, Taylor J, Brunner HI, Huggins JL, Nocton JJ, Haines KA, Edelheit BS, Shishov M, Jung LK, Williams CB, Tesher MS, Costanzo DM, Zemel LS, Dare JA, Passo MH, Ede KC, Olson JC, Cassidy EA, Griffin TA, Wagner-Weiner L, Weiss JE, Vogler LB, Rouster-Stevens KA, Beukelman T, Cron RQ, Kietz D, Schikler K, Mehta J, Ting TV, Verbsky JW, Eberhard AB, Huang B, Giannini EH, Lovell DJ) Arthritis Rheumatol 2019 Mar;71(3):451-459 42 Citations |
| 1 | Stem cell fate in cancer growth, progression and therapy resistance. (Lytle NK, Barber AG, Reya T) Nat Rev Cancer 2018 Nov;18(11):669-680 509 Citations |
| 2 | The association of socioeconomic status with receipt of neoadjuvant chemotherapy. (Neuner JM, Kong A, Blaes A, Riley D, Chrischilles E, Smallwood A, Lizarraga I, Schroeder M) Breast Cancer Res Treat 2019 Jan;173(1):179-188 17 Citations |
| 4 | Platelet Gene Therapy Promotes Targeted Peripheral Tolerance by Clonal Deletion and Induction of Antigen-Specific Regulatory T Cells. (Luo X, Chen J, Schroeder JA, Allen KP, Baumgartner CK, Malarkannan S, Hu J, Williams CB, Shi Q) Front Immunol 2018;9:1950 14 Citations |
| 1 | Impact of Steroid Therapy on Early Growth in Infants with Biliary Atresia: The Multicenter Steroids in Biliary Atresia Randomized Trial. (Alonso EM, Ye W, Hawthorne K, Venkat V, Loomes KM, Mack CL, Hertel PM, Karpen SJ, Kerkar N, Molleston JP, Murray KF, Romero R, Rosenthal P, Schwarz KB, Shneider BL, Suchy FJ, Turmelle YP, Wang KS, Sherker AH, Sokol RJ, Bezerra JA, Magee JC, ChiLDReN Network) J Pediatr 2018 Nov;202:179-185.e4 28 Citations |
| 3 | Management of the axilla after neo-adjuvant chemotherapy for breast cancer: Sentinel node biopsy and radiotherapy considerations. (Currey A, Patten CR, Bergom C, Wilson JF, Kong AL) Breast J 2018 Nov;24(6):902-910 10 Citations |
| 1 | Systemic therapy for relapsed/refractory meningioma: Is there potential for antiangiogenic agents? (Dasanu CA, Samara Y, Codreanu I, Limonadi FM, Hamid O, Alvarez-Argote J) J Oncol Pharm Pract 2019 Apr;25(3):638-647 12 Citations |
| 1 | A novel MRI segmentation method using CNN-based correction network for MRI-guided adaptive radiotherapy. (Fu Y, Mazur TR, Wu X, Liu S, Chang X, Lu Y, Li HH, Kim H, Roach MC, Henke L, Yang D) Med Phys 2018 Nov;45(11):5129-5137 140 Citations |
| 1 | Impact of inter-and intra-fraction anatomic motions on delta-radiomics for radiation therapy of pancreatic cancer (H Nasief, A Li) International Journal of Radiation Oncology, Biology, Physics 102 (3), S212-S213 |
| 1 | Efficacy of salvage chemotherapy in diffuse large B cell lymphoma with primary treatment failure according to putative cell of origin. (Badar T, Hamadani M, Bachanova V, Maddocks KJ, Umyarova E, Chavez JC, Epperla N, Chhabra S, Xavier AC, Karmali R, Salhab M, Reddy N, Glenn MJ, Hernandez-Ilizaliturri FJ, Flowers CR, Evens AM, Zhou Z, Lansigan F, Barta SK, Cohen JB, Fenske TS, Costa LJ) Leuk Lymphoma 2019 Apr;60(4):940-946 3 Citations |
| 1 | Nuts and bolts of 4D-MRI for radiotherapy. (Stemkens B, Paulson ES, Tijssen RHN) Phys Med Biol 2018 Oct 23;63(21):21TR01 117 Citations |
| 2 | Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma. (Yu PY, Beal EW, Hughes TM, Suarez-Kelly LP, Shelby RD, Ethun CG, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard JH) J Surg Res 2018 Nov;231:248-256 3 Citations |
| 1 | Successful implementation of genomically based treatment of chemotherapy refractory peripheral T-cell lymphoma (PTCL). (Galanina N, Kurzrock R) Cancer Biol Ther 2019;20(3):247-251 2 Citations |
| 5 | Investigating the Association Between Advanced Practice Providers and Chemotherapy-Related Adverse Events in Women With Breast Cancer: A Nested Case-Control Study. (Yen TWF, Nattinger AB, McGinley EL, Fergestrom N, Pezzin LE, Laud PW) J Oncol Pract 2018 Oct 10:JOP1800277 2 Citations |
| 1 | Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS. (Nagle SJ, Shah NN, Ganetsky A, Landsburg DJ, Nasta SD, Mato A, Schuster SJ, Reshef R, Tsai DE, Svoboda J) Int J Hematol Oncol 2017 Dec;6(4):113-121 |
| 7 | Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer. (Tsai S, George B, Wittmann D, Ritch PS, Krepline AN, Aldakkak M, Barnes CA, Christians KK, Dua K, Griffin M, Hagen C, Hall WA, Erickson BA, Evans DB) Ann Surg 2020 Apr;271(4):740-747 141 Citations |
| 1 | Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. (Roach M, Moughan J, Lawton CAF, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR Jr, Shipley WU, Sandler HM) Lancet Oncol 2018 Nov;19(11):1504-1515 195 Citations |
| 1 | A Destabilizing Domain Allows for Fast, Noninvasive, Conditional Control of Protein Abundance in the Mouse Eye - Implications for Ocular Gene Therapy. (Datta S, Renwick M, Chau VQ, Zhang F, Nettesheim ER, Lipinski DM, Hulleman JD) Invest Ophthalmol Vis Sci 2018 Oct 01;59(12):4909-4920 17 Citations |
| 3 | Elective Regional Therapy Treatment for Hepatic Adenoma. (Silva JP, Klooster B, Tsai S, Christians KK, Clarke CN, Mogal H, Clark Gamblin T) Ann Surg Oncol 2019 Jan;26(1):125-130 9 Citations |
| 1 | The Marriage Between Genomics and Immunotherapy: Mismatch Meets Its Match. (Subbiah V, Kurzrock R) Oncologist 2019 Jan;24(1):1-3 18 Citations |
| 5 | Variations of MRI-assessed peristaltic motions during radiation therapy. (Mostafaei F, Tai A, Omari E, Song Y, Christian J, Paulson E, Hall W, Erickson B, Li XA) PLoS One 2018;13(10):e0205917 41 Citations |
| 1 | Selection of Patients With Localized Extremity Soft Tissue Sarcoma for Treatment With Perioperative Chemotherapy. (Charlson J) Curr Treat Options Oncol 2018 Oct 25;19(12):65 5 Citations |
| 1 | Neoadjuvant chemotherapy is associated with a high rate of perioperative blood transfusion at the time of interval cytoreductive surgery. (McCool KW, Sampene E, Polnaszek B, Connor J, Medlin EE, Barroilhet L) BMC Cancer 2018 Oct 26;18(1):1041 6 Citations |
| 1 | Maintenance olaparib following platinum-based chemotherapy in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA1/2 mutation (BRCAm): Phase III SOLO1 trial (Friedlander M, Moore K, Colombo N, Scambia G, Kim BG, Oaknin A, Lisyanskaya A, Floquet A, Leary A, Sonke GS, Gourley C, Banerjee S, Oza AM, González-Martín A, Aghajanian C, Bradley W, Lowe ES, Bloomfield R, Disilvestro P) Annals of Oncology November 2018;29:ix174-ix175 |
| 1 | Portland Intensive Insulin Therapy During Living Donor Liver Transplantation: Association with Postreperfusion Hyperglycemia and Clinical Outcomes. (Kang R, Han S, Lee KW, Kim GS, Choi SJ, Ko JS, Lee SH, Gwak MS) Sci Rep 2018 Nov 02;8(1):16306 6 Citations |
| 1 | Radiation Therapy Combined With Checkpoint Blockade Immunotherapy for Metastatic Undifferentiated Pleomorphic Sarcoma of the Maxillary Sinus With a Complete Response. (Guram K, Nunez M, Einck J, Mell LK, Cohen E, Sanders PD, Miyauchi S, Weihe E, Kurzrock R, Boles S, Sharabi AB) Front Oncol 2018;8:435 13 Citations |
| 1 | Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor -T-cell therapy in B-cell non-Hodgkin lymphomas. (Shah NN, Nagle SJ, Torigian DA, Farwell MD, Hwang WT, Frey N, Nasta SD, Landsburg D, Mato A, June CH, Schuster SJ, Porter DL, Svoboda J) Cytotherapy 2018 Dec;20(12):1415-1418 52 Citations |
| 1 | Novel BRAF alteration in desmoplastic infantile ganglioglioma with response to targeted therapy. (Blessing MM, Blackburn PR, Balcom JR, Krishnan C, Harrod VL, Zimmermann MT, Barr Fritcher EG, Zysk CD, Jackson RA, Nair AA, Jenkins RB, Halling KC, Kipp BR, Ida CM) Acta Neuropathol Commun 2018 Nov 05;6(1):118 14 Citations |
| 1 | 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018) : Washington, D.C., USA. 7-11 November 2018. () J Immunother Cancer 2018 Nov 06;6(Suppl 1):115 15 Citations |
| 1 | An avatar for precision cancer therapy. (Kato S, Kurzrock R) Nat Biotechnol 2018 Nov 09;36(11):1053-1055 9 Citations |
| 1 | Antihypertensive therapy prescribing patterns and correlates of blood pressure control among hypertensive patients with chronic kidney disease. (Magvanjav O, Cooper-DeHoff RM, McDonough CW, Gong Y, Segal MS, Hogan WR, Johnson JA) J Clin Hypertens (Greenwich) 2019 Jan;21(1):91-101 13 Citations |
| 1 | Immunogenomic Landscape Contributes to Hyperprogressive Disease after Anti-PD-1 Immunotherapy for Cancer. (Xiong D, Wang Y, Singavi AK, Mackinnon AC, George B, You M) iScience 2018 Nov 30;9:258-277 75 Citations |
| 2 | Inverse Kinematic Assessment of Rehabilitative Therapy in Children Using Orthotics. (Murphy MP, Rammer JR, Vinehout KL, Caballero MR, Cornwell CM, Fritz JM, Harris GF) Annu Int Conf IEEE Eng Med Biol Soc 2018 Jul;2018:2813-2816 |
| 1 | Current Practices of Intraventricular Antibiotic Therapy in the Treatment of Meningitis and Ventriculitis: Results from a Multicenter Retrospective Cohort Study. (Lewin JJ 3rd, Cook AM, Gonzales C, Merola D, Neyens R, Peppard WJ, Brophy GM, Kurczewski L, Giarratano M, Makii J, Rowe AS, Tesoro EP, Zaniewski A, Clark S, Ziai WC) Neurocrit Care 2019 Jun;30(3):609-616 43 Citations |
| 1 | Improved long-term patient-reported health and well-being outcomes of early-stage breast cancer treated with partial breast proton therapy. (Teichman SL, Do S, Lum S, Teichman TS, Preston W, Cochran SE, Garberoglio CA, Grove R, Davis CA, Slater JD, Bush DA) Cancer Med 2018 Dec;7(12):6064-6076 11 Citations |
| 2 | Simultaneous motion monitoring and truth-in-delivery analysis imaging framework for MR-guided radiotherapy. (Mickevicius NJ, Chen X, Boyd Z, Lee HJ, Ibbott GS, Paulson ES) Phys Med Biol 2018 Nov 26;63(23):235014 11 Citations |
| 1 | Using Group-based Trajectory Models and Propensity Score Weighting to Detect Heterogeneous Treatment Effects: The Case Study of Generic Hormonal Therapy for Women With Breast Cancer. (Winn AN, Fergestrom NM, Neuner JM) Med Care 2019 Jan;57(1):85-93 10 Citations |
| 1 | Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420. (Lieberman FS, Wang M, Robins HI, Tsien CI, Curran WJ Jr, Werner-Wasik M, Smith RP, Schultz C, Hartford AC, Zhang P, Mehta MP) Int J Radiat Oncol Biol Phys 2019 Mar 15;103(4):878-886 11 Citations |
| 1 | Adoption of triplet therapy and clinical outcomes in routine practice among newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant in the USA. (Hari P, Blazer M, Raju A, Farrelly E, Labotka R, Skacel T, Romanus D) Expert Rev Hematol 2019 Jan;12(1):71-79 3 Citations |
| 1 | Cytotoxic therapy in acute myeloid leukemia: not quite dead yet. (Michaelis LC) Hematology Am Soc Hematol Educ Program 2018 Nov 30;2018(1):51-62 7 Citations |
| 1 | Identification and Modulation of Microenvironment Is Crucial for Effective Mesenchymal Stromal Cell Therapy in Acute Lung Injury. (Islam D, Huang Y, Fanelli V, Delsedime L, Wu S, Khang J, Han B, Grassi A, Li M, Xu Y, Luo A, Wu J, Liu X, McKillop M, Medin J, Qiu H, Zhong N, Liu M, Laffey J, Li Y, Zhang H) Am J Respir Crit Care Med 2019 May 15;199(10):1214-1224 111 Citations |
| 1 | Strategies toward rheumatoid arthritis therapy; the old and the new. (Abbasi M, Mousavi MJ, Jamalzehi S, Alimohammadi R, Bezvan MH, Mohammadi H, Aslani S) J Cell Physiol 2019 Jul;234(7):10018-10031 320 Citations |
| 1 | Contemporary analysis of complications associated with biliary stents during neoadjuvant therapy for pancreatic adenocarcinoma. (Kim BJ, Prakash L, Narula N, Davis CH, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MH, Tzeng CD) HPB (Oxford) 2019 Jun;21(6):662-668 10 Citations |
| 1 | Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients. (Jensen TJ, Goodman AM, Kato S, Ellison CK, Daniels GA, Kim L, Nakashe P, McCarthy E, Mazloom AR, McLennan G, Grosu DS, Ehrich M, Kurzrock R) Mol Cancer Ther 2019 Feb;18(2):448-458 66 Citations |
| 1 | An Economic Analysis of Radiation Therapy Oncology Group 94-10: Cost-Efficacy of Concurrent vs. Sequential Chemoradiotherapy. (Konski A, Bhargavan M, Owen J, Komaki R, Langer CJ, Gore E, Paulus R, Choy H, Bruner DW, Curran WJ) J Radiat Oncol 2018 Jun;7(2):195-201 |
| 1 | Biologic therapy in psoriasis: navigating the options. (McKay C, Kondratuk KE, Miller JP, Stumpf B, Boh E) Cutis 2018 Nov;102(5S):13-17 5 Citations |
| 1 | Hypertriglyceridemic Pancreatitis: Is Insulin Monotherapy A Feasible Therapeutic Option? (Inayat F, Zafar F, Riaz I, Younus F, Baig AS, Imran Z) Cureus 2018 Oct 17;10(10):e3461 |
| 2 | Patient selection in studies evaluating esophageal stents during neoadjuvant therapy. (Smith ZL, Dua KS) Gastrointest Endosc 2019 Jan;89(1):205-206 2 Citations |
| 3 | First report that prior ECMO therapy does not preclude hematopoietic cell transplantation. (Broglie L, Phelan R, Talano JA) Pediatr Hematol Oncol 2018 May;35(4):245-249 1 Citation |
| 1 | Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning: An ASTRO Consensus Paper. (Wright JL, Yom SS, Awan MJ, Dawes S, Fischer-Valuck B, Kudner R, Mailhot Vega R, Rodrigues G) Pract Radiat Oncol 2019 Mar;9(2):65-72 59 Citations |
| 1 | Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy. (Zandberg DP, Algazi AP, Jimeno A, Good JS, Fayette J, Bouganim N, Ready NE, Clement PM, Even C, Jang RW, Wong S, Keilholz U, Gilbert J, Fenton M, Braña I, Henry S, Remenar E, Papai Z, Siu LL, Jarkowski A, Armstrong JM, Asubonteng K, Fan J, Melillo G, Mesía R) Eur J Cancer 2019 Jan;107:142-152 204 Citations |
| 1 | Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities. (Millis SZ, Jardim DL, Albacker L, Ross JS, Miller VA, Ali SM, Kurzrock R) Cancer 2019 Apr 01;125(7):1185-1199 41 Citations |
| 1 | External beam radiotherapy in the treatment of painful bone metastases (Johnstone C, Ghia AJ, Prayongrat A) Essentials of Interventional Cancer Pain Management 28 December 2018:339-352 |
| 1 | Radiation therapy (Robbins JR, Longo JM, Straza M) Cancer Regional Therapy: HAI, HIPEC, HILP, ILI, PIPAC and Beyond 1 January 2019:461-479 |
| 1 | Molecular therapeutics in hematology: Gene therapy (McKillop WM, Medin JA) Molecular Hematology 1 January 2019:319-338 |
| 1 | Gene therapy for platelet disorders (Wilcox DA) Platelets 1 January 2019:1191-1205 1 Citation |
| 1 | Cancer regional therapy: HAI, HIPEC, HILP, ILI, PIPAC and Beyond (Fong Y, Gamblin TC, Han ES, Lee B, Zager JS) Cancer Regional Therapy: HAI, HIPEC, HILP, ILI, PIPAC and Beyond 1 January 2019:1-488 4 Citations |
| 1 | In the era of immune checkpoint inhibitor therapy, can we safely expand to patients with immunodeficiency? (Bilen MA, Kurzrock R) Journal of Immunotherapy and Precision Oncology 2019;2(4):129 |
| 1 | Dose reductions in ibrutinib therapy are not associated with inferior outcomes in patients with chronic lymphocytic leukemia (CLL). (Akhtar OS, Attwood K, Lund I, Hare R, Hernandez-Ilizaliturri FJ, Torka P) Leuk Lymphoma 2019 Jul;60(7):1650-1655 31 Citations |
| 1 | Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic Syndrome: ARetrospective Cohort Study. (Feih JT, Rinka JRG, Zundel MT) J Cardiothorac Vasc Anesth 2019 May;33(5):1301-1307 29 Citations |
| 1 | The impact of GPIbα on platelet-targeted FVIII gene therapy in hemophilia A mice with pre-existing anti-FVIII immunity. (Chen J, Schroeder JA, Luo X, Montgomery RR, Shi Q) J Thromb Haemost 2019 Mar;17(3):449-459 17 Citations |
| 1 | Short Communication: Relationship Between Contraindicated Drug-Drug Interactions and Subsequent Hospitalizations Among Patients Living with HIV Initiating Combination Antiretroviral Therapy. (Sangiovanni RJ, Jakeman B, Nasiri M, Ruth L, Mahatme S, Patel N) AIDS Res Hum Retroviruses 2019 May;35(5):430-433 8 Citations |
| 1 | Identification of targets for prostate cancer immunotherapy. (Papanicolau-Sengos A, Yang Y, Pabla S, Lenzo FL, Kato S, Kurzrock R, DePietro P, Nesline M, Conroy J, Glenn S, Chatta G, Morrison C) Prostate 2019 Apr;79(5):498-505 24 Citations |
| 1 | The impact of time after radiation treatment on dysphagia in patients with head and neck cancer enrolled in a swallowing therapy program. (Van Daele DJ, Langmore SE, Krisciunas GP, Lazarus CL, Pauloski BR, McCulloch TM, Gramigna GD, Messing BP, Wagner CW, Mott SL) Head Neck 2019 Mar;41(3):606-614 20 Citations |
| 1 | Hypertriglyceridemic Pancreatitis Treated with Insulin Therapy: A Comparative Review of 34 Cases. (Inayat F, Zafar F, Baig AS, Chaudhry NA, Aslam A, Khan ZH, Iqbal MJ) Cureus 2018 Oct 27;10(10):e3501 |
| 1 | Chimeric antigen receptor modified T cell therapy in B cell non-Hodgkin lymphomas. (Levin A, Shah NN) Am J Hematol 2019 May;94(S1):S18-S23 21 Citations |
| 3 | Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial. (Stadtmauer EA, Pasquini MC, Blackwell B, Hari P, Bashey A, Devine S, Efebera Y, Ganguly S, Gasparetto C, Geller N, Horowitz MM, Koreth J, Knust K, Landau H, Brunstein C, McCarthy P, Nelson C, Qazilbash MH, Shah N, Vesole DH, Vij R, Vogl DT, Giralt S, Somlo G, Krishnan A) J Clin Oncol 2019 Mar 01;37(7):589-597 210 Citations |
| 1 | Novel patterns of response under immunotherapy. (Borcoman E, Kanjanapan Y, Champiat S, Kato S, Servois V, Kurzrock R, Goel S, Bedard P, Le Tourneau C) Ann Oncol 2019 Mar 01;30(3):385-396 409 Citations |
| 1 | Tyrosine kinase inhibitor therapy treatment and discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States: a clinical practice perspective. (Ritchie EK, Latremouille-Viau D, Guerin A, Pivneva I, Habucky K, Ndife B, Joseph GJ, Atallah EL) Leuk Lymphoma 2019 Jun;60(6):1476-1484 4 Citations |
| 2 | Modelling CAR-T therapy in humanized mice. (Wu Y, Yu XZ) EBioMedicine 2019 Feb;40:25-26 10 Citations |
| 1 | Re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552-5: Comparing Apples to Oranges: A Self-fulfilling Prophecy? (Kishan AU, Hall WA, Spratt DE) Eur Urol 2019 May;75(5):e133-e134 |
| 1 | Lentiviral interleukin-10 gene therapy: Safety and questions. (Liu M, Juvet SC, Medin JA, Martinu T, Oishi H, Keshavjee S) J Thorac Cardiovasc Surg 2019 Feb;157(2):818-819 1 Citation |
| 1 | Post-radiotherapy PET/CT for predicting treatment outcomes in head and neck cancer after postoperative radiotherapy. (Li Y, Awan MJ, Chang T, Lavertu P, Zender C, Rezaee R, Fowler N, Wasman J, Avril NE, Chen N, Machtay M, Yao M) Eur J Nucl Med Mol Imaging 2019 Apr;46(4):794-800 10 Citations |
| 1 | Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis: Feasibility, Acceptability, and Patient-Oriented Outcomes in a Pilot-Level Quality Improvement Project. (Rabago D, Kansariwala I, Marshall D, Nourani B, Stiffler-Joachim M, Heiderscheit B) J Altern Complement Med 2019 Apr;25(4):406-412 3 Citations |
| 1 | A Care Process Model to Deliver 177Lu-Dotatate Peptide Receptor Radionuclide Therapy for Patients With Neuroendocrine Tumors. (Kasi PM, Maige CL, Shahjehan F, Rodgers JM, Aloszka DL, Ritter A, Andrus ML, Mcmillan JM, Mody K, Sharma A, Jain MK) Front Oncol 2018;8:663 3 Citations |
| 2 | Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival. (Robbins JR, Schmid RK, Hammad AY, Gamblin TC, Erickson BA) Cancer Med 2019 Mar;8(3):928-938 20 Citations |
| 1 | Dosing Oncology Therapeutics in Combination Therapy for Renal Dysfunction: The University of California San Diego Study of Personalized Cancer Therapy to Determine Response and Toxicity (UCSD-PREDICT) Experience. (Nikanjam M, Wing J, Capparelli E, Kurzrock R) Cureus 2018 Nov 26;10(11):e3634 |
| 1 | Complications, oncological and functional outcomes of salvage treatment options following focal therapy for localized prostate cancer: a systematic review and a comprehensive narrative review. (Marra G, Gontero P, Walz JC, Sivaraman A, Tourinho-Barbosa R, Cathelineau X, Sanchez-Salas R) World J Urol 2019 Aug;37(8):1517-1534 25 Citations |
| 4 | Toxicities of CAR T-Cell Therapy and the Role of the Consultation-Liaison Psychiatrist. (Pawar DS, Molinaro JR, Knight JM, Heinrich TW) Psychosomatics 2019;60(5):519-523 2 Citations |
| 1 | APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy. (Boichard A, Pham TV, Yeerna H, Goodman A, Tamayo P, Lippman S, Frampton GM, Tsigelny IF, Kurzrock R) Oncoimmunology 2019;8(3):1550341 58 Citations |
| 1 | Call for improved design and reporting in soft tissue sarcoma studies: A systematic review and meta-analysis of chemotherapy and survival outcomes in resectable STS. (Istl AC, Ruck JM, Morris CD, Levin AS, Meyer CF, Johnston FM) J Surg Oncol 2019 Jun;119(7):824-835 14 Citations |
| 1 | Immunotherapy in extensive small cell lung cancer. (Verma V, Sharma G, Singh A) Exp Hematol Oncol 2019;8:5 30 Citations |
| 8 | Salvage of Recurrence after Surgery and Adjuvant Therapy: A Multi-institutional Study. (Zenga J, Graboyes E, Janz T, Drake V, Rettig E, Desai S, Nickel C, Shabani S, Padhya T, Scarpinato M, Stadler M, Massey B, Campbell B, Shukla M, Awan M, Schultz CJ, Wong S, Jackson RS, Pipkorn P) Otolaryngol Head Neck Surg 2019 Jul;161(1):74-81 18 Citations |
| 1 | Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial. (Bruner DW, Pugh SL, Lee WR, Hall WA, Dignam JJ, Low D, Swanson GP, Shah AB, Malone S, Michalski JM, Dayes IS, Seaward SA, Nguyen PL, Pisansky TM, Chen Y, Sandler HM, Movsas B) JAMA Oncol 2019 May 01;5(5):664-670 41 Citations |
| 1 | Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience. (Yucebay F, Matthews C, Puto M, Li J, William B, Jaglowski SM, Penza SL, Vasu S, Benson DM, Andritsos LA, Devine SM, Efebera YA, Roddy JVF) Leuk Lymphoma 2019 Sep;60(9):2223-2229 16 Citations |
| 1 | American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Perioperative Management of Patients on Preoperative Opioid Therapy. (Edwards DA, Hedrick TL, Jayaram J, Argoff C, Gulur P, Holubar SD, Gan TJ, Mythen MG, Miller TE, Shaw AD, Thacker JKM, McEvoy MD, POQI-4 Working Group) Anesth Analg 2019 Aug;129(2):553-566 74 Citations |
| 1 | Nitric Oxide Antagonism to Anti-Glioblastoma Photodynamic Therapy: Mitigation by Inhibitors of Nitric Oxide Generation. (Fahey JM, Girotti AW) Cancers (Basel) 2019 Feb 15;11(2) 27 Citations |
| 1 | CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy. (Han Y, Sun F, Zhang X, Wang T, Jiang J, Cai J, Gao Q, Hezam K, Liu Y, Xie J, Wang M, Zhang J) J Cancer Res Clin Oncol 2019 May;145(5):1179-1190 38 Citations |
| 1 | Hypersexual Behavior as a Symptom of PTSD: Using Cognitive Processing Therapy in a Veteran with Military Sexual Trauma-Related PTSD. (Larsen SE) Arch Sex Behav 2019 Apr;48(3):987-993 15 Citations |
| 1 | North American Fetal Therapy Network: Timing of and indications for delivery following laser ablation for twin-twin transfusion syndrome. (Zaretsky MV, Tong S, Lagueux M, Lim FY, Khalek N, Emery SP, Davis S, Moon-Grady AJ, Drennan K, Treadwell MC, Petersen E, Santiago-Munoz P, Brown R, North American Fetal Therapy Network) Am J Obstet Gynecol MFM 2019 Mar;1(1):74-81 11 Citations |
| 2 | Pathologic necrosis following neoadjuvant radiotherapy or chemoradiotherapy is prognostic of poor survival in soft tissue sarcoma. (Gannon NP, Stemm MH, King DM, Bedi M) J Cancer Res Clin Oncol 2019 May;145(5):1321-1330 26 Citations |
| 1 | Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy. (Gandhi UH, Cornell RF, Lakshman A, Gahvari ZJ, McGehee E, Jagosky MH, Gupta R, Varnado W, Fiala MA, Chhabra S, Malek E, Mansour J, Paul B, Barnstead A, Kodali S, Neppalli A, Liedtke M, Narayana S, Godby KN, Kang Y, Kansagra A, Umyarova E, Scott EC, Hari P, Vij R, Usmani SZ, Callander NS, Kumar SK, Costa LJ) Leukemia 2019 Sep;33(9):2266-2275 470 Citations |
| 1 | Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium. (DiNorcia J, Florman SS, Haydel B, Tabrizian P, Ruiz RM, Klintmalm GB, Senguttuvan S, Lee DD, Taner CB, Verna EC, Halazun KJ, Hoteit M, Levine MH, Chapman WC, Vachharajani N, Aucejo F, Nguyen MH, Melcher ML, Tevar AD, Humar A, Mobley C, Ghobrial M, Nydam TL, Amundsen B, Markmann JF, Berumen J, Hemming AW, Langnas AN, Carney CA, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Markovic D, Busuttil RW, Agopian VG) Ann Surg 2020 Apr;271(4):616-624 81 Citations |
| 1 | Impact of chemotherapy for breast cancer on leukocyte DNA methylation landscape and cognitive function: a prospective study. (Yao S, Hu Q, Kerns S, Yan L, Onitilo AA, Misleh J, Young K, Lei L, Bautista J, Mohamed M, Mohile SG, Ambrosone CB, Liu S, Janelsins MC) Clin Epigenetics 2019 Mar 12;11(1):45 41 Citations |
| 2 | Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course. (Deneau M, Perito E, Ricciuto A, Gupta N, Kamath BM, Palle S, Vitola B, Smolka V, Ferrari F, Amir AZ, Miloh T, Papadopoulou A, Mohan P, Mack C, Kolho KL, Iorio R, El-Matary W, Venkat V, Chan A, Saubermann L, Valentino PL, Shah U, Miethke A, Lin H, Jensen MK) J Pediatr 2019 Jun;209:92-96.e1 18 Citations |
| 1 | Correction to Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy. (Wang Y, Xie Y, Li J, Peng ZH, Sheinin Y, Zhou J, Oupický D) ACS Nano 2019 Apr 23;13(4):4855 5 Citations |
| 1 | Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial. (Marks WH, Mamode N, Montgomery RA, Stegall MD, Ratner LE, Cornell LD, Rowshani AT, Colvin RB, Dain B, Boice JA, Glotz D, C10-001 Study Group) Am J Transplant 2019 Oct;19(10):2876-2888 118 Citations |
| 1 | Pediatric Celiac Disease and Eosinophilic Esophagitis: Outcome of Dietary Therapy. (Patton T, Chugh A, Padhye L, DeGeeter C, Guandalini S) J Pediatr Gastroenterol Nutr 2019 Aug;69(2):e43-e48 10 Citations |
| 1 | Next-Generation Sequencing of Tissue and Circulating Tumor DNA: The UC San Diego Moores Center for Personalized Cancer Therapy Experience with Breast Malignancies. (Shatsky R, Parker BA, Bui NQ, Helsten T, Schwab RB, Boles SG, Kurzrock R) Mol Cancer Ther 2019 May;18(5):1001-1011 35 Citations |
| 2 | Stem cell damage after chemotherapy- can we do better? (Tang J, Zhu N, Rao S, Carlson KS) Best Pract Res Clin Haematol 2019 Mar;32(1):31-39 6 Citations |
| 3 | RAS Mutation Status Confers Prognostic Relevance in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer. (Morgan Z, Chow BE, Strong EA, Tsai S, Christians K, Mogal H, Gamblin TC, Clarke CN) J Surg Res 2019 Aug;240:130-135 15 Citations |
| 1 | Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study. (Hyams JS, Davis Thomas S, Gotman N, Haberman Y, Karns R, Schirmer M, Mo A, Mack DR, Boyle B, Griffiths AM, LeLeiko NS, Sauer CG, Keljo DJ, Markowitz J, Baker SS, Rosh J, Baldassano RN, Patel A, Pfefferkorn M, Otley A, Heyman M, Noe J, Oliva-Hemker M, Rufo PA, Strople J, Ziring D, Guthery SL, Sudel B, Benkov K, Wali P, Moulton D, Evans J, Kappelman MD, Marquis MA, Sylvester FA, Collins MH, Venkateswaran S, Dubinsky M, Tangpricha V, Spada KL, Saul B, Wang J, Serrano J, Hommel K, Marigorta UM, Gibson G, Xavier RJ, Kugathasan S, Walters T, Denson LA) Lancet 2019 Apr 27;393(10182):1708-1720 129 Citations |
| 1 | Mucoepidermoid Carcinoma of the Parotid: Very Close Margins and Adjuvant Radiotherapy. (Zenga J, Yu Z, Parikh A, Chen JX, Lin DT, Emerick KS, Faquin WC, Varvares MA, Deschler DG) ORL J Otorhinolaryngol Relat Spec 2019;81(1):55-62 17 Citations |
| 1 | Negative Pressure Wound Therapy for Surgical Site Infection Prevention Requires Further Study Before Widespread Adoption. (Murphy P, Kuper T, Ott M) JAMA Surg 2019 Jul 01;154(7):672-673 5 Citations |
| 1 | PET-guided, BEACOPPescalated therapy in advanced Hodgkin lymphoma. (Reid JH, Marini BL, Nachar VR, Devata S, Perissinotti AJ) Lancet Oncol 2019 Apr;20(4):e188 2 Citations |
| 1 | Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer. (Seo YD, Jiang X, Sullivan KM, Jalikis FG, Smythe KS, Abbasi A, Vignali M, Park JO, Daniel SK, Pollack SM, Kim TS, Yeung R, Crispe IN, Pierce RH, Robins H, Pillarisetty VG) Clin Cancer Res 2019 Jul 01;25(13):3934-3945 170 Citations |
| 1 | Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer. (Lee P, Loo BW Jr, Biswas T, Ding GX, El Naqa IM, Jackson A, Kong FM, LaCouture T, Miften M, Solberg T, Tome WA, Tai A, Yorke E, Li XA) Int J Radiat Oncol Biol Phys 2021 May 01;110(1):160-171 42 Citations |
| 1 | Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials. (Hallemeier CL, Zhang P, Pisansky TM, Hanks GE, McGowan DG, Roach M 3rd, Zeitzer KL, Firat SY, Husain SM, D'Souza DP, Souhami L, Parliament MB, Rosenthal SA, Lukka HR, Rotman M, Horwitz EM, Miles EF, Paulus R, Sandler HM) Int J Radiat Oncol Biol Phys 2019 Aug 01;104(5):1057-1065 11 Citations |
| 1 | Reassessing the Role of Radiation Therapy for the Treatment of Lymphoma: Historical Perspective and Opportunities in the Era of Image-Guided and Adaptive Radiation Therapy. (Schultz CJ) J Oncol Pract 2019 Apr;15(4):175-176 1 Citation |
| 4 | What is the Role of Hematopoietic Cell Transplantation (HCT) for Pediatric Acute Lymphoblastic Leukemia (ALL) in the Age of Chimeric Antigen Receptor T-Cell (CART) Therapy? (Taraseviciute A, Broglie L, Phelan R, Bhatt NS, Becktell K, Burke MJ) J Pediatr Hematol Oncol 2019 Jul;41(5):337-344 17 Citations |
| 1 | NIR-Light-Activated Combination Therapy with a Precise Ratio of Photosensitizer and Prodrug Using a Host-Guest Strategy. (Chen H, Zeng X, Tham HP, Phua SZF, Cheng W, Zeng W, Shi H, Mei L, Zhao Y) Angew Chem Int Ed Engl 2019 Jun 03;58(23):7641-7646 148 Citations |
| 1 | Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. (Shi Y, Gao W, Lytle NK, Huang P, Yuan X, Dann AM, Ridinger-Saison M, DelGiorno KE, Antal CE, Liang G, Atkins AR, Erikson G, Sun H, Meisenhelder J, Terenziani E, Woo G, Fang L, Santisakultarm TP, Manor U, Xu R, Becerra CR, Borazanci E, Von Hoff DD, Grandgenett PM, Hollingsworth MA, Leblanc M, Umetsu SE, Collisson EA, Scadeng M, Lowy AM, Donahue TR, Reya T, Downes M, Evans RM, Wahl GM, Pawson T, Tian R, Hunter T) Nature 2019 May;569(7754):131-135 324 Citations |
| 1 | Phenotypic and Genomic Determinants of Immunotherapy Response Associated with Squamousness. (Goodman AM, Kato S, Chattopadhyay R, Okamura R, Saunders IM, Montesion M, Frampton GM, Miller VA, Daniels GA, Kurzrock R) Cancer Immunol Res 2019 Jun;7(6):866-873 22 Citations |
| 1 | Surface-Modified Melphalan Nanoparticles for Intravitreal Chemotherapy of Retinoblastoma. (Sims LB, Tyo KM, Stocke S, Mahmoud MY, Ramasubramanian A, Steinbach-Rankins JM) Invest Ophthalmol Vis Sci 2019 Apr 01;60(5):1696-1705 26 Citations |
| 1 | Nationwide Trends in Heart-Sparing Techniques Utilized in Radiation Therapy for Breast Cancer. (Desai N, Currey A, Kelly T, Bergom C) Adv Radiat Oncol 2019;4(2):246-252 38 Citations |
| 1 | Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study. (Sicklick JK, Kato S, Okamura R, Schwaederle M, Hahn ME, Williams CB, De P, Krie A, Piccioni DE, Miller VA, Ross JS, Benson A, Webster J, Stephens PJ, Lee JJ, Fanta PT, Lippman SM, Leyland-Jones B, Kurzrock R) Nat Med 2019 May;25(5):744-750 505 Citations |
| 1 | Comprehensive Evaluation of Focal Therapy Complications in Prostate Cancer: A Standardized Methodology. (Bakavicius A, Sanchez-Salas R, Muttin F, Sivaraman A, Dell'Oglio P, Barret E, Rozet F, Mombet A, Prapotnich D, Cathala N, Cathelineau X) J Endourol 2019 Jul;33(7):509-515 19 Citations |
| 1 | Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study. (Kotha NV, Baumgartner JM, Veerapong J, Cloyd JM, Ahmed A, Grotz TE, Leiting JL, Fournier K, Lee AJ, Dineen SP, Dessureault S, Clarke C, Mogal H, Zaidi MY, Russell MC, Patel SH, Sussman JJ, Dhar V, Lambert LA, Hendrix RJ, Abbott DE, Pokrzywa C, Lafaro K, Lee B, Greer JB, Fackche N, Lowy AM, Kelly KJ) Ann Surg Oncol 2019 Jul;26(7):2234-2240 17 Citations |
| 1 | Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415. (Thor M, Deasy JO, Paulus R, Robert Lee W, Amin MB, Bruner DW, Low DA, Shah AB, Malone SC, Michalski JM, Dayes IS, Seaward SA, Gore EM, Albert M, Pisansky TM, Faria SL, Chen Y, Koontz BF, Swanson GP, Pugh SL, Sandler HM) Radiother Oncol 2019 Jun;135:19-24 22 Citations |
| 1 | Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand. (Mei L, Zhang J, He K, Zhang J) J Hematol Oncol 2019 Apr 24;12(1):43 99 Citations |
| 1 | Evaluation of two alternative ablation treatments for cervical pre-cancer against standard gas-based cryotherapy: a randomized non-inferiority study. (Cremer M, Alfaro K, Garai J, Salinas M, Maza M, Zevallos A, Taxa L, Diaz AC, Castle P, Alonzo TA, Masch R, Soler M, Conzuelo-Rodriguez G, Gage JC, Felix JC) Int J Gynecol Cancer 2019 Jun 02;29(5):851-856 6 Citations |
| 1 | An update on gene therapy for lysosomal storage disorders. (Nagree MS, Scalia S, McKillop WM, Medin JA) Expert Opin Biol Ther 2019 Jul;19(7):655-670 38 Citations |
| 1 | Revisiting Epidermal Growth Factor Receptor (EGFR) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced Malignancies. (Kato S, Okamura R, Mareboina M, Lee S, Goodman A, Patel SP, Fanta PT, Schwab RB, Vu P, Raymond VM, Lanman RB, Sicklick JK, Lippman SM, Kurzrock R) JCO Precis Oncol 2019;3 52 Citations |
| 1 | Correlation of Immune Markers With Outcomes in Biliary Atresia Following Intravenous Immunoglobulin Therapy. (Kim S, Moore J, Alonso E, Bednarek J, Bezerra JA, Goodhue C, Karpen SJ, Loomes KM, Magee JC, Ng VL, Sherker AH, Smith C, Spino C, Venkat V, Wang K, Sokol RJ, Mack CL, Childhood Liver Disease Research Network) Hepatol Commun 2019 May;3(5):685-696 22 Citations |
| 1 | Dermal elastolysis in the setting of combination immunotherapy. (Dickinson KE, Price L, Wanat KA, Swick BL) J Cutan Pathol 2019 Sep;46(9):684-687 6 Citations |
| 2 | Higher Trough Vedolizumab Concentrations During Maintenance Therapy are Associated With Corticosteroid-Free Remission in Inflammatory Bowel Disease. (Ungaro RC, Yarur A, Jossen J, Phan BL, Chefitz E, Sehgal P, Kamal K, Bruss A, Beniwal-Patel P, Fox C, Patel A, Bahur B, Jain A, Stein D, Naik S, Dubinsky MC) J Crohns Colitis 2019 Aug 14;13(8):963-969 55 Citations |
| 1 | Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy. (Kerns SL, Fachal L, Dorling L, Barnett GC, Baran A, Peterson DR, Hollenberg M, Hao K, Narzo AD, Ahsen ME, Pandey G, Bentzen SM, Janelsins M, Elliott RM, Pharoah PDP, Burnet NG, Dearnaley DP, Gulliford SL, Hall E, Sydes MR, Aguado-Barrera ME, Gómez-Caamaño A, Carballo AM, Peleteiro P, Lobato-Busto R, Stock R, Stone NN, Ostrer H, Usmani N, Singhal S, Tsuji H, Imai T, Saito S, Eeles R, DeRuyck K, Parliament M, Dunning AM, Vega A, Rosenstein BS, West CML) J Natl Cancer Inst 2020 Feb 01;112(2):179-190 79 Citations |
| 1 | Maintenance olaparib after platinum-based chemotherapy in patients (pts) with newly diagnosed advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): Efficacy by surgical and tumor status in the Phase III SOLO1 trial. (Cara Amanda Mathews, Kathleen N. Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Sergeevna Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S. Sonke, Charlie Gourley, Susana N. Banerjee, Amit M. Oza, Antonio González-Martín, Carol Aghajanian, William Hampton Bradley, Elizabeth S. Lowe, Ralph Bloomfield, Paul Disilvestro) Journal of Clinical Oncology DOI: 10.1200/JCO.2019.37.15_suppl.5541 Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019) 5541-5541. |
| 1 | Folic Acid-Functionalized Black Phosphorus Quantum Dots for Targeted Chemo-Photothermal Combination Cancer Therapy. (Luo M, Cheng W, Zeng X, Mei L, Liu G, Deng W) Pharmaceutics 2019 May 21;11(5) 61 Citations |
| 2 | Insights from pharmacists and pharmacy technicians about expedited partner therapy. (Tan KT, Pickett ML, Borchardt LN, Visotcky AM, Drendel AL) Sex Health 2019 Jun;16(3):289-295 5 Citations |
| 1 | Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin-producing Escherichia coli-infected Children. (McKee RS, Schnadower D, Tarr PI, Xie J, Finkelstein Y, Desai N, Lane RD, Bergmann KR, Kaplan RL, Hariharan S, Cruz AT, Cohen DM, Dixon A, Ramgopal S, Rominger A, Powell EC, Kilgar J, Michelson KA, Beer D, Bitzan M, Pruitt CM, Yen K, Meckler GD, Plint AC, Bradin S, Abramo TJ, Gouin S, Kam AJ, Schuh A, Balamuth F, Hunley TE, Kanegaye JT, Jones NE, Avva U, Porter R, Fein DM, Louie JP, Freedman SB, Pediatric Emergency Medicine Collaborative Research Committee and Pediatric Emergency Research Canada) Clin Infect Dis 2020 Apr 10;70(8):1643-1651 20 Citations |
| 1 | Intrathecal Baclofen Therapy in Patients with Multiple Sclerosis: Improved Outcomes and Reduced Costs Through Identification of Catheter Malfunction (Nelson, M.E., McGuire, J.R.) Neuromodulation |
| 2 | Intrathecal Baclofen Therapy in Patients With Multiple Sclerosis: Improved Outcomes and Reduced Costs Through Identification of Catheter Malfunction. (Nelson MES, McGuire JR) Neuromodulation 2019 Oct;22(7):839-842 2 Citations |
| 1 | Patient-Reported Visual Function Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: Preplanned Secondary Analysis of a Randomized Clinical Trial. (Scott IU, VanVeldhuisen PC, Barton F, Oden NL, Ip MS, Blodi BA, Worrall M, Fish GE, Study of Comparative Treatments for Retinal Vein Occlusion 2 Investigator Group) JAMA Ophthalmol 2019 Aug 01;137(8):932-938 7 Citations |
| 1 | Folate as an Adjuvant Therapy in Methanol Poisoning. (Theobald J, Lim C) Nutr Clin Pract 2019 Aug;34(4):521-527 12 Citations |
| 1 | Musculoskeletal Pain in Patients With Chronic Myeloid Leukemia After Tyrosine Kinase Inhibitor Therapy Cessation. (Kota V, Atallah E) Clin Lymphoma Myeloma Leuk 2019 Aug;19(8):480-487 15 Citations |
| 3 | The role of radiation therapy and margin width in localized soft-tissue sarcoma: Analysis from the US Sarcoma Collaborative. (Gannon NP, King DM, Ethun CG, Charlson J, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Votanopoulos K, Krasnick B, Fields RC, Cardona K, Bedi M) J Surg Oncol 2019 Sep;120(3):325-331 18 Citations |
| 3 | Postrelapse survival in diffuse large B-cell lymphoma after therapy failure following autologous transplantation. (Epperla N, Badar T, Szabo A, Vaughn J, Borson S, Saini NY, Patel RD, Shah NN, Hamadani M, Ahmed S, Cashen AF, Fenske TS) Blood Adv 2019 Jun 11;3(11):1661-1669 28 Citations |
| 1 | Cancer therapy-induced cardiovascular toxicity: old/new problems and old drugs. (Beyer AM, Bonini MG, Moslehi J) Am J Physiol Heart Circ Physiol 2019 Jul 01;317(1):H164-H167 21 Citations |
| 3 | The Dosimetric Impact of Interfractional Organ-at-Risk Movement During Liver Stereotactic Body Radiation Therapy. (Schmid RK, Tai A, Klawikowski S, Straza M, Ramahi K, Li XA, Robbins JR) Pract Radiat Oncol 2019 Nov;9(6):e549-e558 5 Citations |
| 1 | Estrogen therapy induces an unfolded protein response to drive cell death in ER+ breast cancer. (Hosford SR, Shee K, Wells JD, Traphagen NA, Fields JL, Hampsch RA, Kettenbach AN, Demidenko E, Miller TW) Mol Oncol 2019 Aug;13(8):1778-1794 17 Citations |
| 1 | Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology Group. (Kelly KM, Cole PD, Pei Q, Bush R, Roberts KB, Hodgson DC, McCarten KM, Cho SY, Schwartz C) Br J Haematol 2019 Oct;187(1):39-48 52 Citations |
| 1 | Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension. (Ivy DD, Feinstein JA, Yung D, Mullen MP, Kirkpatrick EC, Hirsch R, Austin ED, Fineman J, Truong U, Solum D, Deng CQ, Hopper RK) Pulm Circ 2019;9(3):2045894019856471 15 Citations |
| 1 | Radiation therapy for pancreatic adenocarcinoma, a treatment option that must be considered in the management of a devastating malignancy. (Hall WA, Goodman KA) Radiat Oncol 2019 Jun 26;14(1):114 30 Citations |
| 1 | HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation. (Duan T, Xu Z, Sun F, Wang Y, Zhang J, Luo C, Wang M) Biomed Pharmacother 2019 Sep;117:109121 58 Citations |
| 1 | Quantitative Delta T1 (dT1) as a Replacement for Adjudicated Central Reader Analysis of Contrast-Enhancing Tumor Burden: A Subanalysis of the American College of Radiology Imaging Network 6677/Radiation Therapy Oncology Group 0625 Multicenter Brain Tumor Trial. (Schmainda KM, Prah MA, Zhang Z, Snyder BS, Rand SD, Jensen TR, Barboriak DP, Boxerman JL) AJNR Am J Neuroradiol 2019 Jul;40(7):1132-1139 18 Citations |
| 1 | Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study. (Waller EK, Miklos D, Cutler C, Arora M, Jagasia MH, Pusic I, Flowers MED, Logan AC, Nakamura R, Chang S, Clow F, Lal ID, Styles L, Jaglowski S) Biol Blood Marrow Transplant 2019 Oct;25(10):2002-2007 81 Citations |
| 1 | Covered and uncovered biliary metal stents provide similar relief of biliary obstruction during neoadjuvant therapy in pancreatic cancer: a randomized trial. (Seo DW, Sherman S, Dua KS, Slivka A, Roy A, Costamagna G, Deviere J, Peetermans J, Rousseau M, Nakai Y, Isayama H, Kozarek R, Biliary SEMS During Neoadjuvant Therapy Study Group) Gastrointest Endosc 2019 Oct;90(4):602-612.e4 80 Citations |
| 8 | Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery. (Barnes CA, Chavez MI, Tsai S, Aldakkak M, George B, Ritch PS, Dua K, Clarke CN, Tolat P, Hagen C, Hall WA, Erickson BA, Evans DB, Christians KK) Surgery 2019 Sep;166(3):277-285 49 Citations |
| 1 | Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer. (Macedo FI, Ryon E, Maithel SK, Lee RM, Kooby DA, Fields RC, Hawkins WG, Williams G, Maduekwe U, Kim HJ, Ahmad SA, Patel SH, Abbott DE, Schwartz P, Weber SM, Scoggins CR, Martin RCG, Dudeja V, Franceschi D, Livingstone AS, Merchant NB) Ann Surg 2019 Sep;270(3):400-413 132 Citations |
| 1 | Late Health Outcomes After Contemporary Lymphome Malin de Burkitt Therapy for Mature B-Cell Non-Hodgkin Lymphoma: A Report From the Childhood Cancer Survivor Study. (Ehrhardt MJ, Chen Y, Sandlund JT, Bluhm EC, Hayashi RJ, Becktell K, Leisenring WM, Metzger ML, Ness KK, Krull KR, Oeffinger KC, Gibson TM, Cairo MS, Gross TG, Robison LL, Armstrong GT, Yasui Y, Hudson MM, Mulrooney DA) J Clin Oncol 2019 Oct 01;37(28):2556-2570 22 Citations |
| 1 | In vivo generated hematopoietic stem cells from genome edited induced pluripotent stem cells are functional in platelet-targeted gene therapy of murine hemophilia A. (Wang D, Zhang G, Gu J, Shao X, Dai Y, Li J, Pan X, Yao S, Xu A, Jin Y, Huang J, Shi Q, Zhu J, Xi X, Chen Z, Chen S) Haematologica 2020 Apr;105(4):e175-e179 9 Citations |
| 3 | Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Lung Cancer. (Borkenhagen JF, Bergom C, Rapp CT, Klawikowski SJ, Rein LE, Gore EM) Clin Lung Cancer 2019 Nov;20(6):435-441 30 Citations |
| 1 | Insulin therapy in patients with type 2 diabetes and high insulin resistance is associated with increased risk of complications and mortality. (Mendez CE, Walker RJ, Eiler CR, Mishriky BM, Egede LE) Postgrad Med 2019 Aug;131(6):376-382 16 Citations |
| 1 | Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative. (Zaidi MY, Ethun CG, Tran TB, Poultsides G, Grignol VP, Howard JH, Bedi M, Mogal H, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick B, Fields RC, Oskouei S, Reimer N, Monson D, Maithel SK, Cardona K) Ann Surg Oncol 2019 Oct;26(11):3542-3549 19 Citations |
| 1 | Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy. (Elmets CA, Lim HW, Stoff B, Connor C, Cordoro KM, Lebwohl M, Armstrong AW, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kivelevitch D, Korman NJ, Kroshinsky D, Leonardi CL, Lichten J, Mehta NN, Paller AS, Parra SL, Pathy AL, Farley Prater EA, Rupani RN, Siegel M, Strober BE, Wong EB, Wu JJ, Hariharan V, Menter A) J Am Acad Dermatol 2019 Sep;81(3):775-804 130 Citations |
| 1 | Letter: pre-operative anti-TNF therapy in Crohn's disease is not associated with increased complications following elective surgery. (Istl A, Yang ML, Fleshner KA, Parker CE, Guizzetti L, Singh S, Jairath V) Aliment Pharmacol Ther 2019 Aug;50(4):467-468 1 Citation |
| 1 | Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous Adenocarcinoma: a case report and literature review. (Chae YK, Saleem N, Roh Y, Bilal H, Viveiros P, Sukhadia B, Lin X, Sheikh MM, Park LC) BMC Cancer 2019 Jul 30;19(1):748 6 Citations |
| 2 | Preferences for mHealth physical activity interventions during chemotherapy for breast cancer: a qualitative evaluation. (Nielsen AM, Welch WA, Gavin KL, Cottrell AM, Solk P, Torre EA, Blanch-Hartigan D, Phillips SM) Support Care Cancer 2020 Apr;28(4):1919-1928 23 Citations |
| 1 | Optimizing hormone therapy in fresh embryo transfers. (Rydze RT, Gibbons WE) Fertil Steril 2019 Sep;112(3):467-468 |
| 6 | The association of pharmacy fill synchronization with breast cancer endocrine therapy adherence. (Neuner JM, Fergestrom NM, Laud PW, Nattinger AB, Beyer KMM, Flynn KE, Pezzin LE) Cancer 2019 Nov 15;125(22):3960-3965 6 Citations |
| 6 | Use of Neoadjuvant Chemotherapy in the Treatment of Locally Advanced Rectal Cancer. (Hu KY, Simpson MT, Blank JJ, Szabo A, Eastwood D, Ludwig KA, Peterson CY, Ridolfi TJ) J Surg Res 2019 Nov;243:447-452 11 Citations |
| 2 | The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists. (Bergom C, West CM, Higginson DS, Abazeed ME, Arun B, Bentzen SM, Bernstein JL, Evans JD, Gerber NK, Kerns SL, Keen J, Litton JK, Reiner AS, Riaz N, Rosenstein BS, Sawakuchi GO, Shaitelman SF, Powell SN, Woodward WA) Int J Radiat Oncol Biol Phys 2019 Nov 15;105(4):698-712 73 Citations |
| 1 | Thirty-day hospital revisits after prostate brachytherapy: who is at risk? (Li B, Kirshenbaum EJ, Blackwell RH, Gange WS, Saluk J, Zapf MAC, Kothari AN, Flanigan RC, Gupta GN) Prostate Int 2019 Jun;7(2):68-72 3 Citations |
| 3 | Detrimental effects of chemotherapy on human coronary microvascular function. (Hader SN, Zinkevich N, Norwood Toro LE, Kriegel AJ, Kong A, Freed JK, Gutterman DD, Beyer AM) Am J Physiol Heart Circ Physiol 2019 Oct 01;317(4):H705-H710 31 Citations |
| 1 | How I Treat Resectable Pancreatic Cancer With Adjuvant Therapy (PA Philip, M Kamgar) Handbook of Gastrointestinal Cancers: Evidence-Based Treatment and Multidisciplinary Patient Care PA Philip, M Kamgar (2019).'How I Treat Resectable Pancreatic Cancer With Adjuvant Therapy', in T Bekaii-Saab, B El-Rayes, T Pawlik (ed.) Handbook of Gastrointestinal Cancers: Evidence-Based Treatment and Multidisciplinary Patient Care: Springer Publishing Company, PP. 183-190 |
| 1 | Microsatellite-Stable Tumors with High Mutational Burden Benefit from Immunotherapy. (Goodman AM, Sokol ES, Frampton GM, Lippman SM, Kurzrock R) Cancer Immunol Res 2019 Oct;7(10):1570-1573 223 Citations |
| 5 | Factors Associated With HSV PCR CSF Testing and Empiric Acyclovir Therapy in Young Febrile Infants. (Swartz S, Hadjiev J, Kolinski J, Chou E, Allen K, Yan K, Havens PL) Clin Pediatr (Phila) 2019 Oct;58(11-12):1194-1200 2 Citations |
| 1 | Editorial: Pathogenesis and Therapy of Graft-versus-Host Disease. (Betts BC, Yu XZ) Front Immunol 2019;10:1797 6 Citations |
| 1 | Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. (Jain T, Bar M, Kansagra AJ, Chong EA, Hashmi SK, Neelapu SS, Byrne M, Jacoby E, Lazaryan A, Jacobson CA, Ansell SM, Awan FT, Burns L, Bachanova V, Bollard CM, Carpenter PA, DiPersio JF, Hamadani M, Heslop HE, Hill JA, Komanduri KV, Kovitz CA, Lazarus HM, Serrette JM, Mohty M, Miklos D, Nagler A, Pavletic SZ, Savani BN, Schuster SJ, Kharfan-Dabaja MA, Perales MA, Lin Y) Biol Blood Marrow Transplant 2019 Dec;25(12):2305-2321 149 Citations |
| 4 | Estimation of changing gross tumor volume from longitudinal CTs during radiation therapy delivery based on a texture analysis with classifier algorithms: a proof-of-concept study. (Schott D, Schmidt TG, Hall W, Knechtges P, Noid G, Klawikowski S, Erickson B, Li XA) Quant Imaging Med Surg 2019 Jul;9(7):1189-1200 |
| 1 | Four-dimensional computed tomography-based biomechanical measurements of pulmonary function and their correlation with clinical outcome for lung stereotactic body radiation therapy patients. (Sharifi H, McDonald GC, Lee JK, Ajlouni MI, Chetty IJ, Zhong H) Quant Imaging Med Surg 2019 Jul;9(7):1278-1287 6 Citations |
| 1 | Behavior, body composition, and vascular phenotype of homocystinuric mice on methionine-restricted diet or enzyme replacement therapy. (Majtan T, Park I, Cox A, Branchford BR, di Paola J, Bublil EM, Kraus JP) FASEB J 2019 Nov;33(11):12477-12486 19 Citations |
| 1 | What does it mean to have a meaning problem? Meaning, skill, and the mechanisms of change in psychotherapy (Leder G) Philosophy, Psychiatry and Psychology September 2019;26(3):E-35-E-50 5 Citations |
| 1 | Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline (Palta M, Godfrey D, Goodman KA, Hoffe S, Dawson LA, Dessert D, Hall WA, Herman JM, Khorana AA, Merchant N, Parekh A, Patton C, Pepek JM, Salama JK, Tuli R, Koong AC) Practical Radiation Oncology September - October 2019;9(5):322-332 137 Citations |
| 1 | Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. (Palta M, Godfrey D, Goodman KA, Hoffe S, Dawson LA, Dessert D, Hall WA, Herman JM, Khorana AA, Merchant N, Parekh A, Patton C, Pepek JM, Salama JK, Tuli R, Koong AC) Pract Radiat Oncol 2019;9(5):322-332 136 Citations |
| 1 | Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD-L1 expression in cancer patients. (Nikanjam M, Arguello D, Gatalica Z, Swensen J, Barkauskas DA, Kurzrock R) Int J Cancer 2020 Jun 01;146(11):3087-3097 20 Citations |
| 1 | Role of radiation therapy for retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative. (Chouliaras K, Senehi R, Ethun CG, Poultsides G, Grignol V, Clarke CN, Roggin KK, Fields RC, Schwartz PB, Ronnekleiv-Kelly SM, D'Agostino R Jr, Johnson EN, Levine EA, Cardona K, Votanopoulos KI) J Surg Oncol 2019 Dec;120(7):1227-1234 29 Citations |
| 1 | Feasibility and acceptability of intensive longitudinal data collection of activity and patient-reported outcomes during chemotherapy for breast cancer. (Solk P, Gavin K, Fanning J, Welch W, Lloyd G, Cottrell A, Nielsen A, Santa Maria CA, Gradishar W, Khan SA, Kulkarni S, Siddique J, Phillips SM) Qual Life Res 2019 Dec;28(12):3333-3346 19 Citations |
| 1 | Cryoglobulinemic vasculitis with interruption of ibrutinib therapy for chronic lymphocytic leukemia (CLL). (Wright N, Voshtina E, George G, Singavi A, Field J) Int J Hematol 2019 Dec;110(6):751-755 1 Citation |
| 2 | Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas. (Squires MH, Ethun CG, Suarez-Kelly LP, Yu PY, Hughes TM, Shelby RD, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard JH) J Surg Res 2020 Jan;245:577-586 3 Citations |
| 2 | Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice. (Gao C, Schroeder JA, Xue F, Jing W, Cai Y, Scheck A, Subramaniam S, Rao S, Weiler H, Czechowicz A, Shi Q) Blood Adv 2019 Sep 24;3(18):2700-2711 43 Citations |
| 1 | Dramatic response to modified docetaxel, cisplatin, and fluorouracil chemotherapy after immunotherapy in a patient with refractory metastatic anal cancer. (Shahjehan F, Kamatham S, Ritter A, Kasi PM) Clin Case Rep 2019 Sep;7(9):1729-1734 2 Citations |
| 1 | Feasibility of Integrating Panel-Based Pharmacogenomics Testing for Chemotherapy and Supportive Care in Patients With Colorectal Cancer. (Kasi PM, Koep T, Schnettler E, Shahjehan F, Kamatham V, Baldeo C, Hughes CL) Technol Cancer Res Treat 2019 Jan 01;18:1533033819873924 12 Citations |
| 1 | Cobalt Blues: A New Complication of Hydroxocobalamin Therapy for Vasopressor-Resistant Vasoplegia in Patients Treated With Chronic Renal Replacement Therapy? (Pagel PS, Tawil JN, Freed JK) J Cardiothorac Vasc Anesth 2019 Dec;33(12):3406-3408 3 Citations |
| 1 | Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902. (Hamstra DA, Pugh SL, Lepor H, Rosenthal SA, Pienta KJ, Gomella L, Peters C, D'Souza DP, Zeitzer KL, Jones CU, Hall WA, Horwitz E, Pisansky TM, Souhami L, Hartford AC, Dominello M, Feng F, Sandler HM) Radiother Oncol 2019 Dec;141:137-143 11 Citations |
| 1 | Nitric Oxide-Mediated Resistance to Antitumor Photodynamic Therapy. (Girotti AW) Photochem Photobiol 2020 May;96(3):500-505 14 Citations |
| 1 | Stereotactic body radiation therapy and immunotherapy. (Khalife M, Shahid K, Dabney RS, Phan AT) Clin Adv Hematol Oncol 2019 Sep;17(9):518-523 4 Citations |
| 2 | Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors. (Udhane V, Maranto C, Hoang DT, Gu L, Erickson A, Devi S, Talati PG, Banerjee A, Iczkowski KA, Jacobsohn K, See WA, Mirtti T, Kilari D, Nevalainen MT) Mol Cancer Ther 2020 Jan;19(1):231-246 20 Citations |
| 1 | A systems mechanism for KRAS mutant allele-specific responses to targeted therapy. (McFall T, Diedrich JK, Mengistu M, Littlechild SL, Paskvan KV, Sisk-Hackworth L, Moresco JJ, Shaw AS, Stites EC) Sci Signal 2019 Sep 24;12(600) 42 Citations |
| 2 | An Apparent Large Pericardial Effusion: A Consequence of Dual Antiplatelet Therapy or an Entirely Different Diagnosis? (Pagel PS, Millen HT, Peterson TS, Gandhi SD, Lohr NL, Almassi GH) J Cardiothorac Vasc Anesth 2020 Apr;34(4):1105-1110 |
| 4 | A preferred patient decubitus positioning for magnetic resonance image guided online adaptive radiation therapy of pancreatic cancer (Chen Y, Chen X, Hall W, Prior P, Zhang Y, Paulson E, Lang J, Erickson B, Li XA) Physics and Imaging in Radiation Oncology October 2019;12:22-29 1 Citation |
| 1 | Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933 (Bovi JA, Pugh SL, Sabsevitz D, Robinson CG, Paulson E, Mehta MP, Gondi V, Kundapur V, Shahin MS, Chao ST, Machtay M, DeNittis AS, Laack NN, Greenspoon JN, Moore KN, Huang J, Dominello MM, Kachnic LA) Advances in Radiation Oncology October - December 2019;4(4):579-586 20 Citations |
| 1 | Utility of In Vitro Mutagenesis of RPE65 Protein for Verification of Mutational Pathogenicity Before Gene Therapy. (Yang U, Gentleman S, Gai X, Gorin MB, Borchert MS, Lee TC, Villanueva A, Koenekoop R, Maguire AM, Bennett J, Redmond TM, Nagiel A) JAMA Ophthalmol 2019 Dec 01;137(12):1381-1388 16 Citations |
| 1 | In vivo longitudinal imaging of RNA interference-induced endocrine therapy resistance in breast cancer. (Biswal NC, Fu X, Jagtap JM, Shea MJ, Kumar V, Lords T, Roy R, Schiff R, Joshi A) J Biophotonics 2020 Jan;13(1):e201900180 1 Citation |
| 2 | Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor T Cell Therapy. (Ruark J, Mullane E, Cleary N, Cordeiro A, Bezerra ED, Wu V, Voutsinas J, Shaw BE, Flynn KE, Lee SJ, Turtle CJ, Maloney DG, Fann JR, Bar M) Biol Blood Marrow Transplant 2020 Jan;26(1):34-43 127 Citations |
| 1 | Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy. (Sinha S, Dwivedi N, Tao S, Jamadar A, Kakade VR, Neil MO, Weiss RH, Enders J, Calvet JP, Thomas SM, Rao R) Oncogene 2020 Feb;39(6):1231-1245 33 Citations |
| 1 | Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma. (Ludwig AD, Labadie KP, Seo YD, Hamlin DK, Nguyen HM, Mahadev VM, Yeung RS, Wilbur DS, Park JO) J Oncol 2019;2019:4564707 8 Citations |
| 7 | Management of Acute Cholecystitis during Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma. (Jariwalla NR, Khan AH, Dua K, Christians KK, Clarke CN, Aldakkak M, George B, Tutton S, Rilling W, Erickson B, Evans DB, Tsai S) Ann Surg Oncol 2019 Dec;26(13):4515-4521 7 Citations |
| 1 | AAV Gene Therapy Utilizing Glycosylation-Independent Lysosomal Targeting Tagged GAA in the Hypoglossal Motor System of Pompe Mice. (Doyle BM, Turner SMF, Sunshine MD, Doerfler PA, Poirier AE, Vaught LA, Jorgensen ML, Falk DJ, Byrne BJ, Fuller DD) Mol Ther Methods Clin Dev 2019 Dec 13;15:194-203 15 Citations |
| 1 | Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter? (Wiseman JT, Kimbrough C, Beal EW, Zaidi MY, Staley CA, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Raoof M, Lee B, Fackche N, Greer J, Pawlik TM, Abdel-Misih S, Cloyd JM) Ann Surg Oncol 2020 Mar;27(3):783-792 23 Citations |
| 1 | Bystander Effects of Nitric Oxide in Cellular Models of Anti-Tumor Photodynamic Therapy. (Bazak J, Korytowski W, Girotti AW) Cancers (Basel) 2019 Oct 28;11(11) 24 Citations |
| 1 | Integrated pan-cancer gene expression and drug sensitivity analysis reveals SLFN11 mRNA as a solid tumor biomarker predictive of sensitivity to DNA-damaging chemotherapy. (Shee K, Wells JD, Jiang A, Miller TW) PLoS One 2019;14(11):e0224267 34 Citations |
| 1 | Evaluating Acalabrutinib In The Treatment Of Mantle Cell Lymphoma: Design, Development, And Place In Therapy. (Girard J, Reneau J, Devata S, Wilcox RA, Kaminski MS, Mercer J, Carty S, Phillips TJ) Onco Targets Ther 2019;12:8003-8014 8 Citations |
| 2 | Gut microbiome and CAR-T therapy (Abid MB, Shah NN, Maatman TC, Hari PN) Experimental Hematology and Oncology 19 November 2019;8(1) 39 Citations |
| 4 | Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial. (Pidala J, Hamadani M, Dawson P, Martens M, Alousi AM, Jagasia M, Efebera YA, Chhabra S, Pusic I, Holtan SG, Ferrara JLM, Levine JE, Mielcarek M, Anasetti C, Antin JH, Bolaños-Meade J, Howard A, Logan BR, Leifer ES, Pritchard TS, Horowitz MM, MacMillan ML) Blood 2020 Jan 09;135(2):97-107 65 Citations |
| 2 | A preferred patient decubitus positioning for magnetic resonance image guided online adaptive radiation therapy of pancreatic cancer. (Chen Y, Chen X, Hall W, Prior P, Zhang Y, Paulson E, Lang J, Erickson B, Li XA) Phys Imaging Radiat Oncol 2019 Oct;12:22-29 1 Citation |
| 6 | Role of Molecular Profiling of Pancreatic Cancer After Neoadjuvant Therapy: Does it Change Practice? (Krepline AN, Bliss L, Geurts J, Akinola I, Christians KK, George B, Ritch PS, Hall WA, Erickson BA, Evans DB, Tsai S) J Gastrointest Surg 2020 Feb;24(2):235-242 10 Citations |
| 1 | Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a US HIPEC Collaborative Study. (Lee TC, Wima K, Sussman JJ, Ahmad SA, Cloyd JM, Ahmed A, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Zaidi MY, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Blakely AM, Lee B, Johnston FM, Greer J, Patel SH) J Gastrointest Surg 2020 Jan;24(1):165-176 30 Citations |
| 1 | PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors. (Mpilla G, Aboukameel A, Muqbil I, Kim S, Beydoun R, Philip PA, Mohammad RM, Kamgar M, Shidham V, Senapedis W, Baloglu E, Li J, Dyson G, Xue Y, El-Rayes B, Azmi AS) Cancers (Basel) 2019 Nov 29;11(12) 23 Citations |
| 3 | A daily end-to-end quality assurance workflow for MR-guided online adaptive radiation therapy on MR-Linac. (Chen X, Ahunbay E, Paulson ES, Chen G, Li XA) J Appl Clin Med Phys 2020 Jan;21(1):205-212 28 Citations |
| 2 | Opioid Dose and Benzodiazepine Use Among Commercially Insured Individuals on Chronic Opioid Therapy. (Kay C, Fergestrom N, Spanbauer C, Jackson JL) Pain Med 2020 Jun 01;21(6):1181-1187 4 Citations |
| 1 | Immunotherapy and targeted therapy-the new roadmap in cancer treatment. (Shahid K, Khalife M, Dabney R, Phan AT) Ann Transl Med 2019 Oct;7(20):595 |
| 1 | Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia. (Frey NV, Shaw PA, Hexner EO, Pequignot E, Gill S, Luger SM, Mangan JK, Loren AW, Perl AE, Maude SL, Grupp SA, Shah NN, Gilmore J, Lacey SF, Melenhorst JJ, Levine BL, June CH, Porter DL) J Clin Oncol 2020 Feb 10;38(5):415-422 195 Citations |
| 2 | Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE Syndrome. (Olsen GM, Hansen LM, Stefanko NS, Mathes E, Puttgen KB, Tollefson MM, Lauren C, Mancini AJ, McCuaig CC, Frieden IJ, Adams D, Baselga E, Chamlin S, Gupta D, Frommelt P, Garzon MC, Horii K, Klajn J, Maheshwari M, Newell B, Nguyen HL, Nopper A, Powell J, Siegel DH, Drolet BA) JAMA Dermatol 2020 Feb 01;156(2):186-190 37 Citations |
| 3 | Gut microbiome and CAR-T therapy. (Abid MB, Shah NN, Maatman TC, Hari PN) Exp Hematol Oncol 2019;8:31 39 Citations |
| 1 | Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: Executive Summary of an American Society for Radiation Oncology Clinical Practice Guideline. (Likhacheva A, Awan M, Barker CA, Bhatnagar A, Bradfield L, Brady MS, Buzurovic I, Geiger JL, Parvathaneni U, Zaky S, Devlin PM) Pract Radiat Oncol 2020;10(1):8-20 142 Citations |
| 1 | Upregulation of pro-tumor nitric oxide by anti-tumor photodynamic therapy. (Girotti AW, Fahey JM) Biochem Pharmacol 2020 Jun;176:113750 21 Citations |
| 1 | Binimetinib, encorafenib and cetuximab (BEACON Trial) combination therapy for patients with BRAF V600E-mutant metastatic colorectal cancer. (Shahjehan F, Kamatham S, Chandrasekharan C, Kasi PM) Drugs Today (Barc) 2019 Nov;55(11):683-693 11 Citations |
| 1 | Molecular pathways and targeted therapy in cholangiocarcinoma. (Dabney RS, Khalife M, Shahid K, Phan AT) Clin Adv Hematol Oncol 2019 Nov;17(11):630-637 17 Citations |
| 2 | A high mitotic score in breast cancer after neoadjuvant chemotherapy is predictive of outcome and associated with a distinct morphology. (Arispe Angulo KR, Jawa Z, Visotcky A, Majidi SS, Chitambar CR, Jorns JM) Histopathology 2020 Apr;76(5):661-670 2 Citations |
| 1 | Combination Antihypertensive Therapy Prescribing and Blood Pressure Control in a Real-World Setting. (Magvanjav O, Cooper-Dehoff RM, McDonough CW, Gong Y, Hogan WR, Johnson JA) Am J Hypertens 2020 Apr 01;33(4):316-324 6 Citations |
| 1 | An Analysis of Primary Care Clinician Communication About Risk, Benefits, and Goals Related to Chronic Opioid Therapy. (Danielson EC, Mazurenko O, Andraka-Christou BT, DiIulio J, Downs SM, Hurley RW, Harle CA) MDM Policy Pract 2019;4(2):2381468319892572 11 Citations |
| 1 | Prophylactic Negative Pressure Wound Therapy for Closed Laparotomy Incisions: A Meta-analysis of Randomized Controlled Trials. (Kuper TM, Murphy PB, Kaur B, Ott MC) Ann Surg 2020 Jan;271(1):67-74 41 Citations |
| 1 | Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model. (Berger A, Colpitts SJ, Seabrook MSS, Furlonger CL, Bendix MB, Moreau JM, McKillop WM, Medin JA, Paige CJ) J Immunother Cancer 2019 Dec 19;7(1):355 17 Citations |
| 1 | Pharmacotherapy for Pediatric Convulsive Status Epilepticus. (Singh A, Stredny CM, Loddenkemper T) CNS Drugs 2020 Jan;34(1):47-63 35 Citations |
| 1 | A Comparison of Inducible Gene Expression Platforms: Implications for Recombinant Adeno-Associated Virus (rAAV) Vector-Mediated Ocular Gene Therapy. (Lipinski DM) Adv Exp Med Biol 2019;1185:79-83 5 Citations |
| 3 | Trends in postrelapse survival in classic Hodgkin lymphoma patients after experiencing therapy failure following auto-HCT. (Badar T, Epperla N, Szabo A, Borson S, Vaughn J, George G, Saini N, Shah AR, Patel RD, Ahmed S, Shah NN, Cashen AF, Hamadani M, Fenske TS) Blood Adv 2020 Jan 14;4(1):47-54 22 Citations |
| 1 | CD4 rate of increase is preferred to CD4 threshold for predicting outcomes among virologically suppressed HIV-infected adults on antiretroviral therapy. (Aldrete S, Jang JH, Easley KA, Okulicz J, Dai T, Chen YN, Pino M, Agan BK, Maves RC, Paiardini M, Marconi VC) PLoS One 2020;15(1):e0227124 12 Citations |
| 1 | Maternal racial and ethnic disparities in glycemic threshold for pharmacotherapy initiation for gestational diabetes. (Palatnik A, Harrison RK, Walker RJ, Thakkar MY, Egede LE) J Matern Fetal Neonatal Med 2022 Jan;35(1):58-65 12 Citations |
| 1 | American Brachytherapy Society working group report on the patterns of care and a literature review of reirradiation for gynecologic cancers. (Sturdza A, Viswanathan AN, Erickson B, Yashar C, Bruggeman A, Feddock J, Klopp A, Beriwal S, Gaffney D, Han K, Kamrava M) Brachytherapy 2020;19(2):127-138 24 Citations |
| 2 | Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation? (Dreger P, Fenske TS, Montoto S, Pasquini MC, Sureda A, Hamadani M, European Society for Blood and Marrow Transplantation (EBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR)) Biol Blood Marrow Transplant 2020 Apr;26(4):e77-e85 44 Citations |
| 1 | Prospective CYP2C19 Genotyping to Guide Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Pragmatic Randomized Clinical Trial. (Tuteja S, Glick H, Matthai W, Nachamkin I, Nathan A, Monono K, Carcuffe C, Maslowski K, Chang G, Kobayashi T, Anwaruddin S, Hirshfeld J, Wilensky RL, Herrmann HC, Kolansky DM, Rader DJ, Giri J) Circ Genom Precis Med 2020 Feb;13(1):e002640 47 Citations |
| 1 | The Promising Role of Lung Ultrasound in Assessment of Volume Status for Patients Receiving Maintenance Renal Replacement Therapy. (Koratala A, Ronco C, Kazory A) Blood Purif 2020;49(6):643-646 14 Citations |
| 2 | Treatment Strategies for Therapy-related Acute Myeloid Leukemia. (Dhakal P, Pyakuryal B, Pudasainee P, Rajasurya V, Gundabolu K, Bhatt VR) Clin Lymphoma Myeloma Leuk 2020 Mar;20(3):147-155 11 Citations |
| 1 | Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy: a multicenter retrospective cohort study. (Gorga SM, Sahay RD, Askenazi DJ, Bridges BC, Cooper DS, Paden ML, Zappitelli M, Gist KM, Gien J, Basu RK, Jetton JG, Murphy HJ, King E, Fleming GM, Selewski DT) Pediatr Nephrol 2020 May;35(5):871-882 59 Citations |
| 1 | Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study. (Burke MJ, Kostadinov R, Sposto R, Gore L, Kelley SM, Rabik C, Trepel JB, Lee MJ, Yuno A, Lee S, Bhojwani D, Jeha S, Chang BH, Sulis ML, Hermiston ML, Gaynon P, Huynh V, Verma A, Gardner R, Heym KM, Dennis RM, Ziegler DS, Laetsch TW, Oesterheld JE, Dubois SG, Pollard JA, Glade-Bender J, Cooper TM, Kaplan JA, Farooqi MS, Yoo B, Guest E, Wayne AS, Brown PA) Clin Cancer Res 2020 May 15;26(10):2297-2307 34 Citations |
| 3 | Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9. (Nasief H, Hall W, Zheng C, Tsai S, Wang L, Erickson B, Li XA) Front Oncol 2019;9:1464 40 Citations |
| 1 | Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer. (Huang KW, Hsu FF, Qiu JT, Chern GJ, Lee YA, Chang CC, Huang YT, Sung YC, Chiang CC, Huang RL, Lin CC, Dinh TK, Huang HC, Shih YC, Alson D, Lin CY, Lin YC, Chang PC, Lin SY, Chen Y) Sci Adv 2020 Jan;6(3):eaax5032 208 Citations |
| 1 | Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia. (Badar T, Shah NN) Curr Treat Options Oncol 2020 Feb 05;21(2):16 23 Citations |
| 2 | Dose-Escalated Radiation Therapy for Pancreatic Cancer: A Simultaneous Integrated Boost Approach. (Koay EJ, Hanania AN, Hall WA, Taniguchi CM, Rebueno N, Myrehaug S, Aitken KL, Dawson LA, Crane CH, Herman JM, Erickson B) Pract Radiat Oncol 2020;10(6):e495-e507 55 Citations |
| 1 | Instituting a New Central Line Policy to Decrease Central Line-associated Blood Stream Infection Rates During Induction Therapy in Pediatric Acute Lymphoblastic Leukemia Patients. (Berger R, Messina AF, Chandler NM, Amankwah EK, Shaw PH) J Pediatr Hematol Oncol 2020 Oct;42(7):433-437 5 Citations |
| 1 | Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study. (Kurzrock R, Bowles DW, Kang H, Meric-Bernstam F, Hainsworth J, Spigel DR, Bose R, Burris H, Sweeney CJ, Beattie MS, Blotner S, Schulze K, Cuchelkar V, Swanton C) Ann Oncol 2020 Mar;31(3):412-421 98 Citations |
| 2 | Controlling Cytokine Release Syndrome to Harness the Full Potential of CAR-Based Cellular Therapy. (Thakar MS, Kearl TJ, Malarkannan S) Front Oncol 2019;9:1529 26 Citations |
| 1 | ARID1A alterations function as a biomarker for longer progression-free survival after anti-PD-1/PD-L1 immunotherapy. (Okamura R, Kato S, Lee S, Jimenez RE, Sicklick JK, Kurzrock R) J Immunother Cancer 2020 Feb;8(1) 132 Citations |
| 1 | Circulating Tumor DNA-Based Detection of Microsatellite Instability and Response to Immunotherapy in Pancreatic Cancer. (Kamatham S, Shahjehan F, Kasi PM) Front Pharmacol 2020;11:23 7 Citations |
| 1 | Capsule Commentary on Carey et al., Is Non-steroidal Anti-inflammatory Therapy Non-inferior to Antibiotic Therapy in Uncomplicated Urinary Tract Infections: a Systematic Review. (Aldrete S) J Gen Intern Med 2020 Jun;35(6):1936 1 Citation |
| 1 | Myocarditis associated with immune checkpoint inhibitor therapy: a case report of three patients. (Ansari-Gilani K, Tirumani SH, Smith DA, Nelson A, Alahmadi A, Hoimes CJ, Ramaiya NH) Emerg Radiol 2020 Aug;27(4):455-460 9 Citations |
| 1 | Effects of Previous Medication Regimen Factors and Bipolar and Psychotic Disorders on Breast Cancer Endocrine Therapy Adherence. (Haskins CB, Neuner JM, McDowell BD, Carnahan RM, Fiedorowicz JG, Wallace RB, Smith BJ, Chrischilles EA) Clin Breast Cancer 2020 Jun;20(3):e261-e280 2 Citations |
| 1 | Photodynamic therapy for the treatment of tracheobronchial papillomatosis: A multicenter experience. (Glisinski K, Kurman JS, Spandorfer A, Pastis NJ, Murgu S, Cheng GZ) Photodiagnosis Photodyn Ther 2020 Jun;30:101711 3 Citations |
| 1 | Psychosocial care for children receiving chimeric antigen receptor (CAR) T-cell therapy. (Steineck A, Wiener L, Mack JW, Shah NN, Summers C, Rosenberg AR) Pediatr Blood Cancer 2020 May;67(5):e28249 13 Citations |
| 1 | Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review. (Beal EW, Suarez-Kelly LP, Kimbrough CW, Johnston FM, Greer J, Abbott DE, Pokrzywa C, Raoof M, Lee B, Grotz TE, Leiting JL, Fournier K, Lee AJ, Dineen SP, Powers B, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Russell MC, Zaidi MY, Patel SH, Dhar V, Lambert L, Hendrix RJ, Hays J, Abdel-Misih S, Cloyd JM) J Clin Med 2020 Mar 10;9(3) 30 Citations |
| 2 | Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy. (Kanate AS, Majhail NS, Savani BN, Bredeson C, Champlin RE, Crawford S, Giralt SA, LeMaistre CF, Marks DI, Omel JL, Orchard PJ, Palmer J, Saber W, Veys PA, Carpenter PA, Hamadani M) Biol Blood Marrow Transplant 2020 Jul;26(7):1247-1256 185 Citations |
| 1 | Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer. (Dess RT, Sun Y, Jackson WC, Jairath NK, Kishan AU, Wallington DG, Mahal BA, Stish BJ, Zumsteg ZS, Den RB, Hall WA, Gharzai LA, Jaworski EM, Reichert ZR, Morgan TM, Mehra R, Schaeffer EM, Sartor O, Nguyen PL, Lee WR, Rosenthal SA, Michalski JM, Schipper MJ, Dignam JJ, Pisansky TM, Zietman AL, Sandler HM, Efstathiou JA, Feng FY, Shipley WU, Spratt DE) JAMA Oncol 2020 May 01;6(5):735-743 75 Citations |
| 3 | Magnetic resonance-guided stereotactic laser ablation therapy for the treatment of pediatric brain tumors: a multiinstitutional retrospective study. (Arocho-Quinones EV, Lew SM, Handler MH, Tovar-Spinoza Z, Smyth M, Bollo R, Donahue D, Perry MS, Levy ML, Gonda D, Mangano FT, Storm PB, Price AV, Couture DE, Oluigbo C, Duhaime AC, Barnett GH, Muh CR, Sather MD, Fallah A, Wang AC, Bhatia S, Patel K, Tarima S, Graber S, Huckins S, Hafez DM, Rumalla K, Bailey L, Shandley S, Roach A, Alexander E, Jenkins W, Tsering D, Price G, Meola A, Evanoff W, Thompson EM, Brandmeir N, Pediatric Stereotactic Laser Ablation Workgroup) J Neurosurg Pediatr 2020 Jul 01;26(1):13-21 25 Citations |
| 1 | Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline. (Simone CB 2nd, Bogart JA, Cabrera AR, Daly ME, DeNunzio NJ, Detterbeck F, Faivre-Finn C, Gatschet N, Gore E, Jabbour SK, Kruser TJ, Schneider BJ, Slotman B, Turrisi A, Wu AJ, Zeng J, Rosenzweig KE) Pract Radiat Oncol 2020;10(3):158-173 142 Citations |
| 2 | The Incidence of Root Canal Therapy after Full-Coverage Restorations: A 10-Year Retrospective Study. (Yavorek A, Bhagavatula P, Patel K, Szabo A, Ibrahim M) J Endod 2020 May;46(5):605-610 11 Citations |
| 1 | KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma. (Wang M, Munoz J, Goy A, Locke FL, Jacobson CA, Hill BT, Timmerman JM, Holmes H, Jaglowski S, Flinn IW, McSweeney PA, Miklos DB, Pagel JM, Kersten MJ, Milpied N, Fung H, Topp MS, Houot R, Beitinjaneh A, Peng W, Zheng L, Rossi JM, Jain RK, Rao AV, Reagan PM) N Engl J Med 2020 Apr 02;382(14):1331-1342 1343 Citations |
| 1 | Transitioning to non-insulin therapy in a patient receiving high dose insulin. (Mishriky BM, Cummings DM, Mendez CE, Patil SP, Powell JR) J Am Assoc Nurse Pract 2020 Jun;32(6):469-475 |
| 1 | Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline
resectable pancreatic cancer (Chad A. Barnes, MD, Mohammed Aldakkak, MD, Kathleen K. Christians, MD,
Callisia N. Clarke, MD, MS, Kulwinder Dua, MD, Ben George, MD, Paul S. Ritch, MD,
Mandana Kamgar, MD, William A. Hall, MD, Naveen Kulkarni, MD,
Beth A. Erickson, MD, Douglas B. Evans, MD, Susan Tsai, MD, MHS,) Elsevier |
| 2 | Systemic immunosuppressive therapy for inflammatory skin diseases in children: Expert consensus-based guidance for clinical decision-making during the COVID-19 pandemic. (Reynolds SD, Mathur AN, Chiu YE, Brandling-Bennett HA, Pope E, Siegel MP, Holland KE, Paller AS, Siegfried EC, Tom WL, Lara-Corrales I, Tollefson MM, Maguiness S, Eichenfield LF, Sugarman J, Frieden IJ, Oza VS, Cipriano SD, Huang JT, Shah SD, Lauren CT, Castelo-Soccio L, McMahon P, Cordoro KM) Pediatr Dermatol 2020 May;37(3):424-434 10 Citations |
| 1 | Efficacy of risankizumab in patients with moderate-to-severe plaque psoriasis by baseline demographics, disease characteristics and prior biologic therapy: an integrated analysis of the phase III UltIMMa-1 and UltIMMa-2 studies. (Strober B, Menter A, Leonardi C, Gordon K, Lambert J, Puig L, Photowala H, Longcore M, Zhan T, Foley P) J Eur Acad Dermatol Venereol 2020 Dec;34(12):2830-2838 51 Citations |
| 1 | Flavonoid-Based Cancer Therapy: An Updated Review. (Hosseinzadeh E, Hassanzadeh A, Marofi F, Alivand MR, Solali S) Anticancer Agents Med Chem 2020;20(12):1398-1414 35 Citations |
| 1 | Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. (Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB 2nd, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D) Radiother Oncol 2020 May;146:223-229 152 Citations |
| 1 | Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement (Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D) Radiotherapy and Oncology May 2020;146:223-229 152 Citations |
| 8 | Value of Pretreatment 18F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy. (Barnes CA, Aldakkak M, Clarke CN, Christians KK, Bucklan D, Holt M, Tolat P, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S) Front Oncol 2020;10:500 12 Citations |
| 3 | Heritable modifiers of the tumor microenvironment influence nanoparticle uptake, distribution and response to photothermal therapy. (Sharma G, Jagtap JM, Parchur AK, Gogineni VR, Ran S, Bergom C, White SB, Flister MJ, Joshi A) Theranostics 2020;10(12):5368-5383 15 Citations |
| 1 | Outcomes and toxicity after salvage radiotherapy for vaginal relapse of endometrial cancer. (Sapienza LG, Ning MS, de la Pena R, McNew LK, Jhingran A, Georgeon L, Rasool N, Gomes MJL, Abu-Isa E, Baiocchi G) Int J Gynecol Cancer 2020 Oct;30(10):1535-1541 5 Citations |
| 1 | Isobaric Labeling Strategy Utilizing 4-Plex N,N-Dimethyl Leucine (DiLeu) Tags Reveals Proteomic Changes Induced by Chemotherapy in Cerebrospinal Fluid of Children with B-Cell Acute Lymphoblastic Leukemia. (Yu Q, Zhong X, Chen B, Feng Y, Ma M, Diamond CA, Voeller JS, Kim M, DeSantes KB, Capitini CM, Patel NJ, Hoover-Regan ML, Burke MJ, Janko K, Puccetti DM, Ikonomidou C, Li L) J Proteome Res 2020 Jul 02;19(7):2606-2616 10 Citations |
| 2 | Feasibility of real-time motion tracking using cine MRI during MR-guided radiation therapy for abdominal targets. (Keiper TD, Tai A, Chen X, Paulson E, Lathuilière F, Bériault S, Hébert F, Cooper DT, Lachaine M, Li XA) Med Phys 2020 Aug;47(8):3554-3566 46 Citations |
| 3 | Intrathecal chemotherapy for management of steroid-refractory CAR T-cell-associated neurotoxicity syndrome. (Shah NN, Johnson BD, Fenske TS, Raj RV, Hari P) Blood Adv 2020 May 26;4(10):2119-2122 42 Citations |
| 1 | Genomics models in radiotherapy: From mechanistic to machine learning. (Kang J, Coates JT, Strawderman RL, Rosenstein BS, Kerns SL) Med Phys 2020 Jun;47(5):e203-e217 18 Citations |
| 1 | Biomarkers in individualized management of chimeric antigen receptor T cell therapy. (Du M, Hari P, Hu Y, Mei H) Biomark Res 2020;8:13 25 Citations |
| 3 | Testing the Interpersonal-Behavior model to explain intentions to use patient-delivered partner therapy. (John SA, Walsh JL, Quinn KG, Cho YI, Weinhardt LS) PLoS One 2020;15(5):e0233348 |
| 1 | MHC-I genotype and tumor mutational burden predict response to immunotherapy. (Goodman AM, Castro A, Pyke RM, Okamura R, Kato S, Riviere P, Frampton G, Sokol E, Zhang X, Ball ED, Carter H, Kurzrock R) Genome Med 2020 May 19;12(1):45 87 Citations |
| 3 | Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19? (Frigault MJ, Nikiforow S, Mansour MK, Hu ZH, Horowitz MM, Riches ML, Hematti P, Turtle CJ, Zhang MJ, Perales MA, Pasquini MC) Blood 2020 Jul 02;136(1):137-139 58 Citations |
| 1 | Cell-based analysis of CAD variants identifies individuals likely to benefit from uridine therapy. (Del Caño-Ochoa F, Ng BG, Abedalthagafi M, Almannai M, Cohn RD, Costain G, Elpeleg O, Houlden H, Karimiani EG, Liu P, Manzini MC, Maroofian R, Muriello M, Al-Otaibi A, Patel H, Shimon E, Sutton VR, Toosi MB, Wolfe LA, Rosenfeld JA, Freeze HH, Ramón-Maiques S) Genet Med 2020 Oct;22(10):1598-1605 21 Citations |
| 1 | Subacute Liver Failure Following Gene Replacement Therapy for Spinal Muscular Atrophy Type 1. (Feldman AG, Parsons JA, Dutmer CM, Veerapandiyan A, Hafberg E, Maloney N, Mack CL) J Pediatr 2020 Oct;225:252-258.e1 96 Citations |
| 1 | Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. (Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC, Fitch K, Harkenrider MM, Holschneider CH, Kamrava M, Leung E, Lin LL, Mayadev JS, Morcos M, Nwachukwu C, Petereit D, Viswanathan AN) Pract Radiat Oncol 2020;10(4):220-234 158 Citations |
| 7 | 4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience. (Paulson ES, Ahunbay E, Chen X, Mickevicius NJ, Chen GP, Schultz C, Erickson B, Straza M, Hall WA, Li XA) Clin Transl Radiat Oncol 2020 Jul;23:72-79 103 Citations |
| 1 | Impact of Intrathecal Triple Therapy Versus Intrathecal Methotrexate on Disease-Free Survival for High-Risk B-Lymphoblastic Leukemia: Children's Oncology Group Study AALL1131. (Salzer WL, Burke MJ, Devidas M, Dai Y, Hardy KK, Kairalla JA, Gore L, Hilden JM, Larsen E, Rabin KR, Zweidler-McKay PA, Borowitz MJ, Wood B, Heerema NA, Carroll AJ, Winick N, Carroll WL, Raetz EA, Loh ML, Hunger SP) J Clin Oncol 2020 Aug 10;38(23):2628-2638 56 Citations |
| 1 | In vivo enrichment of genetically manipulated platelets for murine hemophilia B gene therapy. (Chen Y, Schroeder JA, Gao C, Li J, Hu J, Shi Q) J Cell Physiol 2021 Jan;236(1):354-365 8 Citations |
| 1 | Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy. (Pham TV, Boichard A, Goodman A, Riviere P, Yeerna H, Tamayo P, Kurzrock R) Mol Oncol 2020 Aug;14(8):1680-1694 37 Citations |
| 3 | Multimodal Therapy Including Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Can Result in Long-term Disease-free Survival in Pediatric Desmoplastic Small Round Cell Tumor With Extraperitoneal Disease. (Xiao J, Browning MB, Boyd KP, Suchi M, Turaga KK, Firat SY, Mortland LJ, Lal DR) J Pediatr Hematol Oncol 2021 Aug 01;43(6):228-231 1 Citation |
| 2 | Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancer. (Annapragada A, Sikora A, Bollard C, Conejo-Garcia J, Cruz CR, Demehri S, Demetriou M, Demirdjian L, Fong L, Horowitz M, Hutson A, Kadash-Edmondson K, Kufe D, Lipkin S, Liu S, McCarthy C, Morgan M, Morris Z, Pan Y, Pasquini M, Schoenberger S, Van Allen E, Vilar E, Xing Y, Zha W, IOTN Consortium, Odunsi A) J Immunother Cancer 2020 Jun;8(1) 10 Citations |
| 1 | Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations. (Elledge CR, Beriwal S, Chargari C, Chopra S, Erickson BA, Gaffney DK, Jhingran A, Klopp AH, Small W Jr, Yashar CM, Viswanathan AN) Gynecol Oncol 2020 Aug;158(2):244-253 30 Citations |
| 1 | Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement. (Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB 2nd, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D) Int J Radiat Oncol Biol Phys 2020 Jul 15;107(4):631-640 41 Citations |
| 2 | Patient-Centric Head and Neck Cancer Radiation Therapy: Role of Advanced Imaging. (Shukla M, Forghani R, Agarwal M) Neuroimaging Clin N Am 2020 Aug;30(3):341-357 3 Citations |
| 1 | Platelet-Targeted FVIII Gene Therapy Restores Hemostasis and Induces Immune Tolerance for Hemophilia A. (Cai Y, Shi Q) Front Immunol 2020;11:964 5 Citations |
| 3 | Treatment-Emergent Tumor Lysis Syndrome With PI3Kδ-γ Inhibition After CAR T-Cell Therapy for Chronic Lymphocytic Leukemia. (Shah NN, Jerkins JH, Johnson BD, Hari P) JCO Oncol Pract 2020 Sep;16(9):613-614 2 Citations |
| 5 | Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes. (Bovi JA, Prah MA, Retzlaff AA, Schmainda KM, Connelly JM, Rand SD, Marszalkowski CS, Mueller WM, Siker ML, Schultz CJ) Int J Radiat Oncol Biol Phys 2020 Nov 15;108(4):979-986 20 Citations |
| 5 | 4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience (Paulson ES, Ahunbay E, Chen X, Mickevicius NJ, Chen GP, Schultz C, Erickson B, Straza M, Hall WA, Li XA) Clinical and Translational Radiation Oncology July 2020;23:72-79 103 Citations |
| 1 | Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline (Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC, Fitch KJ, Harkenrider MM, Holschneider CH, Kamrava M, Leung E, Lin LL, Mayadev JS, Morcos M, Nwachukwu C, Petereit D, Viswanathan AN) Practical Radiation Oncology July - August 2020;10(4):220-234 158 Citations |
| 1 | Reply to "Effective therapy for advanced basal cell carcinoma". (Cohen PR, Kurzrock R) J Am Acad Dermatol 2022 Mar;86(3):e109 2 Citations |
| 1 | Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An opportunity for enhanced recovery pathways. (Eng OS, Blakely AM, Lafaro KJ, Fournier KF, Fackche NT, Johnston FM, Dineen S, Powers B, Hendrix R, Lambert LA, Ronnekleiv-Kelly S, Walle KV, Grotz TE, Leiting JL, Patel SH, Dhar VK, Baumgartner JM, Lowy AM, Clarke CN, Mogal H, Zaidi MY, Staley CA, Kimbrough C, Cloyd JM, Lee B, Raoof M) J Surg Oncol 2020 Oct;122(5):980-985 11 Citations |
| 1 | IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers. (Amin HM, Morani AC, Daw NC, Lamhamedi-Cherradi SE, Subbiah V, Menegaz BA, Vishwamitra D, Eskandari G, George B, Benjamin RS, Patel S, Song J, Lazar AJ, Wang WL, Kurzrock R, Pappo A, Anderson PM, Schwartz GK, Araujo D, Cuglievan B, Ratan R, McCall D, Mohiuddin S, Livingston JA, Molina ER, Naing A, Ludwig JA) Cancers (Basel) 2020 Jul 02;12(7) 23 Citations |
| 1 | Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial. (Fichtenbaum CJ, Ribaudo HJ, Leon-Cruz J, Overton ET, Zanni MV, Malvestutto CD, Aberg JA, Kileel EM, Fitch KV, Van Schalkwyk M, Kumarasamy N, Martinez E, Santos BR, Joseph Y, Lo J, Siminski S, Melbourne K, Sponseller CA, Desvigne-Nickens P, Bloomfield GS, Currier JS, Hoffmann U, Douglas PS, Grinspoon SK, REPRIEVE Investigators) J Infect Dis 2020 Jul 09;222(Suppl 1):S8-S19 10 Citations |
| 8 | Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer. (Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S) Surgery 2020 Sep;168(3):440-447 16 Citations |
| 1 | Persistent Hyperinsulinemia Following High-Dose Insulin Therapy: A Case Report. (Corcoran JN, Jacoby KJ, Olives TD, Bangh SA, Cole JB) J Med Toxicol 2020 Oct;16(4):465-469 10 Citations |
| 1 | The Complexity of Neoadjuvant Therapy for Operable Pancreatic Cancer: Lessons Learned From SWOG S1505. (Evans DB) Ann Surg 2020 Sep 01;272(3):487 12 Citations |
| 1 | Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement (Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D) International Journal of Radiation Oncology Biology Physics 15 July 2020;107(4):631-640 41 Citations |
| 1 | A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas. (Monga V, Skubitz KM, Maliske S, Mott SL, Dietz H, Hirbe AC, Van Tine BA, Oppelt P, Okuno S, Robinson S, O'Connor M, Seetharam M, Attia S, Charlson J, Agulnik M, Milhem M) Cancers (Basel) 2020 Jul 11;12(7) 41 Citations |
| 1 | Cutaneous reactions in children treated with MEK inhibitors, BRAF inhibitors, or combination therapy: A multicenter study. (Boull CL, Gardeen S, Abdali T, Li E, Potts J, Rubin N, Carlberg VM, Gupta D, Hunt R, Luu M, Maguiness SM, Moertel CL, Song H, Vivar KL, Coughlin C, Huang JT, Lara-Corrales I) J Am Acad Dermatol 2021 Jun;84(6):1554-1561 25 Citations |
| 1 | Association of Nonoperative Management Using Antibiotic Therapy vs Laparoscopic Appendectomy With Treatment Success and Disability Days in Children With Uncomplicated Appendicitis. (Minneci PC, Hade EM, Lawrence AE, Sebastião YV, Saito JM, Mak GZ, Fox C, Hirschl RB, Gadepalli S, Helmrath MA, Kohler JE, Leys CM, Sato TT, Lal DR, Landman MP, Kabre R, Fallat ME, Cooper JN, Deans KJ, Midwest Pediatric Surgery Consortium) JAMA 2020 Aug 11;324(6):581-593 108 Citations |
| 2 | Patient-Centric Head and Neck Cancer Radiation Therapy: Role of Advanced Imaging (Shukla M, Forghani R, Agarwal M) Neuroimaging Clinics of North America August 2020;30(3):341-357 3 Citations |
| 1 | Fetal interventions in the setting of the coronavirus disease 2019 pandemic: statement from the North American Fetal Therapy Network (Bahtiyar MO, Baschat A, Deprest J, Emery S, Goodnight WH, Johnson A, McCullough L, Moldenhauer JS, Ryan G, Tsao KJ, Van Mieghem T, Wagner A, Zaretsky M) American Journal of Obstetrics and Gynecology August 2020;223(2):281-284 10 Citations |
| 1 | Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. (Elmets CA, Korman NJ, Prater EF, Wong EB, Rupani RN, Kivelevitch D, Armstrong AW, Connor C, Cordoro KM, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Siegel M, Stoff B, Strober B, Wu JJ, Hariharan V, Menter A) J Am Acad Dermatol 2021 Feb;84(2):432-470 201 Citations |
| 1 | Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis: Data From the Pediatric Primary Sclerosing Cholangitis Consortium. (Laborda TJ, Ricciuto A, Aumar M, Carman N, DiGuglielmo M, Draijer LG, Furuya KN, Gupta N, Koot BGP, Loomes KM, Lytvyak E, Martinez M, Miloh T, Montano-Loza AJ, Perito ER, Sathya P, Shah U, Shteyer E, Singh R, Taylor A, Valentino PL, Vitola B, Zerofsky M, Zizzo A, Deneau MR) J Pediatr Gastroenterol Nutr 2020 Oct;71(4):459-464 15 Citations |
| 1 | High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers. (Riviere P, Goodman AM, Okamura R, Barkauskas DA, Whitchurch TJ, Lee S, Khalid N, Collier R, Mareboina M, Frampton GM, Fabrizio D, Sharabi AB, Kato S, Kurzrock R) Mol Cancer Ther 2020 Oct;19(10):2139-2145 56 Citations |
| 1 | Choice of local therapy for young women with early-stage breast cancer who have young-aged children. (Pan IW, Yen TWF, Huo J, Chen C, Smith BD, Shih YT) Cancer 2020 Nov 01;126(21):4761-4769 1 Citation |
| 1 | Afebrile Pneumonia in a Patient With Multicentric Castleman Disease on Siltuximab: Infection Without Fever on Anti-Interleukin-6 Therapy. (Cohen PR, Nikanjam M, Kato S, Goodman AM, Kurzrock R) Cureus 2020 Jul 02;12(7):e8967 |
| 8 | Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac. (Hall WA, Straza MW, Chen X, Mickevicius N, Erickson B, Schultz C, Awan M, Ahunbay E, Li XA, Paulson ES) PLoS One 2020;15(8):e0236570 58 Citations |
| 3 | Chimeric antigen receptor T cell therapy in multiple myeloma: promise and challenges. (Dhakal B, Hari PN, Usmani SZ, Hamadani M) Bone Marrow Transplant 2021 Jan;56(1):9-19 24 Citations |
| 1 | Stereotactic MRI-guided laser interstitial thermal therapy for extratemporal lobe epilepsy. (Gupta K, Cabaniss B, Kheder A, Gedela S, Koch P, Hewitt KC, Alwaki A, Rich C, Ramesha S, Hu R, Drane DL, Gross RE, Willie JT) Epilepsia 2020 Aug;61(8):1723-1734 46 Citations |
| 2 | Discovery and validation of surface N-glycoproteins in MM cell lines and patient samples uncovers immunotherapy targets. (Oldham RAA, Faber ML, Keppel TR, Buchberger AR, Waas M, Hari P, Gundry RL, Medin JA) J Immunother Cancer 2020 Aug;8(2) 15 Citations |
| 2 | Outcomes With Liver-Directed Therapy for Genitourinary Malignancies: Single-Institution Experience. (Pierro M, Raychaudhuri R, Lea WB, Rilling W, Davis N, Bylow K, Kilari D) Clin Genitourin Cancer 2021 Feb;19(1):87-91 1 Citation |
| 2 | Delayed neurotoxicity after axicabtagene ciloleucel therapy in relapsed refractory diffuse large B-cell lymphoma. (Badar T, Johnson BD, Hamadani M) Bone Marrow Transplant 2021 Mar;56(3):683-685 13 Citations |
| 1 | Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer. (Yan F, Li H, Kaczmar JM, Sharma AK, Day TA, Neskey DM, Pipkorn P, Zenga J, Graboyes EM) JAMA Otolaryngol Head Neck Surg 2020 Dec 01;146(12):1109-1119 9 Citations |
| 1 | Surf early to higher tides: surfactant therapy to optimize tidal volume, lung recruitment, and iNO response. (Konduri GG, Lakshminrusimha S) J Perinatol 2021 Jan;41(1):1-3 6 Citations |
| 1 | CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy. (Thapa B, Caimi PF, Ardeshna KM, Solh M, Carlo-Stella C, Kahl BS, Hamadani M) Blood Adv 2020 Aug 25;4(16):3850-3852 56 Citations |
| 1 | Encapsulated Checkpoint Blocker Before Chemotherapy: The Optimal Sequence of Anti-CTLA-4 and Doxil Combination Therapy. (Alimohammadi R, Alibeigi R, Nikpoor AR, Chalbatani GM, Webster TJ, Jaafari MR, Jalali SA) Int J Nanomedicine 2020;15:5279-5288 20 Citations |
| 1 | Psychotherapy, placebos, and informed consent. (Leder G) J Med Ethics 2020 Aug 20;47(7):444-7 7 Citations |
| 1 | Cytokines, JAK-STAT Signaling and Radiation-Induced DNA Repair in Solid Tumors: Novel Opportunities for Radiation Therapy. (Hall WA, Sabharwal L, Udhane V, Maranto C, Nevalainen MT) Int J Biochem Cell Biol 2020 Oct;127:105827 8 Citations |
| 1 | Chondroblastoma Expresses RANKL by RNA In Situ Hybridization and May Respond to Denosumab Therapy. (Suster DI, Kurzawa P, Neyaz A, Jarzembowski JA, Lozano-Calderon S, Raskin K, Schwab J, Choy E, Chebib I, Deshpande V) Am J Surg Pathol 2020 Dec;44(12):1581-1590 11 Citations |
| 1 | Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer. (Axelrod ML, Nixon MJ, Gonzalez-Ericsson PI, Bergman RE, Pilkinton MA, McDonnell WJ, Sanchez V, Opalenik SR, Loi S, Zhou J, Mackay S, Rexer BN, Abramson VG, Jansen VM, Mallal S, Donaldson J, Tolaney SM, Krop IE, Garrido-Castro AC, Marotti JD, Shee K, Miller TW, Sanders ME, Mayer IA, Salgado R, Balko JM) Clin Cancer Res 2020 Nov 01;26(21):5668-5681 43 Citations |
| 1 | A Pilot Study of Lenalidomide Maintenance Therapy after Autologous Transplantation in Relapsed or Refractory Classical Hodgkin Lymphoma. (Shea L, Watkins MP, Wan F, Cashen AF, Wagner-Johnston ND, Jacoby MA, Abboud CN, Dipersio JF, Hurd DD, Jaglowski SM, Bartlett NL, Fehniger TA) Biol Blood Marrow Transplant 2020 Dec;26(12):2223-2228 3 Citations |
| 1 | Is Biologic Therapy in Inflammatory Bowel Disease Contributing to the Obesity Epidemic? Just Weight One Year. (Mulgund A, Stein D) Dig Dis Sci 2020 Dec;65(12):3420-3421 1 Citation |
| 2 | Locally advanced pancreatic cancer: staging, operability, and the importance of multimodality therapy. (Kim RY, Evans DB, Christians KK) Hepatobiliary Surg Nutr 2020 Aug;9(4):497-500 |
| 2 | Infection prophylaxis patterns following pediatric autologous hematopoietic stem cell transplantation: A survey of Pediatric Transplant and Cell Therapy Consortium centers. (Falcon CP, Broglie L, Phelan R, Choi SW, Auletta JJ, Chewning JH) Pediatr Transplant 2020 Dec;24(8):e13821 4 Citations |
| 1 | Gene Therapy for Spinal Muscular Atrophy: Safety and Early Outcomes. (Waldrop MA, Karingada C, Storey MA, Powers B, Iammarino MA, Miller NF, Alfano LN, Noritz G, Rossman I, Ginsberg M, Mosher KA, Broomall E, Goldstein J, Bass N, Lowes LP, Tsao CY, Mendell JR, Connolly AM) Pediatrics 2020 Sep;146(3) 96 Citations |
| 3 | Improving Structure Delineation for Radiation Therapy Planning Using Dual-Energy CT (Noid G, Zhu J, Tai A, Mistry N, Schott D, Prah D, Paulson E, Schultz C, Li XA) Frontiers in Oncology 28 August 2020;10 15 Citations |
| 1 | Characterizing inclusion and exclusion criteria in clinical trials for chimeric antigen receptor (CAR) T-cell therapy among adults with hematologic malignancies. (Jaggers JL, Giri S, Klepin HD, Wildes TM, Olin RL, Artz A, Wall S, Jaglowski S, William B, Benson DM, Rosko AE) J Geriatr Oncol 2021 Mar;12(2):235-238 14 Citations |
| 3 | Optimized cardiac functional MRI of small-animal models of cancer radiation therapy. (Ibrahim EH, Baruah D, Budde M, Rubenstein J, Frei A, Schlaak R, Gore E, Bergom C) Magn Reson Imaging 2020 Nov;73:130-137 6 Citations |
| 5 | Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer (Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S) Surgery (United States) September 2020;168(3):440-447 16 Citations |
| 1 | Bispecific chimeric antigen receptor T cell therapy for b cell malignancies and multiple myeloma (Cronk RJ, Zurko J, Shah NN) Cancers September 2020;12(9):1-15 39 Citations |
| 1 | Palliative sedation therapy for terminal movement disorders. (Partain DK, Zehm A) BMJ Support Palliat Care 2023 Oct;13(e1):e96-e98 |
| 1 | Commentary: Surgery for locally advanced pancreatic cancer after neoadjuvant therapy. (Evans DB) Surgery 2021 May;169(5):1032-1033 3 Citations |
| 1 | Acquired Factor V Inhibitor After Antibiotic Therapy: A Clinical Case Report and Review of the Literature. (Chartier AR, Hillert CJ, Gill H, Jha P) Cureus 2020 Jul 30;12(7):e9481 |
| 1 | Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial. (Savarirayan R, Tofts L, Irving M, Wilcox W, Bacino CA, Hoover-Fong J, Ullot Font R, Harmatz P, Rutsch F, Bober MB, Polgreen LE, Ginebreda I, Mohnike K, Charrow J, Hoernschemeyer D, Ozono K, Alanay Y, Arundel P, Kagami S, Yasui N, White KK, Saal HM, Leiva-Gea A, Luna-González F, Mochizuki H, Basel D, Porco DM, Jayaram K, Fisheleva E, Huntsman-Labed A, Day J) Lancet 2020 Sep 05;396(10252):684-692 134 Citations |
| 1 | Is Breast Magnetic Resonance Imaging an Accurate Predictor of Nodal Status After Neoadjuvant Chemotherapy? (Cortina CS, Gottschalk N, Kulkarni SA, Karst I) J Surg Res 2021 Jan;257:412-418 5 Citations |
| 3 | The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy (de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Sahgal A, Sarmiento JG, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Hall WA, Verkooijen HM) Frontiers in Oncology 7 September 2020;10 85 Citations |
| 1 | Bispecific Chimeric Antigen Receptor T Cell Therapy for B Cell Malignancies and Multiple Myeloma. (Cronk RJ, Zurko J, Shah NN) Cancers (Basel) 2020 Sep 05;12(9) 39 Citations |
| 1 | NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update. (Small W Jr, Bosch WR, Harkenrider MM, Strauss JB, Abu-Rustum N, Albuquerque KV, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles AW, Hentz CL, Jhingran A, Klopp AH, Kunos CA, Mell LK, Portelance L, Powell ME, Viswanathan AN, Yacoub JH, Yashar CM, Winter KA, Gaffney DK) Int J Radiat Oncol Biol Phys 2021 Feb 01;109(2):413-424 92 Citations |
| 1 | Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patients. (Moheet A, Beisang D, Zhang L, Sagel SD, VanDalfsen JM, Heltshe SL, Frederick C, Mann M, Antos N, Billings J, Rowe SM, Moran A, PROSPECT Investigators of the Cystic Fibrosis Foundation Therapeutics Development Network) J Cyst Fibros 2021 Mar;20(2):333-338 45 Citations |
| 1 | Tumor mutational burden is not predictive of cytotoxic chemotherapy response. (Nikanjam M, Riviere P, Goodman A, Barkauskas DA, Frampton G, Kurzrock R) Oncoimmunology 2020 Jun 24;9(1):1781997 12 Citations |
| 1 | Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia. (Uy GL, Aldoss I, Foster MC, Sayre PH, Wieduwilt MJ, Advani AS, Godwin JE, Arellano ML, Sweet KL, Emadi A, Ravandi F, Erba HP, Byrne M, Michaelis L, Topp MS, Vey N, Ciceri F, Carrabba MG, Paolini S, Huls GA, Jongen-Lavrencic M, Wermke M, Chevallier P, Gyan E, Récher C, Stiff PJ, Pettit KM, Löwenberg B, Church SE, Anderson E, Vadakekolathu J, Santaguida M, Rettig MP, Muth J, Curtis T, Fehr E, Guo K, Zhao J, Bakkacha O, Jacobs K, Tran K, Kaminker P, Kostova M, Bonvini E, Walter RB, Davidson-Moncada JK, Rutella S, DiPersio JF) Blood 2021 Feb 11;137(6):751-762 237 Citations |
| 1 | The ABS brachytherapy schools. (Erickson B, Crook J, Vicini F, Arthur D, Ouhib Z, Thomadsen B, Bice W, Butler WM, Petereit DG, Viswanathan AN) Brachytherapy 2020;19(6):820-826 4 Citations |
| 2 | Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis. (Deneau MR, Mack C, Mogul D, Perito ER, Valentino PL, Amir AZ, DiGuglielmo M, Draijer LG, El-Matary W, Furuya KN, Gupta N, Hochberg JT, Horslen S, Jensen MK, Jonas MM, Kerkar N, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Martinez M, Miethke A, Miloh T, Mohammad S, Ovchinsky N, Rao G, Ricciuto A, Sathya P, Schwarz KB, Shah U, Singh R, Vitola B, Zizzo A, Guthery SL) Hepatology 2021 Mar;73(3):1061-1073 70 Citations |
| 1 | The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy. (Ujjani C, Mato A, Hill BT, Allan JN, Lansigan F, Jacobs R, Skarbnik A, Tuncer H, Pagel J, Brander D, Cheson B, Barr P, Roeker LE, Pu J, Shah NN, Goy A, Schuster SJ, Lamanna N, Sehgal A, Tam CS, Shadman M) Blood Lymphat Cancer 2020;10:1-5 |
| 1 | Outcomes of Autologous Hematopoietic Cell Transplantation in Diffuse Large B Cell Lymphoma Refractory to Firstline Chemoimmunotherapy. (Bal S, Costa LJ, Sauter C, Litovich C, Hamadani M) Transplant Cell Ther 2021 Jan;27(1):55.e1-55.e7 13 Citations |
| 6 | Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia. (Mushtaq MU, Harrington AM, Chaudhary SG, Michaelis LC, Carlson KB, Abedin S, Runass L, Callander NS, Fallon MJ, Juckett M, Hall AC, Hematti P, Mattison RJ, Atallah EL, Guru Murthy GS) Leuk Lymphoma 2021 Jan;62(1):158-166 14 Citations |
| 1 | Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular Therapy. (Dholaria B, Savani BN, Hamilton BK, Oran B, Liu HD, Tallman MS, Ciurea SO, Holtzman NG, Ii GLP, Devine SM, Mannis G, Grunwald MR, Appelbaum F, Rodriguez C, El Chaer F, Shah N, Hashmi SK, Kharfan-Dabaja MA, DeFilipp Z, Aljurf M, AlShaibani A, Inamoto Y, Jain T, Majhail N, Perales MA, Mohty M, Hamadani M, Carpenter PA, Nagler A) Transplant Cell Ther 2021 Jan;27(1):6-20 59 Citations |
| 1 | The ASTRO clinical practice guidelines in cervical cancer: Optimizing radiation therapy for improved outcomes. (Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC, Fitch J, Harkenrider MM, Holschneider CH, Kamrava M, Leung E, Lin LL, Mayadev JS, Morcos M, Nwachukwu C, Petereit D, Viswanathan AN) Gynecol Oncol 2020 Dec;159(3):607-610 29 Citations |
| 1 | PROVIDE-HF primary results: Patient-Reported Outcomes inVestigation following Initiation of Drug therapy with Entresto (sacubitril/valsartan) in heart failure. (Mentz RJ, Xu H, O'Brien EC, Thomas L, Alexy T, Gupta B, Vilaro J, Lala A, DeVore AD, Dhingra R, Briasoulis A, Simon MA, Stehlik J, Rodgers JE, Dunlay SM, Abshire M, Wells QS, Barringhaus KG, Eckman PM, Lowes BD, Espinoza J, Blanco R, Shen X, Duffy CI, Hernandez AF) Am Heart J 2020 Dec;230:35-43 8 Citations |
| 1 | Pharmacotherapy for Obesity-Trends Using a Population Level National Database. (Elangovan A, Shah R, Smith ZL) Obes Surg 2021 Mar;31(3):1105-1112 37 Citations |
| 3 | Improving Structure Delineation for Radiation Therapy Planning Using Dual-Energy CT. (Noid G, Zhu J, Tai A, Mistry N, Schott D, Prah D, Paulson E, Schultz C, Li XA) Front Oncol 2020;10:1694 15 Citations |
| 1 | A Contemporary Analysis of Delayed Diagnoses After Traumatic Injury : The Role of Operative Therapy. (Hatchimonji JS, Sharoky CE, Kaufman EJ, Ma LW, Garcia Whitlock AE, Smith BP, Holena DN) Am Surg 2021 Mar;87(3):384-389 |
| 1 | A Multi-biomarker Panel Including Delta Radiomics to Predict Distant Metastasis after Chemoradiation Therapy of Pancreatic Adenocarcinoma (H Nasief, WA Hall, C Zheng, S Tsai, BA Erickson, A Li) International Journal of Radiation Oncology, Biology, Physics 108 (3), S83 |
| 1 | Cell-based analysis of CAD variants identifies individuals likely to benefit from uridine therapy (del Caño-Ochoa F, Ng BG, Abedalthagafi M, Almannai M, Cohn RD, Costain G, Elpeleg O, Houlden H, Karimiani EG, Liu P, Chiara Manzini M, Maroofian R, Muriello M, Al-Otaibi A, Patel H, Shimon E, Sutton VR Toosi MB, Wolfe LA, Rosenfeld JA, Freeze HH, Ramón-Maiques S.) Genetics in Medicine |
| 2 | Daily Physical Activity and Symptom Reporting in Breast Cancer Patients Undergoing Chemotherapy: An Intensive Longitudinal Examination. (Phillips SM, Welch WA, Fanning J, Santa-Maria CA, Gavin KL, Auster-Gussman LA, Solk P, Lu M, Cullather E, Khan SA, Kulkarni SA, Gradishar W, Siddique J) Cancer Epidemiol Biomarkers Prev 2020 Dec;29(12):2608-2616 17 Citations |
| 1 | Provision and Perception of Physiotherapy in the Nonoperative Management of Degenerative Cervical Myelopathy (DCM): A Cross-Sectional Questionnaire of People Living With DCM. (Butler MB, Mowforth OD, Badran A, Starkey M, Boerger T, Sadler I, Tabrah J, Treanor C, Phys LCGD, Kalsi-Ryan S, Laing RJ, Davies BM, Kotter MRN) Global Spine J 2022 May;12(4):638-645 7 Citations |
| 1 | Comorbidities Predict Inferior Survival in Patients Receiving Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma: A Multicenter Analysis. (Kittai AS, Huang Y, Gordon M, Denlinger N, Mian A, Fitzgerald L, Bishop J, Nagle S, Stephens DM, Jaglowski S, Hill B, Danilov AV) Transplant Cell Ther 2021 Jan;27(1):46-52 43 Citations |
| 8 | Total Neoadjuvant Therapy for Operable Pancreatic Cancer. (Kim RY, Christians KK, Aldakkak M, Clarke CN, George B, Kamgar M, Khan AH, Kulkarni N, Hall WA, Erickson BA, Evans DB, Tsai S) Ann Surg Oncol 2021 Apr;28(4):2246-2256 39 Citations |
| 1 | Stem Cell-Based Disease Modeling and Cell Therapy. (Bai X) Cells 2020 Sep 29;9(10) 23 Citations |
| 4 | Chimeric antigen receptor T-cell therapy for marrow and extramedullary relapse of infant acute lymphoblastic leukemia. (Moskop A, Pommert L, Thakrar P, Talano J, Phelan R) Pediatr Blood Cancer 2021 Jan;68(1):e28739 9 Citations |
| 3 | The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy. (de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Sahgal A, Sarmiento JG, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Hall WA, Verkooijen HM) Front Oncol 2020;10:1328 85 Citations |
| 1 | Pharmacological inhibition of the mitochondrial Ca2+ uniporter: Relevance for pathophysiology and human therapy. (Márta K, Hasan P, Rodríguez-Prados M, Paillard M, Hajnóczky G) J Mol Cell Cardiol 2021 Feb;151:135-144 42 Citations |
| 2 | Adolescents' Awareness of and Attitudes Toward Expedited Partner Therapy Provided in the Emergency Department. (Pickett ML, Hoehn EF, Visotcky AM, Norman B, Drendel AL) Sex Transm Dis 2020 Nov;47(11):754-759 1 Citation |
| 1 | A Pilot Study of Cardiac MRI in Breast Cancer Survivors After Cardiotoxic Chemotherapy and Three-Dimensional Conformal Radiotherapy (Bergom C, Rubenstein J, Wilson JF, Welsh A, Ibrahim ESH, Prior P, Schottstaedt AM, Eastwood D, Zhang MJ, Currey A, Puckett L, Strande JL, Bradley JA, White J) Frontiers in Oncology 16 October 2020;10 10 Citations |
| 1 | AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19. (Gupta S, Coca SG, Chan L, Melamed ML, Brenner SK, Hayek SS, Sutherland A, Puri S, Srivastava A, Leonberg-Yoo A, Shehata AM, Flythe JE, Rashidi A, Schenck EJ, Goyal N, Hedayati SS, Dy R, Bansal A, Athavale A, Nguyen HB, Vijayan A, Charytan DM, Schulze CE, Joo MJ, Friedman AN, Zhang J, Sosa MA, Judd E, Velez JCQ, Mallappallil M, Redfern RE, Bansal AD, Neyra JA, Liu KD, Renaghan AD, Christov M, Molnar MZ, Sharma S, Kamal O, Boateng JO, Short SAP, Admon AJ, Sise ME, Wang W, Parikh CR, Leaf DE, and the STOP-COVID Investigators) J Am Soc Nephrol 2021 Jan;32(1):161-176 219 Citations |
| 1 | rAAV-related therapy fully rescues myonuclear and myofilament function in X-linked myotubular myopathy. (Ross JA, Tasfaout H, Levy Y, Morgan J, Cowling BS, Laporte J, Zanoteli E, Romero NB, Lowe DA, Jungbluth H, Lawlor MW, Mack DL, Ochala J) Acta Neuropathol Commun 2020 Oct 19;8(1):167 15 Citations |
| 1 | Survey of Radiation Oncologists to Assess Interest and Potential Use of a Genetic Test Predicting Susceptibility for the Development of Toxicities After Prostate Cancer Radiation Therapy. (Collado K, Kerns SL, Diefenbach MA, Peterson-Roth E, Koski R, Ostrer H, Stock RG, Mattessich M, Kaplan P, Rosenstein BS) Adv Radiat Oncol 2020;5(5):897-904 2 Citations |
| 1 | Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort (Barata P, Hatton W, Desai A, Koshkin V, Jaeger E, Manogue C, Cotogno P, Light M, Lewis B, Layton J, Sartor O, Basu A, Kilari D, Emamekhoo H, Bilen MA) Frontiers in Oncology 22 October 2020;10 12 Citations |
| 1 | Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort. (Raval AN, Johnston PV, Duckers HJ, Cook TD, Traverse JH, Altman PA, Dhingra R, Hematti P, Borrello I, Anderson RD, Pepine CJ) Int J Cardiol 2021 Mar 01;326:131-138 17 Citations |
| 1 | Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. (Gao C, Wisniewski L, Liu Y, Staal B, Beddows I, Plenker D, Aldakkak M, Hall J, Barnett D, Gouda MK, Allen P, Drake R, Zureikat A, Huang Y, Evans D, Singhi A, Brand RE, Tuveson DA, Tsai S, Haab BB) Clin Cancer Res 2021 Jan 01;27(1):226-236 17 Citations |
| 1 | The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker. (Jardim DL, Goodman A, de Melo Gagliato D, Kurzrock R) Cancer Cell 2021 Feb 08;39(2):154-173 694 Citations |
| 1 | The ABS brachytherapy schools (Erickson B, Crook J, Vicini F, Arthur D, Ouhib Z, Thomadsen B, Bice W, Butler WM, Petereit DG, Viswanathan AN) Brachytherapy 1 November 2020;19(6):820-826 4 Citations |
| 5 | A Patient-Specific Autosegmentation Strategy Using Multi-Input Deformable Image Registration for Magnetic Resonance Imaging–Guided Online Adaptive Radiation Therapy: A Feasibility Study (Zhang Y, Paulson E, Lim S, Hall WA, Ahunbay E, Mickevicius NJ, Straza MW, Erickson B, Li XA) Advances in Radiation Oncology 1 November 2020;5(6):1350-1358 24 Citations |
| 2 | A Patient-Specific Autosegmentation Strategy Using Multi-Input Deformable Image Registration for Magnetic Resonance Imaging-Guided Online Adaptive Radiation Therapy: A Feasibility Study. (Zhang Y, Paulson E, Lim S, Hall WA, Ahunbay E, Mickevicius NJ, Straza MW, Erickson B, Li XA) Adv Radiat Oncol 2020 Nov;5(Suppl 1):17-25 |
| 1 | Cutaneous reactions to pediatric cancer treatment: Part I. Conventional chemotherapy. (Sous D, Armstrong AE, Huang JT, Shah S, Carlberg VM, Coughlin CC) Pediatr Dermatol 2021 Jan;38(1):8-17 4 Citations |
| 2 | A Pilot Study of Cardiac MRI in Breast Cancer Survivors After Cardiotoxic Chemotherapy and Three-Dimensional Conformal Radiotherapy. (Bergom C, Rubenstein J, Wilson JF, Welsh A, Ibrahim EH, Prior P, Schottstaedt AM, Eastwood D, Zhang MJ, Currey A, Puckett L, Strande JL, Bradley JA, White J) Front Oncol 2020;10:506739 10 Citations |
| 1 | A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort. (Massi MC, Gasperoni F, Ieva F, Paganoni AM, Zunino P, Manzoni A, Franco NR, Veldeman L, Ost P, Fonteyne V, Talbot CJ, Rattay T, Webb A, Symonds PR, Johnson K, Lambrecht M, Haustermans K, De Meerleer G, de Ruysscher D, Vanneste B, Van Limbergen E, Choudhury A, Elliott RM, Sperk E, Herskind C, Veldwijk MR, Avuzzi B, Giandini T, Valdagni R, Cicchetti A, Azria D, Jacquet MF, Rosenstein BS, Stock RG, Collado K, Vega A, Aguado-Barrera ME, Calvo P, Dunning AM, Fachal L, Kerns SL, Payne D, Chang-Claude J, Seibold P, West CML, Rancati T) Front Oncol 2020;10:541281 24 Citations |
| 1 | Early Comparative Toxicity Outcomes of Patients With Prostate Cancer Receiving Initial Cryotherapy and Radiotherapy Salvage. (Jiang C, Godette K, Hall WA, Bennett JK, Rossi P, Cooper S, Jani AB, Patel PR) Clin Genitourin Cancer 2021 Jun;19(3):267-270.e1 2 Citations |
| 1 | Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort. (Barata P, Hatton W, Desai A, Koshkin V, Jaeger E, Manogue C, Cotogno P, Light M, Lewis B, Layton J, Sartor O, Basu A, Kilari D, Emamekhoo H, Bilen MA) Front Oncol 2020;10:581189 12 Citations |
| 1 | A Primer on Chimeric Antigen Receptor T-cell Therapy: What Does It Mean for Pathologists? (Cushman-Vokoun AM, Voelkerding KV, Fung MK, Nowak JA, Thorson JA, Duncan HL, Kalicanin T, Anderson MW, Yohe S) Arch Pathol Lab Med 2021 Jun 01;145(6):704-716 3 Citations |
| 2 | Provider-based initiation and management of pharmacologic therapy for gestational diabetes mellitus. (Harrison RK, Johnson C, Cruz M, Wong A, Davitt C, Palatnik A) J Matern Fetal Neonatal Med 2022 Dec;35(23):4478-4484 2 Citations |
| 1 | Targeted Axillary Dissection for Patients Who Convert to Clinically Node Negative After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer (Ludwig K, Kong AL) Current Breast Cancer Reports December 2020;12(4):391-397 |
| 1 | Infection prophylaxis patterns following pediatric autologous hematopoietic stem cell transplantation: A survey of Pediatric Transplant and Cell Therapy Consortium centers (Falcon CP, Broglie L, Phelan R, Choi SW, Auletta JJ, Chewning JH) Pediatric Transplantation December 2020;24(8) 4 Citations |
| 1 | The timing of initiation of pharmacotherapy for women with gestational diabetes mellitus (Harrison RK, Cruz M, Wong A, Davitt C, Palatnik A) BMC Pregnancy and Childbirth December 2020;20(1) 15 Citations |
| 1 | De-Escalation of Local-Regional Therapy for Older Breast Cancer Patients (Cortina CS) Current Breast Cancer Reports December 2020;12(4):344-350 |
| 1 | Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study (Powers BD, Felder S, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Staley CA, Maithel SK, Patel S, Dhar V, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Lee B, Johnston FM, Greer J, Cloyd JM, Kimbrough C, Grotz T, Leiting J, Fournier K, Lee AJ, Imanirad I, Dessureault S, Dineen SP) Annals of Surgical Oncology December 2020;27(13):4883-4891 12 Citations |
| 2 | Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia. (Badar T, Szabo A, Dinner S, Liedtke M, Burkart M, Shallis RM, Yurkiewicz IR, Kuo E, Khan MA, Balasubramanian S, Yang J, Hefazi M, Podoltsev N, Patel A, Curran E, Wang A, Arslan S, Aldoss I, Siebenaller C, Mattison RJ, Litzow MR, Wadleigh M, Advani AS, Atallah E) Cancer 2021 Apr 01;127(7):1039-1048 22 Citations |
| 5 | A Patient-Specific Autosegmentation Strategy Using Multi-Input Deformable Image Registration for Magnetic Resonance Imaging-Guided Online Adaptive Radiation Therapy: A Feasibility Study. (Zhang Y, Paulson E, Lim S, Hall WA, Ahunbay E, Mickevicius NJ, Straza MW, Erickson B, Li XA) Adv Radiat Oncol 2020;5(6):1350-1358 24 Citations |
| 2 | The timing of initiation of pharmacotherapy for women with gestational diabetes mellitus. (Harrison RK, Cruz M, Wong A, Davitt C, Palatnik A) BMC Pregnancy Childbirth 2020 Dec 11;20(1):773 15 Citations |
| 6 | Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoods. (Mora J, Krepline AN, Aldakkak M, Christians KK, George B, Hall WA, Erickson BA, Kulkarni N, Evans DB, Tsai S) Am J Surg 2021 Jul;222(1):10-17 63 Citations |
| 2 | Retinal cotton wool spot associated with cladribine therapy for multiple sclerosis. (Gummi R, Walsh RD, Ahmad B) Mult Scler Relat Disord 2021 Feb;48:102661 2 Citations |
| 1 | Initial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation. (McDonald BA, Vedam S, Yang J, Wang J, Castillo P, Lee B, Sobremonte A, Ahmed S, Ding Y, Mohamed ASR, Balter P, Hughes N, Thorwarth D, Nachbar M, Philippens MEP, Terhaard CHJ, Zips D, Böke S, Awan MJ, Christodouleas J, Fuller CD, MR-Linac Consortium Head and Neck Tumor Site Group) Int J Radiat Oncol Biol Phys 2021 Apr 01;109(5):1606-1618 55 Citations |
| 1 | Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer. (Mahadevan A, Moningi S, Grimm J, Li XA, Forster KM, Palta M, Prior P, Goodman KA, Narang A, Heron DE, Lo SS, Urbanic J, Herman JM) Int J Radiat Oncol Biol Phys 2021 May 01;110(1):206-216 30 Citations |
| 1 | Cutaneous reactions to pediatric cancer treatment part II: Targeted therapy. (Carlberg VM, Davies OMT, Brandling-Bennett HA, Leary SES, Huang JT, Coughlin CC, Gupta D) Pediatr Dermatol 2021 Jan;38(1):18-30 9 Citations |
| 1 | NK cell-mediated immunotherapy: The exquisite role of PGC-1a in metabolic reprogramming (Gerbec Z, Malarkannan S) Successes and Challenges of NK Immunotherapy: Breaking Tolerance to Cancer Resistance 1 January 2021:121-142 |
| 1 | Task group 284 report: magnetic resonance imaging simulation in radiotherapy: considerations for clinical implementation, optimization, and quality assurance. (Glide-Hurst CK, Paulson ES, McGee K, Tyagi N, Hu Y, Balter J, Bayouth J) Med Phys 2021 Jul;48(7):e636-e670 89 Citations |
| 1 | Using nanoparticles for in situ vaccination against cancer: mechanisms and immunotherapy benefits. (Gorbet MJ, Singh A, Mao C, Fiering S, Ranjan A) Int J Hyperthermia 2020 Dec;37(3):18-33 14 Citations |
| 1 | How to obtain informed consent for psychotherapy: a reply to criticism. (Leder G) J Med Ethics 2021 Jan 17 1 Citation |
| 1 | Acute Kidney Injury, Fluid Overload, and Renal Replacement Therapy Differ by Underlying Diagnosis in Neonatal Extracorporeal Support and Impact Mortality Disparately. (Murphy HJ, Gien J, Sahay R, King E, Selewski DT, Bridges BC, Cooper DS, Fleming GM, Paden ML, Zappitelli M, Gist KM, Basu RK, Jetton JG, Askenazi D) Blood Purif 2021;50(6):808-817 17 Citations |
| 2 | Disseminated M. bovis Infection and Vertebral Osteomyelitis following Immunotherapy for Bladder Cancer. (Gill HS, Dasari SP, Pandit S, Ritter TE, Raju SB, Chartier AR, Jha P) Case Rep Infect Dis 2020;2020:6676163 |
| 1 | In situ vaccination with nanoparticles for cancer immunotherapy: understanding the immunology. (Mao C, Gorbet MJ, Singh A, Ranjan A, Fiering S) Int J Hyperthermia 2020 Dec;37(3):4-17 15 Citations |
| 1 | Association of total neoadjuvant therapy with favorable clinical outcomes in patients with locally advanced esophageal and gastroesophageal junction adenocarcinomas (LA-GEJ CA). (L Jurkowski, AV Shreenivas, S Chakrabarti, M Kamgar, JP Thomas,L Puckett, MShukla, E Gore, J Evans, CA Johnstone, M Gasparri, P Linsky, D Johnstone, K Dua, AH Khan, S Madhavan, A Szabo, B George) ournal of Clinical Oncology 39 (3_suppl), 231-231 |
| 2 | Photodynamic Therapy for Benign Cutaneous Neurofibromas Using Aminolevulinic Acid Topical Application and 633 nm Red Light Illumination. (Quirk B, Olasz E, Kumar S, Basel D, Whelan H) Photobiomodul Photomed Laser Surg 2021 Jun;39(6):411-417 11 Citations |
| 1 | Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG Oncology. (Glide-Hurst CK, Lee P, Yock AD, Olsen JR, Cao M, Siddiqui F, Parker W, Doemer A, Rong Y, Kishan AU, Benedict SH, Li XA, Erickson BA, Sohn JW, Xiao Y, Wuthrick E) Int J Radiat Oncol Biol Phys 2021 Mar 15;109(4):1054-1075 181 Citations |
| 1 | Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis. (Kubi B, Nudotor R, Fackche N, Nizam W, Cloyd JM, Grotz TE, Fournier KF, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Patel SH, Lambert LA, Abbott DE, Vande Walle KA, Raoof M, Lee B, Maithel SK, Staley CA, Johnston FM, Greer JB) Ann Surg Oncol 2021 Aug;28(8):4499-4507 13 Citations |
| 4 | Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research late effects and quality of life working committee. (Sharma A, Badawy SM, Suelzer EM, Murthy HS, Prasad P, Eissa H, Carpenter PA, Hamadani M, Labopin M, Schoemans H, Tichelli A, Phelan R, Hamilton BK, Buchbinder D, Im A, Hunter R, Brazauskas R, Burns LJ) Bone Marrow Transplant 2021 Apr;56(4):786-797 6 Citations |
| 1 | Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group. (Lacas B, Carmel A, Landais C, Wong SJ, Licitra L, Tobias JS, Burtness B, Ghi MG, Cohen EEW, Grau C, Wolf G, Hitt R, Corvò R, Budach V, Kumar S, Laskar SG, Mazeron JJ, Zhong LP, Dobrowsky W, Ghadjar P, Fallai C, Zakotnik B, Sharma A, Bensadoun RJ, Ruo Redda MG, Racadot S, Fountzilas G, Brizel D, Rovea P, Argiris A, Nagy ZT, Lee JW, Fortpied C, Harris J, Bourhis J, Aupérin A, Blanchard P, Pignon JP, MACH-NC Collaborative Group) Radiother Oncol 2021 Mar;156:281-293 223 Citations |
| 1 | CA19-9 Response to 1st-Line Neoadjuvant FOLFIRINOX and 2nd-Line Gemcitabine-Based Chemotherapy in Patients with Operable Pancreatic Cancer (S Thalji, M Kamgar, B George, M Aldakkak, K Christians, CN Clarke, B Erickson, W Hall, P Tolat, A Khan, DB Evans, S Tsai) ANNALS OF SURGICAL ONCOLOGY 28 (SUPPL 1), S20-S20 |
| 1 | Commentary: A stitch in time saves nine, but medical therapy makes that stitch shine. (Wyler von Ballmoos MC, Almassi GH) J Thorac Cardiovasc Surg 2022 Dec;164(6):1900-1901 |
| 1 | Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium. (Pikman Y, Tasian SK, Sulis ML, Stevenson K, Blonquist TM, Apsel Winger B, Cooper TM, Pauly M, Maloney KW, Burke MJ, Brown PA, Gossai N, McNeer JL, Shukla NN, Cole PD, Kahn JM, Chen J, Barth MJ, Magee JA, Gennarini L, Adhav AA, Clinton CM, Ocasio-Martinez N, Gotti G, Li Y, Lin S, Imamovic A, Tognon CE, Patel T, Faust HL, Contreras CF, Cremer A, Cortopassi WA, Garrido Ruiz D, Jacobson MP, Dharia NV, Su A, Robichaud AL, Saur Conway A, Tarlock K, Stieglitz E, Place AE, Puissant A, Hunger SP, Kim AS, Lindeman NI, Gore L, Janeway KA, Silverman LB, Tyner JW, Harris MH, Loh ML, Stegmaier K) Cancer Discov 2021 Jun;11(6):1424-1439 28 Citations |
| 2 | Platelet gene therapy induces robust immune tolerance even in a primed model via peripheral clonal deletion of antigen-specific T cells. (Li J, Chen J, Schroeder JA, Hu J, Williams CB, Shi Q) Mol Ther Nucleic Acids 2021 Mar 05;23:719-730 6 Citations |
| 5 | Clinical Implementation and Initial Experience of Real-Time Motion Tracking With Jaws and Multileaf Collimator During Helical Tomotherapy Delivery. (Chen GP, Tai A, Puckett L, Gore E, Lim S, Keiper T, Johnstone C, Shukla M, Lawton C, Li XA) Pract Radiat Oncol 2021;11(5):e486-e495 21 Citations |
| 1 | Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer. (Chesnut GT, Tin AL, Sivaraman A, Takeda T, Lee T, Fainberg J, Benfante N, Sjoberg DD, Vargas HA, Fine SW, Scardino PT, Eastham JA, Coleman JA, Touijer KA, Zelefsky MJ, Ehdaie B) Urol Oncol 2021 Aug;39(8):495.e17-495.e24 2 Citations |
| 1 | In Reply: "On Insulin Kinetics Following High-Dose Insulin Therapy, and When to Stop Therapy". (Corcoran JN, Jacoby KJ, Olives TD, Bangh SA, Cole JB) J Med Toxicol 2021 Apr;17(2):235-236 2 Citations |
| 1 | Lentivirus-mediated gene therapy for Fabry disease. (Khan A, Barber DL, Huang J, Rupar CA, Rip JW, Auray-Blais C, Boutin M, O'Hoski P, Gargulak K, McKillop WM, Fraser G, Wasim S, LeMoine K, Jelinski S, Chaudhry A, Prokopishyn N, Morel CF, Couban S, Duggan PR, Fowler DH, Keating A, West ML, Foley R, Medin JA) Nat Commun 2021 Feb 25;12(1):1178 90 Citations |
| 2 | Cardiac Magnetic Resonance for Early Detection of Radiation Therapy-Induced Cardiotoxicity in a Small Animal Model (Ibrahim ESH, Baruah D, Croisille P, Stojanovska J, Rubenstein JC, Frei A, Schlaak RA, Lin CY, Pipke JL, Lemke A, Xu Z, Klaas A, Brehler M, Flister MJ, Laviolette PS, Gore EM, Bergom C) JACC: CardioOncology March 2021;3(1):113-130 15 Citations |
| 1 | Platelet-targeted hyperfunctional FIX gene therapy for hemophilia B mice even with preexisting anti-FIX immunity. (Schroeder JA, Chen J, Chen Y, Cai Y, Yu H, Mattson JG, Monahan PE, Shi Q) Blood Adv 2021 Mar 09;5(5):1224-1238 5 Citations |
| 2 | Preparing for a Destination Therapy Ventricular Assist Device: The Palliative Care Planning Conversation #410. (Jozwiak R, Stellmacher P, Zehm A) J Palliat Med 2021 Mar;24(3):455-456 |
| 1 | Tyrosine kinase inhibitor therapy discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States after clinical practice guideline updates. (Atallah EL, Sadek I, Maegawa R, Cao X, Latremouille-Viau D, Pivneva I, Rossi C, Guerin A, Kota V) Leuk Lymphoma 2021 Jul;62(7):1730-1739 4 Citations |
| 1 | Platelet gene therapy induces robust immune tolerance even in a primed model via peripheral clonal deletion of antigen-specific T cells (Li J, Chen J, Schroeder JA, Hu J, Williams CB, Shi Q) Molecular Therapy Nucleic Acids 5 March 2021;23:719-730 6 Citations |
| 1 | Longitudinal optical coherence tomography to visualize the in vivo response of middle ear biofilms to antibiotic therapy. (Won J, Hong W, Khampang P, Spillman DR Jr, Marshall S, Yan K, Porter RG, Novak MA, Kerschner JE, Boppart SA) Sci Rep 2021 Mar 04;11(1):5176 15 Citations |
| 1 | Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung Cancer (Crockett CB, Samson P, Chuter R, Dubec M, Faivre-Finn C, Green OL, Hackett SL, McDonald F, Robinson C, Shiarli AM, Straza MW, Verhoeff JJC, Werner-Wasik M, Vlacich G, Cobben D) Frontiers in Oncology 10 March 2021;11 29 Citations |
| 2 | MR-Guided Radiotherapy for Brain and Spine Tumors. (Maziero D, Straza MW, Ford JC, Bovi JA, Diwanji T, Stoyanova R, Paulson ES, Mellon EA) Front Oncol 2021;11:626100 37 Citations |
| 1 | Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung Cancer. (Crockett CB, Samson P, Chuter R, Dubec M, Faivre-Finn C, Green OL, Hackett SL, McDonald F, Robinson C, Shiarli AM, Straza MW, Verhoeff JJC, Werner-Wasik M, Vlacich G, Cobben D) Front Oncol 2021;11:617681 29 Citations |
| 1 | Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review. (Chang Y, Guyatt GH, Teich T, Dawdy JL, Shahid S, Altman JK, Stone RM, Sekeres MA, Mukherjee S, LeBlanc TW, Abel GA, Hourigan CS, Litzow MR, Michaelis LC, Alibhai SMH, Desai P, Buckstein R, MacEachern J, Brignardello-Petersen R) PLoS One 2021;16(3):e0249087 4 Citations |
| 3 | Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR. (Wieduwilt MJ, Stock W, Advani A, Luger S, Larson RA, Tallman M, Appelbaum F, Zhang MJ, Bo-Subait K, Wang HL, Bhatt VR, Dholaria B, Eapen M, Hamadani M, Jamy O, Prestidge T, Pulsipher M, Ritchie D, Rizzieri D, Sharma A, Barba P, Sandmaier BM, de Lima M, Kebriaei P, Litzow M, Saber W, Weisdorf D) Leukemia 2021 Jul;35(7):2076-2085 31 Citations |
| 1 | Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy. (Mangala LS, Wang H, Jiang D, Wu SY, Somasunderam A, Volk DE, Lokesh GLR, Li X, Pradeep S, Yang X, Haemmerle M, Rodriguez-Aguayo C, Nagaraja AS, Rupaimoole R, Bayraktar E, Bayraktar R, Li L, Tanaka T, Hu W, Ivan C, Gharpure KM, McGuire MH, Thiviyanathan V, Zhang X, Maiti SN, Bulayeva N, Choi HJ, Dorniak PL, Cooper LJ, Rosenblatt KP, Lopez-Berestein G, Gorenstein DG, Sood AK) JCI Insight 2021 Apr 08;6(7) |
| 1 | The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer. (Kish JA, Zhang Q, Langer CJ, Nguyen-Tân PF, Rosenthal DI, Weber RS, List MA, Wong SJ, Garden AS, Hu K, Trotti AM, Bonner JA, Jones CU, Yom SS, Thorstad W, Schultz CJ, Ridge JA, Shenouda G, Harris J, Le QT) J Geriatr Oncol 2021 Jul;12(6):937-944 6 Citations |
| 1 | Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1. (Granger MM, Naranjo A, Bagatell R, DuBois SG, McCune JS, Tenney SC, Weiss BD, Mosse YP, Asgharzadeh S, Grupp SA, Hogarty MD, Gastier-Foster JM, Mills D, Shulkin BL, Parisi MT, London WB, Han-Chang J, Panoff J, von Allmen D, Jarzembowski JA, Park JR, Yanik GA) Transplant Cell Ther 2021 Jun;27(6):490.e1-490.e8 22 Citations |
| 1 | Ten-year experience in optimizing neoadjuvant therapy for localized pancreatic cancer-Medical college of Wisconsin perspective. (Ward EP, Evans DB, Tsai S) J Surg Oncol 2021 May;123(6):1405-1413 4 Citations |
| 2 | Comment on "Women Could Avoid Axillary Lymph Node Dissection by Choosing Breast-Conserving Therapy Instead of Mastectomy". (Cortina CS, Kong AL) Ann Surg Oncol 2021 Dec;28(Suppl 3):772-773 3 Citations |
| 1 | Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity. (Franco NR, Massi MC, Ieva F, Manzoni A, Paganoni AM, Zunino P, Veldeman L, Ost P, Fonteyne V, Talbot CJ, Rattay T, Webb A, Johnson K, Lambrecht M, Haustermans K, De Meerleer G, de Ruysscher D, Vanneste B, Van Limbergen E, Choudhury A, Elliott RM, Sperk E, Veldwijk MR, Herskind C, Avuzzi B, Noris Chiorda B, Valdagni R, Azria D, Farcy-Jacquet MP, Brengues M, Rosenstein BS, Stock RG, Vega A, Aguado-Barrera ME, Sosa-Fajardo P, Dunning AM, Fachal L, Kerns SL, Payne D, Chang-Claude J, Seibold P, West CML, Rancati T, REQUITE Consortium Collaborators) Radiother Oncol 2021 Jun;159:241-248 14 Citations |
| 2 | Posterior reversible encephalopathy syndrome in a patient with Richter's syndrome on combination DA-R-EPOCH chemotherapy regimen: a case report. (Egoryan G, Murguia-Fuentes R, Agab M, Abou-Ghanem N, Yanez-Bello MA, Pyakuryal B, Trelles-Garcia DP, Ibrahim R, Filipiuk D, Gidron A, Rodriguez-Nava G) J Med Case Rep 2021 Apr 12;15(1):161 |
| 9 | Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the Prostate for Very High-Risk Adenocarcinoma of the Prostate: A Prospective Phase II Clinical Trial. (Hall WA, Bedi M, Kilari D, Bylow KA, Burfeind J, Johnstone C, Siker M, Currey A, See WA, Nelson A, Johnson S, Straza M, Lawton CAF) Pract Radiat Oncol 2021;11(6):527-533 4 Citations |
| 2 | Voluntary wheel running complements microdystrophin gene therapy to improve muscle function in mdx mice. (Hamm SE, Fathalikhani DD, Bukovec KE, Addington AK, Zhang H, Perry JB, McMillan RP, Lawlor MW, Prom MJ, Vanden Avond MA, Kumar SN, Coleman KE, Dupont JB, Mack DL, Brown DA, Morris CA, Gonzalez JP, Grange RW) Mol Ther Methods Clin Dev 2021 Jun 11;21:144-160 12 Citations |
| 1 | Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis. (Petit C, Lacas B, Pignon JP, Le QT, Grégoire V, Grau C, Hackshaw A, Zackrisson B, Parmar MKB, Lee JW, Ghi MG, Sanguineti G, Temam S, Cheugoua-Zanetsie M, O'Sullivan B, Posner MR, Vokes EE, Cruz Hernandez JJ, Szutkowski Z, Lartigau E, Budach V, Suwiński R, Poulsen M, Kumar S, Ghosh Laskar S, Mazeron JJ, Jeremic B, Simes J, Zhong LP, Overgaard J, Fortpied C, Torres-Saavedra P, Bourhis J, Aupérin A, Blanchard P, MACH-NC and MARCH Collaborative Groups) Lancet Oncol 2021 May;22(5):727-736 67 Citations |
| 1 | Incidence, Predictors, and Outcomes of Acute Kidney Injury in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology National Cardiovascular Data Registry-Transcatheter Valve Therapy Registry. (Julien HM, Stebbins A, Vemulapalli S, Nathan AS, Eneanya ND, Groeneveld P, Fiorilli PN, Herrmann HC, Szeto WY, Desai ND, Anwaruddin S, Vora A, Shah B, Ng VG, Kumbhani DJ, Giri J) Circ Cardiovasc Interv 2021 Apr;14(4):e010032 29 Citations |
| 1 | Optimizing language for effective communication of gene therapy concepts with hemophilia patients: a qualitative study. (Hart DP, Branchford BR, Hendry S, Ledniczky R, Sidonio RF Jr, Négrier C, Kim M, Rice M, Minshall M, Arcé C, Prince S, Kelleher M, Lee S) Orphanet J Rare Dis 2021 Apr 28;16(1):189 23 Citations |
| 1 | Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival. (Lazar V, Magidi S, Girard N, Savignoni A, Martini JF, Massimini G, Bresson C, Berger R, Onn A, Raynaud J, Wunder F, Berindan-Neagoe I, Sekacheva M, Braña I, Tabernero J, Felip E, Porgador A, Kleinman C, Batist G, Solomon B, Tsimberidou AM, Soria JC, Rubin E, Kurzrock R, Schilsky RL) NPJ Precis Oncol 2021 Apr 28;5(1):33 7 Citations |
| 3 | Cardiac Magnetic Resonance for Early Detection of Radiation Therapy-Induced Cardiotoxicity in a Small Animal Model. (Ibrahim EH, Baruah D, Croisille P, Stojanovska J, Rubenstein JC, Frei A, Schlaak RA, Lin CY, Pipke JL, Lemke A, Xu Z, Klaas A, Brehler M, Flister MJ, Laviolette PS, Gore EM, Bergom C) JACC CardioOncol 2021 Mar;3(1):113-130 15 Citations |
| 1 | Commentary: Surgery for locally advanced pancreatic cancer after neoadjuvant therapy (Evans DB) Surgery (United States) May 2021;169(5):1032-1033 3 Citations |
| 1 | Systematic Reviews in Hematopoietic Cell Transplantation and Cellular Therapy: Considerations and Guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and Center for International Blood and Marrow Transplant Research Late Effects and Quality of Life Working Committee (Sharma A, Badawy SM, Suelzer EM, Murthy HS, Prasad P, Eissa H, Carpenter PA, Hamadani M, Labopin M, Schoemans H, Tichelli A, Phelan R, Hamilton BK, Buchbinder D, Im A, Hunter R, Brazauskas R, Burns LJ) Transplantation and Cellular Therapy May 2021;27(5):380-388 4 Citations |
| 1 | MRI-Guided Radiation Therapy. (Lee SL, Hall WA, Morris ZS, Christensen L, Bassetti M) Adv Oncol 2021 May;1:29-39 |
| 1 | The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change? (Ryckman JM, Reames BN, Klute KA, Hall WA, Baine MJ, Abdel-Wahab M, Lin C) Clinical and Translational Radiation Oncology May 2021;28:124-128 7 Citations |
| 1 | Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer (Mahadevan A, Moningi S, Grimm J, Li XA, Forster KM, Palta M, Prior P, Goodman KA, Narang A, Heron DE, Lo SS, Urbanic J, Herman JM) International Journal of Radiation Oncology Biology Physics 1 May 2021;110(1):206-216 30 Citations |
| 1 | Preclinical Models of Cancer Therapy-Associated Cardiovascular Toxicity: A Scientific Statement From the American Heart Association. (Asnani A, Moslehi JJ, Adhikari BB, Baik AH, Beyer AM, de Boer RA, Ghigo A, Grumbach IM, Jain S, Zhu H, American Heart Association Council on Basic Cardiovascular Sciences; Cardio-Oncology Science Subcommittee of Council on Genomic and Precision Medicine and Council on Clinical Cardiology; Council on Peripheral Vascular Disease; and Council on Arteriosclerosis, Thrombosis and Vascular Biology) Circ Res 2021 Jun 25;129(1):e21-e34 51 Citations |
| 4 | Correction: Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research late effects and quality of life working committee. (Sharma A, Badawy SM, Suelzer EM, Murthy HS, Prasad P, Eissa H, Carpenter PA, Hamadani M, Labopin M, Schoemans H, Tichelli A, Phelan R, Hamilton BK, Buchbinder D, Im A, Hunter R, Brazauskas R, Burns LJ) Bone Marrow Transplant 2021 Jun;56(6):1486 2 Citations |
| 4 | Systematic Reviews in Hematopoietic Cell Transplantation and Cellular Therapy: Considerations and Guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and Center for International Blood and Marrow Transplant Research Late Effects and Quality of Life Working Committee. (Sharma A, Badawy SM, Suelzer EM, Murthy HS, Prasad P, Eissa H, Carpenter PA, Hamadani M, Labopin M, Schoemans H, Tichelli A, Phelan R, Hamilton BK, Buchbinder D, Im A, Hunter R, Brazauskas R, Burns LJ) Transplant Cell Ther 2021 May;27(5):380-388 4 Citations |
| 1 | Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival. (Shanmugasundaram K, Goyal S, Switchenko J, Calzada O, Churnetski MC, Kolla B, Bachanova V, Gerson JN, Barta SK, Gordon MJ, Danilov AV, Grover NS, Mathews S, Burkart M, Karmali R, Sawalha Y, Hill BT, Ghosh N, Park SI, Epperla N, Bond DA, Badar T, Blum KA, Hamadani M, Fenske TS, Malecek M, Kahl BS, Martin P, Guo J, Flowers CR, Cohen JB) Eur J Haematol 2021 Sep;107(3):301-310 3 Citations |
| 1 | The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change? (Ryckman JM, Reames BN, Klute KA, Hall WA, Baine MJ, Abdel-Wahab M, Lin C) Clin Transl Radiat Oncol 2021 May;28:124-128 7 Citations |
| 1 | Lower endothelium-dependent microvascular function in adult breast cancer patients receiving radiation therapy. (Banister HR, Hammond ST, Parr SK, Sutterfield SL, Turpin VG, Treinen S, Bell MJ, Ade CJ) Cardiooncology 2021 May 13;7(1):18 7 Citations |
| 2 | KD-PACE Salvage Therapy for Aggressive Relapsed Refractory Multiple Myeloma, Plasma Cell Leukemia and Extramedullary Myeloma. (Alsouqi A, Khan M, Dhakal B, Du L, Harrell S, Hari P, Cornell RF) Clin Lymphoma Myeloma Leuk 2021 Aug;21(8):526-535 16 Citations |
| 2 | Immunotherapy in Multiple Myeloma-Time for a Second Major Paradigm Shift. (Mohan M, Hari P, Dhakal B) JCO Oncol Pract 2021 Jul;17(7):405-413 16 Citations |
| 1 | Prevalence and predictors of peripheral neuropathy after chemotherapy: Outcomes from the Detroit Research on Cancer Survivorship (ROCS) cohort. (K Sreeram, R Seaton, M Kamgar, H Assad, MK Greenwald, JJ Ruterbusch, JL Beebe-Dimmer, AG Schwartz, MS Simon) Journal of Clinical Oncology 39 (15_suppl), 12069-12069 |
| 1 | HER-2/neu-positive breast cancer neoadjuvant chemotherapy response after implementation of 2018 ASCO/CAP focused update. (Wang L, Asirvatham JR, Ma Y, Reisenbichler ES, Jorns JM) Breast J 2021 Aug;27(8):631-637 6 Citations |
| 1 | Dose perturbation caused by metallic port in breast tissue expander in proton beam therapy. (Zhao L, Moskvin VP, Cheng CW, Das IJ) Biomed Phys Eng Express 2020 Nov 18;6(6) 1 Citation |
| 3 | Magnetic Resonance Guided Radiation Therapy for Pancreatic Adenocarcinoma, Advantages, Challenges, Current Approaches, and Future Directions. (Hall WA, Small C, Paulson E, Koay EJ, Crane C, Intven M, Daamen LA, Meijer GJ, Heerkens HD, Bassetti M, Rosenberg SA, Aitken K, Myrehaug S, Dawson LA, Lee P, Gani C, Chuong MD, Parikh PJ, Erickson BA) Front Oncol 2021;11:628155 30 Citations |
| 1 | Final results of a phase 1b study of isatuximab short-duration fixed-volume infusion combination therapy for relapsed/refractory multiple myeloma. (Usmani SZ, Karanes C, Bensinger WI, D'Souza A, Raje N, Tuchman SA, Sborov D, Laubach JP, Bianchi G, Kanagavel D, Saleem R, Dubin F, Campana F, Richardson PG) Leukemia 2021 Dec;35(12):3526-3533 15 Citations |
| 1 | Early Comparative Toxicity Outcomes of Patients With Prostate Cancer Receiving Initial Cryotherapy and Radiotherapy Salvage (Jiang C, Godette K, Hall WA, Bennett JK, Rossi P, Cooper S, Jani AB, Patel PR) Clinical Genitourinary Cancer June 2021;19(3):267-270.e1 3 Citations |
| 1 | Treating Positive Axillary Disease in Elderly Breast Cancer Patients: The Impact of Age on Radiation Therapy (Cortina CS, Woodfin AA, Tangalakis LL, Wang X, Son JD, Poirier J, Rao R, Kopkash K, Madrigrano A) Breast Care 1 June 2021;16(3):276-282 4 Citations |
| 3 | Tumor Control Probability Modeling for Radiation Therapy of Keratinocyte Carcinoma. (Prior P, Awan MJ, Wilson JF, Li XA) Front Oncol 2021;11:621641 5 Citations |
| 1 | The pathways related to glutamine metabolism, glutamine inhibitors and their implication for improving the efficiency of chemotherapy in triple-negative breast cancer. (Delgir S, Bastami M, Ilkhani K, Safi A, Seif F, Alivand MR) Mutat Res Rev Mutat Res 2021;787:108366 36 Citations |
| 3 | Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR. (Wieduwilt MJ, Stock W, Advani A, Luger S, Larson RA, Tallman M, Appelbaum F, Zhang MJ, Bo-Subait K, Wang HL, Bhatt VR, Dholaria B, Eapen M, Hamadani M, Jamy O, Prestidge T, Pulsipher M, Ritchie D, Rizzieri D, Sharma A, Barba P, Sandmaier BM, de Lima M, Kebriaei P, Litzow M, Saber W, Weisdorf D) Leukemia 2021 Jul;35(7):2140 1 Citation |
| 1 | Revisiting biochemistry: severe euglycemic ketoacidosis in the setting of IDH-inhibitor therapy for AML. (Khan M, Roddy JT, Hernandez JR, Bursch K, Bal N, Carlson KS, Bergl PA) Br J Haematol 2021 Sep;194(6):1083-1085 |
| 1 | Antiretroviral Therapy Adherence, Functional Independence, and Falls among People with HIV. (Armstead AB, Wilkerson JM, Gemeinhardt G, Nyitray A, Collins DM) Occup Ther Health Care 2021 Jul;35(3):318-335 1 Citation |
| 4 | Biobehavioral Research and Hematopoietic Stem Cell Transplantation: Expert Review from the Biobehavioral Research Special Interest Group of the American Society for Transplantation and Cellular Therapy. (Kelly DL, Syrjala K, Taylor M, Rentscher KE, Hashmi S, Wood WA, Jim H, Barata A, Flynn KE, Burns LJ, Shaw BE, Petersdorf E, Yero AC, Emmrich AD, Morris KE, Costanzo ES, Knight JM) Transplant Cell Ther 2021 Sep;27(9):747-757 14 Citations |
| 1 | Integration of quantitative imaging biomarkers in clinical trials for MR-guided radiotherapy: Conceptual guidance for multicentre studies from the MR-Linac Consortium Imaging Biomarker Working Group. (van Houdt PJ, Saeed H, Thorwarth D, Fuller CD, Hall WA, McDonald BA, Shukla-Dave A, Kooreman ES, Philippens MEP, van Lier ALHMW, Keesman R, Mahmood F, Coolens C, Stanescu T, Wang J, Tyagi N, Wetscherek A, van der Heide UA) Eur J Cancer 2021 Aug;153:64-71 31 Citations |
| 1 | Intravitreal Chemotherapy Eligibility and Ocular Survival for Advanced Retinoblastoma () Investigative Ophthalmology & Visual Science Laplant J, Wilson MW, Wang F, Pan H, King BA, Brennan R. Intravitreal Chemotherapy Eligibility and Ocular Survival for Advanced Retinoblastoma. Investigative Ophthalmology & Visual Science. 2021 Jun 21;62(8):2851-. |
| 7 | Laboratory Mice - A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma. (Pisano M, Cheng Y, Sun F, Dhakal B, D'Souza A, Chhabra S, Knight JM, Rao S, Zhan F, Hari P, Janz S) Front Immunol 2021;12:667054 3 Citations |
| 1 | Nutrition therapy in the critically injured adult patient: A Western Trauma Association critical decisions algorithm. (Hartwell JL, Peck KA, Ley EJ, Brown CVR, Moore EE, Sperry JL, Rizzo AG, Rosen NG, Brasel KJ, Weinberg JA, de Moya MA, Inaba K, Cotton A, Martin MJ) J Trauma Acute Care Surg 2021 Nov 01;91(5):909-915 6 Citations |
| 1 | Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study. (Berdeja JG, Madduri D, Usmani SZ, Jakubowiak A, Agha M, Cohen AD, Stewart AK, Hari P, Htut M, Lesokhin A, Deol A, Munshi NC, O'Donnell E, Avigan D, Singh I, Zudaire E, Yeh TM, Allred AJ, Olyslager Y, Banerjee A, Jackson CC, Goldberg JD, Schecter JM, Deraedt W, Zhuang SH, Infante J, Geng D, Wu X, Carrasco-Alfonso MJ, Akram M, Hossain F, Rizvi S, Fan F, Lin Y, Martin T, Jagannath S) Lancet 2021 Jul 24;398(10297):314-324 1067 Citations |
| 1 | Early physical therapy intervention in adolescent athlete with L5 Spondylolysis and grade 1 L5-S1 Spondylolisthesis: a case study. (Hong K, Selthafner M, Fehr S, Walter K, Liu XC) Stud Health Technol Inform 2021 Jun 28;280:321 |
| 1 | Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial. (Rahma OE, Yothers G, Hong TS, Russell MM, You YN, Parker W, Jacobs SA, Colangelo LH, Lucas PC, Gollub MJ, Hall WA, Kachnic LA, Vijayvergia N, O'Rourke MA, Faller BA, Valicenti RK, Schefter TE, George S, Kainthla R, Stella PJ, Sigurdson E, Wolmark N, George TJ) JAMA Oncol 2021 Aug 01;7(8):1225-1230 130 Citations |
| 1 | Findings of the AAPM Ad Hoc committee on magnetic resonance imaging in radiation therapy: Unmet needs, opportunities, and recommendations. (McGee KP, Tyagi N, Bayouth JE, Cao M, Fallone BG, Glide-Hurst CK, Goerner FL, Green OL, Kim T, Paulson ES, Yanasak NE, Jackson EF, Goodwin JH, Dieterich S, Jordan DW, Hugo GD, Bernstein MA, Balter JM, Kanal KM, Hazle JD, Pelc NJ) Med Phys 2021 Aug;48(8):4523-4531 4 Citations |
| 1 | Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate-risk Hodgkin lymphoma treated with chemo-radiation therapy: FDG-PET parameter analysis in a subgroup from COG AHOD0031. (Milgrom SA, Kim J, Chirindel A, Kim J, Pei Q, Chen L, Buxton A, Kessel S, Leal J, McCarten KM, Hoppe BS, Wolden SL, Schwartz CL, Friedman DL, Kelly KM, Cho SY) Pediatr Blood Cancer 2021 Sep;68(9):e29212 17 Citations |
| 1 | Treating Positive Axillary Disease in Elderly Breast Cancer Patients: The Impact of Age on Radiation Therapy. (Cortina CS, Woodfin AA, Tangalakis LL, Wang X, Son JD, Poirier J, Rao R, Kopkash K, Madrigrano A) Breast Care (Basel) 2021 Jun;16(3):276-282 4 Citations |
| 1 | Term Pregnancy After Complete Response of Placental Site Trophoblastic Tumor to Immunotherapy. (Polnaszek B, Mullen M, Bligard K, Raghuraman N, Massad LS) Obstet Gynecol 2021 Jul 01;138(1):115-118 18 Citations |
| 1 | Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study. (Cutler C, Lee SJ, Arai S, Rotta M, Zoghi B, Lazaryan A, Ramakrishnan A, DeFilipp Z, Salhotra A, Chai-Ho W, Mehta R, Wang T, Arora M, Pusic I, Saad A, Shah NN, Abhyankar S, Bachier C, Galvin J, Im A, Langston A, Liesveld J, Juckett M, Logan A, Schachter L, Alavi A, Howard D, Waksal HW, Ryan J, Eiznhamer D, Aggarwal SK, Ieyoub J, Schueller O, Green L, Yang Z, Krenz H, Jagasia M, Blazar BR, Pavletic S) Blood 2021 Dec 02;138(22):2278-2289 182 Citations |
| 1 | Cutaneous manifestations of chimeric antigen receptor T-cell therapy: An introduction for dermatologists. (Nusbaum KB, Dulmage B, Choi JN, Jaglowski SM, Korman AM) J Am Acad Dermatol 2022 Sep;87(3):597-604 9 Citations |
| 2 | Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy. (Kharfan-Dabaja MA, Kumar A, Ayala E, Aljurf M, Nishihori T, Marsh R, Burroughs LM, Majhail N, Al-Homsi AS, Al-Kadhimi ZS, Bar M, Bertaina A, Boelens JJ, Champlin R, Chaudhury S, DeFilipp Z, Dholaria B, El-Jawahri A, Fanning S, Fraint E, Gergis U, Giralt S, Hamilton BK, Hashmi SK, Horn B, Inamoto Y, Jacobsohn DA, Jain T, Johnston L, Kanate AS, Kansagra A, Kassim A, Kean LS, Kitko CL, Knight-Perry J, Kurtzberg J, Liu H, MacMillan ML, Mahmoudjafari Z, Mielcarek M, Mohty M, Nagler A, Nemecek E, Olson TS, Oran B, Perales MA, Prockop SE, Pulsipher MA, Pusic I, Riches ML, Rodriguez C, Romee R, Rondon G, Saad A, Shah N, Shaw PJ, Shenoy S, Sierra J, Talano J, Verneris MR, Veys P, Wagner JE, Savani BN, Hamadani M, Carpenter PA) Transplant Cell Ther 2021 Aug;27(8):642-649 108 Citations |
| 1 | Transcatheter Heart Valve Thrombosis in a Patient With Polycythemia Vera Despite Apixaban Therapy for Atrial Fibrillation. (Mahalwar G, Lao N, Babar A, Kapadia SR, Kalra A, Cutler D, Wierup P) JACC Case Rep 2021 Feb;3(2):269-272 2 Citations |
| 1 | GEN-1 in Combination with Neoadjuvant Chemotherapy for Patients with Advanced Epithelial Ovarian Cancer: A Phase I Dose-escalation Study. (Thaker PH, Bradley WH, Leath CA 3rd, Gunderson Jackson C, Borys N, Anwer K, Musso L, Matsuzaki J, Bshara W, Odunsi K, Alvarez RD) Clin Cancer Res 2021 Oct 15;27(20):5536-5545 18 Citations |
| 1 | Radiation Therapy for Treatment of Soft Tissue Sarcoma in Adults: Executive Summary of an ASTRO Clinical Practice Guideline. (Salerno KE, Alektiar KM, Baldini EH, Bedi M, Bishop AJ, Bradfield L, Chung P, DeLaney TF, Folpe A, Kane JM, Li XA, Petersen I, Powell J, Stolten M, Thorpe S, Trent JC, Voermans M, Guadagnolo BA) Pract Radiat Oncol 2021;11(5):339-351 101 Citations |
| 1 | Integration of quantitative imaging biomarkers in clinical trials for MR-guided radiotherapy: Conceptual guidance for multicentre studies from the MR-Linac Consortium Imaging Biomarker Working Group (van Houdt PJ, Saeed H, Thorwarth D, Fuller CD, Hall WA, McDonald BA, Shukla-Dave A, Kooreman ES, Philippens MEP, van Lier ALHMW, Keesman R, Mahmood F, Coolens C, Stanescu T, Wang J, Tyagi N, Wetscherek A, van der Heide UA) European Journal of Cancer August 2021;153:64-71 31 Citations |
| 5 | Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy. (Dhakal B, Abedin S, Fenske T, Chhabra S, Ledeboer N, Hari P, Hamadani M) Blood 2021 Oct 07;138(14):1278-1281 106 Citations |
| 1 | Gene therapy for Fabry disease: Progress, challenges, and outlooks on gene-editing. (Domm JM, Wootton SK, Medin JA, West ML) Mol Genet Metab 2021;134(1-2):117-131 29 Citations |
| 1 | Impact of initial chemotherapy regimen on outcomes for patients with double-expressor lymphoma: A multi-center analysis. (D'Angelo CR, Hanel W, Chen Y, Yu M, Yang D, Guo L, Karmali R, Burkart M, Ciccosanti C, David K, Risch Z, Murga-Zamalloa C, Devata S, Wilcox R, Savani M, Courville EL, Bachanova V, Rabinovich E, Peace D, Osman F, Epperla N, Kenkre VP) Hematol Oncol 2021 Oct;39(4):473-482 7 Citations |
| 1 | Executive Summary: Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. (Stevens SM, Woller SC, Baumann Kreuziger L, Bounameaux H, Doerschug K, Geersing GJ, Huisman MV, Kearon C, King CS, Knighton AJ, Lake E, Murin S, Vintch JRE, Wells PS, Moores LK) Chest 2021 Dec;160(6):2247-2259 310 Citations |
| 1 | Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. (Stevens SM, Woller SC, Kreuziger LB, Bounameaux H, Doerschug K, Geersing GJ, Huisman MV, Kearon C, King CS, Knighton AJ, Lake E, Murin S, Vintch JRE, Wells PS, Moores LK) Chest 2021 Dec;160(6):e545-e608 584 Citations |
| 1 | Missing the target in cancer therapy. (Adashek JJ, Goloubev A, Kato S, Kurzrock R) Nat Cancer 2021 Apr;2:369-371 25 Citations |
| 1 | Comparative Effectiveness of Echinocandins vs Triazoles or Amphotericin B Formulations as Initial Directed Therapy for Invasive Candidiasis in Children and Adolescents. (Fisher BT, Zaoutis TE, Xiao R, Wattier RL, Castagnola E, Pana ZD, Fullenkamp A, Boge CLK, Ross RK, Yildirim I, Palazzi DL, Danziger-Isakov L, Vora SB, Arrieta A, Yin DE, Avilés-Robles M, Sharma T, Tribble AC, Maron G, Berman D, Green M, Sung L, Romero J, Hauger SB, Roilides E, Belani K, Nolt D, Soler-Palacin P, López-Medina E, Muller WJ, Halasa N, Dulek D, Hussain IZB, Pong A, Hoffman J, Rajan S, Gonzalez BE, Hanisch B, Aftandilian C, Carlesse F, Abzug MJ, Huppler AR, Salvatore CM, Ardura MI, Chakrabarti A, Santolaya ME, Localio AR, Steinbach WJ) J Pediatric Infect Dis Soc 2021 Aug 10 |
| 1 | SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer. (Botta GP, Kato S, Patel H, Fanta P, Lee S, Okamura R, Kurzrock R) JCI Insight 2021 Sep 22;6(18) 43 Citations |
| 4 | The Substantial Omission of Indicated Postoperative Radiotherapy in Patients With Advanced-Stage Oral Cancer in the US-A Call to Action. (Awan M, Akakpo KE, Shukla M, Graboyes EM, Pipkorn P, Puram SV, Zenga J) JAMA Otolaryngol Head Neck Surg 2021 Oct 01;147(10):907-909 3 Citations |
| 1 | Tomotherapy Applied Total Lymphoid Irradiation and Allogeneic Hematopoietic Cell Transplantation Generates Mixed Chimerism in the Rhesus Macaque Model. (Forrest L, Fechner J, Post J, Van Asselt N, Kvasnica K, Haynes LD, Coonen J, Brunner K, Haynes WJ, Little C, Burlingham WJ, Hematti P, Strober S, Kaufman DB) Radiat Res 2021 Dec 01;196(6):623-632 5 Citations |
| 1 | Ventricular Assist Devices and Chronic Kidney Replacement Therapy: Technology and Outcomes. (Jawaid O, Gaddy A, Omar HR, Guglin M) Adv Chronic Kidney Dis 2021 Jan;28(1):37-46 3 Citations |
| 1 | CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance (Ma S, Mangala LS, Hu W, Bayaktar E, Yokoi A, Hu W, Pradeep S, Lee S, Piehowski PD, Villar-Prados A, Wu SY, McGuire MH, Lara OD, Rodriguez-Aguayo C, LaFargue CJ, Jennings NB, Rodland KD, Liu T, Kundra V, Ram PT, Ramakrishnan S, Lopez-Berestein G, Coleman RL, Sood AK) Cell Reports 17 August 2021;36(7) 31 Citations |
| 1 | Exosomes from primed MSCs can educate monocytes as a cellular therapy for hematopoietic acute radiation syndrome. (Forsberg MH, Kink JA, Thickens AS, Lewis BM, Childs CJ, Hematti P, Capitini CM) Stem Cell Res Ther 2021 Aug 18;12(1):459 13 Citations |
| 1 | Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults. (Metheny L, Callander NS, Hall AC, Zhang MJ, Bo-Subait K, Wang HL, Agrawal V, Al-Homsi AS, Assal A, Bacher U, Beitinjaneh A, Bejanyan N, Bhatt VR, Bredeson C, Byrne M, Cairo M, Cerny J, DeFilipp Z, Perez MAD, Freytes CO, Ganguly S, Grunwald MR, Hashmi S, Hildebrandt GC, Inamoto Y, Kanakry CG, Kharfan-Dabaja MA, Lazarus HM, Lee JW, Nathan S, Nishihori T, Olsson RF, Ringdén O, Rizzieri D, Savani BN, Savoie ML, Seo S, van der Poel M, Verdonck LF, Wagner JL, Yared JA, Hourigan CS, Kebriaei P, Litzow M, Sandmaier BM, Saber W, Weisdorf D, de Lima M) Transplant Cell Ther 2021 Nov;27(11):923.e1-923.e12 21 Citations |
| 1 | Early toxicity and clinical outcomes after chimeric antigen receptor T-cell (CAR-T) therapy for lymphoma. (Brammer JE, Braunstein Z, Katapadi A, Porter K, Biersmith M, Guha A, Vasu S, Yildiz VO, Smith SA, Buck B, Haddad D, Gumina R, William BM, Penza S, Saad A, Denlinger N, Vallakati A, Baliga R, Benza R, Binkley P, Wei L, Mocarski M, Devine SM, Jaglowski S, Addison D) J Immunother Cancer 2021 Aug;9(8) 38 Citations |
| 1 | American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma. (Munshi PN, Hamadani M, Kumar A, Dreger P, Friedberg JW, Dreyling M, Kahl B, Jerkeman M, Kharfan-Dabaja MA, Locke FL, Shadman M, Hill BT, Ahmed S, Herrera AF, Sauter CS, Bachanova V, Ghosh N, Lunning M, Kenkre VP, Aljurf M, Wang M, Maddocks KJ, Leonard JP, Kamdar M, Phillips T, Cashen AF, Inwards DJ, Sureda A, Cohen JB, Smith SM, Carlo-Stella C, Savani B, Robinson SP, Fenske TS) Transplant Cell Ther 2021 Sep;27(9):720-728 12 Citations |
| 2 | Acute cardiopulmonary failure in a young woman with high-risk gestational trophoblastic neoplasia: A case of induction chemotherapy during extracorporeal membrane oxygenation. (McAlarnen LA, Smith NJ, Nance BA, Tracy Zundel M, Bishop EA) Gynecol Oncol Rep 2021 Aug;37:100849 1 Citation |
| 1 | Using a patient safety analysis to guide infusion therapy for patients with COVID-19 (Hagle M, Snyder K, Janicek K, Bell K, Dietz B, Gundacker N, Kinter A, Severson A) Journal of Infusion Nursing September 2021;44(5):259-267 4 Citations |
| 1 | Outcomes of MR-guided stereotactic radiotherapy (SBRT) or yttrium-90 transarterial radioembolization for hepatocellular carcinoma treated at an urban liver transplant center.” (Liang E, Greer G, Burmeister C, Massa P, Dragovic J, Parikh P) |
| 1 | Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial. (Jones CU, Pugh SL, Sandler HM, Chetner MP, Amin MB, Bruner DW, Zietman AL, Den RB, Leibenhaut MH, Longo JM, Bahary JP, Rosenthal SA, Souhami L, Michalski JM, Hartford AC, Amin PP, Roach M 3rd, Yee D, Efstathiou JA, Rodgers JP, Feng FY, Shipley WU) Int J Radiat Oncol Biol Phys 2022 Feb 01;112(2):294-303 21 Citations |
| 1 | Toward magnetic resonance fingerprinting for low-field MR-guided radiation therapy. (Mickevicius NJ, Kim JP, Zhao J, Morris ZS, Hurst NJ Jr, Glide-Hurst CK) Med Phys 2021 Nov;48(11):6930-6940 22 Citations |
| 2 | Evolution of Systemic Therapy in Metastatic Pancreatic Ductal Adenocarcinoma. (Kamgar M, Chakrabarti S, Shreenivas A, George B) Surg Oncol Clin N Am 2021 Oct;30(4):673-691 2 Citations |
| 2 | Evolving Concepts Regarding Radiation Therapy for Pancreatic Cancer. (Hall WA, Erickson B, Crane CH) Surg Oncol Clin N Am 2021 Oct;30(4):719-730 5 Citations |
| 1 | Online Magnetic Resonance-Guided Radiotherapy (oMRgRT) for Gynecological Cancers. (Portelance L, Corradini S, Erickson B, Lalondrelle S, Padgett K, van der Leij F, van Lier A, Jürgenliemk-Schulz I) Front Oncol 2021;11:628131 17 Citations |
| 1 | Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy. (Bond DA, Switchenko JM, Villa D, Maddocks K, Churnetski M, Gerrie AS, Goyal S, Shanmugasundaram K, Calzada O, Kolla B, Bachanova V, Gerson JN, Barta SK, Hill BT, Sawalha Y, Martin P, Maldonado E, Gordon M, Danilov AV, Grover NS, Mathews S, Burkart M, Karmali R, Ghosh N, Park SI, Epperla N, Badar T, Guo J, Hamadani M, Fenske TS, Malecek MK, Kahl BS, Flowers CR, Blum KA, Cohen JB) Blood Adv 2021 Dec 14;5(23):5179-5189 30 Citations |
| 1 | Role of Vasodilator Therapy in Acute Heart Failure. (Batool A, Salehi N, Chaudhry S, Cross M, Malkawi A, Siraj A) Cureus 2021 Aug;13(8):e17126 |
| 1 | Non-Articular Felty Syndrome Refractory to Granulocyte Colony-Stimulating Factor Therapy. (Saeed H, Ejikeme C, Tucktuck M, Jawed Q, Kessler W) Cureus 2021 Aug;13(8):e17206 |
| 2 | Spinal manipulative therapy and cervical artery dissection: A retrospective comparison with spontaneous, traumatic, and iatrogenic etiologies at a single academic medical center. (Plachinski SJ, Gliedt JA, Sacho R, Schneider MJ, King JA) Clin Neurol Neurosurg 2021 Oct;209:106941 7 Citations |
| 3 | Evaluation of Radiation-induced Pleural Effusions after Radiotherapy to Support Development of Animal Models of Radiation Pneumonitis. (Aqeel M, Medhora M, Gore E, Borkenhagen J, Klawikowski S, Eastwood D, Banerjee A, Jacobs ER) Health Phys 2021 Oct 01;121(4):434-443 3 Citations |
| 2 | Social cognitive variables and physical activity during chemotherapy for breast cancer: An intensive longitudinal examination. (Auster-Gussman LA, Gavin KL, Siddique J, Welch WA, Solk P, Whitaker M, Cullather E, Fanning J, Maria CS, Gradishar W, Khan S, Kulkarni S, Phillips SM) Psychooncology 2022 Mar;31(3):425-435 10 Citations |
| 2 | CAR T-cell therapy for secondary CNS DLBCL. (Ahmed G, Hamadani M, Shah NN) Blood Adv 2021 Dec 28;5(24):5626-5630 52 Citations |
| 1 | Optimal Medical Therapy Following Deep Venous Interventions: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel. (Khaja MS, Obi AT, Sharma AM, Cuker A, McCann SS, Thukral S, Matson JT, Hofmann LV, Charalel R, Kanthi Y, Meek ME, Meissner MH, White SB, Williams DM, Vedantham S) J Vasc Interv Radiol 2022 Jan;33(1):78-85 10 Citations |
| 1 | Comparing the outcomes of intrapleural fibrinolytic and DNase therapy versus intrapleural fibrinolytic or DNase therapy: A systematic review and meta-analysis. (Chong WH, Hu K, Saha BK, Chopra A) Pulm Pharmacol Ther 2021 Dec;71:102081 5 Citations |
| 1 | Fluid Balance Management Informs Renal Replacement Therapy Use During Pediatric Extracorporeal Membrane Oxygenation: A Survey Report From the Kidney Intervention During Extracorporeal Membrane Oxygenation Group. (Gorga SM, Lima L, Askenazi DJ, Bridges BC, Cooper DS, Paden ML, Zappitelli M, Gist KM, Gien J, Jetton JG, Murphy HJ, Fleming GM, Selewski DT, Basu RK) ASAIO J 2022 Mar 01;68(3):407-412 10 Citations |
| 1 | The Effect of Immunomodulatory Treatments on Anti-Dystrophin Immune Response After AAV Gene Therapy in Dystrophin Deficient mdx Mice. (Li N, Parkes JE, Spathis R, Morales M, Mcdonald J, Kendra RM, Ott EM, Brown KJ, Lawlor MW, Nagaraju K) J Neuromuscul Dis 2021;8(s2):S325-S340 13 Citations |
| 4 | Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission. (Shadman M, Pasquini M, Ahn KW, Chen Y, Turtle CJ, Hematti P, Cohen JB, Khimani F, Ganguly S, Merryman RW, Yared JA, Locke FL, Ahmed N, Munshi PN, Beitinjaneh A, Reagan PM, Herrera AF, Sauter CS, Kharfan-Dabaja MA, Hamadani M) Blood 2022 Mar 03;139(9):1330-1339 74 Citations |
| 1 | Targeting cellular metabolism with CPI-613 sensitizes pancreatic cancer cells to radiotherapy (WA Hall, HY Khan, M Kamgar, S Tsai, K Christians, DB Evans, P Philip, C Clarke, B George, B Erickson, AS Azmi.) AACR Pancreatic Virtual Meeting; Poster Presentation |
| 1 | Phase II clinical trial of subtype directed neoadjuvant therapy in patients with
localized pancreatic cancer. (S Tsai, E Borazanci, M Gulley, N Rashid, J Merker, AH Khan, P Chisholm, B Hunt, T Giorgadze, W Hall, M Kamgar, DB Evans, JJ Yeh) AACR Pancreatic Virtual Meeting; Poster Presentation |
| 1 | Retinal Gene Therapy for Usher Syndrome: Current Developments, Challenges, and Perspectives. (Dinculescu A, Link BA, Saperstein DA) Int Ophthalmol Clin 2021 Oct 01;61(4):109-124 8 Citations |
| 1 | 90-day hospitalization as a surrogate for overall survival in hepatocellular carcinoma (HCC) patients treated with magnetic resonance-guided liver stereotactic body radiation therapy: results of a single-center retrospective study”. (Liang E, Kirsch C, Gardey V, Burmeister C, Dragovic J, Parikh P) |
| 1 | Evolution of Systemic Therapy in Metastatic Pancreatic Ductal Adenocarcinoma (Kamgar M, Chakrabarti S, Shreenivas A, George B) Surgical Oncology Clinics of North America October 2021;30(4):673-691 2 Citations |
| 1 | Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer. (Makrakis D, Talukder R, Diamantopoulos LN, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Koshkin VS, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Santos VS, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt ME, Grant M, Lythgoe MP, Pinato DJ, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Murgic J, Fröbe A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Di Lorenzo G, Joshi M, Isaacsson-Velho P, Buznego LA, Duran I, Moses M, Barata P, Sonpavde G, Yu EY, Wright JL, Grivas P, Khaki AR) BJU Int 2022 Nov;130(5):592-603 4 Citations |
| 2 | Isolated Enterococcus faecalis pulmonary valve endocarditis without precipitating risk factors: A case report describing delayed need for surgery three years after antimicrobial therapy. (Biesboer EA, Ayala GD, Cummings AC, Sutter HA, Iqbal Z, Pagel PS, Almassi GH) Int J Surg Case Rep 2021 Oct;87:106426 |
| 1 | Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative. (Sasanejad P, Afshar Hezarkhani L, Arsang-Jang S, Tsivgoulis G, Ghoreishi A, Barlinn K, Rahmig J, Farhoudi M, Sadeghi Hokmabadi E, Borhani-Haghighi A, Sariaslani P, Sharifi-Razavi A, Ghandehari K, Khosravi A, Smith C, Nilanont Y, Akbari Y, Nguyen TN, Bersano A, Yassi N, Yoshimoto T, Lattanzi S, Gupta A, Zand R, Rafie S, Pourandokht Mousavian S, Reza Shahsavaripour M, Amini S, Kamenova SU, Kondybayeva A, Zhanuzakov M, Macri EM, Nobleza COS, Ruland S, Cervantes-Arslanian AM, Desai MJ, Ranta A, Moghadam Ahmadi A, Rostamihosseinkhani M, Foroughi R, Hooshmandi E, Akhoundi FH, Shuaib A, Liebeskind DS, Siegler J, Romano JG, Mayer SA, Bavarsad Shahripour R, Zamani B, Woolsey A, Fazli Y, Mojtaba K, Isaac CF, Biller J, Di Napoli M, Azarpazhooh MR) J Stroke Cerebrovasc Dis 2021 Dec;30(12):106121 17 Citations |
| 1 | Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis. (Pasvolsky O, Yeshurun M, Fraser R, Estrada-Merly N, Rozovski U, Shargian-Alon L, Assal A, Banerjee R, Bumma N, Gale RP, Hagen P, Holmberg L, Hossain NM, Lazarus HM, Lee C, Mian H, Miller KC, Nathan S, Nagler A, Nishihori T, Parrondo RD, Patel S, Schroeder MA, Usmani SZ, Wang T, Wirk B, Kumar S, Shah N, Qazilbash MH, D'Souza A) Bone Marrow Transplant 2022 Jan;57(1):31-37 5 Citations |
| 7 | Updates and new directions in the use of radiation therapy for the treatment of pancreatic adenocarcinoma: dose, sensitization, and novel technology. (Hall WA, Kamgar M, Erickson BA, Ponce SB, Tsai S, Nevalainen MT, Christians KK, George B, Dua KS, Khan AH, Evans DB, Azmi AS) Cancer Metastasis Rev 2021 Sep;40(3):879-889 2 Citations |
| 1 | Treatment-Free Remission: the New Goal in CML Therapy. (Atallah E, Sweet K) Curr Hematol Malig Rep 2021 Oct;16(5):433-439 26 Citations |
| 3 | Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma. (Hall WA, Dawson LA, Hong TS, Palta M, Herman JM, Evans DB, Tsai S, Ferrone CR, B Fleming J, Chang DT, Crane C, Koong AC, Oar A, Parikh P, Erickson B, Hoffe S, Goodman KA) J Clin Oncol 2021 Dec 01;39(34):3773-3777 23 Citations |
| 1 | A Randomized Trial of Photobiomodulation Therapy for Center-Involved Diabetic Macular Edema with Good Visual Acuity (Protocol AE). (Kim JE, Glassman AR, Josic K, Melia M, Aiello LP, Baker C, Eells JT, Jampol LM, Kern TS, Marcus D, Salehi-Had H, Shah SN, Martin DF, Stockdale CR, Sun JK, DRCR Retina Network) Ophthalmol Retina 2022 Apr;6(4):298-307 26 Citations |
| 1 | The Role of Monoclonal Antibodies in the Era of Bi-Specifics Antibodies and CAR T Cell Therapy in Multiple Myeloma. (Mohan M, Maatman TC, Schinke C) Cancers (Basel) 2021 Sep 29;13(19) 5 Citations |
| 1 | SMARCA4: Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy. (Mardinian K, Adashek JJ, Botta GP, Kato S, Kurzrock R) Mol Cancer Ther 2021 Dec;20(12):2341-2351 89 Citations |
| 1 | Cell-Associated Human Immunodeficiency Virus (HIV) Ribonucleic Acid Has a Circadian Cycle in Males With HIV on Antiretroviral Therapy. (Stern J, Solomon A, Dantanarayana A, Pascoe R, Reynaldi A, Davenport MP, Milush J, Deeks SG, Hartogensis W, Hecht FM, Cockerham L, Roche M, Lewin SR) J Infect Dis 2022 May 16;225(10):1721-1730 6 Citations |
| 1 | Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas. (Goodman AM, Holden KA, Jeong AR, Kim L, Fitzgerald KD, Almasri E, McLennan G, Eisenberg M, Jahromi AH, Hoh C, Hurley M, Mulroney C, Tzachanis D, Ball ED, Jensen TJ, Kurzrock R) Transplant Cell Ther 2022 Jan;28(1):30.e1-30.e7 14 Citations |
| 2 | Promise and pitfalls of allogeneic chimeric antigen receptor therapy in plasma cell and lymphoid malignancies. (Dhakal B, Chhabra S, Savani BN, Hamadani M) Br J Haematol 2022 Apr;197(1):28-40 9 Citations |
| 4 | Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis. (Hamadani M, Gopal AK, Pasquini M, Kim S, Qiu X, Ahmed S, Lazaryan A, Bhatt VR, Daly A, Lulla P, Ciurea S, Gauthier J, Agrawal V, Grover NS, Lekakis L, Modi D, Dahi PB, Herr MM, Johnson PC, Hashmi H, Hematti P, Locke FL) Blood Adv 2022 Jan 25;6(2):486-494 32 Citations |
| 1 | The accuracy of helium ion CT based particle therapy range prediction: an experimental study comparing different particle and x-ray CT modalities. (Volz L, Collins-Fekete CA, Bär E, Brons S, Graeff C, Johnson RP, Runz A, Sarosiek C, Schulte RW, Seco J) Phys Med Biol 2021 Nov 29;66(23) 12 Citations |
| 1 | Quantification and Dosimetric Impact of Normal Organ Motion During Adaptive Radiation Therapy Plan Verification Using a 1.5 Tesla Magnetic Resonance Equipped Linear Accelerator (MR LINAC). (Wittman D, Paulson ES, Eastwood D, Banerjee A, Banla LI, Schultz CJ, Awan MJ, Chen X, Omari E, Straza MW Jr, Li A, Erickson BA, Hall WA) Int J Radiat Oncol Biol Phys 2021 Nov 01;111(3S):S48-S49 |
| 1 | Real-Time Motion Tracking and Correction During Tomotherapy for Prostate Cancer: Impact of Fiducial Migration. (Chen GP, Tai A, Omari EA, Bedi M, Lawton CAF, Li A) Int J Radiat Oncol Biol Phys 2021 Nov 01;111(3S):e539-e540 |
| 1 | Examination for the Presence of an Oligo-Metastatic State in Patients with Newly Diagnosed Metastatic Pancreatic Adenocarcinoma Undergoing Systemic Chemotherapy. (Ortiz S, Visotcky A, Banerjee A, Aldakkak M, Tsai S, Evans DB, Christians K, Clarke CN, George B, Shreenivas A, Kamgar M, Chakrabarti S, Dua KS, Khan AH, Erickson BA, Hall WA) Int J Radiat Oncol Biol Phys 2021 Nov 01;111(3S):e66-e67 |
| 1 | On the Development of a Robust Deep Learning Synthetic CT Generation Method for MR-Guided Adaptive Radiation Therapy of Abdominal Tumors. (Ahunbay EE, Xu J, Paulson ES, Thill D, Chen X, Omari EA, Li A) Int J Radiat Oncol Biol Phys 2021 Nov 01;111(3S):e106-e107 |
| 1 | Should Daily Online Adaptive Replanning be Utilized for Every Treatment in MRI-Guided Radiotherapy for Pancreatic Cancer? (Omari E, Nasief H, Zhang Y, Parchur AK, Paulson ES, Chen X, Ahunbay EE, Hall WA, Erickson BA, Li A) Int J Radiat Oncol Biol Phys 2021 Nov 01;111(3S):e66 |
| 2 | Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. (Conger R, Mora J, Straza MW Jr, Erickson BA, Lawton CAF, Schultz CJ, Currey AD, Bedi M, Saeed H, Tsai S, Siker ML, Hall WA) Int J Radiat Oncol Biol Phys 2021 Nov 01;111(3S):e105 |
| 1 | Should Daily Online Adaptive Replanning be Utilized for Every Treatment in MRI-Guided Radiotherapy for Pancreatic Cancer? (E Omari, H Nasief, Y Zhang, AK Parchur, ES Paulson, X Chen, EE Ahunbay, WA Hall, BA Erickson, A Li) International Journal of Radiation Oncology, Biology, Physics Volume 111 Issue 3 Pages e66 |
| 1 | Targeting TIM-3 as a new strategy in immunotherapy: focus on sabatolimab (Murthy GSG, Atallah E) Drugs of the Future November 2021;46(11):901-905 1 Citation |
| 1 | Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients (Maiolino A, Costa LJ, Pasquini M, Crusoe EdQ, Vigorito AC, Salvino MA, Seguro FS, Filho JS, Hungria VTdM) Hematology, Transfusion and Cell Therapy November 2021;43:S30-S34 2 Citations |
| 1 | Quantification and Dosimetric Impact of Normal Organ Motion During Adaptive Radiation Therapy Plan Verification Using a 1.5 Tesla Magnetic Resonance Equipped Linear Accelerator (MR LINAC) (D. Wittman, E.S. Paulson, D. Eastwood, A. Banerjee, L.I. Banla, C.J. Schultz, M.J. Awan, X. Chen, E. Omari, M.W. Straza, A. Li, B.A. Erickson, W.A. Hall) International Journal of Radiation Oncology Biology Physics D. Wittman, E.S. Paulson, D. Eastwood, A. Banerjee, L.I. Banla, C.J. Schultz, M.J. Awan, X. Chen, E. Omari, M.W. Straza, A. Li, B.A. Erickson, W.A. Hall, Quantification and Dosimetric Impact of Normal Organ Motion During Adaptive Radiation Therapy Plan Verification Using a 1.5 Tesla Magnetic Resonance Equipped Linear Accelerator (MR LINAC), International Journal of Radiation Oncology*Biology*Physics, Volume 111, Issue 3, Supplement, 2021 |
| 1 | Automatically Determining Necessity of Online Adaptive Replanning Based on MRI Wavelet Multiscale Texture Features for MRI-Guided Adaptive Radiation Therapy (H. Nasief, E. Omari, Y. Zhang, X. Chen, A.K. Parchur, E.S. Paulson, W.A. Hall, B.A. Erickson, A. Li) International Journal of Radiation Oncology Biology Physics H. Nasief, E. Omari, Y. Zhang, X. Chen, A.K. Parchur, E.S. Paulson, W.A. Hall, B.A. Erickson, A. Li, Automatically Determining Necessity of Online Adaptive Replanning Based on MRI Wavelet Multiscale Texture Features for MRI-Guided Adaptive Radiation Therapy, International Journal of Radiation Oncology*Biology*Physics, Volume 111, Issue 3, Supplement, 2021 |
| 1 | Quantification and Dosimetric Impact of Normal Organ Motion During Adaptive Radiation Therapy Plan Verification Using a 1.5 Tesla Magnetic Resonance Equipped Linear Accelerator (MR LINAC) (D. Wittman, E.S. Paulson, D. Eastwood, A. Banerjee, L.I. Banla, C.J. Schultz, M.J. Awan, X. Chen, E. Omari, M.W. Straza, A. Li, B.A. Erickson, W.A. Hall) International Journal of Radiation Oncology Biology Physics D. Wittman, E.S. Paulson, D. Eastwood, A. Banerjee, L.I. Banla, C.J. Schultz, M.J. Awan, X. Chen, E. Omari, M.W. Straza, A. Li, B.A. Erickson, W.A. Hall, Quantification and Dosimetric Impact of Normal Organ Motion During Adaptive Radiation Therapy Plan Verification Using a 1.5 Tesla Magnetic Resonance Equipped Linear Accelerator (MR LINAC), International Journal of Radiation Oncology*Biology*Physics, Volume 111, Issue 3, Supplement, 2021 |
| 1 | Quantification and Dosimetric Impact of Normal Organ Motion During Adaptive Radiation Therapy Plan Verification Using a 1.5 Tesla Magnetic Resonance Equipped Linear Accelerator (MR LINAC) (D. Wittman, E.S. Paulson, D. Eastwood, A. Banerjee, L.I. Banla, C.J. Schultz, M.J. Awan, X. Chen, E. Omari, M.W. Straza, A. Li, B.A. Erickson, W.A. Hall) International Journal of Radiation Oncology Biology Physics D. Wittman, E.S. Paulson, D. Eastwood, A. Banerjee, L.I. Banla, C.J. Schultz, M.J. Awan, X. Chen, E. Omari, M.W. Straza, A. Li, B.A. Erickson, W.A. Hall, Quantification and Dosimetric Impact of Normal Organ Motion During Adaptive Radiation Therapy Plan Verification Using a 1.5 Tesla Magnetic Resonance Equipped Linear Accelerator (MR LINAC), International Journal of Radiation Oncology*Biology*Physics, Volume 111, Issue 3, Supplement, 2021 |
| 1 | Dose Escalated Radiotherapy (RT) Alone or in Combination With Short-Term Total Androgen Suppression (TAS) for Intermediate Risk Prostate Cancer: Patient Reported Outcomes (PROs) From the NRG Oncology/RTOG 0815 Randomized Trial (B. Movsas, J. Rodgers, M. A. Elshaikh, A. A. Martinez, G. Morton, D. J. Krauss, D. Yan, D. E. Citrin, B. Hershatter, J. M. Michalski, R. J. Ellis III, V. S. Kavadi, E. M. Gore, G. S. Gustafson, C. A. Schulz, V. Velker, A. C. Olson, T. G. Karrison, H. M. Sandler, D. W. Bruner) International Journal of Radiation Oncology Biology Physics B. Movsas, J. Rodgers, M.A. Elshaikh, A.A. Martinez, G. Morton, D.J. Krauss, D. Yan, D.E. Citrin, B. Hershatter, J.M. Michalski, R.J. Ellis, V.S. Kavadi, E.M. Gore, G.S. Gustafson, C.A. Schulz, V. Velker, A.C. Olson, T.G. Karrison, H.M. Sandler, D.W. Bruner, Dose Escalated Radiotherapy (RT) Alone or in Combination With Short-Term Total Androgen Suppression (TAS) for Intermediate Risk Prostate Cancer: Patient Reported Outcomes (PROs) From the NRG Oncology/RTOG 0815 Randomized Trial, International |
| 1 | Evaluating Thresholds to Adopt Hypofractionated Preoperative Radiotherapy as Standard of Care in Sarcoma. (Valle LF, Bernthal N, Eilber FC, Shabason JE, Bedi M, Kalbasi A) Sarcoma 2021;2021:3735874 9 Citations |
| 7 | Characterization of Underrepresented Populations in Modern Era Clinical Trials Involving Radiation Therapy. (Bero EH, Rein LE, Banerjee A, Straza MW, Lawton CAF, Schultz CJ, Erickson BA, Siker ML, Hall WA) Pract Radiat Oncol 2021;11(6):453-459 8 Citations |
| 1 | High-resolution epitope mapping by AllerScan reveals relationships between IgE and IgG repertoires during peanut oral immunotherapy. (Chen G, Shrock EL, Li MZ, Spergel JM, Nadeau KC, Pongracic JA, Umetsu DT, Rachid R, MacGinnitie AJ, Phipatanakul W, Schneider L, Oettgen HC, Elledge SJ) Cell Rep Med 2021 Oct 19;2(10):100410 44 Citations |
| 3 | Post-relapse survival in Waldenstrom macroglobulinemia patients experiencing therapy failure following autologous transplantation. (Ahmed S, Zhao Q, Hanel W, Qazilbash MH, Patel K, Narra R, Kansagra A, Iqbal M, Awan FT, Christian B, Jaglowski SM, Kharfan-Dabaja MA, Hamadani M, Epperla N) Hematol Oncol 2022 Feb;40(1):48-56 2 Citations |
| 1 | Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology Group. (Parikh RR, Kelly KM, Hodgson DC, Hoppe BS, McCarten KM, Karolczuk K, Pei Q, Wu Y, Cho SY, Schwartz C, Cole PD, Roberts K) Int J Radiat Oncol Biol Phys 2022 Mar 15;112(4):890-900 4 Citations |
| 1 | Effectiveness of a novel 1% glucose isotonic electrolyte solution for intraoperative fluid therapy in children: a randomized controlled trial. (Gao ZZ, Wang F, Hua L, Cui XH, Xu J, Fu WY, Chen HZ) J Int Med Res 2021 Nov;49(11):3000605211055624 2 Citations |
| 2 | Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation. (Sidana S, Kumar S, Fraser R, Estrada-Merly N, Giralt S, Agrawal V, Anderson LD Jr, Aljurf M, Banerjee R, Bashey A, Battiwalla M, Beitinjaneh A, Chakraborty R, Chhabra S, Dhakal B, Dholaria B, Hashmi S, Janakiram M, Lee C, Lekakis L, Murthy HS, Parrondo R, Wangjam T, Usmani S, Shah N, Qazilbash M, D'Souza A) Transplant Cell Ther 2022 Feb;28(2):83.e1-83.e9 16 Citations |
| 1 | Non-crisis related pain occurs in adult patients with sickle cell disease despite chronic red blood cell exchange transfusion therapy. (Curtis SA, Raisa BM, Roberts JD, Hendrickson JE, Starrels J, Lesley D, Michelle D, Daniel Z, Brandow AM) Transfus Apher Sci 2022 Apr;61(2):103304 4 Citations |
| 2 | Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy. (Fabrizio VA, Boelens JJ, Mauguen A, Baggott C, Prabhu S, Egeler E, Mavroukakis S, Pacenta H, Phillips CL, Rossoff J, Stefanski HE, Talano JA, Moskop A, Margossian SP, Verneris MR, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston M, Satwani P, Krupski C, Keating AK, Wilcox R, Rabik CA, Chinnabhandar V, Kunicki M, Goksenin AY, Mackall CL, Laetsch TW, Schultz LM, Curran KJ) Blood Adv 2022 Apr 12;6(7):1961-1968 74 Citations |
| 5 | Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians. (Hall WA, Paulson E, Li XA, Erickson B, Schultz C, Tree A, Awan M, Low DA, McDonald BA, Salzillo T, Glide-Hurst CK, Kishan AU, Fuller CD) CA Cancer J Clin 2022 Jan;72(1):34-56 72 Citations |
| 1 | Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients. (Maiolino A, Costa LJ, Pasquini M, Crusoe EQ, Vigorito AC, Salvino MA, Seguro FS, Filho JS, Hungria VTM) Hematol Transfus Cell Ther 2021 Nov;43 Suppl 2(Suppl 2):S30-S34 2 Citations |
| 1 | A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients. (Tan CR, Estrada-Merly N, Landau H, Lekakis L, Banerjee R, Mian H, Usmani SZ, Hanbali A, Lazarus HM, Kyle RA, Dholaria B, Bal S, Strouse C, Murthy HS, Wirk B, Nishihori T, Kumar S, Shah N, Qazilbash M, D'Souza A) Bone Marrow Transplant 2022 Feb;57(2):295-298 3 Citations |
| 2 | Erratum: Voluntary wheel running complements microdystrophin gene therapy to improve muscle function in mdx mice. (Hamm SE, Fathalikhani DD, Bukovec KE, Addington AK, Zhang H, Perry JB, McMillan RP, Lawlor MW, Prom MJ, Vanden Avond MA, Kumar SN, Coleman KE, Dupont JB, Mack DL, Brown DA, Morris CA, Gonzalez JP, Grange RW) Mol Ther Methods Clin Dev 2021 Dec 10;23:460 |
| 1 | Optimization of cardiac resynchronization therapy based on a cardiac electromechanics-perfusion computational model. (Fan L, Choy JS, Raissi F, Kassab GS, Lee LC) Comput Biol Med 2022 Feb;141:105050 12 Citations |
| 1 | Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma. (Costa LJ, Lin Y, Cornell RF, Martin T, Chhabra S, Usmani SZ, Jagannath S, Callander NS, Berdeja JG, Kang Y, Vij R, Godby KN, Malek E, Neppalli A, Liedtke M, Fiala M, Tian H, Valluri S, Marino J, Jackson CC, Banerjee A, Kansagra A, Schecter JM, Kumar S, Hari P) Clin Lymphoma Myeloma Leuk 2022 May;22(5):326-335 38 Citations |
| 1 | Muscle-directed gene therapy corrects Pompe disease and uncovers species-specific GAA immunogenicity. (Eggers M, Vannoy CH, Huang J, Purushothaman P, Brassard J, Fonck C, Meng H, Prom MJ, Lawlor MW, Cunningham J, Sadhu C, Mavilio F) EMBO Mol Med 2022 Jan 11;14(1):e13968 34 Citations |
| 1 | Adrenocorticotropic Hormone Secreting Pituitary Carcinoma: Rare, Durable Response to Concurrent Chemotherapy and Reirradiation With a Review of the Literature. (Orr M, Findling J, Zwagerman N, Connelly J, Albano K, Bovi J) Adv Radiat Oncol 2022;7(2):100813 1 Citation |
| 1 | Author Correction: Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. (Shi Y, Gao W, Lytle NK, Huang P, Yuan X, Dann AM, Ridinger-Saison M, DelGiorno KE, Antal CE, Liang G, Atkins AR, Erikson G, Sun H, Meisenhelder J, Terenziani E, Woo G, Fang L, Santisakultarm TP, Manor U, Xu R, Becerra CR, Borazanci E, Von Hoff DD, Grandgenett PM, Hollingsworth MA, Leblanc M, Umetsu SE, Collisson EA, Scadeng M, Lowy AM, Donahue TR, Reya T, Downes M, Evans RM, Wahl GM, Pawson T, Tian R, Hunter T) Nature 2021 Dec;600(7889):E18 4 Citations |
| 1 | Patterns of Adjuvant Chemotherapy Use and Association With Survival in Adults 80 Years and Older With Pancreatic Adenocarcinoma. (Mehtsun WT, McCleary NJ, Maduekwe UN, Wolpin BM, Schrag D, Wang J) JAMA Oncol 2022 Jan 01;8(1):88-95 16 Citations |
| 1 | Is there an optimal adjunct therapy to traditional cytotoxic induction? (Michaelis LC) Best Pract Res Clin Haematol 2021 Dec;34(4):101326 1 Citation |
| 1 | Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer. (Janelsins MC, Lei L, Netherby-Winslow C, Kleckner AS, Kerns S, Gilmore N, Belcher E, Thompson BD, Werner ZA, Hopkins JO, Long J, Cole S, Culakova E) J Neuroimmunol 2022 Jan 15;362:577769 13 Citations |
| 1 | Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience. (Schaefer A, Huang Y, Kittai A, Maakaron JE, Saygin C, Brammer J, Penza S, Saad A, Jaglowski SM, William BM) Cancer Manag Res 2021;13:8901-8906 19 Citations |
| 2 | Online adaptive MR-guided stereotactic radiotherapy for unresectable malignancies in the upper abdomen using a 1.5T MR-linac. (Daamen LA, de Mol van Otterloo SR, van Goor IWJM, Eijkelenkamp H, Erickson BA, Hall WA, Heerkens HD, Meijer GJ, Molenaar IQ, van Santvoort HC, Verkooijen HM, Intven MPW) Acta Oncol 2022 Jan;61(1):111-115 30 Citations |
| 3 | Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma. (Costa LJ, Chhabra S, Medvedova E, Dholaria BR, Schmidt TM, Godby KN, Silbermann R, Dhakal B, Bal S, Giri S, D'Souza A, Hall A, Hardwick P, Omel J, Cornell RF, Hari P, Callander NS) J Clin Oncol 2022 Sep 01;40(25):2901-2912 163 Citations |
| 1 | Inflammation-mediated vitamin K and vitamin D effects on vascular calcifications in people with HIV on active antiretroviral therapy. (Janus SE, Durieux JC, Hajjari J, Carneiro H, McComsey GA) AIDS 2022 Apr 01;36(5):647-655 12 Citations |
| 1 | CytoSorb Therapy in COVID-19 (CTC) Patients Requiring Extracorporeal Membrane Oxygenation: A Multicenter, Retrospective Registry (Song T, Hayanga J, Durham L, Garrison L, McCarthy P, Barksdale A, Smith D, Bartlett R, Jaros M, Nelson P, Molnar Z, Deliargyris E, Moazami N) Frontiers in Medicine 20 December 2021;8 26 Citations |
| 4 | Risk of infections with B-cell maturation antigen-directed immunotherapy in multiple myeloma. (Mohan M, Nagavally S, Dhakal B, Radhakrishnan SV, Chhabra S, D'Souza A, Hari P) Blood Adv 2022 Apr 26;6(8):2466-2470 40 Citations |
| 1 | The role of radiation therapy in the management of primary thymic epithelial neoplasms (Johnstone C, Simone CB) Journal of Cancer Metastasis and Treatment 2022;8 |
| 1 | ALSUntangled #60: light therapy (Bedlack R, Barkhaus P, Barnes B, Bereman M, Bertorini T, Carter G, Crayle J, Kihuwa-Mani S, Bowser R, Kittrell P, McDermott C, Pattee G, Salmon K, Wicks P) Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2022;23(3-4):315-319 1 Citation |
| 1 | Modern Linear Accelerator-Based Radiotherapy Is Safe and Effective in the Treatment of Secretory and Nonsecretory Pituitary Adenomas. (Janopaul-Naylor JR, Rupji M, Zhong J, Eaton BR, Ali N, Ioachimescu AG, Oyesiku NM, Shu HG) World Neurosurg 2022 Apr;160:e33-e39 2 Citations |
| 1 | Ovarian cancer resistance to PARPi and platinum-containing chemotherapy (Summey R, Uyar D) Cancer Drug Resistance 2022;5(3):637-646 7 Citations |
| 1 | Development of a national pain management competency profile to guide entry-level physiotherapy education in Canada (Augeard N, Bostick G, Miller J, Walton D, Tousignant-Laflamme Y, Hudon A, Bussières A, Cooper L, McNiven N, Thomas A, Singer L, Fishman SM, Bement MH, Hush JM, Sluka KA, Watt-Watson J, Carlesso LC, Dufour S, Fletcher R, Harman K, Hunter J, Ngomo S, Pearson N, Perreault K, Shay B, Stilwell P, Tupper S, Wideman TH) Canadian Journal of Pain 2022;6(1):1-11 10 Citations |
| 1 | Unravelling the underpinnings of hyperprogression and immunotherapy: back to the bench (Subbiah V, Kurzrock R) Oncotarget 2022;13:13-15 |
| 1 | Chronic Myeloid Leukemia: Part I-Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States (Atallah EL, Maegawa R, Latremouille-Viau D, Rossi C, Guérin A, Wu EQ, Patwardhan P) Journal of Health Economics and Outcomes Research 2022;9(2):19-29 2 Citations |
| 1 | Chronic Myeloid Leukemia: Part II-Cost of Care Among Patients in Advanced Phases or Later Lines of Therapy in Chronic Phase in the United States from a Commercial Perspective (Atallah EL, Maegawa R, Latremouille-Viau D, Rossi C, Guérin A) Journal of Health Economics and Outcomes Research 2022;9(2):30-36 2 Citations |
| 1 | New Indications and platforms for CAR-T therapy in lymphomas beyond DLBCL. (Iqbal M, Savani BN, Hamadani M) EJHaem 2022 Jan;3(Suppl 1):11-23 |
| 1 | Muscle-directed gene therapy corrects Pompe disease and uncovers species-specific GAA immunogenicity (Eggers M, Vannoy CH, Huang J, Purushothaman P, Brassard J, Fonck C, Meng H, Prom MJ, Lawlor MW, Cunningham J, Sadhu C, Mavilio F) EMBO Molecular Medicine 11 January 2022;14(1) 34 Citations |
| 1 | A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse. (Lin X, Xu Z, Carey L, Romero J, Makriyannis A, Hillard CJ, Ruggiero E, Dockum M, Houk G, Mackie K, Albrecht PJ, Rice FL, Hohmann AG) Pain 2022 May 01;163(5):834-851 20 Citations |
| 1 | CAR T-cell therapy for B-cell lymphoma. (Denlinger N, Bond D, Jaglowski S) Curr Probl Cancer 2022 Feb;46(1):100826 17 Citations |
| 1 | Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy. (Xie XP, Laks DR, Sun D, Ganbold M, Wang Z, Pedraza AM, Bale T, Tabar V, Brennan C, Zhou X, Parada LF) Dev Cell 2022 Jan 10;57(1):32-46.e8 95 Citations |
| 1 | Unravelling the underpinnings of hyperprogression and immunotherapy: back to the bench. (Subbiah V, Kurzrock R) Oncotarget 2022;13:13-15 |
| 1 | The AntiCD19 Antibody Drug Immunoconjugate Loncastuximab Achieves Responses in DLBCL Relapsing After AntiCD19 CAR-T Cell Therapy. (Caimi PF, Ardeshna KM, Reid E, Ai W, Lunning M, Zain J, Solh M, Kahl BS, Hamadani M) Clin Lymphoma Myeloma Leuk 2022 May;22(5):e335-e339 27 Citations |
| 1 | Anti-Xa based dosing of enoxaparin in hematopoietic stem cell transplant and adoptive cell therapy patients: A single center experience. (Jizzini M, Akhtar OS, Atwood K, Ji W, Pleskow J, Bat T, Balderman S) Thromb Res 2022 Mar;211:6-9 |
| 1 | Endothelial dysfunction as a complication of anti-cancer therapy. (Terwoord JD, Beyer AM, Gutterman DD) Pharmacol Ther 2022 Sep;237:108116 35 Citations |
| 2 | Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer. (Kerns SL, Amidon Morlang A, Lee SM, Peterson DR, Marples B, Zhang H, Bylund K, Rosenzweig D, Hall W, De Ruyck K, Rosenstein BS, Stock RG, Gómez-Caamaño A, Vega A, Sosa-Fajardo P, Taboada-Valladares B, Aguado-Barrera ME, Parker C, Veldeman L, Fonteyne V, Bultijnck R, Talbot CJ, Symonds RP, Johnson K, Rattay T, Webb A, Lambrecht M, de Ruysscher D, Vanneste B, Choudhury A, Elliott RM, Sperk E, Herskind C, Veldwijk MR, Rancati T, Avuzzi B, Valdagni R, Azria D, Farcy Jacquet MP, Chang-Claude J, Seibold P, West C, Janelsins M, Chen Y, Messing E, Morrow G, REQUITE Consortium) Radiother Oncol 2022 Mar;168:75-82 12 Citations |
| 1 | Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development (Paganoni S, Berry JD, Quintana M, Macklin E, Saville BR, Detry MA, Chase M, Sherman AV, Yu H, Drake K, Andrews J, Shefner J, Chibnik LB, Vestrucci M, Cudkowicz ME, Macklin E, Quintana M, Saville BR, Detry MA, Chibnik LB, Bind MA, Chan J, Vestrucci M, Locatelli E, Alameda G, Paganoni S, Cudkowicz ME, McCaffrey A, Berry J, Babu S, Nicholson K, Scalia J, Simmons Z, Grogan J, Su X, Mamarabadi M, Heitzman D, Nasri MA, Katz J, Jenkins L, Felice K, Whitaker C, Ajroud-Driss S, Quick A, Kolb S, Sarah Heintzman NP, Appel SH, Greene E, Thonhoff J, Shroff S, Liao B, Goutman SA, Feldman EL, Miller T, Amber Malcolm NP, Newman DS, Arcila-Londono X, Steijlen K, Owegi MA, Brown RH, Ghasemi M, Fernandes JAM, Piccione E, Thaisetthawatkul P, Weiss MD, Rad N, Ilieva H, Pasinelli P, Judith Guarnieri NP, Ladha S, Jacobsen B, Bowser R, Shefner J, Foster L, Jackson C, Rosenfeld J, Bhuvaneswaran K, Elman L, Quinn C, Julia Yasek NP, Fee D, Heiman-Patterson T, Deboo A, Swenson A, Nance C, Vu T, Suresh N, Farias J, Caress J, Cartwright M, Rezania K, Elliott M, Rutkove S, McIlduff C, Cohen JA, Stommel E, Glass J, Fournier C, Young E, Wymer JP) Annals of Neurology 01 February 2022;91(2):165-175 57 Citations |
| 1 | Toward magnetic resonance fingerprinting for low-field MR-guided radiation therapy (Mickevicius NJ, Morris ZM, Glide-Hurst CK) Proceedings of the Annual Meeting of the American Association of Physicists in Medicine |
| 1 | Initial clinical experience of stereotactic body radiation therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic abdominal nodal recurrence with 4D-MRI based online adaptation and real-time motion monitoring on a 1.5 Tesla MR-Linac (Hall WA, Straza MW, Chen X, Mickevicius NJ, Erickson B, Schultz C, Awan M, Ahunbay E, Li XA, Paulson ES) Proceedings of the Annual Meeting of the American Society for Radiation Oncology |
| 1 | Impact of intrafractional changes of abdominal gas cavities in MR-guided adaptive radiation therapy: Is real-time adaptation necessary? (Keiper T, Tai A, Mickevicius NJ, Lim S, Paulson ES, Klawikowski S, Zhong H, Li XA) Proceedings of the Annual Meeting of the American Society for Radiation Oncology |
| 1 | Simultaneous motion monitoring and truth-in-delivery analysis framework for MR-guided radiotherapy (Mickevicius NJ, Chen X, Boyd Z, Lee HJ, Ibbott GS, Paulson ES) Proceedings of the Annual Meeting of the American Association of Physicists in Medicine |
| 1 | Multiplexed simultaneous orthogonal plane imaging (mSOPI) for intrafraction motion monitoring in MRI-guided radiation therapy (Mickevicius NJ, Paulson ES) Proceedings of the Annual Meeting of the International Symposium on MRI in Radiation Therapy |
| 1 | Toward clinically realizable 4D-MRI for MRI-guided radiation therapy (Mickevicius NJ, Paulson ES) Proceedings of the Annual Meeting of the International Symposium on MRI in Radiation Therapy |
| 1 | Location of brain tumor intersecting white matter tracts predicts survival prior to therapy (Mickevicius NJ, Carle A, Santarriaga S, LaViolette PS) Proceedings of the Annual Meeting of the International Society of Magnetic Resonance in Medicine |
| 1 | Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy. (Shah A, Storek J, Woolson R, Pinckney A, Keyes-Elstein L, Wallace PK, Sempowski GD, McSweeney P, Mayes MD, Crofford L, Csuka ME, Phillips K, Khanna D, Simms R, Ballen K, LeClercq S, Clair WS, Nixon AB, Nash R, Wener M, Brasington R, Silver R, Griffith LM, Furst DE, Goldmuntz E, Sullivan KM) Rheumatology (Oxford) 2022 Oct 06;61(10):4155-4162 7 Citations |
| 1 | Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequences. (Burke MJ, Zalewska-Szewczyk B) Future Oncol 2022 Mar;18(10):1285-1299 31 Citations |
| 1 | Prognostic value of early imaging following CAR-T cell therapy in diffuse large B-cell lymphoma. (Bajwa A, Huang Y, Li R, Denlinger N, Brammer J, Penza S, Saad A, Jaglowski S, Kittai AS) Leuk Lymphoma 2022 Jun;63(6):1492-1495 |
| 2 | Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit. (Mei M, Hamadani M, Ahn KW, Chen Y, Kharfan-Dabaja MA, Sauter C, Herrera AF) Haematologica 2022 May 01;107(5):1214-1217 5 Citations |
| 1 | Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells. (Goff PH, Riolobos L, LaFleur BJ, Spraker MB, Seo YD, Smythe KS, Campbell JS, Pierce RH, Zhang Y, He Q, Kim EY, Schaub SK, Kane GM, Mantilla JG, Chen EY, Ricciotti R, Thompson MJ, Cranmer LD, Wagner MJ, Loggers ET, Jones RL, Murphy E, Blumenschein WM, McClanahan TK, Earls J, Flanagan KC, LaFranzo NA, Kim TS, Pollack SM) Clin Cancer Res 2022 Apr 14;28(8):1701-1711 26 Citations |
| 2 | Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes. (Kapadia M, Lehmann L, Auletta J, Beatty L, Bhatt N, Blacken R, Demmel K, Dodd T, Desmond C, Fitch T, Flesch L, Hartley D, Huber J, Ingraham H, Jakubowski R, Klunk A, Krupski C, Kusnier K, Liberio N, Maakaron J, Mueller M, Myers KC, Pai A, Parker L, Patel S, Phelan R, Polishchuk V, Sigmund A, Sper C, Tarquini S, Juckett M, Jaglowski S, Dandoy C, Rotz S) Transplant Cell Ther 2022 May;28(5):233-241 10 Citations |
| 2 | Hemophagocytosis in cerebrospinal fluid after CAR T-cell therapy. (Shah NN, Harrington AM) Blood 2022 Feb 17;139(7):1116 3 Citations |
| 3 | Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium. (Pommert L, Schafer ES, Malvar J, Gossai N, Florendo E, Pulakanti K, Heimbruch K, Stelloh C, Chi YY, Sposto R, Rao S, Huynh VT, Brown P, Chang BH, Colace SI, Hermiston ML, Heym K, Hutchinson RJ, Kaplan JA, Mody R, O'Brien TA, Place AE, Shaw PH, Ziegler DS, Wayne A, Bhojwani D, Burke MJ) Am J Hematol 2022 May;97(5):613-622 32 Citations |
| 1 | Application of Continuous Positive Airway Pressure for Thoracic Respiratory Motion Management: An Assessment in a Magnetic Resonance Imaging-Guided Radiation Therapy Environment. (Liang E, Dolan JL, Morris ED, Vono J, Bazan LF, Lu M, Glide-Hurst CK) Adv Radiat Oncol 2022;7(3):100889 12 Citations |
| 2 | Pulmonary Vasodilator Therapy in Persistent Pulmonary Hypertension of the Newborn. (Sharma M, Callan E, Konduri GG) Clin Perinatol 2022 Mar;49(1):103-125 7 Citations |
| 1 | First American Cancer Patient to Receive Dicycloplatin (DCP) Chemotherapy Achieves Remission After Seven Weeks of DCP Capsules - A Case Report. (Salkini MW, Yang X, Hashmi FH, Kandzari SJ, Hogan T, Morley C, Zekan D, Werner Z, Williams DJ, Guo YI, Matthew TL, Spangler M, Yu JJ) Anticancer Res 2022 Mar;42(3):1339-1344 2 Citations |
| 1 | A case of infected intracranial aneurysm with Nocardia meningitis treated with endovascular therapy: Case report and literature review (McCormack E, Cornu O, Hanna J, Nerva JD, Aysenne A) Interdisciplinary Neurosurgery: Advanced Techniques and Case Management March 2022;27 2 Citations |
| 1 | Nephrologist-performed portal vein Doppler to monitor response to diuretic therapy. (Koratala A) Clin Case Rep 2022 Feb;10(2):e05357 |
| 3 | Adrenocorticotropic Hormone Secreting Pituitary Carcinoma: Rare, Durable Response to Concurrent Chemotherapy and Reirradiation With a Review of the Literature (Orr M, Findling J, Zwagerman N, Connelly J, Albano K, Bovi J) Advances in Radiation Oncology 1 March 2022;7(2) 1 Citation |
| 1 | Social cognitive variables and physical activity during chemotherapy for breast cancer: An intensive longitudinal examination (Auster-Gussman LA, Gavin KL, Siddique J, Welch WA, Solk P, Whitaker M, Cullather E, Fanning J, Maria CS, Gradishar W, Khan S, Kulkarni S, Phillips SM) Psycho-Oncology March 2022;31(3):425-435 10 Citations |
| 1 | Assessment of Salvage Regimens Post-Chimeric Antigen Receptor T Cell Therapy for Patients with Diffuse Large B Cell Lymphoma. (Sigmund AM, Denlinger N, Huang Y, Bond D, Voorhees T, Bajwa A, Elder P, Brammer JE, Saad A, Penza S, Vasu S, de Lima M, Jaglowski S, Kittai AS) Transplant Cell Ther 2022 Jun;28(6):342.e1-342.e5 9 Citations |
| 3 | Manual therapy interventions in the management of adults with prior cervical spine surgery for degenerative conditions: a scoping review. (Gliedt JA, Dawson AZ, Daniels CJ, Spector AL, Cupler ZA, King J, Egede LE) Chiropr Man Therap 2022 Mar 07;30(1):13 1 Citation |
| 4 | Use of Early Intrathecal Therapy to Manage High-Grade Immune Effector Cell-Associated Neurotoxicity Syndrome. (Zurko JC, Johnson BD, Aschenbrenner E, Fenske TS, Hamadani M, Hari P, Shah NN) JAMA Oncol 2022 May 01;8(5):773-775 22 Citations |
| 1 | Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. (McDonald CM, Marbán E, Hendrix S, Hogan N, Ruckdeschel Smith R, Eagle M, Finkel RS, Tian C, Janas J, Harmelink MM, Varadhachary AS, Taylor MD, Hor KN, Mayer OH, Henricson EK, Furlong P, Ascheim DD, Rogy S, Williams P, Marbán L, HOPE-2 Study Group) Lancet 2022 Mar 12;399(10329):1049-1058 48 Citations |
| 1 | Immunotherapy in Breast Cancer and the Potential Role of Liquid Biopsy (Magbanua MJM, Gumusay O, Kurzrock R, van ‘t Veer LJ, Rugo HS) Frontiers in Oncology 15 March 2022;12 10 Citations |
| 7 | Tumor Derived Extracellular Vesicles Drive T Cell Exhaustion in Tumor Microenvironment through Sphingosine Mediated Signaling and Impacting Immunotherapy Outcomes in Ovarian Cancer. (Gupta P, Kadamberi IP, Mittal S, Tsaih SW, George J, Kumar S, Vijayan DK, Geethadevi A, Parashar D, Topchyan P, McAlarnen L, Volkman BF, Cui W, Zhang KYJ, Di Vizio D, Chaluvally-Raghavan P, Pradeep S) Adv Sci (Weinh) 2022 May;9(14):e2104452 46 Citations |
| 1 | Broad strokes or fine points: Are dialectical behavior therapy modules associated with general or domain-specific changes? (Cheavens JS, Southward MW, Howard KP, Heiy JE, Altenburger EM) Personal Disord 2023 Mar;14(2):137-147 6 Citations |
| 2 | Protocolized screening effectively identifies myocardial recovery following destination therapy left ventricular assist device implantation. (Smith NJ, Collar N, Duvvuri P, Miles B, Wu R, Szabo A, Gaglianello N, Joyce LD, Joyce DL) Artif Organs 2022 Aug;46(8):1636-1648 |
| 1 | Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18. (Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA, SCORE2 Study Investigator Group) JAMA Ophthalmol 2022 May 01;140(5):458-464 4 Citations |
| 1 | Photodynamic therapy for treatment of recurrent adenocarcinoma of the lung with tracheal oligometastasis. (Singh H, Benn BS, Jani C, Abdalla M, Kurman JS) Respir Med Case Rep 2022;37:101620 1 Citation |
| 1 | Cowpea Mosaic Virus Outperforms Other Members of the Secoviridae as In Situ Vaccine for Cancer Immunotherapy. (Beiss V, Mao C, Fiering SN, Steinmetz NF) Mol Pharm 2022 May 02;19(5):1573-1585 20 Citations |
| 1 | Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study). (Van der Weijst L, Aguado-Barrera ME, Azria D, Berkovic P, Boisselier P, Briers E, Bultijnck R, Calvo-Crespo P, Chang-Claude J, Choudhury A, Defraene G, Demontois S, Dunning AM, Elliott RM, Ennis D, Faivre-Finn C, Franceschini M, Gutiérrez-Enríquez S, Herskind C, Higginson DS, Kerns SL, Johnson K, Mollà M, Lambrecht M, Ramos M, Rancati T, Rimner A, Rosenstein BS, De Ruysscher D, Salem A, Sangalli C, Seibold P, Sosa-Fajardo P, Sperk E, Stobart H, Summersgill H, Surmont V, Symonds P, Taboada-Lorenzo B, Talbot CJ, Valdagni R, Vega A, Veldeman L, Veldwijk MR, Ward T, Webb A, West CML, REQUITE Consortium, Lievens Y) Lung Cancer 2022 Apr;166:228-241 9 Citations |
| 1 | Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia. (Baccarani M, Bonifazi F, Soverini S, Castagnetti F, Gugliotta G, Saber W, Estrada-Merly N, Rosti G, Gale RP) Leukemia 2022 May;36(5):1227-1236 12 Citations |
| 1 | A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositis (Schack LMH, Naderi E, Fachal L, Dorling L, Luccarini C, Dunning AM, Barnett G, Barrera MEA, Burnet NG, Calvo LM, Diergaarde B, Dudding T, Dunning AM, Duprez F, Kerns SL, Kiang MCL, Langendijk H, Mehanna H, Ness A, Sim AYL, Spiessens A, Summersgill HR, Tajes JF, Vega A, Welsh C, Wen EOH, West C, Ong EHW, Chua MLK, Langendijk JA, Alizadeh BZ, Overgaard J, Eriksen JG, Andreassen CN, Alsner J) British Journal of Cancer 1 April 2022;126(7):1082-1090 12 Citations |
| 1 | Immunotherapy in Breast Cancer and the Potential Role of Liquid Biopsy. (Magbanua MJM, Gumusay O, Kurzrock R, van 't Veer LJ, Rugo HS) Front Oncol 2022;12:802579 10 Citations |
| 5 | Feasibility of a pharmacist-led symptom monitoring and management intervention to improve breast cancer endocrine therapy adherence. (Neuner J, Weil E, Fergestrom N, Stolley M, Kamaraju S, Oxencis C, Winn A, Laud PW, Flynn KE) J Am Pharm Assoc (2003) 2022;62(4):1321-1328.e3 6 Citations |
| 1 | Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection. (Mason MC, Krasnodebski M, Hester CA, Kothari AN, Barker C, Nishioka Y, Chiang YJ, Newhook TE, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS) Ann Surg Oncol 2022 Aug;29(8):5156-5164 6 Citations |
| 1 | Acceptability and barriers to adopting physical therapy and rehabilitation as standard of care in hernia disease: a prospective national survey of providers and preliminary data. (Renshaw S, Peterson R, Lewis R, Olson M, Henderson W, Kreuz B, Poulose B, Higgins RM) Hernia 2022 Jun;26(3):865-871 2 Citations |
| 1 | Worldwide Network for Blood and Marrow Transplantation Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy. (Alseraihy A, McGrath E, Niederwieser D, Chabannon C, Szer J, Mohty M, Kharfan-Dabaja MA, Orchard K, Schwartz J, Rasheed W, Koh M, Kröger N, Kodera Y, Fakih RE, Worel N, Manson L, Rintala T, Tabakhi A, Savani B, Gergis U, Sureda A, Eldridge PW, Yakoub-Agha I, Hamadani M, Weisdorf D, Greinix H, Aljurf M) Transplant Cell Ther 2022 Aug;28(8):455-462 3 Citations |
| 1 | Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas-Looking Forward. (Istl AC, Gronchi A) Cancers (Basel) 2022 Apr 05;14(7) 12 Citations |
| 1 | Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women. (Wang X, Kapoor PM, Auer PL, Dennis J, Dunning AM, Wang Q, Lush M, Michailidou K, Bolla MK, Aronson KJ, Murphy RA, Brooks-Wilson A, Lee DG, Cordina-Duverger E, Guénel P, Truong T, Mulot C, Teras LR, Patel AV, Dossus L, Kaaks R, Hoppe R, Lo WY, Brüning T, Hamann U, Czene K, Gabrielson M, Hall P, Eriksson M, Jung A, Becher H, Couch FJ, Larson NL, Olson JE, Ruddy KJ, Giles GG, MacInnis RJ, Southey MC, Le Marchand L, Wilkens LR, Haiman CA, Olsson H, Augustinsson A, Krüger U, Wagner P, Scott C, Winham SJ, Vachon CM, Perou CM, Olshan AF, Troester MA, Hunter DJ, Eliassen HA, Tamimi RM, Brantley K, Andrulis IL, Figueroa J, Chanock SJ, Ahearn TU, García-Closas M, Evans GD, Newman WG, van Veen EM, Howell A, Wolk A, Håkansson N, Anton-Culver H, Ziogas A, Jones ME, Orr N, Schoemaker MJ, Swerdlow AJ, Kitahara CM, Linet M, Prentice RL, Easton DF, Milne RL, Kraft P, Chang-Claude J, Lindström S) Sci Rep 2022 Apr 13;12(1):6199 3 Citations |
| 1 | Socioeconomic and Racial Disparity in Chimeric Antigen Receptor T Cell Therapy Access. (Ahmed N, Shahzad M, Shippey E, Bansal R, Mushtaq MU, Mahmoudjafari Z, Faisal MS, Hoffmann M, Abdallah AO, Divine C, Hamadani M, McGuirk J, Shune L) Transplant Cell Ther 2022 Jul;28(7):358-364 81 Citations |
| 1 | Understanding the relationship between patient characteristics and complication in veterans discharged on parenteral antibiotic therapy. (Guenther ED, Sherman KA, Dysart CE, Haque J, Mahatme S, Gundacker ND) Res Social Adm Pharm 2022 Oct;18(10):3864-3866 1 Citation |
| 1 | Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients. (Samson A, West EJ, Carmichael J, Scott KJ, Turnbull S, Kuszlewicz B, Dave RV, Peckham-Cooper A, Tidswell E, Kingston J, Johnpulle M, da Silva B, Jennings VA, Bendjama K, Stojkowitz N, Lusky M, Prasad KR, Toogood GJ, Auer R, Bell J, Twelves CJ, Harrington KJ, Vile RG, Pandha H, Errington-Mais F, Ralph C, Newton DJ, Anthoney A, Melcher AA, Collinson F) Cancer Immunol Res 2022 Jun 03;10(6):745-756 29 Citations |
| 1 | Month 60 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion. (Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, SCORE2 Investigator Group) Am J Ophthalmol 2022 Aug;240:330-341 10 Citations |
| 1 | A Rare Case of Coexisting Psychogenic Polydipsia and Nephrogenic Diabetes Insipidus With Lithium Therapy. (Antala D, Sharma A, Adhikari A, Luitel P, Hirsch S) Cureus 2022 Mar;14(3):e23438 |
| 1 | Using ecological momentary assessment to understand associations between daily physical activity and symptoms in breast cancer patients undergoing chemotherapy. (Whitaker M, Welch WA, Fanning J, Santa-Maria CA, Auster-Gussman LA, Solk P, Khan SA, Kulkarni SA, Gradishar W, Siddique J, Phillips SM) Support Care Cancer 2022 Aug;30(8):6613-6622 6 Citations |
| 1 | Technical Radiotherapy Advances – The Role of Magnetic Resonance Imaging-Guided Radiation in the Delivery of Hypofractionation (Gough J, Hall W, Good J, Nash A, Aitken K) Clinical Oncology May 2022;34(5):301-312 7 Citations |
| 1 | Intravenous Oncolytic Vaccinia Virus Therapy Results in a Differential Immune Response between Cancer Patients (West EJ, Scott KJ, Tidswell E, Bendjama K, Stojkowitz N, Lusky M, Kurzawa M, Prasad R, Toogood G, Ralph C, Anthoney DA, Melcher AA, Collinson FJ, Samson A) Cancers May-1 2022;14(9) 8 Citations |
| 6 | Is 5 the New 25? Long-Term Oncologic Outcomes From a Phase II, Prospective, 5-Fraction Preoperative Radiation Therapy Trial in Patients With Localized Soft Tissue Sarcoma (Bedi M, Singh R, Charlson JA, Kelly T, Johnstone C, Wooldridge A, Hackbarth DA, Moore N, Neilson JC, King DM) Advances in Radiation Oncology 1 May 2022;7(3) 35 Citations |
| 1 | Variation in blood microbial lipopolysaccharide (LPS) contributes to immune reconstitution in response to suppressive antiretroviral therapy in HIV. (Luo Z, Health SL, Li M, Yang H, Wu Y, Collins M, Deeks SG, Martin JN, Scott A, Jiang W) EBioMedicine 2022 Jun;80:104037 23 Citations |
| 1 | Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium. (Kelly KN, Macedo FI, Seaton M, Wilson G, Hammill C, Martin RC, Maduekwe UN, Kim HJ, Maithel SK, Abbott DE, Ahmad SA, Kooby DA, Merchant NB, Datta J) Ann Surg Oncol 2022 Sep;29(9):6004-6012 6 Citations |
| 1 | Matching-adjusted Indirect Comparison of the Efficacy of Loncastuximab Tesirine Versus Treatment in the Chemoimmunotherapy Era for Relapsed/Refractory Diffuse Large B-cell Lymphoma. (Hamadani M, Chen L, Song Y, Xu MK, Liao L, Caimi PF, Carlo-Stella C) Clin Lymphoma Myeloma Leuk 2022 Aug;22(8):e738-e744 6 Citations |
| 1 | Is Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy Still Indicated in Patients With Extraperitoneal Disease? (Beal EW, Chen JC, Kim A, Johnston FM, Abbott DE, Raoof M, Grotz TE, Fournier K, Dineen S, Veerapong J, Clarke C, Staley C, Patel SH, Lambert L, Cloyd JM) J Surg Res 2022 Sep;277:269-278 5 Citations |
| 1 | Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma. (Franssen S, Soares KC, Jolissaint JS, Tsilimigras DI, Buettner S, Alexandrescu S, Marques H, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Margonis GA, Weiss MJ, Bauer TW, Shen F, Poultsides GA, Marsh JW, Cercek A, Kemeny N, Kingham TP, D'Angelica M, Pawlik TM, Jarnagin WR, Koerkamp BG) JAMA Surg 2022 Jul 01;157(7):590-596 38 Citations |
| 1 | Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer. (Kothari A, White MG, Peacock O, Kaur H, Palmquist SM, You N, Taggart M, Salem U, Overman M, Kopetz S, Chang GJ) Br J Surg 2022 May 16;109(6):489-492 22 Citations |
| 1 | Playing with a purpose: The impact of therapeutic recreation during hospitalization for cancer therapy or stem cell transplantation (Hoag, J.A., Bingen, K., Karst, J., Palou, A., Yan, K., & Zhang, J. ) Journal of Pediatric Oncology Nursing |
| 3 | Palliative Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis: Is It Safe and Effective? (Strong EA, Livingston A, Gracz M, Peltier W, Tsai S, Christians K, Gamblin TC, Kersting K, Clarke CN) J Surg Res 2022 Oct;278:31-38 2 Citations |
| 1 | The presence of a neurodiverse disorder is associated with increased use of antegrade enema therapy in children with severe constipation: A study from the Pediatric Colorectal and Pelvic Learning Consortium (PCPLC). (Short SS, Reeder RW, Lewis KE, Dickie B, Grabowski J, Sepuha T, Durham MM, Frischer J, Badillo A, Calkins CM, Rentea RM, Ralls M, Wood RJ, Fuller MK, van Leeuwen K, Avansino JR, Austin K, Rollins MD) J Pediatr Surg 2022 Aug;57(8):1676-1680 4 Citations |
| 1 | Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma. (Holstein SA, Asimakopoulos F, Azab AK, Bianchi G, Bhutani M, Crews LA, Cupedo T, Giles H, Gooding S, Hillengass J, John L, Kaiser S, Lee L, Maclachlan K, Pasquini MC, Pichiorri F, Shah N, Shokeen M, Shy BR, Smith EL, Verona R, Usmani SZ, McCarthy PL) Transplant Cell Ther 2022 Aug;28(8):446-454 1 Citation |
| 6 | Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapy. (Knight JM, Szabo A, Arapi I, Wu R, Emmrich A, Hackett E, Sauber G, Yim S, Johnson B, Hari P, Schneider D, Dropulic B, Cusatis RN, Cole SW, Hillard CJ, Shah NN) Commun Med (Lond) 2022;2(1):49 9 Citations |
| 1 | Acceptability and barriers to adopting physical therapy and rehabilitation as standard of care in hernia disease: a prospective national survey of providers and preliminary data (Renshaw S, Peterson R, Lewis R, Olson M, Henderson W, Kreuz B, Poulose B, Higgins RM) Hernia June 2022;26(3):865-871 2 Citations |
| 1 | Age and weight considerations for the use of continuous positive airway pressure therapy in pediatric populations: an American Academy of Sleep Medicine position statement. (Amos L, Afolabi-Brown O, Gault D, Lloyd R, Prero MY, Rosen CL, Malhotra RK, Martin JL, Ramar K, Rowley JA, Abbasi-Feinberg F, Aurora RN, Kapur VK, Kazmi U, Kuhlmann D, Olson EJ, Shelgikar AV, Thomas SM, Trotti LM) J Clin Sleep Med 2022 Aug 01;18(8):2041-2043 7 Citations |
| 1 | Adaptive Radiation Therapy Physician Guidelines: Recommendations From an Expert Users' Panel. (Kim H, Lee P, Tree AC, Chuong MD, Raldow AC, Kishan AU, Fuller CD, Rosenberg SA, Hall WA, Chie EK, Portelance L) Pract Radiat Oncol 2022;12(5):e355-e362 15 Citations |
| 5 | Is 5 the New 25? Long-Term Oncologic Outcomes From a Phase II, Prospective, 5-Fraction Preoperative Radiation Therapy Trial in Patients With Localized Soft Tissue Sarcoma. (Bedi M, Singh R, Charlson JA, Kelly T, Johnstone C, Wooldridge A, Hackbarth DA, Moore N, Neilson JC, King DM) Adv Radiat Oncol 2022;7(3):100850 35 Citations |
| 2 | AAPM task group report 303 endorsed by the ABS: MRI implementation in HDR brachytherapy-Considerations from simulation to treatment. (Prisciandaro J, Zoberi JE, Cohen G, Kim Y, Johnson P, Paulson E, Song W, Hwang KP, Erickson B, Beriwal S, Kirisits C, Mourtada F) Med Phys 2022 Aug;49(8):e983-e1023 17 Citations |
| 1 | Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma. (Richardson PG, Jacobus SJ, Weller EA, Hassoun H, Lonial S, Raje NS, Medvedova E, McCarthy PL, Libby EN, Voorhees PM, Orlowski RZ, Anderson LD Jr, Zonder JA, Milner CP, Gasparetto C, Agha ME, Khan AM, Hurd DD, Gowin K, Kamble RT, Jagannath S, Nathwani N, Alsina M, Cornell RF, Hashmi H, Campagnaro EL, Andreescu AC, Gentile T, Liedtke M, Godby KN, Cohen AD, Openshaw TH, Pasquini MC, Giralt SA, Kaufman JL, Yee AJ, Scott E, Torka P, Foley A, Fulciniti M, Hebert K, Samur MK, Masone K, Maglio ME, Zeytoonjian AA, Nadeem O, Schlossman RL, Laubach JP, Paba-Prada C, Ghobrial IM, Perrot A, Moreau P, Avet-Loiseau H, Attal M, Anderson KC, Munshi NC, DETERMINATION Investigators) N Engl J Med 2022 Jul 14;387(2):132-147 289 Citations |
| 1 | Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up. (Martin T, Usmani SZ, Berdeja JG, Agha M, Cohen AD, Hari P, Avigan D, Deol A, Htut M, Lesokhin A, Munshi NC, O'Donnell E, Stewart AK, Schecter JM, Goldberg JD, Jackson CC, Yeh TM, Banerjee A, Allred A, Zudaire E, Deraedt W, Olyslager Y, Zhou C, Pacaud L, Madduri D, Jakubowiak A, Lin Y, Jagannath S) J Clin Oncol 2023 Feb 20;41(6):1265-1274 377 Citations |
| 1 | ASTCT Committee on Practice Guidelines Survey on Evaluation & Management of Diffuse Large B-cell Lymphoma after Failure of Chimeric Antigen Receptor T Cell Therapy (CAR-T) Therapy. (Ahmed N, Kumar A, Kharfan-Dabaja MA, DeFilipp Z, Herrera A, Hashmi S, Dholaria B, Perales MA, Carpenter PA, Hamadani M) Transplant Cell Ther 2022 Sep;28(9):523-529 13 Citations |
| 2 | The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521. (Hall WA, Karrison TG, Rosenthal SA, Amin MB, Gomella LG, Purdy JA, Sartor AO, Michalski JM, Garzotto MG, Bergom C, Jani AB, Lawton CAF, Simko JP, Moore JK, Gore EM, Lee WR, Nguyen PL, Danielson BL, Sandler HM, Feng FY) Int J Radiat Oncol Biol Phys 2022 Oct 01;114(2):266-274 3 Citations |
| 1 | Preoperative therapy for pancreatic adenocarcinoma-precision beyond anatomy. (Seo YD, Katz MHG) Cancer 2022 Aug 15;128(16):3041-3056 22 Citations |
| 1 | Author Correction: Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation. (Zheng Y, Sethi R, Mangala LS, Taylor C, Goldsmith J, Wang M, Masuda K, Carrami EM, Mannion D, Miranda F, Herrero-Gonzalez S, Hellner K, Chen F, Alsaadi A, Albukhari A, Fotso DC, Yau C, Jiang D, Pradeep S, Rodriguez-Aguayo C, Lopez-Berestein G, Knapp S, Gray NS, Campo L, Myers KA, Dhar S, Ferguson D, Bast RC Jr, Sood AK, von Delft F, Ahmed AA) Nat Commun 2022 Jun 10;13(1):3352 1 Citation |
| 1 | Systemic Therapy of Metastatic Pancreatic Adenocarcinoma: Current Status, Challenges, and Opportunities. (Chakrabarti S, Kamgar M, Mahipal A) Cancers (Basel) 2022 May 24;14(11) 16 Citations |
| 1 | An Exploratory Study of Neoadjuvant Cetuximab Followed by Cetuximab and Chemoradiotherapy in Women With Newly Diagnosed Locally Advanced Cervical Cancer. (Fracasso PM, Duska LR, Thaker PH, Gao F, Zoberi I, Dehdashti F, Siegel BA, Uliel L, Menias CO, Rehm PK, Goodner SA, Creekmore AN, Lothamer HL, Rader JS) Am J Clin Oncol 2022 Jul 01;45(7):286-293 1 Citation |
| 1 | Selecting appropriate therapy for hairy cell leukemia: current state and future prospects based on molecularly defined characterization. (Dasanu CA, Alvarez-Argote J, Goff CB) Expert Opin Pharmacother 2022 Aug;23(11):1239-1241 |
| 1 | Systematic review of photodynamic therapy for the treatment of hidradenitis suppurativa. (Reshetylo S, Narla S, Bakker C, Freeman T, Farah RS, Hamzavi IH, Goldfarb N) Photodermatol Photoimmunol Photomed 2023 Jan;39(1):39-50 7 Citations |
| 5 | Androgen receptor expression in patients with triple negative breast cancer treated with neoadjuvant chemotherapy: a single institution study. (Sridhar N, Glisch C, Jawa Z, Chaudhary LN, Kamaraju S, Burfeind J, Charlson J, Chitambar CR, Jorns JM, Cheng YC) J Cancer 2022;13(8):2472-2476 6 Citations |
| 1 | Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium. (Schafer ES, Chao K, Stevens AM, Jo E, Hilsenbeck SG, Gossai NP, Doan A, Colace SI, Guinipero T, Otterson D, Kaplan JA, Hinson A, Pommert L, Wayne AS, Bhojwani D, Burke MJ) Pediatr Blood Cancer 2022 Oct;69(10):e29812 9 Citations |
| 4 | Development and implementation of an automatic air delineation technique for MRI-guided adaptive radiation therapy. (Ahunbay E, Parchur AK, Paulson E, Chen X, Omari E, Li XA) Phys Med Biol 2022 Jul 12;67(14) 4 Citations |
| 3 | Impact of autologous hematopoietic cell transplantation on disease burden quantified by next-generation sequencing in multiple myeloma treated with quadruplet therapy. (Bal S, Dhakal B, Silbermann RW, Schmidt TM, Dholaria B, Giri S, Chhabra S, Medvedova E, Godby KN, D'Souza A, Hall AC, Hardwick P, Omel J, Cornell RF, Hari P, Callander NS, Costa LJ) Am J Hematol 2022 Sep;97(9):1170-1177 5 Citations |
| 1 | Glucocorticoid therapy in respiratory illness: bench to bedside. (Amratia DA, Viola H, Ioachimescu OC) J Investig Med 2022 Dec;70(8):1662-1680 10 Citations |
| 1 | Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis. (Parekh A, Keller FG, McCarten KM, Kessel S, Cho S, Pei Q, Wu Y, Castellino SM, Constine LS, Schwartz CL, Hodgson D, Kelly KM, Hoppe BS) Blood 2022 Sep 08;140(10):1086-1093 7 Citations |
| 1 | Role of CD19 Chimeric Antigen Receptor T Cells in Second-Line Large B Cell Lymphoma: Lessons from Phase 3 Trials. An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. (Perales MA, Anderson LD Jr, Jain T, Kenderian SS, Oluwole OO, Shah GL, Svoboda J, Hamadani M) Transplant Cell Ther 2022 Sep;28(9):546-559 22 Citations |
| 1 | The benefits of initiating continuous renal replacement therapy after brain death in organ donors with oligoanuric acute kidney injury. (Marklin GF, Ewald L, Klinkenberg WD, Joy CM, Bander SJ, Rothstein M) Clin Transplant 2022 Sep;36(9):e14764 3 Citations |
| 1 | Corneal fibrosis abrogation by a localized AAV-mediated inhibitor of differentiation 3 (Id3) gene therapy in rabbit eyes in vivo. (Gupta S, Fink MK, Kempuraj D, Sinha NR, Martin LM, Keele LM, Sinha PR, Giuliano EA, Hesemann NP, Raikwar SP, Chaurasia SS, Mohan RR) Mol Ther 2022 Oct 05;30(10):3257-3269 11 Citations |
| 1 | Meta-analysis of ciltacabtagene autoleucel versus physician's choice therapy for the treatment of patients with relapsed or refractory multiple myeloma. (Costa LJ, Hari P, Berdeja JG, De Stefano V, Gay F, Hooper B, Bartlett M, Haltner A, Rosta E, Kumar S, Martin T, Mateos MV, Moreau P, Usmani SZ, Olyslager Y, Schecter JM, Roccia T, Garrett A, Lee S, Nesheiwat T, Pacaud L, Zhou C, Samjoo IA, Lin Y, Diels J, Valluri S, Weisel K) Curr Med Res Opin 2022 Oct;38(10):1759-1767 4 Citations |
| 1 | Implications of peritoneal cancer index distribution on patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. (Wong JSM, Tan GHC, Cheok SHX, Ong CJ, Chia CS, Teo MCC) Pleura Peritoneum 2022 Jun 01;7(2):95-102 5 Citations |
| 4 | Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma. (Zurko J, Ramdial J, Shadman M, Ahmed S, Szabo A, Iovino L, Tomas AA, Sauter C, Perales MA, Shah NN, Acharya UH, Jacobson C, Soiffer RJ, Wang T, Komanduri KV, Jaglowski S, Kittai AS, Denlinger N, Iqbal M, Kharfan-Dabaja MA, Ayala E, Chavez J, Jain M, Locke FL, Samara Y, Budde LE, Mei MG, Pia AD, Feldman T, Ahmed N, Jacobs R, Ghosh N, Dholaria B, Oluwole OO, Hess B, Hassan A, Kenkre VP, Reagan P, Awan F, Nieto Y, Hamadani M, Herrera AF) Haematologica 2023 Jan 01;108(1):98-109 51 Citations |
| 2 | A Systematic Review of Conversion to Resectability in Unresectable Metastatic Colorectal Cancer Chemotherapy Trials. (Chrabaszcz S, Rajeev R, Witmer HDD, Dhiman A, Klooster B, Gamblin TC, Banerjee A, Johnston FM, Turaga KK) Am J Clin Oncol 2022 Aug 01;45(8):366-372 2 Citations |
| 1 | No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity. (Barnett GC, Kerns SL, Dorling L, Fachal L, Aguado-Barrera ME, Martínez-Calvo L, Jandu HK, Welsh C, Tyrer J, Coles CE, Haviland JS, Parker C, Gómez-Caamaño A, Calvo-Crespo P, Sosa-Fajardo P, Burnet NG, Summersgill H, Webb A, De Ruysscher D, Seibold P, Chang-Claude J, Talbot CJ, Rattay T, Parliament M, De Ruyck K, Rosenstein BS, Pharoah PDP, Dunning AM, Vega A, West CML, RGC and REQUITE Consortia) Int J Radiat Oncol Biol Phys 2022 Nov 01;114(3):494-501 3 Citations |
| 1 | Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study. (Sehgal A, Hoda D, Riedell PA, Ghosh N, Hamadani M, Hildebrandt GC, Godwin JE, Reagan PM, Wagner-Johnston N, Essell J, Nath R, Solomon SR, Champion R, Licitra E, Fanning S, Gupta N, Dubowy R, D'Andrea A, Wang L, Ogasawara K, Thorpe J, Gordon LI) Lancet Oncol 2022 Aug;23(8):1066-1077 137 Citations |
| 1 | A comparison of prolonged exposure therapy, pharmacotherapy, and their combination for PTSD: What works best and for whom; study protocol for a randomized trial. (Bredemeier K, Larsen S, Shivakumar G, Grubbs K, McLean C, Tress C, Rosenfield D, DeRubeis R, Xu C, Foa E, Morland L, Pai A, Tsao C, Crawford J, Weitz E, Mayinja L, Feler B, Wachsman T, Lupo M, Hooper V, Cook R, Thase M) Contemp Clin Trials 2022 Aug;119:106850 2 Citations |
| 1 | The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma. (Ali M, Mooi J, Lawrentschuk N, McKay RR, Hannan R, Lo SS, Hall WA, Siva S) Eur Urol 2022 Dec;82(6):613-622 55 Citations |
| 1 | Automatic Contour Refinement for Deep Learning Auto-segmentation of Complex Organs in MRI-guided Adaptive Radiation Therapy. (Ding J, Zhang Y, Amjad A, Xu J, Thill D, Li XA) Adv Radiat Oncol 2022;7(5):100968 16 Citations |
| 2 | Biobehavioral Implications of Covid-19 for Transplantation and Cellular Therapy Recipients. (Knight JM, Taylor MR, Rentscher KE, Henley EC, Uttley HA, Nelson AM, Turcotte LM, McAndrew NS, Amonoo HL, Mohanraj L, Kelly DL, Costanzo ES) Front Immunol 2022;13:877558 4 Citations |
| 2 | A case of early chelation therapy in a potentially lethal mercuric chloride ingestion. (Fox H, Farkas A, Rukamp N, Feldman R) Clin Toxicol (Phila) 2022 Sep;60(9):1076-1078 |
| 1 | CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope. (Karn V, Sandhya S, Hsu W, Parashar D, Singh HN, Jha NK, Gupta S, Dubey NK, Kumar S) Cancer Cell Int 2022 Jul 25;22(1):234 40 Citations |
| 1 | A retrospective cross sectional study assessing factors associated with retention and non-viral suppression among HIV positive FSWs receiving antiretroviral therapy from primary health care facilities in Kampala, Uganda. (Atuhaire L, Shumba CS, Mapahla L, Nyasulu PS) BMC Infect Dis 2022 Jul 26;22(1):642 6 Citations |
| 2 | Secondary Impact of the Coronavirus Disease 19 Pandemic on Patients and the Cellular Therapy Healthcare Ecosystem. (Koo J, Auletta JJ, Hartley DM, Huber J, Jaglowski S, Kapadia M, Kusnier K, Lehmann L, Maakaron J, Myers KC, Pai A, Parker L, Phelan R, Sper C, Rotz SJ, Dandoy CE) Transplant Cell Ther 2022 Nov;28(11):737-746 6 Citations |
| 1 | ASO Visual Abstract: Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection (Mason MC, Krasnodebski M, Hester CA, Kothari AN, Barker C, Nishioka Y, Chiang YJ, Newhook TE, Tzeng CWD, Chun YS, Vauthey JN, Tran Cao HS) Annals of Surgical Oncology August 2022;29(8):5165-5166 |
| 1 | Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection (Mason MC, Krasnodebski M, Hester CA, Kothari AN, Barker C, Nishioka Y, Chiang YJ, Newhook TE, Tzeng CWD, Chun YS, Vauthey JN, Tran Cao HS) Annals of Surgical Oncology August 2022;29(8):5156-5164 6 Citations |
| 1 | Improvement of compliance to the Portland intensive insulin therapy during liver transplantation after introducing an application software: a retrospective single center cohort study. (Choi YW, Han S, Ko JS, Lee SN, Gwak MS, Kim GS) Anesth Pain Med (Seoul) 2022 Jul;17(3):312-319 |
| 1 | Comparison of short- and long-term adverse kidney outcomes after chimeric antigen receptor T cell therapy and autologous hematopoietic stem cell transplant for diffuse large B cell lymphoma. (Hanna P, Strohbehn I, Moreno D, Harden D, Seethapathy H, Gupta S, Lee M, Ouyang T, Frigault M, Sise ME) Bone Marrow Transplant 2022 Oct;57(10):1623-1625 4 Citations |
| 3 | Prospective Risk Stratification Identifies Healthcare Utilization Associated with Home Oxygen Therapy for Infants with Bronchopulmonary Dysplasia. (Lagatta JM, Zhang L, Yan K, Dawson S, Msall ME, Ambalavanan N, Brousseau DC) J Pediatr 2022 Dec;251:105-112.e1 4 Citations |
| 6 | Impact of Chronic Kidney Disease and Acute Kidney Injury on Safety and Outcomes of CAR T-Cell Therapy in Lymphoma Patients. (Ahmed G, Bhasin-Chhabra B, Szabo A, Shah NN, Longo W, Dhakal B, Chhabra S, D'Souza A, Fenske TS, Hamadani M) Clin Lymphoma Myeloma Leuk 2022 Nov;22(11):863-868 7 Citations |
| 1 | Perspective: An International Fludarabine Shortage: Supply Chain Issues Impacting Transplantation and Immune Effector Cell Therapy Delivery. (Maziarz RT, Diaz A, Miklos DB, Shah NN) Transplant Cell Ther 2022 Nov;28(11):723-726 20 Citations |
| 1 | Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against FLT3- mutant acute myeloid leukemia and KMT2A-rearranged acute lymphoblastic leukemia. (Niswander LM, Graff ZT, Chien CD, Chukinas JA, Meadows CA, Leach LC, Loftus JP, Kohler ME, Tasian SK, Fry TJ) Haematologica 2023 Feb 01;108(2):457-471 28 Citations |
| 1 | Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer. (Gupta S, Strohbehn IA, Wang Q, Hanna PE, Seethapathy R, Prosek JM, Herrmann SM, Abudayyeh A, Malik AB, Loew S, Carlos CA, Chang WT, Beckerman P, Mithani Z, Shah CV, Renaghan AD, de Seigneux S, Campedel L, Kitchlu A, Shin DS, Coppock G, Lumlertgul N, Garcia P, Ortiz-Melo DI, Rashidi A, Sprangers B, Aggarwal V, Benesova K, Jhaveri KD, Cortazar FB, Weins A, Zuo Y, Mooradian MJ, Reynolds KL, Leaf DE, Sise ME, ICPi-AKI Consortium) Kidney Int 2022 Oct;102(4):930-935 8 Citations |
| 1 | Chronic Myeloid Leukemia: Part II-Cost of Care Among Patients in Advanced Phases or Later Lines of Therapy in Chronic Phase in the United States from a Commercial Perspective. (Atallah EL, Maegawa R, Latremouille-Viau D, Rossi C, Guérin A) J Health Econ Outcomes Res 2022;9(2):30-36 |
| 1 | Chronic Myeloid Leukemia: Part I-Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States. (Atallah EL, Maegawa R, Latremouille-Viau D, Rossi C, Guérin A, Wu EQ, Patwardhan P) J Health Econ Outcomes Res 2022;9(2):19-29 |
| 1 | Carcinoma of unknown primary: Molecular tumor board-based therapy. (Shreenivas AV, Kato S, Hu J, Skefos C, Sicklick J, Kurzrock R) CA Cancer J Clin 2022 Nov;72(6):510-523 |
| 1 | Combining ablative radiotherapy and anti CD47 monoclonal antibody improves infiltration of immune cells in tumor microenvironments. (Rostami E, Bakhshandeh M, Ghaffari-Nazari H, Alinezhad M, Alimohammadi M, Alimohammadi R, Mahmoodi Chalbatani G, Hejazi E, Webster TJ, Tavakkol-Afshari J, Jalali SA) PLoS One 2022;17(8):e0273547 5 Citations |
| 1 | Corneal fibrosis abrogation by a localized AAV-mediated inhibitor of differentiation 3 (Id3) gene therapy in rabbit eyes in vivo. (Gupta S, Fink MK, Kempuraj D, Sinha NR, Martin LM, Keele LM, Sinha PR, Giuliano EA, Hesemann NP, Raikwar SP, Chaurasia SS, Mohan RR) Mol Ther 2022 Oct 05;30(10):3334 2 Citations |
| 1 | Corrigendum to "The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma" [Eur Urol 2022]. (Ali M, Mooi J, Lawrentschuk N, McKay RR, Hannan R, Lo SS, Hall WA, Siva S) Eur Urol 2022 Nov;82(5):e152 |
| 1 | The impact of socioeconomic status on the burden of atherosclerosis, and the effect of intensive preventive therapy on its progression: A retrospective cohort study. (Woolsey AB, Arsang-Jang S, Spence JD, Hackam DG, Azarpazhooh MR) Atherosclerosis 2022 Oct;358:29-33 6 Citations |
| 1 | Chromatin remodeling (SWI/SNF) complexes, cancer, and response to immunotherapy (Krishnamurthy N, Kato S, Lippman S, Kurzrock R) Journal for ImmunoTherapy of Cancer 2 September 2022;10(9) 14 Citations |
| 1 | Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy. (Fujiwara Y, Kato S, Nesline MK, Conroy JM, DePietro P, Pabla S, Kurzrock R) Cancer Treat Rev 2022 Nov;110:102461 155 Citations |
| 1 | Accuracy and Safety of Scout Dose Resin Yttrium-90 Microspheres for Radioembolization Therapy Treatment Planning: A Prospective Single-Arm Clinical Trial. (Kokabi N, Webster LA, Elsayed M, Switchenko JM, Chen B, Brandon D, Galt J, Sethi I, Cristescu M, Kappadath SC, Schuster DM) J Vasc Interv Radiol 2022 Dec;33(12):1578-1587.e5 16 Citations |
| 2 | Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma. (Juloori A, Katipally RR, Lemons JM, Singh AK, Iyer R, Robbins JR, George B, Hall WA, Pitroda SP, Arif F, Fung J, Pillai A, Liao CY, Sharma M, Liauw SL) Int J Radiat Oncol Biol Phys 2023 Jan 01;115(1):202-213 43 Citations |
| 1 | Use of Aromatherapy for Pediatric Surgical Patients. (Czarnecki ML, Michlig JR, Norton AM, Stelter AJ, Hainsworth KR) Pain Manag Nurs 2022 Dec;23(6):703-710 1 Citation |
| 1 | Dermatologic Disease-Directed Targeted Therapy (D3T2): The Application of Biomarker-Based Precision Medicine for the Personalized Treatment of Skin Conditions-Precision Dermatology. (Cohen PR, Kurzrock R) Dermatol Ther (Heidelb) 2022 Oct;12(10):2249-2271 9 Citations |
| 1 | Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort. (Webb AJ, Harper E, Rattay T, Aguado-Barrera ME, Azria D, Bourgier C, Brengues M, Briers E, Bultijnck R, Chang-Claude J, Choudhury A, Cicchetti A, De Ruysscher D, De Santis MC, Dunning AM, Elliott RM, Fachal L, Gómez-Caamaño A, Gutiérrez-Enríquez S, Johnson K, Lobato-Busto R, Kerns SL, Post G, Rancati T, Reyes V, Rosenstein BS, Seibold P, Seoane A, Sosa-Fajardo P, Sperk E, Taboada-Valladares B, Valdagni R, Vega A, Veldeman L, Ward T, West CM, Symonds RP, Talbot CJ, REQUITE Consortium) EBioMedicine 2022 Oct;84:104269 8 Citations |
| 1 | Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy. (Louie BH, Kato S, Kim KH, Lim HJ, Okamura R, Eskander RN, Botta G, Patel H, Lee S, Lippman SM, Sicklick JK, Kurzrock R) NPJ Precis Oncol 2022 Sep 22;6(1):67 10 Citations |
| 1 | CML-433 ASC2ESCALATE Trial in Progress: A Phase 2 Single-Arm Dose Escalation Study of Asciminib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Previously Treated With 1 Prior Tyrosine Kinase Inhibitor (TKI). (Sasaki K, Mauro MJ, Levy MY, Atallah EL, Koller P, Maegawa R, Damon A, Kumar J, Khan M, Cortes JE) Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S299 |
| 2 | Staged reconstruction of soft tissue sarcoma resections using temporizing negative pressure wound therapy is safe and efficacious (deVries JA, Abbas A, King DM, Hackbarth D, LoGiudice J, Bedi M, Neilson JC) European Journal of Plastic Surgery October 2022;45(5):799-807 1 Citation |
| 1 | Barriers to anti-retroviral therapy adherence among adolescents aged 10 to 19 years living with HIV in sub-Saharan Africa: A mixed-methods systematic review protocol. (Hlophe LD, Tamuzi JL, Shumba C, Nyasulu PS) PLoS One 2022;17(9):e0273435 5 Citations |
| 2 | Ovarian cancer resistance to PARPi and platinum-containing chemotherapy. (Summey R, Uyar D) Cancer Drug Resist 2022;5(3):637-646 7 Citations |
| 9 | Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182, (S1083879120302251), (10.1016/j.bbmt.2020.04.013)] (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM) Transplantation and Cellular Therapy October 2022;28(10):715-716 2 Citations |
| 1 | Re: MRI-guided Focused Ultrasound Focal Therapy for Patients with Intermediate-risk Prostate Cancer: A Phase 2b, Multicentre Study. (Hall WA, Shoag J, Spratt DE) Eur Urol 2022 Dec;82(6):661-662 2 Citations |
| 3 | Changes in Cortical Activity in Stroke Survivors Undergoing Botulinum Neurotoxin Therapy for Treatment of Focal Spasticity. (Vinehout K, Tynes K, Sotelo MR, Hyngstrom AS, McGuire JR, Schmit BD) Front Rehabil Sci 2021;2:735819 1 Citation |
| 1 | Autologous hematopoietic cell transplantation versus whole-brain radiotherapy consolidation in primary central nervous system lymphoma: A systematic review and meta-analysis. (Epperla N, Reljic T, Chowdhury SM, Ferreri AJM, Kumar A, Hamadani M) Hematol Oncol 2023 Feb;41(1):88-96 6 Citations |
| 1 | GEC-ESTRO (ACROP)-ABS-CBG Consensus Brachytherapy Target Definition Guidelines for Recurrent Endometrial and Cervical Tumors in the Vagina. (Kamrava M, Leung E, Bachand F, Beriwal S, Chargari C, D'Souza D, Erickson B, Fokdal L, Han K, Harkenrider M, Lin L, Mahantshetty U, Nesvacil N, Ravi A, Schmid M, Vigneault E, Westerveld H, Yashar C, Nout R) Int J Radiat Oncol Biol Phys 2023 Mar 01;115(3):654-663 18 Citations |
| 1 | Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity. (Nitkin CR, Bamat NA, Lagatta J, DeMauro SB, Lee HC, Patel RM, King B, Slaughter JL, Campbell JP, Richardson T, Lewis T) JAMA Ophthalmol 2022 Nov 01;140(11):1085-1094 10 Citations |
| 3 | Patient-reported cognitive function among hematopoietic stem cell transplant and cellular therapy patients: a scoping review. (Cusatis R, Balza J, Uttke Z, Kode V, Suelzer E, Shaw BE, Flynn KE) Qual Life Res 2023 Apr;32(4):939-964 |
| 6 | Associations between socioeconomic status and bispecific LV20.19 CAR T-cell therapy outcomes. (Knight JM, Hackett E, Szabo A, Wu R, Sauber G, Johnson B, Cusatis RN, Aughey E, Cole SW, Hillard CJ, Shah NN) Haematologica 2023 Feb 01;108(2):588-593 1 Citation |
| 11 | Corrigendum to 'Current Use and Trends in Hematopoietic Cell Transplantation in the United States' [Transplantation and Cellular Therapy 26/8 (2020) e177-e182]. (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM) Transplant Cell Ther 2022 Oct;28(10):715-716 2 Citations |
| 3 | Biobehavioral Implications of Chimeric Antigen Receptor T-cell Therapy: Current State and Future Directions. (Taylor MR, Steineck A, Lahijani S, Hall AG, Jim HSL, Phelan R, Knight JM) Transplant Cell Ther 2023 Jan;29(1):19-26 4 Citations |
| 3 | Predicting Treatment Response From Extracellular Volume Fraction for Chemoradiation Therapy of Pancreatic Cancer. (Noid G, Godfrey G, Hall W, Shah J, Paulson E, Knechtges P, Erickson B, Allen Li X) Int J Radiat Oncol Biol Phys 2023 Mar 01;115(3):803-808 13 Citations |
| 1 | Phase 1b study of carfilzomib with induction chemotherapy in pediatric relapsed/refractory acute lymphoblastic leukemia. (Burke MJ, Ziegler DS, Bautista F, Attarbaschi A, Gore L, Locatelli F, M O'Brien M, Pauly M, Kormany WN, Tian S, Morris CL, Baruchel A) Pediatr Blood Cancer 2022 Dec;69(12):e29999 7 Citations |
| 6 | Predicting necessity of daily online adaptive replanning based on wavelet image features for MRI guided adaptive radiation therapy. (Nasief HG, Parchur AK, Omari E, Zhang Y, Chen X, Paulson E, Hall WA, Erickson B, Li XA) Radiother Oncol 2022 Nov;176:165-171 7 Citations |
| 1 | Evaluation of Bivalirudin Dosing in Pediatric Extracorporeal Membrane Oxygenation with Renal Insufficiency or Renal Replacement Therapy. (Hamzah M, Seelhammer TG, Yabrodi M, Beshish AG, Byrnes JW, Hall J, Wang L, Niebler RA) ASAIO J 2022 Nov 01;68(11):e196-e203 6 Citations |
| 1 | Kidney support for babies: building a comprehensive and integrated neonatal kidney support therapy program. (Mohamed TH, Morgan J, Mottes TA, Askenazi D, Jetton JG, Menon S) Pediatr Nephrol 2023 Jul;38(7):2043-2055 7 Citations |
| 1 | αVEGFR2-MICA fusion antibodies enhance immunotherapy effect and synergize with PD-1 blockade. (Pan M, Wang F, Nan L, Yang S, Qi J, Xie J, Shao S, Zou H, Wang M, Sun F, Zhang J) Cancer Immunol Immunother 2023 Apr;72(4):969-984 9 Citations |
| 1 | Acute kidney injury requiring kidney replacement therapy in childhood lupus nephritis: a cohort study of the Pediatric Nephrology Research Consortium and Childhood Arthritis and Rheumatology Research Alliance. (Stotter BR, Cody E, Gu H, Daga A, Greenbaum LA, Duong MD, Mazo A, Goilav B, Boneparth A, Kallash M, Zeid A, Seeherunvong W, Scobell RR, Alhamoud I, Carter CE, Shah S, Straatmann CE, Dixon BP, Cooper JC, Nelson RD, Levy DM, Brunner HI, Verghese PS, Wenderfer SE) Pediatr Nephrol 2023 May;38(5):1653-1665 8 Citations |
| 1 | Enrollment Lessons from a Biological Assignment Study of Marrow Transplantation versus Standard Care for Adolescents and Young Adults with Sickle Cell Disease: Considerations for Future Gene and Cellular Therapy Trials. (Krishnamurti L, Neuberg D, Sullivan KM, Smith S, Eapen M, Walters MC) Transplant Cell Ther 2023 Apr;29(4):217-221 5 Citations |
| 1 | Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab. (Yarur AJ, McGovern D, Abreu MT, Cheifetz A, Papamichail K, Deepak P, Bruss A, Beniwal-Patel P, Dubinsky M, Targan SR, Melmed GY) Clin Gastroenterol Hepatol 2023 Oct;21(11):2908-2917.e10 16 Citations |
| 1 | Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline. (Harkenrider MM, Abu-Rustum N, Albuquerque K, Bradfield L, Bradley K, Dolinar E, Doll CM, Elshaikh M, Frick MA, Gehrig PA, Han K, Hathout L, Jones E, Klopp A, Mourtada F, Suneja G, Wright AA, Yashar C, Erickson BA) Pract Radiat Oncol 2023;13(1):41-65 46 Citations |
| 4 | Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple Myeloma. (Hammons LR, Szabo A, Janardan A, Dhakal B, Chhabra S, D'Souza A, Mohan M) JAMA Netw Open 2022 Oct 03;5(10):e2238961 25 Citations |
| 1 | Improving Outcomes Prediction Using a Combination of MRI Wavelet Delta-Radiomic Textures and Clinical Biomarkers for MR-Guided Adaptive Radiation Therapy of Pancreatic Cancer (HG Nasief, X Chen, BA Erickson, ES Paulson, A Li, WA Hall) International Journal of Radiation Oncology, Biology, Physics Volume 114 Issue 3 Pages S79-S80 |
| 1 | Corrigendum to “The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma” [Eur Urol 2022] (European Urology, (S030228382202468X), (10.1016/j.eururo.2022.06.017)) (Ali M, Mooi J, Lawrentschuk N, McKay RR, Hannan R, Lo SS, Hall WA, Siva S) European Urology November 2022;82(5):e152 |
| 1 | Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative. (Beal EW, Srinivas S, Shen C, Kim A, Johnston FM, Greer J, Abbott DE, Pokrzywa C, Raoof M, Grotz TE, Leiting JL, Fournier K, Dineen S, Powers B, Veerapong J, Kothari A, Maduekew U, Maithel S, Wilson GC, Patel SH, Lambert L, Abdel-Misih S, Cloyd JM) Ann Surg Oncol 2023 Mar;30(3):1840-1849 3 Citations |
| 1 | Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy (Fujiwara Y, Kato S, Nesline MK, Conroy JM, DePietro P, Pabla S, Kurzrock R) Cancer Treatment Reviews November 2022;110 155 Citations |
| 2 | Erratum: "AAPM task group report 303 endorsed by the ABS: MRI implementation in HDR brachytherapy-Considerations from simulation to treatment" https://doi.org/10.1002/mp.15713. (Prisciandaro J, Zoberi JE, Cohen G, Kim Y, Johnson P, Paulson E, Song W, Hwang KP, Erickson B, Beriwal S, Kirisits C, Mourtada F) Med Phys 2023 Feb;50(2):1258 |
| 1 | Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. (Loo Gan C, Huang J, Pan E, Xie W, Schmidt AL, Labaki C, Meza L, Bouchard G, Li H, Jackson-Spence F, Sánchez-Ruiz C, Powles T, Kumar SA, Weise N, Hall WA, Rose BS, Beuselinck B, Suarez C, Pal SK, Choueiri TK, Heng DYC, McKay RR) Eur Urol Oncol 2023 Apr;6(2):204-211 6 Citations |
| 1 | Prostaglandin-based rAAV-mediated glaucoma gene therapy in Brown Norway rats. (Chern KJ, Nettesheim ER, Reid CA, Li NW, Marcoe GJ, Lipinski DM) Commun Biol 2022 Nov 03;5(1):1169 13 Citations |
| 4 | Incorporating uncertainty bounds in daily deformable dose accumulation for adaptive radiation therapy of head-and-neck cancer. (García-Alvarez JA, Zhong H, Schultz CJ, Li XA, Kainz K) Med Phys 2023 Apr;50(4):2474-2487 3 Citations |
| 3 | Medication delivery factors and adjuvant endocrine therapy adherence in breast cancer. (Neuner JM, Fergestrom N, Pezzin LE, Laud PW, Ruddy KJ, Winn AN) Breast Cancer Res Treat 2023 Jan;197(1):223-233 8 Citations |
| 1 | Impact of Chrome Kidney Disease and Acute Kidney Injury on Safety and Outcomes of CART-Cell Therapy in Lymphoma Patients.
(Ahmed G, Bhasin-Chhabra B, Szabo A, Shah NN, Longo W, Dhakal B, Chhabra S, D'Souza A, Fenske TS, Hamadani M.) Clin Lymphoma Myeloma Leuk (11):863-868 |
| 1 | Evaluation of Adjuvant Chemotherapy Survival Outcomes Among Patients With Surgically Resected Pancreatic Carcinoma With Node-Negative Disease After Neoadjuvant Therapy. (Hammad AY, Hodges JC, AlMasri S, Paniccia A, Lee KK, Bahary N, Singhi AD, Ellsworth SG, Aldakkak M, Evans DB, Tsai S, Zureikat A) JAMA Surg 2023 Jan 01;158(1):55-62 16 Citations |
| 3 | Salvage polatuzumab and allogeneic transplant rescue patients with B-cell lymphoma failing CAR T-cell therapy. (Furqan F, Maring M, Szabo A, Fenske TS, Hamadani M, Shah NN) Blood Adv 2023 Jun 13;7(11):2463-2467 3 Citations |
| 4 | A Randomized, Phase II, Clinical Trial of Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable, Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma. (Saif A, Verbus E, Erickson B, Kamgar M, Tsai S, Evans D, Hernandez JM, Hall WA) Ann Surg Oncol 2023 Feb;30(2):688-690 1 Citation |
| 7 | Development of a multi-layer quality assurance program to evaluate the uncertainty of deformable dose accumulation in adaptive radiotherapy. (Zhong H, Garcia-Alvarez JA, Kainz K, Tai A, Ahunbay E, Erickson B, Schultz CJ, Li XA) Med Phys 2023 Mar;50(3):1766-1778 6 Citations |
| 1 | Benchmarking quality of life to posttraumatic stress disorder symptom changes in cognitive processing therapy. (Hamrick L, Larsen SE, Sippel LM, Sherman K, Resick P, Galovski T) J Anxiety Disord 2023 Jan;93:102647 6 Citations |
| 2 | Hematopoietic Cell Transplantation in the Management of Myelodysplastic Syndrome: An Evidence-Based Review from the American Society for Transplantation and Cellular Therapy Committee on Practice Guidelines. (DeFilipp Z, Ciurea SO, Cutler C, Robin M, Warlick ED, Nakamura R, Brunner AM, Dholaria B, Walker AR, Kröger N, Bejanyan N, Atallah E, Tamari R, Solh MM, Percival ME, de Lima M, Scott B, Oran B, Garcia-Manero G, Hamadani M, Carpenter P, DeZern AE) Transplant Cell Ther 2023 Feb;29(2):71-81 30 Citations |
| 1 | Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research. (Schoettler ML, Carreras E, Cho B, Dandoy CE, Ho VT, Jodele S, Moissev I, Sanchez-Ortega I, Srivastava A, Atsuta Y, Carpenter P, Koreth J, Kroger N, Ljungman P, Page K, Popat U, Shaw BE, Sureda A, Soiffer R, Vasu S) Transplant Cell Ther 2023 Mar;29(3):151-163 64 Citations |
| 1 | Re: MRI-guided Focused Ultrasound Focal Therapy for Patients with Intermediate-risk Prostate Cancer: A Phase 2b, Multicentre Study (Hall WA, Shoag J, Spratt DE) European Urology December 2022;82(6):661-662 2 Citations |
| 3 | A case series of triplet anti-hormonal therapy in androgen receptor-positive recurrent adult ovarian granulosa cell tumor (Summey RM, Rader JS, Moh M, Bradley W, Uyar D, Bishop E, McAlarnen L, Hopp E) Gynecologic Oncology Reports December 2022;44 4 Citations |
| 1 | CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope (Karn V, Sandhya S, Hsu W, Parashar D, Singh HN, Jha NK, Gupta S, Dubey NK, Kumar S) Cancer Cell International December 2022;22(1) 40 Citations |
| 2 | Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX Plus Radiotherapy in Patients With Borderline Resectable Pancreatic Cancer-The A021501 Trial. (Hall WA, Evans DB, Tsai S) JAMA Oncol 2023 Feb 01;9(2):275-276 2 Citations |
| 1 | Magnetic Resonance-Guided Adaptive Radiation Therapy for Prostate Cancer: The First Results from the MOMENTUM study-An International Registry for the Evidence-Based Introduction of Magnetic Resonance-Guided Adaptive Radiation Therapy. (Teunissen FR, Willigenburg T, Tree AC, Hall WA, Choi SL, Choudhury A, Christodouleas JP, de Boer JCJ, de Groot-van Breugel EN, Kerkmeijer LGW, Pos FJ, Schytte T, Vesprini D, Verkooijen HM, van der Voort van Zyp JRN) Pract Radiat Oncol 2023;13(3):e261-e269 22 Citations |
| 3 | Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy. (Khan HY, Kamgar M, Aboukameel A, Bannoura S, Chung BY, Li Y, Hallak MNA, Philip PA, Tsai S, Luther S, Hall WA, Azmi AS) Adv Radiat Oncol 2023;8(1):101122 9 Citations |
| 1 | Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy. (Bevins NJ, Okamura R, Montesion M, Adashek JJ, Goodman AM, Kurzrock R) J Immunother Precis Oncol 2022 Nov;5(4):90-97 17 Citations |
| 1 | Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN Trials. (Chhabra S, Callander N, Watts NL, Costa LJ, Thapa B, Kaufman JL, Laubach J, Sborov DW, Reeves B, Rodriguez C, Chari A, Silbermann R, Anderson LD Jr, Bal S, Dhakal B, Nathwani N, Shah N, Medvedova E, Bumma N, Holstein SA, Costello C, Jakubowiak A, Wildes TM, Schmidt T, Orlowski RZ, Shain KH, Cowan AJ, Dholaria B, Cornell RF, Jerkins JH, Pei H, Cortoos A, Patel S, Lin TS, Usmani SZ, Richardson PG, Voorhees PM) Transplant Cell Ther 2023 Mar;29(3):174.e1-174.e10 37 Citations |
| 1 | Association between Serum Biomarkers with Postoperative Complications and Delay of Adjuvant Chemotherapy Initiation in Ovarian Cancer Patients Undergoing Primary Cytoreductive Surgery: A Pilot Study. (Ade CJ, Dockery L, Walter AC, Benbrook DM, Vesely SK, Hammond ST, Moore KN, Holman LL) Nutr Cancer 2023;75(2):662-669 1 Citation |
| 1 | Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy. (Perl AE, Larson RA, Podoltsev NA, Strickland S, Wang ES, Atallah E, Schiller GJ, Martinelli G, Neubauer A, Sierra J, Montesinos P, Recher C, Yoon SS, Maeda Y, Hosono N, Onozawa M, Kato T, Kim HJ, Hasabou N, Nuthethi R, Tiu R, Levis MJ) Transplant Cell Ther 2023 Apr;29(4):265.e1-265.e10 26 Citations |
| 1 | Stem cell therapy: a novel approach against emerging and re-emerging viral infections with special reference to SARS-CoV-2. (Khandelwal V, Sharma T, Gupta S, Singh S, Sharma MK, Parashar D, Kashyap VK) Mol Biol Rep 2023 Mar;50(3):2663-2683 4 Citations |
| 2 | Magnetic resonance imaging-guided laser interstitial thermal therapy for complete corpus callosotomy: technique and 1-year outcomes. Patient series. (Best BJ, Kim I, Lew SM) J Neurosurg Case Lessons 2022 Dec 19;4(25) 3 Citations |
| 1 | Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors. (Khan SM, Desai R, Coxon A, Livingstone A, Dunn GP, Petti A, Johanns TM) J Immunother Cancer 2022 Dec;10(12) 18 Citations |
| 1 | Exercise "CALM" and make CAR-T therapy work better. (Mei H, Hari P, Hu Y) Sci Bull (Beijing) 2022 Oct 15;67(19):1925-1928 4 Citations |
| 1 | Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia. (Badar T, Litzow MR, Shallis RM, Patel A, Saliba AN, Burkart M, Bewersdorf JP, Stahl M, De Camargo Correia GS, Guru Murthy GS, Abaza Y, Duvall A, Bradshaw D, Kota V, Dinner S, Goldberg AD, Palmisiano N, Al Kali A, Atallah E) Cancer 2023 Mar 15;129(6):934-945 3 Citations |
| 4 | Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy. (Al Hadidi S, Szabo A, Esselmann J, Hammons L, Hussain M, Ogunsesan Y, Thalambedu N, Khan F, Sethi J, Janardan A, Radhakrishnan SV, Thanendrarajan S, Schinke C, Dhakal B, Janz S, Chhabra S, D'Souza A, Zangari M, van Rhee F, Mohan M) Bone Marrow Transplant 2023 Apr;58(4):443-445 15 Citations |
| 7 | Case report: Fractional brain tumor burden magnetic resonance mapping to assess response to pulsed low-dose-rate radiotherapy in newly-diagnosed glioblastoma. (Amidon RF, Santos-Pinheiro F, Straza M, Prah MA, Mueller WM, Krucoff MO, Connelly JM, Kleefisch CJ, Coss DJ, Cochran EJ, Bovi JA, Schultz CJ, Schmainda KM) Front Oncol 2022;12:1066191 3 Citations |
| 1 | Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer. (Schweizer MT, Gulati R, Yezefski T, Cheng HH, Mostaghel E, Haffner MC, Patel RA, De Sarkar N, Ha G, Dumpit R, Woo B, Lin A, Panlasigui P, McDonald N, Lai M, Nega K, Hammond J, Grivas P, Hsieh A, Montgomery B, Nelson PS, Yu EY) Prostate Cancer Prostatic Dis 2023 Mar;26(1):194-200 12 Citations |
| 1 | Longitudinal Sedentary Time and Symptoms in Breast Cancer Patients during Chemotherapy Using Ecological Momentary Assessment. (Welch WA, Solk P, Auster-Gussman L, Whitaker M, Siddique J, Fanning J, Mishory A, Khan S, Santa-Maria C, Kulkarni S, Phillips SM) Med Sci Sports Exerc 2023 May 01;55(5):966-974 4 Citations |
| 4 | A case series of triplet anti-hormonal therapy in androgen receptor-positive recurrent adult ovarian granulosa cell tumor. (Summey RM, Rader JS, Moh M, Bradley W, Uyar D, Bishop E, McAlarnen L, Hopp E) Gynecol Oncol Rep 2022 Dec;44:101118 4 Citations |
| 1 | Therapy for patients with chronic phase-chronic myeloid leukemia previously treated with ⩾2 tyrosine kinase inhibitors: a systematic literature review (Atallah E, Saini L, Maegawa R, Rajput T, Corbin R, Viana R) Therapeutic Advances in Hematology January-December 2023;14 |
| 1 | Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation? (Alaklabi S, Roy AM, Chaudhary LN, Gandhi S) Exploration of Targeted Anti-tumor Therapy 2023;4(6):1301-1309 |
| 1 | Germline genomics in radiotherapy (Rosenstein BS, West C, Kerns S, Barnett G, Zuhour R) Machine Learning and Artificial Intelligence in Radiation Oncology: A Guide for Clinicians 1 January 2023:197-215 |
| 1 | Benchmarking quality of life to posttraumatic stress disorder symptom changes in cognitive processing therapy (Hamrick L, Larsen SE, Sippel LM, Sherman K, Resick P, Galovski T) Journal of Anxiety Disorders January 2023;93 5 Citations |
| 1 | Outcomes of Antineoplastic Immunotherapy at a Large Healthcare Organization: Impact of Provider, Race and Socioeconomic Status (Mirsky MM, Mitchell C, Hong A, Cao S, Fu P, Margevicius S, Wu S, Dowlati A, Nelson A, Eva Selfridge J, Ramaiya N, Hoimes C, Alahmadi A, Bruno DS) Cancer Management and Research 2023;15:913-927 4 Citations |
| 2 | Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy (Khan HY, Kamgar M, Aboukameel A, Bannoura S, Chung BY, Li Y, Hallak MNA, Philip PA, Tsai S, Luther S, Hall WA, Azmi AS) Advances in Radiation Oncology 1 January 2023;8(1) 9 Citations |
| 1 | Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials. (Nguyen PL, Huang HR, Spratt DE, Davicioni E, Sandler HM, Shipley WU, Efstathiou JA, Simko JP, Pollack A, Dicker AP, Roach M, Rosenthal SA, Zeitzer KL, Mendez LC, Hartford AC, Hall WA, Desai AB, Rabinovitch RA, Peters CA, Rodgers JP, Tran P, Feng FY) Int J Radiat Oncol Biol Phys 2023 Jul 01;116(3):521-529 24 Citations |
| 2 | Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study. (Schmid MP, Lindegaard JC, Mahantshetty U, Tanderup K, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza A, Hoskin P, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Petric P, Ramazanova D, Ristl R, Kannan S, Hawaldar R, Ecker S, Kirchheiner K, Tan LT, Nout R, Nesvacil N, de Leeuw A, Pötter R, Kirisits C, EMBRACE Collaborative Group) J Clin Oncol 2023 Apr 01;41(10):1933-1942 31 Citations |
| 1 | Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study. (Chesney J, Lewis KD, Kluger H, Hamid O, Whitman E, Thomas S, Wermke M, Cusnir M, Domingo-Musibay E, Phan GQ, Kirkwood JM, Hassel JC, Orloff M, Larkin J, Weber J, Furness AJS, Khushalani NI, Medina T, Egger ME, Graf Finckenstein F, Jagasia M, Hari P, Sulur G, Shi W, Wu X, Sarnaik A) J Immunother Cancer 2022 Dec;10(12) 141 Citations |
| 1 | Stereotactic Body Radiation Therapy for Nodal Metastases in Gynecologic Cancers: Is it the Swan Song or the Opening Number? (Hathout L, Fields EC, Erickson BA) Int J Radiat Oncol Biol Phys 2023 Feb 01;115(2):297-301 1 Citation |
| 1 | Personalized matched targeted therapy in advanced pancreatic cancer: a pilot cohort analysis. (Shaya J, Kato S, Adashek JJ, Patel H, Fanta PT, Botta GP, Sicklick JK, Kurzrock R) NPJ Genom Med 2023 Jan 20;8(1):1 20 Citations |
| 1 | Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-Analysis. (Shahzad M, Hussain A, Tariq E, Anwar I, Faisal MS, Syed L, Karam A, Chaudhary SG, Ahmed N, Bansal R, Khurana S, Singh AK, Byrd KP, Hematti P, Abhyankar SH, McGuirk JP, Mushtaq MU) Clin Lymphoma Myeloma Leuk 2023 Mar;23(3):178-187 6 Citations |
| 2 | SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report. (McNerney KO, Richards RM, Aguayo-Hiraldo P, Calkoen FG, Talano JA, Moskop A, Balduzzi A, Krajewski J, Dave H, Vatsayan A, Callahan C, Liu H, Li Y, Davis KL, Maude SL) J Immunother Cancer 2023 Jan;11(1) 11 Citations |
| 1 | Two for two: Dual therapy with erlotinib and acitretin for twins with severe keratoderma in Olmsted syndrome. (Butala S, Phan S, Siegel DH, Carlberg V, Paller AS) Pediatr Dermatol 2023;40(4):735-737 4 Citations |
| 1 | Paving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions to Improving Efficiency of Clinical Center Certification and Maintenance of Operations for Commercially Approved Immune Effector Cell Therapies. (Nikiforow S, Frigault MJ, Frey NV, Gardner RA, Komanduri KV, Perales MA, Kebriaei P, Warkentin PI, Pasquini M, Aho JL, Levine BL, Heslop HE, Hlucky TL, Habucky K, Gharibo M, Jagasia M, Locke FL) Transplant Cell Ther 2023 Apr;29(4):228-239 14 Citations |
| 1 | Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial. (Mell LK, Pugh SL, Jones CU, Nelson TJ, Zakeri K, Rose BS, Zeitzer KL, Gore EM, Bahary JP, Souhami L, Michalski JM, Hartford AC, Mishra MV, Roach M 3rd, Parliament MB, Choi KN, Pisansky TM, Husain SM, Malone SC, Horwitz EM, Feng F) Eur Urol 2024 Apr;85(4):373-381 5 Citations |
| 1 | Urine biomarker score captures response to induction therapy with lupus nephritis. (Cody EM, Wenderfer SE, Sullivan KE, Kim AHJ, Figg W, Ghumman H, Qiu T, Huang B, Devarajan P, Brunner HI) Pediatr Nephrol 2023 Aug;38(8):2679-2688 6 Citations |
| 2 | Deep learning based automatic contour refinement for inaccurate auto-segmentation in MR-guided adaptive radiotherapy. (Ding J, Zhang Y, Amjad A, Sarosiek C, Dang NP, Zarenia M, Li XA) Phys Med Biol 2023 Feb 20;68(5) 6 Citations |
| 2 | Seizure Occurring During Baclofen Monotherapy for Phenibut Withdrawal. (Patt A, Fox H, Wells L, Theobald J, Feldman R) Clin Neuropharmacol 2023 Mar-Apr 01;46(2):79-81 5 Citations |
| 1 | A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma. (Shouse G, Kaempf A, Gordon MJ, Artz A, Yashar D, Sigmund AM, Smilnak G, Bair SM, Mian A, Fitzgerald LA, Bajwa A, Jaglowski S, Bailey N, Shadman M, Patel K, Stephens DM, Kamdar M, Hill BT, Gauthier J, Karmali R, Nastoupil LJ, Kittai AS, Danilov AV) Blood Adv 2023 Jul 25;7(14):3516-3529 29 Citations |
| 1 | Effects of 20% albumin infusion therapy during liver transplantation on plasma neutrophil gelatinase-associated lipocalin level: A randomized controlled trial. (Kim D, Kim J, Han S, Jung H, Park HD, Ko JS, Gwak MS, Kim GS) Liver Transpl 2023 Aug 01;29(8):861-870 7 Citations |
| 1 | Images in Immunotherapy and Precision Oncology: Angiosarcoma of the Spleen and Liver. (Deshpande A, Munoz J, Kelemen K, Dabak V, Hanbali A, Kurzrock R) J Immunother Precis Oncol 2023 Feb;6(1):56-58 2 Citations |
| 1 | Empagliflozin in Adults with Chronic Kidney Disease (CKD): Current Evidence and Place in Therapy. (Colbert GB, Madariaga HM, Gaddy A, Elrggal ME, Lerma EV) Ther Clin Risk Manag 2023;19:133-142 4 Citations |
| 1 | Responsiveness to Vasoconstrictor Therapy in Hepatorenal Syndrome Type 1. (Velez JCQ, Karakala N, Tayebi K, Wickman TJ, Mohamed MMB, Kovacic RA, Therapondos G, Kanduri SR, Allegretti AS, Belcher JM, Regner KR, Wentowski C) Kidney360 2023 Apr 01;4(4):e448-e456 10 Citations |
| 3 | Access to Radiation Therapy and Related Clinical Outcomes in Patients With Cervical and Breast Cancer Across Sub-Saharan Africa: A Systematic Review. (Beltrán Ponce SE, Abunike SA, Bikomeye JC, Sieracki R, Niyonzima N, Mulamira P, Kibudde S, Ortiz de Choudens S, Siker M, Small C, Beyer KMM) JCO Glob Oncol 2023 Feb;9:e2200218 9 Citations |
| 3 | Perceptions of Transgender and Nonbinary Persons Toward Breast and Cervical Cancer Development, Screening, and Potential Impact on Gender-Affirming Hormone Therapy. (Roznovjak D, Petroll AE, Lakatos AEB, Narayan R, Cortina CS) JCO Oncol Pract 2023 May;19(5):e794-e800 24 Citations |
| 1 | TCR-engineered adoptive cell therapy effectively treats intracranial murine glioblastoma. (Schaettler MO, Desai R, Wang AZ, Livingstone AJ, Kobayashi DK, Coxon AT, Bowman-Kirigin JA, Liu CJ, Li M, Bender DE, White MJ, Kranz DM, Johanns TM, Dunn GP) J Immunother Cancer 2023 Feb;11(2) 6 Citations |
| 1 | Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). (Badar T, Atallah E, Shallis R, Saliba AN, Patel A, Bewersdorf JP, Grenet J, Stahl M, Duvall A, Burkart M, Palmisiano N, Bradshaw D, Kubiak M, Dinner S, Goldberg AD, Abaza Y, Murthy GSG, Kota V, Litzow MR) Leukemia 2023 Apr;37(4):799-806 30 Citations |
| 1 | Persistent hematopoietic polyclonality after lentivirus-mediated gene therapy for Fabry disease. (Saleh AH, Rothe M, Barber DL, McKillop WM, Fraser G, Morel CF, Schambach A, Auray-Blais C, West ML, Khan A, Fowler DH, Rupar CA, Foley R, Medin JA, Keating A) Mol Ther Methods Clin Dev 2023 Mar 09;28:262-271 9 Citations |
| 1 | Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023. (Joshi M, Tuanquin L, Zhu J, Walter V, Schell T, Kaag M, Kilari D, Liao J, Holder SL, Emamekhoo H, Sankin A, Merrill S, Zheng H, Warrick J, Hauke R, Gartrel B, Stein M, Drabick J, Degraff DJ, Zakharia Y) J Immunother Cancer 2023 Feb;11(2) 16 Citations |
| 1 | Cancer immunity marker RNA expression levels across gynecologic cancers: Implications for immunotherapy. (Jou J, Kato S, Miyashita H, Thangathurai K, Pabla S, DePietro P, Nesline M, Conroy J, Rubin E, Eskander R, Kurzrock R) Res Sq 2023 Feb 16 |
| 1 | Corrigendum to "Gene therapy for Fabry disease: Progress, challenges, and outlooks on gene-editing" [2021 Sep-Oct;134(1-2):117-131]. (Domm JM, Wootton SK, Medin JA, West ML) Mol Genet Metab 2023 May;139(1):107541 1 Citation |
| 1 | Modeling normal bladder injury after radiation therapy. (Kerns SL, Williams JP, Marples B) Int J Radiat Biol 2023;99(7):1046-1054 1 Citation |
| 1 | Evolution of the Targeted Therapy Landscape for Cholangiocarcinoma: Is Cholangiocarcinoma the ‘NSCLC’ of GI Oncology? (Gupta A, Kurzrock R, Adashek JJ) Cancers March 2023;15(5) 14 Citations |
| 8 | Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy. (Gutkin PM, Gore E, Charlson J, Neilson JC, Johnstone C, King DM, Hackbarth DA, Wooldridge A, Mannem R, Bedi M) Radiat Oncol 2023 Mar 01;18(1):42 6 Citations |
| 3 | Magnetic resonance imaging-guided stereotactic laser ablation therapy for the treatment of pediatric epilepsy: a retrospective multiinstitutional study. (Arocho-Quinones EV, Lew SM, Handler MH, Tovar-Spinoza Z, Smyth MD, Bollo RJ, Donahue D, Perry MS, Levy M, Gonda D, Mangano FT, Kennedy BC, Storm PB, Price AV, Couture DE, Oluigbo C, Duhaime AC, Barnett GH, Muh CR, Sather MD, Fallah A, Wang AC, Bhatia S, Eastwood D, Tarima S, Graber S, Huckins S, Hafez D, Rumalla K, Bailey L, Shandley S, Roach A, Alexander E, Jenkins W, Tsering D, Price G, Meola A, Evanoff W, Thompson EM, Brandmeir N, Pediatric Stereotactic Laser Ablation Workgroup) J Neurosurg Pediatr 2023 Mar 03:1-14 8 Citations |
| 2 | Real-time motion monitoring using orthogonal cine MRI during MR-guided adaptive radiation therapy for abdominal tumors on 1.5T MR-Linac. (Jassar H, Tai A, Chen X, Keiper TD, Paulson E, Lathuilière F, Bériault S, Hébert F, Savard L, Cooper DT, Cloake S, Li XA) Med Phys 2023 May;50(5):3103-3116 25 Citations |
| 1 | Point of Care Ultrasonography to Monitor Decongestive Therapy in Heart Failure: Seeing is Believing. (Koratala A) POCUS J 2022;7(Kidney):14-16 |
| 1 | Evolution of the Targeted Therapy Landscape for Cholangiocarcinoma: Is Cholangiocarcinoma the 'NSCLC' of GI Oncology? (Gupta A, Kurzrock R, Adashek JJ) Cancers (Basel) 2023 Mar 03;15(5) 14 Citations |
| 2 | Commentary: "Multimodality advanced cardiovascular and molecular imaging for early detection and monitoring of cancer therapy-associated cardiotoxicity and the role of artificial intelligence and big data". (Sun LY, Echefu G, Doshi K, Roberts ML, Hamid A, Cheng RK, Olson J, Brown SA) Front Cardiovasc Med 2023;10:982028 2 Citations |
| 1 | Chemotherapy-induced peripheral neuropathy in the detroit research on cancer survivors (ROCS) cohort. (Sreeram K, Seaton R, Greenwald MK, Kamgar M, Assad H, Baird T, Schwartz AG, Ruterbusch J, Simon MS) Cancer Causes Control 2023 May;34(5):459-468 4 Citations |
| 1 | Is External Beam Radiation Therapy Really Associated With Low Rates of Heterotopic Ossification After Acetabular Surgery? (Boissonneault A, Harkin E, Slobogean G, Gupta J, Benzel C, O'Hara N, O'Toole RV) J Orthop Trauma 2023 Aug 01;37(8):382-385 1 Citation |
| 3 | Symptom change prior to treatment discontinuation (dropout) from a naturalistic Veterans Affairs evidence-based psychotherapy clinic for PTSD and depression. (Larsen SE, Hamrick LA, Thomas KB, Hessinger JD, Melka SE, Khaled M, Hove MC, Maieritsch K) Psychol Serv 2023 Nov;20(4):831-838 4 Citations |
| 9 | Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity. (Thalji SZ, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Chisholm P, Kulkarni N, Doucette S, Evans DB, Tsai S) J Surg Oncol 2023 Jul;128(1):41-50 3 Citations |
| 1 | Singla S, Putman M, Liew J, Gordon K: Association between biologic immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study. Lancet Rheumatol, 2023 doi: 10.1016/S2665-9913(23)00034-6
Pedersen C, Tai S, Valley E, Henry K, Duarte-García A, Singla S, Putman M. Unpublished clinical trials of common rheumatic diseases. Rheumatology (Oxford). 2023 Mar 27:kead141. doi: 10.1093/rheumatology/kead141. Epub ahead of print. PMID: 36971599.
Singla S, Putman M, Liew J, Gordon K. Differentiating biologics to prevent psoriatic arthritis in patients with psoriasis – Authors' reply, Lancet Rheumatol, 2023, Page e313. ISSN 2665-9913. doi: 10.1016/S2665-9913(23)00124-8.
() |
| 1 | On the correction of respiratory motion-induced image reconstruction errors in positron-emission tomography-guided radiation therapy. (Zhong H, Ren L, Lu Y, Liu Y) Phys Imaging Radiat Oncol 2023 Apr;26:100430 2 Citations |
| 1 | Bridging the Gap: Early Transition and Hybrid Models of Care to Improve Access to Chimeric Antigen Receptor T Cell Therapy. (Ahmed N, Mahmoudjafari Z, Hamadani M, Hashmi H) Transplant Cell Ther 2023 Jun;29(6):399-402 4 Citations |
| 1 | Radiation Therapy at the End of-Life: Quality of Life and Financial Toxicity Considerations. (Yerramilli D, Johnstone CA) Semin Radiat Oncol 2023 Apr;33(2):203-210 3 Citations |
| 1 | Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer. (Semenkovich NP, Samson PP, Badiyan SN, Vlacich G, Stowe HB, Wang YE, Star R, Devarakonda S, Govindan R, Waqar SN, Robinson CG, Pellini B, Chaudhuri AA) Res Sq 2023 Mar 22 |
| 1 | Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer. (Traphagen NA, Schwartz GN, Tau S, Jiang A, Hosford SR, Goen AE, Roberts AM, Romo BA, Johnson AL, Duffy EK, Demidenko E, Heverly P, Mosesson Y, Soucy SM, Kolling F, Miller TW) bioRxiv 2023 Mar 17 |
| 1 | Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials. (Wang D, Harris J, Kraybill WG, Eisenberg B, Kirsch DG, Ettinger DS, Kane JM 3rd, Barry PN, Naghavi A, Freeman CR, Chen YL, Hitchcock YJ, Bedi M, Salerno KE, Severin D, Godette KD, Larrier NA, Curran WJ Jr, Torres-Saavedra PA, Lucas DR) JAMA Oncol 2023 May 01;9(5):646-655 24 Citations |
| 2 | On the correction of respiratory motion-induced image reconstruction errors in positron-emission tomography-guided radiation therapy (Zhong H, Ren L, Lu Y, Liu Y) Physics and Imaging in Radiation Oncology April 2023;26 2 Citations |
| 3 | Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistance. (Gao X, Wu Y, Chick JM, Abbott A, Jiang B, Wang DJ, Comte-Walters S, Johnson RH, Oberholtzer N, Nishimura MI, Gygi SP, Mehta A, Guttridge DC, Ball L, Mehrotra S, Sicinski P, Yu XZ, Wang H) Cell Rep 2023 Apr 25;42(4):112314 2 Citations |
| 3 | Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study (Singla S, Putman M, Liew J, Gordon K) The Lancet Rheumatology April 2023;5(4):e200-e207 52 Citations |
| 3 | Preoperative n-BCA embolization in the resection of submandibular lymphatic malformations refractory to sclerotherapy treatment: A pilot case series. (Shum A, Beydoun AS, Khalifee E, Carlberg V, Plunk M, Chun R) Int J Pediatr Otorhinolaryngol 2023 May;168:111510 |
| 1 | The Confusion Surrounding Androgen Deprivation Therapy and Cognitive Dysfunction. (Pierro MJ, Kilari D) Eur Urol Focus 2023 May;9(3):409-410 1 Citation |
| 1 | Optimizing Respiratory Therapy Resources by De-Implementing Low-Value Care. (Fleming K, George JL, Bazelak SJ, Roeske JA, Biggs AD, Landry CM, Lipchik RJ, Truwit JD) Respir Care 2023 May;68(5):559-564 8 Citations |
| 2 | Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma. (Bumma N, Dhakal B, Fraser R, Estrada-Merly N, Anderson K, Freytes CO, Hildebrandt GC, Holmberg L, Krem MM, Lee C, Lekakis L, Lazarus HM, Mian H, Murthy HS, Nathan S, Nishihori T, Parrondo R, Patel SS, Solh M, Strouse C, Vesole DH, Kumar S, Qazilbash MH, Shah N, D'Souza A, Sidana S) Cancer 2023 Jul 15;129(14):2179-2191 3 Citations |
| 2 | Protracted viral infections in patients with multiple myeloma receiving bispecific T-cell engager therapy targeting B-cell maturation antigen. (Palmen B, Hari P, D'Souza A, Abid MB) Haematologica 2023 Nov 01;108(11):3186-3190 6 Citations |
| 1 | Patient-specific synthetic magnetic resonance imaging generation from cone beam computed tomography for image guidance in liver stereotactic body radiation therapy. (Zhang Z, Jiang Z, Zhong H, Lu K, Yin FF, Ren L) Precis Radiat Oncol 2022 Jun;6(2):110-118 8 Citations |
| 8 | Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy. (Chaudhary LN, Jorns J, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo M, Kong A, Patten C, Yen T, Cortina C, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I, Weil E, Chitambar CR, Rui H) Res Sq 2023 Apr 07 |
| 1 | Late gene therapy limits the restoration of retinal function in a mouse model of retinitis pigmentosa. (Scalabrino ML, Thapa M, Wang T, Sampath AP, Chen J, Field GD) bioRxiv 2023 Apr 08 |
| 11 | Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic Cancer. (Thalji SZ, Fernando D, Dua KS, Madhavan S, Chisholm P, Smith ZL, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Evans DB, Tsai S) Ann Surg 2023 Dec 01;278(6):e1224-e1231 3 Citations |
| 1 | Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials. (Hallemeier CL, Moughan J, Haddock MG, Herskovic AM, Minsky BD, Suntharalingam M, Zeitzer KL, Garg MK, Greenwald BD, Komaki RU, Puckett LL, Kim H, Lloyd S, Bush DA, Kim HE, Lad TE, Meyer JE, Okawara GS, Raben A, Schefter TE, Barker JL Jr, Falkson CI, Videtic GMM, Jacob R, Winter KA, Crane CH) JAMA Netw Open 2023 Apr 03;6(4):e238504 4 Citations |
| 1 | How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy? (Juckett M, Dandoy C, DeFilipp Z, Kindwall-Keller TL, Spellman SR, Ustun C, Waldman BM, Weisdorf DJ, Wood WA, Horowitz MM, Burns LJ, Khera N) Blood Rev 2023 Jul;60:101079 3 Citations |
| 1 | Durable remission of thrombotic thrombocytopenic purpura in the setting of pembrolizumab therapy. (Kozak M, Rubenstein W, Okwan-Duodu D, Friedman K, Nassir Y, Perez-Alvarez I, Gibb DR, Klapper E, Pepkowitz S) Transfusion 2023 Jun;63(6):1241-1245 2 Citations |
| 1 | Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L. (LaFargue CJ, Amero P, Noh K, Mangala LS, Wen Y, Bayraktar E, Umamaheswaran S, Stur E, Dasari SK, Ivan C, Pradeep S, Yoo W, Lu C, Jennings NB, Vathipadiekal V, Hu W, Chelariu-Raicu A, Ku Z, Deng H, Xiong W, Choi HJ, Hu M, Kiyama T, Mao CA, Ali-Fehmi R, Birrer MJ, Liu J, Zhang N, Lopez-Berestein G, de Franciscis V, An Z, Sood AK) Nat Commun 2023 Apr 26;14(1):2407 19 Citations |
| 1 | Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial. (Movsas B, Rodgers JP, Elshaikh MA, Martinez AA, Morton GC, Krauss DJ, Yan D, Citrin DE, Hershatter BW, Michalski JM, Ellis RJ, Kavadi VS, Gore EM, Gustafson GS, Schulz CA, Velker VM, Olson AC, Cury FL, Papagikos MA, Karrison TG, Sandler HM, Bruner DW) J Clin Oncol 2023 Jun 10;41(17):3217-3224 9 Citations |
| 1 | Radiation Therapy Use in Refractory and Relapsed Adolescent and Young Adult Hodgkin Lymphoma: A Report from the Children's Oncology Group. (Mailhot Vega RB, Harker-Murray PD, Forlenza CJ, Cole P, Kelly KM, Milgrom SA, Parikh RR, Hodgson DC, Castellino SM, Kahn J, Roberts KB, Constine LS, Hoppe BS) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2):400-403 2 Citations |
| 1 | Chemotherapy-induced peripheral neuropathy in the detroit research on cancer survivors (ROCS) cohort (Sreeram K, Seaton R, Greenwald MK, Kamgar M, Assad H, Baird T, Schwartz AG, Ruterbusch J, Simon MS) Cancer Causes and Control May 2023;34(5):459-468 4 Citations |
| 1 | Carfilzomib-based antibody mediated rejection therapy in pediatric kidney transplant recipients. (Cody EM, Varnell C Jr, Lazear D, VandenHeuvel K, Flores FX, Woodle ES, Hooper DK) Pediatr Transplant 2023 Nov;27(7):e14534 1 Citation |
| 2 | Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells. (Fraunhoffer NA, Moreno Vega AI, Abuelafia AM, Morvan M, Lebarbier E, Mary-Huard T, Zimmermann MT, Lomberk G, Urrutia R, Dusetti N, Blum Y, Nicolle R, Iovanna J) EBioMedicine 2023 Jun;92:104602 3 Citations |
| 7 | Increased CXCL10 is seen at 1-year after autologous hematopoietic cell transplantation in multiple myeloma patients on maintenance lenalidomide therapy. (Mohan M, Janz S, Brazauskas R, Dwinell MB, Teng BQ, Yun G, Dong J, Pasquini MC, Giralt S, Landau H, Stadtmauer E, Krishnan A, D'Souza A) Bone Marrow Transplant 2023 Aug;58(8):953-955 |
| 6 | Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. (Conger RL, Mora J, Straza MW, Erickson BA, Lawton CAF, Schultz CJ, Currey A, Bedi M, Siker ML, Hall WA) Adv Radiat Oncol 2023;8(4):101206 2 Citations |
| 1 | Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study. (Epperla N, Welkie RL, Torka P, Shouse G, Karmali R, Shea L, Anampa-Guzmán A, Oh TS, Reaves H, Tavakkoli M, Lindsey K, Greenwell IB, Hansinger E, Thomas C, Chowdhury SM, Annunzio K, Christian B, Barta SK, Geethakumari PR, Bartlett NL, Herrera AF, Grover NS, Olszewski AJ) J Hematol Oncol 2023 May 08;16(1):49 9 Citations |
| 1 | Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis. (Shahzad M, Nguyen A, Hussain A, Ammad-Ud-Din M, Faisal MS, Tariq E, Ali F, Butt A, Anwar I, Chaudhary SG, Lutfi F, Ahmed N, Singh AK, Hematti P, McGuirk JP, Mushtaq MU) Front Immunol 2023;14:1152457 19 Citations |
| 1 | Adjunctive Dietary Therapy Is Associated With Improved Gastrointestinal Symptoms in Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease: A Case Series. (Kaenkumchorn T, Suskind DL, Lee D, Singh N, Ford M, Skeen K, Macris PC, Yeung C, Summers C, Carpenter PA, Zheng HB) JPGN Rep 2022 May;3(2):e203 |
| 1 | From bugs to drugs: Bacterial 3-IAA enhances efficacy of chemotherapy in pancreatic cancer. (Seo YD, Wargo JA) Cell Rep Med 2023 May 16;4(5):101039 5 Citations |
| 1 | Barriers and facilitators to anti-retroviral therapy adherence among adolescents aged 10 to 19 years living with HIV in sub-Saharan Africa: A mixed-methods systematic review and meta-analysis. (Hlophe LD, Tamuzi JL, Shumba CS, Nyasulu PS) PLoS One 2023;18(5):e0276411 14 Citations |
| 1 | Sequential therapy with supercharged NK cells with either chemotherapy drug cisplatin or anti-PD-1 antibody decreases the tumor size and significantly enhances the NK function in Hu-BLT mice. (Kaur K, Chen PC, Ko MW, Mei A, Senjor E, Malarkannan S, Kos J, Jewett A) Front Immunol 2023;14:1132807 14 Citations |
| 1 | Use of Metformin and Survival in Patients with Hepatocellular Carcinoma (HCC) Undergoing Liver Directed Therapy: Analysis of a Nationwide Cancer Registry. (Mukherjee K, Elsayed M, Choksi E, Loya MF, Duszak R, Akce M, Majdalany BS, Bercu ZL, Cristescu M, Kokabi N) Cardiovasc Intervent Radiol 2023 Jul;46(7):870-879 1 Citation |
| 1 | CAR T-cell therapy has comparable efficacy with autologous transplantation in older adults with DLBCL in partial response. (Akhtar OS, Cao B, Wang X, Torka P, Al-Jumayli M, Locke FL, Freeman CL) Blood Adv 2023 Oct 10;7(19):5937-5940 3 Citations |
| 1 | Predicting the germline dependence of hematuria risk in prostate cancer radiotherapy patients. (Oh JH, Lee S, Thor M, Rosenstein BS, Tannenbaum A, Kerns S, Deasy JO) Radiother Oncol 2023 Aug;185:109723 3 Citations |
| 5 | GAP (gestational diabetes and pharmacotherapy) - study protocol for a randomized controlled, two-arm, single-site trial. (Palatnik A, Saffian E, Flynn KE, Pan AY, Yee LM, Basir MA, Cruz M) Contemp Clin Trials 2023 Aug;131:107237 1 Citation |
| 1 | A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development. (Dickinson MJ, Barba P, Jäger U, Shah NN, Blaise D, Briones J, Shune L, Boissel N, Bondanza A, Mariconti L, Marchal AL, Quinn DS, Yang J, Price A, Sohoni A, Treanor LM, Orlando EJ, Mataraza J, Davis J, Lu D, Zhu X, Engels B, Moutouh-de Parseval L, Brogdon JL, Moschetta M, Flinn IW) Cancer Discov 2023 Sep 06;13(9):1982-1997 70 Citations |
| 3 | Automated deep learning auto-segmentation of air volumes for MRI-guided online adaptive radiation therapy of abdominal tumors. (Ahunbay E, Parchur AK, Xu J, Thill D, Paulson ES, Li XA) Phys Med Biol 2023 Jun 15;68(12) 2 Citations |
| 3 | Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells (Fraunhoffer NA, Moreno Vega AI, Abuelafia AM, Morvan M, Lebarbier E, Mary-Huard T, Zimmermann M, Lomberk G, Urrutia R, Dusetti N, Blum Y, Nicolle R, Iovanna J) eBioMedicine June 2023;92 3 Citations |
| 2 | Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy. (Nakamura R, Patel BA, Kim S, Wong FL, Armenian SH, Groarke EM, Keesler DA, Hebert KM, Heim M, Eapen M, Young NS) Haematologica 2023 Dec 01;108(12):3298-3307 4 Citations |
| 1 | Phase 2 study of batiraxcept (AVB-S6-500, an AXL inhibitor) as monotherapy, in combination with cabozantinib (cabo), and in combination with cabo and nivolumab (nivo) in patients with advanced clear cell renal cell carcinoma (ccRCC). (Katy Beckermann, Matthew T Campbell, Naomi B. Haas, Moshe Chaim Ornstein, Xin Gao, Shifeng S. Mao, Hans J. Hammers, Saby George, Ariel Ann Nelson, Theodore Stewart Gourdin, Holavanahalli Keshava-Prasad, Arif Hussain, Christopher J. Hoimes, Hongxia Yan, Vanessa Esquibel, Gail McIntyre, Robert B. Geller, Martin H Voss, Brian I. Rini, Neil J. Shah) Journal of Clinical Oncology J Clin Oncol 41, 2023 (suppl 16; abstr 4534) |
| 1 | A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors. (Bauer TM, Moore KN, Rader JS, Simpkins F, Mita AC, Beck JT, Hart L, Chu Q, Oza A, Tinker AV, Imedio ER, Kumar S, Mugundu G, Jenkins S, Chmielecki J, Jones S, Spigel D, Fu S) Target Oncol 2023 Jul;18(4):517-530 17 Citations |
| 1 | Recommendations on prevention of infections during chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma. (Mohan M, Chakraborty R, Bal S, Nellore A, Baljevic M, D'Souza A, Pappas PG, Berdeja JG, Callander N, Costa LJ) Br J Haematol 2023 Dec;203(5):736-746 42 Citations |
| 2 | Validation of the AJCC 8th Edition Staging System for Disseminated Appendiceal Cancer Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-institutional Analysis. (SenthilKumar G, Kothari AN, Maduekwe UN, Fournier K, Abbott DE, Wilson GC, Patel SH, Greer J, Johnston F, Dineen SP, Powers BD, Baumgartner J, Veerapong J, Leiting J, Grotz TE, Maithel SK, Staley C, Raoof M, Lambert L, Lee A, Kim A, Cloyd JM, Mogal H) Ann Surg Oncol 2023 Sep;30(9):5743-5753 6 Citations |
| 1 | An Update on the Molecular and Cellular Basis of Pharmacotherapy in Type 2 Diabetes Mellitus. (Mahgoub MO, Ali II, Adeghate JO, Tekes K, Kalász H, Adeghate EA) Int J Mol Sci 2023 May 26;24(11) 25 Citations |
| 2 | Vaccines and use of immunosuppressive and immunomodulatory therapy in a pediatric dermatology clinic-A single institution experience. (Tran J, Trinh DL, Pan AY, Humphrey SR) Pediatr Dermatol 2023;40(4):644-646 |
| 1 | Modified bare-back micro-retrograde tibial arterial access to facilitate peripheral endovascular therapy. (Gani F, Jammeh ML, Zayed MA) J Vasc Surg Cases Innov Tech 2023 Sep;9(3):101204 |
| 3 | The Variation of Withdrawal of Life Sustaining Therapy in Older Adults With Traumatic Brain Injury. (Pokrzywa CJ, Al Tannir AH, Sparapani R, Rabas MS, Holena D, Murphy PB, Creutzfeldt CJ, Somberg L, Nattinger A, Morris RS) J Surg Res 2023 Nov;291:34-42 5 Citations |
| 1 | Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry. (Hayanga JWA, Song T, Durham L, Garrison L, Smith D, Molnar Z, Scheier J, Deliargyris EN, Moazami N) Crit Care 2023 Jun 19;27(1):243 14 Citations |
| 3 | A Paradigm Shift in Primary Liver Cancer Therapy Utilizing Genomics, Molecular Biomarkers, and Artificial Intelligence. (Moroney J, Trivella J, George B, White SB) Cancers (Basel) 2023 May 17;15(10) 2 Citations |
| 1 | Evaluation of potential cost savings through chemotherapy and biotherapy dose-rounding at a pediatric institution. (Graff JM, Cramer J, Kolb LL, Agherrabi Z, Burgess M) J Oncol Pharm Pract 2024 Jun;30(4):705-709 |
| 1 | Venetoclax-based Treatment as Frontline Therapy for Chronic Lymphocytic Leukemia. (Guru Murthy GS, Atallah E) Hematol Oncol Stem Cell Ther 2023 May 23;16(4):346-350 1 Citation |
| 1 | From support to therapy: rethinking the role of nutrition in acute graft-versus-host disease. (Limpert R, Pan P, Wang LS, Chen X) Front Immunol 2023;14:1192084 5 Citations |
| 1 | Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy. (Panian J, Saidian A, Hakimi K, Ajmera A, Anderson WJ, Barata P, Berg S, Signoretti S, Lee Chang S, D'Andrea V, George D, Dzimitrowicz H, El Zarif T, Emamekhoo H, Gross E, Kilari D, Lam E, Lashgari I, Psutka S, Rauterkus GP, Shabaik A, Thapa B, Wang L, Weise N, Yim K, Zhang T, Derweesh I, McKay RR) Oncologist 2024 Oct 03;29(10):870-877 4 Citations |
| 1 | Correlation between biomarkers and treatment outcomes in diverse cancers: a systematic review and meta-analysis of phase I and II immunotherapy clinical trials. (Fountzilas E, Vo HH, Mueller P, Kurzrock R, Tsimberidou AM) Eur J Cancer 2023 Aug;189:112927 9 Citations |
| 1 | Cell Therapy Informatics: Updates on the Integration of HCT/IEC Functionalities into an Electronic Medical Record System in the US to Promote Efficiency, Patient Safety, Research, and Data Interoperability. (Ho VT, Klumpp TR, Liang WH, Prestegaard M, Horwitz M, Hamilton BK, Page K, Jaglowski S, Huber J, Martinez C, Shenoy V, Chen A, Rizzo D) Transplant Cell Ther 2023 Sep;29(9):539-547 1 Citation |
| 1 | Diffuse Pigment Release in a Patient Undergoing Tumor-Infiltrating Lymphocyte Immunotherapy for Acral Malignant Melanoma (Kerley M, Piri N, Ramasubramanian A) Journal of Ophthalmic and Vision Research July 2023;18(3):339-341 |
| 2 | Risk of Hepatic Artery Complications After Liver Transplantation in Patients Who Received Pretransplant Transarterial Chemoembolization Therapy: A Single-Center Experience. (Selim M, Hohenwalter EJ, Rilling WS, Hong JC) Transplant Proc 2023 Sep;55(7):1631-1637 1 Citation |
| 4 | Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (Conger RL, Mora J, Straza MW, Erickson BA, Lawton CAF, Schultz CJ, Currey A, Bedi M, Siker ML, Hall WA) Advances in Radiation Oncology 1 July 2023;8(4) 2 Citations |
| 1 | How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy? (Juckett M, Dandoy C, DeFilipp Z, Kindwall-Keller TL, Spellman SR, Ustun C, Waldman BM, Weisdorf DJ, Wood WA, Horowitz MM, Burns LJ, Khera N) Blood Reviews July 2023;60 3 Citations |
| 1 | Development of an adaptive clinical web-based prediction tool for kidney replacement therapy in children with chronic kidney disease. (Ng DK, Matheson MB, Schwartz GJ, Wang FM, Mendley SR, Furth SL, Warady BA, CKiD investigators) Kidney Int 2023 Nov;104(5):985-994 6 Citations |
| 1 | Phase 2 study of batiraxcept (AVB-S6-500, an AXL inhibitor) as monotherapy, in combination with cabozantinib (cabo), and in combination with cabo and nivolumab (nivo) in patients with advanced clear cell renal cell carcinoma (ccRCC) (Katy Beckermann, Matthew T Campbell, Naomi B. Haas, Moshe Chaim Ornstein, Xin Gao, Shifeng S. Mao, Hans J. Hammers, Saby George, Ariel Ann Nelson, Theodore Stewart Gourdin, Holavanahalli Keshava-Prasad, Arif Hussain, Christopher J. Hoimes, Hongxia Yan, Vanessa Esquibel, Gail McIntyre, Robert B. Geller, Martin H Voss, Brian I. Rini, Neil J. Shah) J Clin Oncol J Clin Oncol 41, 2023 (suppl 16; abstr 4534) |
| 4 | Considerations for pharmacologic thromboprophylaxis following inpatient brachytherapy for gynecologic malignancies. (McAlarnen LA, Small C, Tostrud L, Pan AY, Erickson B, Bedi M, Bradley WH) Brachytherapy 2023;22(5):630-639 2 Citations |
| 1 | Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement. (Deivasigamani S, Kotamarti S, Rastinehad AR, Salas RS, de la Rosette JJMCH, Lepor H, Pinto P, Ahmed HU, Gill I, Klotz L, Taneja SS, Emberton M, Lawrentschuk N, Wysock J, Feller JF, Crouzet S, Kumar M P, Seguier D, Adams ES, Michael Z, Abreu A, Jack Tay K, Ward JF, Shinohara K, Katz AE, Villers A, Chin JL, Stricker PD, Baco E, Macek P, Ahmad AE, Chiu PKF, Crawford ED, Rogers CG, Futterer JJ, Rais-Bahrami S, Robertson CN, Hadaschik B, Marra G, Valerio M, Chong KT, Kasivisvanathan V, Tan WP, Lomas D, Walz J, Guimaraes GC, Mertziotis NI, Becher E, Finelli A, Kasraeian A, Lebastchi AH, Vora A, Rosen MA, Bakir B, Arcot R, Yee S, Netsch C, Meng X, de Reijke TM, Tan YG, Regusci S, Benjamin TGR, Olivares R, Noureldin M, Bianco FJ, Sivaraman A, Kim FJ, Given RW, Dason S, Sheetz TJ, Shoji S, Schulman A, Royce P, Shah TT, Scionti S, Salomon G, Laguna P, Tourinho-Barbosa R, Aminsharifi A, Cathelineau X, Gontero P, Stabile A, Grummet J, Ledbetter L, Graton M, Stephen Jones J, Polascik TJ, Focal Therapy Society) Eur Urol 2023 Dec;84(6):547-560 17 Citations |
| 2 | Updated Indications for Immune Effector Cell Therapy: 2023 Guidelines from the American Society for Transplantation and Cellular Therapy. (Kanate AS, Majhail N, DeFilipp Z, Dhakal B, Dholaria B, Hamilton B, Herrera AF, Inamoto Y, Jain T, Perales MA, Carpenter PA, Hamadani M) Transplant Cell Ther 2023 Oct;29(10):594-597 26 Citations |
| 1 | Helical TomoTherapy Total Lymphoid Irradiation and Hematopoietic Cell Transplantation for Kidney Transplant Tolerance in Rhesus Macaques. (Kaufman DB, Forrest LJ, Fechner J, Post J, Coonen J, Haynes LD, Haynes WJ, Christensen N, Zhong W, Little CJ, D'Alessandro A, Fernandez L, Brunner K, Jensen K, Burlingham WJ, Hematti P, Strober S) Transpl Int 2023;36:11279 1 Citation |
| 4 | Re-induction with venetoclax combinations or IDH inhibitors result in similar remission rates and lower treatment related morbidity among AML patients initially receiving intensive induction chemotherapy. (Taylor S, Murthy GSG, Runaas L, Michaelis LC, Carlson K, Atallah EL, Abedin SM) Leuk Res 2023 Sep;132:107348 1 Citation |
| 7 | Photoactivated HPPH-Liposomal therapy for the treatment of HPV-Negative head and neck cancer. (Zenga J, Awan M, Hadi Razeghi Kondelaji M, Hansen C, Shafiee S, Frei A, Foeckler J, Kuehn R, Bruening J, Massey B, Wong S, Joshi A, Himburg HA) Oral Oncol 2023 Sep;144:106487 2 Citations |
| 1 | Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer. (Traphagen NA, Schwartz GN, Tau S, Roberts AM, Jiang A, Hosford SR, Marotti JD, Goen AE, Romo BA, Johnson AL, Duffy EK, Demidenko E, Heverly P, Mosesson Y, Soucy SM, Kolling F, Miller TW) Clin Cancer Res 2023 Sep 15;29(18):3717-3728 8 Citations |
| 1 | Introduction to the Reports from the Insights in Pediatric CAR T-cell Immunotherapy: Recent Advances and Future Directions (INSPIRED) Symposium. (Schultz L, Jacoby E, Lamble AJ, Maude SL, McNerney KO, Moskop A, Myers RM, Pulsipher MA, Shah NN) Transplant Cell Ther 2023 Oct;29(10):592-593 1 Citation |
| 1 | Comparative In Silico Analysis of Ultra-Hypofractionated Intensity-Modulated Photon Radiotherapy (IMRT) Versus Intensity-Modulated Proton Therapy (IMPT) in the Pre-Operative Treatment of Retroperitoneal Sarcoma. (Gogineni E, Chen H, Istl AC, Johnston FM, Narang A, Deville C Jr) Cancers (Basel) 2023 Jul 04;15(13) |
| 1 | Can Immunotherapy Replace Radiation in Locally Advanced Endometrial Cancer?: Treatment for Advanced Endometrial Cancer. (Hathout L, Erickson B, Gehrig P, Harkenrider M, Klopp A, Small W Jr) Pract Radiat Oncol 2023;13(6):551-557 2 Citations |
| 1 | Kidney Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. (Poppe MM, Tai A, Li XA, Miften M, Olch A, Marks LB, Qureshi BM, Spunt SL, Shnorhavorian M, Nelson G, Ronckers C, Kalapurakal J, Marples B, Constine LS, Liu AK) Int J Radiat Oncol Biol Phys 2024 Jun 01;119(2):560-574 6 Citations |
| 12 | Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy. (Chaudhary LN, Jorns JM, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo MB, Kong AL, Patten C, Yen T, Cortina CS, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I, Weil E, Chitambar CR, Rui H) Breast Cancer Res Treat 2023 Oct;201(3):387-396 6 Citations |
| 6 | X-ray and MR Contrast Bearing Nanoparticles Enhance the Therapeutic Response of Image-Guided Radiation Therapy for Oral Cancer. (Sharma G, Razeghi Kondelaji MH, Sharma GP, Hansen C, Parchur AK, Shafiee S, Jagtap JM, Fish B, Bergom C, Paulson E, Hall WA, Himburg HA, Joshi A) Technol Cancer Res Treat 2023;22:15330338231189593 4 Citations |
| 1 | Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma. (Hall WA, Li J, You YN, Gollub MJ, Grajo JR, Rosen M, dePrisco G, Yothers G, Dorth JA, Rahma OE, Russell MM, Gross HM, Jacobs SA, Faller BA, George S, Al Baghdadi T, Haddock MG, Valicenti R, Hong TS, George TJ) J Clin Oncol 2023 Oct 10;41(29):4643-4651 16 Citations |
| 1 | Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study. (Yarur AJ, Bruss A, Moosreiner A, Beniwal-Patel P, Nunez L, Berens B, Colombel JF, Targan SR, Fox C, Melmed GY, Abreu MT, Deepak P) Gastroenterology 2023 Oct;165(4):963-975.e5 20 Citations |
| 1 | N-acetylcysteine as adjuvant therapy for hospitalized Covid-19 patients: A single-center prospective cohort study. (Afaghi S, Moghimi N, Malekpour Alamdari N, Rahimi FS, Irilouzadian R, Esmaeili Tarki F, Moghimi M, Besharat S, Salehi Omran H, Karimi A) Caspian J Intern Med 2023;14(3):543-552 2 Citations |
| 1 | Correlation between biomarkers and treatment outcomes in diverse cancers: a systematic review and meta-analysis of phase I and II immunotherapy clinical trials (Fountzilas E, Vo HH, Mueller P, Kurzrock R, Tsimberidou AM) European Journal of Cancer August 2023;189 9 Citations |
| 1 | Tumour mutational burden and survival with molecularly matched therapy. (de Bortoli T, Benary M, Horak P, Lamping M, Stintzing S, Tinhofer I, Leyvraz S, Schäfer R, Klauschen F, Keller U, Stenzinger A, Fröhling S, Kurzrock R, Keilholz U, Rieke DT, Jelas I) Eur J Cancer 2023 Sep;190:112925 4 Citations |
| 1 | T-cell priming transcriptomic markers: implications of immunome heterogeneity for precision immunotherapy. (Miyashita H, Kurzrock R, Bevins NJ, Thangathurai K, Lee S, Pabla S, Nesline M, Glenn ST, Conroy JM, DePietro P, Rubin E, Sicklick JK, Kato S) NPJ Genom Med 2023 Aug 08;8(1):19 10 Citations |
| 1 | Platelet-targeted gene therapy induces immune tolerance in hemophilia and beyond. (Kumar S, Schroeder JA, Shi Q) J Thromb Haemost 2024 Jan;22(1):23-34 4 Citations |
| 1 | Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter Analysis. (Hakimi K, Saidian A, Panian J, Barata P, Berg S, Chang SL, Saliby RM, Dzimitrowicz H, Emamekhoo H, Gross E, Kilari D, Lam E, Nguyen M, Meagher M, Wang L, Rauterkus GP, D'Andrea V, Yim K, Psutka S, Thapa B, Weise N, Zhang T, McKay RR, Derweesh IH) Clin Genitourin Cancer 2023 Dec;21(6):694-702 1 Citation |
| 1 | Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial. (Rees CA, Brousseau DC, Cohen DM, Villella A, Dampier C, Brown K, Campbell A, Chumpitazi CE, Airewele G, Chang T, Denton C, Ellison A, Thompson A, Ahmad F, Bakshi N, Coleman KD, Leibovich S, Leake D, Hatabah D, Wilkinson H, Robinson M, Casper TC, Vichinsky E, Morris CR, SCD Arginine Study Group and PECARN) Trials 2023 Aug 17;24(1):538 8 Citations |
| 1 | Role of IL-6 and IL-6 targeted therapy in systemic lupus erythematosus. (Nepal D, Gazeley D) Rheumatology (Oxford) 2023 Dec 01;62(12):3804-3810 13 Citations |
| 1 | Addressing fears of children with Williams syndrome: therapist and child behavior in the context of a novel play-and humor-infused exposure therapy approach. (Young BN, Mohanty E, Levine K, Klein-Tasman BP) Front Psychol 2023;14:1098449 4 Citations |
| 1 | Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma. (Steiner RE, Hwang SR, Khurana A, Habermann TM, Epperla N, Annunzio K, Allen PB, Baird K, Paulino D, Alderuccio JP, Lossos IS, David K, Evens AM, Pandya K, Bair SM, Kamdar M, Ba Aqeel S, Torka P, Lynch R, Smith S, Feng L, Noorani M, Ahmed S, Nair R, Vega F, Wu S, Fang P, Pinnix CC, Gunther JR, Dabaja BS, Lee HJ) Blood Adv 2023 Dec 26;7(24):7485-7493 7 Citations |
| 1 | Humoral immune reconstitution following therapy with daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara-KRd), autologous hematopoietic cell transplantation, and measurable residual disease-response-adapted treatment cessation. (Silbermann RW, Schmidt TM, Bal S, Dhakal B, Dholaria B, Biltibo E, Chhabra S, Giri S, Godby KN, Gowda S, Medvedova E, Cornell RF, Callander NS, Costa LJ) EJHaem 2023 Aug;4(3):775-778 |
| 1 | Cancer-Immunity Marker RNA Expression Levels across Gynecologic Cancers: Implications for Immunotherapy. (Jou J, Kato S, Miyashita H, Thangathurai K, Pabla S, DePietro P, Nesline MK, Conroy JM, Rubin E, Eskander RN, Kurzrock R) Mol Cancer Ther 2023 Nov 01;22(11):1352-1362 3 Citations |
| 3 | Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy. (Winicki NM, Radomski SN, Florissi IS, Cloyd JM, Gutta G, Grotz TE, Scally CP, Fournier KF, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Kothari AN, Maduekwe UN, Patel SH, Wilson GC, Schwartz P, Varley PR, Raoof M, Lee B, Malik I, Johnston FM, Greer JB) Ann Surg Oncol 2023 Nov;30(12):7840-7847 6 Citations |
| 1 | Development of Prostate Bed Delineation Consensus Guidelines for Magnetic Resonance Image-Guided Radiotherapy and Assessment of Its Effect on Interobserver Variability. (Sritharan K, Akhiat H, Cahill D, Choi S, Choudhury A, Chung P, Diaz J, Dysager L, Hall W, Huddart R, Kerkmeijer LGW, Lawton C, Mohajer J, Murray J, Nyborg CJ, Pos FJ, Rigo M, Schytte T, Sidhom M, Sohaib A, Tan A, van der Voort van Zyp J, Vesprini D, Zelefsky MJ, Tree AC) Int J Radiat Oncol Biol Phys 2024 Feb 01;118(2):378-389 3 Citations |
| 1 | Incidence of Pneumocystis Jiroveci Pneumonia in Patients With ANCA-Associated Vasculitis Initiating Therapy With Rituximab or Cyclophosphamide. (Nettleton E, Sattui SE, Wallace Z, Putman M) Arthritis Care Res (Hoboken) 2024 Feb;76(2):288-294 6 Citations |
| 7 | The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma. (Hammons L, Szabo A, Janardan A, Bhatlapenumarthi V, Annyapu E, Dhakal B, Al Hadidi S, Radhakrishnan SV, Narra R, Bhutani D, Thanendrarajan S, Janz S, Zangari M, Lentzsch S, Van Rhee F, Crescencio JCR, D'Souza A, Chakraborty R, Mohan M, Schinke C) Haematologica 2024 Mar 01;109(3):906-914 21 Citations |
| 1 | Tumour mutational burden and survival with molecularly matched therapy (de Bortoli T, Benary M, Horak P, Lamping M, Stintzing S, Tinhofer I, Leyvraz S, Schäfer R, Klauschen F, Keller U, Stenzinger A, Fröhling S, Kurzrock R, Keilholz U, Rieke DT, Jelas I) European Journal of Cancer September 2023;190 4 Citations |
| 2 | Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy. (Simone CB 2nd, Serebrenik AA, Gore EM, Mohindra P, Brown SL, Wang D, Chetty IJ, Vujaskovic Z, Menon S, Thompson J, Fine G, Kaytor MD, Movsas B) Int J Radiat Oncol Biol Phys 2024 Feb 01;118(2):404-414 6 Citations |
| 1 | Widening demographic gaps in CAR-T therapy utilization for multiple myeloma in the United States () |
| 5 | Widening demographic gaps in CAR-T therapy utilization for multiple myeloma in the United States. (Lin M, Estrada-Merly N, Eapen M, Zamora AE, Pezzin LE, Winn AN, Philip J, Schinke C, Drobyski WR, Anderson LD Jr, D'Souza A) Bone Marrow Transplant 2023 Dec;58(12):1400-1402 |
| 1 | Outcomes of Antineoplastic Immunotherapy at a Large Healthcare Organization: Impact of Provider, Race and Socioeconomic Status. (Mirsky MM, Mitchell C, Hong A, Cao S, Fu P, Margevicius S, Wu S, Dowlati A, Nelson A, Selfridge JE, Ramaiya N, Hoimes C, Alahmadi A, Bruno DS) Cancer Manag Res 2023;15:913-927 4 Citations |
| 1 | INSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia. (Lamble AJ, Moskop A, Pulsipher MA, Maude SL, Summers C, Annesley C, Baruchel A, Gore L, Amrolia P, Shah N) Transplant Cell Ther 2023 Nov;29(11):674-684 5 Citations |
| 1 | Assessing prescriber adherence with Global Initiative for Asthma (GINA) guideline-recommended reliever therapy. (Tchen S, Vu T, Fleischman M, Ward J, Trapp C, Hu K) Intern Emerg Med 2023 Oct;18(7):2029-2036 1 Citation |
| 1 | Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer. (Hwang C, Henderson NC, Chu SC, Holland B, Cackowski FC, Pilling A, Jang A, Rothstein S, Labriola M, Park JJ, Ghose A, Bilen MA, Mustafa S, Kilari D, Pierro MJ, Thapa B, Tripathi A, Garje R, Ravindra A, Koshkin VS, Hernandez E, Schweizer MT, Armstrong AJ, McKay RR, Dorff TB, Alva AS, Barata PC) JAMA Netw Open 2023 Sep 05;6(9):e2334208 6 Citations |
| 1 | Safety and efficacy of anti-BCMA CAR-T cell therapy in older adults with multiple myeloma: A systematic review and meta-analysis. (Akhtar OS, Sheeba BA, Azad F, Alessi L, Hansen D, Alsina M, Baz R, Shain K, Grajales Cruz A, Castaneda Puglianini O, Liu H, Blue B, Nishihori T, Al Jumayli M, Extermann M, Locke FL, Mhaskar R, Freeman CL) J Geriatr Oncol 2024 Mar;15(2):101628 15 Citations |
| 1 | Stereotactic body radiation therapy versus conventional external beam radiotherapy for spinal metastases: A systematic review and meta-analysis of randomized controlled trials. (Wong HCY, Lee SF, Chan AW, Caini S, Hoskin P, Simone CB 2nd, Johnstone P, van der Linden Y, van der Velden JM, Martin E, Alcorn S, Johnstone C, Isabelle Choi J, Nader Marta G, Oldenburger E, Raman S, Rembielak A, Vassiliou V, Bonomo P, Nguyen QN, Chow E, Ryu S) Radiother Oncol 2023 Dec;189:109914 14 Citations |
| 1 | Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline. (Del Rivero J, Perez K, Kennedy EB, Mittra ES, Vijayvergia N, Arshad J, Basu S, Chauhan A, Dasari AN, Bellizzi AM, Gangi A, Grady E, Howe JR, Ivanidze J, Lewis M, Mailman J, Raj N, Soares HP, Soulen MC, White SB, Chan JA, Kunz PL, Singh S, Halfdanarson TR, Strosberg JR, Bergsland EK) J Clin Oncol 2023 Nov 10;41(32):5049-5067 24 Citations |
| 1 | Assessing prescriber adherence with Global Initiative for Asthma (GINA) guideline-recommended reliever therapy (Tchen S, Vu T, Fleischman M, Ward J, Trapp C, Hu K) Internal and Emergency Medicine October 2023;18(7):2029-2036 1 Citation |
| 3 | Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial. (Costa LJ, Chhabra S, Medvedova E, Dholaria BR, Schmidt TM, Godby KN, Silbermann R, Dhakal B, Bal S, Giri S, D'Souza A, Hall AC, Hardwick P, Omel J, Cornell RF, Hari P, Callander NS) Lancet Haematol 2023 Nov;10(11):e890-e901 82 Citations |
| 1 | Quality of Life in Prostate Cancer Patients Undergoing Daily Adaptive Versus Non-Adaptive Radiation Therapy Utilizing A 1.5 Tesla MR-Linac (SE Beltran Ponce, LA Daamen, J Van der Voort vanZyp, JM Westerhoff, FJ Pos, JP Christodouleas, A Choudhury, U van der Heide, CAF Lawton, MW Straza, M Bedi, ES Paulson, HG Nasief, A Li, H Verkooijen, A Tree, WA Hall) International Journal of Radiation Oncology, Biology, Physics |
| 1 | Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer. (Semenkovich NP, Badiyan SN, Samson PP, Stowe HB, Wang YE, Star R, Devarakonda S, Govindan R, Waqar SN, Robinson CG, Vlacich G, Pellini B, Chaudhuri AA) NPJ Precis Oncol 2023 Oct 02;7(1):100 8 Citations |
| 3 | Outcomes of Tolerability, Acute Toxicity and Quality of Life from MR-Guided Radiation Therapy (1.5T MR-Linac) for Liver Metastases in the MOMENTUM Study. (Westley R, Peltenburg J, Aitken KL, Awan MJ, Braam PM, Daamen LA, Hosni A, Intven MPW, Janssen T, Schytte T, Sonke JJ, Straza MW Jr, Paulson ES, Hall WA, Nowee ME) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):e156 |
| 4 | Differential Response in Quantitative MRI Parameters Detected in Head and Neck Cancer Patients Treated with Concurrent Immunotherapy during Hypo-Fractionated MR-gRT. (Bonate R, Paulson ES, Frei A, Shukla ME, Tarima S, Wong S, Himburg HA, Zenga J, Awan MJ) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):S65 |
| 3 | Pre-Operative Radiotherapy in STS: Does Downsizing Matter? (Gutkin PM, King DM, Charlson J, Wooldridge A, Hackbarth D, Kelly TR, Neilson J, Johnstone C, Bedi M) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):S148-S149 |
| 1 | Characterizing the Impact of Race and Redlining on Receipt of Guideline-Compliant Locoregional Therapy among Older Women with Breast Cancer. (Beltran Ponce SE, Canales B, McGinley E, Yen T, Tarima S, Zhou Y, Bikomeye JC, Beyer K) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):e7 |
| 2 | Patient-Specific Deep Learning Auto-Segmentation for MR-Guided Adaptive Radiotherapy of Prostate Cancer. (Amjad A, Chen X, Hall WA, Lawton CAF, Li A, Paulson ES) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):e638-e639 |
| 3 | Quality of Life in Prostate Cancer Patients Undergoing Daily Adaptive Versus Non-Adaptive Radiation Therapy Utilizing A 1.5 Tesla MR-Linac. (Ponce SEB, Daamen LA, Van der Voort vanZyp J, Westerhoff JM, Pos FJ, Christodouleas JP, Choudhury A, van der Heide U, Lawton CAF, Straza MW Jr, Bedi M, Paulson ES, Nasief HG, Li A, Verkooijen H, Tree A, Hall WA) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):S114-S115 |
| 3 | Patterns of Locoregional Pancreatic Cancer Recurrence after Total Neoadjuvant Therapy and Implications on Optimal Neoadjuvant Radiation Treatment Volumes. (Ponce SEB, Small CJ, Ahmad T, Patel K, Tsai S, Kamgar M, George B, Kharofa JR, Saeed H, Dua KS, Clarke C, Aldakkak M, Evans DB, Christians K, Paulson ES, de Choudens SO, Erickson BA, Hall WA) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):e284-e285 |
| 1 | Consolidative Radio therapy in Place of Autologous Stem Cell Transplant in Patients with Low-Risk Relapsed/Refractory (R/R) Classic Hodgkin Lymphoma (cHL) Treated with Nivolumab plus Brentuximab Vedotin: CheckMate 744. (Hoppe BS, Daw S, Cole P, Hodgson D, Beishuizen A, Garnier N, Buffardi S, Mascarin M, Ebeling T, Akyol A, Crowe R, Xu Y, Drachtman R, Kelly KM, Leblanc T, Harker-Murray PD) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):S1-S2 |
| 1 | Evolution of the MOMENTUM Study for Evidence-Based Implementation of MR-Guided Radiotherapy Using the 1.5 Tesla MR-Linac. (Daamen LA, Westerhoff JM, Christodouleas JP, Orrling K, Eggert D, Choudhury A, Fuller CD, van der Heide U, Sahgal A, Schultz CJ, Schytte T, Tersteeg R, Tree A, Hall WA, Verkooijen H) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):e576-e577 |
| 1 | Validation of a Genomic Classifier in the NRG Oncology/RTOG 0521 Phase III Trial of Docetaxel with Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer. (Phillips R, Proudfoot J, Davicioni E, Spratt DE, Feng FY, Simko J, Den RB, Pollack A, Rosenthal SA, Sartor O, Sweeney C, Attard G, Patel SI, Hall WA, Efstathiou JA, Shah AB, Hoffman KE, Pugh S, Sandler HM, Tran PT) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):S34-S35 |
| 1 | Weekend Discharge Is Not Associated With Increased Readmission After Hyperthermic Intraperitoneal Chemotherapy. (Florissi I, Radomski SN, Shou B, Cloyd JM, Kim A, Grotz T, Fournier K, Baumgartner JM, Lambert L, Abbott DE, Schwartz P, Staley CA, Clarke C, Dineen S, Patel SH, Wilson GC, Raoof M, Johnston FM, Greer JB) J Surg Res 2024 Jan;293:403-412 |
| 1 | INSPIRED Symposium Part 4A: Access to CAR T Cell Therapy in Unique Populations with B Cell Acute Lymphoblastic Leukemia. (Winestone LE, Bhojwani D, Ghorashian S, Muffly L, Leahy AB, Chao K, Steineck A, Rössig C, Lamble A, Maude SL, Myers R, Rheingold SR) Transplant Cell Ther 2024 Jan;30(1):56-70 4 Citations |
| 1 | Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma: A Phase 1 Nonrandomized Controlled Trial. (Seo YD, Lu H, Black G, Smythe K, Yu Y, Hsu C, Ng J, Hermida de Viveiros P, Warren EH, Schroeder BA, O'Malley RB, Cranmer LD, Loggers ET, Wagner MJ, Bonham L, Pillarisetty VG, Kane G, Berglund P, Hsu FJ, Mi X, Alexiev BA, Pierce RH, Riddell SR, Jones RL, Ter Meulen J, Kim EY, Pollack SM) JAMA Oncol 2023 Dec 01;9(12):1660-1668 16 Citations |
| 1 | Is triptan therapy a safe option for acute migraine in pregnancy? (Passolt, Brooke MD; Andreoli, Matthew MD; Walhardt, Jeremy DO; Lalonde, Crystal MD) Evidence-Based Practice Passolt, Brooke MD; Andreoli, Matthew MD; Waldhart, Jeremy DO; Lalonde, Crystal MD. Is triptan therapy a safe option for acute migraine in pregnancy?. Evidence-Based Practice ():10.1097/EBP.0000000000001997, October 13, 2023. | DOI: 10.1097/EBP.0000000000001997 |
| 1 | Multimodal Imaging of Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer-A State-of-the-Art Review. (Cronin M, Seher M, Arsang-Jang S, Lowery A, Kerin M, Wijns W, Soliman O) J Clin Med 2023 Sep 29;12(19) 4 Citations |
| 3 | Clinical outcomes after online adaptive MR-guided stereotactic body radiotherapy for pancreatic tumors on a 1.5 T MR-linac. (Eijkelenkamp H, Grimbergen G, Daamen LA, Heerkens HD, van de Ven S, Mook S, Meijer GJ, Molenaar IQ, van Santvoort HC, Paulson E, Erickson BA, Verkooijen HM, Hall WA, Intven MPW) Front Oncol 2023;13:1040673 7 Citations |
| 1 | Elucidating the Benefit of Radiation Therapy in GI Cancers: Rethinking Trial End Points and Patient Selection. (Sanford NN, Hong TS, Hall WA) J Clin Oncol 2024 Mar 10;42(8):868-871 8 Citations |
| 2 | Incidence of Esophageal Adenocarcinoma, Mortality, and Esophagectomy in Barrett's Esophagus Patients Undergoing Endoscopic Eradication Therapy. (Smith ZL, Thorgerson AM, Dawson AZ, Wani S) Dig Dis Sci 2023 Dec;68(12):4439-4448 2 Citations |
| 4 | National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial. (Rogers C, Cobb AN, Lloren JIC, Chaudhary LN, Johnson MK, Huang CC, Teshome M, Kong AL, Singh P, Cortina CS) Breast Cancer Res Treat 2024 Jan;203(2):317-328 8 Citations |
| 1 | Bone Marrow Aplasia after CAR-T-Cell Therapy for Relapsed/Refractory Burkitt's Lymphoma. (Kenkel TJ, Sridhar N, Hammons LR, Hintzke M, Shah NN) Med Sci (Basel) 2023 Oct 12;11(4) 1 Citation |
| 1 | Stereotactic Body Radiation Therapy for Gynecologic Malignancies: A Case-Based Radiosurgery Society Practice Review. (Ladbury C, Sueyoshi MH, Brovold NM, Kumar R, Andraos TY, Gogineni E, Kim M, Klopp A, Albuquerque K, Kunos C, Leung E, Mantz C, Biswas T, Beriwal S, Small W Jr, Erickson B, Gaffney D, Lo SS, Viswanathan AN) Pract Radiat Oncol 2024;14(3):252-266 |
| 1 | Local Control Following Stereotactic Body Radiation Therapy for Liver Oligometastases: Lessons from a Quarter Century. (Mheid S, Allen S, Ng SSW, Hall WA, Sanford NN, Aguilera TA, Elamir AM, Bahij R, Intven MPW, Radhakrishna G, Mohamad I, De Leon J, Tan H, Lewis S, Gani C, Stanecu T, Dell'Acqua V, Hosni A) Curr Oncol 2023 Oct 19;30(10):9230-9243 3 Citations |
| 4 | Obtaining organ-specific radiobiological parameters from clinical data for radiation therapy planning of head and neck cancers. (Quashie EE, Li XA, Prior P, Awan M, Schultz C, Tai A) Phys Med Biol 2023 Dec 11;68(24) 3 Citations |
| 1 | The crux of menopausal hormone therapy: dose, route, and age (Hobbs LM, Baumann Kreuziger LM) Research and Practice in Thrombosis and Haemostasis November 2023;7(8) |
| 1 | Kids Mod PAH trial: A multicenter trial comparing mono- versus duo-therapy for initial treatment of pediatric pulmonary hypertension. (Collaco JM, Abman SH, Austin ED, Avitabile CM, Bates A, Fineman JR, Freire GA, Handler SS, Ivy DD, Krishnan US, Mullen MP, Varghese NP, Yung D, Nies MK, Everett AD, Zimmerman KO, Simmons W, Chakraborty H, Yenokyan G, Newell-Sturdivant A, Christensen E, Eyzaguirre LM, Hanley DF, Rosenzweig EB, Romer LH) Pulm Circ 2023 Oct;13(4):e12305 3 Citations |
| 2 | Chimeric Antigen Receptor T Cell Therapy for Myeloma: Where Are We Now and What Is Needed to Move Chimeric Antigen Receptor T Cells Forward to Earlier Lines of Therapy? Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. (Anderson LD Jr, Dhakal B, Jain T, Oluwole OO, Shah GL, Sidana S, Perales MA, Pasquini MC) Transplant Cell Ther 2024 Jan;30(1):17-37 23 Citations |
| 1 | Programs and processes for advancing pediatric acute kidney support therapy in hospitalized and critically ill children: a report from the 26th Acute Disease Quality Initiative (ADQI) consensus conference. (Neumayr TM, Bayrakci B, Chanchlani R, Deep A, Morgan J, Arikan AA, Basu RK, Goldstein SL, Askenazi DJ, ADQI 26 workgroup) Pediatr Nephrol 2024 Mar;39(3):993-1004 3 Citations |
| 2 | Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study. (Epperla N, Feng L, Shah NN, Fitzgerald L, Shah H, Stephens DM, Lee CJ, Ollila T, Shouse G, Danilov AV, David KA, Torka P, Hashmi H, Hess B, Barta SK, Romancik JT, Cohen JB, Annunzio K, Kittai AS, Reneau J, Zurko J, Nizamuddin IA, Winter JN, Gordon LI, Ma S, Patel R, Nastoupil L, Ahmed S, Karmali R) J Hematol Oncol 2023 Nov 09;16(1):111 18 Citations |
| 1 | Chimeric Antigen Receptor T-Cell Therapy in the Outpatient Setting: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. (Oluwole OO, Dholaria B, Knight TE, Jain T, Locke FL, Ramsdell L, Nikiforow S, Hashmi H, Mooney K, Bhaskar ST, Morris K, Gatwood K, Baer B, Anderson LD Jr, Hamadani M) Transplant Cell Ther 2024 Feb;30(2):131-142 16 Citations |
| 1 | PD1+TIGIT+2B4+KLRG1+ Cells Might Underlie T Cell Dysfunction in Patients Treated with BCMA-Directed Chimeric Antigen Receptor T Cell Therapy. (Mishra AK, Schmidt TM, Martell EB, Chen AS, Dogru RE, Hematti P, Callander NS) Transplant Cell Ther 2024 Feb;30(2):191-202 7 Citations |
| 1 | Changes in Therapy Are Not Associated With Increased Remission in Patients With Crohn's Disease of the Pouch. (Kayal M, Deepak P, Beniwal-Patel P, Raffals L, Dubinsky M, Chang S, Higgins PDR, Jiang Y, Cross RK, Long MD, Herfarth HH, Barnes EL) Am J Gastroenterol 2024 Mar 01;119(3):584-587 2 Citations |
| 1 | Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy. (Iqbal M, Jagadeesh D, Chavez J, Khurana A, Rosenthal A, Craver E, Epperla N, Li Z, Isufi I, Awan FT, Dholaria BR, Maakaron JE, Sandoval-Sus JD, Mishra R, Saha A, Annunzio K, Bhaskar ST, Sumransub N, Fijalka A, Ivanov SA, Lin Y, Kharfan-Dabaja MA) Bone Marrow Transplant 2024 Feb;59(2):211-216 7 Citations |
| 1 | Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy. (Fields EC, Erickson B, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M) Int J Radiat Oncol Biol Phys 2023 Dec 01;117(5):1138-1142 2 Citations |
| 1 | Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies. (Carneiro BA, Cavalcante L, Mahalingam D, Saeed A, Safran H, Ma WW, Coveler AL, Powell S, Bastos B, Davis E, Sahai V, Mikrut W, Longstreth J, Smith S, Weisskittel T, Li H, Borden BA, Harvey RD, Sahebjam S, Cervantes A, Koukol A, Mazar AP, Steeghs N, Kurzrock R, Giles FJ, Munster P) Clin Cancer Res 2024 Feb 01;30(3):522-531 4 Citations |
| 1 | Live to fight another day: Combining parenchymal sparing resection and ablative therapy in neuroendocrine tumor liver metastases. (Bello RJ, Clarke CN) Am J Surg 2024 Mar;229:15-16 2 Citations |
| 1 | Vosoritide therapy in children with achondroplasia aged 3-59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial. (Savarirayan R, Wilcox WR, Harmatz P, Phillips J 3rd, Polgreen LE, Tofts L, Ozono K, Arundel P, Irving M, Bacino CA, Basel D, Bober MB, Charrow J, Mochizuki H, Kotani Y, Saal HM, Army C, Jeha G, Qi Y, Han L, Fisheleva E, Huntsman-Labed A, Day J) Lancet Child Adolesc Health 2024 Jan;8(1):40-50 29 Citations |
| 1 | Overcoming Immune Checkpoint Therapy Resistance with SHP2 Inhibition in Cancer and Immune Cells: A Review of the Literature and Novel Combinatorial Approaches. (Tojjari A, Saeed A, Sadeghipour A, Kurzrock R, Cavalcante L) Cancers (Basel) 2023 Nov 13;15(22) 3 Citations |
| 1 | KDM3B Single-Nucleotide Polymorphisms Impact Radiation Therapy Toxicity Through Circular RNA-Mediated KDM3B Expression and Inflammatory Responses. (Sun Y, Tsai Y, Wood R, Shen B, Chen J, Zhou Z, Zeng G, Marples B, Kerns S, Chen Y) Int J Radiat Oncol Biol Phys 2024 May 01;119(1):251-260 |
| 1 | Dataset of phase I and II immunotherapy clinical trials used for a meta-analysis to assess the role of biomarkers in treatment outcomes in diverse cancers. (Fountzilas E, Hiep Vo H, Mueller P, Kurzrock R, Tsimberidou AM) Data Brief 2023 Dec;51:109698 3 Citations |
| 1 | Chronic anti-coagulation therapy reduced mortality in patients with high cardiovascular risk early in COVID-19 pandemic (Zaghloul MS, Jammeh M, Gibson A, Luo S, Chadwick-Mansker K, Liu Q, Yan Y, Zayed MA) Thrombosis Journal December 2023;21(1) 2 Citations |
| 1 | Oral antibiotic step-down therapy for nonstaphylococcal gram-positive bloodstream infections (Gandhi K, Wrzesinski M, Bunnell K, Gibble A) Diagnostic Microbiology and Infectious Disease December 2023;107(4) 2 Citations |
| 1 | T-cell priming transcriptomic markers: implications of immunome heterogeneity for precision immunotherapy (Miyashita H, Kurzrock R, Bevins NJ, Thangathurai K, Lee S, Pabla S, Nesline M, Glenn ST, Conroy JM, DePietro P, Rubin E, Sicklick JK, Kato S) npj Genomic Medicine December 2023;8(1) 10 Citations |
| 1 | Personalized matched targeted therapy in advanced pancreatic cancer: a pilot cohort analysis (Shaya J, Kato S, Adashek JJ, Patel H, Fanta PT, Botta GP, Sicklick JK, Kurzrock R) npj Genomic Medicine December 2023;8(1) 20 Citations |
| 1 | Lipid-nanoparticles-based co-delivery of black phosphorus quantum dots and melphalan by photothermal therapy combined with chemotherapy for retinoblastoma (Shijing Wang#*, Pengxue Wei, Yujun Zhang, Shaochong Zhang*) Polymer Testing |
| 1 | Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy (Fields EC, Erickson B, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M) International Journal of Radiation Oncology Biology Physics 1 December 2023;117(5):1138-1142 2 Citations |
| 1 | Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study (Epperla N, Feng L, Shah NN, Fitzgerald L, Shah H, Stephens DM, Lee CJ, Ollila T, Shouse G, Danilov AV, David KA, Torka P, Hashmi H, Hess B, Barta SK, Romancik JT, Cohen JB, Annunzio K, Kittai AS, Reneau J, Zurko J, Nizamuddin IA, Winter JN, Gordon LI, Ma S, Patel R, Nastoupil L, Ahmed S, Karmali R) Journal of Hematology and Oncology December 2023;16(1) 19 Citations |
| 1 | ACR Appropriateness Criteria® Staging and Post-Therapy Assessment of Head and Neck Cancer. (Expert Panel on Neurological Imaging, Gule-Monroe MK, Calle S, Policeni B, Juliano AF, Agarwal M, Chow LQM, Dubey P, Friedman ER, Hagiwara M, Hanrahan KD, Jain V, Rath TJ, Smith RB, Subramaniam RM, Taheri MR, Yom SS, Zander D, Burns J) J Am Coll Radiol 2023 Nov;20(11S):S521-S564 5 Citations |
| 1 | Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma : A Cost-Effectiveness Analysis. (Kelkar AH, Cliff ERS, Jacobson CA, Abel GA, Dijk SW, Krijkamp EM, Redd R, Zurko JC, Hamadani M, Hunink MGM, Cutler C) Ann Intern Med 2023 Dec;176(12):1625-1637 14 Citations |
| 1 | Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA. (Jagsi R, Griffith KA, Harris EE, Wright JL, Recht A, Taghian AG, Lee L, Moran MS, Small W Jr, Johnstone C, Rahimi A, Freedman G, Muzaffar M, Haffty B, Horst K, Powell SN, Sharp J, Sabel M, Schott A, El-Tamer M) J Clin Oncol 2024 Feb 01;42(4):390-398 46 Citations |
| 1 | Radiotherapy Combination: Insight from Tumor Immune Microenvironment (TIME). (Alimohammadi M, Ghaffari-Nazari H, Alimohammadi R, Bakhshandeh M, Jalali SA, Rezaei N) Avicenna J Med Biotechnol 2023;15(4):209-215 |
| 1 | Effects of gene replacement therapy with resamirigene bilparvovec (AT132) on skeletal muscle pathology in X-linked myotubular myopathy: results from a substudy of the ASPIRO open-label clinical trial. (Lawlor MW, Schoser B, Margeta M, Sewry CA, Jones KA, Shieh PB, Kuntz NL, Smith BK, Dowling JJ, Müller-Felber W, Bönnemann CG, Seferian AM, Blaschek A, Neuhaus S, Foley AR, Saade DN, Tsuchiya E, Qasim UR, Beatka M, Prom MJ, Ott E, Danielson S, Krakau P, Kumar SN, Meng H, Vanden Avond M, Wells C, Gordish-Dressman H, Beggs AH, Christensen S, Conner E, James ES, Lee J, Sadhu C, Miller W, Sepulveda B, Varfaj F, Prasad S, Rico S) EBioMedicine 2024 Jan;99:104894 2 Citations |
| 1 | Late gene therapy limits the restoration of retinal function in a mouse model of retinitis pigmentosa. (Scalabrino ML, Thapa M, Wang T, Sampath AP, Chen J, Field GD) Nat Commun 2023 Dec 12;14(1):8256 3 Citations |
| 1 | Therapeutic options for large B-cell lymphoma relapsing after CD19-directed CAR T-cell therapy. (El Warrak S, Kharfan-Dabaja MA, Iqbal M, Hamadani M, Chavez J, Mohty R) Bone Marrow Transplant 2024 Feb;59(2):162-170 2 Citations |
| 1 | Therapy for patients with chronic phase-chronic myeloid leukemia previously treated with ⩾2 tyrosine kinase inhibitors: a systematic literature review. (Atallah E, Saini L, Maegawa R, Rajput T, Corbin R, Viana R) Ther Adv Hematol 2023;14:20406207221150305 |
| 1 | The Use of MR-Guided Radiation Therapy for Pancreatic Cancer. (Daamen LA, Parikh PJ, Hall WA) Semin Radiat Oncol 2024 Jan;34(1):23-35 8 Citations |
| 1 | Simple Score of Albumin and CRP Predicts High-Grade Toxicity in Patients with Multiple Myeloma Receiving CAR-T Therapy. (Akhtar OS, Modi K, Kim J, Skelson L, Smith E, Al-Jumayli MA, Extermann M, De Avila G, Parker N, Castaneda Puglianini O, Grajales Cruz A, Baz R, Blue B, Shain K, Alsina M, Liu H, Nishihori T, Jain MD, Locke FL, Hansen DK, Freeman CL) Transplant Cell Ther 2024 Mar;30(3):283.e1-283.e10 8 Citations |
| 10 | Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy. (de Ortiz de Choudens S, Visotcky A, Banerjee A, Aldakkak M, Tsai S, Evans DB, Christians KK, Clarke CN, George B, Shreenivas A, Kamgar M, Chakrabarti S, Dua KS, Khan AH, Madhavan S, Erickson BA, Hall WA) Cancer Med 2024 Jan;13(1):e6582 |
| 7 | Efficacy of Multiple SARS-CoV-2 Vaccine Doses in Patients with B Cell Hematologic Malignancies Receiving Chimeric Antigen Receptor T Cell Therapy: A Contemporary Cohort Analysis. (Abid MB, Rubin M, Szabo A, Longo W, Fenske TS, McCoy C, Lorge A, Abedin S, D'Souza A, Dhakal B, Shah NN, Hamadani M) Transplant Cell Ther 2024 Mar;30(3):285-297 7 Citations |
| 1 | Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy. (Shah RK, Cygan E, Kozlik T, Colina A, Zamora AE) Front Immunol 2023;14:1301100 1 Citation |
| 2 | Systematic Review on Gender-Affirming Testosterone Therapy and the Risk of Breast Cancer: A Challenge for Physicians Treating Patients from Transgender and Gender-Diverse Populations. (Pamulapati S, Conroy M, Cortina C, Harding E, Kamaraju S) Arch Sex Behav 2024 May;53(5):1969-1980 4 Citations |
| 6 | Cystic Brain Metastasis Outcomes After Gamma Knife Radiation Therapy (Amidon RF, Livingston K, Kleefisch CJ, Martens M, Straza M, Puckett L, Schultz CJ, Mueller WM, Connelly JM, Noid G, Morris K, Bovi JA) Advances in Radiation Oncology January 2024;9(1) |
| 2 | Implementation and Adaptations of Written Exposure Therapy: Lessons Learned Across Settings (Larsen SE, Andrews AR, Astin MC, Lamp KE, Lee JY, Melka SE, Shepard SJ, Skopp NA) Cognitive and Behavioral Practice 2024 |
| 1 | Neuropsychological manifestations of chemotherapy (Santos-Pinheiro F, Butts A) Neuropsychological and Psychosocial Foundations of Neuro-Oncology 1 January 2024:181-197 |
| 1 | Principles of Dermatologic Therapy (Humphrey SR) Nelson Textbook of Pediatrics: Volume 1-2 1 January 2024:4038-4040.e1 |
| 1 | Anticoagulant and Thrombolytic Therapy (Raffini LJ, Branchford BR) Nelson Textbook of Pediatrics: Volume 1-2 1 January 2024:3040-3045.e2 |
| 1 | Kernicterus and Therapy of Hyperbilirubinemia (Ryan KS, Kliegman RM) Nelson Textbook of Pediatrics: Volume 1-2 1 January 2024:1106-1116.e1 |
| 1 | Hematopoietic Stem Cell-Based Platelet-Targeted Gene Therapy for Hemophilia (Shi Q) Comprehensive Hematology and Stem Cell Research: Volume 1-5 1 January 2024;5:V5:406-V5:418 |
| 1 | Shifting neoadjuvant chemotherapy treatment paradigms for breast cancer and its impact on axillary nodal management for clinically node-negative patients (Cortina CS) Gland Surgery 2024;13(7):1154-1158 1 Citation |
| 1 | Is triptan therapy a safe option for acute migraine in pregnancy? (Brooke Passolt, Jeremy Waldhart, Matthew Andreoli, Crystal Lalonde) Evidence-Based Practice |
| 1 | The Use of MR-Guided Radiation Therapy for Pancreatic Cancer (Daamen LA, Parikh PJ, Hall WA) Seminars in Radiation Oncology January 2024;34(1):23-35 8 Citations |
| 1 | Impaired microvascular reactivity in patients treated with 5-fluorouracil chemotherapy regimens: Potential role of endothelial dysfunction. (Hammond ST, Baumfalk DR, Parr SK, Butenas ALE, Scheuermann BC, Turpin VG, Behnke BJ, Hashmi MH, Ade CJ) Int J Cardiol Heart Vasc 2023 Dec;49:101300 1 Citation |
| 1 | High CTLA-4 transcriptomic expression correlates with high expression of other checkpoints and with immunotherapy outcome. (Krishnamurthy N, Nishizaki D, Lippman SM, Miyashita H, Nesline MK, Pabla S, Conroy JM, DePietro P, Kato S, Kurzrock R) Ther Adv Med Oncol 2024;16:17588359231220510 9 Citations |
| 1 | The crux of menopausal hormone therapy: dose, route, and age. (Hobbs LM, Baumann Kreuziger LM) Res Pract Thromb Haemost 2023 Nov;7(8):102269 |
| 1 | Tissue-targeted and localized AAV5-DCN and AAV5-PEDF combination gene therapy abrogates corneal fibrosis and concurrent neovascularization in rabbit eyes in vivo. (Mohan RR, Gupta S, Kumar R, Sinha NR, Landreneau J, Sinha PR, Tandon A, Chaurasia SS, Hesemann NP) Ocul Surf 2024 Apr;32:13-25 5 Citations |
| 1 | Unanswered questions following reports of secondary malignancies after CAR-T cell therapy. (Levine BL, Pasquini MC, Connolly JE, Porter DL, Gustafson MP, Boelens JJ, Horwitz EM, Grupp SA, Maus MV, Locke FL, Ciceri F, Ruggeri A, Snowden J, Heslop HE, Mackall CL, June CH, Sureda AM, Perales MA) Nat Med 2024 Feb;30(2):338-341 120 Citations |
| 1 | Alliance for Clinical Trials in Oncology (Alliance) trial A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur). (Hitchcock KE, Miller ED, Shi Q, Dixon JG, Gholami S, White SB, Wu C, Goulet CC, George M, Jee KW, Wright CL, Yaeger R, Shergill A, Hong TS, George TJ, O'Reilly EM, Meyerhardt JA, Romesser PB) Res Sq 2023 Dec 23 |
| 1 | Association between spinal manipulative therapy and lumbar spine reoperation after discectomy: a retrospective cohort study. (Trager RJ, Gliedt JA, Labak CM, Daniels CJ, Dusek JA) BMC Musculoskelet Disord 2024 Jan 10;25(1):46 2 Citations |
| 1 | Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation? (Alaklabi S, Roy AM, Chaudhary LN, Gandhi S) Explor Target Antitumor Ther 2023;4(6):1301-1309 |
| 1 | Re-Examining Trials of Radiotherapy Omission: When Less Is Not Always More. (Sanford NN, Hall WA, Booth CM) JCO Oncol Pract 2024 Apr;20(4):460-462 1 Citation |
| 1 | Correlation between tumor size change and outcome in a rare cancer immunotherapy basket trial. (Othus M, Patel SP, Chae YK, Dietrich E, Streicher H, Sharon E, Kurzrock R) J Natl Cancer Inst 2024 May 08;116(5):673-680 1 Citation |
| 1 | Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy. (Crombie JL, Graff T, Falchi L, Karimi YH, Bannerji R, Nastoupil L, Thieblemont C, Ursu R, Bartlett N, Nachar V, Weiss J, Osterson J, Patel K, Brody J, Abramson JS, Lunning M, Shah NN, Ayed A, Kamdar M, Parsons B, Caimi P, Flinn I, Herrera A, Sharman J, McKenna M, Armand P, Kahl B, Smith S, Zelenetz A, Budde LE, Hutchings M, Phillips T, Dickinson M) Blood 2024 Apr 18;143(16):1565-1575 46 Citations |
| 3 | Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study. (Singla S, Putman M, Liew J, Gordon K) Lancet Rheumatol 2023 Apr;5(4):e200-e207 52 Citations |
| 6 | Cystic Brain Metastasis Outcomes After Gamma Knife Radiation Therapy. (Amidon RF, Livingston K, Kleefisch CJ, Martens M, Straza M, Puckett L, Schultz CJ, Mueller WM, Connelly JM, Noid G, Morris K, Bovi JA) Adv Radiat Oncol 2024 Jan;9(1):101304 |
| 3 | Does Neoadjuvant Chemotherapy in Clinical T1-T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery? (Cortina CS, Lloren JI, Rogers C, Johnson MK, Cobb AN, Huang CC, Kong AL, Singh P, Teshome M) Ann Surg Oncol 2024 May;31(5):3128-3140 3 Citations |
| 1 | Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. (RECOVERY Collaborative Group) Lancet Child Adolesc Health 2024 Mar;8(3):190-200 13 Citations |
| 1 | Virologic outcomes of antiretroviral therapy in patients with HIV-1 following bariatric surgery: A case series and review of the literature (Badowski M, Kassem S, Labedz M, Taylor C, Bunnell K, Hall A, Darnell H, Huesgen E) International Journal of STD and AIDS February 2024;35(2):103-111 1 Citation |
| 1 | Opinion: Percutaneous electrical nerve field stimulation compared to standard medical therapy in adolescents with functional abdominal pain disorders. (Miranda A) Front Pain Res (Lausanne) 2024;5:1279946 1 Citation |
| 1 | Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative. (Fackche NT, Schmocker RK, Nudotor R, Kubi B, Cloyd JM, Grotz TE, Fournier KF, Dineen SP, Veerapong J, Baumgartner JM, Clarke CN, Patel SH, Wilson GC, Lambert LA, Pokrzywa C, Abbott DE, Lee B, Staley CA, Zaidi MY, Johnston FM, Greer JB) Ann Surg Oncol 2024 May;31(5):3314-3324 1 Citation |
| 1 | Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET. (Olson R, Abraham H, Leclerc C, Benny A, Baker S, Matthews Q, Chng N, Bergman A, Mou B, Dunne EM, Schellenberg D, Jiang W, Chan E, Atrchian S, Lefresne S, Carolan H, Valev B, Tyldesley S, Bang A, Berrang T, Clark H, Hsu F, Louie AV, Warner A, Palma DA, Howell D, Barry A, Dawson L, Grendarova P, Walker D, Sinha R, Tsai J, Bahig H, Thibault I, Koul R, Senthi S, Phillips I, Grose D, Kelly P, Armstrong J, McDermott R, Johnstone C, Vasan S, Aherne N, Harrow S, Liu M) BMC Cancer 2024 Feb 03;24(1):171 1 Citation |
| 1 | Prenatal Diagnosis of Fetal Aqueductal Stenosis: A Multicenter Prospective Observational Study through the North American Fetal Therapy Network. (Emery SP, Lopa S, Peterson E, Jelin AC, Treadwell MC, Gebb J, Galan HL, Bergh E, Criebaum A, McLennan A, Lillegard J, Blumenfeld YJ) Fetal Diagn Ther 2024;51(3):216-224 5 Citations |
| 1 | Erratum to: Fields EC, Erickson B, Hubbard A, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M. Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy. Int J Radiat Oncol Biol Phys 2023;117:1138-1142. (correct author list should read:, Fields EC, Erickson B, Hubbard A, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M) Int J Radiat Oncol Biol Phys 2024 Mar 01;118(3):869 |
| 1 | ASO Author Reflections: Neoadjuvant Systemic Therapy and Nodal Management in cT1-2 N0 Triple-Negative Breast Cancer. (Cortina CS, Rogers CC, Teshome M) Ann Surg Oncol 2024 May;31(5):3196-3197 2 Citations |
| 2 | SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101). (Hill JA, Martens MJ, Young JH, Bhavsar K, Kou J, Chen M, Lee LW, Baluch A, Dhodapkar MV, Nakamura R, Peyton K, Howard DS, Ibrahim U, Shahid Z, Armistead P, Westervelt P, McCarty J, McGuirk J, Hamadani M, DeWolf S, Hosszu K, Sharon E, Spahn A, Toor AA, Waldvogel S, Greenberger LM, Auletta JJ, Horowitz MM, Riches ML, Perales MA) medRxiv 2024 Jan 25 |
| 3 | In vivo biodistribution and ototoxicity assessment of cationic liposomal-ceftriaxone via noninvasive trans-tympanic delivery in chinchilla models: Implications for otitis media therapy. (Shafiee S, Hong W, Lucas J, Khampang P, Runge CL, Wells C, Yan K, Kerschner JE, Joshi A) Int J Pediatr Otorhinolaryngol 2024 Mar;178:111894 3 Citations |
| 1 | Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur). (Hitchcock KE, Miller ED, Shi Q, Dixon JG, Gholami S, White SB, Wu C, Goulet CC, George M, Jee KW, Wright CL, Yaeger R, Shergill A, Hong TS, George TJ, O'Reilly EM, Meyerhardt JA, Romesser PB) BMC Cancer 2024 Feb 13;24(1):201 |
| 1 | TEMPORAL LOBE HERNIATION AND CHIASMOPATHY DURING DOPAMINE AGONIST THERAPY FOR PROLACTINOMA. (Giraldi EA, Saindane A, Pradilla G, Biousse V, Ioachimescu AG) Acta Endocrinol (Buchar) 2023;19(3):339-344 |
| 7 | Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma. (Mohan M, Szabo A, Patwari A, Esselmann J, Patel T, Bachu R, Rein LE, Janardan A, Bhatlapenumarthi V, Annyapu E, Skoog C, Goff A, Hadidi SA, Radhakrishnan SV, Thanendrarajan S, Zangari M, Shah N, van Rhee F, Dhakal B, Hamadani M, D'Souza A, Schinke C) Bone Marrow Transplant 2024 May;59(5):647-652 7 Citations |
| 1 | New phase 1 SURPASS trial cohort: Early-line ADP-A2M4CD8 T-cell receptor T-cell therapy plus pembrolizumab in urothelial carcinoma (David H Aggen, Alejandro Garcia, Jose M Saro Suarez, Amy Sauer, Sebastiano Cristiani, Francine Elizabeth Brophy, Sharon Streets, Elliot Norry, Ariel Ann Nelson, Deepak Kilari, Benjamin Garmezy, John A. Charlson, Jon Zugazagoitia, Emiliano Calvo, Irene Moreno, Victor Moreno, Christopher J. Hoimes, David S. Hong, Andres Cervantes) J Clin Oncol J Clin Oncol 42, 2024 (suppl 4; abstr TPS708) |
| 1 | International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update. (Rotz SJ, Bhatt NS, Hamilton BK, Duncan C, Aljurf M, Atsuta Y, Beebe K, Buchbinder D, Burkhard P, Carpenter PA, Chaudhri N, Elemary M, Elsawy M, Guilcher GM, Hamad N, Karduss A, Peric Z, Purtill D, Rizzo D, Rodrigues M, Ostriz MBR, Salooja N, Schoemans H, Seber A, Sharma A, Srivastava A, Stewart SK, Baker KS, Majhail NS, Phelan R) Transplant Cell Ther 2024 Apr;30(4):349-385 5 Citations |
| 1 | International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update. (Rotz SJ, Bhatt NS, Hamilton BK, Duncan C, Aljurf M, Atsuta Y, Beebe K, Buchbinder D, Burkhard P, Carpenter PA, Chaudhri N, Elemary M, Elsawy M, Guilcher GMT, Hamad N, Karduss A, Peric Z, Purtill D, Rizzo D, Rodrigues M, Ostriz MBR, Salooja N, Schoemans H, Seber A, Sharma A, Srivastava A, Stewart SK, Baker KS, Majhail NS, Phelan R) Bone Marrow Transplant 2024 Jun;59(6):717-741 5 Citations |
| 1 | Erratum to: Fields EC, Erickson B, Hubbard A, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M. Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy. Int J Radiat Oncol Biol Phys 2023;117:1138–1142 (International Journal of Radiation Oncology, Biology, Physics (2023) 117(5) (1138–1142), (S0360301623075922), (10.1016/j.ijrobp.2023.06.2516)) (Fields EC, Erickson B, Hubbard A, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M) International Journal of Radiation Oncology Biology Physics 1 March 2024;118(3):869 |
| 1 | Association of Tongue Strength and Maximum Incisal Opening with Oral Intake in Persons with Head and Neck Cancer Treated with Radiotherapy: A Retrospective Study. (Pauloski BR, Nitschke T, Schultz S, Bloedel S, Amman A, Kessler L, Lisowski K) Dysphagia 2024 Aug;39(4):726-734 |
| 1 | Molecular therapeutics in hematology: Gene therapy (McKillop WM, Medin JA) Molecular Hematology 8 March 2024:321-341 1 Citation |
| 1 | Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021. (Stevens SM, Woller SC, Baumann Kreuziger L, Doerschug K, Geersing GJ, Klok FA, King CS, Murin S, Vintch JRE, Wells PS, Wasan S, Moores LK) Chest 2024 Aug;166(2):388-404 18 Citations |
| 1 | Future direction of total neoadjuvant therapy for locally advanced rectal cancer. (Kagawa Y, Smith JJ, Fokas E, Watanabe J, Cercek A, Greten FR, Bando H, Shi Q, Garcia-Aguilar J, Romesser PB, Horvat N, Sanoff H, Hall W, Kato T, Rödel C, Dasari A, Yoshino T) Nat Rev Gastroenterol Hepatol 2024 Jun;21(6):444-455 17 Citations |
| 3 | Inpatient education reduces length of outpatient oxygen therapy in bronchopulmonary dysplasia: A quality improvement project. (Berlin KEK, Lagatta J, Dawson S, Malnory M, Scott W, Sprecher A) Pediatr Pulmonol 2024 Jun;59(6):1677-1685 |
| 1 | Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy. (Melody M, Epperla N, Shouse G, Romancik J, Allen P, Moyo TK, Kenkre V, Ollila T, Fitzgerald L, Hess B, David K, Herr MM, Odetola O, Lin A, Moreira J, Ma S, Winter JN, Roy I, Stephens D, Danilov A, Shah NN, Barta SK, Cortese M, Cohen JB, Gordon LI, Karmali R) Blood Adv 2024 May 28;8(10):2327-2331 10 Citations |
| 1 | Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapy. (Lunning MA, Wang HL, Hu ZH, Locke FL, Siddiqi T, Jacobson CA, Ahmed S, Miklos DB, Lin Y, Hill BT, Ghobadi A, Neelapu SS, Westin J, Dieyi C, Field P, Miao H, Shahani SA, Patel A, Spooner C, Fu C, Muramoto D, Xu H, Pasquini MC) Am J Hematol 2024 May;99(5):880-889 2 Citations |
| 1 | DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma. (Kirk AM, Crawford JC, Chou CH, Guy C, Pandey K, Kozlik T, Shah RK, Chung S, Nguyen P, Zhang X, Wang J, Bell M, Mettelman RC, Allen EK, Pogorelyy MV, Kim H, Minervina AA, Awad W, Bajracharya R, White T, Long D Jr, Gordon B, Morrison M, Glazer ES, Murphy AJ, Jiang Y, Fitzpatrick EA, Yarchoan M, Sethupathy P, Croft NP, Purcell AW, Federico SM, Stewart E, Gottschalk S, Zamora AE, DeRenzo C, Strome SE, Thomas PG) Cell Rep Med 2024 Mar 19;5(3):101469 3 Citations |
| 1 | Image-Based Biomarkers in Magnetic Resonance-Guided Radiotherapy (MRgRT) (Andrea D’Aviero, Haidy Nasief, Charlotte Robert & Davide Cusumano ) Springer Nature |
| 1 | Necrotizing granulomatous epididymo-orchitis post intravesical BCG administration after brachytherapy for prostate cancer. (Jhaveri JK, Dahmen A, Lazarovich A, Nusbaum D, Trinh QD, Gupta N, Agarwal PK) Urol Case Rep 2024 May;54:102694 |
| 1 | An anti-GD2 aptamer-based bifunctional spherical nucleic acid nanoplatform for synergistic therapy targeting MDM2 for retinoblastoma. (Wang S, Zhao Y, Yao F, Wei P, Ma L, Zhang S) Biomed Pharmacother 2024 May;174:116437 2 Citations |
| 4 | Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy. (SenthilKumar G, Schottstaedt AM, Peterson LL, Pedersen LN, Chitambar CR, Vistocky A, Banerjee A, Longo JM, Kelly T, Currey A, Stolley MR, Bergom C) Cancer Res Commun 2024 May 07;4(5):1211-1226 3 Citations |
| 2 | Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy. (Karmali R, Machhi R, Epperla N, Shouse G, Romancik J, Moyo TK, Kenkre V, Ollila TA, Fitzgerald L, Hess B, David K, Roy I, Zurko J, Chowdhury SM, Annunzio K, Ferdman R, Bhansali RS, Harris EI, Liu J, Nizamuddin I, Ma S, Moreira J, Winter J, Pro B, Stephens DM, Danilov A, Shah NN, Cohen JB, Barta SK, Torka P, Gordon LI) Blood Adv 2024 May 28;8(10):2592-2599 9 Citations |
| 1 | Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study. (Kittai AS, Bond D, Huang Y, Bhat SA, Blyth E, Byrd JC, Chavez JC, Davids MS, Dela Cruz JP, Dowling MR, Duffy C, Ho C, Jacobson C, Jaglowski S, Jain N, Lin KH, Miller C, McCarthy C, Omer Z, Parry E, Rai M, Rogers KA, Saha A, Schachter L, Scott H, Senapati J, Shadman M, Siddiqi T, Stephens DM, Vanguru V, Wierda W, Woyach JA, Thompson PA) J Clin Oncol 2024 Jun 10;42(17):2071-2079 12 Citations |
| 1 | Efficacy of Multiple SARS-CoV-2 Vaccine Doses in Patients with B Cell Hematologic Malignancies Receiving Chimeric Antigen Receptor T Cell Therapy: A Contemporary Cohort Analysis. (Abid MB, Rubin M, Szabo A, Longo W, Fenske TS, McCoy C, Lorge A, Abedin S, D'Souza A, Dhaka! B, Shah NN, Hamadani M.) Transplant Cell Ther. 30(3):285-297 |
| 4 | Adherence to adjuvant endocrine therapy for breast cancer: a qualitative exploration of attribution of symptoms among post-menopausal women. (Lee AY, Lyons AT, Makris V, Kamaraju S, Stolley MR, Neuner JM, Flynn KE) Support Care Cancer 2024 Apr 02;32(4):265 |
| 1 | Local Immunoradiotherapy in Patients With Metastatic Soft-Tissue Sarcoma-Reply. (Seo YD, Pollack SM) JAMA Oncol 2024 Jun 01;10(6):830-831 |
| 1 | Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma. (Denlinger N, Song NJ, Zhang X, Jeon H, Peterson C, Wang Y, Reynolds K, Bolz RM, Miao J, Song C, Wu D, Chan WK, Bezerra E, Epperla N, Voorhees TJ, Brammer J, Kittai AS, Bond DA, Sawalha Y, Sigmund A, Reneau JC, Rubinstein MP, Hanel W, Christian B, Baiocchi RA, Maddocks K, Alinari L, Vasu S, de Lima M, Chung D, Jaglowski S, Li Z, Huang X, Yang Y) Blood Adv 2024 Jun 25;8(12):3140-3153 2 Citations |
| 1 | Effects of photobiomodulation therapy on muscle function in individuals with multiple sclerosis. (Rouhani M, Tolentino M, Lyons JA, Ng AV) Mult Scler Relat Disord 2024 Jun;86:105598 2 Citations |
| 2 | ASTCT Committee on Practice Guidelines Survey on Evaluation and Management of Relapsed/Refractory Multiple Myeloma after Failure of Chimeric Antigen Receptor T Cell Therapy. (Hashmi H, Kumar A, Kharfan-Dabaja MA, Munshi PN, Inamoto Y, DeFilipp Z, Dholaria B, Jain T, Perales MA, Carpenter PA, Hamadani M, Dhakal B, Usmani SZ) Transplant Cell Ther 2024 Aug;30(8):750-759 1 Citation |
| 1 | Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy. (Sepah YJ, Do DV, Mesquida M, Day BM, Blotner S, Afridi R, Halim MS, Hong K, Wakshull E, Fauser S, Stoilov I, Dong Nguyen Q, HARBOR, READ-3 Investigators) Eye (Lond) 2024 Jun;38(9):1755-1761 1 Citation |
| 3 | Evaluation and mitigation of deformable image registration uncertainties for MRI-guided adaptive radiotherapy. (Zhong H, Kainz KK, Paulson ES) J Appl Clin Med Phys 2024 Jun;25(6):e14358 2 Citations |
| 1 | High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapy. (Fujiwara Y, Kato S, Nishizaki D, Miyashita H, Lee S, Nesline MK, Conroy JM, DePietro P, Pabla S, Lippman SM, Kurzrock R) iScience 2024 Apr 19;27(4):109632 3 Citations |
| 1 | High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapy (Fujiwara Y, Kato S, Nishizaki D, Miyashita H, Lee S, Nesline MK, Conroy JM, DePietro P, Pabla S, Lippman SM, Kurzrock R) iScience 19 April 2024;27(4) 3 Citations |
| 1 | Navigating uncharted territory: a case report and literature review on the remarkable response to personalized crizotinib containing combinational therapy in a pazopanib refractory patient with novel alterations. (Aydın E, Tokat ÜM, Özgü E, Adibi A, Tutar O, Kurzrock R, Demiray M) Ther Adv Med Oncol 2024;16:17588359241247023 |
| 2 | Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk. (Callander NS, Silbermann R, Kaufman JL, Godby KN, Laubach J, Schmidt TM, Sborov DW, Medvedova E, Reeves B, Dhakal B, Rodriguez C, Chhabra S, Chari A, Bal S, Anderson LD Jr, Dholaria BR, Nathwani N, Hari P, Shah N, Bumma N, Holstein SA, Costello C, Jakubowiak A, Wildes TM, Orlowski RZ, Shain KH, Cowan AJ, Pei H, Cortoos A, Patel S, Lin TS, Giri S, Costa LJ, Usmani SZ, Richardson PG, Voorhees PM) Blood Cancer J 2024 Apr 22;14(1):69 13 Citations |
| 1 | Amniotic Membrane Augmentation for Enucleation After Chemotherapy in Retinoblastoma. (Ramasubramanian A, Rehman NS, Chauhan A, Rodriguez A, Leverant A, Tiwari N) J Pediatr Ophthalmol Strabismus 2024;61(4):291-295 |
| 1 | MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study (Sritharan K, Daamen L, Pathmanathan A, Schytte T, Pos F, Choudhury A, van der Voort van Zyp JRN, Kerkmeijer LGW, Hall W, Hall E, Verkooijen HM, Herbert T, Hafeez S, Mitchell A, Tree AC) Clinical and Translational Radiation Oncology May 2024;46 2 Citations |
| 3 | Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy. (Westerhoff JM, Daamen LA, Christodouleas JP, Blezer ELA, Choudhury A, Westley RL, Erickson BA, Fuller CD, Hafeez S, van der Heide UA, Intven MPW, Kirby AM, Lalondrelle S, Minsky BD, Mook S, Nowee ME, Marijnen CAM, Orrling KM, Sahgal A, Schultz CJ, Faivre-Finn C, Tersteeg RJHA, Tree AC, Tseng CL, Schytte T, Silk DM, Eggert D, Luzzara M, van der Voort van Zyp JRN, Verkooijen HM, Hall WA) JAMA Netw Open 2024 May 01;7(5):e2410819 4 Citations |
| 1 | Correlation between steroid receptor expression and response to progestational therapy in patients with atypical endometrial hyperplasia or cancer. (Zaiem F, Bedi M, Kheil M, Abujamea A, Jain D, Rosen D, Alkaram W, Kim S, Ali-Fehmi R, Gogoi R) Gynecol Oncol Rep 2024 Jun;53:101402 |
| 2 | CAR T-cell therapy in mantle cell lymphoma with secondary CNS involvement: a multicenter experience. (Ahmed G, Alsouqi A, Szabo A, Samples L, Shadman M, Awan FT, Rojek AE, Riedell PA, Iqbal M, Fenske TS, Kharfan-Dabaja MA, Ito S, Hamadani M) Blood Adv 2024 Jul 09;8(13):3528-3531 3 Citations |
| 1 | Potential limitations of microdystrophin gene therapy for Duchenne muscular dystrophy. (Hart CC, Lee YI, Xie J, Gao G, Lin BL, Hammers DW, Sweeney HL) JCI Insight 2024 May 07;9(11) 8 Citations |
| 1 | ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer. (Alvarez J, Shi Q, Dasari A, Garcia-Aguilar J, Sanoff H, George TJ, Hong TS, Yothers G, Philip PA, Nelson GD, Al Baghdadi T, Alese O, Zambare W, Omer DM, Verheij FS, Buckley J, Williams H, George M, Garcia R, O'Reilly EM, Meyerhardt JA, Shergill A, Horvat N, Romesser PB, Hall WA, Smith JJ) medRxiv 2024 Apr 27 |
| 1 | Images in Immunotherapy and Precision Oncology: A Case Report of Neurofibromatosis-1. (Deshpande A, Munoz J, Dabak V, Hanbali A, Kurzrock R) J Immunother Precis Oncol 2024 May;7(2):122-125 |
| 1 | Impact of Glucocorticoid Dose on Complete Response, Serious Infections, and Mortality During the Initial Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis of the Control Arms of Randomized Controlled Trials. (Figueroa-Parra G, Cuéllar-Gutiérrez MC, González-Treviño M, Sanchez-Rodriguez A, Flores-Gouyonnet J, Meade-Aguilar JA, Prokop LJ, Murad MH, Dall'Era M, Rovin BH, Houssiau F, Tamirou F, Fervenza FC, Crowson CS, Putman MS, Duarte-García A) Arthritis Rheumatol 2024 Sep;76(9):1408-1418 6 Citations |
| 2 | Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysis. (Alsouqi A, Ahmed G, Wang J, Cassanello G, Szabo A, Rojek AE, Riedell PA, Awan F, Samples L, Shadman M, Hu M, Bachanova V, Wesson W, Ahmed N, Iqbal M, Kharfan-Dabaja MA, Scordo M, Johnson PC, Chen YB, Ito S, Hamadani M, Frigault M) Am J Hematol 2024 Aug;99(8):1624-1627 3 Citations |
| 8 | Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series. (Mehdi M, Szabo A, Shreenivas A, Thomas JP, Tsai S, Christians KK, Evans DB, Clarke CN, Hall WA, Erickson B, Ahmed G, Thapa B, McFall T, George B, Kurzrock R, Kamgar M) Ther Adv Med Oncol 2024;16:17588359241253113 2 Citations |
| 2 | Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial. (Saba NF, Wong SJ, Nasti T, McCook-Veal AA, McDonald MW, Stokes WA, Anderson AM, Ekpenyong A, Rupji M, Abousaud M, Rudra S, Bates JE, Remick JS, Joshi NP, Woody NM, Awan M, Geiger JL, Shreenivas A, Samsa J, Ward MC, Schmitt NC, Patel MR, Higgins KA, Teng Y, Steuer CE, Shin DM, Liu Y, Ahmed R, Koyfman SA) JAMA Oncol 2024 Jul 01;10(7):896-904 2 Citations |
| 1 | External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline. (Alcorn S, Cortés ÁA, Bradfield L, Brennan M, Dennis K, Diaz DA, Doung YC, Elmore S, Hertan L, Johnstone C, Jones J, Larrier N, Lo SS, Nguyen QN, Tseng YD, Yerramilli D, Zaky S, Balboni T) Pract Radiat Oncol 2024;14(5):377-397 12 Citations |
| 2 | Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T-cell therapy: A CIBMTR analysis. (Epperla N, Hashmi H, Ahn KW, Allbee-Johnson M, Chen AI, Wirk B, Kanakry JA, Lekakis L, Kharfan-Dabaja MA, Scordo M, Riedell PA, Jain T, Shadman M, Sauter C, Hamadani M, Herrera AF, Ahmed S) Br J Haematol 2024 Sep;205(3):1202-1207 2 Citations |
| 3 | SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study. (Hill JA, Martens MJ, Young JH, Bhavsar K, Kou J, Chen M, Lee LW, Baluch A, Dhodapkar MV, Nakamura R, Peyton K, Howard DS, Ibrahim U, Shahid Z, Armistead P, Westervelt P, McCarty J, McGuirk J, Hamadani M, DeWolf S, Hosszu K, Sharon E, Spahn A, Toor AA, Waldvogel S, Greenberger LM, Auletta JJ, Horowitz MM, Riches ML, Perales MA) Clin Infect Dis 2024 Aug 16;79(2):542-554 8 Citations |
| 1 | Evaluation of potential cost savings through chemotherapy and biotherapy dose-rounding at a pediatric institution (Graff JM, Cramer J, Kolb LL, Agherrabi Z, Burgess M) Journal of Oncology Pharmacy Practice June 2024;30(4):705-709 |
| 1 | Patient-Reported Outcomes Following Magnetic Resonance-Guided Radiation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis. (Westerhoff JM, Lalmahomed TA, Meijers LTC, Henke L, Teunissen FR, Bruynzeel AME, Alongi F, Hall WA, Kishan AU, Intven MPW, Verkooijen HM, van der Voort van Zyp JRN, Daamen LA) Int J Radiat Oncol Biol Phys 2024 Sep 01;120(1):38-48 2 Citations |
| 2 | Weathering the storm when the end of the road is near: A qualitative analysis of supportive care needs during CAR T-cell therapy in pediatrics. (Steineck A, Silbert SK, Palm K, Nepper J, Vaughn D, Shipman K, Shalabi H, Wiener L, Comiskey L, Knight JM, Levine D) Pediatr Blood Cancer 2024 Sep;71(9):e31092 1 Citation |
| 1 | Timing of Toxicities and Non-Relapse Mortality Following CAR T Therapy in Myeloma. (Wesson W, Dima D, Suleman N, Saif MSI, Tabak C, Logan E, Davis JA, McGann M, Furqan F, Mohan M, Rashid A, Abdallah AO, Ullah F, Shune L, Mushtaq MU, Raza S, McGuirk J, Hamadani M, Anwer F, Hashmi H, Ahmed N) Transplant Cell Ther 2024 Sep;30(9):876-884 8 Citations |
| 1 | Charting the Course: Sequencing Immunotherapy for Multiple Myeloma. (Mohan M, Van Oekelen O, Akhtar OS, Cohen A, Parekh S) Am Soc Clin Oncol Educ Book 2024 Jun;44(3):e432204 |
| 1 | A multi-institutional comparison of retrospective deformable dose accumulation for online adaptive magnetic resonance-guided radiotherapy. (Murr M, Bernchou U, Bubula-Rehm E, Ruschin M, Sadeghi P, Voet P, Winter JD, Yang J, Younus E, Zachiu C, Zhao Y, Zhong H, Thorwarth D) Phys Imaging Radiat Oncol 2024 Apr;30:100588 1 Citation |
| 2 | Patient engagement in hematopoietic stem cell transplantation and cell therapy: a survey by the EBMT patient engagement task force & transplantation complications working party. (Schoemans H, Burns LJ, Liptrott SJ, Murray J, Kenyon M, Barata A, Bolaños N, Scholl I, Hamilton B, Phelan R, Buchbinder D, Penack O, Moiseev I, Boreland W, Peczynski C, De Geest S, Sureda A, Snowden JA, Shaw B, Peric Z, Kroeger N) Bone Marrow Transplant 2024 Sep;59(9):1286-1294 2 Citations |
| 1 | EDucated: The emergency medicine pharmacotherapy literature of 2023. (Koehl J, Brown CS, Faine B, Rech MA, Zimmerman DE, Flack T, Gilbert BW, Howington GT, Laub J, Porter B, Slocum GW, Zepeski A, Feldman R, Santiago RD, Sarangarm P) Am J Emerg Med 2024 Aug;82:166-173 1 Citation |
| 1 | Reassess Antibiotic Therapy (Shannon, ET) SIDP Author, blog post. “Reassess Antibiotic Therapy”. Invited writer by the Society of Infectious Diseases Pharmacist (SIDP) for the Antibiotic Awareness Week Campaign. Available at:https://sidp.org/AAWReassessing. November 2019. |
| 10 | Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry. (Cusatis R, Litovich C, Feng Z, Allbee-Johnson M, Kapfhammer M, Mattila D, Akinola I, Phelan R, Broglie L, Auletta JJ, Steinert P, Bolon YT, Akhtar O, Bloomquist J, Chen M, Devine SM, Bupp C, Hamadani M, Hengen M, Jaglowski S, Kaur M, Kuxhausen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Rizzo D, Saber W, Spellman SR, Stefanski HE, Tuschl E, Yusuf R, Zhan K, Flynn KE, Shaw BE) Transplant Cell Ther 2024 Sep;30(9):917.e1-917.e12 20 Citations |
| 1 | Effect of Non-ablative Medical Therapy on Progression of Hearing Loss in Menière's Disease: A Systematic Review and meta-Analysis. (Thompson-Harvey A, Pyle M, Harvey E, Harris MS) Otol Neurotol 2024 Sep 01;45(8):833-839 1 Citation |
| 1 | International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges faced. (Gupta AO, Azul M, Bhoopalan SV, Abraham A, Bertaina A, Bidgoli A, Bonfim C, DeZern A, Li J, Louis CU, Purtill D, Ruggeri A, Boelens JJ, Prockop S, Sharma A) Cytotherapy 2024 Nov;26(11):1411-1420 3 Citations |
| 1 | Bifunctional black phosphorus quantum dots platform: Delivery and remarkable immunotherapy enhancement of STING agonist. (Zhang Y, Wang S, Rha H, Xu C, Pei Y, Ji X, Zhang J, Lu R, Zhang S, Xie Z, Kim JS) Biomaterials 2024 Dec;311:122696 4 Citations |
| 1 | Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society for Transplantation and Cellular Therapy and the European Society for Blood and Marrow Transplantation. (Iqbal M, Kumar A, Dreger P, Chavez J, Sauter CS, Sureda AM, Bachanova V, Maziarz RT, Dreyling M, Smith SM, Jacobson C, Glass B, Casulo C, Oluwole OO, Montoto S, Advani R, Cohen J, Salles G, Hamad N, Kuruvilla J, Kahl BS, Shadman M, Kanate AS, Budde LE, Kamdar M, Flowers C, Hamadani M, Kharfan-Dabaja MA) Transplant Cell Ther 2024 Sep;30(9):832-843 1 Citation |
| 3 | Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission. (Shadman M, Ahn KW, Kaur M, Lekakis L, Beitinjaneh A, Iqbal M, Ahmed N, Hill B, Hossain NM, Riedell P, Gopal AK, Grover N, Frigault M, Brammer J, Ghosh N, Merryman R, Lazaryan A, Ram R, Hertzberg M, Savani B, Awan F, Khimani F, Ahmed S, Kenkre VP, Ulrickson M, Shah N, Kharfan-Dabaja MA, Herrera A, Sauter C, Hamadani M) Blood Cancer J 2024 Jul 08;14(1):108 5 Citations |
| 1 | North American Fetal Therapy Network: Maternal Outcomes in Fetal Aqueductal Stenosis. (Emery SP, Lopa S, Peterson E, Miller JL, Treadwell MC, Gebb J, Galan H, Bergh EP, Criebaum A, McLennan A, Lillegard JB, Blumenfeld YJ, Turan OM, Streitman DC) Fetal Diagn Ther 2024;51(6):612-616 1 Citation |
| 2 | CD19-directed CART therapy for T-cell/histiocyte-rich large B-cell lymphoma. (Pophali PA, Fein JA, Ahn KW, Allbee-Johnson M, Ahmed N, Awan FT, Farhan S, Grover NS, Hilal T, Iqbal M, Maakaron J, Modi D, Nasrollahi E, Schachter LG, Sauter C, Hamadani M, Herrera A, Shouval R, Shadman M) Blood Adv 2024 Oct 22;8(20):5290-5296 5 Citations |
| 3 | Sequencing of Targeted Therapy in Psoriasis: Does it Matter? (Boswell ND, Singla S, Gordon KB) Am J Clin Dermatol 2024 Sep;25(5):795-810 2 Citations |
| 1 | TIM-3 blockade enhances ex vivo stimulated allogeneic NK cell therapy for relapsed murine neuroblastoma after hematopoietic cell transplant. (Quamine A, Mohrdieck NR, King CA, Griggs AA, Kline JM, Cho MM, Rinella SP, Tippins KE, Bates PD, Shi L, Song L, Hess NJ, Kearl TJ, Johnson BD, Capitini CM) bioRxiv 2024 Jul 12 |
| 1 | Deformable dose accumulation is required for adaptive radiotherapy practice. (Zhong H, Pursley JM, Rong Y) J Appl Clin Med Phys 2024 Aug;25(8):e14457 1 Citation |
| 1 | Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer. (Alvarez JA, Shi Q, Dasari A, Garcia-Aguilar J, Sanoff H, George TJ, Hong T, Yothers G, Philip P, Nelson G, Al Baghdadi T, Alese OB, Zambare W, Omer D, Verheij FS, Bercz A, Kim MJ, Buckley J, Williams H, George M, Garcia R, Gallagher P, O'Reilly EM, Meyerhardt JA, Crawley J, Shergill A, Horvat N, Romesser PB, Hall W, Smith JJ) BMC Cancer 2024 Jul 26;24(1):901 6 Citations |
| 2 | In Pursuit of Optimal Outcomes: A Framework for Quality Standards in Immune Effector Cell Therapy. (Dandoy CE, Adams J, Artz A, Bredeson C, Dahi PB, Dodd T, Jaglowski S, Lehmann L, LeMaistre CF, Mian A, Neal A, Page K, Rizzo JD, Rotz S, Sorror M, Steinberg A, Viswabandya A, Howard DS, Committee on Quality Outcomes of the American Society of Transplant and Cellular Therapy) Transplant Cell Ther 2024 Oct;30(10):942-954 1 Citation |
| 1 | EDucated: The emergency medicine pharmacotherapy literature of 2023 (Koehl J, Brown CS, Faine B, Rech MA, Zimmerman DE, Flack T, Gilbert BW, Howington GT, Laub J, Porter B, Slocum GW, Zepeski A, Feldman R, Santiago RD, Sarangarm P) American Journal of Emergency Medicine August 2024;82:166-173 1 Citation |
| 1 | Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies. (Shahid Z, Jain T, Dioverti V, Pennisi M, Mikkilineni L, Thiruvengadam SK, Shah NN, Dadwal S, Papanicolaou G, Hamadani M, Carpenter PA, Alfaro GM, Seo SK, Hill JA) Transplant Cell Ther 2024 Oct;30(10):955-969 10 Citations |
| 1 | Evaluating clinically translatable conditioning for platelet gene therapy in murine hemophilia A with inhibitors. (Chen Y, Li J, Schroeder JA, Jing W, Shi Q) J Thromb Haemost 2024 Nov;22(11):3035-3047 |
| 2 | Extracorporeal Membrane Oxygenation (ECMO)-Assisted Tracheostomy in a Patient with a "Woody Neck" Due to Radiation Therapy and Complicated by Bilateral Internal Jugular Vein Occlusion: A Case Report. (Bales T, Hamid A, Fadumiye CO) Int Med Case Rep J 2024;17:739-744 |
| 3 | Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma. (Chakraborty R, Cheruvalath H, Patwari A, Szabo A, Schinke C, Dhakal B, Lentzsch S, D'Souza A, Mohyuddin GR, Julian K, Midha S, Costello P, Kaiser M, Hing MNL, Harrison SJ, Cliff ERS, Mohan M) Blood Cancer J 2024 Aug 12;14(1):137 2 Citations |
| 1 | Shifting neoadjuvant chemotherapy treatment paradigms for breast cancer and its impact on axillary nodal management for clinically node-negative patients. (Cortina CS) Gland Surg 2024 Jul 30;13(7):1154-1158 1 Citation |
| 1 | Clinical, Pathologic, and Dosimetric Predictors of Head and Neck Lymphedema Following Definitive or Adjuvant Radiation Therapy for Head and Neck Cancer. (Rogacki KR, Teo PT, Gopalakrishnan M, Pachigolla SL, Lyons CE, Abazeed ME, Das I, Mittal BB, Gentile M) Adv Radiat Oncol 2024 Sep;9(9):101545 |
| 7 | Patterns of Locoregional Pancreatic Cancer Recurrence After Total Neoadjuvant Therapy and Implications on Optimal Neoadjuvant Radiation Treatment Volumes. (Beltran Ponce SE, Small CJ, Ahmad T, Patel K, Tsai S, Kamgar M, George B, Kharofa JR, Saeed H, Dua KS, Clarke CN, Aldakkak M, Evans DB, Christians K, Paulson ES, Erickson B, Hall WA) Pract Radiat Oncol 2025;15(1):e47-e56 |
| 1 | Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy. (Chakraborty R, Zanwar S, Hegenbart U, Bhutani D, Gertz MA, Dispenzieri A, Kumar S, D'Souza A, Patwari A, Cowan A, Chen G, Milani P, Palladini G, Sanchorawala V, Bodanapu G, Schönland SO, Lentzsch S, Muchtar E) Blood 2024 Dec 19;144(25):2613-2624 4 Citations |
| 1 | Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemotherapy: A Multicenter Experience. (Krishnan J, Patel A, Roy AM, Alharbi M, Kapoor A, Yao S, Khoury T, Hong CC, Held N, Chakraborty A, Kaliniski P, Salman A, Catalfamo K, Attwood K, Kirtani V, Shaikh SS, Chaudhary LN, Gandhi S) Clin Breast Cancer 2024 Dec;24(8):e701-e711.e2 2 Citations |
| 2 | Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy. (Mercadal S, Ahn KW, Allbee-Johnson M, Ganguly S, Geethakumari PR, Hong S, Malone A, Murthy H, Pawarode A, Sica AR, Solh M, Ustun C, Shadman M, Sauter CS, Hamadani M, Herrera AF, Lee CJ) Haematologica 2025 Jan 01;110(1):218-221 1 Citation |
| 1 | Pre-post assessment of student application of medication therapy management skills in virtual environments using English and non-English patients. (Kavanaugh R, Koehler J, Barazowski J, Sokhal D) Curr Pharm Teach Learn 2024 Dec;16(12):102186 |
| 1 | Platinum Chemotherapy After PARP Inhibition in HRR-Deficient Metastatic Castration-Resistant Prostate Cancer. (Obasi J, Sharma K, De Sarkar N, Antonarakis ES, Kilari D) Clin Genitourin Cancer 2024 Dec;22(6):102187 |
| 1 | Effects of Antihypertensive Therapy During Pregnancy on Postpartum Blood Pressure Control. (Martin SL, Kuo HC, Boggess K, Dugoff L, Sibai B, Lawrence K, Hughes BL, Bell J, Aagaard K, Gibson KS, Haas DM, Plante L, Metz TD, Casey BM, Esplin S, Longo S, Hoffman M, Saade GR, Foroutan J, Tuuli MG, Owens MY, Simhan HN, Frey HA, Rosen T, Palatnik A, Baker S, August P, Reddy UM, Kinzler W, Su EJ, Krishna I, Nguyen N, Norton ME, Skupski D, El-Sayed YY, Ogunyemi D, Galis ZS, Ambalavanan N, Oparil S, Librizzi R, Pereira L, Magann EF, Habli M, Williams S, Mari G, Pridjian G, McKenna DS, Parrish M, Chang E, Osmundson S, Quinones J, Werner E, Szychowski JM, Tita ATN, CHAP Consortium) Obstet Gynecol 2024 Oct 01;144(4):536-542 |
| 1 | Accrual to Radiotherapy Trials in the US-Pitfalls and Potential Solutions. (Sanford NN, Hall WA) JAMA Oncol 2024 Nov 01;10(11):1493-1494 |
| 1 | Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer. (Powles T, Catto JWF, Galsky MD, Al-Ahmadie H, Meeks JJ, Nishiyama H, Vu TQ, Antonuzzo L, Wiechno P, Atduev V, Kann AG, Kim TH, Suárez C, Chang CH, Roghmann F, Özgüroğlu M, Eigl BJ, Oliveira N, Buchler T, Gadot M, Zakharia Y, Armstrong J, Gupta A, Hois S, van der Heijden MS, NIAGARA Investigators) N Engl J Med 2024 Nov 14;391(19):1773-1786 40 Citations |
| 1 | Allogeneic Hematopoietic Cell Transplantation for the Treatment of Severe Aplastic Anemia: Evidence-Based Guidelines From the American Society for Transplantation and Cellular Therapy. (Iftikhar R, DeFilipp Z, DeZern AE, Pulsipher MA, Bejanyan N, Burroughs LM, Kharfan-Dabaja MA, Arai S, Kassim A, Nakamura R, Saldaña BJD, Aljurf M, Hamadani M, Carpenter PA, Antin JH) Transplant Cell Ther 2024 Dec;30(12):1155-1170 1 Citation |
| 3 | Integrating PARP Inhibitors in mCRPC Therapy: Current Strategies and Emerging Trends. (Thapa B, De Sarkar N, Giri S, Sharma K, Kim M, Kilari D) Cancer Manag Res 2024;16:1267-1283 3 Citations |
| 1 | Association of Hepatorenal Syndrome-Acute Kidney Injury with Mortality in Patients with Cirrhosis Requiring Renal Replacement Therapy: Results from the HRS-HARMONY Consortium. (Cama-Olivares A, Ouyang T, Takeuchi T, St Hillien SA, Robinson JE, Chung RT, Cullaro G, Karvellas CJ, Levitsky J, Orman ES, Patidar KR, Regner KR, Saly DL, Sawinski D, Sharma P, Teixeira JP, Ufere NN, Velez JCQ, Wadei HM, Wahid N, Allegretti AS, Neyra JA, Belcher JM, HRS-HARMONY Consortium) Kidney360 2025 Feb 01;6(2):247-256 |
| 1 | Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial. (Shah NN, Wang M, Roeker LE, Patel K, Woyach JA, Wierda WG, Ujjani CS, Eyre TA, Zinzani PL, Alencar AJ, Ghia P, Lamanna N, Hoffmann MS, Patel MR, Flinn I, Gerson JN, Ma S, Coombs CC, Cheah CY, Lech-Maranda E, Fakhri B, Kim WS, Barve MA, Cohen JB, Jurczak W, Munir T, Thompson MC, Tsai DE, Bao K, Cangemi NA, Kherani JF, Walgren RA, Han H, Ruppert AS, Brown JR) Haematologica 2025 Jan 01;110(1):92-102 3 Citations |
| 1 | Dual convolution-transformer UNet (DCT-UNet) for organs at risk and clinical target volume segmentation in MRI for cervical cancer brachytherapy. (Kim G, Viswanathan AN, Bhatia R, Landman Y, Roumeliotis M, Erickson B, Schmidt EJ, Lee J) Phys Med Biol 2024 Oct 18;69(21) |
| 1 | Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review. (Karimi M, Shirsalimi N, Hashempour Z, Salehi Omran H, Sedighi E, Beigi F, Mortezazadeh M) Front Immunol 2024;15:1439176 9 Citations |
| 7 | Outcomes of frail patients undergoing high-dose chemotherapy and autologous stem cell transplantation for multiple myeloma. (Yohay S, Oloyede T, Kim S, Fang X, Dhakal B, Aijaz A, Mohan M, Narra R, Pasquini M, D'Souza A, Hamadani M, Freeman CL, Akhtar OS) Br J Haematol 2024 Dec;205(6):2370-2375 |
| 1 | Clonal dynamics of aggressive systemic mastocytosis on avapritinib therapy. (Huang X, Pomicter AD, Ahmann J, Qiao Y, Chen OS, George TI, Cruz-Rodriguez N, Guru SA, Marth GT, Deininger MW) Blood Cancer J 2024 Oct 14;14(1):179 |
| 1 | Evaluation of Retinal Structure and Visual Function in Blue Cone Monochromacy to Develop Clinical Endpoints for L-opsin Gene Therapy. (Cideciyan AV, Roman AJ, Warner RL, Sumaroka A, Wu V, Jiang YY, Swider M, Garafalo AV, Viarbitskaya I, Russell RC, Kohl S, Wissinger B, Ripamonti C, Barbur JL, Bach M, Carroll J, Morgan JIW, Aleman TS) Int J Mol Sci 2024 Oct 02;25(19) |
| 1 | Real-world treatment of large B-cell lymphoma with chimeric antigen receptor T-cell therapy after loncastuximab tesirine. (Hamadani M, Lucero M, DeVos JD, Chen L) EJHaem 2024 Oct;5(5):1110-1113 |
| 1 | Characterization of brass mesh bolus for electron beam therapy. (Lim SN, Sohn JJ, Klawikowski SJ, Hayes JP, Donnelly E, Das IJ) Biomed Phys Eng Express 2024 Oct 25;10(6) 1 Citation |
| 1 | Quality and Safety Considerations for Adaptive Radiation Therapy: An ASTRO White Paper. (Chetty IJ, Cai B, Chuong MD, Dawes SL, Hall WA, Helms AR, Kirby S, Laugeman E, Mierzwa M, Pursley J, Ray X, Subashi E, Henke LE) Int J Radiat Oncol Biol Phys 2024 Oct 16 2 Citations |
| 1 | Antihypertensive therapy and unplanned maternal postpartum healthcare utilization in patients with mild chronic hypertension. (Palatnik A, Leach J, Harper L, Sibai B, Longo S, Dugoff L, Lawrence K, Hughes BL, Bell J, Edwards RK, Gibson KS, Rouse C, Plante L, Hoppe KK, Foroutan J, Tuuli M, Simhan HN, Frey H, Rosen T, Metz TD, Baker S, Kinzler W, Su EJ, Krishna I, Norton ME, Skupski D, El-Sayed YY, Pereira L, Magann EF, Habli M, Geller NL, Williams S, McKenna DS, Chang E, Quiñones J, Szychowski JM, Tita ATN) Am J Obstet Gynecol MFM 2024 Dec;6(12):101525 |
| 1 | Outcomes with chimeric antigen receptor T-cell therapy in Rheumatological disorders: A systematic review. (Zulfiqar F, Shahzad M, Amin MK, Vyas A, Sarfraz Z, Zainab A, Qasim H, Kaur D, Khavandgar N, Lutfi F, Hematti P, McGuirk JP, Mushtaq MU) Transpl Immunol 2024 Dec;87:102137 1 Citation |
| 2 | Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis. (Pidala J, Kim J, Kalos D, Cutler C, DeFilipp Z, Flowers MED, Hamilton BK, Chin KK, Rotta M, El Jurdi N, Hamadani M, Ahmed G, Kitko C, Ponce D, Sung A, Tang H, Farhadfar N, Nemecek E, Pusic I, Qayed M, Rangarajan H, Hogan W, Etra A, Jaglowski S) Blood Adv 2025 Mar 11;9(5):1040-1048 2 Citations |
| 1 | Current Status of Immunotherapy in Management of Small Bowel Neuroendocrine Tumors. (Fields BC, Ayabe RI, Seo YD, Maxwell JE, Halperin DM) Curr Oncol Rep 2024 Nov;26(11):1530-1542 |
| 1 | Expedited Partner Therapy Review. (Jackson KJ, Pickett ML) Pediatr Emerg Care 2024 Nov 01;40(11):828-832 |
| 3 | Evaluation of Isopropyl Alcohol Aromatherapy in Treating Nausea in Helicopter Emergency Medical Services Patients (Koenig D, Young KP, Treat R, Liu JM, Lenz T) Air Medical Journal 1 November 2024;43(6):518-522 |
| 1 | Antigen-specific immunotherapy for platelet alloimmune disorders (Newman DK, Newman PJ) Human Immunology November 2024;85(6) |
| 1 | Life After EBPs: Characterizing Subsequent Engagement in Evidence-Based Psychotherapy After Completion of an Initial Trauma-Focused EBP in a National Sample of VA Patients. (Grau PP, Ganoczy D, Larsen SE, LoSavio ST, Sripada RK) Adm Policy Ment Health 2025 Mar;52(2):441-453 |
| 1 | Antigen-specific immunotherapy for platelet alloimmune disorders. (Newman DK, Newman PJ) Hum Immunol 2024 Nov;85(6):111172 |
| 1 | Transition to Enteral Triazole Antifungal Therapy for Pediatric Invasive Candidiasis: Secondary Analysis of a Multicenter Cohort Study Conducted by the Pediatric Fungal Network. (Bucayu RFT, Boge CLK, Yildirim I, Avilés-Robles M, Vora SB, Berman DM, Sharma TS, Sung L, Castagnola E, Palazzi DL, Danziger-Isakov L, Yin DE, Roilides E, Maron G, Tribble AC, Soler-Palacin P, López-Medina E, Romero J, Belani K, Arrieta AC, Carlesse F, Nolt D, Halasa N, Dulek D, Rajan S, Muller WJ, Ardura MI, Pong A, Gonzalez BE, Salvatore CM, Huppler AR, Aftandilian C, Abzug MJ, Chakrabarti A, Green M, Lutsar I, Knackstedt ED, Johnson SK, Steinbach WJ, Fisher BT, Wattier RL) J Pediatric Infect Dis Soc 2024 Dec 30;13(12):633-638 |
| 1 | Barriers to CAR T-cell therapy in rheumatology. (Lungova K, Putman M) Lancet Rheumatol 2025 Mar;7(3):e212-e216 1 Citation |
| 3 | NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiation Therapy. (Sanford NN, Narang AK, Aguilera TA, Bassetti MF, Chuong MD, Erickson BA, Goodman KA, Herman JM, Intven M, Kilcoyne A, Kim H, Paulson E, Reyngold M, Tsai S, Tchelebi LT, Tuli R, Versteijne E, Wei AC, Wo JY, Zhang Y, Hong TS, Hall WA) Int J Radiat Oncol Biol Phys 2025 Mar 15;121(4):918-929 2 Citations |
| 1 | Association between rheumatoid arthritis and risk of radiotherapy toxicity: a systematic review. (Liebenberg N, McWilliam A, Kerns SL, Marshall DC, West CM) BMJ Oncol 2024 Jan;3(1) |
| 1 | An energy-conserving dose summation method for dose accumulation in radiotherapy. (Zhong H) Med Phys 2025 Feb;52(2):1305-1310 |
| 1 | Consensus Guidelines for Delineation of Clinical Target Volumes for Intensity Modulated Radiation Therapy for Intact Cervical Cancer: An Update. (Fields EC, Bosch WR, Albuquerque KV, Bhatia R, Chino J, Dyer B, Erickson B, Fabian D, Gaffney D, Glaser S, Han K, Hathout L, Hsu IC, Jegadeesh N, Kahn J, Kidd E, Klopp A, Leung E, Lin L, Ludwig M, Ma T, Mell L, Mayadev J, Petersen I, Portelance L, Rash D, Taunk N, Viswanathan A, Wolfson A, Yashar C, Yeung A, Yoshida E, Fisher CM) Pract Radiat Oncol 2025;15(2):171-179 |
| 2 | Adjuvant breast radiation therapy practice patterns in the United States from 2012-2017. (Gellings JA, Cortina CS, Kijak J, Bradley J, Aldakkak M, Bergom C, Kong AL) Surg Oncol Insight 2024 Dec;1(4) |
| 1 | Role of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) in the Treatment of Peritoneal Carcinomatosis From Small Bowel Adenocarcinoma-A Systematic Review and Meta-Analysis. (Fernando DG, Sparapani R, Mogal H) J Surg Oncol 2024 Nov 17 |
| 3 | The association of distress and depression screening measures and other electronic health record information with adjuvant endocrine therapy persistence. (Neuner JM, Stolley M, Kamaraju S, Tiegs J, Sparapani R, Makris V, Flynn KE) Breast Cancer Res Treat 2025 Feb;209(3):541-552 |
| 2 | Platinum Chemotherapy After PARP Inhibition in HRR-Deficient Metastatic Castration-Resistant Prostate Cancer (Obasi J, Sharma K, De Sarkar N, Antonarakis ES, Kilari D) Clinical Genitourinary Cancer December 2024;22(6) |
| 2 | CAR T-cell therapy for B-cell lymphomas: outcomes and resistance mechanisms. (Kearl TJ, Furqan F, Shah NN) Cancer Metastasis Rev 2024 Dec 01;44(1):12 1 Citation |
| 1 | Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma. (Cloyd JM, Sarna A, Arango MJ, Bates SE, Bhutani MS, Bloomston M, Chung V, Dotan E, Ferrone CR, Gambino PF, Goenka AH, Goodman KA, Hall WA, He J, Hogg ME, Jayaraman S, Kambadakone A, Katz MHG, Khorana AA, Ko AH, Koay EJ, Kooby DA, Krishna SG, Larsson LK, Lee RT, Maitra A, Massarweh NN, Mikhail S, Muzaffar M, O'Reilly EM, Palta M, Petzel MQB, Philip PA, Reyngold M, Santa Mina D, Sohal DPS, Sundaresan TK, Tsai S, Turner KL, Vreeland TJ, Walston S, Washington MK, Williams TM, Wo JY, Snyder RA) JAMA Surg 2025 Feb 01;160(2):172-180 |
| 2 | Evaluation of Isopropyl Alcohol Aromatherapy in Treating Nausea in Helicopter Emergency Medical Services Patients. (Koenig D, Young KP, Treat R, Liu JM, Lenz T) Air Med J 2024;43(6):518-522 |
| 1 | Lacosamide as an Adjunctive Therapy in the Management of Refractory Neonatal Seizures: A Retrospective Study. (Sah JP, Javarayee P, Jain S, Karia S, Karakas C) J Child Neurol 2025 Apr;40(4):256-263 |
| 1 | Smart Polymer-Based Delivery Systems for Curcumin in Colon Cancer Therapy: A Review. (Kamath AJ, Donadkar AD, Nair B, Kumar AR, Sabitha M, Sethi G, Chauhan AS, Nath LR) Phytother Res 2025 Feb;39(2):698-713 |
| 1 | Characteristics and outcomes in patients with lenalidomide-refractory multiple myeloma treated with 1-3 prior lines of therapy: Analysis of individual patient-level data from daratumumab clinical trials. (Yong K, Einsele H, Schecter JM, Roccia T, Deraedt W, Lendvai N, Slaughter A, Lonardi C, Connors K, Qi K, Londhe A, Carson R, Kharat A, Cost P, Valluri S, Mendes J, Pacaud L, Patel N, Florendo E, Dhakal B) Eur J Cancer 2025 Jan 17;215:115157 1 Citation |
| 1 | Benchmarks of Success in Radiotherapy versus Systemic Therapy National Clinical Trials Network (NCTN) Randomized Controlled Trials Sponsored by the National Cancer Institute (NCI). (Sanford NN, Shi Q, Hein DM, Hall WA) J Natl Cancer Inst 2024 Dec 05 |
| 1 | Baseline echocardiographic variables as predictors of hemodynamically significant cytokine release syndrome in adults treated with CD19 CAR T-cell therapy for hematological malignancies. (Daryanani AE, Abbasi MA, Gomez Ardila MF, Tellez-Garcia E, Garzon-Dangond JM, Lin Y, Paludo J, Herrmann J, Ansell SM, Rosenthal AC, Villarraga HR) Cardiooncology 2024 Dec 21;10(1):91 |
| 1 | Enhancing Outcome Prediction for Pancreatic Cancer Following Stereotactic Body Radiotherapy Through MRI Radiomics Analysis (Jacob Marasco and Yu Lei and Ashok Bhandari and Garett Ostdiek-Wille and Alex Kolomaya and Charlene Rhodd and Fang Yu and Sumin Zhou and Chi Lin and Shuo Wang) Medical Research Archives MARASCO, Jacob T. et al. Enhancing Outcome Prediction for Pancreatic Cancer Following Stereotactic Body Radiotherapy Through MRI Radiomics Analysis. Medical Research Archives, [S.l.], v. 12, n. 12, dec. 2024. ISSN 2375-1924 |
| 1 | Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part IV. Patient Important Outcomes. (Rotz SJ, Wiener L, Baker KS, Choi SW, Phelan R, Cuvelier GDE, Duncan C, Williams KM, Qayed M) Transplant Cell Ther 2025 Apr;31(4):224.e1-224.e13 |
| 2 | Novel Approaches of Cellular Therapy in Multiple Myeloma: Focus on Chimeric Antigen Receptor T-Cells. (Narra RK, Peshin S, Dhakal B) Acta Haematol 2024 Dec 28:1-16 |
| 1 | Revisiting Injectable Estrogen Dosing Recommendations for Gender-Affirming Hormone Therapy. (Rothman MS, Hamnvik OR, Davidge-Pitts C, Safer JD, Ariel D, Tangpricha V, Abramowitz J, Soe K, Sarvaideo J, Kelley C, Irwig MS, Iwamoto SJ) Transgend Health 2024 Dec;9(6):463-465 2 Citations |
| 1 | Correction to: Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials (Dermatology and Therapy, (2024), 14, 8, (2235-2248), 10.1007/s13555-024-01224-x) (Armstrong AW, Augustin M, Beaumont JL, Pham TP, Hudgens S, Gordon KB, Zhuo J, Becker B, Zhong Y, Kisa RM, Banerjee S, Papp KA) Dermatology and Therapy 2025 |
| 1 | BIOLOGICAL INDIVIDUALIZATION OF RADIOTHERAPY (West CML, Marignol L, Kerns SL) Basic Clinical Radiobiology, Sixth Edition 1 January 2025:237-249 |
| 1 | “She tells me the HIV is eating my brains”: barriers and facilitators to antiretroviral therapy adherence among Eswatini adolescents living with HIV (Hlophe LD, Nyasulu PS, Shumba CS) AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV 2025;37(2):310-323 |
| 6 | Quantitative magnetic resonance imaging responses in head and neck cancer patients treated with magnetic resonance-guided hypofractionated radiation therapy (Bonate R, Awan MJ, Himburg HA, Wong S, Shukla M, Tarima S, Zenga J, Paulson ES) Physics and Imaging in Radiation Oncology January 2025;33 |
| 1 | New rectum dose surface mapping methodology to identify rectal subregions associated with toxicities following prostate cancer radiotherapy (Bouzaki A, Green D, van Herk M, Shortall J, Puri T, Kerns S, Azria D, Farcy-Jacquet MP, Chang-Claude J, Choudhury A, Dunning A, Lambrecht M, Avuzzi B, Ruysscher DD, Seibold P, Sperk E, Talbot C, Vega A, Veldeman L, Webb A, Rosenstein B, West CM, Gioscio E, Rancati T, Osorio EV, McWilliam A) Physics and Imaging in Radiation Oncology January 2025;33 |
| 1 | Utility of color Doppler imaging in patients with retinoblastoma treated by intra-arterial chemotherapy. (McInnis-Smith K, Abruzzo T, Riemann M, Goncalves LF, Ramasubramanian A) J AAPOS 2025 Feb;29(1):104093 |
| 2 | Engraft: A Collaborative Learning Health Network for Enhanced Transplant and Cellular Therapy Outcomes. (Dandoy CE, Auletta JJ, Badia P, Bidgoli A, Daraiseh NM, DeSalvo AM, Diaz J, Davies SM, Demmel K, Cook E, Craddock JA, Huber J, Sampson M, Fitch TJ, French K, Jodele S, Jaglowski SM, Kapadia MA, Khera N, Kent GR, Leung KS, Lehmann LE, Liang WH, Maier S, Nelson A, Nishitani M, O'Mathúna D, Johnson DJ, Magee K, Pai A, Parker LM, Phelan R, Epling P, Rotz S, Salem BM, Snyder A, Juckett M, Hartley D) Transplant Cell Ther 2025 Mar;31(3):123-134 |
| 1 | Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma: A Nonrandomized Clinical Trial. (Hoppe BS, Milgrom SA, Renfro LA, Wu Y, Schwartz CL, Constine LS, McCarten KM, Kelly KM, Hodgson D, Castellino SM, Keller FG) JAMA Oncol 2025 Mar 01;11(3):340-342 1 Citation |
| 1 | Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy-Tolerant Persister Cells in ER+ Breast Cancer. (Tau S, Chamberlin MD, Yang H, Marotti JD, Muskus PC, Roberts AM, Carmichael MM, Cressey L, Dragnev CPC, Demidenko E, Hampsch RA, Soucy SM, Kolling FW, Samkoe KS, Alvarez JV, Kettenbach AN, Miller TW) Cancer Res 2025 Mar 14;85(6):1145-1161 |
| 1 | The potential of antibody-drug conjugates for effective therapy in diffuse large B-cell lymphoma. (Ahmed G, Hamadani M, Al-Juhaishi T) Expert Opin Biol Ther 2025;25(2):161-173 |
| 1 | Lentivirus-mediated gene therapy for Fabry disease: 5-year End-of-Study results from the Canadian FACTs trial. (Khan A, Barber DL, McKillop WM, Rupar CA, Auray-Blais C, Fraser G, Fowler DH, Berger A, Foley R, Keating A, West ML, Medin JA) Clin Transl Med 2025 Jan;15(1):e70073 |
| 1 | "She tells me the HIV is eating my brains": barriers and facilitators to antiretroviral therapy adherence among Eswatini adolescents living with HIV. (Hlophe LD, Nyasulu PS, Shumba CS) AIDS Care 2025 Feb;37(2):310-323 |
| 1 | Evaluating the Effectiveness of Medical Therapy in Infantile Epileptic Spasms Syndrome due to surgically-remediable lesions (Singh, Avantika; Hadjincolaou, Aris; Briscoe Abath, Christina; Donatelli, Stephanie; Salussolia, Catherine; Gupta, Nishtha; Almansa, Alexandra Santana; Zhang, Bo; Stone, Scellig; Libenson, Mark; Samanta, Debopam; Bolton, Jeffrey; Harini, Chellamani
) Epilepsia |
| 5 | Platelet-Targeted Gene Therapy for Hemophilia A with Inhibitor History. (Eapen M, Malec LM, Armant MA, Johnson BD, Shi Q, Xu H, Du LM, Jerkins JH, Duffy LJ, Bushman FD, Lee C, Petrichenko A, Hematti P, Brazauskas R, Jobe SM, Hari PN, Wilcox DA) N Engl J Med 2025 Jan 23;392(4):412-414 3 Citations |
| 3 | Characterizing the Impact of Race and Contemporary Redlining on Receipt of Guideline-Concordant Locoregional Therapy Among Older Women With Breast Cancer. (Beltrán Ponce S, Canales B, McGinley EL, Yen TWF, Tarima S, Zhou Y, Bikomeye JC, Beyer KMM) Adv Radiat Oncol 2025 Feb;10(2):101688 |
| 1 | Access to CARe: A Narrative of Real-World Medical Decision-Making to Access Chimeric Antigen Receptor (CAR) T-Cell Therapy in Children, Adolescents, and Young Adults. (Steineck A, Chao K, Hall AG, Jacoby E, Leahy AB, Ligon JA, Luciani K, Schultz LM, Summers CN, Ward L, Winestone LE, Shah NN) Pediatr Blood Cancer 2025 Apr;72(4):e31516 |
| 1 | MEK inhibitor-based therapy in metastatic pancreatic adenocarcinoma with KRAS G12R alteration. (Auckley E, Ying G, Yohay S, Aldakkak M, Thalji SZ, Vakili P, Grahl J, Mayer B, Shahjehan F, Low SK, Evans DB, Christians KK, Seo YD, Erickson B, Hall WA, McFall T, Kurzrock R, George B, Kamgar M) Clin Oncol 43, 2025 (suppl 4; abstr 725), ASCO Gastrointestinal Cancer symposium, Poster Presentation; San Francisco, January 2025 |
| 1 | MEK inhibitor-based therapy in metastatic pancreatic adenocarcinoma with KRAS G12D or KRAS G12V alteration. (Yohay S, Ying G, Auckley E, Aldakkak M, Thalji SZ, Vakili P, Grahl J, Mayer B, Shahjehan F, Low SK, Evans DB, Christians KK, Seo YD, Erickson B, Hall WA, McFall T, Kurzrock R, George B, Kamgar M) Clin Oncol 43, 2025 (suppl 4; abstr 726), ASCO Gastrointestinal Cancer symposium, Poster Presentation; San Francisco, January 2025 |
| 1 | Impact of neoadjuvant radiation therapy modalities on post-surgical lymphopenia in operable pancreatic cancer. ( Low SK, Thalji S, Aldakkak M, Ying G, Yohay S, Auckley E, Vakili P, Shahjehan F , Evans DB , Christians KK , Seo YD, Erickson B, Small C , Heyer V, Neupane B, George B, Kothari A, Hall WA , Kamgar M) Clin Oncol 43, 2025 (suppl 4; abstr 710), ASCO Gastrointestinal Cancer symposium, Poster Presentation; San Francisco, January 2025 |
| 1 | Correction: Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy. (Sinha S, Dwivedi N, Tao S, Jamadar A, Kakade VR, O' Neil M, Weiss RH, Enders J, Calvet JP, Thomas SM, Rao R) Oncogene 2025 Mar;44(9):632-633 |
| 2 | Quantitative magnetic resonance imaging responses in head and neck cancer patients treated with magnetic resonance-guided hypofractionated radiation therapy. (Bonate R, Awan MJ, Himburg HA, Wong S, Shukla M, Tarima S, Zenga J, Paulson ES) Phys Imaging Radiat Oncol 2025 Jan;33:100693 |
| 2 | Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myeloma. (Dhakal B, Hari P, Chhabra S, Szabo A, Lum LG, Glass DD, Park JH, Donato M, Siegel DS, Felizardo TC, Fowler DH) J Immunother Cancer 2025 Jan 28;13(1) |
| 1 | Deep learning-based quick MLC sequencing for MRI-guided online adaptive radiotherapy: a feasibility study for pancreatic cancer patients. (Ahunbay A, Paulson E, Ahunbay E, Zhang Y) Phys Med Biol 2025 Feb 12;70(4) |
| 1 | The FACTs trial for Fabry disease highlights the promise and challenges of gene therapy (Medin JA, West ML) Clinical and Translational Discovery February 2025;5(1) |
| 4 | Characterizing the Impact of Race and Contemporary Redlining on Receipt of Guideline-Concordant Locoregional Therapy Among Older Women With Breast Cancer (Beltrán Ponce S, Canales B, McGinley EL, Yen TWF, Tarima S, Zhou Y, Bikomeye JC, Beyer KMM) Advances in Radiation Oncology February 2025;10(2) |
| 1 | Defining the Role of Adjuvant Radiotherapy for Biliary Tract Cancers: A Site-Specific Propensity-Matched Analysis (Seo YD, Acidi B, Newton A, Haddad A, Chiang YJ, Coelho R, Newhook TE, Tzeng CWD, Chun YS, Ludmir EB, Koay EJ, Javle M, Vauthey JN, Cao HST) Cancers February 2025;17(3) |
| 1 | Factors associated with longitudinal progression of the cumulative burden of morbidity and overall mortality after cisplatin-based chemotherapy for testicular cancer. (Kerns SL, Dinh PC Jr, Monahan PO, Stump T, Fung C, Sesso HD, Feldman DR, Hamilton RJ, Vaughn DJ, Huddart R, Kollmannsberger C, Martin NE, Nevel K, Kincaid J, Einhorn LH, Travis LB) J Natl Cancer Inst 2025 Feb 03 |
| 1 | How do you do it?: Gynecologic brachytherapy best practices at high volume institutions within the United States and Canada. (Small C, Ortiz S, Bedi M, Joyner M, Fields E, Glaser S, Erickson B) Brachytherapy 2025 Feb 03 |
| 1 | Maximum Surgical Resection Followed by Radiation Therapy for the Management of Mucinous Adenocarcinoma of the Prostate. (Patel KR, Hall WA) Int J Radiat Oncol Biol Phys 2025 Mar 01;121(3):582 |
| 1 | Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy. (Costa LJ, Medvedova E, Dhakal B, Dholaria BR, Godby KN, Bal S, Ravi G, Giri S, Chhabra S, Silbermann R, Callander NS) Blood Cancer J 2025 Feb 05;15(1):13 |
| 2 | Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial. (Shah NN, Schafer ES, Chi YY, Malvar J, Heym KM, Place AE, Burns M, Chang BH, Slone T, Verma A, Gossai N, Shaw PH, Burke MJ, Hermiston M, Schore RJ, Cooper T, Pauly M, Rushing T, Jarosinski P, Florendo E, Yates B, Widemann BC, Peer CJ, Figg WD, Silverman LB, Bhojwani D, Wayne AS) Pediatr Blood Cancer 2025 May;72(5):e31584 |
| 1 | Evaluating the effectiveness of medical therapy in infantile epileptic spasms syndrome due to surgically-remediable lesions. (Singh A, Hadjinicolaou A, Briscoe-Abath C, Donatelli S, Salussolia C, Gupta N, Almansa AS, Zhang B, Stone S, Libenson M, Samanta D, Bolton J, Harini C) Epilepsia 2025 Feb 13 |
| 1 | Automated hallucination detection for synthetic CT images used in MR-only radiotherapy workflows. (Parchur AK, Zarenia M, Gage C, Paulson ES, Ahunbay E) Phys Med Biol 2025 Feb 25;70(5) |
| 1 | Clinical Characteristics and Patient Outcomes with HLH-like Toxicities after CDl 9 Based CART-Cell Therapy. (Furqan, F., E. Aschenbrenner, J. Talano, A. Moskop, W. Longo, B.D. Johnson, T.S. Fenske, M. Hamadani, and N.N. Shah
) Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy 29(2): p. S131-S132. POSTER |
| 1 | Combination of pirtobrutinib and lentiviral transduced bispecific anti-CD20/CD 19 (LV20.19) CART-cell therapy to improve outcomes in patients with relapsed/refractory lymphoma (Furqan, F., K. Palen, B.D. Johnson, T. Kearl, P. Hematti, W. Longo, M. Hamadani, T. Fenske, and N.N. Shah) Journal of Clinical Oncology 42(suppl 16; abstr 7043). POSTER |
| 3 | Phase 1 study of lintuzumab-Ac225 combined with CLAG-M salvage therapy in relapsed/refractory acute myeloid leukemia. (Abedin SM, Guru Murthy GS, Hamadani M, Michaelis LC, Carlson KS, Runaas L, Gauger K, Desai AG, Chen MM, Li KL, Rotibi M, Syed U, Vusirikala M, Harrington A, Atallah EL) Leukemia 2025 Apr;39(4):837-843 |
| 1 | Mortality and amputation outcomes of infrainguinal bypass versus endovascular therapy based on body mass index. (Kricfalusi M, Hamouda M, Abdelkarim A, Farber A, Hart JP, Malas MB) J Vasc Surg 2025 Feb 19 |
| 1 | Cilostazol following endovascular therapy in peripheral arterial disease: Patient adherence (to yet another medication) could prove to be a bridge too far. (Hart JP) J Vasc Surg 2025 Mar;81(3):775-776 |
| 1 | Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials. (Dal Pra A, Ghadjar P, Ryu HM, Proudfoot JA, Hayoz S, Michalski JM, Spratt DE, Liu Y, Schär C, Berlin AM, Zwahlen DR, Simko JP, Hölscher T, Efstathiou JA, Polat B, Sandler HM, Hildebrandt G, Parliament MB, Mueller AC, Dayes IS, Plasswilm L, Correa RJM, Robertson JM, Karrison TG, Davicioni E, Hall WA, Feng FY, Pollack A, Thalmann GN, Nguyen PL, Aebersold DM, Tran PT, Zhao SG) Ann Oncol 2025 Feb 13 |
| 1 | Cardiac MRI for differentiating chemotherapy-induced cardiotoxicity in sarcoma and breast cancer. (Ibrahim EH, Chaudhary L, Cheng YC, Sosa A, An D, Charlson J) Radiol Oncol 2025 Mar 01;59(1):79-90 |
| 2 | A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate Cancer. (Farazi M, Yang X, Gehl CJ, Barnett GC, Burnet NG, Chang-Claude J, Parker CC, Dunning AM, Azria D, Choudhury A, Rancati T, De Ruysscher D, Seibold P, Sperk E, Talbot CJ, Veldeman L, Webb AJ, Elliott R, Aguado-Barrera ME, Carballo AM, Fuentes-Ríos O, Gómez-Caamaño A, Peleteiro P, Vega A, Ostrer H, Rosenstein BS, Saito S, Parliament M, Usmani N, Marples B, Chen Y, Morrow G, Messing E, Janelsins MC, Hall W, West CML, Auer PL, Kerns S) Cancer Epidemiol Biomarkers Prev 2025 Mar 03 |
| 1 | Reply to the Commentary on "Effect of Non-ablative Medical Therapy on Progression of Hearing Loss in Menière's Disease: A Systematic Review and Meta-Analysis". (Thompson-Harvey A, Pyle M, Harvey E, Harris MS) Otol Neurotol 2025 Feb 19 |
| 1 | Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma. (Banerjee R, Richards A, Midha S, Afrough A, Anwer F, Atanackovic D, Atrash S, Bachanova V, Beitinjaneh AM, Ouchveridze E, Castaneda Puglianini O, Chhabra S, Cicero KI, Davis JA, Dhakal B, Dima D, Ferreri CJ, Forsberg PA, Freeman CL, Herr MM, Jain T, Janakiram M, Khouri J, Kocoglu MH, Kumar AD, Liu Y, Locke FL, McGuirk JP, Mikkilineni L, Nadeem O, Parrondo RD, Pasvolsky O, Peres LC, Purvey S, Raza S, Reshef R, Richard S, Rossi AC, Sborov DW, Shune L, Wagner CB, Zanwar SS, Sidana S, Patel KK, Hansen DK, Kumar SK, Lin Y, Martin TG, Voorhees PM, Anderson LD Jr, Cowan AJ, Kaur G) Blood Adv 2025 Mar 15 |
| 1 | Electroconvulsive Therapy in a severely depressed, bipolar 1 disorder patient, who is a three-time liver transplant recipient due to primary sclerosing cholangitis (Ilic T, Steele I, McCarthy C) Journal of ECT |
| 2 | Real World Outcomes for Young Adult Patients Receiving CD19 CAR T-cell Therapy. (Lust H, Schultz LM, Kwon S, Roloff GW, Aldoss I, Baggott C, John S, Rossoff J, McNerney KO, Fabrizio VA, Talano JA, Moskop A, Curran KJ, Phillips CL, Karras NA, Baumeister SHC, Cooper S, Hermiston ML, Satwani P, Qayed M, Raikar SS, MacMillan ML, Hall EM, Nguyen K, Cassaday RD, Kopmar NE, Kota VK, Mathews J, Shaughnessy PJ, Schwartz MS, Ladha A, Yaghmour G, Kumaran M, Bachanova V, Tracy SI, Othman T, Luskin MR, Chen EC, Advani AS, Jeyakumar N, Miller K, Zhang A, Shah BD, Muffly LS, Faramand RG) Blood Adv 2025 Mar 24 |
| 1 | YIA25-001: Molecular Residual Disease (MRD) Guided Adjuvant Therapy In Renal Cell Carcinoma (RCC) - The MRD GATE RCC Study. (Basu A, Sidhom F, Hwang C, Ferguson J, Peyton C, Bae S, Kilari D, Desai A, Rais-Bahrami S) J Natl Compr Canc Netw 2025 Mar 28;23(3.5) |
| 1 | Immunomodulators for Steroid-Dependent Recurrent Acute Pancreatitis After Immune Checkpoint Inhibitor Therapy: A Case Series. (Peck H, Pagani W, Smith A, Madhavan S) ACG Case Rep J 2025 Apr;12(4):e01653 |
| 1 | Is CPAP the best therapy for all phenotypes of OSA? A case of complete epiglottic collapse treated with CPAP. (Hajihossainlou B, Kogan D, Woodson T) Sleep Med 2025 May;129:412-415 |
| 4 | Supporting Hematopoietic Stem Cell Transplant Family Caregivers: A Pilot Study of Nurse-Led Meaning-Centered Psychotherapy for Cancer Caregivers. (McAndrew NS, Wallace L, Guttormson J, McCracken C, Olex M, Banerjee A, Visotcky A, Bartowitz J, Seaman JB, Knight JM, Ferrell B, El-Jawahri A, Applebaum AJ) Psychooncology 2025 Apr;34(4):e70142 |
| 1 | Comparing durvalumab, olaparib, and cediranib monotherapy, combination therapy, or chemotherapy in patients with platinum-resistant ovarian cancer with prior bevacizumab: the phase II NRG-GY023 trial. (Lee JM, Miller A, Rose PG, AlHilli M, Washington C, John VS, Shah CA, Matsuo K, Siedel J, Miller DS, Hopp EE, O'Shea A, Chan JK, Bradford LS, Morse CB, Nagel CI, Rodabaugh KJ, Kohn EC, Moore KN, Liu JF) Clin Cancer Res 2025 Apr 07 |
| 1 | Establishing measurable residual disease trajectories for patients on treatment for newly diagnosed multiple myeloma as benchmark for deployment of T-cell redirection therapy. (Bal S, Magnusson T, Ravi G, Giri S, Godby K, Dhakal B, Callander NS, Silbermann RW, Dholaria B, Reddy VB, Costa LJ) Blood Cancer J 2025 Apr 23;15(1):73 |
| 1 | Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma. (Mohan M, Szabo A, Cheruvalath H, Clennon A, Bhatlapenumarthi V, Patwari A, Balev M, Bhutani D, Shrestha A, Thanendrarajan S, Dhakal B, Zangari M, Trikannad A, Vellanki S, Al-Hadidi S, Lentzsch S, van Rhee F, Bag A, D'Souza A, Shah N, Chakraborty R, Shah MR, Schinke C) Blood Cancer J 2025 Apr 23;15(1):74 |
| 2 | Quantification and Dosimetric Impact of Normal Organ Motion During Adaptive Radiation Therapy Planning Using a 1.5 Tesla Magnetic Resonance–Equipped Linear Accelerator (MR-Linac) (Wittmann D, Paulson ES, Banerjee A, Banla LI, Schultz C, Awan M, Chen X, Omari EA, Straza M, Li XA, Erickson B, Hall WA) Advances in Radiation Oncology May 2025;10(5) |
